CINXE.COM

<!DOCTYPE html><html lang="en"><head><meta charSet="utf-8"/><meta name="viewport" content="width=device-width"/><title>Cannabis News - Benzinga Cannabis</title><script type="application/ld+json">{ "@context": "http://schema.org", "@type": "WebPage", "publisher": {"@type":"Organization","logo":{"@type":"ImageObject","url":"/next-assets/images/schema-publisher-logo-benzinga.png"},"name":"Benzinga","url":"https://www.benzinga.com"}, "mainEntityOfPage": { "@type": "WebPage", "@id": "https://www.benzinga.com/cannabis" }, "mainEntity": "WebPage", "headline": "Cannabis News - Benzinga Cannabis", "url": "https://www.benzinga.com/cannabis", "dateCreated": "2023-03-10T09:19:44.000000Z", "datePublished": "2023-03-10T09:19:44.000000Z", "dateModified": "2010-01-01T00:00:00Z", "creator": { "@type": "Person", "name": "Benzinga" }, "author": { "@type": "Person", "name": "Benzinga" }, "description": "The latest cannabis news on Benzinga Cannabis. 30+ daily articles on cannabis stocks + hemp, CBD & psychedelics finance, business, politics and culture.", "keywords": [], "mentions": [], "image": "/next-assets/images/schema-image-default.png" }</script><script type="application/ld+json">{ "@context": "http://schema.org", "@type": "NewsMediaOrganization", "name": "Benzinga", "email": "info@benzinga.com", "legalName": "Benzinga", "telephone": "877-440-9464", "url": "https://www.benzinga.com/", "logo": "/next-assets/images/schema-publisher-logo-benzinga.png", "image": "/next-assets/images/schema-image-default.png", "address": { "@type": "PostalAddress", "addressLocality": "Detroit", "addressRegion": "MI", "postalCode": "48226", "streetAddress": "1 Campus Martius Suite 200", "addressCountry": "USA" }, "sameAs": [ "https://www.facebook.com/pages/Benzingacom/159483118580?v=app_7146470109", "https://twitter.com/benzinga", "https://www.linkedin.com/company/benzinga", "https://plus.google.com/108838891574408087738/posts", "https://www.youtube.com/user/BenzingaTV" ], "brand": [ { "@type": "Brand", "name": "Benzinga PreMarket Prep", "url": "https://www.benzinga.com/premarket" }, { "@type": "Brand", "name": "Benzinga Markets", "url": "https://www.benzinga.com/markets/" }, { "@type": "Brand", "name": "Benzinga Pro", "url": "https://pro.benzinga.com/" }, { "@type": "Brand", "name": "Benzinga Cloud: Data & APIs", "url": "https://www.benzinga.com/apis" }, { "@type": "Brand", "name": "Benzinga Events", "url": "https://www.benzinga.com/events" }, { "@type": "Brand", "name": "Benzinga Money", "url": "https://www.benzinga.com/money/" }, { "@type": "Brand", "name": "Benzinga Marketfy", "url": "https://marketfy.com/" } ] }</script><meta content="Copyright Benzinga. All rights reserved." name="copyright"/><meta content="The latest cannabis news on Benzinga Cannabis. 30+ daily articles on cannabis stocks + hemp, CBD & psychedelics finance, business, politics and culture." name="description"/><link href="https://www.benzinga.com/cannabis" rel="canonical"/><meta content="Benzinga" name="author"/><link color="#1177BA" href="/next-assets/images/safari-pinned-tab.svg" rel="mask-icon"/><link href="/next-assets/images/apple-touch-icon.png" rel="apple-touch-icon" sizes="180x180"/><link href="/next-assets/images/favicon-32x32.png" rel="icon" sizes="32x32" type="image/png"/><link href="/next-assets/images/favicon-16x16.png" rel="icon" sizes="16x16" type="image/png"/><link href="/next-assets/site.webmanifest" rel="manifest"/><link color="#5bbad5" href="/next-assets/images/safari-pinned-tab.svg" rel="mask-icon"/><meta content="#2d89ef" name="msapplication-TileColor"/><meta content="#ffffff" name="theme-color"/><meta content="159483118580" property="fb:app_id"/><link href="http://feeds.benzinga.com/benzinga" rel="alternate" title="Benzinga" type="application/rss+xml"/><meta content="https://www.benzinga.com/cannabis" name="syndication-source"/><meta content="summary" name="twitter:card"/><meta content="@benzinga" name="twitter:site"/><meta content="Cannabis News - Benzinga Cannabis" name="twitter:title"/><meta content="The latest cannabis news on Benzinga Cannabis. 30+ daily articles on cannabis stocks + hemp, CBD & psychedelics finance, business, politics and culture." name="twitter:description"/><meta content="Benzinga" property="og:site_name"/><meta content="https://www.benzinga.com/cannabis" property="og:url"/><meta content="Cannabis News - Benzinga Cannabis" property="og:title"/><meta content="website" property="og:type"/><meta content="The latest cannabis news on Benzinga Cannabis. 30+ daily articles on cannabis stocks + hemp, CBD & psychedelics finance, business, politics and culture." property="og:description"/><meta content="/next-assets/images/schema-image-default.png" property="og:image"/><meta content="image/jpeg" property="og:image:type"/><meta content="1200" property="og:image:width"/><meta content="630" property="og:image:height"/><meta content="app-id=688949481, app-argument=https://itunes.apple.com/us/app/id688949481" name="apple-itunes-app" property="Benzinga for iOS"/><meta content="yes" name="apple-mobile-web-app-capable"/><meta content="black" name="apple-mobile-web-app-status-bar-style"/><meta content="max-image-preview:large" name="robots"/><link href="/manifest.json" rel="manifest"/><meta content="648186192" property="fb:admins"/><meta content="B01B3489A33F83DDA4083E88C260097C" name="msvalidate.01"/><meta content="84f3b1552db5dfbe" name="y_key"/><meta content="101a0095-334d-4935-b87e-0e8fc771214e" name="fo-verify"/><meta content="English" name="language"/><script id="voice-search-schema" type="application/ld+json">{"@context":"https://schema.org/","@type":"WebPage","name":"Benzinga","speakable":{"@type":"SpeakableSpecification","xpath":["/html/head/title","/html/head/meta[@name='description']/@content"]},"url":"https://www.benzinga.com/"}</script><script id="sitelink-search-schema" type="application/ld+json">{"@context":"https://schema.org/","@type":"WebSite","name":"Benzinga","potentialAction":{"@type":"SearchAction","query-input":"required name=search_term_string","target":"https://www.benzinga.com/search/fast?cx={search_term_string}"},"url":"https://www.benzinga.com/","hasPart":{"@type":"WebPageElement","cssSelector":".paywall-content","isAccessibleForFree":false},"isAccessibleForFree":false}</script><script id="navigation-header-schema" type="application/ld+json">{"@context":"https://schema.org","@type":"SiteNavigationElement","Name":["Our Services","News","Markets","Options","Ratings","Ideas","Money","Crypto","Cannabis"],"Url":["https://www.benzinga.com/services","https://www.benzinga.com/news","https://www.benzinga.com/markets","https://www.benzinga.com/markets/options","https://www.benzinga.com/analyst-stock-ratings","https://www.benzinga.com/trading-ideas","https://www.benzinga.com/money","https://www.benzinga.com/crypto","https://www.benzinga.com/cannabis"]}</script><link as="image" href="https://cdn.benzinga.com/files/images/story/2024/11/26/High-Sicence-Thumbnail-2.jpeg?width=100" rel="preload"/><link as="image" href="https://cdn.benzinga.com/files/images/story/2024/11/26/High-Sicence-Thumbnail-2.jpeg?optimize=medium&dpr=2&auto=webp&width=630" rel="preload"/><link as="image" href="https://cdn.benzinga.com/files/images/story/2024/11/26/AI-Generated-Image_1.jpeg?optimize=medium&dpr=2&auto=webp&width=240" media="(min-width: 601px)" rel="preload"/><link as="image" href="https://cdn.benzinga.com/files/images/story/2024/11/26/Cannabis-Plant-With-Green-Leaves-And-Whi.jpeg?optimize=medium&dpr=2&auto=webp&width=240" media="(min-width: 601px)" rel="preload"/><link as="image" href="https://cdn.benzinga.com/files/images/story/2024/11/26/AI-Generated-Image_1.jpeg?width=100" rel="preload"/><link as="image" href="https://cdn.benzinga.com/files/images/story/2024/11/26/AI-Generated-Image_1.jpeg?optimize=medium&dpr=2&auto=webp&width=150" media="(max-width: 600px)" rel="preload"/><link as="image" href="https://cdn.benzinga.com/files/images/story/2024/11/26/Cannabis-Plant-With-Green-Leaves-And-Whi.jpeg?width=100" rel="preload"/><link as="image" href="https://cdn.benzinga.com/files/images/story/2024/11/26/Cannabis-Plant-With-Green-Leaves-And-Whi.jpeg?optimize=medium&dpr=2&auto=webp&width=150" media="(max-width: 600px)" rel="preload"/><link as="image" href="https://cdn.benzinga.com/files/images/story/2024/11/26/joe-biden-cannabis-liberty-adam-schultz-.jpeg?optimize=medium&dpr=2&auto=webp&width=150" media="(max-width: 600px)" rel="preload"/><link as="image" href="https://cdn.benzinga.com/files/images/story/2024/11/26/wesley-gibbs-NxRx7-mPdEk-unsplash.jpeg?optimize=medium&dpr=2&auto=webp&width=150" media="(max-width: 600px)" rel="preload"/><link as="image" href="https://cdn.benzinga.com/files/images/story/2024/11/26/joe-biden-cannabis-liberty-adam-schultz-.jpeg?width=100" rel="preload"/><link as="image" href="https://cdn.benzinga.com/files/images/story/2024/11/26/joe-biden-cannabis-liberty-adam-schultz-.jpeg?optimize=medium&dpr=2&auto=webp&width=260" rel="preload"/><link as="image" href="https://cdn.benzinga.com/files/images/story/2024/11/26/wesley-gibbs-NxRx7-mPdEk-unsplash.jpeg?width=100" rel="preload"/><link as="image" href="https://cdn.benzinga.com/files/images/story/2024/11/26/wesley-gibbs-NxRx7-mPdEk-unsplash.jpeg?optimize=medium&dpr=2&auto=webp&width=260" rel="preload"/><link as="image" href="https://cdn.benzinga.com/files/images/story/2024/11/26/2-12.png?width=100" rel="preload"/><link as="image" href="https://cdn.benzinga.com/files/images/story/2024/11/26/2-12.png?optimize=medium&dpr=2&auto=webp&width=260" rel="preload"/><link as="image" href="https://cdn.benzinga.com/files/images/story/2024/11/26/DEA-hearing.png?width=100" rel="preload"/><link as="image" href="https://cdn.benzinga.com/files/images/story/2024/11/26/DEA-hearing.png?optimize=medium&dpr=2&auto=webp&width=260" rel="preload"/><meta name="next-head-count" content="64"/><link as="font" crossorigin="anonymous" href="/next-assets/fonts/manrope-v15-latin/manrope-v15-latin-300.woff2" rel="preload" type="font/woff2"/><link as="font" crossorigin="anonymous" href="/next-assets/fonts/manrope-v15-latin/manrope-v15-latin-regular.woff2" rel="preload" type="font/woff2"/><link as="font" crossorigin="anonymous" href="/next-assets/fonts/manrope-v15-latin/manrope-v15-latin-500.woff2" rel="preload" type="font/woff2"/><link as="font" crossorigin="anonymous" href="/next-assets/fonts/manrope-v15-latin/manrope-v15-latin-600.woff2" rel="preload" type="font/woff2"/><link as="font" crossorigin="anonymous" href="/next-assets/fonts/manrope-v15-latin/manrope-v15-latin-700.woff2" rel="preload" type="font/woff2"/><link as="font" crossorigin="anonymous" href="/next-assets/fonts/manrope-v15-latin/manrope-v15-latin-800.woff2" rel="preload" type="font/woff2"/><link href="https://cdn.benzinga.com" rel="dns-prefetch"/><link href="https://cdn.segment.com" rel="preconnect"/><link href="https://www.googletagservices.com" rel="preconnect"/><link as="script" href="https://cdn.parsely.com/keys/benzinga.com/p.js" rel="preload"/><link as="script" href="https://www.google-analytics.com/analytics.js" rel="preload"/><style>:root, :host { --fa-font-solid: normal 900 1em/1 "Font Awesome 6 Solid"; --fa-font-regular: normal 400 1em/1 "Font Awesome 6 Regular"; --fa-font-light: normal 300 1em/1 "Font Awesome 6 Light"; --fa-font-thin: normal 100 1em/1 "Font Awesome 6 Thin"; --fa-font-duotone: normal 900 1em/1 "Font Awesome 6 Duotone"; --fa-font-sharp-solid: normal 900 1em/1 "Font Awesome 6 Sharp"; --fa-font-sharp-regular: normal 400 1em/1 "Font Awesome 6 Sharp"; --fa-font-sharp-light: normal 300 1em/1 "Font Awesome 6 Sharp"; --fa-font-sharp-thin: normal 100 1em/1 "Font Awesome 6 Sharp"; --fa-font-brands: normal 400 1em/1 "Font Awesome 6 Brands"; } svg:not(:root).svg-inline--fa, svg:not(:host).svg-inline--fa { overflow: visible; box-sizing: content-box; } .svg-inline--fa { display: var(--fa-display, inline-block); height: 1em; overflow: visible; vertical-align: -0.125em; } .svg-inline--fa.fa-2xs { vertical-align: 0.1em; } .svg-inline--fa.fa-xs { vertical-align: 0em; } .svg-inline--fa.fa-sm { vertical-align: -0.0714285705em; } .svg-inline--fa.fa-lg { vertical-align: -0.2em; } .svg-inline--fa.fa-xl { vertical-align: -0.25em; } .svg-inline--fa.fa-2xl { vertical-align: -0.3125em; } .svg-inline--fa.fa-pull-left { margin-right: var(--fa-pull-margin, 0.3em); width: auto; } .svg-inline--fa.fa-pull-right { margin-left: var(--fa-pull-margin, 0.3em); width: auto; } .svg-inline--fa.fa-li { width: var(--fa-li-width, 2em); top: 0.25em; } .svg-inline--fa.fa-fw { width: var(--fa-fw-width, 1.25em); } .fa-layers svg.svg-inline--fa { bottom: 0; left: 0; margin: auto; position: absolute; right: 0; top: 0; } .fa-layers-counter, .fa-layers-text { display: inline-block; position: absolute; text-align: center; } .fa-layers { display: inline-block; height: 1em; position: relative; text-align: center; vertical-align: -0.125em; width: 1em; } .fa-layers svg.svg-inline--fa { -webkit-transform-origin: center center; transform-origin: center center; } .fa-layers-text { left: 50%; top: 50%; -webkit-transform: translate(-50%, -50%); transform: translate(-50%, -50%); -webkit-transform-origin: center center; transform-origin: center center; } .fa-layers-counter { background-color: var(--fa-counter-background-color, #ff253a); border-radius: var(--fa-counter-border-radius, 1em); box-sizing: border-box; color: var(--fa-inverse, #fff); line-height: var(--fa-counter-line-height, 1); max-width: var(--fa-counter-max-width, 5em); min-width: var(--fa-counter-min-width, 1.5em); overflow: hidden; padding: var(--fa-counter-padding, 0.25em 0.5em); right: var(--fa-right, 0); text-overflow: ellipsis; top: var(--fa-top, 0); -webkit-transform: scale(var(--fa-counter-scale, 0.25)); transform: scale(var(--fa-counter-scale, 0.25)); -webkit-transform-origin: top right; transform-origin: top right; } .fa-layers-bottom-right { bottom: var(--fa-bottom, 0); right: var(--fa-right, 0); top: auto; -webkit-transform: scale(var(--fa-layers-scale, 0.25)); transform: scale(var(--fa-layers-scale, 0.25)); -webkit-transform-origin: bottom right; transform-origin: bottom right; } .fa-layers-bottom-left { bottom: var(--fa-bottom, 0); left: var(--fa-left, 0); right: auto; top: auto; -webkit-transform: scale(var(--fa-layers-scale, 0.25)); transform: scale(var(--fa-layers-scale, 0.25)); -webkit-transform-origin: bottom left; transform-origin: bottom left; } .fa-layers-top-right { top: var(--fa-top, 0); right: var(--fa-right, 0); -webkit-transform: scale(var(--fa-layers-scale, 0.25)); transform: scale(var(--fa-layers-scale, 0.25)); -webkit-transform-origin: top right; transform-origin: top right; } .fa-layers-top-left { left: var(--fa-left, 0); right: auto; top: var(--fa-top, 0); -webkit-transform: scale(var(--fa-layers-scale, 0.25)); transform: scale(var(--fa-layers-scale, 0.25)); -webkit-transform-origin: top left; transform-origin: top left; } .fa-1x { font-size: 1em; } .fa-2x { font-size: 2em; } .fa-3x { font-size: 3em; } .fa-4x { font-size: 4em; } .fa-5x { font-size: 5em; } .fa-6x { font-size: 6em; } .fa-7x { font-size: 7em; } .fa-8x { font-size: 8em; } .fa-9x { font-size: 9em; } .fa-10x { font-size: 10em; } .fa-2xs { font-size: 0.625em; line-height: 0.1em; vertical-align: 0.225em; } .fa-xs { font-size: 0.75em; line-height: 0.0833333337em; vertical-align: 0.125em; } .fa-sm { font-size: 0.875em; line-height: 0.0714285718em; vertical-align: 0.0535714295em; } .fa-lg { font-size: 1.25em; line-height: 0.05em; vertical-align: -0.075em; } .fa-xl { font-size: 1.5em; line-height: 0.0416666682em; vertical-align: -0.125em; } .fa-2xl { font-size: 2em; line-height: 0.03125em; vertical-align: -0.1875em; } .fa-fw { text-align: center; width: 1.25em; } .fa-ul { list-style-type: none; margin-left: var(--fa-li-margin, 2.5em); padding-left: 0; } .fa-ul > li { position: relative; } .fa-li { left: calc(var(--fa-li-width, 2em) * -1); position: absolute; text-align: center; width: var(--fa-li-width, 2em); line-height: inherit; } .fa-border { border-color: var(--fa-border-color, #eee); border-radius: var(--fa-border-radius, 0.1em); border-style: var(--fa-border-style, solid); border-width: var(--fa-border-width, 0.08em); padding: var(--fa-border-padding, 0.2em 0.25em 0.15em); } .fa-pull-left { float: left; margin-right: var(--fa-pull-margin, 0.3em); } .fa-pull-right { float: right; margin-left: var(--fa-pull-margin, 0.3em); } .fa-beat { -webkit-animation-name: fa-beat; animation-name: fa-beat; -webkit-animation-delay: var(--fa-animation-delay, 0s); animation-delay: var(--fa-animation-delay, 0s); -webkit-animation-direction: var(--fa-animation-direction, normal); animation-direction: var(--fa-animation-direction, normal); -webkit-animation-duration: var(--fa-animation-duration, 1s); animation-duration: var(--fa-animation-duration, 1s); -webkit-animation-iteration-count: var(--fa-animation-iteration-count, infinite); animation-iteration-count: var(--fa-animation-iteration-count, infinite); -webkit-animation-timing-function: var(--fa-animation-timing, ease-in-out); animation-timing-function: var(--fa-animation-timing, ease-in-out); } .fa-bounce { -webkit-animation-name: fa-bounce; animation-name: fa-bounce; -webkit-animation-delay: var(--fa-animation-delay, 0s); animation-delay: var(--fa-animation-delay, 0s); -webkit-animation-direction: var(--fa-animation-direction, normal); animation-direction: var(--fa-animation-direction, normal); -webkit-animation-duration: var(--fa-animation-duration, 1s); animation-duration: var(--fa-animation-duration, 1s); -webkit-animation-iteration-count: var(--fa-animation-iteration-count, infinite); animation-iteration-count: var(--fa-animation-iteration-count, infinite); -webkit-animation-timing-function: var(--fa-animation-timing, cubic-bezier(0.28, 0.84, 0.42, 1)); animation-timing-function: var(--fa-animation-timing, cubic-bezier(0.28, 0.84, 0.42, 1)); } .fa-fade { -webkit-animation-name: fa-fade; animation-name: fa-fade; -webkit-animation-delay: var(--fa-animation-delay, 0s); animation-delay: var(--fa-animation-delay, 0s); -webkit-animation-direction: var(--fa-animation-direction, normal); animation-direction: var(--fa-animation-direction, normal); -webkit-animation-duration: var(--fa-animation-duration, 1s); animation-duration: var(--fa-animation-duration, 1s); -webkit-animation-iteration-count: var(--fa-animation-iteration-count, infinite); animation-iteration-count: var(--fa-animation-iteration-count, infinite); -webkit-animation-timing-function: var(--fa-animation-timing, cubic-bezier(0.4, 0, 0.6, 1)); animation-timing-function: var(--fa-animation-timing, cubic-bezier(0.4, 0, 0.6, 1)); } .fa-beat-fade { -webkit-animation-name: fa-beat-fade; animation-name: fa-beat-fade; -webkit-animation-delay: var(--fa-animation-delay, 0s); animation-delay: var(--fa-animation-delay, 0s); -webkit-animation-direction: var(--fa-animation-direction, normal); animation-direction: var(--fa-animation-direction, normal); -webkit-animation-duration: var(--fa-animation-duration, 1s); animation-duration: var(--fa-animation-duration, 1s); -webkit-animation-iteration-count: var(--fa-animation-iteration-count, infinite); animation-iteration-count: var(--fa-animation-iteration-count, infinite); -webkit-animation-timing-function: var(--fa-animation-timing, cubic-bezier(0.4, 0, 0.6, 1)); animation-timing-function: var(--fa-animation-timing, cubic-bezier(0.4, 0, 0.6, 1)); } .fa-flip { -webkit-animation-name: fa-flip; animation-name: fa-flip; -webkit-animation-delay: var(--fa-animation-delay, 0s); animation-delay: var(--fa-animation-delay, 0s); -webkit-animation-direction: var(--fa-animation-direction, normal); animation-direction: var(--fa-animation-direction, normal); -webkit-animation-duration: var(--fa-animation-duration, 1s); animation-duration: var(--fa-animation-duration, 1s); -webkit-animation-iteration-count: var(--fa-animation-iteration-count, infinite); animation-iteration-count: var(--fa-animation-iteration-count, infinite); -webkit-animation-timing-function: var(--fa-animation-timing, ease-in-out); animation-timing-function: var(--fa-animation-timing, ease-in-out); } .fa-shake { -webkit-animation-name: fa-shake; animation-name: fa-shake; -webkit-animation-delay: var(--fa-animation-delay, 0s); animation-delay: var(--fa-animation-delay, 0s); -webkit-animation-direction: var(--fa-animation-direction, normal); animation-direction: var(--fa-animation-direction, normal); -webkit-animation-duration: var(--fa-animation-duration, 1s); animation-duration: var(--fa-animation-duration, 1s); -webkit-animation-iteration-count: var(--fa-animation-iteration-count, infinite); animation-iteration-count: var(--fa-animation-iteration-count, infinite); -webkit-animation-timing-function: var(--fa-animation-timing, linear); animation-timing-function: var(--fa-animation-timing, linear); } .fa-spin { -webkit-animation-name: fa-spin; animation-name: fa-spin; -webkit-animation-delay: var(--fa-animation-delay, 0s); animation-delay: var(--fa-animation-delay, 0s); -webkit-animation-direction: var(--fa-animation-direction, normal); animation-direction: var(--fa-animation-direction, normal); -webkit-animation-duration: var(--fa-animation-duration, 2s); animation-duration: var(--fa-animation-duration, 2s); -webkit-animation-iteration-count: var(--fa-animation-iteration-count, infinite); animation-iteration-count: var(--fa-animation-iteration-count, infinite); -webkit-animation-timing-function: var(--fa-animation-timing, linear); animation-timing-function: var(--fa-animation-timing, linear); } .fa-spin-reverse { --fa-animation-direction: reverse; } .fa-pulse, .fa-spin-pulse { -webkit-animation-name: fa-spin; animation-name: fa-spin; -webkit-animation-direction: var(--fa-animation-direction, normal); animation-direction: var(--fa-animation-direction, normal); -webkit-animation-duration: var(--fa-animation-duration, 1s); animation-duration: var(--fa-animation-duration, 1s); -webkit-animation-iteration-count: var(--fa-animation-iteration-count, infinite); animation-iteration-count: var(--fa-animation-iteration-count, infinite); -webkit-animation-timing-function: var(--fa-animation-timing, steps(8)); animation-timing-function: var(--fa-animation-timing, steps(8)); } @media (prefers-reduced-motion: reduce) { .fa-beat, .fa-bounce, .fa-fade, .fa-beat-fade, .fa-flip, .fa-pulse, .fa-shake, .fa-spin, .fa-spin-pulse { -webkit-animation-delay: -1ms; animation-delay: -1ms; -webkit-animation-duration: 1ms; animation-duration: 1ms; -webkit-animation-iteration-count: 1; animation-iteration-count: 1; -webkit-transition-delay: 0s; transition-delay: 0s; -webkit-transition-duration: 0s; transition-duration: 0s; } } @-webkit-keyframes fa-beat { 0%, 90% { -webkit-transform: scale(1); transform: scale(1); } 45% { -webkit-transform: scale(var(--fa-beat-scale, 1.25)); transform: scale(var(--fa-beat-scale, 1.25)); } } @keyframes fa-beat { 0%, 90% { -webkit-transform: scale(1); transform: scale(1); } 45% { -webkit-transform: scale(var(--fa-beat-scale, 1.25)); transform: scale(var(--fa-beat-scale, 1.25)); } } @-webkit-keyframes fa-bounce { 0% { -webkit-transform: scale(1, 1) translateY(0); transform: scale(1, 1) translateY(0); } 10% { -webkit-transform: scale(var(--fa-bounce-start-scale-x, 1.1), var(--fa-bounce-start-scale-y, 0.9)) translateY(0); transform: scale(var(--fa-bounce-start-scale-x, 1.1), var(--fa-bounce-start-scale-y, 0.9)) translateY(0); } 30% { -webkit-transform: scale(var(--fa-bounce-jump-scale-x, 0.9), var(--fa-bounce-jump-scale-y, 1.1)) translateY(var(--fa-bounce-height, -0.5em)); transform: scale(var(--fa-bounce-jump-scale-x, 0.9), var(--fa-bounce-jump-scale-y, 1.1)) translateY(var(--fa-bounce-height, -0.5em)); } 50% { -webkit-transform: scale(var(--fa-bounce-land-scale-x, 1.05), var(--fa-bounce-land-scale-y, 0.95)) translateY(0); transform: scale(var(--fa-bounce-land-scale-x, 1.05), var(--fa-bounce-land-scale-y, 0.95)) translateY(0); } 57% { -webkit-transform: scale(1, 1) translateY(var(--fa-bounce-rebound, -0.125em)); transform: scale(1, 1) translateY(var(--fa-bounce-rebound, -0.125em)); } 64% { -webkit-transform: scale(1, 1) translateY(0); transform: scale(1, 1) translateY(0); } 100% { -webkit-transform: scale(1, 1) translateY(0); transform: scale(1, 1) translateY(0); } } @keyframes fa-bounce { 0% { -webkit-transform: scale(1, 1) translateY(0); transform: scale(1, 1) translateY(0); } 10% { -webkit-transform: scale(var(--fa-bounce-start-scale-x, 1.1), var(--fa-bounce-start-scale-y, 0.9)) translateY(0); transform: scale(var(--fa-bounce-start-scale-x, 1.1), var(--fa-bounce-start-scale-y, 0.9)) translateY(0); } 30% { -webkit-transform: scale(var(--fa-bounce-jump-scale-x, 0.9), var(--fa-bounce-jump-scale-y, 1.1)) translateY(var(--fa-bounce-height, -0.5em)); transform: scale(var(--fa-bounce-jump-scale-x, 0.9), var(--fa-bounce-jump-scale-y, 1.1)) translateY(var(--fa-bounce-height, -0.5em)); } 50% { -webkit-transform: scale(var(--fa-bounce-land-scale-x, 1.05), var(--fa-bounce-land-scale-y, 0.95)) translateY(0); transform: scale(var(--fa-bounce-land-scale-x, 1.05), var(--fa-bounce-land-scale-y, 0.95)) translateY(0); } 57% { -webkit-transform: scale(1, 1) translateY(var(--fa-bounce-rebound, -0.125em)); transform: scale(1, 1) translateY(var(--fa-bounce-rebound, -0.125em)); } 64% { -webkit-transform: scale(1, 1) translateY(0); transform: scale(1, 1) translateY(0); } 100% { -webkit-transform: scale(1, 1) translateY(0); transform: scale(1, 1) translateY(0); } } @-webkit-keyframes fa-fade { 50% { opacity: var(--fa-fade-opacity, 0.4); } } @keyframes fa-fade { 50% { opacity: var(--fa-fade-opacity, 0.4); } } @-webkit-keyframes fa-beat-fade { 0%, 100% { opacity: var(--fa-beat-fade-opacity, 0.4); -webkit-transform: scale(1); transform: scale(1); } 50% { opacity: 1; -webkit-transform: scale(var(--fa-beat-fade-scale, 1.125)); transform: scale(var(--fa-beat-fade-scale, 1.125)); } } @keyframes fa-beat-fade { 0%, 100% { opacity: var(--fa-beat-fade-opacity, 0.4); -webkit-transform: scale(1); transform: scale(1); } 50% { opacity: 1; -webkit-transform: scale(var(--fa-beat-fade-scale, 1.125)); transform: scale(var(--fa-beat-fade-scale, 1.125)); } } @-webkit-keyframes fa-flip { 50% { -webkit-transform: rotate3d(var(--fa-flip-x, 0), var(--fa-flip-y, 1), var(--fa-flip-z, 0), var(--fa-flip-angle, -180deg)); transform: rotate3d(var(--fa-flip-x, 0), var(--fa-flip-y, 1), var(--fa-flip-z, 0), var(--fa-flip-angle, -180deg)); } } @keyframes fa-flip { 50% { -webkit-transform: rotate3d(var(--fa-flip-x, 0), var(--fa-flip-y, 1), var(--fa-flip-z, 0), var(--fa-flip-angle, -180deg)); transform: rotate3d(var(--fa-flip-x, 0), var(--fa-flip-y, 1), var(--fa-flip-z, 0), var(--fa-flip-angle, -180deg)); } } @-webkit-keyframes fa-shake { 0% { -webkit-transform: rotate(-15deg); transform: rotate(-15deg); } 4% { -webkit-transform: rotate(15deg); transform: rotate(15deg); } 8%, 24% { -webkit-transform: rotate(-18deg); transform: rotate(-18deg); } 12%, 28% { -webkit-transform: rotate(18deg); transform: rotate(18deg); } 16% { -webkit-transform: rotate(-22deg); transform: rotate(-22deg); } 20% { -webkit-transform: rotate(22deg); transform: rotate(22deg); } 32% { -webkit-transform: rotate(-12deg); transform: rotate(-12deg); } 36% { -webkit-transform: rotate(12deg); transform: rotate(12deg); } 40%, 100% { -webkit-transform: rotate(0deg); transform: rotate(0deg); } } @keyframes fa-shake { 0% { -webkit-transform: rotate(-15deg); transform: rotate(-15deg); } 4% { -webkit-transform: rotate(15deg); transform: rotate(15deg); } 8%, 24% { -webkit-transform: rotate(-18deg); transform: rotate(-18deg); } 12%, 28% { -webkit-transform: rotate(18deg); transform: rotate(18deg); } 16% { -webkit-transform: rotate(-22deg); transform: rotate(-22deg); } 20% { -webkit-transform: rotate(22deg); transform: rotate(22deg); } 32% { -webkit-transform: rotate(-12deg); transform: rotate(-12deg); } 36% { -webkit-transform: rotate(12deg); transform: rotate(12deg); } 40%, 100% { -webkit-transform: rotate(0deg); transform: rotate(0deg); } } @-webkit-keyframes fa-spin { 0% { -webkit-transform: rotate(0deg); transform: rotate(0deg); } 100% { -webkit-transform: rotate(360deg); transform: rotate(360deg); } } @keyframes fa-spin { 0% { -webkit-transform: rotate(0deg); transform: rotate(0deg); } 100% { -webkit-transform: rotate(360deg); transform: rotate(360deg); } } .fa-rotate-90 { -webkit-transform: rotate(90deg); transform: rotate(90deg); } .fa-rotate-180 { -webkit-transform: rotate(180deg); transform: rotate(180deg); } .fa-rotate-270 { -webkit-transform: rotate(270deg); transform: rotate(270deg); } .fa-flip-horizontal { -webkit-transform: scale(-1, 1); transform: scale(-1, 1); } .fa-flip-vertical { -webkit-transform: scale(1, -1); transform: scale(1, -1); } .fa-flip-both, .fa-flip-horizontal.fa-flip-vertical { -webkit-transform: scale(-1, -1); transform: scale(-1, -1); } .fa-rotate-by { -webkit-transform: rotate(var(--fa-rotate-angle, none)); transform: rotate(var(--fa-rotate-angle, none)); } .fa-stack { display: inline-block; vertical-align: middle; height: 2em; position: relative; width: 2.5em; } .fa-stack-1x, .fa-stack-2x { bottom: 0; left: 0; margin: auto; position: absolute; right: 0; top: 0; z-index: var(--fa-stack-z-index, auto); } .svg-inline--fa.fa-stack-1x { height: 1em; width: 1.25em; } .svg-inline--fa.fa-stack-2x { height: 2em; width: 2.5em; } .fa-inverse { color: var(--fa-inverse, #fff); } .sr-only, .fa-sr-only { position: absolute; width: 1px; height: 1px; padding: 0; margin: -1px; overflow: hidden; clip: rect(0, 0, 0, 0); white-space: nowrap; border-width: 0; } .sr-only-focusable:not(:focus), .fa-sr-only-focusable:not(:focus) { position: absolute; width: 1px; height: 1px; padding: 0; margin: -1px; overflow: hidden; clip: rect(0, 0, 0, 0); white-space: nowrap; border-width: 0; } .svg-inline--fa .fa-primary { fill: var(--fa-primary-color, currentColor); opacity: var(--fa-primary-opacity, 1); } .svg-inline--fa .fa-secondary { fill: var(--fa-secondary-color, currentColor); opacity: var(--fa-secondary-opacity, 0.4); } .svg-inline--fa.fa-swap-opacity .fa-primary { opacity: var(--fa-secondary-opacity, 0.4); } .svg-inline--fa.fa-swap-opacity .fa-secondary { opacity: var(--fa-primary-opacity, 1); } .svg-inline--fa mask .fa-primary, .svg-inline--fa mask .fa-secondary { fill: black; } .fad.fa-inverse, .fa-duotone.fa-inverse { color: var(--fa-inverse, #fff); }</style><script type="text/javascript">window.OneSignal = window.OneSignal || [];</script><script id="parsely" type="text/javascript" data-nscript="beforeInteractive">window.PARSELY = window.PARSELY || {}; window.PARSELY.use_localstorage = true;</script><link rel="preload" href="/_next/static/css/929a5001b1407f4c.css" as="style"/><link rel="stylesheet" href="/_next/static/css/929a5001b1407f4c.css" data-n-g=""/><noscript data-n-css=""></noscript><script defer="" nomodule="" src="/_next/static/chunks/polyfills-78c92fac7aa8fdd8.js"></script><script src="/_next/static/chunks/webpack-649d649e012ba0d3.js" defer=""></script><script src="/_next/static/chunks/framework-e6b7f5edbdf1e600.js" defer=""></script><script src="/_next/static/chunks/main-9d28f16cbee1375d.js" defer=""></script><script src="/_next/static/chunks/pages/_app-c4b030d904fd353d.js" defer=""></script><script src="/_next/static/chunks/97209-33e9c9fa12e49518.js" defer=""></script><script src="/_next/static/chunks/77302-76fb5f9431d1cf0e.js" defer=""></script><script src="/_next/static/chunks/56181-de58bfbe47344119.js" defer=""></script><script src="/_next/static/chunks/39879-e09a9a278717bc39.js" defer=""></script><script src="/_next/static/chunks/43157-aea3641b36ee4562.js" defer=""></script><script src="/_next/static/chunks/5677-df7bd716ab23e316.js" defer=""></script><script src="/_next/static/chunks/95012-12a836d891da43a3.js" defer=""></script><script src="/_next/static/chunks/56880-ae2e9c9afbee1470.js" defer=""></script><script src="/_next/static/chunks/88228-6b0b1f595a537e8d.js" defer=""></script><script src="/_next/static/chunks/pages/cannabis-f24ec5a5871e6015.js" defer=""></script><script src="/_next/static/WM8kbeRE-wCNojMmjQ6we/_buildManifest.js" defer=""></script><script src="/_next/static/WM8kbeRE-wCNojMmjQ6we/_ssgManifest.js" defer=""></script><style data-styled="" data-styled-version="6.1.8">.bz-featured-ad{position:relative;}/*!sc*/ .bz-featured-ad::after{position:absolute;content:'Featured Ad';padding:1px 10px;vertical-align:super;font-size:12px;display:inline-block;background:#f5f5f5;border-radius:16px;margin-left:3px;border:1px solid #cacaca;bottom:5px;left:inherit;}/*!sc*/ data-styled.g37[id="sc-global-jWNYke1"]{content:"sc-global-jWNYke1,"}/*!sc*/ .gTmJxW{font-size:2.6rem;line-height:3.25rem;font-weight:bold;}/*!sc*/ @media (max-width: 600px){.gTmJxW{font-size:1.5rem;line-height:1.9rem;font-weight:800;}}/*!sc*/ data-styled.g45[id="sc-cbDaos"]{content:"gTmJxW,"}/*!sc*/ .bBMOVF .layout-above .section-description{margin-bottom:1rem;}/*!sc*/ .bBMOVF .related-info-container{display:inline-flex;margin:0.5rem 0;}/*!sc*/ @media (min-width: 800px){.bBMOVF .has-left-sidebar .layout-sidebar{display:none;}}/*!sc*/ @media (min-width: 1100px){.bBMOVF .has-left-sidebar .layout-sidebar{display:block;}}/*!sc*/ @media (min-width: 800px){.bBMOVF .layout-flex{flex-direction:row;}}/*!sc*/ @media (max-width: 799px){.bBMOVF .layout-flex >div{width:100%;}}/*!sc*/ .bBMOVF .layout-header.full-width{padding:0;}/*!sc*/ .bBMOVF .layout-header.full-width .layout-container{max-width:100%;}/*!sc*/ .bBMOVF .layout-main{overflow-x:auto;width:100%;}/*!sc*/ @media (min-width: 1300px){.bBMOVF .layout-container{max-width:1300px;}}/*!sc*/ @media (max-width: 1300px){.bBMOVF .layout-container,.bBMOVF .layout-header{padding-left:0.25rem;padding-right:0.25rem;}.bBMOVF .layout-container.full-width .layout-container,.bBMOVF .layout-header.full-width .layout-container{padding:0;}}/*!sc*/ data-styled.g47[id="sc-iCKXBC"]{content:"bBMOVF,"}/*!sc*/ .cdHtnJ{margin-top:1rem;margin-bottom:1.5rem;}/*!sc*/ data-styled.g48[id="sc-egTsrv"]{content:"cdHtnJ,"}/*!sc*/ .dbntgF{width:300px;}/*!sc*/ @media (min-width: 800px){.dbntgF{margin-left:1rem;}}/*!sc*/ data-styled.g49[id="sc-cSxRuM"]{content:"dbntgF,"}/*!sc*/ .htSQUf .right{float:right;margin-left:1rem;}/*!sc*/ @media screen and (max-width: 648px){.htSQUf .right{max-width:150px;}}/*!sc*/ .htSQUf .left{float:left;margin-right:1rem;}/*!sc*/ .htSQUf >h1,.htSQUf >h2{margin-top:2rem;margin-bottom:1rem;color:#395173;}/*!sc*/ .htSQUf >h1{font-size:36px;}/*!sc*/ .htSQUf >h2{font-size:30px;}/*!sc*/ .htSQUf >h3{font-size:24px;margin:1rem 0px 0.5rem 0px;}/*!sc*/ .htSQUf >h4{margin:1rem 0px 0.5rem 0px;}/*!sc*/ .htSQUf >ul{list-style:disc;margin-left:2rem;margin-bottom:2rem;}/*!sc*/ .htSQUf >p{font-size:1.1rem;}/*!sc*/ .htSQUf a{color:#2ca2d1;}/*!sc*/ .htSQUf .alignright{float:right;margin-left:18px;}/*!sc*/ .htSQUf.image-wrapper{margin-bottom:1rem;}/*!sc*/ .htSQUf .wp-block-table{overflow-x:auto;}/*!sc*/ .htSQUf .wp-block-table table{margin:1rem 0;width:100%;}/*!sc*/ .htSQUf .wp-block-table table tbody{display:table;}/*!sc*/ .htSQUf .wp-block-table table tr:first-child{border-top:1px solid #d6d6d6;}/*!sc*/ .htSQUf .wp-block-table table tr:nth-child(odd){background:#f9f9f9;}/*!sc*/ .htSQUf .wp-block-table table td{border-bottom:1px solid #d6d6d6;padding:4px 8px;}/*!sc*/ .htSQUf .wp-block-quote{padding:0 1em;margin:0px 0px 2rem;line-height:1.6;color:#2d2d2d;border-left:2px solid #1e429f;font-style:italic;}/*!sc*/ data-styled.g52[id="sc-bCvmQg"]{content:"htSQUf,"}/*!sc*/ .iBQycf{display:table;}/*!sc*/ .iBQycf .image-caption{display:table-caption;caption-side:bottom;margin-top:0.5em;margin-bottom:1em;padding:0.4rem;border-radius:2px;background:#e6e6e6;border:1px solid #d6d6d6;width:100%;font-size:18px;font-weight:400;}/*!sc*/ .iBQycf .image-caption em{color:rgb(40, 61, 89);}/*!sc*/ data-styled.g53[id="sc-cPtzlb"]{content:"iBQycf,"}/*!sc*/ .soDJY .block{margin:1rem 0;}/*!sc*/ .soDJY .block:first-of-type{margin-top:0;}/*!sc*/ .soDJY .block:last-of-type{margin-bottom:0;}/*!sc*/ .soDJY .right{float:right;margin-left:0.5rem;}/*!sc*/ .soDJY .left{float:left;margin-right:0.5rem;}/*!sc*/ .soDJY .center{text-align:center;margin:auto;}/*!sc*/ .soDJY .center >figure,.soDJY .center >img,.soDJY .center >div{margin:auto;}/*!sc*/ .soDJY h1.core-block,.soDJY h2.core-block{margin-top:2rem;margin-bottom:1rem;}/*!sc*/ .soDJY h1.core-block{font-size:36px;}/*!sc*/ .soDJY h2.core-block{font-size:30px;color:#395173;}/*!sc*/ .soDJY h3.core-block{font-size:24px;margin:1rem 0px 0.5rem 0px;}/*!sc*/ .soDJY h4.core-block{margin:1rem 0px 0.5rem 0px;}/*!sc*/ .soDJY ul.core-block{list-style:disc;margin-left:2rem;margin-bottom:2rem;}/*!sc*/ .soDJY ul.core-block ul,.soDJY ul.core-block ol{margin-bottom:0;}/*!sc*/ .soDJY ol.core-block{list-style:decimal;margin-left:2rem;margin-bottom:2rem;}/*!sc*/ .soDJY ol.core-block li{margin-bottom:0.2rem;}/*!sc*/ .soDJY ol.core-block ul,.soDJY ol.core-block ol{margin-bottom:0;}/*!sc*/ .soDJY .wp-block-spacer{clear:both;}/*!sc*/ .soDJY p.core-block{font-size:1.1rem;}/*!sc*/ .soDJY .core-block a{color:#2ca2d1;}/*!sc*/ .soDJY .alignright{float:right;margin-left:18px;}/*!sc*/ .soDJY .image-wrapper{margin-bottom:1rem;}/*!sc*/ .soDJY .wp-block-table{overflow-x:auto;}/*!sc*/ .soDJY .wp-element-caption{border-bottom:1px solid #d6d6d6;border-top:1px solid #d6d6d6;background-color:#f4f4f4;font-size:14px;text-align:center;margin-top:-1rem;margin-bottom:1rem;}/*!sc*/ .soDJY table.core-block,.soDJY figure.core-block table,.soDJY figure.wp-block-table table{width:100%;}/*!sc*/ .soDJY table.core-block th,.soDJY figure.core-block table th,.soDJY figure.wp-block-table table th{background-color:#3f83f8;color:#ffffff;padding:4px 8px;font-size:14px;}/*!sc*/ .soDJY table.core-block tbody thead tr th,.soDJY figure.core-block table tbody thead tr th,.soDJY figure.wp-block-table table tbody thead tr th,.soDJY table.core-block tbody >tr:first-of-type th,.soDJY figure.core-block table tbody >tr:first-of-type th,.soDJY figure.wp-block-table table tbody >tr:first-of-type th{padding:4px 8px;font-size:14px;font-weight:600;}/*!sc*/ .soDJY table.core-block tbody tr:nth-child(even),.soDJY figure.core-block table tbody tr:nth-child(even),.soDJY figure.wp-block-table table tbody tr:nth-child(even){background:#f9f9f9;}/*!sc*/ .soDJY table.core-block tbody td,.soDJY figure.core-block table tbody td,.soDJY figure.wp-block-table table tbody td{padding:4px 8px;}/*!sc*/ .soDJY .blocks-gallery-grid,.soDJY .wp-block-gallery{display:flex;flex-wrap:wrap;list-style-type:none;padding:0;margin:0;}/*!sc*/ .soDJY .blocks-gallery-grid .blocks-gallery-item,.soDJY .wp-block-gallery .blocks-gallery-item{margin:0 1em 1em 0;display:flex;flex-grow:1;flex-direction:column;justify-content:center;position:relative;width:calc(50% - 1em);}/*!sc*/ .soDJY .blocks-gallery-grid .blocks-gallery-item img,.soDJY .wp-block-gallery .blocks-gallery-item img{display:block;max-width:100%;}/*!sc*/ .soDJY .blocks-gallery-grid .blocks-gallery-item figure,.soDJY .wp-block-gallery .blocks-gallery-item figure{display:flex;align-items:flex-end;justify-content:flex-start;}/*!sc*/ @media (min-width: 600px){.soDJY .blocks-gallery-grid.columns-3 .blocks-gallery-grid .blocks-gallery-item,.soDJY .wp-block-gallery.columns-3 .blocks-gallery-grid .blocks-gallery-item{width:calc(32% - 0.66667em);margin-right:1em;}}/*!sc*/ .soDJY .wp-block-quote{padding:0 1em;margin:0px 0px 2rem;line-height:1.6;color:#2d2d2d;border-left:2px solid #1e429f;font-style:italic;}/*!sc*/ .soDJY >div >img,.soDJY >div >figure{max-width:100%;}/*!sc*/ .soDJY >div >table,.soDJY >div >figure table,.soDJY >div .core-block-table-wrapper table{margin:1rem 0;width:100%;max-width:100%;}/*!sc*/ .soDJY >div >table th,.soDJY >div >figure table th,.soDJY >div .core-block-table-wrapper table th{background-color:#3f83f8;color:#ffffff;padding:4px 8px;text-align:left;}/*!sc*/ .soDJY >div >table tbody thead tr th,.soDJY >div >figure table tbody thead tr th,.soDJY >div .core-block-table-wrapper table tbody thead tr th,.soDJY >div >table tbody >tr:first-of-type th,.soDJY >div >figure table tbody >tr:first-of-type th,.soDJY >div .core-block-table-wrapper table tbody >tr:first-of-type th{padding:4px 8px;font-size:14px;}/*!sc*/ .soDJY >div >table tbody tr:nth-child(even),.soDJY >div >figure table tbody tr:nth-child(even),.soDJY >div .core-block-table-wrapper table tbody tr:nth-child(even){background:#f9f9f9;}/*!sc*/ .soDJY >div >table tbody td,.soDJY >div >figure table tbody td,.soDJY >div .core-block-table-wrapper table tbody td{padding:4px 8px;font-size:14px;}/*!sc*/ .soDJY >div >h1,.soDJY >div >h2{margin-top:2rem;margin-bottom:1rem;}/*!sc*/ .soDJY >div >h1{font-size:36px;}/*!sc*/ .soDJY >div >h2{font-size:30px;color:#395173;}/*!sc*/ .soDJY >div >h3{font-size:24px;margin:1rem 0px 0.5rem 0px;}/*!sc*/ .soDJY >div >h4{margin:1rem 0px 0.5rem 0px;}/*!sc*/ .soDJY >div >ul{list-style:disc;margin-left:2rem;margin-bottom:2rem;}/*!sc*/ .soDJY >div >ol{list-style:decimal;margin-left:2rem;margin-bottom:2rem;}/*!sc*/ .soDJY >div >ol li{margin-bottom:0.2rem;}/*!sc*/ .soDJY >div >p{font-size:1.1rem;}/*!sc*/ .soDJY >div a{color:#2ca2d1;}/*!sc*/ .soDJY .bz-campaign hr{background:#5294c1;border:0;height:1px;margin-bottom:26px;padding:0;}/*!sc*/ data-styled.g54[id="sc-BCDEK"]{content:"soDJY,"}/*!sc*/ .giYyj{font-size:14px;color:#192940;font-weight:600;display:inline-flex;text-decoration:none;align-items:center;justify-content:center;line-height:1rem;background:#ffffff;box-shadow:0 1px 2px 0 rgba(0, 0, 0, 0.05);border:solid 1px #E1EBFA;border-radius:4px;padding-top:0.5rem;padding-bottom:0.5rem;padding-left:0.75rem;padding-right:0.75rem;transition:0.25s background-color ease-in-out,0.25s color ease-in-out,0.25s border-color ease-in-out;}/*!sc*/ .giYyj >span{display:contents;}/*!sc*/ .giYyj.sm{padding-left:0.35rem;padding-right:0.35rem;width:auto;height:24px;font-size:0.75rem;border-radius:0.25rem;}/*!sc*/ .giYyj.lg{height:56px;padding:1rem 2.5rem;font-weight:700;font-size:1rem;line-height:1.25rem;}/*!sc*/ .giYyj.fusion-md{height:40px;padding:0 1rem;font-weight:700;flex-shrink:0;}/*!sc*/ .giYyj:focus{outline:none;}/*!sc*/ .giYyj.danger{color:#c81e1e;border:solid 1px #f98080;background:#fdf2f2;}/*!sc*/ .giYyj.danger:hover{background:#fde8e8;}/*!sc*/ .giYyj.flat{color:#395173;border:solid 1px #E1EBFA;background:transparent;}/*!sc*/ .giYyj.danger-filled{color:#ffffff;border:solid 1px #e02424;background:#e02424;}/*!sc*/ .giYyj.danger-filled:hover{background:#f05252;}/*!sc*/ .giYyj.primary{color:#1a56db;border:solid 1px #3f83f8;background:#c3ddfd;}/*!sc*/ .giYyj.primary:hover{background:#a4cafe;}/*!sc*/ .giYyj.success-filled{color:#ffffff;border:solid 1px #0e9f6e;background:#0e9f6e;}/*!sc*/ .giYyj.success-filled:hover{background:#31c48d;}/*!sc*/ .giYyj.success{color:#046c4e;border:solid 1px #0e9f6e;background:#bcf0da;}/*!sc*/ .giYyj.success:hover{background:#84e1bc;}/*!sc*/ .giYyj.warning{color:#b43403;border:solid 1px #ff5a1f;background:#fcd9bd;}/*!sc*/ .giYyj.warning:hover{background:#fdba8c;}/*!sc*/ .giYyj.full{width:100%;display:inherit;}/*!sc*/ .giYyj.full span{width:100%;text-align:center;}/*!sc*/ .giYyj.cta{background-color:#002d45;color:#ffffff;height:2.5rem;letter-spacing:0.1em;text-transform:uppercase;width:100%;}/*!sc*/ .giYyj.cta:hover{background-color:rgb(217, 105, 0);box-shadow:0 4px 6px -1px rgba(0, 0, 0, 0.1),0 2px 4px -1px rgba(0, 0, 0, 0.06);position:relative;bottom:2px;}/*!sc*/ .giYyj.flat-orange{color:#ffffff;border:solid 1px #ff5a1f;background:#ff5a1f;}/*!sc*/ .giYyj.flat-orange:hover{background:#d03801;}/*!sc*/ .giYyj.flat-black{color:#ffffff;border:solid 1px #000000;background:#000000;transition:0.2s;}/*!sc*/ .giYyj.flat-black:hover{background:#ffffff;color:#000000;}/*!sc*/ .giYyj.flat-gray{color:#ffffff;border:solid 1px #5B7292;background:#5B7292;transition:0.2s;}/*!sc*/ .giYyj.flat-gray:hover{background:#ffffff;color:#000000;}/*!sc*/ .giYyj.light-gray{color:#000000;border:solid 1px #CEDDF2;background:#CEDDF2;transition:0.2s;}/*!sc*/ .giYyj.light-gray:hover{background:#B8CBE6;color:#000000;}/*!sc*/ .giYyj.flat-blue{color:#ffffff;border:solid 1px #3f83f8;background:#3f83f8;}/*!sc*/ .giYyj.flat-blue:hover{background:#1c64f2;}/*!sc*/ .giYyj.dark-blue{color:#ffffff;border:solid 1px #233876;background:#233876;}/*!sc*/ .giYyj.dark-blue:hover{background:#1e429f;}/*!sc*/ .giYyj.flat-light-blue{color:#3f83f8;border:solid 1px #e1effe;background:#e1effe;}/*!sc*/ .giYyj.flat-light-blue:hover{background:#c3ddfd;}/*!sc*/ .giYyj.flat-light-blue-outlined{color:#3f83f8;border:solid 1px #CEDDF2;background:#e1effe;box-shadow:unset;}/*!sc*/ .giYyj.flat-light-blue-outlined:hover{background:#c3ddfd;}/*!sc*/ .giYyj.flat-red{color:#ffffff;border:solid 1px #f05252;background:#f05252;}/*!sc*/ .giYyj.flat-red:hover{background:#e02424;}/*!sc*/ .giYyj.flat-ind-blue{color:#ffffff;border:solid 1px #24344F;background:#24344F;}/*!sc*/ .giYyj.flat-ind-blue:hover{background:#24344F;}/*!sc*/ .giYyj.white-outline{background:rgba(26, 121, 255, 0.05);border:1px solid #ffffff;color:#ffffff;}/*!sc*/ .giYyj.white-outline:hover{background:rgba(210, 210, 210, 0.1);}/*!sc*/ .giYyj.fusion-outline{background:rgba(26, 121, 255, 0.05);border:1px solid rgba(26, 121, 255, 0.75);color:#3f83f8;}/*!sc*/ .giYyj.fusion-outline:hover{background:rgba(26, 121, 255, 0.1);}/*!sc*/ .giYyj.fusion-secondary{background:#E1EBFA;border:0;color:#3f83f8;}/*!sc*/ .giYyj.fusion-secondary:hover{background:rgba(26, 121, 255, 0.1);}/*!sc*/ .giYyj.fusion-white{background:#ffffff;color:#3f83f8;border:none;}/*!sc*/ .giYyj.fusion-white:hover{background:#3f83f8;color:#ffffff;}/*!sc*/ data-styled.g55[id="sc-kiTBBF"]{content:"giYyj,"}/*!sc*/ .gxvcdh{background:url(https://cdn.benzinga.com/files/images/story/2024/11/26/High-Sicence-Thumbnail-2.jpeg?width=100);position:absolute;width:100%;height:100%;background-repeat:no-repeat;background-size:cover;filter:blur(20px);}/*!sc*/ .hnOfzG{background:url(https://cdn.benzinga.com/files/images/story/2024/11/26/AI-Generated-Image_1.jpeg?width=100);position:absolute;width:100%;height:100%;background-repeat:no-repeat;background-size:cover;filter:blur(20px);}/*!sc*/ .jwDqcY{background:url(https://cdn.benzinga.com/files/images/story/2024/11/26/Cannabis-Plant-With-Green-Leaves-And-Whi.jpeg?width=100);position:absolute;width:100%;height:100%;background-repeat:no-repeat;background-size:cover;filter:blur(20px);}/*!sc*/ .joEPHQ{background:url(https://cdn.benzinga.com/files/images/story/2024/11/26/joe-biden-cannabis-liberty-adam-schultz-.jpeg?width=100);position:absolute;width:100%;height:100%;background-repeat:no-repeat;background-size:cover;filter:blur(20px);}/*!sc*/ .kynSFO{background:url(https://cdn.benzinga.com/files/images/story/2024/11/26/wesley-gibbs-NxRx7-mPdEk-unsplash.jpeg?width=100);position:absolute;width:100%;height:100%;background-repeat:no-repeat;background-size:cover;filter:blur(20px);}/*!sc*/ .dSuRQF{background:url(https://cdn.benzinga.com/files/images/story/2024/11/26/2-12.png?width=100);position:absolute;width:100%;height:100%;background-repeat:no-repeat;background-size:cover;filter:blur(20px);}/*!sc*/ .bzLEga{background:url(https://cdn.benzinga.com/files/images/story/2024/11/26/DEA-hearing.png?width=100);position:absolute;width:100%;height:100%;background-repeat:no-repeat;background-size:cover;filter:blur(20px);}/*!sc*/ data-styled.g63[id="sc-ppzwM"]{content:"gxvcdh,hnOfzG,jwDqcY,joEPHQ,kynSFO,dSuRQF,bzLEga,"}/*!sc*/ .hSWwyX.benzinga-logo{display:inline-block;}/*!sc*/ .hSWwyX.benzinga-logo.desktop{width:192px;min-width:192px;max-width:192px;}/*!sc*/ .hSWwyX.benzinga-logo img,.hSWwyX.benzinga-logo svg{width:100%;height:100%;}/*!sc*/ data-styled.g64[id="sc-hiTDLB"]{content:"hSWwyX,"}/*!sc*/ .gTjEzu{margin-top:0;padding-top:10px;font-size:12px;line-height:21px;text-decoration:none;}/*!sc*/ data-styled.g65[id="sc-ejCKsa"]{content:"gTjEzu,"}/*!sc*/ .gHhitR{transition:color 0.2s cubic-bezier(0.25, 0.46, 0.45, 0.94),color 0.2s ease;text-decoration:none;}/*!sc*/ data-styled.g66[id="sc-ldgOGP"]{content:"gHhitR,"}/*!sc*/ .ggmtMZ{display:flex;justify-content:center;align-items:center;width:40px;height:40px;border-radius:0.25rem;font-size:30px;color:#ffffff;-webkit-transition:color 200ms cubic-bezier(0.25, 0.46, 0.45, 0.94),color 200ms ease;transition:color 200ms cubic-bezier(0.25, 0.46, 0.45, 0.94),color 200ms ease;}/*!sc*/ .ggmtMZ:hover{color:#3b5998;}/*!sc*/ .ggmtMZ svg{fill:#ffffff;}/*!sc*/ .efaIqf{display:flex;justify-content:center;align-items:center;width:40px;height:40px;border-radius:0.25rem;font-size:30px;color:#ffffff;-webkit-transition:color 200ms cubic-bezier(0.25, 0.46, 0.45, 0.94),color 200ms ease;transition:color 200ms cubic-bezier(0.25, 0.46, 0.45, 0.94),color 200ms ease;}/*!sc*/ .efaIqf:hover{color:#e1306c;}/*!sc*/ .efaIqf svg{fill:#ffffff;}/*!sc*/ .hErREj{display:flex;justify-content:center;align-items:center;width:40px;height:40px;border-radius:0.25rem;font-size:30px;color:#ffffff;-webkit-transition:color 200ms cubic-bezier(0.25, 0.46, 0.45, 0.94),color 200ms ease;transition:color 200ms cubic-bezier(0.25, 0.46, 0.45, 0.94),color 200ms ease;}/*!sc*/ .hErREj:hover{color:#0072b1;}/*!sc*/ .hErREj svg{fill:#ffffff;}/*!sc*/ .cwvTpL{display:flex;justify-content:center;align-items:center;width:40px;height:40px;border-radius:0.25rem;font-size:30px;color:#ffffff;-webkit-transition:color 200ms cubic-bezier(0.25, 0.46, 0.45, 0.94),color 200ms ease;transition:color 200ms cubic-bezier(0.25, 0.46, 0.45, 0.94),color 200ms ease;}/*!sc*/ .cwvTpL:hover{color:#fe5000;}/*!sc*/ .cwvTpL svg{fill:#ffffff;}/*!sc*/ .cwwMnJ{display:flex;justify-content:center;align-items:center;width:40px;height:40px;border-radius:0.25rem;font-size:30px;color:#ffffff;-webkit-transition:color 200ms cubic-bezier(0.25, 0.46, 0.45, 0.94),color 200ms ease;transition:color 200ms cubic-bezier(0.25, 0.46, 0.45, 0.94),color 200ms ease;}/*!sc*/ .cwwMnJ:hover{color:#000000;}/*!sc*/ .cwwMnJ svg{fill:#ffffff;}/*!sc*/ .ikwCNR{display:flex;justify-content:center;align-items:center;width:40px;height:40px;border-radius:0.25rem;font-size:30px;color:#ffffff;-webkit-transition:color 200ms cubic-bezier(0.25, 0.46, 0.45, 0.94),color 200ms ease;transition:color 200ms cubic-bezier(0.25, 0.46, 0.45, 0.94),color 200ms ease;}/*!sc*/ .ikwCNR:hover{color:red;}/*!sc*/ .ikwCNR svg{fill:#ffffff;}/*!sc*/ data-styled.g67[id="sc-gHWSBU"]{content:"ggmtMZ,efaIqf,hErREj,cwvTpL,cwwMnJ,ikwCNR,"}/*!sc*/ .cIhrRX.button-wrapper{border-radius:6px;overflow:hidden;background-color:#ffffff;display:flex;align-items:center;justify-content:center;padding:5px;min-width:140px;-webkit-transition:all 200ms ease;transition:all 200ms ease;height:50px;box-sizing:border-box;}/*!sc*/ .cIhrRX.button-wrapper:hover{background-color:#CEDDF2;}/*!sc*/ data-styled.g68[id="sc-cmfnrN"]{content:"cIhrRX,"}/*!sc*/ .hMLEoT.footer-row{display:grid;grid-auto-flow:column;grid-gap:20px;width:100%;padding-top:0.5rem;padding-bottom:2rem;padding-left:1rem;padding-right:1rem;margin-left:auto;margin-right:auto;}/*!sc*/ @media screen and (min-width: 480px){.hMLEoT.footer-row{max-width:480px;}}/*!sc*/ @media screen and (min-width: 768px){.hMLEoT.footer-row{padding-left:4rem;padding-right:4rem;max-width:100%;grid-gap:30px;}}/*!sc*/ @media screen and (max-width: 1000px){.hMLEoT.footer-row{grid-auto-flow:row;grid-template-columns:repeat(auto-fill, minmax(200px, 1fr));}}/*!sc*/ data-styled.g70[id="sc-EFWon"]{content:"hMLEoT,"}/*!sc*/ .cbhZCu{display:flex;flex-direction:column;text-align:left;}/*!sc*/ .cbhZCu h3{display:flex;color:#ffffff;font-size:18px;font-weight:600;margin:0;}/*!sc*/ @media screen and (min-width: 480px){.cbhZCu h3{margin-top:0;}}/*!sc*/ @media screen and (min-width: 768px){.cbhZCu h3{font-size:16px;margin-top:2rem;}}/*!sc*/ .cbhZCu ul{list-style:none;padding:0;}/*!sc*/ .cbhZCu ul li{font-size:16px;}/*!sc*/ @media screen and (min-width: 768px){.cbhZCu ul li{font-size:14px;}}/*!sc*/ .cbhZCu ul li >a{color:#CEDDF2;}/*!sc*/ .cbhZCu ul li >a:hover{color:#ffffff;}/*!sc*/ data-styled.g71[id="sc-fYlSAf"]{content:"cbhZCu,"}/*!sc*/ .PtwYC{display:flex;align-items:center;margin:0 4px;padding-right:0px;width:192px;min-width:144px;}/*!sc*/ .PtwYC .benzinga-crypto-logo-wrapper{margin-bottom:-1px;}/*!sc*/ .PtwYC >a{display:inline-flex;}/*!sc*/ data-styled.g76[id="sc-jPQKUW"]{content:"PtwYC,"}/*!sc*/ .hIXnUa{display:flex;position:relative;width:100%;padding-left:unset;}/*!sc*/ .hIXnUa .search-icon{align-items:center;color:#378aff;display:flex;height:44px;justify-content:center;width:44px;}/*!sc*/ .hIXnUa .cancel-button{font-size:1.2rem;padding:0 10px;color:#378aff;}/*!sc*/ .hIXnUa .search-button{border-radius:0;width:50px;}/*!sc*/ .hIXnUa input{background-color:transparent;border-width:0;outline:none;width:100%;font-weight:bold;font-size:16px;}/*!sc*/ data-styled.g83[id="sc-cZpZpK"]{content:"hIXnUa,"}/*!sc*/ .hffEc{position:relative;width:100%;}/*!sc*/ data-styled.g85[id="sc-jPpdYo"]{content:"hffEc,"}/*!sc*/ .bdnXYZ.searchbar-wrapper{box-shadow:0px 0px 2px 0 rgb(0 0 0 / 15%);background:#ffffff;padding:4px 12px;padding-right:10px;flex-grow:1;max-width:290px;position:relative;max-width:none;}/*!sc*/ @media screen and (max-width: 800px){.bdnXYZ.searchbar-wrapper{max-width:none;}}/*!sc*/ .bdnXYZ.searchbar-wrapper a{text-decoration:none;}/*!sc*/ .bdnXYZ.searchbar-wrapper.searchbar-box,.bdnXYZ.searchbar-wrapper.searchbar-inline{padding:0;border:solid 1px #E1EBFA;box-shadow:none;}/*!sc*/ .bdnXYZ.searchbar-wrapper.searchbar-box .search-results-wrapper,.bdnXYZ.searchbar-wrapper.searchbar-inline .search-results-wrapper{padding:0;}/*!sc*/ .bdnXYZ.searchbar-wrapper.searchbar-box .search-result-wrapper,.bdnXYZ.searchbar-wrapper.searchbar-inline .search-result-wrapper{padding:0;}/*!sc*/ .bdnXYZ.searchbar-wrapper.searchbar-box .search-icon,.bdnXYZ.searchbar-wrapper.searchbar-inline .search-icon{height:36px;}/*!sc*/ .bdnXYZ.searchbar-wrapper.searchbar-box input ::placeholder,.bdnXYZ.searchbar-wrapper.searchbar-inline input ::placeholder{color:#99AECC;}/*!sc*/ .bdnXYZ.searchbar-wrapper.searchbar-inline{box-shadow:none;}/*!sc*/ .bdnXYZ.searchbar-wrapper.searchbar-inline .search-dropdown{position:relative;box-shadow:none;border:none;}/*!sc*/ .bdnXYZ.searchbar-wrapper input:focus{box-shadow:none;}/*!sc*/ .bdnXYZ.searchbar-wrapper input ::placeholder{color:#395173;}/*!sc*/ data-styled.g97[id="sc-fGrmBj"]{content:"bdnXYZ,"}/*!sc*/ .jdorvA{align-items:center;display:flex;justify-content:space-between;}/*!sc*/ data-styled.g98[id="sc-dsAqUS"]{content:"jdorvA,"}/*!sc*/ .cIdFlt{color:#CEDDF2;font-weight:600;font-size:14px;line-height:20px;}/*!sc*/ data-styled.g99[id="sc-dmcoYd"]{content:"cIdFlt,"}/*!sc*/ .hfIiBn{color:#ffffff;font-size:12px;line-height:16px;}/*!sc*/ data-styled.g100[id="sc-YltrM"]{content:"hfIiBn,"}/*!sc*/ .kruvvw{color:#f05252;font-weight:700;display:flex;align-items:center;}/*!sc*/ .kruvvw .quote-icon{margin:0 4px;font-size:12px;}/*!sc*/ .gUNJVP{color:#0e9f6e;font-weight:700;display:flex;align-items:center;}/*!sc*/ .gUNJVP .quote-icon{margin:0 4px;font-size:12px;}/*!sc*/ data-styled.g101[id="sc-imiRDh"]{content:"kruvvw,gUNJVP,"}/*!sc*/ .dPuOYX{display:block;width:100%;max-width:145px;min-width:132px;padding:8px;background:linear-gradient(90deg, #f0525200 0%, #f052520d 100%);}/*!sc*/ .dPuOYX .dark{color:#99AECC!important;}/*!sc*/ .dPuOYX .light{color:#395173!important;}/*!sc*/ .eDEUMb{display:block;width:100%;max-width:145px;min-width:132px;padding:8px;background:linear-gradient(90deg, #0e9f6e00 0%, #0e9f6e0d 100%);}/*!sc*/ .eDEUMb .dark{color:#99AECC!important;}/*!sc*/ .eDEUMb .light{color:#395173!important;}/*!sc*/ data-styled.g102[id="sc-vIyEI"]{content:"dPuOYX,eDEUMb,"}/*!sc*/ .jSzLBk{display:flex;flex-grow:1;height:52px;}/*!sc*/ data-styled.g103[id="sc-bjUHJT"]{content:"jSzLBk,"}/*!sc*/ .kgifvw{position:relative;overflow:hidden;white-space:nowrap;}/*!sc*/ .kgifvw::before{animation:cUwltg 5s ease-in-out infinite;content:'';position:absolute;top:0;width:100%;height:100%;background:linear-gradient(120deg, transparent, rgba(255, 255, 255, 0.2), transparent);}/*!sc*/ data-styled.g104[id="sc-eIPYkq"]{content:"kgifvw,"}/*!sc*/ .juPIzz{line-height:48px;padding:0 10px;font-family:Manrope,Manrope-fallback,sans-serif;font-weight:bold;font-size:14px;color:#000000;height:100%;display:inline-flex;align-items:center;justify-content:center;}/*!sc*/ .juPIzz:hover{background-color:#e1effe;color:unset;}/*!sc*/ .juPIzz.trading-school{color:#298ccd!important;}/*!sc*/ @media screen and (min-width: 1292px){.juPIzz.trading-school svg{display:none;}}/*!sc*/ @media screen and (max-width: 800px){.juPIzz{color:white;width:100%;text-align:left;display:inline-flex;justify-content:start;}.juPIzz:hover{background-color:inherit;}}/*!sc*/ data-styled.g105[id="sc-hBgdUx"]{content:"juPIzz,"}/*!sc*/ .drA-dBo{line-height:2em;}/*!sc*/ .drA-dBo a{color:black;}/*!sc*/ .drA-dBo a:hover{color:#1a56db;}/*!sc*/ data-styled.g106[id="sc-labuuU"]{content:"drA-dBo,"}/*!sc*/ .gBYoJd{line-height:2em;}/*!sc*/ .gBYoJd a{display:block;padding:6px 12px;line-height:1.4rem;}/*!sc*/ .gBYoJd:hover{color:#1a79ff;}/*!sc*/ .gBYoJd.highlight{padding:0 5px;margin-bottom:5px;}/*!sc*/ .gBYoJd.highlight a{color:#ffffff;background-color:unset;font-weight:unset;text-align:center;}/*!sc*/ .gBYoJd.highlight:hover{color:unset;}/*!sc*/ .bFLWIV{line-height:2em;}/*!sc*/ .bFLWIV a{display:block;padding:6px 12px;line-height:1.4rem;}/*!sc*/ .bFLWIV:hover{color:#1a79ff;}/*!sc*/ .bFLWIV.highlight{padding:0 5px;margin-bottom:5px;}/*!sc*/ .bFLWIV.highlight a{color:#ffffff;background-color:#63bc47;font-weight:600;text-align:center;}/*!sc*/ .bFLWIV.highlight:hover{color:#ffffff;}/*!sc*/ data-styled.g107[id="sc-yRUbj"]{content:"gBYoJd,bFLWIV,"}/*!sc*/ .byUlBP{display:grid;gap:8px;grid-template-columns:repeat(2, minmax(0px, 1fr));}/*!sc*/ data-styled.g108[id="sc-dXNkBG"]{content:"byUlBP,"}/*!sc*/ .bzULrg{border-bottom:1px solid #B8CBE6;color:#395173;font-weight:bold;margin-top:4px;margin-bottom:4px;margin-left:16px;margin-right:16px;padding-bottom:4px;}/*!sc*/ data-styled.g109[id="sc-jFREAR"]{content:"bzULrg,"}/*!sc*/ .djnqwI{display:none;position:absolute;width:max-content;top:48px;z-index:2000;background-color:#ffffff;box-shadow:0 4px 6px -1px rgba(0, 0, 0, 0.1),0 2px 4px -1px rgba(0, 0, 0, 0.06);}/*!sc*/ .djnqwI:hover{display:flex;}/*!sc*/ .djnqwI .subnav{right:0;}/*!sc*/ .djnqwI .menu-wrapper a{width:100%;justify-content:left;}/*!sc*/ @media screen and (min-width: 910px){.djnqwI{min-width:initial;}}/*!sc*/ @media screen and (min-width: 950px){.djnqwI >div:nth-of-type(1){display:none;}}/*!sc*/ @media screen and (min-width: 1000px){.djnqwI >div:nth-of-type(2){display:none;}}/*!sc*/ @media screen and (min-width: 1100px){.djnqwI >div:nth-of-type(3){display:none;}}/*!sc*/ @media screen and (min-width: 1130px){.djnqwI >div:nth-of-type(4){display:none;}}/*!sc*/ @media screen and (min-width: 1190px){.djnqwI >div:nth-of-type(5){display:none;}}/*!sc*/ @media screen and (min-width: 1250px){.djnqwI >div:nth-of-type(6){display:none;}}/*!sc*/ @media screen and (min-width: 1315px){.djnqwI >div:nth-of-type(7){display:none;}}/*!sc*/ data-styled.g110[id="sc-bPrlCs"]{content:"djnqwI,"}/*!sc*/ .ksgWfK.sub-group-wrapper{background-color:#ffffff;border-width:1px;border-top-width:1px;border-color:#CEDDF2;border-bottom-left-radius:2px;border-bottom-right-radius:2px;padding:8px 0;scrollbar-width:thin;max-height:calc(90vh - 100px);}/*!sc*/ .ksgWfK.sub-group-wrapper ::-webkit-scrollbar{width:6px!important;}/*!sc*/ .ksgWfK.sub-group-wrapper ::-webkit-scrollbar-track{background:#f1f1f1;}/*!sc*/ .ksgWfK.sub-group-wrapper ::-webkit-scrollbar-thumb{background:#888;}/*!sc*/ .ksgWfK.sub-group-wrapper ::-webkit-scrollbar-thumb:hover{background:#555;}/*!sc*/ data-styled.g111[id="sc-fYrVWQ"]{content:"ksgWfK,"}/*!sc*/ .cjSToK.secondary{position:relative;}/*!sc*/ .cjSToK.secondary .subnav{position:absolute;right:0;top:48px;}/*!sc*/ .cjSToK .subnav{display:none;position:absolute;z-index:2000;}/*!sc*/ .cjSToK .subnav .third-level-menu{display:none;position:absolute;left:100%;background:#ffffff;border:1px solid #CEDDF2;border-bottom-left-radius:2px;border-bottom-right-radius:2px;height:100%;z-index:999999;overflow:auto;top:0;height:auto;min-width:160px;}/*!sc*/ .cjSToK .subnav .more-nav-menu{position:absolute;top:50%;right:0;transform:translateY(-50%);}/*!sc*/ .cjSToK:hover .subnav{display:block;}/*!sc*/ .cjSToK .menu-items{padding:4px;}/*!sc*/ .cjSToK .menu-items .dropdown-menu-item{position:relative;}/*!sc*/ .cjSToK .menu-items .dropdown-menu-item:hover .third-level-menu{display:block;}/*!sc*/ @media screen and (max-width: 800px){.cjSToK .subnav{display:none!important;}}/*!sc*/ data-styled.g112[id="sc-GkLId"]{content:"cjSToK,"}/*!sc*/ .ZorAP{text-align:left;}/*!sc*/ .ZorAP.has-groups{width:480px;}/*!sc*/ .ZorAP.has-groups.money-app{max-width:480px;width:auto;min-width:180px;}/*!sc*/ data-styled.g113[id="sc-jYnQyy"]{content:"ZorAP,"}/*!sc*/ .gXrePV{display:flex;align-items:center;justify-content:center;font-size:12px;font-weight:700;white-space:nowrap;}/*!sc*/ .gXrePV.others-btn{height:48px;color:#192940;text-transform:capitalize;padding:0 8px;}/*!sc*/ .gXrePV.others-btn:hover{color:#1a56db;}/*!sc*/ .gXrePV.research-btn{height:34px;color:white;text-transform:uppercase;border-radius:5px;letter-spacing:1px;padding:0 14px;}/*!sc*/ .gXrePV.research-btn:hover{opacity:100;color:white;}/*!sc*/ .gXrePV.invest-in-art-btn{height:34px;color:#000000;border-radius:5px;letter-spacing:1px;padding:0 10px;margin-right:8px;}/*!sc*/ .gXrePV.invest-in-art-btn:hover{background-color:#a4cafe;}/*!sc*/ data-styled.g114[id="sc-eGgGjL"]{content:"gXrePV,"}/*!sc*/ .kUONMW.menu-wrapper{background-color:#033251;position:relative;min-width:65px;}/*!sc*/ .kUONMW.menu-wrapper:hover .global-menu-dropdown{display:block;}/*!sc*/ @media screen and (max-width: 800px){.kUONMW.menu-wrapper{background-color:transparent;}}/*!sc*/ .kUONMW.menu-wrapper .menu-button{align-items:center;color:white;cursor:pointer;display:inline-flex;font-size:12px;height:32px;padding:0px 12px;}/*!sc*/ .kUONMW.menu-wrapper .menu-button .anticon-user{color:#1a79ff;margin-right:12px;}/*!sc*/ @media screen and (max-width: 800px){.kUONMW.menu-wrapper .menu-button{padding:0px 6px;}.kUONMW.menu-wrapper .menu-button .anticon-user{color:#a4cafe;font-size:18px;}.kUONMW.menu-wrapper .menu-button .anticon-down{display:none;}}/*!sc*/ .kUONMW.menu-wrapper .global-menu-dropdown{background-color:#033251;display:none;position:absolute;width:110px;width:max-content;z-index:100;}/*!sc*/ @media screen and (max-width: 800px){.kUONMW.menu-wrapper .global-menu-dropdown{right:0px;}}/*!sc*/ .kUONMW.menu-wrapper .global-menu-item{color:white;cursor:pointer;font-size:12px;padding:8px 12px;display:block;margin:0;}/*!sc*/ .kUONMW.menu-wrapper .global-menu-item a{color:white;display:flex;align-items:center;}/*!sc*/ .kUONMW.menu-wrapper .global-menu-item span{display:inline-block;vertical-align:middle;line-height:1;margin-right:10px;}/*!sc*/ .kUONMW.menu-wrapper .global-menu-item img{width:30px;display:inline-block;vertical-align:middle;}/*!sc*/ .kUONMW.menu-wrapper .global-text{margin-right:14px;}/*!sc*/ @media screen and (max-width: 800px){.kUONMW.menu-wrapper .global-text{margin-right:0;}}/*!sc*/ @media screen and (max-width: 800px){.kUONMW.menu-wrapper{width:3rem;text-align:center;}}/*!sc*/ data-styled.g115[id="sc-fnpiog"]{content:"kUONMW,"}/*!sc*/ .LChwz.menu-wrapper{background-color:#033251;position:relative;width:140px;white-space:nowrap;}/*!sc*/ @media screen and (max-width: 800px){.LChwz.menu-wrapper{background-color:transparent;}}/*!sc*/ @media screen and (min-width: 800px){.LChwz.menu-wrapper:hover .account-menu-dropdown{display:block;box-shadow:0 1px 2px 0 rgba(0, 0, 0, 0.05);}}/*!sc*/ .LChwz.menu-wrapper .menu-button{align-items:center;color:white;cursor:pointer;display:inline-flex;font-size:12px;height:32px;padding:0px 12px;}/*!sc*/ .LChwz.menu-wrapper .menu-button .anticon-user{color:#1a79ff;margin-right:12px;}/*!sc*/ @media screen and (max-width: 800px){.LChwz.menu-wrapper .menu-button .anticon-user{color:#a4cafe;font-size:18px;margin-right:0;}.LChwz.menu-wrapper .menu-button .anticon-down{display:none;}}/*!sc*/ .LChwz.menu-wrapper .account-menu-dropdown{background-color:#ffffff;border:1px solid #E1EBFA;display:none;position:absolute;width:140px;z-index:104;}/*!sc*/ @media screen and (max-width: 800px){.LChwz.menu-wrapper .account-menu-dropdown{right:0px;}}/*!sc*/ .LChwz.menu-wrapper .account-menu-dropdown.open{display:block;}/*!sc*/ .LChwz.menu-wrapper .account-menu-dropdown .checkbox-container label{display:flex;font-size:12px;}/*!sc*/ .LChwz.menu-wrapper .account-menu-item{color:#000000;cursor:pointer;font-size:12px;font-weight:700;padding:8px 12px;}/*!sc*/ .LChwz.menu-wrapper .account-menu-item a{color:#000000;display:inline-flex;}/*!sc*/ .LChwz.menu-wrapper .account-menu-item.benzinga-plus a{color:#ff5a1f;}/*!sc*/ .LChwz.menu-wrapper .account-menu-item.benzinga-pro a{color:#1A79FF;}/*!sc*/ .LChwz.menu-wrapper .account-menu-item.benzinga-edge a{color:#3f83f8;}/*!sc*/ .LChwz.menu-wrapper .divider{margin:0 auto;width:85%;border-color:#CEDDF2;}/*!sc*/ .LChwz.menu-wrapper .my-account-text{margin-right:14px;}/*!sc*/ @media screen and (max-width: 800px){.LChwz.menu-wrapper .my-account-text{display:none;}}/*!sc*/ @media screen and (max-width: 800px){.LChwz.menu-wrapper{width:3rem;}}/*!sc*/ data-styled.g117[id="sc-jnlcPO"]{content:"LChwz,"}/*!sc*/ .jRqJvd{position:fixed;z-index:100;top:0;left:0;right:0;width:100%;transition:all linear 0.12s;}/*!sc*/ .jRqJvd .mobile-header,.jRqJvd .mobile-menu-wrapper,.jRqJvd .mobile-quote-bar{background-color:#08244d;}/*!sc*/ .jRqJvd .mobile-header{border-bottom:1px solid #36537e;}/*!sc*/ .jRqJvd .menu-icon-wrapper{display:flex;align-items:center;justify-content:center;cursor:pointer;flex-shrink:0;width:3rem;height:3rem;color:#CEDDF2;font-size:18px;}/*!sc*/ .jRqJvd.fullscreen .account-menu{pointer-events:none;}/*!sc*/ .jRqJvd .search-wrapper{background:linear-gradient(180deg, #082132 0%, #1d446a 100%);width:100%;z-index:30;}/*!sc*/ .jRqJvd .search-wrapper.fixed{position:fixed;top:181px;}/*!sc*/ .jRqJvd .search-wrapper.fullscreen{position:fixed;background:#242424e0;z-index:999;height:100vh;}/*!sc*/ .jRqJvd .search-wrapper.fullscreen .searchbar-wrapper{padding:0;}/*!sc*/ .jRqJvd .search-wrapper.fullscreen .searchbar-wrapper .search-input-container{border-bottom:1px solid #a4a4a4;padding:8px 12px;background-color:#1d446a;}/*!sc*/ .jRqJvd .search-wrapper.fullscreen .searchbar-wrapper .search-input-wrapper{background-color:white;border-radius:4px;}/*!sc*/ .jRqJvd .search-wrapper.fullscreen .search-dropdown{border-radius:unset;border:none;box-shadow:none;position:unset;}/*!sc*/ .jRqJvd .search-wrapper.fullscreen .search-result-wrapper{border-radius:unset;}/*!sc*/ .jRqJvd .search-wrapper .searchbar-wrapper{padding:8px 12px;background-color:transparent;font-weight:bold;line-height:15px;}/*!sc*/ .jRqJvd .search-wrapper .searchbar-wrapper .search-icon{width:32px;}/*!sc*/ .jRqJvd .search-wrapper .searchbar-wrapper input{font-size:14px;height:45px;}/*!sc*/ .jRqJvd .search-wrapper .searchbar-wrapper .searchbar-container{background-color:white;border-radius:2px;}/*!sc*/ @media screen and (max-width: 800px){.jRqJvd .search-wrapper .searchbar-wrapper input{font-size:16px;}}/*!sc*/ .jRqJvd .mobile-menu-wrapper{z-index:999999;}/*!sc*/ .jRqJvd .mobile-menu-wrapper .premium-button{color:white;line-height:40px;padding:4px 10px;position:fixed;height:min-content;bottom:0px;z-index:10000;background-color:#062b4c;}/*!sc*/ .jRqJvd .mobile-menu-wrapper .premium-button div{background-color:#ff5a1f;border-radius:10px;padding:0px 10px;width:100%;border-radius:5px;margin:2px 0px;text-align:center;}/*!sc*/ .jRqJvd .mobile-menu-wrapper .premium-button svg{font-size:20px;padding-right:5px;}/*!sc*/ .jRqJvd .mobile-menu-wrapper .premium-button:hover div{background-color:#ff8a4c;border-bottom:3px solid #d03801;}/*!sc*/ .jRqJvd .bz-pro-logo{height:60px;background:#062b4c;margin-bottom:60px;}/*!sc*/ .jRqJvd .bz-pro-logo a{border-top:solid 1px #666;padding:1rem;width:100%;}/*!sc*/ .jRqJvd .mobile-logo-wrapper{margin:0;padding:0;width:205px;margin-right:auto;}/*!sc*/ .jRqJvd .mobile-logo-wrapper .benzinga-crypto-logo-wrapper{margin-top:5px;}/*!sc*/ .jRqJvd .mobile-logo-wrapper .benzinga-logo{height:18.2px;width:134.35px;}/*!sc*/ .jRqJvd .mobile-logo-wrapper .benzinga-logo.reactive-holiday-logo{height:30px;}/*!sc*/ data-styled.g121[id="sc-hlqirL"]{content:"jRqJvd,"}/*!sc*/ .egAjKC{padding-top:242px;width:100%;}/*!sc*/ data-styled.g122[id="sc-gWQvRS"]{content:"egAjKC,"}/*!sc*/ .iJrqFm.top-bar-wrapper{background-color:#072232;height:32px;}/*!sc*/ .iJrqFm.top-bar-wrapper .bar-layout-width{max-width:1400px;margin:0 auto;}/*!sc*/ .iJrqFm.top-bar-wrapper .top-bar-inner-wrapper{display:flex;justify-content:space-between;}/*!sc*/ .iJrqFm.top-bar-wrapper .top-bar-list{list-style:none;display:flex;margin:0;}/*!sc*/ .iJrqFm.top-bar-wrapper .auth-buttons{display:flex;height:32px;min-width:234px;}/*!sc*/ .iJrqFm.top-bar-wrapper .auth-link-button{color:#ffffff;cursor:pointer;line-height:32px;padding:0 12px;text-transform:uppercase;font-size:14px;font-weight:700;}/*!sc*/ .iJrqFm.top-bar-wrapper .bz-pro-btn{display:flex;align-items:center;justify-content:space-between;padding:0 12px;border-radius:3px;height:26px;color:white;font-weight:semi-bold;background-color:#0075cd;margin:3px 3px 0px 0px;}/*!sc*/ .iJrqFm.top-bar-wrapper .bz-top-bar-list-item-label{color:white;font-size:12px;line-height:30px;margin:0 8px;white-space:nowrap;}/*!sc*/ .iJrqFm.top-bar-wrapper .contributor-link{align-items:center;color:white;display:inline-flex;font-size:12px;height:32px;margin:0 12px;}/*!sc*/ .iJrqFm.top-bar-wrapper .contributor-link a{color:white;}/*!sc*/ .iJrqFm.top-bar-wrapper .bz-top-bar-list-item{border-top:2px solid #3f83f8;color:#ffffff;text-transform:uppercase;line-height:28px;font-weight:500;font-size:14px;margin:0;text-align:center;}/*!sc*/ .iJrqFm.top-bar-wrapper .bz-top-bar-list-item.ProLabel{border-top:none;text-transform:none;min-width:140px;}/*!sc*/ .iJrqFm.top-bar-wrapper .bz-top-bar-list-item:nth-child(2){border-top-color:#f05252;min-width:84px;}/*!sc*/ .iJrqFm.top-bar-wrapper .bz-top-bar-list-item:nth-child(3){border-top-color:#c27803;min-width:66px;}/*!sc*/ .iJrqFm.top-bar-wrapper .bz-top-bar-list-item:nth-child(4){border-top-color:#046c4e;min-width:83px;}/*!sc*/ .iJrqFm.top-bar-wrapper .bz-top-bar-list-item:nth-child(5){border-top-color:#c81e1e;min-width:93px;}/*!sc*/ .iJrqFm.top-bar-wrapper .bz-top-bar-list-item:nth-child(6){border-top-color:#0e9f6e;min-width:59px;}/*!sc*/ .iJrqFm.top-bar-wrapper .bz-top-bar-list-item:nth-child(7){min-width:86px;}/*!sc*/ data-styled.g126[id="sc-glNIji"]{content:"iJrqFm,"}/*!sc*/ .cDBmGl.quote-bar-container{background:linear-gradient(180deg, #082132 0%, #1d446a 100%);}/*!sc*/ .cDBmGl.quote-bar-container .quote-bar-layout-width{max-width:1400px;margin:0 auto;height:52px;}/*!sc*/ .cDBmGl.quote-bar-container .quote-bar-wrapper,.cDBmGl.quote-bar-container .quotes-list{display:flex;flex-grow:1;}/*!sc*/ .cDBmGl.quote-bar-container .quote-list-container{flex-grow:1;overflow-x:auto;scrollbar-width:none;}/*!sc*/ .cDBmGl.quote-bar-container .quote-list-container ::-webkit-scrollbar{display:none;}/*!sc*/ .cDBmGl.quote-bar-container .search-wrapper{width:100%;max-width:288px;}/*!sc*/ .cDBmGl.quote-bar-container .search-wrapper .searchbar-wrapper{padding:8px 12px;background-color:transparent;font-weight:bold;font-size:16px;line-height:15px;}/*!sc*/ .cDBmGl.quote-bar-container .search-wrapper .searchbar-wrapper .search-icon{width:32px;}/*!sc*/ .cDBmGl.quote-bar-container .search-wrapper .searchbar-wrapper input{font-size:12px;}/*!sc*/ .cDBmGl.quote-bar-container .search-wrapper .searchbar-wrapper .searchbar-container{background-color:white;border-radius:2px;}/*!sc*/ @media (min-width: 1300px){.cDBmGl.quote-bar-container .search-wrapper .searchbar-wrapper{padding-right:0;}.cDBmGl.quote-bar-container .search-wrapper .searchbar-wrapper .search-icon{width:36px;}}/*!sc*/ .cDBmGl.quote-bar-container .search-wrapper .search-icon{height:36px;}/*!sc*/ data-styled.g127[id="sc-fnfGmV"]{content:"cDBmGl,"}/*!sc*/ .iAQCXw.quote-switcher-wrapper{overflow-y:auto;height:52px;width:70px;scrollbar-width:none;flex:none;}/*!sc*/ .iAQCXw.quote-switcher-wrapper ::-webkit-scrollbar{display:none;}/*!sc*/ .iAQCXw.quote-switcher-wrapper .quote-switcher-container{display:flex;flex-direction:column;}/*!sc*/ data-styled.g128[id="sc-eYFTNc"]{content:"iAQCXw,"}/*!sc*/ .hBLAMO.quote-switcher-button{max-width:73px;width:100%;border-left:1px solid #99AECC;background:linear-gradient(90deg, #99AECC1a 0%, #99AECC00 100%);text-align:left;color:#99AECC;font-size:12px;line-height:18px;padding:4px 9px;flex-grow:1;}/*!sc*/ .hBLAMO.quote-switcher-button :focus{outline:none;}/*!sc*/ .hkLhtO.quote-switcher-button{max-width:73px;width:100%;border-left:1px solid #E1EBFA;background:linear-gradient(90deg, #1c64f21a 0%, #1c64f200 100%);text-align:left;color:#ffffff;font-size:12px;line-height:18px;padding:4px 9px;flex-grow:1;}/*!sc*/ .hkLhtO.quote-switcher-button :focus{outline:none;}/*!sc*/ data-styled.g129[id="sc-iEYVpv"]{content:"hBLAMO,hkLhtO,"}/*!sc*/ .gLmRHE{display:flex;overflow-x:scroll;scrollbar-width:none;justify-content:flex-start;}/*!sc*/ .gLmRHE ::-webkit-scrollbar{display:none;}/*!sc*/ .gLmRHE li{flex-shrink:0;}/*!sc*/ .gLmRHE li:nth-of-type(3),.gLmRHE li:nth-of-type(4),.gLmRHE li:nth-of-type(5),.gLmRHE li:nth-of-type(6),.gLmRHE li:nth-of-type(7),.gLmRHE li:nth-of-type(8),.gLmRHE li:nth-of-type(9),.gLmRHE li:nth-of-type(10),.gLmRHE li:nth-of-type(11),.gLmRHE li:nth-of-type(12){display:none;}/*!sc*/ @media screen and (min-width: 850px){.gLmRHE li:nth-of-type(3){display:initial;}}/*!sc*/ @media screen and (min-width: 900px){.gLmRHE li:nth-of-type(4){display:initial;}}/*!sc*/ @media screen and (min-width: 950px){.gLmRHE li:nth-of-type(5){display:initial;}}/*!sc*/ @media screen and (min-width: 1000px){.gLmRHE li:nth-of-type(6){display:initial;}}/*!sc*/ @media screen and (min-width: 1100px){.gLmRHE li:nth-of-type(7){display:initial;}}/*!sc*/ @media screen and (min-width: 1130px){.gLmRHE li:nth-of-type(8){display:initial;}}/*!sc*/ @media screen and (min-width: 1190px){.gLmRHE li:nth-of-type(9){display:initial;}}/*!sc*/ @media screen and (min-width: 1250px){.gLmRHE li:nth-of-type(10){display:initial;}}/*!sc*/ @media screen and (min-width: 1315px){.gLmRHE li:nth-of-type(11){display:initial;}}/*!sc*/ @media screen and (min-width: 1360px){.gLmRHE li:nth-of-type(12){display:initial;}}/*!sc*/ data-styled.g132[id="sc-kUNLVD"]{content:"gLmRHE,"}/*!sc*/ .djYNFx{display:block;position:unset;top:unset;width:unset;z-index:999;box-shadow:unset;}/*!sc*/ @media (max-width: 800px){.djYNFx{display:none;}}/*!sc*/ .djYNFx .breaking-news-banner{position:absolute;top:-50px;transition:all ease-in 0.5s;z-index:-1;}/*!sc*/ .djYNFx .breaking-news-wrapper{position:relative;}/*!sc*/ .djYNFx .breaking-news-wrapper--visible .breaking-news-banner{position:unset;top:0;}/*!sc*/ .djYNFx .more-nav-tabs-icon-container{position:relative;display:flex;align-items:center;justify-content:center;margin-left:5px;margin-right:5px;cursor:pointer;}/*!sc*/ .djYNFx .more-nav-tabs-icon-container:hover >div{display:flex;}/*!sc*/ @media screen and (min-width: 1315px){.djYNFx .more-nav-tabs-icon-container{display:none!important;}}/*!sc*/ data-styled.g133[id="sc-dxfTlo"]{content:"djYNFx,"}/*!sc*/ .ihnpVB{background-color:#ffffff;border-bottom:0px solid #B8CBE6;width:100%;padding:0;}/*!sc*/ data-styled.g134[id="sc-juusvx"]{content:"ihnpVB,"}/*!sc*/ .hsBJnI{height:48px;max-width:1400px;margin:0 auto;}/*!sc*/ data-styled.g135[id="sc-emwzcK"]{content:"hsBJnI,"}/*!sc*/ .eAxjKW{display:flex;position:relative;height:100%;justify-content:center;}/*!sc*/ data-styled.g138[id="sc-iJrEMN"]{content:"eAxjKW,"}/*!sc*/ .dHIdf{flex-grow:1;margin-left:20px;}/*!sc*/ data-styled.g139[id="sc-grhZJe"]{content:"dHIdf,"}/*!sc*/ .knRqnT{display:inline-flex;align-items:center;justify-content:flex-end;height:48px;min-width:244px;}/*!sc*/ data-styled.g140[id="sc-ZaPur"]{content:"knRqnT,"}/*!sc*/ .jnhVCZ.header-container .navbar-placeholder{height:132px;}/*!sc*/ .jnhVCZ.header-container.money-app .main-menu-bar{background-color:#192940;border:none;}/*!sc*/ .jnhVCZ.header-container.money-app .main-menu-bar .main-menu-wrapper{max-width:1300px;}/*!sc*/ .jnhVCZ.header-container.money-app .main-menu-bar .main-menu-wrapper .menu-wrapper:hover{background-color:#151f2e;}/*!sc*/ .jnhVCZ.header-container.money-app .main-menu-bar .logo-wrapper{width:260px;}/*!sc*/ .jnhVCZ.header-container.money-app .main-menu-bar .menu-item-link{color:#ceddf2;}/*!sc*/ .jnhVCZ.header-container.money-app .main-menu-bar .menu-item-link:hover{background-color:transparent;}/*!sc*/ data-styled.g153[id="sc-KDzwu"]{content:"jnhVCZ,"}/*!sc*/ .dAVAzt{display:block;margin-bottom:0;}/*!sc*/ @media screen and (min-width: 800px){.dAVAzt{display:none;}}/*!sc*/ data-styled.g155[id="sc-dlDPRo"]{content:"dAVAzt,"}/*!sc*/ @keyframes cUwltg{0%{left:-100%;transition-property:left;}11.504424778761061%,100%{left:100%;transition-property:left;}}/*!sc*/ data-styled.g436[id="sc-keyframes-cUwltg"]{content:"cUwltg,"}/*!sc*/ .fACrUT{height:24px;width:80px;}/*!sc*/ data-styled.g439[id="sc-ekaoJE"]{content:"fACrUT,"}/*!sc*/ .cXVRMB{font-size:24px;font-weight:bold;margin-bottom:0;text-transform:uppercase;width:100%;}/*!sc*/ .cXVRMB >h1,.cXVRMB >h2,.cXVRMB >h3,.cXVRMB >h4,.cXVRMB >h5,.cXVRMB >h6,.cXVRMB >span{font-size:inherit;}/*!sc*/ .cXVRMB.bordered{border-bottom:solid 1px #99AECC;border-color:#e1ebfa;font-weight:bold;margin-top:12px;margin-bottom:8px;padding:4px 0;}/*!sc*/ .cXVRMB.border-through{margin:12px 0;padding:4px 0;overflow:hidden;text-align:center;}/*!sc*/ .cXVRMB.border-through >h1,.cXVRMB.border-through >h2,.cXVRMB.border-through >h3,.cXVRMB.border-through >h4,.cXVRMB.border-through >h5,.cXVRMB.border-through >h6,.cXVRMB.border-through >span{position:relative;display:inline-block;}/*!sc*/ .cXVRMB.border-through >h1:before,.cXVRMB.border-through >h2:before,.cXVRMB.border-through >h3:before,.cXVRMB.border-through >h4:before,.cXVRMB.border-through >h5:before,.cXVRMB.border-through >h6:before,.cXVRMB.border-through >span:before,.cXVRMB.border-through >h1:after,.cXVRMB.border-through >h2:after,.cXVRMB.border-through >h3:after,.cXVRMB.border-through >h4:after,.cXVRMB.border-through >h5:after,.cXVRMB.border-through >h6:after,.cXVRMB.border-through >span:after{content:'';position:absolute;top:50%;border-bottom:1px solid #99AECC;width:100vw;margin:0 20px;}/*!sc*/ .cXVRMB.border-through >h1:before,.cXVRMB.border-through >h2:before,.cXVRMB.border-through >h3:before,.cXVRMB.border-through >h4:before,.cXVRMB.border-through >h5:before,.cXVRMB.border-through >h6:before,.cXVRMB.border-through >span:before{right:100%;}/*!sc*/ .cXVRMB.border-through >h1:after,.cXVRMB.border-through >h2:after,.cXVRMB.border-through >h3:after,.cXVRMB.border-through >h4:after,.cXVRMB.border-through >h5:after,.cXVRMB.border-through >h6:after,.cXVRMB.border-through >span:after{left:100%;}/*!sc*/ .cXVRMB.contains-right-slot{display:flex;align-items:center;justify-content:space-between;}/*!sc*/ .cXVRMB .see-more{font-size:12px;font-weight:600;text-transform:none;color:rgb(44, 162, 209);}/*!sc*/ data-styled.g441[id="sc-dkXDdO"]{content:"cXVRMB,"}/*!sc*/ .jYfzbt{color:#283D59!important;font-size:14px;font-weight:bold;}/*!sc*/ data-styled.g460[id="sc-gUDIDV"]{content:"jYfzbt,"}/*!sc*/ .dDLddz{align-items:center;background:#ffffff;border-color:#E1EBFA!important;border-radius:0.2rem;border-width:1px;color:#283D59;display:inline-flex;margin:0;padding-left:4px;padding-right:4px;overflow:hidden;text-decoration:none;text-align:left;line-height:22px;height:24px;cursor:pointer;white-space:nowrap;}/*!sc*/ .dDLddz .direction{height:24px;}/*!sc*/ .dDLddz .direction .anticon{top:2px;position:relative;}/*!sc*/ .dDLddz .download-report{text-decoration:underline;font-size:14px;padding:0 5px;}/*!sc*/ data-styled.g464[id="sc-dVraiA"]{content:"dDLddz,"}/*!sc*/ .iavXuM.carousel-container{overflow:hidden;border-radius:0;}/*!sc*/ .iavXuM.carousel-container .splide__list{backface-visibility:hidden;display:-ms-flexbox;display:flex;height:100%;margin:0!important;padding:0!important;}/*!sc*/ .iavXuM.carousel-container .splide__sr{display:none!important;visibility:hidden;}/*!sc*/ .iavXuM.carousel-container .carousel-pagination{display:flex;width:100%;}/*!sc*/ .iavXuM.carousel-container .carousel-pagination .splide__arrows{display:flex;margin-left:auto;}/*!sc*/ .iavXuM.carousel-container .carousel-pagination .splide__arrows >span{font-size:20px;}/*!sc*/ .iavXuM.carousel-container .carousel-pagination button{width:50px;height:40px;display:flex;align-items:center;justify-content:center;}/*!sc*/ .iavXuM.carousel-container .carousel-pagination button.page-left-button{margin-right:10px;}/*!sc*/ .iavXuM.carousel-container.center-arrows .carousel-pagination{display:block;text-align:center;margin-top:12px;margin-bottom:24px;}/*!sc*/ .iavXuM.carousel-container.center-arrows .carousel-pagination .splide__arrows{align-items:center;justify-content:center;}/*!sc*/ .iavXuM.carousel-container.center-arrows .carousel-pagination .splide__arrows button{width:90px;height:32px;}/*!sc*/ .iavXuM.carousel-container.on-component-arrows{position:relative;}/*!sc*/ .iavXuM.carousel-container.on-component-arrows .carousel-pagination{display:none;}/*!sc*/ .iavXuM.carousel-container.on-component-arrows .on-component-arrows-container .splide__arrow--prev{position:absolute;top:0;left:0;}/*!sc*/ .iavXuM.carousel-container.on-component-arrows .on-component-arrows-container .splide__arrow--next{position:absolute;top:0;right:0;}/*!sc*/ .iavXuM.carousel-container.on-component-arrows .on-component-arrows-container .splide__arrow{background:rgba(0, 0, 0, 0.5);color:#fff;border:none;width:20px;height:200px;display:flex;align-items:center;justify-content:center;cursor:pointer;z-index:2;}/*!sc*/ data-styled.g488[id="sc-hrmvde"]{content:"iavXuM,"}/*!sc*/ .hrLfRc{height:200px;width:100%;max-width:600px;margin:0 auto;background:linear-gradient(180deg, #0c1c33 0%, #050e18 100%);position:relative;cursor:pointer;}/*!sc*/ .hrLfRc .banner{background-image:url('/next-assets/images/banners/edge/cta/cta-bg.png');width:100%;height:200px;background-size:cover;background-position:center;background-repeat:no-repeat;padding:1rem;display:flex;justify-content:space-between;}/*!sc*/ .hrLfRc .button-wrapper{display:flex;flex-direction:column;align-items:flex-end;justify-content:space-between;gap:1rem;z-index:10;}/*!sc*/ .hrLfRc .logo{width:200px;height:40px;}/*!sc*/ .hrLfRc .content{display:flex;flex-direction:column;justify-content:space-between;max-width:500px;z-index:10;}/*!sc*/ .hrLfRc h2{color:#f2f8ff;font-size:24px;font-weight:700;text-transform:uppercase;}/*!sc*/ .hrLfRc h3{color:#e1ebfa;font-size:16px;font-weight:700;line-height:24px;}/*!sc*/ .hrLfRc p{color:#ceddf2;font-size:16px;line-height:24px;}/*!sc*/ .hrLfRc button{background:#3f83f8;color:white;padding:8px 16px;border-radius:4px;font-size:18px;}/*!sc*/ @media (max-width: 800px){.hrLfRc .logo{width:80px;height:20px;}.hrLfRc .content{padding:0;}.hrLfRc .banner{height:100px;}.hrLfRc .banner-bg-end{background-size:cover;}.hrLfRc h2{font-size:16px;line-height:1;}.hrLfRc h3{font-size:12px;line-height:1;}.hrLfRc p{font-size:12px;line-height:14px;}.hrLfRc button{font-size:10px;padding:4px 8px;}}/*!sc*/ @media (max-width: 600px){.hrLfRc .banner{padding:0.75rem;}}/*!sc*/ .hrLfRc.gov-trades .banner-bg-end{background-image:url('/next-assets/images/banners/edge/cta/bg-gov-trades.png');width:100%;height:200px;background-size:contain;background-position:right;background-repeat:no-repeat;position:absolute;bottom:0;z-index:1;}/*!sc*/ @media (max-width: 800px){.hrLfRc.gov-trades{height:100px;}.hrLfRc.gov-trades h2{font-size:14px;}.hrLfRc.gov-trades h3{font-size:10px;}.hrLfRc.gov-trades p{font-size:10px;}.hrLfRc.gov-trades .banner-bg-end{height:100px;overflow:hidden;}}/*!sc*/ .hrLfRc.stock-of-the-day{max-width:764px;height:180px;}/*!sc*/ .hrLfRc.stock-of-the-day h3{font-size:20px;font-weight:700;}/*!sc*/ .hrLfRc.stock-of-the-day .banner{height:180px;}/*!sc*/ .hrLfRc.stock-of-the-day .banner-bg-end{background-image:url('/next-assets/images/banners/edge/cta/bg-stock-of-the-day.png');width:100%;height:180px;background-size:contain;background-position:right;background-repeat:no-repeat;position:absolute;bottom:0;z-index:1;}/*!sc*/ @media (max-width: 1000px){.hrLfRc.stock-of-the-day .logo{width:160px;height:20px;}.hrLfRc.stock-of-the-day h2{font-size:20px;}.hrLfRc.stock-of-the-day h3{font-size:16px;}.hrLfRc.stock-of-the-day p{font-size:14px;line-height:14px;}.hrLfRc.stock-of-the-day button{font-size:16px;}}/*!sc*/ @media (max-width: 800px){.hrLfRc.stock-of-the-day{height:100px;}.hrLfRc.stock-of-the-day h2{font-size:16px;}.hrLfRc.stock-of-the-day h3{font-size:12px;}.hrLfRc.stock-of-the-day p{font-size:10px;}.hrLfRc.stock-of-the-day .banner,.hrLfRc.stock-of-the-day .banner-bg-end{height:100px;overflow:hidden;}.hrLfRc.stock-of-the-day .logo{width:80px;height:20px;}.hrLfRc.stock-of-the-day button{font-size:10px;padding:4px 8px;}}/*!sc*/ .hrLfRc.whisper-index{max-width:764px;height:180px;}/*!sc*/ .hrLfRc.whisper-index h3{font-size:20px;font-weight:700;}/*!sc*/ .hrLfRc.whisper-index .banner{height:180px;}/*!sc*/ .hrLfRc.whisper-index .banner-bg-end{background-image:url('/next-assets/images/banners/edge/cta/bg-whisper-index.png');width:100%;height:180px;background-size:contain;background-position:right;background-repeat:no-repeat;position:absolute;bottom:0;z-index:1;}/*!sc*/ @media (max-width: 1000px){.hrLfRc.whisper-index .logo{width:160px;height:20px;}.hrLfRc.whisper-index h2{font-size:20px;}.hrLfRc.whisper-index h3{font-size:16px;}.hrLfRc.whisper-index p{font-size:14px;line-height:14px;}.hrLfRc.whisper-index button{font-size:16px;}}/*!sc*/ @media (max-width: 800px){.hrLfRc.whisper-index{height:100px;}.hrLfRc.whisper-index h2{font-size:16px;}.hrLfRc.whisper-index h3{font-size:12px;}.hrLfRc.whisper-index p{font-size:10px;}.hrLfRc.whisper-index .banner,.hrLfRc.whisper-index .banner-bg-end{height:100px;overflow:hidden;}.hrLfRc.whisper-index .logo{width:80px;height:20px;}.hrLfRc.whisper-index button{font-size:10px;padding:4px 8px;}}/*!sc*/ .hrLfRc.unusual-options-activity .banner-bg-end{background-image:url('/next-assets/images/banners/edge/cta/bg-unusual-options.png');width:100%;height:200px;background-size:contain;background-position:right;background-repeat:no-repeat;position:absolute;bottom:0;z-index:1;}/*!sc*/ @media (max-width: 800px){.hrLfRc.unusual-options-activity{height:100px;}.hrLfRc.unusual-options-activity .banner,.hrLfRc.unusual-options-activity .banner-bg-end{height:100px;}}/*!sc*/ .hrLfRc.insider-trades .banner-bg-end{background-image:url('/next-assets/images/banners/edge/cta/bg-insider-trades.png');width:100%;height:200px;background-size:contain;background-position:right;background-repeat:no-repeat;position:absolute;bottom:0;z-index:1;}/*!sc*/ @media (max-width: 800px){.hrLfRc.insider-trades{height:100px;}.hrLfRc.insider-trades .banner,.hrLfRc.insider-trades .banner-bg-end{height:100px;}}/*!sc*/ .hrLfRc.earnings .banner-bg-end{background-image:url('/next-assets/images/banners/edge/cta/bg-earnings.png');width:100%;height:200px;background-size:contain;background-position:right;background-repeat:no-repeat;position:absolute;bottom:0;z-index:1;}/*!sc*/ @media (max-width: 800px){.hrLfRc.earnings{height:100px;}.hrLfRc.earnings .banner,.hrLfRc.earnings .banner-bg-end{height:100px;}.hrLfRc.earnings p{font-size:10px;}}/*!sc*/ .hrLfRc.analyst-ratings .banner-bg-end{background-image:url('/next-assets/images/banners/edge/cta/bg-analyst-calendar.png');width:100%;height:200px;background-size:contain;background-position:right;background-repeat:no-repeat;position:absolute;bottom:0;z-index:1;}/*!sc*/ @media (max-width: 800px){.hrLfRc.analyst-ratings{height:100px;}.hrLfRc.analyst-ratings .banner,.hrLfRc.analyst-ratings .banner-bg-end{height:100px;}}/*!sc*/ .hrLfRc.analyst-predictions .banner-bg-end{background-image:url('/next-assets/images/banners/edge/cta/bg-analyst.png');width:100%;height:200px;background-size:contain;background-position:right;background-repeat:no-repeat;position:absolute;bottom:0;z-index:1;}/*!sc*/ @media (max-width: 800px){.hrLfRc.analyst-predictions{height:100px;}.hrLfRc.analyst-predictions .banner,.hrLfRc.analyst-predictions .banner-bg-end{height:100px;}}/*!sc*/ .hrLfRc.bulls-vs-bears{height:80px;}/*!sc*/ .hrLfRc.bulls-vs-bears .banner-bg-end{background-image:url('/next-assets/images/banners/edge/cta/bg-bulls-vs-bears.png');width:100%;height:80px;background-size:contain;background-position:right;background-repeat:no-repeat;position:absolute;bottom:0;z-index:1;}/*!sc*/ .hrLfRc.bulls-vs-bears .logo{width:80px;height:20px;}/*!sc*/ .hrLfRc.bulls-vs-bears .banner{height:80px;}/*!sc*/ .hrLfRc.bulls-vs-bears h2{font-size:16px;}/*!sc*/ .hrLfRc.bulls-vs-bears p{font-size:10px;line-height:12px;padding-right:0.5rem;}/*!sc*/ .hrLfRc.bulls-vs-bears button{font-size:10px;padding:4px 8px;white-space:nowrap;}/*!sc*/ .hrLfRc.stock-report .banner-bg-end{background-image:url('/next-assets/images/banners/edge/cta/bg-stock-report.png');width:100%;height:200px;background-size:contain;background-position:right;background-repeat:no-repeat;position:absolute;bottom:0;z-index:1;}/*!sc*/ @media (max-width: 800px){.hrLfRc.stock-report{height:100px;}.hrLfRc.stock-report .banner,.hrLfRc.stock-report .banner-bg-end{height:100px;}.hrLfRc.stock-report p{font-size:10px;}}/*!sc*/ .hrLfRc.basic-calendar .banner-bg-end{background-image:url('/next-assets/images/banners/edge/cta/bg-earnings.png');width:100%;height:200px;background-size:contain;background-position:right;background-repeat:no-repeat;position:absolute;bottom:0;z-index:1;}/*!sc*/ @media (max-width: 800px){.hrLfRc.basic-calendar{height:100px;}.hrLfRc.basic-calendar .banner,.hrLfRc.basic-calendar .banner-bg-end{height:100px;}.hrLfRc.basic-calendar p{font-size:10px;}}/*!sc*/ data-styled.g647[id="sc-ibLMv"]{content:"hrLfRc,"}/*!sc*/ .fZlzMk{position:relative;}/*!sc*/ @media only screen and (max-width: 1000px){.fZlzMk{width:100%;order:1;}}/*!sc*/ @media only screen and (max-width: 800px){.fZlzMk:before{content:'';display:block;width:20px;height:100%;position:absolute;right:0;top:0;background:linear-gradient(90deg, rgba(255, 255, 255, 0) 0, #f2f7ff 67%);z-index:2;}}/*!sc*/ .fZlzMk .top-tabs{display:flex;position:relative;overflow:auto;gap:0 8px;}/*!sc*/ .fZlzMk .top-tabs__tab{background:rgba(26, 121, 255, 0.025);border:2px solid rgba(26, 121, 255, 0.1);box-sizing:border-box;border-radius:4px;color:#3f83f8;padding:8px 16px;font-size:14px;font-weight:600;font-family:Manrope,Manrope-fallback,sans-serif;line-height:20px;cursor:pointer;white-space:nowrap;}/*!sc*/ .fZlzMk .top-tabs__tab:hover,.fZlzMk .top-tabs__tab--active{background:#3f83f8;color:#fff;}/*!sc*/ @media only screen and (max-width: 800px){.fZlzMk .top-tabs:after{content:'';display:block;width:20px;flex-shrink:0;}}/*!sc*/ data-styled.g664[id="sc-fQffii"]{content:"fZlzMk,"}/*!sc*/ .hHZIFV{width:100%;font-size:0.725rem;font-weight:600;min-height:35px;height:35px;}/*!sc*/ .hHZIFV tr{text-align:left;border-collapse:collapse;color:#ffffff;background-color:#3f83f8;border-bottom:2px solid #E1EBFA;position:sticky;top:0;z-index:1;}/*!sc*/ .hHZIFV tr th{border-left:none;}/*!sc*/ .hHZIFV tr th:first-child{border-left:none;border-left:1px solid #3f83f8;}/*!sc*/ .hHZIFV tr th:last-of-type{text-align:unset;border-right:1px solid #3f83f8;}/*!sc*/ .hHZIFV th,.hHZIFV td{position:sticky;top:0;z-index:1;}/*!sc*/ data-styled.g667[id="sc-gtQWWF"]{content:"hHZIFV,"}/*!sc*/ .ipuYMQ{width:100%;text-align:left;font-size:12px;font-family:sans-serif;font-weight:normal;}/*!sc*/ .ipuYMQ tr{font-size:inherit;}/*!sc*/ .ipuYMQ th,.ipuYMQ td{padding:0.35rem 0.5rem;}/*!sc*/ .ipuYMQ td:last-of-type{text-align:unset;}/*!sc*/ data-styled.g669[id="sc-iWlszP"]{content:"ipuYMQ,"}/*!sc*/ .iSuQrx.benzinga-core-table-tbody,.iSuQrx.benzinga-core-virtualized-table-tbody{font-size:0.75rem;height:unset;}/*!sc*/ @media (max-width: 800px){.iSuQrx.benzinga-core-table-tbody tr,.iSuQrx.benzinga-core-virtualized-table-tbody tr{height:40px;}}/*!sc*/ data-styled.g670[id="sc-eHtwCI"]{content:"iSuQrx,"}/*!sc*/ .ccHFLQ{opacity:0;visibility:hidden;transition:opacity 0.3s ease-in-out,visibility 0.3s ease-in-out;position:absolute;top:0;right:0;bottom:0;width:20px;box-shadow:inset -14px 0 20px -12px rgba(0, 0, 0, 0.2);z-index:1;pointer-events:none;}/*!sc*/ data-styled.g672[id="sc-khoNTN"]{content:"ccHFLQ,"}/*!sc*/ .eJquqN .loader-wrapper{position:absolute;top:0;left:0;right:0;bottom:0;z-index:10;background-color:rgba(#fff, 0.2);display:flex;justify-content:center;align-items:center;}/*!sc*/ .eJquqN .loader-wrapper__loader{position:absolute;color:#3f83f8;font-size:30px;animation:1s spin infinite linear;transform-origin:center;}/*!sc*/ data-styled.g673[id="sc-gpielE"]{content:"eJquqN,"}/*!sc*/ .hzOZJg.carousel-block{margin:1rem 0;overflow:hidden;}/*!sc*/ .hzOZJg.carousel-block.reverse .title{margin-top:10px;-webkit-line-clamp:3;}/*!sc*/ .hzOZJg.carousel-block.reverse .carousel-item-wrapper{display:flex;flex-direction:column-reverse;}/*!sc*/ .hzOZJg.carousel-block .section-title{margin-bottom:15px;border-bottom:solid 1px #99AECC;}/*!sc*/ .hzOZJg.carousel-block .carousel-container .carousel-pagination{text-align:center;margin-top:12px;margin-bottom:24px;display:block;}/*!sc*/ .hzOZJg.carousel-block .carousel-container .carousel-pagination >div{align-items:center;justify-content:center;}/*!sc*/ .hzOZJg.carousel-block .carousel-container .carousel-pagination >div button{width:90px;height:32px;}/*!sc*/ data-styled.g754[id="sc-gFYmAs"]{content:"hzOZJg,"}/*!sc*/ .hAXDhr{font-size:16px;font-weight:700;color:#283D59;text-overflow:ellipsis;overflow:hidden;display:-webkit-box;-webkit-box-orient:vertical;-webkit-line-clamp:1;}/*!sc*/ data-styled.g755[id="sc-bnRclF"]{content:"hAXDhr,"}/*!sc*/ .hspwUF{margin-bottom:8px;}/*!sc*/ data-styled.g758[id="sc-iPYwOE"]{content:"hspwUF,"}/*!sc*/ .gXQkGo{display:block;width:300px;margin-right:15px;}/*!sc*/ .gXQkGo:last-of-type{margin-right:0;}/*!sc*/ data-styled.g759[id="sc-dxRmzR"]{content:"gXQkGo,"}/*!sc*/ .hliDyh{position:relative;border-radius:2px;height:197px;width:300px;overflow:hidden;background-color:#ffffff;border-radius:0px;}/*!sc*/ data-styled.g760[id="sc-hPnoVK"]{content:"hliDyh,"}/*!sc*/ .fBnIMc{margin:1rem auto;}/*!sc*/ data-styled.g762[id="sc-dTaEtF"]{content:"fBnIMc,"}/*!sc*/ .kTMIHF.post-card-wrapper{display:flex;}/*!sc*/ .kTMIHF.post-card-wrapper .post-card-article-link{color:#000000;}/*!sc*/ .kTMIHF.post-card-wrapper .post-card-article-link:hover{color:#76a9fa;}/*!sc*/ .kTMIHF.post-card-wrapper .post-card-hero,.kTMIHF.post-card-wrapper .post-card-hero-compact{background:#17253A;}/*!sc*/ @media screen and (max-width: 1024px){.kTMIHF.post-card-wrapper .post-card-hero,.kTMIHF.post-card-wrapper .post-card-hero-compact{margin-bottom:12px;}}/*!sc*/ .kTMIHF.post-card-wrapper .post-card-hero .post-card-text,.kTMIHF.post-card-wrapper .post-card-hero-compact .post-card-text{background:#17253A;color:white;margin-top:-3em;z-index:0;}/*!sc*/ .kTMIHF.post-card-wrapper .post-card-hero .post-card-text:before,.kTMIHF.post-card-wrapper .post-card-hero-compact .post-card-text:before{content:' ';background:linear-gradient(transparent, #17253A);height:3em;margin-top:-3em;position:relative;}/*!sc*/ .kTMIHF.post-card-wrapper .post-card-hero .post-card-text .post-card-text-wrapper,.kTMIHF.post-card-wrapper .post-card-hero-compact .post-card-text .post-card-text-wrapper{padding:0.5em 0.75em;min-height:56px;}/*!sc*/ .kTMIHF.post-card-wrapper .post-card-hero .post-card-text .post-card-text-wrapper:hover,.kTMIHF.post-card-wrapper .post-card-hero-compact .post-card-text .post-card-text-wrapper:hover{text-decoration:underline;}/*!sc*/ .kTMIHF.post-card-wrapper .post-card-description{font-size:12px;-webkit-box-orient:vertical;display:-webkit-box;overflow:hidden;text-overflow:ellipsis;-webkit-line-clamp:2;color:#192940;font-weight:400;line-height:1.25rem;}/*!sc*/ .kTMIHF.post-card-wrapper .news-item-sponsored-tag{display:block;font-size:13px;color:#3f83f8;}/*!sc*/ .kTMIHF.post-card-wrapper .image-wrapper{position:relative;overflow:hidden;border-radius:2px;display:inline-flex;flex:1;width:100%;height:100%;}/*!sc*/ .kTMIHF.post-card-wrapper .image-wrapper img{object-fit:cover;}/*!sc*/ .kTMIHF.post-card-wrapper .image-wrapper-india{position:relative;overflow:hidden;border-radius:8px;display:inline-flex;flex:1;width:100%;height:100%;}/*!sc*/ .kTMIHF.post-card-wrapper .image-wrapper-india img{object-fit:cover;}/*!sc*/ .kTMIHF.post-card-wrapper .post-elapsed-india-primary{margin-top:24px;margin-left:24px;height:22px;color:#b8cbe5;}/*!sc*/ .kTMIHF.post-card-wrapper .post-elapsed-india-secondary{margin-top:16px;margin-left:16px;height:18px;color:#b8cbe5;}/*!sc*/ .kTMIHF.post-card-wrapper .post-card-default .image-wrapper{height:360px;}/*!sc*/ @media (max-width: 768px){.kTMIHF.post-card-wrapper .post-card-default .image-wrapper{height:108px;}}/*!sc*/ .kTMIHF.post-card-wrapper .post-card-card{border-radius:6px;background:#ffffff;border:1px solid #E1EBFA;}/*!sc*/ .kTMIHF.post-card-wrapper .post-card-card .image-wrapper{height:130px;margin-bottom:0;display:block;}/*!sc*/ .kTMIHF.post-card-wrapper .post-card-card .post-card-text-wrapper{padding:1rem;}/*!sc*/ .kTMIHF.post-card-wrapper .post-card-card .post-title{font-size:16px;margin-bottom:0.25rem;display:block;}/*!sc*/ .kTMIHF.post-card-wrapper .post-card-card .post-teaser{font-size:16px;color:#5B7292;font-weight:300;}/*!sc*/ .kTMIHF.post-card-wrapper .post-card-feed .post-card-description{font-size:14px;}/*!sc*/ .kTMIHF.post-card-wrapper .post-card-feed .image-wrapper{max-height:126px;min-width:160px;max-width:160px;min-height:126px;}/*!sc*/ @media (max-width: 768px){.kTMIHF.post-card-wrapper .post-card-feed .image-wrapper{max-height:108px;min-height:108px;}}/*!sc*/ .kTMIHF.post-card-wrapper .post-card-size-compact .image-wrapper{max-height:180px;}/*!sc*/ @media (max-width: 768px){.kTMIHF.post-card-wrapper .post-card-size-compact .image-wrapper{max-height:108px;min-height:108px;}}/*!sc*/ .kTMIHF.post-card-wrapper .post-card-size-nano .image-wrapper{max-height:108px;}/*!sc*/ @media (max-width: 768px){.kTMIHF.post-card-wrapper .post-card-size-nano .image-wrapper{max-height:120px;}}/*!sc*/ .kTMIHF.post-card-wrapper .post-card-feed .post-card-title{font-size:20px;-webkit-line-clamp:3;}/*!sc*/ .kTMIHF.post-card-wrapper .post-card-feed .post-card-image{margin-right:16px;margin-bottom:0;}/*!sc*/ @media screen and (max-width: 800px){.kTMIHF.post-card-wrapper .post-card-hero .post-card-title{font-size:18px;}.kTMIHF.post-card-wrapper .post-card-feed{display:inline-flex;flex-direction:row;}.kTMIHF.post-card-wrapper .post-card-feed .post-card-title{font-size:18px;}.kTMIHF.post-card-wrapper .post-card-feed .post-card-image{height:100px;min-height:100px;min-width:100px;max-height:100px;max-width:100px;width:100px;}.kTMIHF.post-card-wrapper .post-card-feed .post-card-text{margin-left:0;}.kTMIHF.post-card-wrapper .post-card-feed .post-card-description{font-size:12px;font-weight:normal;line-height:18px;}}/*!sc*/ @media screen and (max-width: 500px){.kTMIHF.post-card-wrapper .post-card-description{display:none;}}/*!sc*/ data-styled.g773[id="sc-hpmCTx"]{content:"kTMIHF,"}/*!sc*/ .cbhkbf{border-radius:2px;display:flex;font-size:18px;font-weight:600;overflow:hidden;flex-direction:column;}/*!sc*/ .cbhkbf .post-card-title{font-size:24px;}/*!sc*/ .cbhkbg{border-radius:2px;display:flex;font-size:18px;font-weight:600;overflow:hidden;flex-direction:column;}/*!sc*/ .cbhkbg .post-card-title{font-size:14px;}/*!sc*/ .cMobMa{border-radius:2px;display:block;font-size:14px;font-weight:600;overflow:hidden;flex-direction:column;}/*!sc*/ .cMobMa .post-card-title{font-size:14px;}/*!sc*/ data-styled.g774[id="sc-ehEeqy"]{content:"cbhkbf,cbhkbg,cMobMa,"}/*!sc*/ .iWtdjm.post-title{line-height:1.4em;font-weight:600;display:-webkit-box;}/*!sc*/ @media screen and (max-width: 600px){.iWtdjm.post-title{font-size:0.95rem;line-height:1.4rem;-webkit-box-orient:vertical;-webkit-line-clamp:3;overflow:hidden;text-overflow:ellipsis;display:inherit;}}/*!sc*/ data-styled.g775[id="sc-keSDAH"]{content:"iWtdjm,"}/*!sc*/ .kRlPph.post-thumb{border-radius:2px;width:100%;position:relative;margin-right:16px;}/*!sc*/ data-styled.g779[id="sc-ZxepX"]{content:"kRlPph,"}/*!sc*/ .gyiUav.line-wrapper{-webkit-box-orient:vertical;display:-webkit-box;overflow:hidden;text-overflow:ellipsis;}/*!sc*/ data-styled.g780[id="sc-cLGQGY"]{content:"gyiUav,"}/*!sc*/ .epEOZZ{-webkit-line-clamp:6;font-size:1.5rem;}/*!sc*/ @media screen and (max-width: 600px){.epEOZZ{font-size:0.7rem;-webkit-line-clamp:3;}}/*!sc*/ data-styled.g782[id="sc-jNBTOL"]{content:"epEOZZ,"}/*!sc*/ @media screen and (max-width: 800px){.encpHI .post-title{margin-top:-4px;}}/*!sc*/ data-styled.g783[id="sc-bXbAQm"]{content:"encpHI,"}/*!sc*/ .gtCDQI{display:grid;gap:16px;grid-template-columns:repeat(1, minmax(0, 1fr));}/*!sc*/ @media (min-width: 1024px){.gtCDQI{grid-template-columns:repeat(3, minmax(0, 1fr));}}/*!sc*/ .gtCDQI .top-story.desktop .post-card-article-link .post-title,.gtCDQI .top-story.primary-story .post-card-article-link .post-title{color:#ffffff;}/*!sc*/ .gtCDQI .secondary-stories{grid-column:span 2/span 2;}/*!sc*/ @media (min-width: 1024px){.gtCDQI .secondary-stories{grid-column:span 1/span 2;}}/*!sc*/ .gtCDQI .primary-story{grid-column:span 2/span 2;}/*!sc*/ .gtCDQI .primary-story .post-card{height:416px;}/*!sc*/ @media screen and (max-width: 800px){.gtCDQI .primary-story .post-card{height:auto;min-height:300px;}}/*!sc*/ .gtCDQI .primary-story .post-card-text-wrapper{min-height:5em;}/*!sc*/ @media (max-width: 768px){.gtCDQI .primary-story .post-card-image{height:220px;}}/*!sc*/ .gtCDQI .secondary-story{display:grid;gap:12px;grid-template-columns:repeat(2, minmax(0, 1fr));margin:0!important;margin-left:auto;margin-right:auto;}/*!sc*/ .gtCDQI .secondary-story .post-card{height:200px;}/*!sc*/ .gtCDQI .secondary-story.mobile{display:none;}/*!sc*/ @media (min-width: 1024px){.gtCDQI .secondary-story{gap:16px;grid-template-columns:repeat(1, minmax(0, 1fr));}}/*!sc*/ @media screen and (max-width: 800px){.gtCDQI .secondary-story{margin-top:12px;height:auto;border:none;}.gtCDQI .secondary-story.desktop{display:none!important;}.gtCDQI .secondary-story.mobile{display:flex!important;flex-direction:column;}.gtCDQI .secondary-story.mobile .post-card{display:flex;flex-direction:row;height:unset;}.gtCDQI .secondary-story.mobile .post-card .post-title{font-size:1rem;line-height:1.5rem;}.gtCDQI .secondary-story.mobile .image-wrapper{height:100px;width:140px;min-width:140px;max-width:140px;margin-right:1rem;margin-bottom:0;}}/*!sc*/ data-styled.g784[id="sc-jKJZnd"]{content:"gtCDQI,"}/*!sc*/ .dTmZtg{display:block;margin:16px 0;}/*!sc*/ .dTmZtg .news-section-header{align-items:center;display:inline-flex;justify-content:space-between;width:100%;border-bottom:solid 1px #99AECC;margin:16px 0;padding:4px 0;}/*!sc*/ .dTmZtg .news-section-container{display:grid;gap:12px;grid-template-columns:repeat(4, minmax(0, 1fr));grid-template-rows:repeat(1, minmax(0, 1fr));}/*!sc*/ @media (max-width: 768px){.dTmZtg .news-section-container{grid-template-columns:repeat(2, minmax(0, 1fr));grid-template-rows:repeat(2, minmax(0, 1fr));}}/*!sc*/ .dTmZtg .news-section-container .post-title .line-wrapper{-webkit-line-clamp:4;}/*!sc*/ data-styled.g786[id="sc-cdZxpv"]{content:"dTmZtg,"}/*!sc*/ .cwCVgz{margin:1rem auto;}/*!sc*/ data-styled.g787[id="sc-fCUNPS"]{content:"cwCVgz,"}/*!sc*/ .hyiaGS{width:100%;position:relative;}/*!sc*/ .hyiaGS .content-feed-list{display:flex;flex-direction:column;gap:1rem;}/*!sc*/ .hyiaGS .newsfeed-card{color:#000000;}/*!sc*/ .hyiaGS .newsfeed-card.highlight.fade .post-card-wrapper{animation:fade 5s forwards;}/*!sc*/ @keyframes fade{0%{background-color:#fdf8db;}100%{background-color:transparent;}}/*!sc*/ .hyiaGS .newsfeed-card .post-teaser{color:#7c7c7c;font-weight:400;font-size:12px;}/*!sc*/ .hyiaGS .news-block{border-bottom:solid 1px #CEDDF2;line-height:1.5;padding:12px 0;}/*!sc*/ .hyiaGS .news-block .news-block-headline{color:#000000;}/*!sc*/ .hyiaGS .news-block .article-title{font-size:16px;font-weight:600;}/*!sc*/ data-styled.g791[id="sc-nbCPO"]{content:"hyiaGS,"}/*!sc*/ .ddclwE.news-block{line-height:1.5;}/*!sc*/ .ddclwE.news-block .news-block-headline a{color:#000000;}/*!sc*/ .ddclwE.news-block .news-block-headline a:hover{color:#69a5ff;}/*!sc*/ .ddclwE.news-block .news-block-headline .news-item-sponsored-tag{display:block;font-size:13px;color:#3f83f8;font-weight:600;}/*!sc*/ .ddclwE.news-block .news-block-image-wrapper{width:90px;height:90px;min-width:90px;margin-right:1rem;border-radius:4px;overflow:hidden;}/*!sc*/ .ddclwE.news-block .article-title{font-size:16px;font-weight:600;}/*!sc*/ .ddclwE.news-block .article-teaser{font-size:14px;font-weight:400;}/*!sc*/ .ddclwE.news-block .date-box{min-width:130px;}/*!sc*/ data-styled.g792[id="sc-hmzteu"]{content:"ddclwE,"}/*!sc*/ .gNYhnT.ticker-list .ticker-list-container{display:flex;flex-wrap:wrap;gap:8px;margin-top:4px;}/*!sc*/ data-styled.g793[id="sc-bUsiPH"]{content:"gNYhnT,"}/*!sc*/ .hBTmYJ .other-tickers{position:absolute;display:none;max-height:120px;margin:2px 0;overflow-y:scroll;z-index:50;}/*!sc*/ .hBTmYJ .other-tickers,.hBTmYJ .other-tickers-label{align-items:baseline;background-color:white;border-radius:4px;border:solid 1px #B8CBE6;color:#395173;font-weight:bold;padding:0px 4px;}/*!sc*/ .hBTmYJ .other-tickers-label{display:inline-flex;}/*!sc*/ .hBTmYJ .ticker-box{border:none;}/*!sc*/ .hBTmYJ:hover .other-tickers{display:block;}/*!sc*/ data-styled.g794[id="sc-hwTdGM"]{content:"hBTmYJ,"}/*!sc*/ .bjJtVr{text-overflow:ellipsis;overflow:hidden;display:-webkit-box;-webkit-line-clamp:2;-webkit-box-orient:vertical;}/*!sc*/ @media (max-width: 768px){.bjJtVr{-webkit-line-clamp:4;font-weight:normal;}}/*!sc*/ data-styled.g795[id="sc-ceLTrZ"]{content:"bjJtVr,"}/*!sc*/ .iOEnob.news-list-wrapper .news-block{border-bottom:solid 1px #CEDDF2;line-height:1.5;padding:12px 0;}/*!sc*/ .iOEnob.news-list-wrapper .news-block .news-block-headline{color:#000000;}/*!sc*/ .iOEnob.news-list-wrapper .news-block .article-title{font-size:16px;font-weight:600;}/*!sc*/ .iOEnob.news-list-wrapper .news-block-title{border-color:#99AECC;}/*!sc*/ .iOEnob.news-list-wrapper .news-block-title .see-more{font-size:12px;font-weight:600;text-transform:none;white-space:nowrap;}/*!sc*/ .iOEnob.news-list-wrapper .news-block-list-container{display:grid;}/*!sc*/ .iOEnob.news-list-wrapper a.news-block-list-headline:hover{color:#69a5ff;}/*!sc*/ data-styled.g796[id="sc-kSsGea"]{content:"iOEnob,"}/*!sc*/ .kLNFwH.latest-news-list .watchlist-create-box{margin-top:20px;}/*!sc*/ .kLNFwH.latest-news-list .news-block-header{margin-bottom:8px;}/*!sc*/ .kLNFwH.latest-news-list .news-block-header h3{font-size:24px;}/*!sc*/ .kLNFwH.latest-news-list .news-block-title{border-bottom:none;}/*!sc*/ data-styled.g797[id="sc-fAlvPn"]{content:"kLNFwH,"}/*!sc*/ .hdmTnE{display:flex;align-items:center;justify-content:center;text-align:center;margin:5px 0;font-weight:bold;color:#3f83f8;width:100%;padding:10px 0;cursor:pointer;}/*!sc*/ data-styled.g798[id="sc-lcMqGs"]{content:"hdmTnE,"}/*!sc*/ .icxwYm.news-list-group-wrapper{display:grid;gap:32px;grid-template-columns:repeat(2, minmax(0, 1fr));}/*!sc*/ @media (max-width: 640px){.icxwYm.news-list-group-wrapper{gap:32px;grid-column:2;grid-template-columns:repeat(1, minmax(0, 1fr));}}/*!sc*/ .icxwYm.news-list-group-wrapper .parsely-news-list .news-block-header,.icxwYm.news-list-group-wrapper .latest-news-list .news-block-header{display:flex;white-space:nowrap;justify-content:space-between;align-items:center;border-bottom:solid 1px #99AECC;padding:4px 0;margin-top:12px;}/*!sc*/ @media (max-width: 850px){.icxwYm.news-list-group-wrapper .parsely-news-list .news-block-header,.icxwYm.news-list-group-wrapper .latest-news-list .news-block-header{flex-wrap:wrap;}}/*!sc*/ @media (max-width: 780px){.icxwYm.news-list-group-wrapper .parsely-news-list .news-block-header,.icxwYm.news-list-group-wrapper .latest-news-list .news-block-header{flex-wrap:unset;}}/*!sc*/ .icxwYm.news-list-group-wrapper .parsely-news-list .news-block-header .news-block-title,.icxwYm.news-list-group-wrapper .latest-news-list .news-block-header .news-block-title{font-size:1.2rem;}/*!sc*/ .icxwYm.news-list-group-wrapper .parsely-news-list .news-block-header .news-block-tabs-list,.icxwYm.news-list-group-wrapper .latest-news-list .news-block-header .news-block-tabs-list{min-width:224px;}/*!sc*/ .icxwYm.news-list-group-wrapper .parsely-news-list .news-block-header .news-block-tabs-list button,.icxwYm.news-list-group-wrapper .latest-news-list .news-block-header .news-block-tabs-list button{text-transform:uppercase;color:#395173;font-size:14px;font-weight:600;border-bottom:2px solid transparent;}/*!sc*/ .icxwYm.news-list-group-wrapper .parsely-news-list .news-block-header .news-block-tabs-list button.active,.icxwYm.news-list-group-wrapper .latest-news-list .news-block-header .news-block-tabs-list button.active{color:#1c64f2;border-bottom:2px solid;}/*!sc*/ .icxwYm.news-list-group-wrapper .parsely-news-list .news-block-header .news-block-tabs-list .divider,.icxwYm.news-list-group-wrapper .latest-news-list .news-block-header .news-block-tabs-list .divider{margin:0 5px;}/*!sc*/ data-styled.g799[id="sc-fKFgrF"]{content:"icxwYm,"}/*!sc*/ .kTbgNs.news-list-group-block{margin:1rem auto;}/*!sc*/ data-styled.g800[id="sc-fCzvdW"]{content:"kTbgNs,"}/*!sc*/ .jjVqAK{width:100%;}/*!sc*/ .jjVqAK .header-container{display:flex;align-items:center;margin-bottom:0.75rem;}/*!sc*/ .jjVqAK .header-container .header-title{z-index:2;font-weight:600;font-size:14px;line-height:1;padding-right:0.5rem;word-wrap:break-word;white-space:normal;}/*!sc*/ .jjVqAK .header-container .see-more-link{font-weight:700;font-size:12px;color:#3f83f8;margin-left:0.625rem;}/*!sc*/ .jjVqAK .benzinga-core-virtualized-table-wrapper{height:400px;border-left:1px solid #f0f0f0;border-right:1px solid #f0f0f0;border-bottom:1px solid #f0f0f0;}/*!sc*/ .jjVqAK table{table-layout:fixed;border-collapse:collapse;border-spacing:0;}/*!sc*/ .jjVqAK table th{padding:0.4rem;}/*!sc*/ .jjVqAK table td{padding:0.35rem 0.5rem;}/*!sc*/ .jjVqAK table td:last-of-type{text-align:unset;}/*!sc*/ .jjVqAK thead{margin:0;position:sticky;top:0;z-index:2;}/*!sc*/ data-styled.g803[id="sc-bCcCHF"]{content:"jjVqAK,"}/*!sc*/ .kafOiN{font-family:Helvetica Neue,Helvetica,OpenSans,Arial,sans-serif;}/*!sc*/ data-styled.g808[id="sc-hVwoBy"]{content:"kafOiN,"}/*!sc*/ .kxoPLy{position:relative;}/*!sc*/ .kxoPLy a{line-height:inherit;color:#2ca2d1;text-decoration:none;cursor:pointer;}/*!sc*/ .kxoPLy img{display:inline-block;vertical-align:middle;max-width:100%;height:auto;}/*!sc*/ data-styled.g809[id="sc-fehoED"]{content:"kxoPLy,"}/*!sc*/ .jPywwb{display:flex;align-items:center;justify-content:space-between;overflow-x:auto;margin-bottom:0.5rem;}/*!sc*/ @media only screen and (max-width: 800px){.jPywwb{flex-direction:column;align-items:flex-start;}}/*!sc*/ data-styled.g810[id="sc-izxAxU"]{content:"jPywwb,"}/*!sc*/ .TiiOD{margin-bottom:8px;text-transform:uppercase;font-weight:bold;font-size:24px;color:#283d59;}/*!sc*/ data-styled.g811[id="sc-fIiAAZ"]{content:"TiiOD,"}/*!sc*/ .bCfCnu{box-sizing:border-box;background:rgba(26, 121, 255, 0.025);overflow:hidden;position:relative;}/*!sc*/ data-styled.g812[id="sc-lmVGTp"]{content:"bCfCnu,"}/*!sc*/ .cbJLow{display:block;background:#f2f8ff;border:0.5px solid #e1ebfa;box-sizing:border-box;width:16px;height:16px;border-radius:50px;font-size:9px;color:#2ca2d1;display:flex;justify-content:center;align-items:center;}/*!sc*/ data-styled.g813[id="sc-huOXlg"]{content:"cbJLow,"}/*!sc*/ .cianqS{display:flex;width:100%;justify-content:center;align-items:center;padding:8px 0;cursor:pointer;border:1px solid #E1EBFA;border-top:none;border-bottom-left-radius:4px;border-bottom-right-radius:4px;}/*!sc*/ .cianqS a{font-size:14px;line-height:20px;text-decoration:none;font-size:0.875rem;cursor:pointer;font-weight:500;color:#2ca2d1;margin-right:8px;}/*!sc*/ .cianqS a:hover{text-decoration:underline;}/*!sc*/ data-styled.g814[id="sc-ekHxab"]{content:"cianqS,"}/*!sc*/ .kvjVGb .section-header{align-items:center;display:inline-flex;justify-content:space-between;width:100%;border-bottom:solid 1px #99AECC;margin:16px 0;padding:4px 0;}/*!sc*/ .kvjVGb .section-header a{font-size:16px;}/*!sc*/ .kvjVGb .event-videos{margin-bottom:16px;}/*!sc*/ .kvjVGb .iframe-wrapper{position:relative;padding-bottom:56.25%;height:0;overflow:hidden;width:100%;margin-bottom:24px;}/*!sc*/ .kvjVGb .iframe-wrapper iframe{position:absolute;top:0;left:0;width:100%;height:100%;}/*!sc*/ .kvjVGb .ad-wrapper{overflow:hidden;margin-bottom:0.5rem;}/*!sc*/ .kvjVGb .ad-wrapper iframe{margin:auto;}/*!sc*/ .kvjVGb .news-list-group-wrapper .section-title{margin-bottom:0px;}/*!sc*/ .kvjVGb .news-list-group-wrapper .load-more-button{text-align:left;display:inline-block;}/*!sc*/ .kvjVGb .watchlist-create-box-title{font-size:1.4rem;}/*!sc*/ .kvjVGb .watchlist-create-box-subtitle{font-size:1rem;}/*!sc*/ data-styled.g1416[id="sc-bkTvXO"]{content:"kvjVGb,"}/*!sc*/ .iUkejh.page-title{font-size:2.6rem;color:#111;}/*!sc*/ data-styled.g1417[id="sc-jCWTJb"]{content:"iUkejh,"}/*!sc*/ .gSsgJX.page-title-wrapper{display:inline-flex;margin-bottom:0.75rem;align-items:baseline;border-bottom:solid 1px #99AECC;padding-bottom:0.25rem;width:100%;}/*!sc*/ @media (max-width: 768px){.gSsgJX.page-title-wrapper{flex-direction:column;}}/*!sc*/ data-styled.g1418[id="sc-kOzJCk"]{content:"gSsgJX,"}/*!sc*/ .btQGbg{font-size:12px;font-style:italic;}/*!sc*/ data-styled.g1419[id="sc-hRhxOB"]{content:"btQGbg,"}/*!sc*/ .eGMBfQ.calendars-widget-block{margin:1rem auto;}/*!sc*/ data-styled.g1420[id="sc-hzJlkW"]{content:"eGMBfQ,"}/*!sc*/ </style></head><body><div id="__next"><div class="sc-KDzwu jnhVCZ header-container "><div class="sc-dlDPRo dAVAzt mobile-header-wrapper"><div class="sc-gWQvRS egAjKC"><div class="sc-hlqirL jRqJvd mobile-header-wrapper" id="navigation-header"><div class="top-banner-fallback h-20 bg-[#0b131d] relative py-4"><div class="animate-pulse h-full relative rounded-full bg-slate-700/50 max-w-[1400px] mx-auto"></div></div><div class="left-0 right-0 top-0 z-[9999999]" id="mobile-main-block"><div class="mobile-header flex items-center justify-between relative" style="transition:all linear 0.3s;z-index:20"><div class="menu-icon-wrapper"><div><svg aria-hidden="true" class="leading-none" stroke="currentColor" stroke-width="1" style="height:1em;width:1em" viewBox="0 0 448 512" xmlns="http://www.w3.org/2000/svg"><path d="M0 80c0-8.8 7.2-16 16-16H432c8.8 0 16 7.2 16 16s-7.2 16-16 16H16C7.2 96 0 88.8 0 80zM0 240c0-8.8 7.2-16 16-16H432c8.8 0 16 7.2 16 16s-7.2 16-16 16H16c-8.8 0-16-7.2-16-16zM448 400c0 8.8-7.2 16-16 16H16c-8.8 0-16-7.2-16-16s7.2-16 16-16H432c8.8 0 16 7.2 16 16z" fill="currentColor"></path></svg></div></div><div class="sc-jPQKUW PtwYC logo-wrapper mobile-logo-wrapper"><a aria-label="Click to go home" href="/"><span class="sc-hiTDLB hSWwyX benzinga-logo light mobile"><svg height="100%" role="img" viewBox="0 0 471.1 63.8" width="100%" xmlns="http://www.w3.org/2000/svg"><path d="M67.7 63.8h45.2V51.9H81.4V37.3h26.1V25.4H81.4V11.9h31.7V0H67.7zm99.6-23.6L137.7 0h-20.4l6.4 8.1V64h13.6V22.1l30.6 41.7H181V0h-13.7zM47.1 31c6-1.1 11-6.7 11-14.6C58.1 7.9 51.9 0 39.6 0H0l6.2 7.9v56H41c12.3 0 18.7-7.7 18.7-17.3-.3-7.9-5.7-14.7-12.6-15.6zM19.8 12h17.1c4.6 0 7.5 2.7 7.5 6.7s-2.9 6.7-7.5 6.7H19.8V12zm17.7 40H19.8V37.3h17.7c5.2 0 8.1 3.3 8.1 7.3 0 4.6-3.1 7.3-8.1 7.4zm343.3-11.8h7.1v7.5c-3.7 3-8.3 4.7-13.1 4.8-11.4 0-19.4-8.7-19.4-20.4s8.1-20.4 19.4-20.4c5.9 0 11.4 3.1 14.6 8.1l10.8-6C395.6 6.5 387.5 0 374.7 0c-18.1 0-33.1 12.5-33.1 31.9s14.8 31.9 33.1 31.9c10 .2 19.5-4.1 26.1-11.5V28.7h-29.2l9.2 11.5zm-61.5 0L289.6 0h-20.3l6.3 8.1V64h13.7V22.1l30.6 41.7h13V0h-13.6zM446 0h-26.3l6.3 8.1-1.1 3.1L404.5 64h15.4l4-10.8h27.5l4 10.8h15.4L446 0zm-18.6 41.2l10-27.5 10 27.5h-20zM247.7 0h13.7v64.1h-13.7zm-10.9 11V0h-48.1v11.9h30.2l-30.2 41v10.9h48.6V51.9h-30.9z" fill="#FFFFFF"></path></svg></span></a></div><div class="flex h-12 items-center text-blue-300"><div class="sc-fnpiog kUONMW global-menu menu-wrapper"><div aria-label="Global Menu" class="menu-button" role="button"><span class="global-text w-[25px] h-[16px]"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 513 342" title="USA"><path fill="#FFF" d="M0 0h513v342H0z"></path><path fill="#D80027" d="M0 0h513v38H0zm0 76h513v38H0zm0 76h513v38H0zm0 76h513v38H0zm0 76h513v38H0z"></path><path fill="#2E52B2" d="M0 0h256.5v190H0z"></path><path fill="#FFF" d="m47.8 141.9-4-12.8-4.3 12.8H26.3l10.7 7.7-4 12.8 10.8-7.9 10.7 7.9-4.2-12.8 10.9-7.7zm56.4 0-4.1-12.8-4.2 12.8H82.7l10.7 7.7-4.1 12.8 10.8-7.9 10.7 7.9-4-12.8 10.8-7.7zm56.4 0-4.2-12.8-4 12.8h-13.5l10.9 7.7-4.2 12.8 10.8-7.9 10.9 7.9-4.2-12.8 10.8-7.7zm56.3 0-4.1-12.8-4.2 12.8h-13.2l10.7 7.7-4 12.8 10.7-7.9 10.8 7.9-4.2-12.8 10.9-7.7zM100.1 78.3l-4.2 12.8H82.7L93.4 99l-4.1 12.6 10.8-7.8 10.7 7.8-4-12.6 10.8-7.9h-13.4zm-56.3 0-4.3 12.8H26.3L37 99l-4 12.6 10.8-7.8 10.7 7.8L50.3 99l10.9-7.9H47.8zm112.6 0-4 12.8h-13.5l10.9 7.9-4.2 12.6 10.8-7.8 10.9 7.8-4.2-12.6 10.8-7.9h-13.3zm56.4 0-4.2 12.8h-13.2l10.7 7.9-4 12.6 10.7-7.8 10.8 7.8-4.2-12.6 10.9-7.9h-13.4zm-169-50.6-4.3 12.6H26.3L37 48.2l-4 12.7L43.8 53l10.7 7.9-4.2-12.7 10.9-7.9H47.8zm56.3 0-4.2 12.6H82.7l10.7 7.9-4.1 12.7 10.8-7.9 10.7 7.9-4-12.7 10.8-7.9h-13.4zm56.3 0-4 12.6h-13.5l10.9 7.9-4.2 12.7 10.8-7.9 10.9 7.9-4.2-12.7 10.8-7.9h-13.3zm56.4 0-4.2 12.6h-13.2l10.7 7.9-4 12.7 10.7-7.9 10.8 7.9-4.2-12.7 10.9-7.9h-13.4z"></path></svg></span><span role="img" aria-label="down" class="anticon anticon-down"><svg viewBox="64 64 896 896" focusable="false" data-icon="down" width="1em" height="1em" fill="currentColor" aria-hidden="true"><path d="M884 256h-75c-5.1 0-9.9 2.5-12.9 6.6L512 654.2 227.9 262.6c-3-4.1-7.8-6.6-12.9-6.6h-75c-6.5 0-10.3 7.4-6.5 12.7l352.6 486.1c12.8 17.6 39 17.6 51.7 0l352.6-486.1c3.9-5.3.1-12.7-6.4-12.7z"></path></svg></span></div><div class="global-menu-dropdown"><div class="global-menu-item"><a href="https://es.benzinga.com" rel="noreferrer" tabindex="0" target="_blank"><span class="w-[25px] h-[16px]"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 85.333 512 341.333" title="España"><path fill="#FFDA44" d="M0 85.331h512v341.337H0z"></path><path fill="#D80027" d="M0 85.331h512v113.775H0zm0 227.551h512v113.775H0z"></path></svg></span><span>España</span></a></div><div class="global-menu-item"><a href="https://in.benzinga.com" rel="noreferrer" tabindex="0" target="_blank"><span class="w-[25px] h-[16px]"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 85.333 512 341.333" title="India"><path fill="#FFF" d="M0 85.337h512v341.326H0z"></path><path fill="#FF9811" d="M0 85.337h512v113.775H0z"></path><path fill="#6DA544" d="M0 312.888h512v113.775H0z"></path><circle cx="256" cy="256" r="43.896" fill="#0052B4"></circle><circle cx="256" cy="256" r="27.434" fill="#FFF"></circle><path fill="#0052B4" d="m256 222.146 8.464 19.195 20.855-2.268L272.927 256l12.392 16.927-20.855-2.268L256 289.854l-8.464-19.195-20.855 2.268L239.073 256l-12.392-16.927 20.855 2.268z"></path></svg></span><span>India</span></a></div><div class="global-menu-item"><a href="https://it.benzinga.com" rel="noreferrer" tabindex="0" target="_blank"><span class="w-[25px] h-[16px]"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 85.333 512 341.333" title="Italia"><path fill="#FFF" d="M341.334 85.33H0v341.332h512V85.33z"></path><path fill="#6DA544" d="M0 85.333h170.663V426.67H0z"></path><path fill="#D80027" d="M341.337 85.333H512V426.67H341.337z"></path></svg></span><span>Italia</span></a></div><div class="global-menu-item"><a href="https://kr.benzinga.com/" rel="noreferrer" tabindex="0" target="_blank"><span class="w-[25px] h-[16px]"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 85.333 512 341.333" title="대한민국"><path fill="#FFF" d="M0 85.331h512v341.337H0z"></path><path fill="#D80027" d="M318.33 255.994c0 15.583-27.906 54.539-62.33 54.539s-62.33-38.957-62.33-54.539c0-34.424 27.906-62.33 62.33-62.33s62.33 27.906 62.33 62.33"></path><path fill="#0052B4" d="M318.33 255.994c0 34.424-27.906 62.33-62.33 62.33s-62.33-27.906-62.33-62.33"></path><path d="m322.114 311.096 16.528-16.528 11.018 11.018-16.528 16.528zm-27.548 27.534 16.528-16.527 11.018 11.018-16.528 16.528zm60.604 5.502 16.527-16.528 11.018 11.018-16.527 16.528zm-27.549 27.557 16.528-16.528 11.018 11.018-16.528 16.528zm11.02-44.075 16.528-16.527 11.018 11.018-16.527 16.527zm-27.547 27.546 16.528-16.528 11.018 11.018-16.528 16.527zm44.083-154.264-44.073-44.073 11.018-11.018 44.073 44.073zm-44.078-11.015-16.528-16.527 11.017-11.018 16.528 16.528zm27.536 27.55-16.528-16.527 11.017-11.018 16.528 16.528zm5.5-60.606-16.528-16.528 11.018-11.018 16.528 16.528zm27.559 27.549-16.528-16.527 11.019-11.019 16.527 16.528zM140.31 327.61l44.073 44.074-11.018 11.018-44.074-44.073zm44.058 11.025 16.527 16.527-11.017 11.018-16.528-16.528zm-27.536-27.548 16.528 16.528-11.019 11.018-16.527-16.528zm16.531-16.523 44.073 44.073-11.018 11.019-44.073-44.074zm11.021-154.277-44.073 44.074-11.018-11.018 44.073-44.074zm16.511 16.536-44.073 44.074-11.018-11.018 44.073-44.074zm16.529 16.528-44.074 44.074-11.017-11.017 44.074-44.074z"></path></svg></span><span>대한민국</span></a></div><div class="global-menu-item"><a href="https://jp.benzinga.com/" rel="noreferrer" tabindex="0" target="_blank"><span class="w-[25px] h-[16px]"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 85.333 512 341.333" title="日本"><path fill="#FFF" d="M0 85.331h512v341.337H0z"></path><circle cx="256" cy="255.994" r="96" fill="#D80027"></circle></svg></span><span>日本</span></a></div></div></div><div class="sc-jnlcPO LChwz account-menu menu-wrapper"><button class="menu-button"><span role="img" aria-label="user" class="anticon anticon-user"><svg viewBox="64 64 896 896" focusable="false" data-icon="user" width="1em" height="1em" fill="currentColor" aria-hidden="true"><path d="M858.5 763.6a374 374 0 00-80.6-119.5 375.63 375.63 0 00-119.5-80.6c-.4-.2-.8-.3-1.2-.5C719.5 518 760 444.7 760 362c0-137-111-248-248-248S264 225 264 362c0 82.7 40.5 156 102.8 201.1-.4.2-.8.3-1.2.5-44.8 18.9-85 46-119.5 80.6a375.63 375.63 0 00-80.6 119.5A371.7 371.7 0 00136 901.8a8 8 0 008 8.2h60c4.4 0 7.9-3.5 8-7.8 2-77.2 33-149.5 87.8-204.3 56.7-56.7 132-87.9 212.2-87.9s155.5 31.2 212.2 87.9C779 752.7 810 825 812 902.2c.1 4.4 3.6 7.8 8 7.8h60a8 8 0 008-8.2c-1-47.8-10.9-94.3-29.5-138.2zM512 534c-45.9 0-89.1-17.9-121.6-50.4S340 407.9 340 362c0-45.9 17.9-89.1 50.4-121.6S466.1 190 512 190s89.1 17.9 121.6 50.4S684 316.1 684 362c0 45.9-17.9 89.1-50.4 121.6S557.9 534 512 534z"></path></svg></span><span class="my-account-text">My Account</span><span role="img" aria-label="down" class="anticon anticon-down"><svg viewBox="64 64 896 896" focusable="false" data-icon="down" width="1em" height="1em" fill="currentColor" aria-hidden="true"><path d="M884 256h-75c-5.1 0-9.9 2.5-12.9 6.6L512 654.2 227.9 262.6c-3-4.1-7.8-6.6-12.9-6.6h-75c-6.5 0-10.3 7.4-6.5 12.7l352.6 486.1c12.8 17.6 39 17.6 51.7 0l352.6-486.1c3.9-5.3.1-12.7-6.4-12.7z"></path></svg></span></button><div class="account-menu-dropdown"><div class="account-menu-item"><span><a href="/account">My Account</a></span></div><div class="account-menu-item"><a href="https://www.benzinga.com/profile/portfolio/?action=notifications">Notifications</a></div><div class="account-menu-item"><a href="https://www.benzinga.com/profile/portfolio">Overview</a></div><div class="account-menu-item"><a href="https://www.benzinga.com/profile/portfolio/?action=new_watchlist">+ New Watchlist</a></div><hr class="divider"/><div class="account-menu-item benzinga-edge"><a href="https://www.benzinga.com/profile/portfolio">Benzinga Edge</a></div><div class="account-menu-item benzinga-plus"><a href="https://www.benzinga.com/research">Benzinga Research</a></div><div class="account-menu-item benzinga-pro"><a href="https://pro.benzinga.com">Benzinga Pro</a></div><hr class="divider"/><div class="account-menu-item"><a href="https://www.benzinga.com/profile/portfolio/?action=login">Log In</a></div></div></div></div></div></div><div class="mobile-quote-bar overflow-x-scroll" id="mobile-quote-bar"><div class="sc-bjUHJT jSzLBk quote-list-wrapper"><a class="sc-vIyEI dPuOYX quote-block negative" href="/quote/SMG"><h5 class="sc-dmcoYd cIdFlt quotebox-quote-name">SMG</h5><div class="sc-dsAqUS jdorvA quotebox-quote-data"><span class="sc-YltrM hfIiBn quotebox-quote-price">77.80</span><span class="sc-YltrM sc-imiRDh hfIiBn kruvvw quotebox-quote-change negative"><span role="img" aria-label="caret-down" class="anticon anticon-caret-down quote-icon"><svg viewBox="0 0 1024 1024" focusable="false" data-icon="caret-down" width="1em" height="1em" fill="currentColor" aria-hidden="true"><path d="M840.4 300H183.6c-19.7 0-30.7 20.8-18.5 35l328.4 380.8c9.4 10.9 27.5 10.9 37 0L858.9 335c12.2-14.2 1.2-35-18.5-35z"></path></svg></span><span>4.81%</span></span></div></a><a class="sc-vIyEI dPuOYX quote-block negative" href="/quote/TLRY"><h5 class="sc-dmcoYd cIdFlt quotebox-quote-name">TLRY</h5><div class="sc-dsAqUS jdorvA quotebox-quote-data"><span class="sc-YltrM hfIiBn quotebox-quote-price">1.36</span><span class="sc-YltrM sc-imiRDh hfIiBn kruvvw quotebox-quote-change negative"><span role="img" aria-label="caret-down" class="anticon anticon-caret-down quote-icon"><svg viewBox="0 0 1024 1024" focusable="false" data-icon="caret-down" width="1em" height="1em" fill="currentColor" aria-hidden="true"><path d="M840.4 300H183.6c-19.7 0-30.7 20.8-18.5 35l328.4 380.8c9.4 10.9 27.5 10.9 37 0L858.9 335c12.2-14.2 1.2-35-18.5-35z"></path></svg></span><span>4.23%</span></span></div></a><a class="sc-vIyEI dPuOYX quote-block negative" href="/quote/IIPR"><h5 class="sc-dmcoYd cIdFlt quotebox-quote-name">IIPR</h5><div class="sc-dsAqUS jdorvA quotebox-quote-data"><span class="sc-YltrM hfIiBn quotebox-quote-price">109.15</span><span class="sc-YltrM sc-imiRDh hfIiBn kruvvw quotebox-quote-change negative"><span role="img" aria-label="caret-down" class="anticon anticon-caret-down quote-icon"><svg viewBox="0 0 1024 1024" focusable="false" data-icon="caret-down" width="1em" height="1em" fill="currentColor" aria-hidden="true"><path d="M840.4 300H183.6c-19.7 0-30.7 20.8-18.5 35l328.4 380.8c9.4 10.9 27.5 10.9 37 0L858.9 335c12.2-14.2 1.2-35-18.5-35z"></path></svg></span><span>2.37%</span></span></div></a><a class="sc-vIyEI dPuOYX quote-block negative" href="/quote/CGC"><h5 class="sc-dmcoYd cIdFlt quotebox-quote-name">CGC</h5><div class="sc-dsAqUS jdorvA quotebox-quote-data"><span class="sc-YltrM hfIiBn quotebox-quote-price">3.93</span><span class="sc-YltrM sc-imiRDh hfIiBn kruvvw quotebox-quote-change negative"><span role="img" aria-label="caret-down" class="anticon anticon-caret-down quote-icon"><svg viewBox="0 0 1024 1024" focusable="false" data-icon="caret-down" width="1em" height="1em" fill="currentColor" aria-hidden="true"><path d="M840.4 300H183.6c-19.7 0-30.7 20.8-18.5 35l328.4 380.8c9.4 10.9 27.5 10.9 37 0L858.9 335c12.2-14.2 1.2-35-18.5-35z"></path></svg></span><span>5.3%</span></span></div></a><a class="sc-vIyEI dPuOYX quote-block negative" href="/quote/ACB"><h5 class="sc-dmcoYd cIdFlt quotebox-quote-name">ACB</h5><div class="sc-dsAqUS jdorvA quotebox-quote-data"><span class="sc-YltrM hfIiBn quotebox-quote-price">4.47</span><span class="sc-YltrM sc-imiRDh hfIiBn kruvvw quotebox-quote-change negative"><span role="img" aria-label="caret-down" class="anticon anticon-caret-down quote-icon"><svg viewBox="0 0 1024 1024" focusable="false" data-icon="caret-down" width="1em" height="1em" fill="currentColor" aria-hidden="true"><path d="M840.4 300H183.6c-19.7 0-30.7 20.8-18.5 35l328.4 380.8c9.4 10.9 27.5 10.9 37 0L858.9 335c12.2-14.2 1.2-35-18.5-35z"></path></svg></span><span>2.19%</span></span></div></a><a class="sc-vIyEI dPuOYX quote-block negative" href="/quote/SNDL"><h5 class="sc-dmcoYd cIdFlt quotebox-quote-name">SNDL</h5><div class="sc-dsAqUS jdorvA quotebox-quote-data"><span class="sc-YltrM hfIiBn quotebox-quote-price">1.97</span><span class="sc-YltrM sc-imiRDh hfIiBn kruvvw quotebox-quote-change negative"><span role="img" aria-label="caret-down" class="anticon anticon-caret-down quote-icon"><svg viewBox="0 0 1024 1024" focusable="false" data-icon="caret-down" width="1em" height="1em" fill="currentColor" aria-hidden="true"><path d="M840.4 300H183.6c-19.7 0-30.7 20.8-18.5 35l328.4 380.8c9.4 10.9 27.5 10.9 37 0L858.9 335c12.2-14.2 1.2-35-18.5-35z"></path></svg></span><span>2.48%</span></span></div></a><a class="sc-vIyEI eDEUMb quote-block positive" href="/quote/GTBIF"><h5 class="sc-dmcoYd cIdFlt quotebox-quote-name">GTBIF</h5><div class="sc-dsAqUS jdorvA quotebox-quote-data"><span class="sc-YltrM hfIiBn quotebox-quote-price">9.34</span><span class="sc-YltrM sc-imiRDh hfIiBn gUNJVP quotebox-quote-change positive"><span role="img" aria-label="caret-up" class="anticon anticon-caret-up quote-icon"><svg viewBox="0 0 1024 1024" focusable="false" data-icon="caret-up" width="1em" height="1em" fill="currentColor" aria-hidden="true"><path d="M858.9 689L530.5 308.2c-9.4-10.9-27.5-10.9-37 0L165.1 689c-12.2 14.2-1.2 35 18.5 35h656.8c19.7 0 30.7-20.8 18.5-35z"></path></svg></span><span>3.66%</span></span></div></a><a class="sc-vIyEI dPuOYX quote-block negative" href="/quote/TCNNF"><h5 class="sc-dmcoYd cIdFlt quotebox-quote-name">TCNNF</h5><div class="sc-dsAqUS jdorvA quotebox-quote-data"><span class="sc-YltrM hfIiBn quotebox-quote-price">5.92</span><span class="sc-YltrM sc-imiRDh hfIiBn kruvvw quotebox-quote-change negative"><span role="img" aria-label="caret-down" class="anticon anticon-caret-down quote-icon"><svg viewBox="0 0 1024 1024" focusable="false" data-icon="caret-down" width="1em" height="1em" fill="currentColor" aria-hidden="true"><path d="M840.4 300H183.6c-19.7 0-30.7 20.8-18.5 35l328.4 380.8c9.4 10.9 27.5 10.9 37 0L858.9 335c12.2-14.2 1.2-35-18.5-35z"></path></svg></span><span>2.47%</span></span></div></a><a class="sc-vIyEI dPuOYX quote-block negative" href="/quote/MJ"><h5 class="sc-dmcoYd cIdFlt quotebox-quote-name">MJ</h5><div class="sc-dsAqUS jdorvA quotebox-quote-data"><span class="sc-YltrM hfIiBn quotebox-quote-price">2.60</span><span class="sc-YltrM sc-imiRDh hfIiBn kruvvw quotebox-quote-change negative"><span role="img" aria-label="caret-down" class="anticon anticon-caret-down quote-icon"><svg viewBox="0 0 1024 1024" focusable="false" data-icon="caret-down" width="1em" height="1em" fill="currentColor" aria-hidden="true"><path d="M840.4 300H183.6c-19.7 0-30.7 20.8-18.5 35l328.4 380.8c9.4 10.9 27.5 10.9 37 0L858.9 335c12.2-14.2 1.2-35-18.5-35z"></path></svg></span><span>0.38%</span></span></div></a><a class="sc-vIyEI dPuOYX quote-block negative" href="/quote/GNLN"><h5 class="sc-dmcoYd cIdFlt quotebox-quote-name">GNLN</h5><div class="sc-dsAqUS jdorvA quotebox-quote-data"><span class="sc-YltrM hfIiBn quotebox-quote-price">1.76</span><span class="sc-YltrM sc-imiRDh hfIiBn kruvvw quotebox-quote-change negative"><span role="img" aria-label="caret-down" class="anticon anticon-caret-down quote-icon"><svg viewBox="0 0 1024 1024" focusable="false" data-icon="caret-down" width="1em" height="1em" fill="currentColor" aria-hidden="true"><path d="M840.4 300H183.6c-19.7 0-30.7 20.8-18.5 35l328.4 380.8c9.4 10.9 27.5 10.9 37 0L858.9 335c12.2-14.2 1.2-35-18.5-35z"></path></svg></span><span>6.88%</span></span></div></a></div></div><div class="search-wrapper transition" id="mobile-search-bar" style="transition:all linear 0.3s"><div class="sc-fGrmBj bdnXYZ searchbar-wrapper searchbar-default"><div class="sc-jPpdYo hffEc searchbar-container"><div class="sc-drMgrp bEqVKz search-input-container"><div class="sc-cZpZpK hIXnUa search-input-wrapper" style="flex-direction:row"><div class="search-icon" role="presentation"><span role="img" aria-label="search" class="anticon anticon-search"><svg viewBox="64 64 896 896" focusable="false" data-icon="search" width="1em" height="1em" fill="currentColor" aria-hidden="true"><path d="M909.6 854.5L649.9 594.8C690.2 542.7 712 479 712 412c0-80.2-31.3-155.4-87.9-212.1-56.6-56.7-132-87.9-212.1-87.9s-155.5 31.3-212.1 87.9C143.2 256.5 112 331.8 112 412c0 80.1 31.3 155.5 87.9 212.1C256.5 680.8 331.8 712 412 712c67 0 130.6-21.8 182.7-62l259.7 259.6a8.2 8.2 0 0011.6 0l43.6-43.5a8.2 8.2 0 000-11.6zM570.4 570.4C528 612.7 471.8 636 412 636s-116-23.3-158.4-65.6C211.3 528 188 471.8 188 412s23.3-116.1 65.6-158.4C296 211.3 352.2 188 412 188s116.1 23.2 158.4 65.6S636 352.2 636 412s-23.3 116.1-65.6 158.4z"></path></svg></span></div><input aria-label="Search" class="search-input" placeholder="Search Tickers, Companies or News..." role="searchbox" tabindex="0" type="search" value=""/></div></div></div></div></div></div></div></div><div class="sc-dxfTlo djYNFx desktop-menu-wrapper" id="navigation-header"><div class="top-banner-fallback h-20 bg-[#0b131d] relative py-4"><div class="animate-pulse h-full relative rounded-full bg-slate-700/50 max-w-[1400px] mx-auto"></div></div><div class="sc-glNIji iJrqFm top-bar-wrapper"><div class="bar-layout-width"><div class="top-bar-inner-wrapper"><ul class="top-bar-list"><li class="bz-top-bar-list-item ProLabel"><a aria-label="Get Benzinga Pro" class="sc-eIPYkq kgifvw shine-effect text-white bz-pro-btn" href="https://www.benzinga.com/pro/register?utm_source=homepage-blue-button">Get Benzinga Pro </a></li><li class="bz-top-bar-list-item"><a href="https://www.benzinga.com/apis"><div class="bz-top-bar-list-item-label">Data & APIs</div></a></li><li class="bz-top-bar-list-item"><a href="https://www.benzinga.com/events"><div class="bz-top-bar-list-item-label">Events</div></a></li><li class="bz-top-bar-list-item"><a href="https://marketfy.com/?__hstc=258999573.1ab86f21505b156c04ee556f3ea4a8de.1617281961141.1623244531459.1623314433592.60&__hssc=258999573.1.1623314433592&__hsfp=58102761"><div class="bz-top-bar-list-item-label">Marketfy</div></a></li><li class="bz-top-bar-list-item"><a href="https://www.benzinga.com/premarket"><div class="bz-top-bar-list-item-label">Premarket</div></a></li><li class="bz-top-bar-list-item"><a href="https://boost.benzinga.com"><div class="bz-top-bar-list-item-label">Boost</div></a></li><li class="bz-top-bar-list-item"><a href="https://advertise.benzinga.com"><div class="bz-top-bar-list-item-label">Advertise</div></a></li></ul><div class="auth-buttons"><div class="contributor-link"><a href="https://contributor.benzinga.com/contributor-onboarding">Contribute</a></div><div class="sc-fnpiog kUONMW global-menu menu-wrapper"><div aria-label="Global Menu" class="menu-button" role="button"><span class="global-text w-[25px] h-[16px]"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 513 342" title="USA"><path fill="#FFF" d="M0 0h513v342H0z"></path><path fill="#D80027" d="M0 0h513v38H0zm0 76h513v38H0zm0 76h513v38H0zm0 76h513v38H0zm0 76h513v38H0z"></path><path fill="#2E52B2" d="M0 0h256.5v190H0z"></path><path fill="#FFF" d="m47.8 141.9-4-12.8-4.3 12.8H26.3l10.7 7.7-4 12.8 10.8-7.9 10.7 7.9-4.2-12.8 10.9-7.7zm56.4 0-4.1-12.8-4.2 12.8H82.7l10.7 7.7-4.1 12.8 10.8-7.9 10.7 7.9-4-12.8 10.8-7.7zm56.4 0-4.2-12.8-4 12.8h-13.5l10.9 7.7-4.2 12.8 10.8-7.9 10.9 7.9-4.2-12.8 10.8-7.7zm56.3 0-4.1-12.8-4.2 12.8h-13.2l10.7 7.7-4 12.8 10.7-7.9 10.8 7.9-4.2-12.8 10.9-7.7zM100.1 78.3l-4.2 12.8H82.7L93.4 99l-4.1 12.6 10.8-7.8 10.7 7.8-4-12.6 10.8-7.9h-13.4zm-56.3 0-4.3 12.8H26.3L37 99l-4 12.6 10.8-7.8 10.7 7.8L50.3 99l10.9-7.9H47.8zm112.6 0-4 12.8h-13.5l10.9 7.9-4.2 12.6 10.8-7.8 10.9 7.8-4.2-12.6 10.8-7.9h-13.3zm56.4 0-4.2 12.8h-13.2l10.7 7.9-4 12.6 10.7-7.8 10.8 7.8-4.2-12.6 10.9-7.9h-13.4zm-169-50.6-4.3 12.6H26.3L37 48.2l-4 12.7L43.8 53l10.7 7.9-4.2-12.7 10.9-7.9H47.8zm56.3 0-4.2 12.6H82.7l10.7 7.9-4.1 12.7 10.8-7.9 10.7 7.9-4-12.7 10.8-7.9h-13.4zm56.3 0-4 12.6h-13.5l10.9 7.9-4.2 12.7 10.8-7.9 10.9 7.9-4.2-12.7 10.8-7.9h-13.3zm56.4 0-4.2 12.6h-13.2l10.7 7.9-4 12.7 10.7-7.9 10.8 7.9-4.2-12.7 10.9-7.9h-13.4z"></path></svg></span><span role="img" aria-label="down" class="anticon anticon-down"><svg viewBox="64 64 896 896" focusable="false" data-icon="down" width="1em" height="1em" fill="currentColor" aria-hidden="true"><path d="M884 256h-75c-5.1 0-9.9 2.5-12.9 6.6L512 654.2 227.9 262.6c-3-4.1-7.8-6.6-12.9-6.6h-75c-6.5 0-10.3 7.4-6.5 12.7l352.6 486.1c12.8 17.6 39 17.6 51.7 0l352.6-486.1c3.9-5.3.1-12.7-6.4-12.7z"></path></svg></span></div><div class="global-menu-dropdown"><div class="global-menu-item"><a href="https://es.benzinga.com" rel="noreferrer" tabindex="0" target="_blank"><span class="w-[25px] h-[16px]"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 85.333 512 341.333" title="España"><path fill="#FFDA44" d="M0 85.331h512v341.337H0z"></path><path fill="#D80027" d="M0 85.331h512v113.775H0zm0 227.551h512v113.775H0z"></path></svg></span><span>España</span></a></div><div class="global-menu-item"><a href="https://in.benzinga.com" rel="noreferrer" tabindex="0" target="_blank"><span class="w-[25px] h-[16px]"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 85.333 512 341.333" title="India"><path fill="#FFF" d="M0 85.337h512v341.326H0z"></path><path fill="#FF9811" d="M0 85.337h512v113.775H0z"></path><path fill="#6DA544" d="M0 312.888h512v113.775H0z"></path><circle cx="256" cy="256" r="43.896" fill="#0052B4"></circle><circle cx="256" cy="256" r="27.434" fill="#FFF"></circle><path fill="#0052B4" d="m256 222.146 8.464 19.195 20.855-2.268L272.927 256l12.392 16.927-20.855-2.268L256 289.854l-8.464-19.195-20.855 2.268L239.073 256l-12.392-16.927 20.855 2.268z"></path></svg></span><span>India</span></a></div><div class="global-menu-item"><a href="https://it.benzinga.com" rel="noreferrer" tabindex="0" target="_blank"><span class="w-[25px] h-[16px]"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 85.333 512 341.333" title="Italia"><path fill="#FFF" d="M341.334 85.33H0v341.332h512V85.33z"></path><path fill="#6DA544" d="M0 85.333h170.663V426.67H0z"></path><path fill="#D80027" d="M341.337 85.333H512V426.67H341.337z"></path></svg></span><span>Italia</span></a></div><div class="global-menu-item"><a href="https://kr.benzinga.com/" rel="noreferrer" tabindex="0" target="_blank"><span class="w-[25px] h-[16px]"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 85.333 512 341.333" title="대한민국"><path fill="#FFF" d="M0 85.331h512v341.337H0z"></path><path fill="#D80027" d="M318.33 255.994c0 15.583-27.906 54.539-62.33 54.539s-62.33-38.957-62.33-54.539c0-34.424 27.906-62.33 62.33-62.33s62.33 27.906 62.33 62.33"></path><path fill="#0052B4" d="M318.33 255.994c0 34.424-27.906 62.33-62.33 62.33s-62.33-27.906-62.33-62.33"></path><path d="m322.114 311.096 16.528-16.528 11.018 11.018-16.528 16.528zm-27.548 27.534 16.528-16.527 11.018 11.018-16.528 16.528zm60.604 5.502 16.527-16.528 11.018 11.018-16.527 16.528zm-27.549 27.557 16.528-16.528 11.018 11.018-16.528 16.528zm11.02-44.075 16.528-16.527 11.018 11.018-16.527 16.527zm-27.547 27.546 16.528-16.528 11.018 11.018-16.528 16.527zm44.083-154.264-44.073-44.073 11.018-11.018 44.073 44.073zm-44.078-11.015-16.528-16.527 11.017-11.018 16.528 16.528zm27.536 27.55-16.528-16.527 11.017-11.018 16.528 16.528zm5.5-60.606-16.528-16.528 11.018-11.018 16.528 16.528zm27.559 27.549-16.528-16.527 11.019-11.019 16.527 16.528zM140.31 327.61l44.073 44.074-11.018 11.018-44.074-44.073zm44.058 11.025 16.527 16.527-11.017 11.018-16.528-16.528zm-27.536-27.548 16.528 16.528-11.019 11.018-16.527-16.528zm16.531-16.523 44.073 44.073-11.018 11.019-44.073-44.074zm11.021-154.277-44.073 44.074-11.018-11.018 44.073-44.074zm16.511 16.536-44.073 44.074-11.018-11.018 44.073-44.074zm16.529 16.528-44.074 44.074-11.017-11.017 44.074-44.074z"></path></svg></span><span>대한민국</span></a></div><div class="global-menu-item"><a href="https://jp.benzinga.com/" rel="noreferrer" tabindex="0" target="_blank"><span class="w-[25px] h-[16px]"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 85.333 512 341.333" title="日本"><path fill="#FFF" d="M0 85.331h512v341.337H0z"></path><circle cx="256" cy="255.994" r="96" fill="#D80027"></circle></svg></span><span>日本</span></a></div></div></div><button class="auth-link-button">Login</button><button class="auth-link-button bg-orange-600">Register</button></div></div></div></div><div class="sc-juusvx ihnpVB main-menu-bar"><div class="sc-emwzcK hsBJnI main-menu-wrapper"><div class="sc-iJrEMN eAxjKW bar-content-layout"><div class="sc-jPQKUW PtwYC logo-wrapper mobile-logo-wrapper"><a aria-label="Click to go home" href="/"><span class="sc-hiTDLB hSWwyX benzinga-logo dark desktop"><svg height="100%" role="img" viewBox="0 0 471.1 63.8" width="100%" xmlns="http://www.w3.org/2000/svg"><path d="M67.7 63.8h45.2V51.9H81.4V37.3h26.1V25.4H81.4V11.9h31.7V0H67.7zm99.6-23.6L137.7 0h-20.4l6.4 8.1V64h13.6V22.1l30.6 41.7H181V0h-13.7zM47.1 31c6-1.1 11-6.7 11-14.6C58.1 7.9 51.9 0 39.6 0H0l6.2 7.9v56H41c12.3 0 18.7-7.7 18.7-17.3-.3-7.9-5.7-14.7-12.6-15.6zM19.8 12h17.1c4.6 0 7.5 2.7 7.5 6.7s-2.9 6.7-7.5 6.7H19.8V12zm17.7 40H19.8V37.3h17.7c5.2 0 8.1 3.3 8.1 7.3 0 4.6-3.1 7.3-8.1 7.4zm343.3-11.8h7.1v7.5c-3.7 3-8.3 4.7-13.1 4.8-11.4 0-19.4-8.7-19.4-20.4s8.1-20.4 19.4-20.4c5.9 0 11.4 3.1 14.6 8.1l10.8-6C395.6 6.5 387.5 0 374.7 0c-18.1 0-33.1 12.5-33.1 31.9s14.8 31.9 33.1 31.9c10 .2 19.5-4.1 26.1-11.5V28.7h-29.2l9.2 11.5zm-61.5 0L289.6 0h-20.3l6.3 8.1V64h13.7V22.1l30.6 41.7h13V0h-13.6zM446 0h-26.3l6.3 8.1-1.1 3.1L404.5 64h15.4l4-10.8h27.5l4 10.8h15.4L446 0zm-18.6 41.2l10-27.5 10 27.5h-20zM247.7 0h13.7v64.1h-13.7zm-10.9 11V0h-48.1v11.9h30.2l-30.2 41v10.9h48.6V51.9h-30.9z" fill="#093451"></path></svg></span></a></div><div class="sc-grhZJe dHIdf primary-menu-wrapper"><ul class="sc-kUNLVD gLmRHE menu-item-container"><li><div class="sc-GkLId cjSToK menu-wrapper primary"><a class="sc-hBgdUx juPIzz menu-item-link initial" data-action="Navigation Main Menu Click" href="/services" style="min-width:108px" title="Our Services">Our Services </a></div></li><li><div class="sc-GkLId cjSToK menu-wrapper primary"><a class="sc-hBgdUx juPIzz menu-item-link initial" data-action="Navigation Main Menu Click" href="/news" style="min-width:57px" title="News">News </a><div class="sc-jYnQyy ZorAP sub-nav-wrapper subnav"><div class="sc-fYrVWQ ksgWfK sub-group-wrapper"><div class="menu-items"><div class="sc-labuuU drA-dBo menu-item-wrapper"><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/earnings" title="Earnings">Earnings</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/calendars/guidance" title="Guidance">Guidance</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/dividends" title="Dividends">Dividends</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/calendars/m-a" title="M&amp;A">M&A</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/news/buybacks" title="Buybacks">Buybacks</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/news/legal" title="Legal">Legal</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/interview" title="Interviews">Interviews</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/news/management" title="Management">Management</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/news/offerings" title="Offerings">Offerings</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/calendars/ipos" title="IPOs">IPOs</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/news/insider-trades" title="Insider Trades">Insider Trades</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/fda-calendar" title="Biotech/FDA">Biotech/FDA</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/general/politics" title="Politics">Politics</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/topic/healthcare" title="Healthcare">Healthcare</a></div></div></div></div></div></div></li><li><div class="sc-GkLId cjSToK menu-wrapper primary"><a class="sc-hBgdUx juPIzz menu-item-link initial" data-action="Navigation Main Menu Click" href="/markets" style="min-width:75px" title="Markets">Markets </a><div class="sc-jYnQyy ZorAP sub-nav-wrapper subnav"><div class="sc-fYrVWQ ksgWfK sub-group-wrapper"><div class="menu-items"><div class="sc-labuuU drA-dBo menu-item-wrapper"><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/premarket" title="Pre-Market">Pre-Market</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/after-hours-center" title="After Hours">After Hours</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/movers" title="Movers">Movers</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/etfs" title="ETFs">ETFs</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/markets/forex" title="Forex">Forex</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/cannabis" title="Cannabis">Cannabis</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/markets/commodities" title="Commodities">Commodities</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/markets/binary-options" title="Binary Options">Binary Options</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/markets/bonds" title="Bonds">Bonds</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/futures" title="Futures">Futures</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/author/cme-group" title="CME Group">CME Group</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/calendars/economic" title="Global Economics">Global Economics</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/topic/mining" title="Mining">Mining</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/trading-ideas/previews" title="Previews">Previews</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/news/small-cap" title="Small-Cap">Small-Cap</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/real-estate" title="Real Estate">Real Estate</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/best-penny-stocks" title="Penny Stocks">Penny Stocks</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/topic/digital-securities" title="Digital Securities">Digital Securities</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/topic/volatility" title="Volatility">Volatility</a></div></div></div></div></div></div></li><li><div class="sc-GkLId cjSToK menu-wrapper primary"><a class="sc-hBgdUx juPIzz menu-item-link initial" data-action="Navigation Main Menu Click" href="/markets/options" style="min-width:75px" title="Options">Options </a></div></li><li><div class="sc-GkLId cjSToK menu-wrapper primary"><a class="sc-hBgdUx juPIzz menu-item-link initial" data-action="Navigation Main Menu Click" href="/analyst-stock-ratings" style="min-width:73px" title="Ratings">Ratings </a><div class="sc-jYnQyy ZorAP sub-nav-wrapper subnav"><div class="sc-fYrVWQ ksgWfK sub-group-wrapper"><div class="menu-items"><div class="sc-labuuU drA-dBo menu-item-wrapper"><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/analyst-ratings/analyst-color" title="Analyst Color">Analyst Color</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/analyst-stock-ratings/downgrades" title="Downgrades">Downgrades</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/analyst-stock-ratings/upgrades" title="Upgrades">Upgrades</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/analyst-stock-ratings/initiations" title="Initiations">Initiations</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/analyst-ratings/price-target" title="Price Target">Price Target</a></div></div></div></div></div></div></li><li><div class="sc-GkLId cjSToK menu-wrapper primary"><a class="sc-hBgdUx juPIzz menu-item-link initial" data-action="Navigation Main Menu Click" href="/trading-ideas" style="min-width:57px" title="Ideas">Ideas </a><div class="sc-jYnQyy ZorAP sub-nav-wrapper subnav has-groups"><div class="sc-fYrVWQ ksgWfK sub-group-wrapper"><div class="sc-dXNkBG byUlBP group-list"><div><div class="sc-jFREAR bzULrg group-list-item-label">Trade Ideas</div><div><div class="menu-items"><div class="sc-labuuU drA-dBo menu-item-wrapper"><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/trading-ideas/long-ideas" title="Long Ideas">Long Ideas</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/trading-ideas/short-ideas" title="Short Ideas">Short Ideas</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/trading-ideas/technicals" title="Technicals">Technicals</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/media" title="From The Press">From The Press</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/topic/jim-cramer" title="Jim Cramer">Jim Cramer</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/news/rumors" title="Rumors">Rumors</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/topic/stock-whisper-index" title="Whisper Index">Whisper Index</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/topic/stock-of-the-day" title="Stock of the Day">Stock of the Day</a></div></div></div></div></div><div><div class="sc-jFREAR bzULrg group-list-item-label">Best Stocks & ETFs</div><div><div class="menu-items"><div class="sc-labuuU drA-dBo menu-item-wrapper"><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/best-penny-stocks" title="Best Penny Stocks">Best Penny Stocks</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/best-sp-500-etfs" title="Best S&P 500 ETFs">Best S&P 500 ETFs</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/best-swing-trade-stocks" title="Best Swing Trade Stocks">Best Swing Trade Stocks</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/best-blue-chip-stocks" title="Best Blue Chip Stocks">Best Blue Chip Stocks</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/best-high-volume-penny-stocks" title="Best High-Volume Penny Stocks">Best High-Volume Penny Stocks</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/best-small-cap-etfs" title="Best Small Cap ETFs">Best Small Cap ETFs</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/best-stocks-to-day-trade" title="Best Stocks to Day Trade">Best Stocks to Day Trade</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/best-reits" title="Best Stocks to Day Trade">Best REITs</a></div></div></div></div></div></div></div></div></div></li><li><div class="sc-GkLId cjSToK menu-wrapper primary"><a class="sc-hBgdUx juPIzz menu-item-link initial" data-action="Navigation Main Menu Click" href="/money" style="min-width:66px" title="Money">Money </a><div class="sc-jYnQyy ZorAP sub-nav-wrapper subnav"><div class="sc-fYrVWQ ksgWfK sub-group-wrapper"><div class="menu-items"><div class="sc-labuuU drA-dBo menu-item-wrapper"><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/investing" title="Investing">Investing</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/crypto" title="Cryptocurrency">Cryptocurrency</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/mortgage-rates" title="Mortgage">Mortgage</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/insurance" title="Insurance">Insurance</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/yield-investments" title="Yield">Yield</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/personal-finance" title="Personal Finance">Personal Finance</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/markets/forex" title="Forex">Forex</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/alternative-investments/startups" title="Startup Investing">Startup Investing</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/alternative-investments/real-estate" title="Real Estate Investing">Real Estate Investing</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/best-prop-trading-firms" title="Prop Trading">Prop Trading</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/best-credit-cards" title="Credit Cards">Credit Cards</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/best-stock-brokers-in-the-us" title="Stock Brokers">Stock Brokers</a></div></div></div></div></div></div></li><li><div class="sc-GkLId cjSToK menu-wrapper primary"><a class="sc-hBgdUx juPIzz menu-item-link initial" data-action="Navigation Main Menu Click" href="/crypto" style="min-width:fit-content" title="Crypto">Crypto </a></div></li><li><div class="sc-GkLId cjSToK menu-wrapper primary"><a class="sc-hBgdUx juPIzz menu-item-link initial" data-action="Navigation Main Menu Click" href="/cannabis" style="min-width:84px" title="Cannabis">Cannabis </a><div class="sc-jYnQyy ZorAP sub-nav-wrapper subnav"><div class="sc-fYrVWQ ksgWfK sub-group-wrapper"><div class="menu-items"><div class="sc-labuuU drA-dBo menu-item-wrapper"><div class="sc-yRUbj bFLWIV highlight dropdown-menu-item"><a data-action="Get Tickets to the Cannabis Conference" href="/events/cannabis-conference/" title="Cannabis Conference">Cannabis Conference</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/cannabis/earnings" title="Earnings">Earnings</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/cannabis/interviews" title="Interviews">Interviews</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/cannabis/deals" title="Deals">Deals</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/topic/cannabis-regulation" title="Regulations">Regulations</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/markets/psychedelics" title="Psychedelics">Psychedelics</a></div></div></div></div></div></div></li></ul></div><button aria-label="Click to open more navbar items" class="more-nav-tabs-icon-container"><div class="text-2xl text-black"><svg aria-hidden="true" class="leading-none" stroke="currentColor" stroke-width="1" style="height:1em;width:1em" viewBox="0 0 448 512" xmlns="http://www.w3.org/2000/svg"><path d="M432 256a48 48 0 1 1 -96 0 48 48 0 1 1 96 0zm-160 0a48 48 0 1 1 -96 0 48 48 0 1 1 96 0zM64 304a48 48 0 1 1 0-96 48 48 0 1 1 0 96z" fill="currentColor"></path></svg></div><div class="sc-bPrlCs djnqwI more-menu-items-dropdown-container"><div class="sc-GkLId cjSToK menu-wrapper primary"><a class="sc-hBgdUx juPIzz menu-item-link initial" data-action="Navigation Main Menu Click" href="/markets" style="min-width:75px" title="Markets">Markets </a><div class="sc-jYnQyy ZorAP sub-nav-wrapper subnav"><div class="sc-fYrVWQ ksgWfK sub-group-wrapper"><div class="menu-items"><div class="sc-labuuU drA-dBo menu-item-wrapper"><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/premarket" title="Pre-Market">Pre-Market</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/after-hours-center" title="After Hours">After Hours</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/movers" title="Movers">Movers</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/etfs" title="ETFs">ETFs</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/markets/forex" title="Forex">Forex</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/cannabis" title="Cannabis">Cannabis</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/markets/commodities" title="Commodities">Commodities</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/markets/binary-options" title="Binary Options">Binary Options</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/markets/bonds" title="Bonds">Bonds</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/futures" title="Futures">Futures</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/author/cme-group" title="CME Group">CME Group</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/calendars/economic" title="Global Economics">Global Economics</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/topic/mining" title="Mining">Mining</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/trading-ideas/previews" title="Previews">Previews</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/news/small-cap" title="Small-Cap">Small-Cap</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/real-estate" title="Real Estate">Real Estate</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/best-penny-stocks" title="Penny Stocks">Penny Stocks</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/topic/digital-securities" title="Digital Securities">Digital Securities</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/topic/volatility" title="Volatility">Volatility</a></div></div></div></div></div></div><div class="sc-GkLId cjSToK menu-wrapper primary"><a class="sc-hBgdUx juPIzz menu-item-link initial" data-action="Navigation Main Menu Click" href="/markets/options" style="min-width:75px" title="Options">Options </a></div><div class="sc-GkLId cjSToK menu-wrapper primary"><a class="sc-hBgdUx juPIzz menu-item-link initial" data-action="Navigation Main Menu Click" href="/analyst-stock-ratings" style="min-width:73px" title="Ratings">Ratings </a><div class="sc-jYnQyy ZorAP sub-nav-wrapper subnav"><div class="sc-fYrVWQ ksgWfK sub-group-wrapper"><div class="menu-items"><div class="sc-labuuU drA-dBo menu-item-wrapper"><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/analyst-ratings/analyst-color" title="Analyst Color">Analyst Color</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/analyst-stock-ratings/downgrades" title="Downgrades">Downgrades</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/analyst-stock-ratings/upgrades" title="Upgrades">Upgrades</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/analyst-stock-ratings/initiations" title="Initiations">Initiations</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/analyst-ratings/price-target" title="Price Target">Price Target</a></div></div></div></div></div></div><div class="sc-GkLId cjSToK menu-wrapper primary"><a class="sc-hBgdUx juPIzz menu-item-link initial" data-action="Navigation Main Menu Click" href="/trading-ideas" style="min-width:57px" title="Ideas">Ideas </a><div class="sc-jYnQyy ZorAP sub-nav-wrapper subnav has-groups"><div class="sc-fYrVWQ ksgWfK sub-group-wrapper"><div class="sc-dXNkBG byUlBP group-list"><div><div class="sc-jFREAR bzULrg group-list-item-label">Trade Ideas</div><div><div class="menu-items"><div class="sc-labuuU drA-dBo menu-item-wrapper"><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/trading-ideas/long-ideas" title="Long Ideas">Long Ideas</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/trading-ideas/short-ideas" title="Short Ideas">Short Ideas</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/trading-ideas/technicals" title="Technicals">Technicals</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/media" title="From The Press">From The Press</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/topic/jim-cramer" title="Jim Cramer">Jim Cramer</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/news/rumors" title="Rumors">Rumors</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/topic/stock-whisper-index" title="Whisper Index">Whisper Index</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/topic/stock-of-the-day" title="Stock of the Day">Stock of the Day</a></div></div></div></div></div><div><div class="sc-jFREAR bzULrg group-list-item-label">Best Stocks & ETFs</div><div><div class="menu-items"><div class="sc-labuuU drA-dBo menu-item-wrapper"><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/best-penny-stocks" title="Best Penny Stocks">Best Penny Stocks</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/best-sp-500-etfs" title="Best S&P 500 ETFs">Best S&P 500 ETFs</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/best-swing-trade-stocks" title="Best Swing Trade Stocks">Best Swing Trade Stocks</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/best-blue-chip-stocks" title="Best Blue Chip Stocks">Best Blue Chip Stocks</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/best-high-volume-penny-stocks" title="Best High-Volume Penny Stocks">Best High-Volume Penny Stocks</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/best-small-cap-etfs" title="Best Small Cap ETFs">Best Small Cap ETFs</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/best-stocks-to-day-trade" title="Best Stocks to Day Trade">Best Stocks to Day Trade</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/best-reits" title="Best Stocks to Day Trade">Best REITs</a></div></div></div></div></div></div></div></div></div><div class="sc-GkLId cjSToK menu-wrapper primary"><a class="sc-hBgdUx juPIzz menu-item-link initial" data-action="Navigation Main Menu Click" href="/money" style="min-width:66px" title="Money">Money </a><div class="sc-jYnQyy ZorAP sub-nav-wrapper subnav"><div class="sc-fYrVWQ ksgWfK sub-group-wrapper"><div class="menu-items"><div class="sc-labuuU drA-dBo menu-item-wrapper"><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/investing" title="Investing">Investing</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/crypto" title="Cryptocurrency">Cryptocurrency</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/mortgage-rates" title="Mortgage">Mortgage</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/insurance" title="Insurance">Insurance</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/yield-investments" title="Yield">Yield</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/personal-finance" title="Personal Finance">Personal Finance</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/markets/forex" title="Forex">Forex</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/alternative-investments/startups" title="Startup Investing">Startup Investing</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/alternative-investments/real-estate" title="Real Estate Investing">Real Estate Investing</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/best-prop-trading-firms" title="Prop Trading">Prop Trading</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/best-credit-cards" title="Credit Cards">Credit Cards</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/best-stock-brokers-in-the-us" title="Stock Brokers">Stock Brokers</a></div></div></div></div></div></div><div class="sc-GkLId cjSToK menu-wrapper primary"><a class="sc-hBgdUx juPIzz menu-item-link initial" data-action="Navigation Main Menu Click" href="/crypto" style="min-width:fit-content" title="Crypto">Crypto </a></div><div class="sc-GkLId cjSToK menu-wrapper primary"><a class="sc-hBgdUx juPIzz menu-item-link initial" data-action="Navigation Main Menu Click" href="/cannabis" style="min-width:84px" title="Cannabis">Cannabis </a><div class="sc-jYnQyy ZorAP sub-nav-wrapper subnav"><div class="sc-fYrVWQ ksgWfK sub-group-wrapper"><div class="menu-items"><div class="sc-labuuU drA-dBo menu-item-wrapper"><div class="sc-yRUbj bFLWIV highlight dropdown-menu-item"><a data-action="Get Tickets to the Cannabis Conference" href="/events/cannabis-conference/" title="Cannabis Conference">Cannabis Conference</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/cannabis/earnings" title="Earnings">Earnings</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/cannabis/interviews" title="Interviews">Interviews</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/cannabis/deals" title="Deals">Deals</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/topic/cannabis-regulation" title="Regulations">Regulations</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/markets/psychedelics" title="Psychedelics">Psychedelics</a></div></div></div></div></div></div></div></button><div class="sc-ZaPur knRqnT secondary-menu-wrapper"><div class="sc-GkLId cjSToK menu-wrapper secondary"><a aria-label="This opens Research in a new tab" class="sc-eGgGjL gXrePV others-btn primary-toolbar-button" href="https://www.benzinga.com/research" style="min-width:110px" target="_blank" title="Research"><div class="text-xl pr-2"><svg aria-hidden="true" class="leading-none" stroke="currentColor" stroke-width="1" style="height:1em;width:1em" viewBox="0 0 576 512" xmlns="http://www.w3.org/2000/svg"><path d="M96 32C60.7 32 32 60.7 32 96V384H96V96l384 0V384h64V96c0-35.3-28.7-64-64-64H96zM224 384v32H32c-17.7 0-32 14.3-32 32s14.3 32 32 32H544c17.7 0 32-14.3 32-32s-14.3-32-32-32H416V384c0-17.7-14.3-32-32-32H256c-17.7 0-32 14.3-32 32z" fill="currentColor"></path></svg></div>Research</a></div><div class="sc-GkLId cjSToK menu-wrapper secondary"><a aria-label="This opens My Stocks in a new tab" class="sc-eGgGjL gXrePV others-btn primary-toolbar-button" href="https://www.benzinga.com/login?action=register&next=https://www.benzinga.com/profile/portfolio" style="min-width:105px" target="_blank" title="My Stocks"><div class="text-xl pr-1"><svg aria-hidden="true" class="leading-none" stroke="currentColor" stroke-width="1" style="height:1em;width:1em" viewBox="0 0 512 512" xmlns="http://www.w3.org/2000/svg"><path d="M500 89c13.8-11 16-31.2 5-45s-31.2-16-45-5L319.4 151.5 211.2 70.4c-11.7-8.8-27.8-8.5-39.2 .6L12 199c-13.8 11-16 31.2-5 45s31.2 16 45 5L192.6 136.5l108.2 81.1c11.7 8.8 27.8 8.5 39.2-.6L500 89zM160 256V448c0 17.7 14.3 32 32 32s32-14.3 32-32V256c0-17.7-14.3-32-32-32s-32 14.3-32 32zM32 352v96c0 17.7 14.3 32 32 32s32-14.3 32-32V352c0-17.7-14.3-32-32-32s-32 14.3-32 32zm288-64c-17.7 0-32 14.3-32 32V448c0 17.7 14.3 32 32 32s32-14.3 32-32V320c0-17.7-14.3-32-32-32zm96-32V448c0 17.7 14.3 32 32 32s32-14.3 32-32V256c0-17.7-14.3-32-32-32s-32 14.3-32 32z" fill="currentColor"></path></svg></div>My Stocks</a></div><div class="sc-GkLId cjSToK menu-wrapper secondary"><a aria-label="This opens Tools in a new tab" class="sc-eGgGjL gXrePV others-btn primary-toolbar-button" href="https://www.benzinga.com/tools" style="min-width:100px" target="_blank" title="Tools"><div class="text-xl pr-1"><svg aria-hidden="true" class="leading-none" stroke="currentColor" stroke-width="1" style="height:1em;width:1em" viewBox="0 0 512 512" xmlns="http://www.w3.org/2000/svg"><path d="M352 320c88.4 0 160-71.6 160-160c0-15.3-2.2-30.1-6.2-44.2c-3.1-10.8-16.4-13.2-24.3-5.3l-76.8 76.8c-3 3-7.1 4.7-11.3 4.7H336c-8.8 0-16-7.2-16-16V118.6c0-4.2 1.7-8.3 4.7-11.3l76.8-76.8c7.9-7.9 5.4-21.2-5.3-24.3C382.1 2.2 367.3 0 352 0C263.6 0 192 71.6 192 160c0 19.1 3.4 37.5 9.5 54.5L19.9 396.1C7.2 408.8 0 426.1 0 444.1C0 481.6 30.4 512 67.9 512c18 0 35.3-7.2 48-19.9L297.5 310.5c17 6.2 35.4 9.5 54.5 9.5zM80 408a24 24 0 1 1 0 48 24 24 0 1 1 0-48z" fill="currentColor"></path></svg></div>Tools</a><div class="sc-jYnQyy ZorAP sub-nav-wrapper subnav has-groups"><div class="sc-fYrVWQ ksgWfK sub-group-wrapper"><a aria-label="Free Benzinga Pro Trial" class="sc-eIPYkq kgifvw shine-effect text-white block py-2 rounded-sm bg-bzblue-600 text-center mx-2 md:mx-4 my-2" href="https://pro.benzinga.com/register/?utm_source=tools-bz-pro-free-trial">Free Benzinga Pro Trial </a><div class="sc-dXNkBG byUlBP group-list"><div><div class="sc-jFREAR bzULrg group-list-item-label">Calendars</div><div><div class="menu-items"><div class="sc-labuuU drA-dBo menu-item-wrapper"><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/analyst-stock-ratings" title="Analyst Ratings Calendar">Analyst Ratings Calendar</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/calendars/conference-calls" title="Conference Call Calendar">Conference Call Calendar</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/dividends" title="Dividend Calendar">Dividend Calendar</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/earnings" title="Earnings Calendar">Earnings Calendar</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/calendars/economic" title="Economic Calendar">Economic Calendar</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/fda-calendar" title="FDA Calendar">FDA Calendar</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/calendars/guidance" title="Guidance Calendar">Guidance Calendar</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/calendars/ipos" title="IPO Calendar">IPO Calendar</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/calendars/m-a" title="M&A Calendar">M&A Calendar</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/calendars/spac" title="SPAC Calendar">SPAC Calendar</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/calendars/stock-splits" title="Stock Split Calendar">Stock Split Calendar</a></div></div></div></div></div><div><div class="sc-jFREAR bzULrg group-list-item-label">Trade Ideas</div><div><div class="menu-items"><div class="sc-labuuU drA-dBo menu-item-wrapper"><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/reports" title="Free Stock Reports">Free Stock Reports</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/sec/insider-trades/" title="Insider Trades">Insider Trades</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/trading-ideas" title="Trade Idea Feed">Trade Idea Feed</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/analyst-stock-ratings" title="Analyst Ratings">Analyst Ratings</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/calendars/unusual-options-activity" title="Unusual Options Activity">Unusual Options Activity</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/research/tools/heatmap" title="Heatmaps">Heatmaps</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/free-newsletters" title="Free Newsletter">Free Newsletter</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/gov-trades" title="Government Trades">Government Trades</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/portfolio/perfect-stock-portfolio" title="Perfect Stock Portfolio">Perfect Stock Portfolio</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/portfolio/easy-income-portfolio" title="Easy Income Portfolio">Easy Income Portfolio</a></div></div></div></div></div><div><div class="sc-jFREAR bzULrg group-list-item-label">Short Interest</div><div><div class="menu-items"><div class="sc-labuuU drA-dBo menu-item-wrapper"><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/short-interest/most-shorted" title="Most Shorted">Most Shorted</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/short-interest/largest-increase" title="Largest Increase">Largest Increase</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/short-interest/largest-decrease" title="Largest Decrease">Largest Decrease</a></div></div></div></div></div><div><div class="sc-jFREAR bzULrg group-list-item-label">Calculators</div><div><div class="menu-items"><div class="sc-labuuU drA-dBo menu-item-wrapper"><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/margin-calculator" title="Margin Calculator">Margin Calculator</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/forex-profit-calculator" title="Forex Profit Calculator">Forex Profit Calculator</a></div><div class="sc-yRUbj gBYoJd dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/research/tools/100x-options-profit-calculator" title="100x Options Profit Calculator">100x Options Profit Calculator</a></div></div></div></div></div></div></div></div></div></div></div></div></div><div class="sc-fnfGmV cDBmGl quote-bar-container"><div class="quote-bar-layout-width"><div class="quote-bar-wrapper"><div class="sc-eYFTNc iAQCXw quote-switcher-wrapper"><div class="quote-switcher-container"><button class="sc-iEYVpv hBLAMO quote-switcher-button">Recent</button><button class="sc-iEYVpv hkLhtO quote-switcher-button">Markets</button></div></div><div class="quote-list-container"><div class="sc-bjUHJT jSzLBk quote-list-wrapper"><a class="sc-vIyEI dPuOYX quote-block negative" href="/quote/SMG"><h5 class="sc-dmcoYd cIdFlt quotebox-quote-name">SMG</h5><div class="sc-dsAqUS jdorvA quotebox-quote-data"><span class="sc-YltrM hfIiBn quotebox-quote-price">77.80</span><span class="sc-YltrM sc-imiRDh hfIiBn kruvvw quotebox-quote-change negative"><span role="img" aria-label="caret-down" class="anticon anticon-caret-down quote-icon"><svg viewBox="0 0 1024 1024" focusable="false" data-icon="caret-down" width="1em" height="1em" fill="currentColor" aria-hidden="true"><path d="M840.4 300H183.6c-19.7 0-30.7 20.8-18.5 35l328.4 380.8c9.4 10.9 27.5 10.9 37 0L858.9 335c12.2-14.2 1.2-35-18.5-35z"></path></svg></span><span>4.81%</span></span></div></a><a class="sc-vIyEI dPuOYX quote-block negative" href="/quote/TLRY"><h5 class="sc-dmcoYd cIdFlt quotebox-quote-name">TLRY</h5><div class="sc-dsAqUS jdorvA quotebox-quote-data"><span class="sc-YltrM hfIiBn quotebox-quote-price">1.36</span><span class="sc-YltrM sc-imiRDh hfIiBn kruvvw quotebox-quote-change negative"><span role="img" aria-label="caret-down" class="anticon anticon-caret-down quote-icon"><svg viewBox="0 0 1024 1024" focusable="false" data-icon="caret-down" width="1em" height="1em" fill="currentColor" aria-hidden="true"><path d="M840.4 300H183.6c-19.7 0-30.7 20.8-18.5 35l328.4 380.8c9.4 10.9 27.5 10.9 37 0L858.9 335c12.2-14.2 1.2-35-18.5-35z"></path></svg></span><span>4.23%</span></span></div></a><a class="sc-vIyEI dPuOYX quote-block negative" href="/quote/IIPR"><h5 class="sc-dmcoYd cIdFlt quotebox-quote-name">IIPR</h5><div class="sc-dsAqUS jdorvA quotebox-quote-data"><span class="sc-YltrM hfIiBn quotebox-quote-price">109.15</span><span class="sc-YltrM sc-imiRDh hfIiBn kruvvw quotebox-quote-change negative"><span role="img" aria-label="caret-down" class="anticon anticon-caret-down quote-icon"><svg viewBox="0 0 1024 1024" focusable="false" data-icon="caret-down" width="1em" height="1em" fill="currentColor" aria-hidden="true"><path d="M840.4 300H183.6c-19.7 0-30.7 20.8-18.5 35l328.4 380.8c9.4 10.9 27.5 10.9 37 0L858.9 335c12.2-14.2 1.2-35-18.5-35z"></path></svg></span><span>2.37%</span></span></div></a><a class="sc-vIyEI dPuOYX quote-block negative" href="/quote/CGC"><h5 class="sc-dmcoYd cIdFlt quotebox-quote-name">CGC</h5><div class="sc-dsAqUS jdorvA quotebox-quote-data"><span class="sc-YltrM hfIiBn quotebox-quote-price">3.93</span><span class="sc-YltrM sc-imiRDh hfIiBn kruvvw quotebox-quote-change negative"><span role="img" aria-label="caret-down" class="anticon anticon-caret-down quote-icon"><svg viewBox="0 0 1024 1024" focusable="false" data-icon="caret-down" width="1em" height="1em" fill="currentColor" aria-hidden="true"><path d="M840.4 300H183.6c-19.7 0-30.7 20.8-18.5 35l328.4 380.8c9.4 10.9 27.5 10.9 37 0L858.9 335c12.2-14.2 1.2-35-18.5-35z"></path></svg></span><span>5.3%</span></span></div></a><a class="sc-vIyEI dPuOYX quote-block negative" href="/quote/ACB"><h5 class="sc-dmcoYd cIdFlt quotebox-quote-name">ACB</h5><div class="sc-dsAqUS jdorvA quotebox-quote-data"><span class="sc-YltrM hfIiBn quotebox-quote-price">4.47</span><span class="sc-YltrM sc-imiRDh hfIiBn kruvvw quotebox-quote-change negative"><span role="img" aria-label="caret-down" class="anticon anticon-caret-down quote-icon"><svg viewBox="0 0 1024 1024" focusable="false" data-icon="caret-down" width="1em" height="1em" fill="currentColor" aria-hidden="true"><path d="M840.4 300H183.6c-19.7 0-30.7 20.8-18.5 35l328.4 380.8c9.4 10.9 27.5 10.9 37 0L858.9 335c12.2-14.2 1.2-35-18.5-35z"></path></svg></span><span>2.19%</span></span></div></a><a class="sc-vIyEI dPuOYX quote-block negative" href="/quote/SNDL"><h5 class="sc-dmcoYd cIdFlt quotebox-quote-name">SNDL</h5><div class="sc-dsAqUS jdorvA quotebox-quote-data"><span class="sc-YltrM hfIiBn quotebox-quote-price">1.97</span><span class="sc-YltrM sc-imiRDh hfIiBn kruvvw quotebox-quote-change negative"><span role="img" aria-label="caret-down" class="anticon anticon-caret-down quote-icon"><svg viewBox="0 0 1024 1024" focusable="false" data-icon="caret-down" width="1em" height="1em" fill="currentColor" aria-hidden="true"><path d="M840.4 300H183.6c-19.7 0-30.7 20.8-18.5 35l328.4 380.8c9.4 10.9 27.5 10.9 37 0L858.9 335c12.2-14.2 1.2-35-18.5-35z"></path></svg></span><span>2.48%</span></span></div></a><a class="sc-vIyEI eDEUMb quote-block positive" href="/quote/GTBIF"><h5 class="sc-dmcoYd cIdFlt quotebox-quote-name">GTBIF</h5><div class="sc-dsAqUS jdorvA quotebox-quote-data"><span class="sc-YltrM hfIiBn quotebox-quote-price">9.34</span><span class="sc-YltrM sc-imiRDh hfIiBn gUNJVP quotebox-quote-change positive"><span role="img" aria-label="caret-up" class="anticon anticon-caret-up quote-icon"><svg viewBox="0 0 1024 1024" focusable="false" data-icon="caret-up" width="1em" height="1em" fill="currentColor" aria-hidden="true"><path d="M858.9 689L530.5 308.2c-9.4-10.9-27.5-10.9-37 0L165.1 689c-12.2 14.2-1.2 35 18.5 35h656.8c19.7 0 30.7-20.8 18.5-35z"></path></svg></span><span>3.66%</span></span></div></a><a class="sc-vIyEI dPuOYX quote-block negative" href="/quote/TCNNF"><h5 class="sc-dmcoYd cIdFlt quotebox-quote-name">TCNNF</h5><div class="sc-dsAqUS jdorvA quotebox-quote-data"><span class="sc-YltrM hfIiBn quotebox-quote-price">5.92</span><span class="sc-YltrM sc-imiRDh hfIiBn kruvvw quotebox-quote-change negative"><span role="img" aria-label="caret-down" class="anticon anticon-caret-down quote-icon"><svg viewBox="0 0 1024 1024" focusable="false" data-icon="caret-down" width="1em" height="1em" fill="currentColor" aria-hidden="true"><path d="M840.4 300H183.6c-19.7 0-30.7 20.8-18.5 35l328.4 380.8c9.4 10.9 27.5 10.9 37 0L858.9 335c12.2-14.2 1.2-35-18.5-35z"></path></svg></span><span>2.47%</span></span></div></a><a class="sc-vIyEI dPuOYX quote-block negative" href="/quote/MJ"><h5 class="sc-dmcoYd cIdFlt quotebox-quote-name">MJ</h5><div class="sc-dsAqUS jdorvA quotebox-quote-data"><span class="sc-YltrM hfIiBn quotebox-quote-price">2.60</span><span class="sc-YltrM sc-imiRDh hfIiBn kruvvw quotebox-quote-change negative"><span role="img" aria-label="caret-down" class="anticon anticon-caret-down quote-icon"><svg viewBox="0 0 1024 1024" focusable="false" data-icon="caret-down" width="1em" height="1em" fill="currentColor" aria-hidden="true"><path d="M840.4 300H183.6c-19.7 0-30.7 20.8-18.5 35l328.4 380.8c9.4 10.9 27.5 10.9 37 0L858.9 335c12.2-14.2 1.2-35-18.5-35z"></path></svg></span><span>0.38%</span></span></div></a><a class="sc-vIyEI dPuOYX quote-block negative" href="/quote/GNLN"><h5 class="sc-dmcoYd cIdFlt quotebox-quote-name">GNLN</h5><div class="sc-dsAqUS jdorvA quotebox-quote-data"><span class="sc-YltrM hfIiBn quotebox-quote-price">1.76</span><span class="sc-YltrM sc-imiRDh hfIiBn kruvvw quotebox-quote-change negative"><span role="img" aria-label="caret-down" class="anticon anticon-caret-down quote-icon"><svg viewBox="0 0 1024 1024" focusable="false" data-icon="caret-down" width="1em" height="1em" fill="currentColor" aria-hidden="true"><path d="M840.4 300H183.6c-19.7 0-30.7 20.8-18.5 35l328.4 380.8c9.4 10.9 27.5 10.9 37 0L858.9 335c12.2-14.2 1.2-35-18.5-35z"></path></svg></span><span>6.88%</span></span></div></a></div></div><div class="search-wrapper"><div class="sc-fGrmBj bdnXYZ searchbar-wrapper searchbar-default"><div class="sc-jPpdYo hffEc searchbar-container"><div class="sc-drMgrp bEqVKz search-input-container"><div class="sc-cZpZpK hIXnUa search-input-wrapper" style="flex-direction:row"><div class="search-icon" role="presentation"><span role="img" aria-label="search" class="anticon anticon-search"><svg viewBox="64 64 896 896" focusable="false" data-icon="search" width="1em" height="1em" fill="currentColor" aria-hidden="true"><path d="M909.6 854.5L649.9 594.8C690.2 542.7 712 479 712 412c0-80.2-31.3-155.4-87.9-212.1-56.6-56.7-132-87.9-212.1-87.9s-155.5 31.3-212.1 87.9C143.2 256.5 112 331.8 112 412c0 80.1 31.3 155.5 87.9 212.1C256.5 680.8 331.8 712 412 712c67 0 130.6-21.8 182.7-62l259.7 259.6a8.2 8.2 0 0011.6 0l43.6-43.5a8.2 8.2 0 000-11.6zM570.4 570.4C528 612.7 471.8 636 412 636s-116-23.3-158.4-65.6C211.3 528 188 471.8 188 412s23.3-116.1 65.6-158.4C296 211.3 352.2 188 412 188s116.1 23.2 158.4 65.6S636 352.2 636 412s-23.3 116.1-65.6 158.4z"></path></svg></span></div><input aria-label="Search" class="search-input" placeholder="Search Tickers, Companies or News..." role="searchbox" tabindex="0" type="search" value=""/></div></div></div></div></div></div></div></div></div></div><div class="sc-bkTvXO kvjVGb"><div class="sc-iCKXBC bBMOVF"><div class="layout-flex flex flex-col w-full items-start relative"><div class="layout-header w-full py-4 overflow-hidden default" style="top:0px;z-index:20"><div class="layout-container mx-auto"><div class="sc-BCDEK soDJY money-blocks-wrapper"><div style="display:inline"> <div style="height:10px" aria-hidden="true" class="wp-block-spacer"></div> </div></div></div></div></div><div class="sc-egTsrv cdHtnJ layout-content-container lg:px-0 mx-auto px-4 layout-container max-w-7xl"><div class="main-content-container layout-container mx-auto"><div class="layout-flex flex flex-col w-full items-start relative"><div class="layout-main flex flex-grow flex-col justify-between"><div class="sc-BCDEK soDJY money-blocks-wrapper"><div class="sc-kOzJCk gSsgJX page-title-wrapper"><h1 class="sc-cbDaos sc-jCWTJb gTmJxW iUkejh page-title">Complete Cannabis News</h1><a href="https://elplanteo.com/" class="sc-hRhxOB btQGbg">CAMBIAR A ESPAÑOL</a></div><div class="sc-fCUNPS cwCVgz"><div class="news-featured-section-block"><div class="sc-jKJZnd gtCDQI top-section-container"><div class="top-story primary-story"><div data-action="Featured Card Click" class="sc-bXbAQm encpHI"><div class="sc-hpmCTx kTMIHF post-card-wrapper"><div class="sc-ehEeqy cbhkbf post-card post-card-hero post-card-size-default" title="YouTube's High Science Is A Must-Watch For Cannabis Enthusiasts"><a class="post-card-article-link post-card-image image-wrapper" href="/24/11/42204210/why-youtubes-high-science-is-a-must-watch-for-cannabis-enthusiasts"><span style="background:none;border:0;box-sizing:border-box;display:block;height:initial;margin:0;opacity:1;overflow:hidden;padding:0;width:initial;position:absolute;top:0;left:0;bottom:0;right:0"><div role="img" class="sc-ppzwM gxvcdh"></div><img alt="" sizes="(max-width: 800px) 120px, (min-width: 800px) 240px" src="https://cdn.benzinga.com/files/images/story/2024/11/26/High-Sicence-Thumbnail-2.jpeg?optimize=medium&dpr=2&auto=webp&width=630" srcSet="https://cdn.benzinga.com/files/images/story/2024/11/26/High-Sicence-Thumbnail-2.jpeg?optimize=medium&dpr=2&auto=webp&width=630 16w, https://cdn.benzinga.com/files/images/story/2024/11/26/High-Sicence-Thumbnail-2.jpeg?optimize=medium&dpr=2&auto=webp&width=630 32w, https://cdn.benzinga.com/files/images/story/2024/11/26/High-Sicence-Thumbnail-2.jpeg?optimize=medium&dpr=2&auto=webp&width=630 48w, https://cdn.benzinga.com/files/images/story/2024/11/26/High-Sicence-Thumbnail-2.jpeg?optimize=medium&dpr=2&auto=webp&width=630 64w, https://cdn.benzinga.com/files/images/story/2024/11/26/High-Sicence-Thumbnail-2.jpeg?optimize=medium&dpr=2&auto=webp&width=630 96w, https://cdn.benzinga.com/files/images/story/2024/11/26/High-Sicence-Thumbnail-2.jpeg?optimize=medium&dpr=2&auto=webp&width=630 128w, https://cdn.benzinga.com/files/images/story/2024/11/26/High-Sicence-Thumbnail-2.jpeg?optimize=medium&dpr=2&auto=webp&width=630 256w, https://cdn.benzinga.com/files/images/story/2024/11/26/High-Sicence-Thumbnail-2.jpeg?optimize=medium&dpr=2&auto=webp&width=630 384w, https://cdn.benzinga.com/files/images/story/2024/11/26/High-Sicence-Thumbnail-2.jpeg?optimize=medium&dpr=2&auto=webp&width=630 640w, https://cdn.benzinga.com/files/images/story/2024/11/26/High-Sicence-Thumbnail-2.jpeg?optimize=medium&dpr=2&auto=webp&width=630 750w, https://cdn.benzinga.com/files/images/story/2024/11/26/High-Sicence-Thumbnail-2.jpeg?optimize=medium&dpr=2&auto=webp&width=630 828w, https://cdn.benzinga.com/files/images/story/2024/11/26/High-Sicence-Thumbnail-2.jpeg?optimize=medium&dpr=2&auto=webp&width=630 1080w, https://cdn.benzinga.com/files/images/story/2024/11/26/High-Sicence-Thumbnail-2.jpeg?optimize=medium&dpr=2&auto=webp&width=630 1200w, https://cdn.benzinga.com/files/images/story/2024/11/26/High-Sicence-Thumbnail-2.jpeg?optimize=medium&dpr=2&auto=webp&width=630 1920w, https://cdn.benzinga.com/files/images/story/2024/11/26/High-Sicence-Thumbnail-2.jpeg?optimize=medium&dpr=2&auto=webp&width=630 2048w, https://cdn.benzinga.com/files/images/story/2024/11/26/High-Sicence-Thumbnail-2.jpeg?optimize=medium&dpr=2&auto=webp&width=630 3840w" class="sc-ZxepX kRlPph post-thumb" decoding="sync" style="border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:cover"/><noscript><img alt="" sizes="(max-width: 800px) 120px, (min-width: 800px) 240px" src="https://cdn.benzinga.com/files/images/story/2024/11/26/High-Sicence-Thumbnail-2.jpeg?optimize=medium&dpr=2&auto=webp&width=630" srcSet="https://cdn.benzinga.com/files/images/story/2024/11/26/High-Sicence-Thumbnail-2.jpeg?optimize=medium&dpr=2&auto=webp&width=630 16w, https://cdn.benzinga.com/files/images/story/2024/11/26/High-Sicence-Thumbnail-2.jpeg?optimize=medium&dpr=2&auto=webp&width=630 32w, https://cdn.benzinga.com/files/images/story/2024/11/26/High-Sicence-Thumbnail-2.jpeg?optimize=medium&dpr=2&auto=webp&width=630 48w, https://cdn.benzinga.com/files/images/story/2024/11/26/High-Sicence-Thumbnail-2.jpeg?optimize=medium&dpr=2&auto=webp&width=630 64w, https://cdn.benzinga.com/files/images/story/2024/11/26/High-Sicence-Thumbnail-2.jpeg?optimize=medium&dpr=2&auto=webp&width=630 96w, https://cdn.benzinga.com/files/images/story/2024/11/26/High-Sicence-Thumbnail-2.jpeg?optimize=medium&dpr=2&auto=webp&width=630 128w, https://cdn.benzinga.com/files/images/story/2024/11/26/High-Sicence-Thumbnail-2.jpeg?optimize=medium&dpr=2&auto=webp&width=630 256w, https://cdn.benzinga.com/files/images/story/2024/11/26/High-Sicence-Thumbnail-2.jpeg?optimize=medium&dpr=2&auto=webp&width=630 384w, https://cdn.benzinga.com/files/images/story/2024/11/26/High-Sicence-Thumbnail-2.jpeg?optimize=medium&dpr=2&auto=webp&width=630 640w, https://cdn.benzinga.com/files/images/story/2024/11/26/High-Sicence-Thumbnail-2.jpeg?optimize=medium&dpr=2&auto=webp&width=630 750w, https://cdn.benzinga.com/files/images/story/2024/11/26/High-Sicence-Thumbnail-2.jpeg?optimize=medium&dpr=2&auto=webp&width=630 828w, https://cdn.benzinga.com/files/images/story/2024/11/26/High-Sicence-Thumbnail-2.jpeg?optimize=medium&dpr=2&auto=webp&width=630 1080w, https://cdn.benzinga.com/files/images/story/2024/11/26/High-Sicence-Thumbnail-2.jpeg?optimize=medium&dpr=2&auto=webp&width=630 1200w, https://cdn.benzinga.com/files/images/story/2024/11/26/High-Sicence-Thumbnail-2.jpeg?optimize=medium&dpr=2&auto=webp&width=630 1920w, https://cdn.benzinga.com/files/images/story/2024/11/26/High-Sicence-Thumbnail-2.jpeg?optimize=medium&dpr=2&auto=webp&width=630 2048w, https://cdn.benzinga.com/files/images/story/2024/11/26/High-Sicence-Thumbnail-2.jpeg?optimize=medium&dpr=2&auto=webp&width=630 3840w" class="sc-ZxepX kRlPph post-thumb" decoding="async" loading="eager" style="border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:cover"/></noscript></span></a><div class="post-card-text lg:w-auto flex flex-col space-y-2"><div class="post-card-text-wrapper"><a class="post-card-article-link" href="/24/11/42204210/why-youtubes-high-science-is-a-must-watch-for-cannabis-enthusiasts"><span class="sc-keSDAH iWtdjm post-title"><div class="sc-cLGQGY sc-jNBTOL gyiUav epEOZZ line-wrapper post-card-title leading-snug text-2xl"><span>YouTube's High Science Is A Must-Watch For Cannabis Enthusiasts</span></div></span></a><div class="post-card-article-link flex items-center"></div></div></div></div></div></div></div><div class="secondary-stories"><div class="top-story secondary-story desktop"><div data-action="Featured Card Click" class="sc-bXbAQm encpHI"><div class="sc-hpmCTx kTMIHF post-card-wrapper"><div class="sc-ehEeqy cbhkbg post-card post-card-hero post-card-size-compact" title="Kentucky Awards First Medical Cannabis Dispensary Licenses"><a class="post-card-article-link post-card-image image-wrapper" href="/24/11/42203777/kentucky-awards-first-medical-cannabis-dispensary-licenses"><span style="background:none;border:0;box-sizing:border-box;display:block;height:initial;margin:0;opacity:1;overflow:hidden;padding:0;width:initial;position:absolute;top:0;left:0;bottom:0;right:0"><div role="img" class="sc-ppzwM hnOfzG"></div><img alt="" sizes="(max-width: 800px) 120px, (min-width: 800px) 240px" src="https://cdn.benzinga.com/files/images/story/2024/11/26/AI-Generated-Image_1.jpeg?optimize=medium&dpr=2&auto=webp&width=240" srcSet="https://cdn.benzinga.com/files/images/story/2024/11/26/AI-Generated-Image_1.jpeg?optimize=medium&dpr=2&auto=webp&width=240 16w, https://cdn.benzinga.com/files/images/story/2024/11/26/AI-Generated-Image_1.jpeg?optimize=medium&dpr=2&auto=webp&width=240 32w, https://cdn.benzinga.com/files/images/story/2024/11/26/AI-Generated-Image_1.jpeg?optimize=medium&dpr=2&auto=webp&width=240 48w, https://cdn.benzinga.com/files/images/story/2024/11/26/AI-Generated-Image_1.jpeg?optimize=medium&dpr=2&auto=webp&width=240 64w, https://cdn.benzinga.com/files/images/story/2024/11/26/AI-Generated-Image_1.jpeg?optimize=medium&dpr=2&auto=webp&width=240 96w, https://cdn.benzinga.com/files/images/story/2024/11/26/AI-Generated-Image_1.jpeg?optimize=medium&dpr=2&auto=webp&width=240 128w, https://cdn.benzinga.com/files/images/story/2024/11/26/AI-Generated-Image_1.jpeg?optimize=medium&dpr=2&auto=webp&width=240 256w, https://cdn.benzinga.com/files/images/story/2024/11/26/AI-Generated-Image_1.jpeg?optimize=medium&dpr=2&auto=webp&width=240 384w, https://cdn.benzinga.com/files/images/story/2024/11/26/AI-Generated-Image_1.jpeg?optimize=medium&dpr=2&auto=webp&width=240 640w, https://cdn.benzinga.com/files/images/story/2024/11/26/AI-Generated-Image_1.jpeg?optimize=medium&dpr=2&auto=webp&width=240 750w, https://cdn.benzinga.com/files/images/story/2024/11/26/AI-Generated-Image_1.jpeg?optimize=medium&dpr=2&auto=webp&width=240 828w, https://cdn.benzinga.com/files/images/story/2024/11/26/AI-Generated-Image_1.jpeg?optimize=medium&dpr=2&auto=webp&width=240 1080w, https://cdn.benzinga.com/files/images/story/2024/11/26/AI-Generated-Image_1.jpeg?optimize=medium&dpr=2&auto=webp&width=240 1200w, https://cdn.benzinga.com/files/images/story/2024/11/26/AI-Generated-Image_1.jpeg?optimize=medium&dpr=2&auto=webp&width=240 1920w, https://cdn.benzinga.com/files/images/story/2024/11/26/AI-Generated-Image_1.jpeg?optimize=medium&dpr=2&auto=webp&width=240 2048w, https://cdn.benzinga.com/files/images/story/2024/11/26/AI-Generated-Image_1.jpeg?optimize=medium&dpr=2&auto=webp&width=240 3840w" class="sc-ZxepX kRlPph post-thumb" decoding="sync" style="border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:cover"/><noscript><img alt="" sizes="(max-width: 800px) 120px, (min-width: 800px) 240px" src="https://cdn.benzinga.com/files/images/story/2024/11/26/AI-Generated-Image_1.jpeg?optimize=medium&dpr=2&auto=webp&width=240" srcSet="https://cdn.benzinga.com/files/images/story/2024/11/26/AI-Generated-Image_1.jpeg?optimize=medium&dpr=2&auto=webp&width=240 16w, https://cdn.benzinga.com/files/images/story/2024/11/26/AI-Generated-Image_1.jpeg?optimize=medium&dpr=2&auto=webp&width=240 32w, https://cdn.benzinga.com/files/images/story/2024/11/26/AI-Generated-Image_1.jpeg?optimize=medium&dpr=2&auto=webp&width=240 48w, https://cdn.benzinga.com/files/images/story/2024/11/26/AI-Generated-Image_1.jpeg?optimize=medium&dpr=2&auto=webp&width=240 64w, https://cdn.benzinga.com/files/images/story/2024/11/26/AI-Generated-Image_1.jpeg?optimize=medium&dpr=2&auto=webp&width=240 96w, https://cdn.benzinga.com/files/images/story/2024/11/26/AI-Generated-Image_1.jpeg?optimize=medium&dpr=2&auto=webp&width=240 128w, https://cdn.benzinga.com/files/images/story/2024/11/26/AI-Generated-Image_1.jpeg?optimize=medium&dpr=2&auto=webp&width=240 256w, https://cdn.benzinga.com/files/images/story/2024/11/26/AI-Generated-Image_1.jpeg?optimize=medium&dpr=2&auto=webp&width=240 384w, https://cdn.benzinga.com/files/images/story/2024/11/26/AI-Generated-Image_1.jpeg?optimize=medium&dpr=2&auto=webp&width=240 640w, https://cdn.benzinga.com/files/images/story/2024/11/26/AI-Generated-Image_1.jpeg?optimize=medium&dpr=2&auto=webp&width=240 750w, https://cdn.benzinga.com/files/images/story/2024/11/26/AI-Generated-Image_1.jpeg?optimize=medium&dpr=2&auto=webp&width=240 828w, https://cdn.benzinga.com/files/images/story/2024/11/26/AI-Generated-Image_1.jpeg?optimize=medium&dpr=2&auto=webp&width=240 1080w, https://cdn.benzinga.com/files/images/story/2024/11/26/AI-Generated-Image_1.jpeg?optimize=medium&dpr=2&auto=webp&width=240 1200w, https://cdn.benzinga.com/files/images/story/2024/11/26/AI-Generated-Image_1.jpeg?optimize=medium&dpr=2&auto=webp&width=240 1920w, https://cdn.benzinga.com/files/images/story/2024/11/26/AI-Generated-Image_1.jpeg?optimize=medium&dpr=2&auto=webp&width=240 2048w, https://cdn.benzinga.com/files/images/story/2024/11/26/AI-Generated-Image_1.jpeg?optimize=medium&dpr=2&auto=webp&width=240 3840w" class="sc-ZxepX kRlPph post-thumb" decoding="async" loading="eager" style="border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:cover"/></noscript></span></a><div class="post-card-text lg:w-auto flex flex-col space-y-2"><div class="post-card-text-wrapper"><a class="post-card-article-link" href="/24/11/42203777/kentucky-awards-first-medical-cannabis-dispensary-licenses"><span class="sc-keSDAH iWtdjm post-title"><div class="sc-cLGQGY sc-jNBTOL gyiUav epEOZZ line-wrapper post-card-title leading-snug text-base"><span>Kentucky Awards First Medical Cannabis Dispensary Licenses</span></div></span></a><div class="post-card-article-link flex items-center"></div></div></div></div></div></div><div data-action="Featured Card Click" class="sc-bXbAQm encpHI"><div class="sc-hpmCTx kTMIHF post-card-wrapper"><div class="sc-ehEeqy cbhkbg post-card post-card-hero post-card-size-compact" title="Berlin's Justice Senator Says Cannabis Law Benefits Mafia-Like Structures And It Should Be Repealed"><a class="post-card-article-link post-card-image image-wrapper" href="/markets/cannabis/24/11/42203747/berlins-justice-senator-says-cannabis-law-benefits-mafia-like-structures-and-that-it-should-be-repealed"><span style="background:none;border:0;box-sizing:border-box;display:block;height:initial;margin:0;opacity:1;overflow:hidden;padding:0;width:initial;position:absolute;top:0;left:0;bottom:0;right:0"><div role="img" class="sc-ppzwM jwDqcY"></div><img alt="" sizes="(max-width: 800px) 120px, (min-width: 800px) 240px" src="https://cdn.benzinga.com/files/images/story/2024/11/26/Cannabis-Plant-With-Green-Leaves-And-Whi.jpeg?optimize=medium&dpr=2&auto=webp&width=240" srcSet="https://cdn.benzinga.com/files/images/story/2024/11/26/Cannabis-Plant-With-Green-Leaves-And-Whi.jpeg?optimize=medium&dpr=2&auto=webp&width=240 16w, https://cdn.benzinga.com/files/images/story/2024/11/26/Cannabis-Plant-With-Green-Leaves-And-Whi.jpeg?optimize=medium&dpr=2&auto=webp&width=240 32w, https://cdn.benzinga.com/files/images/story/2024/11/26/Cannabis-Plant-With-Green-Leaves-And-Whi.jpeg?optimize=medium&dpr=2&auto=webp&width=240 48w, https://cdn.benzinga.com/files/images/story/2024/11/26/Cannabis-Plant-With-Green-Leaves-And-Whi.jpeg?optimize=medium&dpr=2&auto=webp&width=240 64w, https://cdn.benzinga.com/files/images/story/2024/11/26/Cannabis-Plant-With-Green-Leaves-And-Whi.jpeg?optimize=medium&dpr=2&auto=webp&width=240 96w, https://cdn.benzinga.com/files/images/story/2024/11/26/Cannabis-Plant-With-Green-Leaves-And-Whi.jpeg?optimize=medium&dpr=2&auto=webp&width=240 128w, https://cdn.benzinga.com/files/images/story/2024/11/26/Cannabis-Plant-With-Green-Leaves-And-Whi.jpeg?optimize=medium&dpr=2&auto=webp&width=240 256w, https://cdn.benzinga.com/files/images/story/2024/11/26/Cannabis-Plant-With-Green-Leaves-And-Whi.jpeg?optimize=medium&dpr=2&auto=webp&width=240 384w, https://cdn.benzinga.com/files/images/story/2024/11/26/Cannabis-Plant-With-Green-Leaves-And-Whi.jpeg?optimize=medium&dpr=2&auto=webp&width=240 640w, https://cdn.benzinga.com/files/images/story/2024/11/26/Cannabis-Plant-With-Green-Leaves-And-Whi.jpeg?optimize=medium&dpr=2&auto=webp&width=240 750w, https://cdn.benzinga.com/files/images/story/2024/11/26/Cannabis-Plant-With-Green-Leaves-And-Whi.jpeg?optimize=medium&dpr=2&auto=webp&width=240 828w, https://cdn.benzinga.com/files/images/story/2024/11/26/Cannabis-Plant-With-Green-Leaves-And-Whi.jpeg?optimize=medium&dpr=2&auto=webp&width=240 1080w, https://cdn.benzinga.com/files/images/story/2024/11/26/Cannabis-Plant-With-Green-Leaves-And-Whi.jpeg?optimize=medium&dpr=2&auto=webp&width=240 1200w, https://cdn.benzinga.com/files/images/story/2024/11/26/Cannabis-Plant-With-Green-Leaves-And-Whi.jpeg?optimize=medium&dpr=2&auto=webp&width=240 1920w, https://cdn.benzinga.com/files/images/story/2024/11/26/Cannabis-Plant-With-Green-Leaves-And-Whi.jpeg?optimize=medium&dpr=2&auto=webp&width=240 2048w, https://cdn.benzinga.com/files/images/story/2024/11/26/Cannabis-Plant-With-Green-Leaves-And-Whi.jpeg?optimize=medium&dpr=2&auto=webp&width=240 3840w" class="sc-ZxepX kRlPph post-thumb" decoding="sync" style="border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:cover"/><noscript><img alt="" sizes="(max-width: 800px) 120px, (min-width: 800px) 240px" src="https://cdn.benzinga.com/files/images/story/2024/11/26/Cannabis-Plant-With-Green-Leaves-And-Whi.jpeg?optimize=medium&dpr=2&auto=webp&width=240" srcSet="https://cdn.benzinga.com/files/images/story/2024/11/26/Cannabis-Plant-With-Green-Leaves-And-Whi.jpeg?optimize=medium&dpr=2&auto=webp&width=240 16w, https://cdn.benzinga.com/files/images/story/2024/11/26/Cannabis-Plant-With-Green-Leaves-And-Whi.jpeg?optimize=medium&dpr=2&auto=webp&width=240 32w, https://cdn.benzinga.com/files/images/story/2024/11/26/Cannabis-Plant-With-Green-Leaves-And-Whi.jpeg?optimize=medium&dpr=2&auto=webp&width=240 48w, https://cdn.benzinga.com/files/images/story/2024/11/26/Cannabis-Plant-With-Green-Leaves-And-Whi.jpeg?optimize=medium&dpr=2&auto=webp&width=240 64w, https://cdn.benzinga.com/files/images/story/2024/11/26/Cannabis-Plant-With-Green-Leaves-And-Whi.jpeg?optimize=medium&dpr=2&auto=webp&width=240 96w, https://cdn.benzinga.com/files/images/story/2024/11/26/Cannabis-Plant-With-Green-Leaves-And-Whi.jpeg?optimize=medium&dpr=2&auto=webp&width=240 128w, https://cdn.benzinga.com/files/images/story/2024/11/26/Cannabis-Plant-With-Green-Leaves-And-Whi.jpeg?optimize=medium&dpr=2&auto=webp&width=240 256w, https://cdn.benzinga.com/files/images/story/2024/11/26/Cannabis-Plant-With-Green-Leaves-And-Whi.jpeg?optimize=medium&dpr=2&auto=webp&width=240 384w, https://cdn.benzinga.com/files/images/story/2024/11/26/Cannabis-Plant-With-Green-Leaves-And-Whi.jpeg?optimize=medium&dpr=2&auto=webp&width=240 640w, https://cdn.benzinga.com/files/images/story/2024/11/26/Cannabis-Plant-With-Green-Leaves-And-Whi.jpeg?optimize=medium&dpr=2&auto=webp&width=240 750w, https://cdn.benzinga.com/files/images/story/2024/11/26/Cannabis-Plant-With-Green-Leaves-And-Whi.jpeg?optimize=medium&dpr=2&auto=webp&width=240 828w, https://cdn.benzinga.com/files/images/story/2024/11/26/Cannabis-Plant-With-Green-Leaves-And-Whi.jpeg?optimize=medium&dpr=2&auto=webp&width=240 1080w, https://cdn.benzinga.com/files/images/story/2024/11/26/Cannabis-Plant-With-Green-Leaves-And-Whi.jpeg?optimize=medium&dpr=2&auto=webp&width=240 1200w, https://cdn.benzinga.com/files/images/story/2024/11/26/Cannabis-Plant-With-Green-Leaves-And-Whi.jpeg?optimize=medium&dpr=2&auto=webp&width=240 1920w, https://cdn.benzinga.com/files/images/story/2024/11/26/Cannabis-Plant-With-Green-Leaves-And-Whi.jpeg?optimize=medium&dpr=2&auto=webp&width=240 2048w, https://cdn.benzinga.com/files/images/story/2024/11/26/Cannabis-Plant-With-Green-Leaves-And-Whi.jpeg?optimize=medium&dpr=2&auto=webp&width=240 3840w" class="sc-ZxepX kRlPph post-thumb" decoding="async" loading="eager" style="border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:cover"/></noscript></span></a><div class="post-card-text lg:w-auto flex flex-col space-y-2"><div class="post-card-text-wrapper"><a class="post-card-article-link" href="/markets/cannabis/24/11/42203747/berlins-justice-senator-says-cannabis-law-benefits-mafia-like-structures-and-that-it-should-be-repealed"><span class="sc-keSDAH iWtdjm post-title"><div class="sc-cLGQGY sc-jNBTOL gyiUav epEOZZ line-wrapper post-card-title leading-snug text-base"><span>Berlin's Justice Senator Says Cannabis Law Benefits Mafia-Like Structures And It Should Be Repealed</span></div></span></a><div class="post-card-article-link flex items-center"></div></div></div></div></div></div></div><div class="top-story secondary-story mobile"><div data-action="Featured Card Click" class="sc-bXbAQm encpHI"><div class="sc-hpmCTx kTMIHF post-card-wrapper"><div class="sc-ehEeqy cMobMa post-card post-card-default post-card-size-compact" title="Kentucky Awards First Medical Cannabis Dispensary Licenses"><a class="post-card-article-link post-card-image image-wrapper" href="/24/11/42203777/kentucky-awards-first-medical-cannabis-dispensary-licenses"><span style="background:none;border:0;box-sizing:border-box;display:block;height:initial;margin:0;opacity:1;overflow:hidden;padding:0;width:initial;position:absolute;top:0;left:0;bottom:0;right:0"><div role="img" class="sc-ppzwM hnOfzG"></div><img alt="" sizes="(max-width: 800px) 120px, (min-width: 800px) 240px" src="https://cdn.benzinga.com/files/images/story/2024/11/26/AI-Generated-Image_1.jpeg?optimize=medium&dpr=2&auto=webp&width=150" srcSet="https://cdn.benzinga.com/files/images/story/2024/11/26/AI-Generated-Image_1.jpeg?optimize=medium&dpr=2&auto=webp&width=150 16w, https://cdn.benzinga.com/files/images/story/2024/11/26/AI-Generated-Image_1.jpeg?optimize=medium&dpr=2&auto=webp&width=150 32w, https://cdn.benzinga.com/files/images/story/2024/11/26/AI-Generated-Image_1.jpeg?optimize=medium&dpr=2&auto=webp&width=150 48w, https://cdn.benzinga.com/files/images/story/2024/11/26/AI-Generated-Image_1.jpeg?optimize=medium&dpr=2&auto=webp&width=150 64w, https://cdn.benzinga.com/files/images/story/2024/11/26/AI-Generated-Image_1.jpeg?optimize=medium&dpr=2&auto=webp&width=150 96w, https://cdn.benzinga.com/files/images/story/2024/11/26/AI-Generated-Image_1.jpeg?optimize=medium&dpr=2&auto=webp&width=150 128w, https://cdn.benzinga.com/files/images/story/2024/11/26/AI-Generated-Image_1.jpeg?optimize=medium&dpr=2&auto=webp&width=150 256w, https://cdn.benzinga.com/files/images/story/2024/11/26/AI-Generated-Image_1.jpeg?optimize=medium&dpr=2&auto=webp&width=150 384w, https://cdn.benzinga.com/files/images/story/2024/11/26/AI-Generated-Image_1.jpeg?optimize=medium&dpr=2&auto=webp&width=150 640w, https://cdn.benzinga.com/files/images/story/2024/11/26/AI-Generated-Image_1.jpeg?optimize=medium&dpr=2&auto=webp&width=150 750w, https://cdn.benzinga.com/files/images/story/2024/11/26/AI-Generated-Image_1.jpeg?optimize=medium&dpr=2&auto=webp&width=150 828w, https://cdn.benzinga.com/files/images/story/2024/11/26/AI-Generated-Image_1.jpeg?optimize=medium&dpr=2&auto=webp&width=150 1080w, https://cdn.benzinga.com/files/images/story/2024/11/26/AI-Generated-Image_1.jpeg?optimize=medium&dpr=2&auto=webp&width=150 1200w, https://cdn.benzinga.com/files/images/story/2024/11/26/AI-Generated-Image_1.jpeg?optimize=medium&dpr=2&auto=webp&width=150 1920w, https://cdn.benzinga.com/files/images/story/2024/11/26/AI-Generated-Image_1.jpeg?optimize=medium&dpr=2&auto=webp&width=150 2048w, https://cdn.benzinga.com/files/images/story/2024/11/26/AI-Generated-Image_1.jpeg?optimize=medium&dpr=2&auto=webp&width=150 3840w" class="sc-ZxepX kRlPph post-thumb" decoding="sync" style="border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:cover"/><noscript><img alt="" sizes="(max-width: 800px) 120px, (min-width: 800px) 240px" src="https://cdn.benzinga.com/files/images/story/2024/11/26/AI-Generated-Image_1.jpeg?optimize=medium&dpr=2&auto=webp&width=150" srcSet="https://cdn.benzinga.com/files/images/story/2024/11/26/AI-Generated-Image_1.jpeg?optimize=medium&dpr=2&auto=webp&width=150 16w, https://cdn.benzinga.com/files/images/story/2024/11/26/AI-Generated-Image_1.jpeg?optimize=medium&dpr=2&auto=webp&width=150 32w, https://cdn.benzinga.com/files/images/story/2024/11/26/AI-Generated-Image_1.jpeg?optimize=medium&dpr=2&auto=webp&width=150 48w, https://cdn.benzinga.com/files/images/story/2024/11/26/AI-Generated-Image_1.jpeg?optimize=medium&dpr=2&auto=webp&width=150 64w, https://cdn.benzinga.com/files/images/story/2024/11/26/AI-Generated-Image_1.jpeg?optimize=medium&dpr=2&auto=webp&width=150 96w, https://cdn.benzinga.com/files/images/story/2024/11/26/AI-Generated-Image_1.jpeg?optimize=medium&dpr=2&auto=webp&width=150 128w, https://cdn.benzinga.com/files/images/story/2024/11/26/AI-Generated-Image_1.jpeg?optimize=medium&dpr=2&auto=webp&width=150 256w, https://cdn.benzinga.com/files/images/story/2024/11/26/AI-Generated-Image_1.jpeg?optimize=medium&dpr=2&auto=webp&width=150 384w, https://cdn.benzinga.com/files/images/story/2024/11/26/AI-Generated-Image_1.jpeg?optimize=medium&dpr=2&auto=webp&width=150 640w, https://cdn.benzinga.com/files/images/story/2024/11/26/AI-Generated-Image_1.jpeg?optimize=medium&dpr=2&auto=webp&width=150 750w, https://cdn.benzinga.com/files/images/story/2024/11/26/AI-Generated-Image_1.jpeg?optimize=medium&dpr=2&auto=webp&width=150 828w, https://cdn.benzinga.com/files/images/story/2024/11/26/AI-Generated-Image_1.jpeg?optimize=medium&dpr=2&auto=webp&width=150 1080w, https://cdn.benzinga.com/files/images/story/2024/11/26/AI-Generated-Image_1.jpeg?optimize=medium&dpr=2&auto=webp&width=150 1200w, https://cdn.benzinga.com/files/images/story/2024/11/26/AI-Generated-Image_1.jpeg?optimize=medium&dpr=2&auto=webp&width=150 1920w, https://cdn.benzinga.com/files/images/story/2024/11/26/AI-Generated-Image_1.jpeg?optimize=medium&dpr=2&auto=webp&width=150 2048w, https://cdn.benzinga.com/files/images/story/2024/11/26/AI-Generated-Image_1.jpeg?optimize=medium&dpr=2&auto=webp&width=150 3840w" class="sc-ZxepX kRlPph post-thumb" decoding="async" loading="eager" style="border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:cover"/></noscript></span></a><div class="post-card-text lg:w-auto flex flex-col space-y-2"><div class="post-card-text-wrapper"><a class="post-card-article-link" href="/24/11/42203777/kentucky-awards-first-medical-cannabis-dispensary-licenses"><span class="sc-keSDAH iWtdjm post-title"><div class="sc-cLGQGY sc-jNBTOL gyiUav epEOZZ line-wrapper post-card-title leading-snug text-base"><span>Kentucky Awards First Medical Cannabis Dispensary Licenses</span></div></span></a><div class="post-card-article-link flex items-center"><div class="sc-ekaoJE fACrUT"></div></div></div></div></div></div></div><div data-action="Featured Card Click" class="sc-bXbAQm encpHI"><div class="sc-hpmCTx kTMIHF post-card-wrapper"><div class="sc-ehEeqy cMobMa post-card post-card-default post-card-size-compact" title="Berlin's Justice Senator Says Cannabis Law Benefits Mafia-Like Structures And It Should Be Repealed"><a class="post-card-article-link post-card-image image-wrapper" href="/markets/cannabis/24/11/42203747/berlins-justice-senator-says-cannabis-law-benefits-mafia-like-structures-and-that-it-should-be-repealed"><span style="background:none;border:0;box-sizing:border-box;display:block;height:initial;margin:0;opacity:1;overflow:hidden;padding:0;width:initial;position:absolute;top:0;left:0;bottom:0;right:0"><div role="img" class="sc-ppzwM jwDqcY"></div><img alt="" sizes="(max-width: 800px) 120px, (min-width: 800px) 240px" src="https://cdn.benzinga.com/files/images/story/2024/11/26/Cannabis-Plant-With-Green-Leaves-And-Whi.jpeg?optimize=medium&dpr=2&auto=webp&width=150" srcSet="https://cdn.benzinga.com/files/images/story/2024/11/26/Cannabis-Plant-With-Green-Leaves-And-Whi.jpeg?optimize=medium&dpr=2&auto=webp&width=150 16w, https://cdn.benzinga.com/files/images/story/2024/11/26/Cannabis-Plant-With-Green-Leaves-And-Whi.jpeg?optimize=medium&dpr=2&auto=webp&width=150 32w, https://cdn.benzinga.com/files/images/story/2024/11/26/Cannabis-Plant-With-Green-Leaves-And-Whi.jpeg?optimize=medium&dpr=2&auto=webp&width=150 48w, https://cdn.benzinga.com/files/images/story/2024/11/26/Cannabis-Plant-With-Green-Leaves-And-Whi.jpeg?optimize=medium&dpr=2&auto=webp&width=150 64w, https://cdn.benzinga.com/files/images/story/2024/11/26/Cannabis-Plant-With-Green-Leaves-And-Whi.jpeg?optimize=medium&dpr=2&auto=webp&width=150 96w, https://cdn.benzinga.com/files/images/story/2024/11/26/Cannabis-Plant-With-Green-Leaves-And-Whi.jpeg?optimize=medium&dpr=2&auto=webp&width=150 128w, https://cdn.benzinga.com/files/images/story/2024/11/26/Cannabis-Plant-With-Green-Leaves-And-Whi.jpeg?optimize=medium&dpr=2&auto=webp&width=150 256w, https://cdn.benzinga.com/files/images/story/2024/11/26/Cannabis-Plant-With-Green-Leaves-And-Whi.jpeg?optimize=medium&dpr=2&auto=webp&width=150 384w, https://cdn.benzinga.com/files/images/story/2024/11/26/Cannabis-Plant-With-Green-Leaves-And-Whi.jpeg?optimize=medium&dpr=2&auto=webp&width=150 640w, https://cdn.benzinga.com/files/images/story/2024/11/26/Cannabis-Plant-With-Green-Leaves-And-Whi.jpeg?optimize=medium&dpr=2&auto=webp&width=150 750w, https://cdn.benzinga.com/files/images/story/2024/11/26/Cannabis-Plant-With-Green-Leaves-And-Whi.jpeg?optimize=medium&dpr=2&auto=webp&width=150 828w, https://cdn.benzinga.com/files/images/story/2024/11/26/Cannabis-Plant-With-Green-Leaves-And-Whi.jpeg?optimize=medium&dpr=2&auto=webp&width=150 1080w, https://cdn.benzinga.com/files/images/story/2024/11/26/Cannabis-Plant-With-Green-Leaves-And-Whi.jpeg?optimize=medium&dpr=2&auto=webp&width=150 1200w, https://cdn.benzinga.com/files/images/story/2024/11/26/Cannabis-Plant-With-Green-Leaves-And-Whi.jpeg?optimize=medium&dpr=2&auto=webp&width=150 1920w, https://cdn.benzinga.com/files/images/story/2024/11/26/Cannabis-Plant-With-Green-Leaves-And-Whi.jpeg?optimize=medium&dpr=2&auto=webp&width=150 2048w, https://cdn.benzinga.com/files/images/story/2024/11/26/Cannabis-Plant-With-Green-Leaves-And-Whi.jpeg?optimize=medium&dpr=2&auto=webp&width=150 3840w" class="sc-ZxepX kRlPph post-thumb" decoding="sync" style="border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:cover"/><noscript><img alt="" sizes="(max-width: 800px) 120px, (min-width: 800px) 240px" src="https://cdn.benzinga.com/files/images/story/2024/11/26/Cannabis-Plant-With-Green-Leaves-And-Whi.jpeg?optimize=medium&dpr=2&auto=webp&width=150" srcSet="https://cdn.benzinga.com/files/images/story/2024/11/26/Cannabis-Plant-With-Green-Leaves-And-Whi.jpeg?optimize=medium&dpr=2&auto=webp&width=150 16w, https://cdn.benzinga.com/files/images/story/2024/11/26/Cannabis-Plant-With-Green-Leaves-And-Whi.jpeg?optimize=medium&dpr=2&auto=webp&width=150 32w, https://cdn.benzinga.com/files/images/story/2024/11/26/Cannabis-Plant-With-Green-Leaves-And-Whi.jpeg?optimize=medium&dpr=2&auto=webp&width=150 48w, https://cdn.benzinga.com/files/images/story/2024/11/26/Cannabis-Plant-With-Green-Leaves-And-Whi.jpeg?optimize=medium&dpr=2&auto=webp&width=150 64w, https://cdn.benzinga.com/files/images/story/2024/11/26/Cannabis-Plant-With-Green-Leaves-And-Whi.jpeg?optimize=medium&dpr=2&auto=webp&width=150 96w, https://cdn.benzinga.com/files/images/story/2024/11/26/Cannabis-Plant-With-Green-Leaves-And-Whi.jpeg?optimize=medium&dpr=2&auto=webp&width=150 128w, https://cdn.benzinga.com/files/images/story/2024/11/26/Cannabis-Plant-With-Green-Leaves-And-Whi.jpeg?optimize=medium&dpr=2&auto=webp&width=150 256w, https://cdn.benzinga.com/files/images/story/2024/11/26/Cannabis-Plant-With-Green-Leaves-And-Whi.jpeg?optimize=medium&dpr=2&auto=webp&width=150 384w, https://cdn.benzinga.com/files/images/story/2024/11/26/Cannabis-Plant-With-Green-Leaves-And-Whi.jpeg?optimize=medium&dpr=2&auto=webp&width=150 640w, https://cdn.benzinga.com/files/images/story/2024/11/26/Cannabis-Plant-With-Green-Leaves-And-Whi.jpeg?optimize=medium&dpr=2&auto=webp&width=150 750w, https://cdn.benzinga.com/files/images/story/2024/11/26/Cannabis-Plant-With-Green-Leaves-And-Whi.jpeg?optimize=medium&dpr=2&auto=webp&width=150 828w, https://cdn.benzinga.com/files/images/story/2024/11/26/Cannabis-Plant-With-Green-Leaves-And-Whi.jpeg?optimize=medium&dpr=2&auto=webp&width=150 1080w, https://cdn.benzinga.com/files/images/story/2024/11/26/Cannabis-Plant-With-Green-Leaves-And-Whi.jpeg?optimize=medium&dpr=2&auto=webp&width=150 1200w, https://cdn.benzinga.com/files/images/story/2024/11/26/Cannabis-Plant-With-Green-Leaves-And-Whi.jpeg?optimize=medium&dpr=2&auto=webp&width=150 1920w, https://cdn.benzinga.com/files/images/story/2024/11/26/Cannabis-Plant-With-Green-Leaves-And-Whi.jpeg?optimize=medium&dpr=2&auto=webp&width=150 2048w, https://cdn.benzinga.com/files/images/story/2024/11/26/Cannabis-Plant-With-Green-Leaves-And-Whi.jpeg?optimize=medium&dpr=2&auto=webp&width=150 3840w" class="sc-ZxepX kRlPph post-thumb" decoding="async" loading="eager" style="border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:cover"/></noscript></span></a><div class="post-card-text lg:w-auto flex flex-col space-y-2"><div class="post-card-text-wrapper"><a class="post-card-article-link" href="/markets/cannabis/24/11/42203747/berlins-justice-senator-says-cannabis-law-benefits-mafia-like-structures-and-that-it-should-be-repealed"><span class="sc-keSDAH iWtdjm post-title"><div class="sc-cLGQGY sc-jNBTOL gyiUav epEOZZ line-wrapper post-card-title leading-snug text-base"><span>Berlin's Justice Senator Says Cannabis Law Benefits Mafia-Like Structures And It Should Be Repealed</span></div></span></a><div class="post-card-article-link flex items-center"><div class="sc-ekaoJE fACrUT"></div></div></div></div></div></div></div><div data-action="Featured Card Click" class="sc-bXbAQm encpHI"><div class="sc-hpmCTx kTMIHF post-card-wrapper"><div class="sc-ehEeqy cMobMa post-card post-card-default post-card-size-compact" title="Elizabeth Warren, Bernie Sanders & 12 Congress Members To Biden: Issue Clemency And Pardons For Cannabis Prisoners"><a class="post-card-article-link post-card-image image-wrapper" href="/news/legal/24/11/42202403/elizabeth-warren-bernie-sanders-12-congress-members-to-biden-issue-clemency-and-pardons-for-cannabis-prisoners"><span style="background:none;border:0;box-sizing:border-box;display:block;height:initial;margin:0;opacity:1;overflow:hidden;padding:0;width:initial;position:absolute;top:0;left:0;bottom:0;right:0"><div role="img" class="sc-ppzwM joEPHQ"></div><img alt="" sizes="(max-width: 800px) 120px, (min-width: 800px) 240px" src="https://cdn.benzinga.com/files/images/story/2024/11/26/joe-biden-cannabis-liberty-adam-schultz-.jpeg?optimize=medium&dpr=2&auto=webp&width=150" srcSet="https://cdn.benzinga.com/files/images/story/2024/11/26/joe-biden-cannabis-liberty-adam-schultz-.jpeg?optimize=medium&dpr=2&auto=webp&width=150 16w, https://cdn.benzinga.com/files/images/story/2024/11/26/joe-biden-cannabis-liberty-adam-schultz-.jpeg?optimize=medium&dpr=2&auto=webp&width=150 32w, https://cdn.benzinga.com/files/images/story/2024/11/26/joe-biden-cannabis-liberty-adam-schultz-.jpeg?optimize=medium&dpr=2&auto=webp&width=150 48w, https://cdn.benzinga.com/files/images/story/2024/11/26/joe-biden-cannabis-liberty-adam-schultz-.jpeg?optimize=medium&dpr=2&auto=webp&width=150 64w, https://cdn.benzinga.com/files/images/story/2024/11/26/joe-biden-cannabis-liberty-adam-schultz-.jpeg?optimize=medium&dpr=2&auto=webp&width=150 96w, https://cdn.benzinga.com/files/images/story/2024/11/26/joe-biden-cannabis-liberty-adam-schultz-.jpeg?optimize=medium&dpr=2&auto=webp&width=150 128w, https://cdn.benzinga.com/files/images/story/2024/11/26/joe-biden-cannabis-liberty-adam-schultz-.jpeg?optimize=medium&dpr=2&auto=webp&width=150 256w, https://cdn.benzinga.com/files/images/story/2024/11/26/joe-biden-cannabis-liberty-adam-schultz-.jpeg?optimize=medium&dpr=2&auto=webp&width=150 384w, https://cdn.benzinga.com/files/images/story/2024/11/26/joe-biden-cannabis-liberty-adam-schultz-.jpeg?optimize=medium&dpr=2&auto=webp&width=150 640w, https://cdn.benzinga.com/files/images/story/2024/11/26/joe-biden-cannabis-liberty-adam-schultz-.jpeg?optimize=medium&dpr=2&auto=webp&width=150 750w, https://cdn.benzinga.com/files/images/story/2024/11/26/joe-biden-cannabis-liberty-adam-schultz-.jpeg?optimize=medium&dpr=2&auto=webp&width=150 828w, https://cdn.benzinga.com/files/images/story/2024/11/26/joe-biden-cannabis-liberty-adam-schultz-.jpeg?optimize=medium&dpr=2&auto=webp&width=150 1080w, https://cdn.benzinga.com/files/images/story/2024/11/26/joe-biden-cannabis-liberty-adam-schultz-.jpeg?optimize=medium&dpr=2&auto=webp&width=150 1200w, https://cdn.benzinga.com/files/images/story/2024/11/26/joe-biden-cannabis-liberty-adam-schultz-.jpeg?optimize=medium&dpr=2&auto=webp&width=150 1920w, https://cdn.benzinga.com/files/images/story/2024/11/26/joe-biden-cannabis-liberty-adam-schultz-.jpeg?optimize=medium&dpr=2&auto=webp&width=150 2048w, https://cdn.benzinga.com/files/images/story/2024/11/26/joe-biden-cannabis-liberty-adam-schultz-.jpeg?optimize=medium&dpr=2&auto=webp&width=150 3840w" class="sc-ZxepX kRlPph post-thumb" decoding="sync" style="border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:cover"/><noscript><img alt="" sizes="(max-width: 800px) 120px, (min-width: 800px) 240px" src="https://cdn.benzinga.com/files/images/story/2024/11/26/joe-biden-cannabis-liberty-adam-schultz-.jpeg?optimize=medium&dpr=2&auto=webp&width=150" srcSet="https://cdn.benzinga.com/files/images/story/2024/11/26/joe-biden-cannabis-liberty-adam-schultz-.jpeg?optimize=medium&dpr=2&auto=webp&width=150 16w, https://cdn.benzinga.com/files/images/story/2024/11/26/joe-biden-cannabis-liberty-adam-schultz-.jpeg?optimize=medium&dpr=2&auto=webp&width=150 32w, https://cdn.benzinga.com/files/images/story/2024/11/26/joe-biden-cannabis-liberty-adam-schultz-.jpeg?optimize=medium&dpr=2&auto=webp&width=150 48w, https://cdn.benzinga.com/files/images/story/2024/11/26/joe-biden-cannabis-liberty-adam-schultz-.jpeg?optimize=medium&dpr=2&auto=webp&width=150 64w, https://cdn.benzinga.com/files/images/story/2024/11/26/joe-biden-cannabis-liberty-adam-schultz-.jpeg?optimize=medium&dpr=2&auto=webp&width=150 96w, https://cdn.benzinga.com/files/images/story/2024/11/26/joe-biden-cannabis-liberty-adam-schultz-.jpeg?optimize=medium&dpr=2&auto=webp&width=150 128w, https://cdn.benzinga.com/files/images/story/2024/11/26/joe-biden-cannabis-liberty-adam-schultz-.jpeg?optimize=medium&dpr=2&auto=webp&width=150 256w, https://cdn.benzinga.com/files/images/story/2024/11/26/joe-biden-cannabis-liberty-adam-schultz-.jpeg?optimize=medium&dpr=2&auto=webp&width=150 384w, https://cdn.benzinga.com/files/images/story/2024/11/26/joe-biden-cannabis-liberty-adam-schultz-.jpeg?optimize=medium&dpr=2&auto=webp&width=150 640w, https://cdn.benzinga.com/files/images/story/2024/11/26/joe-biden-cannabis-liberty-adam-schultz-.jpeg?optimize=medium&dpr=2&auto=webp&width=150 750w, https://cdn.benzinga.com/files/images/story/2024/11/26/joe-biden-cannabis-liberty-adam-schultz-.jpeg?optimize=medium&dpr=2&auto=webp&width=150 828w, https://cdn.benzinga.com/files/images/story/2024/11/26/joe-biden-cannabis-liberty-adam-schultz-.jpeg?optimize=medium&dpr=2&auto=webp&width=150 1080w, https://cdn.benzinga.com/files/images/story/2024/11/26/joe-biden-cannabis-liberty-adam-schultz-.jpeg?optimize=medium&dpr=2&auto=webp&width=150 1200w, https://cdn.benzinga.com/files/images/story/2024/11/26/joe-biden-cannabis-liberty-adam-schultz-.jpeg?optimize=medium&dpr=2&auto=webp&width=150 1920w, https://cdn.benzinga.com/files/images/story/2024/11/26/joe-biden-cannabis-liberty-adam-schultz-.jpeg?optimize=medium&dpr=2&auto=webp&width=150 2048w, https://cdn.benzinga.com/files/images/story/2024/11/26/joe-biden-cannabis-liberty-adam-schultz-.jpeg?optimize=medium&dpr=2&auto=webp&width=150 3840w" class="sc-ZxepX kRlPph post-thumb" decoding="async" loading="eager" style="border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:cover"/></noscript></span></a><div class="post-card-text lg:w-auto flex flex-col space-y-2"><div class="post-card-text-wrapper"><a class="post-card-article-link" href="/news/legal/24/11/42202403/elizabeth-warren-bernie-sanders-12-congress-members-to-biden-issue-clemency-and-pardons-for-cannabis-prisoners"><span class="sc-keSDAH iWtdjm post-title"><div class="sc-cLGQGY sc-jNBTOL gyiUav epEOZZ line-wrapper post-card-title leading-snug text-base"><span>Elizabeth Warren, Bernie Sanders & 12 Congress Members To Biden: Issue Clemency And Pardons For Cannabis Prisoners</span></div></span></a><div class="post-card-article-link flex items-center"><div class="sc-ekaoJE fACrUT"></div></div></div></div></div></div></div><div data-action="Featured Card Click" class="sc-bXbAQm encpHI"><div class="sc-hpmCTx kTMIHF post-card-wrapper"><div class="sc-ehEeqy cMobMa post-card post-card-default post-card-size-compact" title="Aurora Cannabis Reveals Latest Product Innovations: Ultra-High Potency Indicas And Strains For Veterans"><a class="post-card-article-link post-card-image image-wrapper" href="/news/retail-sales/24/11/42199358/aurora-cannabis-reveals-latest-product-innovations-ultra-high-potency-indicas-and-strains-for-veterans"><span style="background:none;border:0;box-sizing:border-box;display:block;height:initial;margin:0;opacity:1;overflow:hidden;padding:0;width:initial;position:absolute;top:0;left:0;bottom:0;right:0"><div role="img" class="sc-ppzwM kynSFO"></div><img alt="" sizes="(max-width: 800px) 120px, (min-width: 800px) 240px" src="https://cdn.benzinga.com/files/images/story/2024/11/26/wesley-gibbs-NxRx7-mPdEk-unsplash.jpeg?optimize=medium&dpr=2&auto=webp&width=150" srcSet="https://cdn.benzinga.com/files/images/story/2024/11/26/wesley-gibbs-NxRx7-mPdEk-unsplash.jpeg?optimize=medium&dpr=2&auto=webp&width=150 16w, https://cdn.benzinga.com/files/images/story/2024/11/26/wesley-gibbs-NxRx7-mPdEk-unsplash.jpeg?optimize=medium&dpr=2&auto=webp&width=150 32w, https://cdn.benzinga.com/files/images/story/2024/11/26/wesley-gibbs-NxRx7-mPdEk-unsplash.jpeg?optimize=medium&dpr=2&auto=webp&width=150 48w, https://cdn.benzinga.com/files/images/story/2024/11/26/wesley-gibbs-NxRx7-mPdEk-unsplash.jpeg?optimize=medium&dpr=2&auto=webp&width=150 64w, https://cdn.benzinga.com/files/images/story/2024/11/26/wesley-gibbs-NxRx7-mPdEk-unsplash.jpeg?optimize=medium&dpr=2&auto=webp&width=150 96w, https://cdn.benzinga.com/files/images/story/2024/11/26/wesley-gibbs-NxRx7-mPdEk-unsplash.jpeg?optimize=medium&dpr=2&auto=webp&width=150 128w, https://cdn.benzinga.com/files/images/story/2024/11/26/wesley-gibbs-NxRx7-mPdEk-unsplash.jpeg?optimize=medium&dpr=2&auto=webp&width=150 256w, https://cdn.benzinga.com/files/images/story/2024/11/26/wesley-gibbs-NxRx7-mPdEk-unsplash.jpeg?optimize=medium&dpr=2&auto=webp&width=150 384w, https://cdn.benzinga.com/files/images/story/2024/11/26/wesley-gibbs-NxRx7-mPdEk-unsplash.jpeg?optimize=medium&dpr=2&auto=webp&width=150 640w, https://cdn.benzinga.com/files/images/story/2024/11/26/wesley-gibbs-NxRx7-mPdEk-unsplash.jpeg?optimize=medium&dpr=2&auto=webp&width=150 750w, https://cdn.benzinga.com/files/images/story/2024/11/26/wesley-gibbs-NxRx7-mPdEk-unsplash.jpeg?optimize=medium&dpr=2&auto=webp&width=150 828w, https://cdn.benzinga.com/files/images/story/2024/11/26/wesley-gibbs-NxRx7-mPdEk-unsplash.jpeg?optimize=medium&dpr=2&auto=webp&width=150 1080w, https://cdn.benzinga.com/files/images/story/2024/11/26/wesley-gibbs-NxRx7-mPdEk-unsplash.jpeg?optimize=medium&dpr=2&auto=webp&width=150 1200w, https://cdn.benzinga.com/files/images/story/2024/11/26/wesley-gibbs-NxRx7-mPdEk-unsplash.jpeg?optimize=medium&dpr=2&auto=webp&width=150 1920w, https://cdn.benzinga.com/files/images/story/2024/11/26/wesley-gibbs-NxRx7-mPdEk-unsplash.jpeg?optimize=medium&dpr=2&auto=webp&width=150 2048w, https://cdn.benzinga.com/files/images/story/2024/11/26/wesley-gibbs-NxRx7-mPdEk-unsplash.jpeg?optimize=medium&dpr=2&auto=webp&width=150 3840w" class="sc-ZxepX kRlPph post-thumb" decoding="sync" style="border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:cover"/><noscript><img alt="" sizes="(max-width: 800px) 120px, (min-width: 800px) 240px" src="https://cdn.benzinga.com/files/images/story/2024/11/26/wesley-gibbs-NxRx7-mPdEk-unsplash.jpeg?optimize=medium&dpr=2&auto=webp&width=150" srcSet="https://cdn.benzinga.com/files/images/story/2024/11/26/wesley-gibbs-NxRx7-mPdEk-unsplash.jpeg?optimize=medium&dpr=2&auto=webp&width=150 16w, https://cdn.benzinga.com/files/images/story/2024/11/26/wesley-gibbs-NxRx7-mPdEk-unsplash.jpeg?optimize=medium&dpr=2&auto=webp&width=150 32w, https://cdn.benzinga.com/files/images/story/2024/11/26/wesley-gibbs-NxRx7-mPdEk-unsplash.jpeg?optimize=medium&dpr=2&auto=webp&width=150 48w, https://cdn.benzinga.com/files/images/story/2024/11/26/wesley-gibbs-NxRx7-mPdEk-unsplash.jpeg?optimize=medium&dpr=2&auto=webp&width=150 64w, https://cdn.benzinga.com/files/images/story/2024/11/26/wesley-gibbs-NxRx7-mPdEk-unsplash.jpeg?optimize=medium&dpr=2&auto=webp&width=150 96w, https://cdn.benzinga.com/files/images/story/2024/11/26/wesley-gibbs-NxRx7-mPdEk-unsplash.jpeg?optimize=medium&dpr=2&auto=webp&width=150 128w, https://cdn.benzinga.com/files/images/story/2024/11/26/wesley-gibbs-NxRx7-mPdEk-unsplash.jpeg?optimize=medium&dpr=2&auto=webp&width=150 256w, https://cdn.benzinga.com/files/images/story/2024/11/26/wesley-gibbs-NxRx7-mPdEk-unsplash.jpeg?optimize=medium&dpr=2&auto=webp&width=150 384w, https://cdn.benzinga.com/files/images/story/2024/11/26/wesley-gibbs-NxRx7-mPdEk-unsplash.jpeg?optimize=medium&dpr=2&auto=webp&width=150 640w, https://cdn.benzinga.com/files/images/story/2024/11/26/wesley-gibbs-NxRx7-mPdEk-unsplash.jpeg?optimize=medium&dpr=2&auto=webp&width=150 750w, https://cdn.benzinga.com/files/images/story/2024/11/26/wesley-gibbs-NxRx7-mPdEk-unsplash.jpeg?optimize=medium&dpr=2&auto=webp&width=150 828w, https://cdn.benzinga.com/files/images/story/2024/11/26/wesley-gibbs-NxRx7-mPdEk-unsplash.jpeg?optimize=medium&dpr=2&auto=webp&width=150 1080w, https://cdn.benzinga.com/files/images/story/2024/11/26/wesley-gibbs-NxRx7-mPdEk-unsplash.jpeg?optimize=medium&dpr=2&auto=webp&width=150 1200w, https://cdn.benzinga.com/files/images/story/2024/11/26/wesley-gibbs-NxRx7-mPdEk-unsplash.jpeg?optimize=medium&dpr=2&auto=webp&width=150 1920w, https://cdn.benzinga.com/files/images/story/2024/11/26/wesley-gibbs-NxRx7-mPdEk-unsplash.jpeg?optimize=medium&dpr=2&auto=webp&width=150 2048w, https://cdn.benzinga.com/files/images/story/2024/11/26/wesley-gibbs-NxRx7-mPdEk-unsplash.jpeg?optimize=medium&dpr=2&auto=webp&width=150 3840w" class="sc-ZxepX kRlPph post-thumb" decoding="async" loading="eager" style="border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:cover"/></noscript></span></a><div class="post-card-text lg:w-auto flex flex-col space-y-2"><div class="post-card-text-wrapper"><a class="post-card-article-link" href="/news/retail-sales/24/11/42199358/aurora-cannabis-reveals-latest-product-innovations-ultra-high-potency-indicas-and-strains-for-veterans"><span class="sc-keSDAH iWtdjm post-title"><div class="sc-cLGQGY sc-jNBTOL gyiUav epEOZZ line-wrapper post-card-title leading-snug text-base"><span>Aurora Cannabis Reveals Latest Product Innovations: Ultra-High Potency Indicas And Strains For Veterans</span></div></span></a><div class="post-card-article-link flex items-center"><div class="sc-ekaoJE fACrUT"></div></div></div></div></div></div></div></div></div></div><hr class="my-4"/><div><div class="sc-cdZxpv dTmZtg"><div class="news-section-container"><div data-action="Featured Card Click" class="sc-bXbAQm encpHI"><div class="sc-hpmCTx kTMIHF post-card-wrapper"><div class="sc-ehEeqy cMobMa post-card post-card-default post-card-size-compact" title="Elizabeth Warren, Bernie Sanders & 12 Congress Members To Biden: Issue Clemency And Pardons For Cannabis Prisoners"><a class="post-card-article-link post-card-image image-wrapper" href="https://www.benzinga.com/news/legal/24/11/42202403/elizabeth-warren-bernie-sanders-12-congress-members-to-biden-issue-clemency-and-pardons-for-cannabis-prisoners"><span style="background:none;border:0;box-sizing:border-box;display:block;height:initial;margin:0;opacity:1;overflow:hidden;padding:0;width:initial;position:absolute;top:0;left:0;bottom:0;right:0"><div role="img" class="sc-ppzwM joEPHQ"></div><img alt="" sizes="(max-width: 800px) 120px, (min-width: 800px) 240px" src="https://cdn.benzinga.com/files/images/story/2024/11/26/joe-biden-cannabis-liberty-adam-schultz-.jpeg?optimize=medium&dpr=2&auto=webp&width=260" srcSet="https://cdn.benzinga.com/files/images/story/2024/11/26/joe-biden-cannabis-liberty-adam-schultz-.jpeg?optimize=medium&dpr=2&auto=webp&width=260 16w, https://cdn.benzinga.com/files/images/story/2024/11/26/joe-biden-cannabis-liberty-adam-schultz-.jpeg?optimize=medium&dpr=2&auto=webp&width=260 32w, https://cdn.benzinga.com/files/images/story/2024/11/26/joe-biden-cannabis-liberty-adam-schultz-.jpeg?optimize=medium&dpr=2&auto=webp&width=260 48w, https://cdn.benzinga.com/files/images/story/2024/11/26/joe-biden-cannabis-liberty-adam-schultz-.jpeg?optimize=medium&dpr=2&auto=webp&width=260 64w, https://cdn.benzinga.com/files/images/story/2024/11/26/joe-biden-cannabis-liberty-adam-schultz-.jpeg?optimize=medium&dpr=2&auto=webp&width=260 96w, https://cdn.benzinga.com/files/images/story/2024/11/26/joe-biden-cannabis-liberty-adam-schultz-.jpeg?optimize=medium&dpr=2&auto=webp&width=260 128w, https://cdn.benzinga.com/files/images/story/2024/11/26/joe-biden-cannabis-liberty-adam-schultz-.jpeg?optimize=medium&dpr=2&auto=webp&width=260 256w, https://cdn.benzinga.com/files/images/story/2024/11/26/joe-biden-cannabis-liberty-adam-schultz-.jpeg?optimize=medium&dpr=2&auto=webp&width=260 384w, https://cdn.benzinga.com/files/images/story/2024/11/26/joe-biden-cannabis-liberty-adam-schultz-.jpeg?optimize=medium&dpr=2&auto=webp&width=260 640w, https://cdn.benzinga.com/files/images/story/2024/11/26/joe-biden-cannabis-liberty-adam-schultz-.jpeg?optimize=medium&dpr=2&auto=webp&width=260 750w, https://cdn.benzinga.com/files/images/story/2024/11/26/joe-biden-cannabis-liberty-adam-schultz-.jpeg?optimize=medium&dpr=2&auto=webp&width=260 828w, https://cdn.benzinga.com/files/images/story/2024/11/26/joe-biden-cannabis-liberty-adam-schultz-.jpeg?optimize=medium&dpr=2&auto=webp&width=260 1080w, https://cdn.benzinga.com/files/images/story/2024/11/26/joe-biden-cannabis-liberty-adam-schultz-.jpeg?optimize=medium&dpr=2&auto=webp&width=260 1200w, https://cdn.benzinga.com/files/images/story/2024/11/26/joe-biden-cannabis-liberty-adam-schultz-.jpeg?optimize=medium&dpr=2&auto=webp&width=260 1920w, https://cdn.benzinga.com/files/images/story/2024/11/26/joe-biden-cannabis-liberty-adam-schultz-.jpeg?optimize=medium&dpr=2&auto=webp&width=260 2048w, https://cdn.benzinga.com/files/images/story/2024/11/26/joe-biden-cannabis-liberty-adam-schultz-.jpeg?optimize=medium&dpr=2&auto=webp&width=260 3840w" class="sc-ZxepX kRlPph post-thumb" decoding="sync" style="border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:cover"/><noscript><img alt="" sizes="(max-width: 800px) 120px, (min-width: 800px) 240px" src="https://cdn.benzinga.com/files/images/story/2024/11/26/joe-biden-cannabis-liberty-adam-schultz-.jpeg?optimize=medium&dpr=2&auto=webp&width=260" srcSet="https://cdn.benzinga.com/files/images/story/2024/11/26/joe-biden-cannabis-liberty-adam-schultz-.jpeg?optimize=medium&dpr=2&auto=webp&width=260 16w, https://cdn.benzinga.com/files/images/story/2024/11/26/joe-biden-cannabis-liberty-adam-schultz-.jpeg?optimize=medium&dpr=2&auto=webp&width=260 32w, https://cdn.benzinga.com/files/images/story/2024/11/26/joe-biden-cannabis-liberty-adam-schultz-.jpeg?optimize=medium&dpr=2&auto=webp&width=260 48w, https://cdn.benzinga.com/files/images/story/2024/11/26/joe-biden-cannabis-liberty-adam-schultz-.jpeg?optimize=medium&dpr=2&auto=webp&width=260 64w, https://cdn.benzinga.com/files/images/story/2024/11/26/joe-biden-cannabis-liberty-adam-schultz-.jpeg?optimize=medium&dpr=2&auto=webp&width=260 96w, https://cdn.benzinga.com/files/images/story/2024/11/26/joe-biden-cannabis-liberty-adam-schultz-.jpeg?optimize=medium&dpr=2&auto=webp&width=260 128w, https://cdn.benzinga.com/files/images/story/2024/11/26/joe-biden-cannabis-liberty-adam-schultz-.jpeg?optimize=medium&dpr=2&auto=webp&width=260 256w, https://cdn.benzinga.com/files/images/story/2024/11/26/joe-biden-cannabis-liberty-adam-schultz-.jpeg?optimize=medium&dpr=2&auto=webp&width=260 384w, https://cdn.benzinga.com/files/images/story/2024/11/26/joe-biden-cannabis-liberty-adam-schultz-.jpeg?optimize=medium&dpr=2&auto=webp&width=260 640w, https://cdn.benzinga.com/files/images/story/2024/11/26/joe-biden-cannabis-liberty-adam-schultz-.jpeg?optimize=medium&dpr=2&auto=webp&width=260 750w, https://cdn.benzinga.com/files/images/story/2024/11/26/joe-biden-cannabis-liberty-adam-schultz-.jpeg?optimize=medium&dpr=2&auto=webp&width=260 828w, https://cdn.benzinga.com/files/images/story/2024/11/26/joe-biden-cannabis-liberty-adam-schultz-.jpeg?optimize=medium&dpr=2&auto=webp&width=260 1080w, https://cdn.benzinga.com/files/images/story/2024/11/26/joe-biden-cannabis-liberty-adam-schultz-.jpeg?optimize=medium&dpr=2&auto=webp&width=260 1200w, https://cdn.benzinga.com/files/images/story/2024/11/26/joe-biden-cannabis-liberty-adam-schultz-.jpeg?optimize=medium&dpr=2&auto=webp&width=260 1920w, https://cdn.benzinga.com/files/images/story/2024/11/26/joe-biden-cannabis-liberty-adam-schultz-.jpeg?optimize=medium&dpr=2&auto=webp&width=260 2048w, https://cdn.benzinga.com/files/images/story/2024/11/26/joe-biden-cannabis-liberty-adam-schultz-.jpeg?optimize=medium&dpr=2&auto=webp&width=260 3840w" class="sc-ZxepX kRlPph post-thumb" decoding="async" loading="eager" style="border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:cover"/></noscript></span></a><div class="post-card-text lg:w-auto flex flex-col space-y-2"><div class="post-card-text-wrapper"><a class="post-card-article-link" href="https://www.benzinga.com/news/legal/24/11/42202403/elizabeth-warren-bernie-sanders-12-congress-members-to-biden-issue-clemency-and-pardons-for-cannabis-prisoners"><span class="sc-keSDAH iWtdjm post-title"><div class="sc-cLGQGY sc-jNBTOL gyiUav epEOZZ line-wrapper post-card-title leading-snug text-base"><span>Elizabeth Warren, Bernie Sanders & 12 Congress Members To Biden: Issue Clemency And Pardons For Cannabis Prisoners</span></div></span></a><div class="post-card-article-link flex items-center"><div class="sc-ekaoJE fACrUT"></div></div></div></div></div></div></div><div data-action="Featured Card Click" class="sc-bXbAQm encpHI"><div class="sc-hpmCTx kTMIHF post-card-wrapper"><div class="sc-ehEeqy cMobMa post-card post-card-default post-card-size-compact" title="Aurora Cannabis Reveals Latest Product Innovations: Ultra-High Potency Indicas And Strains For Veterans"><a class="post-card-article-link post-card-image image-wrapper" href="https://www.benzinga.com/news/retail-sales/24/11/42199358/aurora-cannabis-reveals-latest-product-innovations-ultra-high-potency-indicas-and-strains-for-veterans"><span style="background:none;border:0;box-sizing:border-box;display:block;height:initial;margin:0;opacity:1;overflow:hidden;padding:0;width:initial;position:absolute;top:0;left:0;bottom:0;right:0"><div role="img" class="sc-ppzwM kynSFO"></div><img alt="" sizes="(max-width: 800px) 120px, (min-width: 800px) 240px" src="https://cdn.benzinga.com/files/images/story/2024/11/26/wesley-gibbs-NxRx7-mPdEk-unsplash.jpeg?optimize=medium&dpr=2&auto=webp&width=260" srcSet="https://cdn.benzinga.com/files/images/story/2024/11/26/wesley-gibbs-NxRx7-mPdEk-unsplash.jpeg?optimize=medium&dpr=2&auto=webp&width=260 16w, https://cdn.benzinga.com/files/images/story/2024/11/26/wesley-gibbs-NxRx7-mPdEk-unsplash.jpeg?optimize=medium&dpr=2&auto=webp&width=260 32w, https://cdn.benzinga.com/files/images/story/2024/11/26/wesley-gibbs-NxRx7-mPdEk-unsplash.jpeg?optimize=medium&dpr=2&auto=webp&width=260 48w, https://cdn.benzinga.com/files/images/story/2024/11/26/wesley-gibbs-NxRx7-mPdEk-unsplash.jpeg?optimize=medium&dpr=2&auto=webp&width=260 64w, https://cdn.benzinga.com/files/images/story/2024/11/26/wesley-gibbs-NxRx7-mPdEk-unsplash.jpeg?optimize=medium&dpr=2&auto=webp&width=260 96w, https://cdn.benzinga.com/files/images/story/2024/11/26/wesley-gibbs-NxRx7-mPdEk-unsplash.jpeg?optimize=medium&dpr=2&auto=webp&width=260 128w, https://cdn.benzinga.com/files/images/story/2024/11/26/wesley-gibbs-NxRx7-mPdEk-unsplash.jpeg?optimize=medium&dpr=2&auto=webp&width=260 256w, https://cdn.benzinga.com/files/images/story/2024/11/26/wesley-gibbs-NxRx7-mPdEk-unsplash.jpeg?optimize=medium&dpr=2&auto=webp&width=260 384w, https://cdn.benzinga.com/files/images/story/2024/11/26/wesley-gibbs-NxRx7-mPdEk-unsplash.jpeg?optimize=medium&dpr=2&auto=webp&width=260 640w, https://cdn.benzinga.com/files/images/story/2024/11/26/wesley-gibbs-NxRx7-mPdEk-unsplash.jpeg?optimize=medium&dpr=2&auto=webp&width=260 750w, https://cdn.benzinga.com/files/images/story/2024/11/26/wesley-gibbs-NxRx7-mPdEk-unsplash.jpeg?optimize=medium&dpr=2&auto=webp&width=260 828w, https://cdn.benzinga.com/files/images/story/2024/11/26/wesley-gibbs-NxRx7-mPdEk-unsplash.jpeg?optimize=medium&dpr=2&auto=webp&width=260 1080w, https://cdn.benzinga.com/files/images/story/2024/11/26/wesley-gibbs-NxRx7-mPdEk-unsplash.jpeg?optimize=medium&dpr=2&auto=webp&width=260 1200w, https://cdn.benzinga.com/files/images/story/2024/11/26/wesley-gibbs-NxRx7-mPdEk-unsplash.jpeg?optimize=medium&dpr=2&auto=webp&width=260 1920w, https://cdn.benzinga.com/files/images/story/2024/11/26/wesley-gibbs-NxRx7-mPdEk-unsplash.jpeg?optimize=medium&dpr=2&auto=webp&width=260 2048w, https://cdn.benzinga.com/files/images/story/2024/11/26/wesley-gibbs-NxRx7-mPdEk-unsplash.jpeg?optimize=medium&dpr=2&auto=webp&width=260 3840w" class="sc-ZxepX kRlPph post-thumb" decoding="sync" style="border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:cover"/><noscript><img alt="" sizes="(max-width: 800px) 120px, (min-width: 800px) 240px" src="https://cdn.benzinga.com/files/images/story/2024/11/26/wesley-gibbs-NxRx7-mPdEk-unsplash.jpeg?optimize=medium&dpr=2&auto=webp&width=260" srcSet="https://cdn.benzinga.com/files/images/story/2024/11/26/wesley-gibbs-NxRx7-mPdEk-unsplash.jpeg?optimize=medium&dpr=2&auto=webp&width=260 16w, https://cdn.benzinga.com/files/images/story/2024/11/26/wesley-gibbs-NxRx7-mPdEk-unsplash.jpeg?optimize=medium&dpr=2&auto=webp&width=260 32w, https://cdn.benzinga.com/files/images/story/2024/11/26/wesley-gibbs-NxRx7-mPdEk-unsplash.jpeg?optimize=medium&dpr=2&auto=webp&width=260 48w, https://cdn.benzinga.com/files/images/story/2024/11/26/wesley-gibbs-NxRx7-mPdEk-unsplash.jpeg?optimize=medium&dpr=2&auto=webp&width=260 64w, https://cdn.benzinga.com/files/images/story/2024/11/26/wesley-gibbs-NxRx7-mPdEk-unsplash.jpeg?optimize=medium&dpr=2&auto=webp&width=260 96w, https://cdn.benzinga.com/files/images/story/2024/11/26/wesley-gibbs-NxRx7-mPdEk-unsplash.jpeg?optimize=medium&dpr=2&auto=webp&width=260 128w, https://cdn.benzinga.com/files/images/story/2024/11/26/wesley-gibbs-NxRx7-mPdEk-unsplash.jpeg?optimize=medium&dpr=2&auto=webp&width=260 256w, https://cdn.benzinga.com/files/images/story/2024/11/26/wesley-gibbs-NxRx7-mPdEk-unsplash.jpeg?optimize=medium&dpr=2&auto=webp&width=260 384w, https://cdn.benzinga.com/files/images/story/2024/11/26/wesley-gibbs-NxRx7-mPdEk-unsplash.jpeg?optimize=medium&dpr=2&auto=webp&width=260 640w, https://cdn.benzinga.com/files/images/story/2024/11/26/wesley-gibbs-NxRx7-mPdEk-unsplash.jpeg?optimize=medium&dpr=2&auto=webp&width=260 750w, https://cdn.benzinga.com/files/images/story/2024/11/26/wesley-gibbs-NxRx7-mPdEk-unsplash.jpeg?optimize=medium&dpr=2&auto=webp&width=260 828w, https://cdn.benzinga.com/files/images/story/2024/11/26/wesley-gibbs-NxRx7-mPdEk-unsplash.jpeg?optimize=medium&dpr=2&auto=webp&width=260 1080w, https://cdn.benzinga.com/files/images/story/2024/11/26/wesley-gibbs-NxRx7-mPdEk-unsplash.jpeg?optimize=medium&dpr=2&auto=webp&width=260 1200w, https://cdn.benzinga.com/files/images/story/2024/11/26/wesley-gibbs-NxRx7-mPdEk-unsplash.jpeg?optimize=medium&dpr=2&auto=webp&width=260 1920w, https://cdn.benzinga.com/files/images/story/2024/11/26/wesley-gibbs-NxRx7-mPdEk-unsplash.jpeg?optimize=medium&dpr=2&auto=webp&width=260 2048w, https://cdn.benzinga.com/files/images/story/2024/11/26/wesley-gibbs-NxRx7-mPdEk-unsplash.jpeg?optimize=medium&dpr=2&auto=webp&width=260 3840w" class="sc-ZxepX kRlPph post-thumb" decoding="async" loading="eager" style="border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:cover"/></noscript></span></a><div class="post-card-text lg:w-auto flex flex-col space-y-2"><div class="post-card-text-wrapper"><a class="post-card-article-link" href="https://www.benzinga.com/news/retail-sales/24/11/42199358/aurora-cannabis-reveals-latest-product-innovations-ultra-high-potency-indicas-and-strains-for-veterans"><span class="sc-keSDAH iWtdjm post-title"><div class="sc-cLGQGY sc-jNBTOL gyiUav epEOZZ line-wrapper post-card-title leading-snug text-base"><span>Aurora Cannabis Reveals Latest Product Innovations: Ultra-High Potency Indicas And Strains For Veterans</span></div></span></a><div class="post-card-article-link flex items-center"><div class="sc-ekaoJE fACrUT"></div></div></div></div></div></div></div><div data-action="Featured Card Click" class="sc-bXbAQm encpHI"><div class="sc-hpmCTx kTMIHF post-card-wrapper"><div class="sc-ehEeqy cMobMa post-card post-card-default post-card-size-compact" title="Veteran Access To Psychedelic Mental Health Therapies Stalls In Virginia"><a class="post-card-article-link post-card-image image-wrapper" href="https://www.benzinga.com/markets/cannabis/24/11/42198858/veteran-access-to-psychedelic-mental-health-therapies-stalls-in-virginia"><span style="background:none;border:0;box-sizing:border-box;display:block;height:initial;margin:0;opacity:1;overflow:hidden;padding:0;width:initial;position:absolute;top:0;left:0;bottom:0;right:0"><div role="img" class="sc-ppzwM dSuRQF"></div><img alt="" sizes="(max-width: 800px) 120px, (min-width: 800px) 240px" src="https://cdn.benzinga.com/files/images/story/2024/11/26/2-12.png?optimize=medium&dpr=2&auto=webp&width=260" srcSet="https://cdn.benzinga.com/files/images/story/2024/11/26/2-12.png?optimize=medium&dpr=2&auto=webp&width=260 16w, https://cdn.benzinga.com/files/images/story/2024/11/26/2-12.png?optimize=medium&dpr=2&auto=webp&width=260 32w, https://cdn.benzinga.com/files/images/story/2024/11/26/2-12.png?optimize=medium&dpr=2&auto=webp&width=260 48w, https://cdn.benzinga.com/files/images/story/2024/11/26/2-12.png?optimize=medium&dpr=2&auto=webp&width=260 64w, https://cdn.benzinga.com/files/images/story/2024/11/26/2-12.png?optimize=medium&dpr=2&auto=webp&width=260 96w, https://cdn.benzinga.com/files/images/story/2024/11/26/2-12.png?optimize=medium&dpr=2&auto=webp&width=260 128w, https://cdn.benzinga.com/files/images/story/2024/11/26/2-12.png?optimize=medium&dpr=2&auto=webp&width=260 256w, https://cdn.benzinga.com/files/images/story/2024/11/26/2-12.png?optimize=medium&dpr=2&auto=webp&width=260 384w, https://cdn.benzinga.com/files/images/story/2024/11/26/2-12.png?optimize=medium&dpr=2&auto=webp&width=260 640w, https://cdn.benzinga.com/files/images/story/2024/11/26/2-12.png?optimize=medium&dpr=2&auto=webp&width=260 750w, https://cdn.benzinga.com/files/images/story/2024/11/26/2-12.png?optimize=medium&dpr=2&auto=webp&width=260 828w, https://cdn.benzinga.com/files/images/story/2024/11/26/2-12.png?optimize=medium&dpr=2&auto=webp&width=260 1080w, https://cdn.benzinga.com/files/images/story/2024/11/26/2-12.png?optimize=medium&dpr=2&auto=webp&width=260 1200w, https://cdn.benzinga.com/files/images/story/2024/11/26/2-12.png?optimize=medium&dpr=2&auto=webp&width=260 1920w, https://cdn.benzinga.com/files/images/story/2024/11/26/2-12.png?optimize=medium&dpr=2&auto=webp&width=260 2048w, https://cdn.benzinga.com/files/images/story/2024/11/26/2-12.png?optimize=medium&dpr=2&auto=webp&width=260 3840w" class="sc-ZxepX kRlPph post-thumb" decoding="sync" style="border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:cover"/><noscript><img alt="" sizes="(max-width: 800px) 120px, (min-width: 800px) 240px" src="https://cdn.benzinga.com/files/images/story/2024/11/26/2-12.png?optimize=medium&dpr=2&auto=webp&width=260" srcSet="https://cdn.benzinga.com/files/images/story/2024/11/26/2-12.png?optimize=medium&dpr=2&auto=webp&width=260 16w, https://cdn.benzinga.com/files/images/story/2024/11/26/2-12.png?optimize=medium&dpr=2&auto=webp&width=260 32w, https://cdn.benzinga.com/files/images/story/2024/11/26/2-12.png?optimize=medium&dpr=2&auto=webp&width=260 48w, https://cdn.benzinga.com/files/images/story/2024/11/26/2-12.png?optimize=medium&dpr=2&auto=webp&width=260 64w, https://cdn.benzinga.com/files/images/story/2024/11/26/2-12.png?optimize=medium&dpr=2&auto=webp&width=260 96w, https://cdn.benzinga.com/files/images/story/2024/11/26/2-12.png?optimize=medium&dpr=2&auto=webp&width=260 128w, https://cdn.benzinga.com/files/images/story/2024/11/26/2-12.png?optimize=medium&dpr=2&auto=webp&width=260 256w, https://cdn.benzinga.com/files/images/story/2024/11/26/2-12.png?optimize=medium&dpr=2&auto=webp&width=260 384w, https://cdn.benzinga.com/files/images/story/2024/11/26/2-12.png?optimize=medium&dpr=2&auto=webp&width=260 640w, https://cdn.benzinga.com/files/images/story/2024/11/26/2-12.png?optimize=medium&dpr=2&auto=webp&width=260 750w, https://cdn.benzinga.com/files/images/story/2024/11/26/2-12.png?optimize=medium&dpr=2&auto=webp&width=260 828w, https://cdn.benzinga.com/files/images/story/2024/11/26/2-12.png?optimize=medium&dpr=2&auto=webp&width=260 1080w, https://cdn.benzinga.com/files/images/story/2024/11/26/2-12.png?optimize=medium&dpr=2&auto=webp&width=260 1200w, https://cdn.benzinga.com/files/images/story/2024/11/26/2-12.png?optimize=medium&dpr=2&auto=webp&width=260 1920w, https://cdn.benzinga.com/files/images/story/2024/11/26/2-12.png?optimize=medium&dpr=2&auto=webp&width=260 2048w, https://cdn.benzinga.com/files/images/story/2024/11/26/2-12.png?optimize=medium&dpr=2&auto=webp&width=260 3840w" class="sc-ZxepX kRlPph post-thumb" decoding="async" loading="eager" style="border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:cover"/></noscript></span></a><div class="post-card-text lg:w-auto flex flex-col space-y-2"><div class="post-card-text-wrapper"><a class="post-card-article-link" href="https://www.benzinga.com/markets/cannabis/24/11/42198858/veteran-access-to-psychedelic-mental-health-therapies-stalls-in-virginia"><span class="sc-keSDAH iWtdjm post-title"><div class="sc-cLGQGY sc-jNBTOL gyiUav epEOZZ line-wrapper post-card-title leading-snug text-base"><span>Veteran Access To Psychedelic Mental Health Therapies Stalls In Virginia</span></div></span></a><div class="post-card-article-link flex items-center"><div class="sc-ekaoJE fACrUT"></div></div></div></div></div></div></div><div data-action="Featured Card Click" class="sc-bXbAQm encpHI"><div class="sc-hpmCTx kTMIHF post-card-wrapper"><div class="sc-ehEeqy cMobMa post-card post-card-default post-card-size-compact" title="Prohibitionist Group Denies Collusion Allegations Ahead Of DEA Cannabis Rescheduling Hearing"><a class="post-card-article-link post-card-image image-wrapper" href="https://www.benzinga.com/government/regulations/24/11/42198793/prohibitionist-group-denies-collusion-allegations-ahead-of-dea-cannabis-rescheduling-hearing"><span style="background:none;border:0;box-sizing:border-box;display:block;height:initial;margin:0;opacity:1;overflow:hidden;padding:0;width:initial;position:absolute;top:0;left:0;bottom:0;right:0"><div role="img" class="sc-ppzwM bzLEga"></div><img alt="" sizes="(max-width: 800px) 120px, (min-width: 800px) 240px" src="https://cdn.benzinga.com/files/images/story/2024/11/26/DEA-hearing.png?optimize=medium&dpr=2&auto=webp&width=260" srcSet="https://cdn.benzinga.com/files/images/story/2024/11/26/DEA-hearing.png?optimize=medium&dpr=2&auto=webp&width=260 16w, https://cdn.benzinga.com/files/images/story/2024/11/26/DEA-hearing.png?optimize=medium&dpr=2&auto=webp&width=260 32w, https://cdn.benzinga.com/files/images/story/2024/11/26/DEA-hearing.png?optimize=medium&dpr=2&auto=webp&width=260 48w, https://cdn.benzinga.com/files/images/story/2024/11/26/DEA-hearing.png?optimize=medium&dpr=2&auto=webp&width=260 64w, https://cdn.benzinga.com/files/images/story/2024/11/26/DEA-hearing.png?optimize=medium&dpr=2&auto=webp&width=260 96w, https://cdn.benzinga.com/files/images/story/2024/11/26/DEA-hearing.png?optimize=medium&dpr=2&auto=webp&width=260 128w, https://cdn.benzinga.com/files/images/story/2024/11/26/DEA-hearing.png?optimize=medium&dpr=2&auto=webp&width=260 256w, https://cdn.benzinga.com/files/images/story/2024/11/26/DEA-hearing.png?optimize=medium&dpr=2&auto=webp&width=260 384w, https://cdn.benzinga.com/files/images/story/2024/11/26/DEA-hearing.png?optimize=medium&dpr=2&auto=webp&width=260 640w, https://cdn.benzinga.com/files/images/story/2024/11/26/DEA-hearing.png?optimize=medium&dpr=2&auto=webp&width=260 750w, https://cdn.benzinga.com/files/images/story/2024/11/26/DEA-hearing.png?optimize=medium&dpr=2&auto=webp&width=260 828w, https://cdn.benzinga.com/files/images/story/2024/11/26/DEA-hearing.png?optimize=medium&dpr=2&auto=webp&width=260 1080w, https://cdn.benzinga.com/files/images/story/2024/11/26/DEA-hearing.png?optimize=medium&dpr=2&auto=webp&width=260 1200w, https://cdn.benzinga.com/files/images/story/2024/11/26/DEA-hearing.png?optimize=medium&dpr=2&auto=webp&width=260 1920w, https://cdn.benzinga.com/files/images/story/2024/11/26/DEA-hearing.png?optimize=medium&dpr=2&auto=webp&width=260 2048w, https://cdn.benzinga.com/files/images/story/2024/11/26/DEA-hearing.png?optimize=medium&dpr=2&auto=webp&width=260 3840w" class="sc-ZxepX kRlPph post-thumb" decoding="sync" style="border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:cover"/><noscript><img alt="" sizes="(max-width: 800px) 120px, (min-width: 800px) 240px" src="https://cdn.benzinga.com/files/images/story/2024/11/26/DEA-hearing.png?optimize=medium&dpr=2&auto=webp&width=260" srcSet="https://cdn.benzinga.com/files/images/story/2024/11/26/DEA-hearing.png?optimize=medium&dpr=2&auto=webp&width=260 16w, https://cdn.benzinga.com/files/images/story/2024/11/26/DEA-hearing.png?optimize=medium&dpr=2&auto=webp&width=260 32w, https://cdn.benzinga.com/files/images/story/2024/11/26/DEA-hearing.png?optimize=medium&dpr=2&auto=webp&width=260 48w, https://cdn.benzinga.com/files/images/story/2024/11/26/DEA-hearing.png?optimize=medium&dpr=2&auto=webp&width=260 64w, https://cdn.benzinga.com/files/images/story/2024/11/26/DEA-hearing.png?optimize=medium&dpr=2&auto=webp&width=260 96w, https://cdn.benzinga.com/files/images/story/2024/11/26/DEA-hearing.png?optimize=medium&dpr=2&auto=webp&width=260 128w, https://cdn.benzinga.com/files/images/story/2024/11/26/DEA-hearing.png?optimize=medium&dpr=2&auto=webp&width=260 256w, https://cdn.benzinga.com/files/images/story/2024/11/26/DEA-hearing.png?optimize=medium&dpr=2&auto=webp&width=260 384w, https://cdn.benzinga.com/files/images/story/2024/11/26/DEA-hearing.png?optimize=medium&dpr=2&auto=webp&width=260 640w, https://cdn.benzinga.com/files/images/story/2024/11/26/DEA-hearing.png?optimize=medium&dpr=2&auto=webp&width=260 750w, https://cdn.benzinga.com/files/images/story/2024/11/26/DEA-hearing.png?optimize=medium&dpr=2&auto=webp&width=260 828w, https://cdn.benzinga.com/files/images/story/2024/11/26/DEA-hearing.png?optimize=medium&dpr=2&auto=webp&width=260 1080w, https://cdn.benzinga.com/files/images/story/2024/11/26/DEA-hearing.png?optimize=medium&dpr=2&auto=webp&width=260 1200w, https://cdn.benzinga.com/files/images/story/2024/11/26/DEA-hearing.png?optimize=medium&dpr=2&auto=webp&width=260 1920w, https://cdn.benzinga.com/files/images/story/2024/11/26/DEA-hearing.png?optimize=medium&dpr=2&auto=webp&width=260 2048w, https://cdn.benzinga.com/files/images/story/2024/11/26/DEA-hearing.png?optimize=medium&dpr=2&auto=webp&width=260 3840w" class="sc-ZxepX kRlPph post-thumb" decoding="async" loading="eager" style="border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:cover"/></noscript></span></a><div class="post-card-text lg:w-auto flex flex-col space-y-2"><div class="post-card-text-wrapper"><a class="post-card-article-link" href="https://www.benzinga.com/government/regulations/24/11/42198793/prohibitionist-group-denies-collusion-allegations-ahead-of-dea-cannabis-rescheduling-hearing"><span class="sc-keSDAH iWtdjm post-title"><div class="sc-cLGQGY sc-jNBTOL gyiUav epEOZZ line-wrapper post-card-title leading-snug text-base"><span>Prohibitionist Group Denies Collusion Allegations Ahead Of DEA Cannabis Rescheduling Hearing</span></div></span></a><div class="post-card-article-link flex items-center"><div class="sc-ekaoJE fACrUT"></div></div></div></div></div></div></div></div></div></div></div></div><div class="sc-fCzvdW kTbgNs news-list-group-block"><div class="sc-fKFgrF icxwYm news-list-group-wrapper"><div class="parsely-news-list"><div class="sc-kSsGea iOEnob news-list-wrapper"><div class="sc-nbCPO hyiaGS content-feed "><div class="sc-dkXDdO cXVRMB section-title news-block-title bordered"><h3>Popular Stories</h3></div><div class="content-feed-container"><div class="content-feed-list"><div class="sc-hmzteu ddclwE news-block primary"><div class="news-block-headline"><div class="flex"><div><a data-action="Popular Stories Article Click" href="/news/legal/24/11/42202403/elizabeth-warren-bernie-sanders-12-congress-members-to-biden-issue-clemency-and-pardons-for-cannabis-prisoners"><div class="sc-ceLTrZ bjJtVr article-title"><span>Elizabeth Warren, Bernie Sanders & 12 Congress Members To Biden: Issue Clemency And Pardons For Cannabis Prisoners</span></div></a><div><div class="flex items-center"><div class="sc-ekaoJE fACrUT"></div></div></div></div></div></div></div><div class="sc-hmzteu ddclwE news-block primary"><div class="news-block-headline"><div class="flex"><div><a data-action="Popular Stories Article Click" href="/general/health-care/24/11/42077935/trump-picks-dr-oz-who-says-seniors-should-give-medical-marijuana-a-try-to-lead-centers-for-medicare-and-medicaid-services"><div class="sc-ceLTrZ bjJtVr article-title"><span>Trump Picks Dr. Oz, Who Says Seniors Should Give Medical Marijuana A Try, To Lead Centers For Medicare And Medicaid Services</span></div></a><div><div class="flex items-center"><div class="sc-ekaoJE fACrUT"></div></div></div></div></div></div></div><div class="sc-hmzteu ddclwE news-block primary"><div class="news-block-headline"><div class="flex"><div><a data-action="Popular Stories Article Click" href="/markets/cannabis/24/11/42190193/tilray-introduces-new-indica-strain-with-potent-thc-and-a-unique-terpene-profile"><div class="sc-ceLTrZ bjJtVr article-title"><span>Tilray Introduces New Indica Strain With 'Potent THC And A Unique Terpene Profile'</span></div></a><div><div class="flex items-center"><div class="sc-ekaoJE fACrUT"></div></div></div></div></div></div><div class="sc-bUsiPH gNYhnT ticker-list"><div class="ticker-list-container"><div class="sc-dVraiA dDLddz ticker-box-wrapper"><a aria-label="Go to Quote Page for TLRY" rel="dofollow" class="items-end ticker-link-wrapper inline-flex" href="/quote/tlry" target="_blank"><span class="sc-gUDIDV jYfzbt">TLRY</span></a></div></div></div></div><div class="sc-hmzteu ddclwE news-block primary"><div class="news-block-headline"><div class="flex"><div><a data-action="Popular Stories Article Click" href="/markets/cannabis/24/11/42152643/dea-banned-from-random-airport-searches-after-scathing-justice-department-report-uncovers-corruption"><div class="sc-ceLTrZ bjJtVr article-title"><span>DEA Banned From Random Airport Searches After Scathing Justice Department Report Uncovers Corruption</span></div></a><div><div class="flex items-center"><div class="sc-ekaoJE fACrUT"></div></div></div></div></div></div></div></div></div></div></div><div class="sc-lcMqGs hdmTnE load-more-button" tabindex="0">Load more</div></div><div class="sc-fAlvPn kLNFwH latest-news-list"><div class="sc-kSsGea iOEnob news-list-wrapper"><div class="sc-nbCPO hyiaGS content-feed "><div class="news-block-header"><div class="sc-dkXDdO cXVRMB section-title news-block-title"><h3>Latest</h3></div><div class="news-block-tabs-list"><span><button class="active">All News</button><span class="divider">|</span></span><span><button class="">My Watchlist News</button></span></div></div><div class="content-feed-container"><div class="content-feed-list"><div class="sc-hmzteu ddclwE news-block primary"><div class="news-block-headline"><div class="flex"><div><a data-action="Latest Article Click" href="/24/11/42204210/why-youtubes-high-science-is-a-must-watch-for-cannabis-enthusiasts"><div class="sc-ceLTrZ bjJtVr article-title"><span>YouTube's High Science Is A Must-Watch For Cannabis Enthusiasts</span></div></a><div><div class="flex items-center"><div class="sc-ekaoJE fACrUT"></div></div></div></div></div></div></div><div class="sc-hmzteu ddclwE news-block primary"><div class="news-block-headline"><div class="flex"><div><a data-action="Latest Article Click" href="/24/11/42203777/kentucky-awards-first-medical-cannabis-dispensary-licenses"><div class="sc-ceLTrZ bjJtVr article-title"><span>Kentucky Awards First Medical Cannabis Dispensary Licenses</span></div></a><div><div class="flex items-center"><div class="sc-ekaoJE fACrUT"></div></div></div></div></div></div></div><div class="sc-hmzteu ddclwE news-block primary"><div class="news-block-headline"><div class="flex"><div><a data-action="Latest Article Click" href="/markets/cannabis/24/11/42203747/berlins-justice-senator-says-cannabis-law-benefits-mafia-like-structures-and-that-it-should-be-repealed"><div class="sc-ceLTrZ bjJtVr article-title"><span>Berlin's Justice Senator Says Cannabis Law Benefits Mafia-Like Structures And It Should Be Repealed</span></div></a><div><div class="flex items-center"><div class="sc-ekaoJE fACrUT"></div></div></div></div></div></div></div><div class="sc-hmzteu ddclwE news-block primary"><div class="news-block-headline"><div class="flex"><div><a data-action="Latest Article Click" href="/news/legal/24/11/42202403/elizabeth-warren-bernie-sanders-12-congress-members-to-biden-issue-clemency-and-pardons-for-cannabis-prisoners"><div class="sc-ceLTrZ bjJtVr article-title"><span>Elizabeth Warren, Bernie Sanders & 12 Congress Members To Biden: Issue Clemency And Pardons For Cannabis Prisoners</span></div></a><div><div class="flex items-center"><div class="sc-ekaoJE fACrUT"></div></div></div></div></div></div></div></div></div></div></div></div></div></div><div class="sc-bCvmQg htSQUf image-wrapper"><figure class="sc-cPtzlb iBQycf core-image"><a href="https://www.benzinga.com/psychedelics" rel="noreferrer" target="_blank"><span style="background:none;border:0;box-sizing:border-box;display:inline-block;height:initial;margin:0;opacity:1;overflow:hidden;padding:0;width:initial;position:relative;max-width:100%"><span style="background:none;border:0;box-sizing:border-box;display:block;height:initial;margin:0;opacity:1;padding:0;width:initial;max-width:100%"><img alt="" aria-hidden="true" src="data:image/svg+xml;base64,PHN2ZyB3aWR0aD0iOTAwIiBoZWlnaHQ9IjExMSIgeG1sbnM9Imh0dHA6Ly93d3cudzMub3JnLzIwMDAvc3ZnIiB2ZXJzaW9uPSIxLjEiLz4=" style="background:none;border:0;display:block;height:initial;margin:0;max-width:100%;opacity:1;padding:0;width:initial"/></span><img alt="Copy-of-April-2022-Psychedelics-Ad-728x90-1" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" style="border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:contain"/><noscript><img alt="Copy-of-April-2022-Psychedelics-Ad-728x90-1" sizes="(max-width: 800px) 900px, (min-width: 800px) 900px" src="https://cdnwp-s3.benzinga.com/wp-content/uploads/2022/04/29135419/Copy-of-April-2022-Psychedelics-Ad-728x90-1.png?optimize=medium&dpr=2&auto=webp&width=1920" srcSet="https://cdnwp-s3.benzinga.com/wp-content/uploads/2022/04/29135419/Copy-of-April-2022-Psychedelics-Ad-728x90-1.png?optimize=medium&dpr=2&auto=webp&width=1080 1x, https://cdnwp-s3.benzinga.com/wp-content/uploads/2022/04/29135419/Copy-of-April-2022-Psychedelics-Ad-728x90-1.png?optimize=medium&dpr=2&auto=webp&width=1920 2x" decoding="async" loading="lazy" style="border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:contain"/></noscript></span></a></figure></div><div class="sc-dTaEtF fBnIMc"><div class="sc-gFYmAs hzOZJg carousel-block reverse"><a class="sc-dkXDdO cXVRMB section-title bordered contains-right-slot" aria-label="Click here to see more Cannabis Interviews & Exclusives Carousel content" data-action=" Cannabis Interviews & Exclusives Carousel See More Click" href="/cannabis/interviews"><h3> Cannabis Interviews & Exclusives</h3><span class="right-slot"><span class="see-more">See more</span></span></a><div class="sc-hrmvde iavXuM carousel-container"><div class="splide" aria-label="Carousel"><div class="splide-track-wrapper"><div class="splide__track"><ul class="splide__list"><li class="splide__slide"><a class="sc-dxRmzR gXQkGo carousel-item-wrapper item" data-action=" Cannabis Interviews & Exclusives Carousel Card Item Click" href="/government/regulations/24/11/42173811/hemp-and-thanksgiving-from-the-mayflower-to-independence-the-crop-that-helped-build-a-nation" target="_blank" width="300"><div class="sc-iPYwOE hspwUF"><div class="sc-bnRclF hAXDhr title">Hemp And Thanksgiving: From The Mayflower To Independence, The Crop That Helped Build A Nation</div></div><div class="sc-hPnoVK hliDyh carousel-item-thumbnail" height="197" width="300"><span style="background:none;border:0;box-sizing:border-box;display:block;height:initial;margin:0;opacity:1;overflow:hidden;padding:0;width:initial;position:absolute;top:0;left:0;bottom:0;right:0"><img alt="" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" style="border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:cover"/><noscript><img alt="" sizes="100vw" src="https://cdn.benzinga.com/files/images/story/2024/11/25/AI-Generated-Image.jpeg?optimize=medium&dpr=2&auto=webp&width=340" srcSet="https://cdn.benzinga.com/files/images/story/2024/11/25/AI-Generated-Image.jpeg?optimize=medium&dpr=2&auto=webp&width=340 640w, https://cdn.benzinga.com/files/images/story/2024/11/25/AI-Generated-Image.jpeg?optimize=medium&dpr=2&auto=webp&width=340 750w, https://cdn.benzinga.com/files/images/story/2024/11/25/AI-Generated-Image.jpeg?optimize=medium&dpr=2&auto=webp&width=340 828w, https://cdn.benzinga.com/files/images/story/2024/11/25/AI-Generated-Image.jpeg?optimize=medium&dpr=2&auto=webp&width=340 1080w, https://cdn.benzinga.com/files/images/story/2024/11/25/AI-Generated-Image.jpeg?optimize=medium&dpr=2&auto=webp&width=340 1200w, https://cdn.benzinga.com/files/images/story/2024/11/25/AI-Generated-Image.jpeg?optimize=medium&dpr=2&auto=webp&width=340 1920w, https://cdn.benzinga.com/files/images/story/2024/11/25/AI-Generated-Image.jpeg?optimize=medium&dpr=2&auto=webp&width=340 2048w, https://cdn.benzinga.com/files/images/story/2024/11/25/AI-Generated-Image.jpeg?optimize=medium&dpr=2&auto=webp&width=340 3840w" decoding="async" loading="lazy" style="border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:cover"/></noscript></span></div></a></li><li class="splide__slide"><a class="sc-dxRmzR gXQkGo carousel-item-wrapper item" data-action=" Cannabis Interviews & Exclusives Carousel Card Item Click" href="/general/market-summary/24/11/42147417/80-leverage-5-5x-ebitda-is-cresco-the-high-risk-high-reward-play-investors-need" target="_blank" width="300"><div class="sc-iPYwOE hspwUF"><div class="sc-bnRclF hAXDhr title">80% Leverage, 5.5x EBITDA: Is Cresco The High-Risk, High-Reward Play Investors Need?</div></div><div class="sc-hPnoVK hliDyh carousel-item-thumbnail" height="197" width="300"><span style="background:none;border:0;box-sizing:border-box;display:block;height:initial;margin:0;opacity:1;overflow:hidden;padding:0;width:initial;position:absolute;top:0;left:0;bottom:0;right:0"><img alt="" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" style="border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:cover"/><noscript><img alt="" sizes="100vw" src="https://cdn.benzinga.com/files/images/story/2024/11/22/AI-Generated-Image_1.jpeg?optimize=medium&dpr=2&auto=webp&width=340" srcSet="https://cdn.benzinga.com/files/images/story/2024/11/22/AI-Generated-Image_1.jpeg?optimize=medium&dpr=2&auto=webp&width=340 640w, https://cdn.benzinga.com/files/images/story/2024/11/22/AI-Generated-Image_1.jpeg?optimize=medium&dpr=2&auto=webp&width=340 750w, https://cdn.benzinga.com/files/images/story/2024/11/22/AI-Generated-Image_1.jpeg?optimize=medium&dpr=2&auto=webp&width=340 828w, https://cdn.benzinga.com/files/images/story/2024/11/22/AI-Generated-Image_1.jpeg?optimize=medium&dpr=2&auto=webp&width=340 1080w, https://cdn.benzinga.com/files/images/story/2024/11/22/AI-Generated-Image_1.jpeg?optimize=medium&dpr=2&auto=webp&width=340 1200w, https://cdn.benzinga.com/files/images/story/2024/11/22/AI-Generated-Image_1.jpeg?optimize=medium&dpr=2&auto=webp&width=340 1920w, https://cdn.benzinga.com/files/images/story/2024/11/22/AI-Generated-Image_1.jpeg?optimize=medium&dpr=2&auto=webp&width=340 2048w, https://cdn.benzinga.com/files/images/story/2024/11/22/AI-Generated-Image_1.jpeg?optimize=medium&dpr=2&auto=webp&width=340 3840w" decoding="async" loading="lazy" style="border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:cover"/></noscript></span></div></a></li><li class="splide__slide"><a class="sc-dxRmzR gXQkGo carousel-item-wrapper item" data-action=" Cannabis Interviews & Exclusives Carousel Card Item Click" href="/government/regulations/24/11/42146896/exclusive-how-equa-tackles-stigma-in-cannabis-insurance-with-tailored-solutions" target="_blank" width="300"><div class="sc-iPYwOE hspwUF"><div class="sc-bnRclF hAXDhr title">EXCLUSIVE: How EQUA Tackles Stigma In Cannabis Insurance With Tailored Solutions</div></div><div class="sc-hPnoVK hliDyh carousel-item-thumbnail" height="197" width="300"><span style="background:none;border:0;box-sizing:border-box;display:block;height:initial;margin:0;opacity:1;overflow:hidden;padding:0;width:initial;position:absolute;top:0;left:0;bottom:0;right:0"><img alt="" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" style="border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:cover"/><noscript><img alt="" sizes="100vw" src="https://cdn.benzinga.com/files/images/story/2024/11/22/equaloretta.png?optimize=medium&dpr=2&auto=webp&width=340" srcSet="https://cdn.benzinga.com/files/images/story/2024/11/22/equaloretta.png?optimize=medium&dpr=2&auto=webp&width=340 640w, https://cdn.benzinga.com/files/images/story/2024/11/22/equaloretta.png?optimize=medium&dpr=2&auto=webp&width=340 750w, https://cdn.benzinga.com/files/images/story/2024/11/22/equaloretta.png?optimize=medium&dpr=2&auto=webp&width=340 828w, https://cdn.benzinga.com/files/images/story/2024/11/22/equaloretta.png?optimize=medium&dpr=2&auto=webp&width=340 1080w, https://cdn.benzinga.com/files/images/story/2024/11/22/equaloretta.png?optimize=medium&dpr=2&auto=webp&width=340 1200w, https://cdn.benzinga.com/files/images/story/2024/11/22/equaloretta.png?optimize=medium&dpr=2&auto=webp&width=340 1920w, https://cdn.benzinga.com/files/images/story/2024/11/22/equaloretta.png?optimize=medium&dpr=2&auto=webp&width=340 2048w, https://cdn.benzinga.com/files/images/story/2024/11/22/equaloretta.png?optimize=medium&dpr=2&auto=webp&width=340 3840w" decoding="async" loading="lazy" style="border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:cover"/></noscript></span></div></a></li><li class="splide__slide"><a class="sc-dxRmzR gXQkGo carousel-item-wrapper item" data-action=" Cannabis Interviews & Exclusives Carousel Card Item Click" href="/general/market-summary/24/11/42146751/jupiters-burnout-can-tilt-holdings-reverse-its-five-year-vape-decline" target="_blank" width="300"><div class="sc-iPYwOE hspwUF"><div class="sc-bnRclF hAXDhr title">Jupiter's Burnout: Can TILT Holdings Reverse Its Five-Year Vape Decline?</div></div><div class="sc-hPnoVK hliDyh carousel-item-thumbnail" height="197" width="300"><span style="background:none;border:0;box-sizing:border-box;display:block;height:initial;margin:0;opacity:1;overflow:hidden;padding:0;width:initial;position:absolute;top:0;left:0;bottom:0;right:0"><img alt="" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" style="border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:cover"/><noscript><img alt="" sizes="100vw" src="https://cdn.benzinga.com/files/images/story/2024/11/22/AI-Generated-Image_0.jpeg?optimize=medium&dpr=2&auto=webp&width=340" srcSet="https://cdn.benzinga.com/files/images/story/2024/11/22/AI-Generated-Image_0.jpeg?optimize=medium&dpr=2&auto=webp&width=340 640w, https://cdn.benzinga.com/files/images/story/2024/11/22/AI-Generated-Image_0.jpeg?optimize=medium&dpr=2&auto=webp&width=340 750w, https://cdn.benzinga.com/files/images/story/2024/11/22/AI-Generated-Image_0.jpeg?optimize=medium&dpr=2&auto=webp&width=340 828w, https://cdn.benzinga.com/files/images/story/2024/11/22/AI-Generated-Image_0.jpeg?optimize=medium&dpr=2&auto=webp&width=340 1080w, https://cdn.benzinga.com/files/images/story/2024/11/22/AI-Generated-Image_0.jpeg?optimize=medium&dpr=2&auto=webp&width=340 1200w, https://cdn.benzinga.com/files/images/story/2024/11/22/AI-Generated-Image_0.jpeg?optimize=medium&dpr=2&auto=webp&width=340 1920w, https://cdn.benzinga.com/files/images/story/2024/11/22/AI-Generated-Image_0.jpeg?optimize=medium&dpr=2&auto=webp&width=340 2048w, https://cdn.benzinga.com/files/images/story/2024/11/22/AI-Generated-Image_0.jpeg?optimize=medium&dpr=2&auto=webp&width=340 3840w" decoding="async" loading="lazy" style="border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:cover"/></noscript></span></div></a></li><li class="splide__slide"><a class="sc-dxRmzR gXQkGo carousel-item-wrapper item" data-action=" Cannabis Interviews & Exclusives Carousel Card Item Click" href="/24/11/42145274/the-most-authentic-celebrity-story-in-cannabis-building-trust-through-real-connections" target="_blank" width="300"><div class="sc-iPYwOE hspwUF"><div class="sc-bnRclF hAXDhr title">'The Most Authentic Celebrity Story In Cannabis': Khalifa Kush Exec</div></div><div class="sc-hPnoVK hliDyh carousel-item-thumbnail" height="197" width="300"><span style="background:none;border:0;box-sizing:border-box;display:block;height:initial;margin:0;opacity:1;overflow:hidden;padding:0;width:initial;position:absolute;top:0;left:0;bottom:0;right:0"><img alt="" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" style="border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:cover"/><noscript><img alt="" sizes="100vw" src="https://cdn.benzinga.com/files/images/story/2024/11/22/Wiz-Khalifa-Duki.png?optimize=medium&dpr=2&auto=webp&width=340" srcSet="https://cdn.benzinga.com/files/images/story/2024/11/22/Wiz-Khalifa-Duki.png?optimize=medium&dpr=2&auto=webp&width=340 640w, https://cdn.benzinga.com/files/images/story/2024/11/22/Wiz-Khalifa-Duki.png?optimize=medium&dpr=2&auto=webp&width=340 750w, https://cdn.benzinga.com/files/images/story/2024/11/22/Wiz-Khalifa-Duki.png?optimize=medium&dpr=2&auto=webp&width=340 828w, https://cdn.benzinga.com/files/images/story/2024/11/22/Wiz-Khalifa-Duki.png?optimize=medium&dpr=2&auto=webp&width=340 1080w, https://cdn.benzinga.com/files/images/story/2024/11/22/Wiz-Khalifa-Duki.png?optimize=medium&dpr=2&auto=webp&width=340 1200w, https://cdn.benzinga.com/files/images/story/2024/11/22/Wiz-Khalifa-Duki.png?optimize=medium&dpr=2&auto=webp&width=340 1920w, https://cdn.benzinga.com/files/images/story/2024/11/22/Wiz-Khalifa-Duki.png?optimize=medium&dpr=2&auto=webp&width=340 2048w, https://cdn.benzinga.com/files/images/story/2024/11/22/Wiz-Khalifa-Duki.png?optimize=medium&dpr=2&auto=webp&width=340 3840w" decoding="async" loading="lazy" style="border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:cover"/></noscript></span></div></a></li><li class="splide__slide"><a class="sc-dxRmzR gXQkGo carousel-item-wrapper item" data-action=" Cannabis Interviews & Exclusives Carousel Card Item Click" href="/markets/cannabis/24/11/42144102/california-has-the-finest-weed-in-the-world-says-lab-expert-and-how-to-save-its-struggling-market" target="_blank" width="300"><div class="sc-iPYwOE hspwUF"><div class="sc-bnRclF hAXDhr title">California Has The Finest Weed In The World, Says Lab Expert, And How To Save Its Struggling Market</div></div><div class="sc-hPnoVK hliDyh carousel-item-thumbnail" height="197" width="300"><span style="background:none;border:0;box-sizing:border-box;display:block;height:initial;margin:0;opacity:1;overflow:hidden;padding:0;width:initial;position:absolute;top:0;left:0;bottom:0;right:0"><img alt="" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" style="border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:cover"/><noscript><img alt="" sizes="100vw" src="https://cdn.benzinga.com/files/images/story/2024/11/25/Microbiology-Testing-PCR-5.jpeg?optimize=medium&dpr=2&auto=webp&width=340" srcSet="https://cdn.benzinga.com/files/images/story/2024/11/25/Microbiology-Testing-PCR-5.jpeg?optimize=medium&dpr=2&auto=webp&width=340 640w, https://cdn.benzinga.com/files/images/story/2024/11/25/Microbiology-Testing-PCR-5.jpeg?optimize=medium&dpr=2&auto=webp&width=340 750w, https://cdn.benzinga.com/files/images/story/2024/11/25/Microbiology-Testing-PCR-5.jpeg?optimize=medium&dpr=2&auto=webp&width=340 828w, https://cdn.benzinga.com/files/images/story/2024/11/25/Microbiology-Testing-PCR-5.jpeg?optimize=medium&dpr=2&auto=webp&width=340 1080w, https://cdn.benzinga.com/files/images/story/2024/11/25/Microbiology-Testing-PCR-5.jpeg?optimize=medium&dpr=2&auto=webp&width=340 1200w, https://cdn.benzinga.com/files/images/story/2024/11/25/Microbiology-Testing-PCR-5.jpeg?optimize=medium&dpr=2&auto=webp&width=340 1920w, https://cdn.benzinga.com/files/images/story/2024/11/25/Microbiology-Testing-PCR-5.jpeg?optimize=medium&dpr=2&auto=webp&width=340 2048w, https://cdn.benzinga.com/files/images/story/2024/11/25/Microbiology-Testing-PCR-5.jpeg?optimize=medium&dpr=2&auto=webp&width=340 3840w" decoding="async" loading="lazy" style="border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:cover"/></noscript></span></div></a></li><li class="splide__slide"><a class="sc-dxRmzR gXQkGo carousel-item-wrapper item" data-action=" Cannabis Interviews & Exclusives Carousel Card Item Click" href="/24/11/42130221/the-best-and-worst-performing-states-for-cannabis-sales-in-2024-ytd-winners-and-losers" target="_blank" width="300"><div class="sc-iPYwOE hspwUF"><div class="sc-bnRclF hAXDhr title">Best And Worst Performing States For Cannabis Sales In 2024: YTD Winners & Losers</div></div><div class="sc-hPnoVK hliDyh carousel-item-thumbnail" height="197" width="300"><span style="background:none;border:0;box-sizing:border-box;display:block;height:initial;margin:0;opacity:1;overflow:hidden;padding:0;width:initial;position:absolute;top:0;left:0;bottom:0;right:0"><img alt="" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" style="border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:cover"/><noscript><img alt="" sizes="100vw" src="https://cdn.benzinga.com/files/images/story/2024/11/21/AI-Generated-Image_4.jpeg?optimize=medium&dpr=2&auto=webp&width=340" srcSet="https://cdn.benzinga.com/files/images/story/2024/11/21/AI-Generated-Image_4.jpeg?optimize=medium&dpr=2&auto=webp&width=340 640w, https://cdn.benzinga.com/files/images/story/2024/11/21/AI-Generated-Image_4.jpeg?optimize=medium&dpr=2&auto=webp&width=340 750w, https://cdn.benzinga.com/files/images/story/2024/11/21/AI-Generated-Image_4.jpeg?optimize=medium&dpr=2&auto=webp&width=340 828w, https://cdn.benzinga.com/files/images/story/2024/11/21/AI-Generated-Image_4.jpeg?optimize=medium&dpr=2&auto=webp&width=340 1080w, https://cdn.benzinga.com/files/images/story/2024/11/21/AI-Generated-Image_4.jpeg?optimize=medium&dpr=2&auto=webp&width=340 1200w, https://cdn.benzinga.com/files/images/story/2024/11/21/AI-Generated-Image_4.jpeg?optimize=medium&dpr=2&auto=webp&width=340 1920w, https://cdn.benzinga.com/files/images/story/2024/11/21/AI-Generated-Image_4.jpeg?optimize=medium&dpr=2&auto=webp&width=340 2048w, https://cdn.benzinga.com/files/images/story/2024/11/21/AI-Generated-Image_4.jpeg?optimize=medium&dpr=2&auto=webp&width=340 3840w" decoding="async" loading="lazy" style="border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:cover"/></noscript></span></div></a></li><li class="splide__slide"><a class="sc-dxRmzR gXQkGo carousel-item-wrapper item" data-action=" Cannabis Interviews & Exclusives Carousel Card Item Click" href="/24/11/42130001/green-wednesdays-biggest-weed-buyers-the-surprising-archetypes-driving-sales" target="_blank" width="300"><div class="sc-iPYwOE hspwUF"><div class="sc-bnRclF hAXDhr title">Green Wednesday's Biggest Weed Buyers: The Surprising Archetypes Driving Sales</div></div><div class="sc-hPnoVK hliDyh carousel-item-thumbnail" height="197" width="300"><span style="background:none;border:0;box-sizing:border-box;display:block;height:initial;margin:0;opacity:1;overflow:hidden;padding:0;width:initial;position:absolute;top:0;left:0;bottom:0;right:0"><img alt="" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" style="border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:cover"/><noscript><img alt="" sizes="100vw" src="https://cdn.benzinga.com/files/images/story/2024/11/21/AI-Generated-Image_3.jpeg?optimize=medium&dpr=2&auto=webp&width=340" srcSet="https://cdn.benzinga.com/files/images/story/2024/11/21/AI-Generated-Image_3.jpeg?optimize=medium&dpr=2&auto=webp&width=340 640w, https://cdn.benzinga.com/files/images/story/2024/11/21/AI-Generated-Image_3.jpeg?optimize=medium&dpr=2&auto=webp&width=340 750w, https://cdn.benzinga.com/files/images/story/2024/11/21/AI-Generated-Image_3.jpeg?optimize=medium&dpr=2&auto=webp&width=340 828w, https://cdn.benzinga.com/files/images/story/2024/11/21/AI-Generated-Image_3.jpeg?optimize=medium&dpr=2&auto=webp&width=340 1080w, https://cdn.benzinga.com/files/images/story/2024/11/21/AI-Generated-Image_3.jpeg?optimize=medium&dpr=2&auto=webp&width=340 1200w, https://cdn.benzinga.com/files/images/story/2024/11/21/AI-Generated-Image_3.jpeg?optimize=medium&dpr=2&auto=webp&width=340 1920w, https://cdn.benzinga.com/files/images/story/2024/11/21/AI-Generated-Image_3.jpeg?optimize=medium&dpr=2&auto=webp&width=340 2048w, https://cdn.benzinga.com/files/images/story/2024/11/21/AI-Generated-Image_3.jpeg?optimize=medium&dpr=2&auto=webp&width=340 3840w" decoding="async" loading="lazy" style="border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:cover"/></noscript></span></div></a></li><li class="splide__slide"><a class="sc-dxRmzR gXQkGo carousel-item-wrapper item" data-action=" Cannabis Interviews & Exclusives Carousel Card Item Click" href="/24/11/42117877/innovation-starts-at-the-farm-how-cannabis-brands-balance-quality-with-consumer-demand" target="_blank" width="300"><div class="sc-iPYwOE hspwUF"><div class="sc-bnRclF hAXDhr title">'Innovation Starts At The Farm': How Cannabis Brands Balance Quality With Consumer Demand</div></div><div class="sc-hPnoVK hliDyh carousel-item-thumbnail" height="197" width="300"><span style="background:none;border:0;box-sizing:border-box;display:block;height:initial;margin:0;opacity:1;overflow:hidden;padding:0;width:initial;position:absolute;top:0;left:0;bottom:0;right:0"><img alt="" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" style="border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:cover"/><noscript><img alt="" sizes="100vw" src="https://cdn.benzinga.com/files/images/story/2024/11/21/AI-Generated-Image_0.jpeg?optimize=medium&dpr=2&auto=webp&width=340" srcSet="https://cdn.benzinga.com/files/images/story/2024/11/21/AI-Generated-Image_0.jpeg?optimize=medium&dpr=2&auto=webp&width=340 640w, https://cdn.benzinga.com/files/images/story/2024/11/21/AI-Generated-Image_0.jpeg?optimize=medium&dpr=2&auto=webp&width=340 750w, https://cdn.benzinga.com/files/images/story/2024/11/21/AI-Generated-Image_0.jpeg?optimize=medium&dpr=2&auto=webp&width=340 828w, https://cdn.benzinga.com/files/images/story/2024/11/21/AI-Generated-Image_0.jpeg?optimize=medium&dpr=2&auto=webp&width=340 1080w, https://cdn.benzinga.com/files/images/story/2024/11/21/AI-Generated-Image_0.jpeg?optimize=medium&dpr=2&auto=webp&width=340 1200w, https://cdn.benzinga.com/files/images/story/2024/11/21/AI-Generated-Image_0.jpeg?optimize=medium&dpr=2&auto=webp&width=340 1920w, https://cdn.benzinga.com/files/images/story/2024/11/21/AI-Generated-Image_0.jpeg?optimize=medium&dpr=2&auto=webp&width=340 2048w, https://cdn.benzinga.com/files/images/story/2024/11/21/AI-Generated-Image_0.jpeg?optimize=medium&dpr=2&auto=webp&width=340 3840w" decoding="async" loading="lazy" style="border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:cover"/></noscript></span></div></a></li><li class="splide__slide"><a class="sc-dxRmzR gXQkGo carousel-item-wrapper item" data-action=" Cannabis Interviews & Exclusives Carousel Card Item Click" href="/general/biotech/24/11/42116309/traceable-reliable-stable-seeds-dutch-passion-the-cannabis-biotech-you-didnt-know-you-needed" target="_blank" width="300"><div class="sc-iPYwOE hspwUF"><div class="sc-bnRclF hAXDhr title">Traceable, Reliable, Stable Seeds: Dutch Passion, The Cannabis Biotech You Didn't Know You Needed</div></div><div class="sc-hPnoVK hliDyh carousel-item-thumbnail" height="197" width="300"><span style="background:none;border:0;box-sizing:border-box;display:block;height:initial;margin:0;opacity:1;overflow:hidden;padding:0;width:initial;position:absolute;top:0;left:0;bottom:0;right:0"><img alt="" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" style="border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:cover"/><noscript><img alt="" sizes="100vw" src="https://cdn.benzinga.com/files/images/story/2024/11/21/Courtesy-of-Dutch-Passion-Seeds.jpeg?optimize=medium&dpr=2&auto=webp&width=340" srcSet="https://cdn.benzinga.com/files/images/story/2024/11/21/Courtesy-of-Dutch-Passion-Seeds.jpeg?optimize=medium&dpr=2&auto=webp&width=340 640w, https://cdn.benzinga.com/files/images/story/2024/11/21/Courtesy-of-Dutch-Passion-Seeds.jpeg?optimize=medium&dpr=2&auto=webp&width=340 750w, https://cdn.benzinga.com/files/images/story/2024/11/21/Courtesy-of-Dutch-Passion-Seeds.jpeg?optimize=medium&dpr=2&auto=webp&width=340 828w, https://cdn.benzinga.com/files/images/story/2024/11/21/Courtesy-of-Dutch-Passion-Seeds.jpeg?optimize=medium&dpr=2&auto=webp&width=340 1080w, https://cdn.benzinga.com/files/images/story/2024/11/21/Courtesy-of-Dutch-Passion-Seeds.jpeg?optimize=medium&dpr=2&auto=webp&width=340 1200w, https://cdn.benzinga.com/files/images/story/2024/11/21/Courtesy-of-Dutch-Passion-Seeds.jpeg?optimize=medium&dpr=2&auto=webp&width=340 1920w, https://cdn.benzinga.com/files/images/story/2024/11/21/Courtesy-of-Dutch-Passion-Seeds.jpeg?optimize=medium&dpr=2&auto=webp&width=340 2048w, https://cdn.benzinga.com/files/images/story/2024/11/21/Courtesy-of-Dutch-Passion-Seeds.jpeg?optimize=medium&dpr=2&auto=webp&width=340 3840w" decoding="async" loading="lazy" style="border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:cover"/></noscript></span></div></a></li><li class="splide__slide"><a class="sc-dxRmzR gXQkGo carousel-item-wrapper item" data-action=" Cannabis Interviews & Exclusives Carousel Card Item Click" href="/24/11/42111313/exclusive-fluent-launches-new-cannabis-concentrates-line-for-medical-marijuana-patients-in-florida" target="_blank" width="300"><div class="sc-iPYwOE hspwUF"><div class="sc-bnRclF hAXDhr title">FLUENT Launches New Cannabis Concentrates Line For Medical Marijuana Patients In Florida</div></div><div class="sc-hPnoVK hliDyh carousel-item-thumbnail" height="197" width="300"><span style="background:none;border:0;box-sizing:border-box;display:block;height:initial;margin:0;opacity:1;overflow:hidden;padding:0;width:initial;position:absolute;top:0;left:0;bottom:0;right:0"><img alt="" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" style="border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:cover"/><noscript><img alt="" sizes="100vw" src="https://cdn.benzinga.com/files/images/story/2024/11/21/Cannabis-Concentrate--High-Thc--Pieces-O.jpeg?optimize=medium&dpr=2&auto=webp&width=340" srcSet="https://cdn.benzinga.com/files/images/story/2024/11/21/Cannabis-Concentrate--High-Thc--Pieces-O.jpeg?optimize=medium&dpr=2&auto=webp&width=340 640w, https://cdn.benzinga.com/files/images/story/2024/11/21/Cannabis-Concentrate--High-Thc--Pieces-O.jpeg?optimize=medium&dpr=2&auto=webp&width=340 750w, https://cdn.benzinga.com/files/images/story/2024/11/21/Cannabis-Concentrate--High-Thc--Pieces-O.jpeg?optimize=medium&dpr=2&auto=webp&width=340 828w, https://cdn.benzinga.com/files/images/story/2024/11/21/Cannabis-Concentrate--High-Thc--Pieces-O.jpeg?optimize=medium&dpr=2&auto=webp&width=340 1080w, https://cdn.benzinga.com/files/images/story/2024/11/21/Cannabis-Concentrate--High-Thc--Pieces-O.jpeg?optimize=medium&dpr=2&auto=webp&width=340 1200w, https://cdn.benzinga.com/files/images/story/2024/11/21/Cannabis-Concentrate--High-Thc--Pieces-O.jpeg?optimize=medium&dpr=2&auto=webp&width=340 1920w, https://cdn.benzinga.com/files/images/story/2024/11/21/Cannabis-Concentrate--High-Thc--Pieces-O.jpeg?optimize=medium&dpr=2&auto=webp&width=340 2048w, https://cdn.benzinga.com/files/images/story/2024/11/21/Cannabis-Concentrate--High-Thc--Pieces-O.jpeg?optimize=medium&dpr=2&auto=webp&width=340 3840w" decoding="async" loading="lazy" style="border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:cover"/></noscript></span></div></a></li><li class="splide__slide"><a class="sc-dxRmzR gXQkGo carousel-item-wrapper item" data-action=" Cannabis Interviews & Exclusives Carousel Card Item Click" href="/24/11/42098929/culture-is-not-something-you-can-buy-why-genuine-engagement-matters-in-cannabis" target="_blank" width="300"><div class="sc-iPYwOE hspwUF"><div class="sc-bnRclF hAXDhr title">'Culture Is Not Something You Can Buy': Why Genuine Engagement Matters In Cannabis</div></div><div class="sc-hPnoVK hliDyh carousel-item-thumbnail" height="197" width="300"><span style="background:none;border:0;box-sizing:border-box;display:block;height:initial;margin:0;opacity:1;overflow:hidden;padding:0;width:initial;position:absolute;top:0;left:0;bottom:0;right:0"><img alt="" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" style="border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:cover"/><noscript><img alt="" sizes="100vw" src="https://cdn.benzinga.com/files/images/story/2024/11/20/cannabis-ai3-copy.jpeg?optimize=medium&dpr=2&auto=webp&width=340" srcSet="https://cdn.benzinga.com/files/images/story/2024/11/20/cannabis-ai3-copy.jpeg?optimize=medium&dpr=2&auto=webp&width=340 640w, https://cdn.benzinga.com/files/images/story/2024/11/20/cannabis-ai3-copy.jpeg?optimize=medium&dpr=2&auto=webp&width=340 750w, https://cdn.benzinga.com/files/images/story/2024/11/20/cannabis-ai3-copy.jpeg?optimize=medium&dpr=2&auto=webp&width=340 828w, https://cdn.benzinga.com/files/images/story/2024/11/20/cannabis-ai3-copy.jpeg?optimize=medium&dpr=2&auto=webp&width=340 1080w, https://cdn.benzinga.com/files/images/story/2024/11/20/cannabis-ai3-copy.jpeg?optimize=medium&dpr=2&auto=webp&width=340 1200w, https://cdn.benzinga.com/files/images/story/2024/11/20/cannabis-ai3-copy.jpeg?optimize=medium&dpr=2&auto=webp&width=340 1920w, https://cdn.benzinga.com/files/images/story/2024/11/20/cannabis-ai3-copy.jpeg?optimize=medium&dpr=2&auto=webp&width=340 2048w, https://cdn.benzinga.com/files/images/story/2024/11/20/cannabis-ai3-copy.jpeg?optimize=medium&dpr=2&auto=webp&width=340 3840w" decoding="async" loading="lazy" style="border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:cover"/></noscript></span></div></a></li></ul></div><div class="carousel-pagination"><div class="splide__arrows"><button class="sc-kiTBBF giYyj primary md splide__arrow splide__arrow--prev page-left-button" type="button"><span><div><svg aria-hidden="true" class="leading-none" stroke="currentColor" stroke-width="1" style="height:1em;width:1em" viewBox="0 0 320 512" xmlns="http://www.w3.org/2000/svg"><path d="M15 239c-9.4 9.4-9.4 24.6 0 33.9L207 465c9.4 9.4 24.6 9.4 33.9 0s9.4-24.6 0-33.9L65.9 256 241 81c9.4-9.4 9.4-24.6 0-33.9s-24.6-9.4-33.9 0L15 239z" fill="currentColor"></path></svg></div></span></button><button class="sc-kiTBBF giYyj primary md splide__arrow splide__arrow--next page-right-button" type="button"><span><div><svg aria-hidden="true" class="leading-none" stroke="currentColor" stroke-width="1" style="height:1em;width:1em" viewBox="0 0 320 512" xmlns="http://www.w3.org/2000/svg"><path d="M305 239c9.4 9.4 9.4 24.6 0 33.9L113 465c-9.4 9.4-24.6 9.4-33.9 0s-9.4-24.6 0-33.9l175-175L79 81c-9.4-9.4-9.4-24.6 0-33.9s24.6-9.4 33.9 0L305 239z" fill="currentColor"></path></svg></div></span></button></div></div></div></div></div></div></div><div class="sc-fCzvdW kTbgNs news-list-group-block"><div class="sc-fKFgrF icxwYm news-list-group-wrapper"><div class="sc-kSsGea iOEnob news-list-wrapper"><div class="sc-nbCPO hyiaGS content-feed "><a class="sc-dkXDdO cXVRMB section-title news-block-title bordered contains-right-slot" aria-label="Click here to see more Earnings content" data-action="Earnings See More Click" href="https://www.benzinga.com/cannabis/earnings"><h3>Earnings</h3><span class="right-slot"><span class="see-more">See more</span></span></a><div class="content-feed-container"><div class="content-feed-list"><div class="sc-hmzteu ddclwE news-block primary"><div class="news-block-headline"><div class="flex"><div><a data-action="Article Click" href="/24/11/42137701/canadian-cannabis-co-decibel-reports-12-yoy-drop-in-q3-revenue-but-increases-gross-margin-to-53"><div class="sc-ceLTrZ bjJtVr article-title"><span>Canadian Cannabis Co. Decibel Reports 12% YoY Drop In Q3 Revenue But Increases Gross Margin To 53%</span></div></a><div><div class="flex items-center"><div class="sc-ekaoJE fACrUT"></div></div></div></div></div></div><div class="sc-bUsiPH gNYhnT ticker-list"><div class="ticker-list-container"><div class="sc-dVraiA dDLddz ticker-box-wrapper"><a aria-label="Go to Quote Page for DB" rel="dofollow" class="items-end ticker-link-wrapper inline-flex" href="/quote/db" target="_blank"><span class="sc-gUDIDV jYfzbt">DB</span></a></div><div class="sc-dVraiA dDLddz ticker-box-wrapper"><a aria-label="Go to Quote Page for DBCCF" rel="dofollow" class="items-end ticker-link-wrapper inline-flex" href="/quote/dbccf" target="_blank"><span class="sc-gUDIDV jYfzbt">DBCCF</span></a></div><div class="sc-dVraiA dDLddz ticker-box-wrapper"><a aria-label="Go to Quote Page for TSXV:DB" rel="dofollow" class="items-end ticker-link-wrapper inline-flex" href="/quote/tsxv:db" target="_blank"><span class="sc-gUDIDV jYfzbt">TSXV:DB</span></a></div></div></div></div><div class="sc-hmzteu ddclwE news-block primary"><div class="news-block-headline"><div class="flex"><div><a data-action="Article Click" href="/24/11/42122829/cannabinoid-leader-innocan-pharma-reports-174-yoy-revenue-growth"><div class="sc-ceLTrZ bjJtVr article-title"><span>Cannabinoid Leader Innocan Pharma's Q3: 174% YoY Revenue Growth</span></div></a><div><div class="flex items-center"><div class="sc-ekaoJE fACrUT"></div></div></div></div></div></div><div class="sc-bUsiPH gNYhnT ticker-list"><div class="ticker-list-container"><div class="sc-dVraiA dDLddz ticker-box-wrapper"><a aria-label="Go to Quote Page for INNPF" rel="dofollow" class="items-end ticker-link-wrapper inline-flex" href="/quote/innpf" target="_blank"><span class="sc-gUDIDV jYfzbt">INNPF</span></a></div></div></div></div><div class="sc-hmzteu ddclwE news-block primary"><div class="news-block-headline"><div class="flex"><div><a data-action="Article Click" href="/24/11/42115532/this-cannabis-co-is-capitalizing-on-ohios-recreational-sales-reports-165-yoy-increase-in-q3-adjusted-ebitda"><div class="sc-ceLTrZ bjJtVr article-title"><span>Ohio's Weed Enthusiasts Help This Cannabis Company's Bottom Line: 165% YoY Increase In Q3 Adjusted EBITDA</span></div></a><div><div class="flex items-center"><div class="sc-ekaoJE fACrUT"></div></div></div></div></div></div><div class="sc-bUsiPH gNYhnT ticker-list"><div class="ticker-list-container"><div class="sc-dVraiA dDLddz ticker-box-wrapper"><a aria-label="Go to Quote Page for CSE:VEXT" rel="dofollow" class="items-end ticker-link-wrapper inline-flex" href="/quote/cse:vext" target="_blank"><span class="sc-gUDIDV jYfzbt">CSE:VEXT</span></a></div><div class="sc-dVraiA dDLddz ticker-box-wrapper"><a aria-label="Go to Quote Page for VEXTF" rel="dofollow" class="items-end ticker-link-wrapper inline-flex" href="/quote/vextf" target="_blank"><span class="sc-gUDIDV jYfzbt">VEXTF</span></a></div></div></div></div><div class="sc-hmzteu ddclwE news-block primary"><div class="news-block-headline"><div class="flex"><div><a data-action="Article Click" href="/news/earnings/24/11/42039385/enveric-biosciences-trims-losses-eyes-key-drug-approval-for-difficult-to-treat-mental-health-disorders"><div class="sc-ceLTrZ bjJtVr article-title"><span>Enveric Biosciences Trims Losses, Eyes Key Drug Approval For Difficult-To-Treat Mental Health Disorders</span></div></a><div><div class="flex items-center"><div class="sc-ekaoJE fACrUT"></div></div></div></div></div></div><div class="sc-bUsiPH gNYhnT ticker-list"><div class="ticker-list-container"><div class="sc-dVraiA dDLddz ticker-box-wrapper"><a aria-label="Go to Quote Page for ENVB" rel="dofollow" class="items-end ticker-link-wrapper inline-flex" href="/quote/envb" target="_blank"><span class="sc-gUDIDV jYfzbt">ENVB</span></a></div></div></div></div></div></div></div></div><div class="sc-kSsGea iOEnob news-list-wrapper"><div class="sc-nbCPO hyiaGS content-feed "><a class="sc-dkXDdO cXVRMB section-title news-block-title bordered contains-right-slot" aria-label="Click here to see more Deals content" data-action="Deals See More Click" href="https://www.benzinga.com/cannabis/deals"><h3>Deals</h3><span class="right-slot"><span class="see-more">See more</span></span></a><div class="content-feed-container"><div class="content-feed-list"><div class="sc-hmzteu ddclwE news-block primary"><div class="news-block-headline"><div class="flex"><div><a data-action="Article Click" href="/24/11/42196557/canopy-usas-acquisition-of-acreage-could-mean-loss-for-some-shareholders-heres-why"><div class="sc-ceLTrZ bjJtVr article-title"><span>Canopy USA's Acquisition Of Acreage Could Mean Staggering Losses For Some Shareholders</span></div></a><div><div class="flex items-center"><div class="sc-ekaoJE fACrUT"></div></div></div></div></div></div><div class="sc-bUsiPH gNYhnT ticker-list"><div class="ticker-list-container"><div class="sc-dVraiA dDLddz ticker-box-wrapper"><a aria-label="Go to Quote Page for ACRDF" rel="dofollow" class="items-end ticker-link-wrapper inline-flex" href="/quote/acrdf" target="_blank"><span class="sc-gUDIDV jYfzbt">ACRDF</span></a></div><div class="sc-dVraiA dDLddz ticker-box-wrapper"><a aria-label="Go to Quote Page for ACRHF" rel="dofollow" class="items-end ticker-link-wrapper inline-flex" href="/quote/acrhf" target="_blank"><span class="sc-gUDIDV jYfzbt">ACRHF</span></a></div><div class="sc-dVraiA dDLddz ticker-box-wrapper"><a aria-label="Go to Quote Page for CGC" rel="dofollow" class="items-end ticker-link-wrapper inline-flex" href="/quote/cgc" target="_blank"><span class="sc-gUDIDV jYfzbt">CGC</span></a></div><div class="sc-hwTdGM hBTmYJ"><div class="other-tickers-label">5 others</div><div class="other-tickers"><div><div class="sc-dVraiA dDLddz ticker-box-wrapper"><a aria-label="Go to Quote Page for CSE:ACRG" rel="dofollow" class="items-end ticker-link-wrapper inline-flex" href="/quote/cse:acrg" target="_blank"><span class="sc-gUDIDV jYfzbt">CSE:ACRG</span></a></div></div><div><div class="sc-dVraiA dDLddz ticker-box-wrapper"><a aria-label="Go to Quote Page for TSNDF" rel="dofollow" class="items-end ticker-link-wrapper inline-flex" href="/quote/tsndf" target="_blank"><span class="sc-gUDIDV jYfzbt">TSNDF</span></a></div></div><div><div class="sc-dVraiA dDLddz ticker-box-wrapper"><a aria-label="Go to Quote Page for TSX:TSND" rel="dofollow" class="items-end ticker-link-wrapper inline-flex" href="/quote/tsx:tsnd" target="_blank"><span class="sc-gUDIDV jYfzbt">TSX:TSND</span></a></div></div><div><div class="sc-dVraiA dDLddz ticker-box-wrapper"><a aria-label="Go to Quote Page for TSX:WEED" rel="dofollow" class="items-end ticker-link-wrapper inline-flex" href="/quote/tsx:weed" target="_blank"><span class="sc-gUDIDV jYfzbt">TSX:WEED</span></a></div></div><div><div class="sc-dVraiA dDLddz ticker-box-wrapper"><a aria-label="Go to Quote Page for WEED" rel="dofollow" class="items-end ticker-link-wrapper inline-flex" href="/quote/weed" target="_blank"><span class="sc-gUDIDV jYfzbt">WEED</span></a></div></div></div></div></div></div></div><div class="sc-hmzteu ddclwE news-block primary"><div class="news-block-headline"><div class="flex"><div><a data-action="Article Click" href="/markets/cannabis/24/11/42193953/thrive-capital-tiger-global-backed-cannabis-wholesale-platform-leaflink-buys-leaf-trade-co-will-process-9b-in-annual-gmv"><div class="sc-ceLTrZ bjJtVr article-title"><span>Thrive Capital, Tiger Global-Backed Cannabis Wholesale Platform LeafLink Buys Leaf Trade: Co. Will Process ~$9B In Annual GMV</span></div></a><div><div class="flex items-center"><div class="sc-ekaoJE fACrUT"></div></div></div></div></div></div></div><div class="sc-hmzteu ddclwE news-block primary"><div class="news-block-headline"><div class="flex"><div><a data-action="Article Click" href="/news/financing/24/11/42164794/decibel-cannabis-raises-1-18m-secures-capital-for-agmedica-bioscience-integration"><div class="sc-ceLTrZ bjJtVr article-title"><span>Decibel Cannabis Raises $1.18M, Secures Capital For AgMedica BioScience Integration</span></div></a><div><div class="flex items-center"><div class="sc-ekaoJE fACrUT"></div></div></div></div></div></div><div class="sc-bUsiPH gNYhnT ticker-list"><div class="ticker-list-container"><div class="sc-dVraiA dDLddz ticker-box-wrapper"><a aria-label="Go to Quote Page for DB" rel="dofollow" class="items-end ticker-link-wrapper inline-flex" href="/quote/db" target="_blank"><span class="sc-gUDIDV jYfzbt">DB</span></a></div><div class="sc-dVraiA dDLddz ticker-box-wrapper"><a aria-label="Go to Quote Page for DBCCF" rel="dofollow" class="items-end ticker-link-wrapper inline-flex" href="/quote/dbccf" target="_blank"><span class="sc-gUDIDV jYfzbt">DBCCF</span></a></div></div></div></div><div class="sc-hmzteu ddclwE news-block primary"><div class="news-block-headline"><div class="flex"><div><a data-action="Article Click" href="/general/market-summary/24/11/42146751/jupiters-burnout-can-tilt-holdings-reverse-its-five-year-vape-decline"><div class="sc-ceLTrZ bjJtVr article-title"><span>Jupiter's Burnout: Can TILT Holdings Reverse Its Five-Year Vape Decline?</span></div></a><div><div class="flex items-center"><div class="sc-ekaoJE fACrUT"></div></div></div></div></div></div><div class="sc-bUsiPH gNYhnT ticker-list"><div class="ticker-list-container"><div class="sc-dVraiA dDLddz ticker-box-wrapper"><a aria-label="Go to Quote Page for TLLTF" rel="dofollow" class="items-end ticker-link-wrapper inline-flex" href="/quote/tlltf" target="_blank"><span class="sc-gUDIDV jYfzbt">TLLTF</span></a></div></div></div></div></div></div></div></div></div></div><div class="sc-dTaEtF fBnIMc"><div class="sc-gFYmAs hzOZJg carousel-block reverse"><div class="sc-dkXDdO cXVRMB section-title bordered" href=""><h3>MARIJUANA LEGISLATION, LEGALIZATION & REGULATORY UPDATES</h3></div><div class="sc-hrmvde iavXuM carousel-container"><div class="splide" aria-label="Carousel"><div class="splide-track-wrapper"><div class="splide__track"><ul class="splide__list"><li class="splide__slide"><a class="sc-dxRmzR gXQkGo carousel-item-wrapper item" data-action="MARIJUANA LEGISLATION, LEGALIZATION & REGULATORY UPDATES Carousel Card Item Click" href="/24/11/42203777/kentucky-awards-first-medical-cannabis-dispensary-licenses" target="_blank" width="300"><div class="sc-iPYwOE hspwUF"><div class="sc-bnRclF hAXDhr title">Kentucky Awards First Medical Cannabis Dispensary Licenses</div></div><div class="sc-hPnoVK hliDyh carousel-item-thumbnail" height="197" width="300"><span style="background:none;border:0;box-sizing:border-box;display:block;height:initial;margin:0;opacity:1;overflow:hidden;padding:0;width:initial;position:absolute;top:0;left:0;bottom:0;right:0"><img alt="" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" style="border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:cover"/><noscript><img alt="" sizes="100vw" src="https://cdn.benzinga.com/files/images/story/2024/11/26/AI-Generated-Image_1.jpeg?optimize=medium&dpr=2&auto=webp&width=340" srcSet="https://cdn.benzinga.com/files/images/story/2024/11/26/AI-Generated-Image_1.jpeg?optimize=medium&dpr=2&auto=webp&width=340 640w, https://cdn.benzinga.com/files/images/story/2024/11/26/AI-Generated-Image_1.jpeg?optimize=medium&dpr=2&auto=webp&width=340 750w, https://cdn.benzinga.com/files/images/story/2024/11/26/AI-Generated-Image_1.jpeg?optimize=medium&dpr=2&auto=webp&width=340 828w, https://cdn.benzinga.com/files/images/story/2024/11/26/AI-Generated-Image_1.jpeg?optimize=medium&dpr=2&auto=webp&width=340 1080w, https://cdn.benzinga.com/files/images/story/2024/11/26/AI-Generated-Image_1.jpeg?optimize=medium&dpr=2&auto=webp&width=340 1200w, https://cdn.benzinga.com/files/images/story/2024/11/26/AI-Generated-Image_1.jpeg?optimize=medium&dpr=2&auto=webp&width=340 1920w, https://cdn.benzinga.com/files/images/story/2024/11/26/AI-Generated-Image_1.jpeg?optimize=medium&dpr=2&auto=webp&width=340 2048w, https://cdn.benzinga.com/files/images/story/2024/11/26/AI-Generated-Image_1.jpeg?optimize=medium&dpr=2&auto=webp&width=340 3840w" decoding="async" loading="lazy" style="border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:cover"/></noscript></span></div></a></li><li class="splide__slide"><a class="sc-dxRmzR gXQkGo carousel-item-wrapper item" data-action="MARIJUANA LEGISLATION, LEGALIZATION & REGULATORY UPDATES Carousel Card Item Click" href="/news/legal/24/11/42202403/elizabeth-warren-bernie-sanders-12-congress-members-to-biden-issue-clemency-and-pardons-for-cannabis-prisoners" target="_blank" width="300"><div class="sc-iPYwOE hspwUF"><div class="sc-bnRclF hAXDhr title">Elizabeth Warren, Bernie Sanders & 12 Congress Members To Biden: Issue Clemency And Pardons For Cannabis Prisoners</div></div><div class="sc-hPnoVK hliDyh carousel-item-thumbnail" height="197" width="300"><span style="background:none;border:0;box-sizing:border-box;display:block;height:initial;margin:0;opacity:1;overflow:hidden;padding:0;width:initial;position:absolute;top:0;left:0;bottom:0;right:0"><img alt="" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" style="border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:cover"/><noscript><img alt="" sizes="100vw" src="https://cdn.benzinga.com/files/images/story/2024/11/26/joe-biden-cannabis-liberty-adam-schultz-.jpeg?optimize=medium&dpr=2&auto=webp&width=340" srcSet="https://cdn.benzinga.com/files/images/story/2024/11/26/joe-biden-cannabis-liberty-adam-schultz-.jpeg?optimize=medium&dpr=2&auto=webp&width=340 640w, https://cdn.benzinga.com/files/images/story/2024/11/26/joe-biden-cannabis-liberty-adam-schultz-.jpeg?optimize=medium&dpr=2&auto=webp&width=340 750w, https://cdn.benzinga.com/files/images/story/2024/11/26/joe-biden-cannabis-liberty-adam-schultz-.jpeg?optimize=medium&dpr=2&auto=webp&width=340 828w, https://cdn.benzinga.com/files/images/story/2024/11/26/joe-biden-cannabis-liberty-adam-schultz-.jpeg?optimize=medium&dpr=2&auto=webp&width=340 1080w, https://cdn.benzinga.com/files/images/story/2024/11/26/joe-biden-cannabis-liberty-adam-schultz-.jpeg?optimize=medium&dpr=2&auto=webp&width=340 1200w, https://cdn.benzinga.com/files/images/story/2024/11/26/joe-biden-cannabis-liberty-adam-schultz-.jpeg?optimize=medium&dpr=2&auto=webp&width=340 1920w, https://cdn.benzinga.com/files/images/story/2024/11/26/joe-biden-cannabis-liberty-adam-schultz-.jpeg?optimize=medium&dpr=2&auto=webp&width=340 2048w, https://cdn.benzinga.com/files/images/story/2024/11/26/joe-biden-cannabis-liberty-adam-schultz-.jpeg?optimize=medium&dpr=2&auto=webp&width=340 3840w" decoding="async" loading="lazy" style="border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:cover"/></noscript></span></div></a></li><li class="splide__slide"><a class="sc-dxRmzR gXQkGo carousel-item-wrapper item" data-action="MARIJUANA LEGISLATION, LEGALIZATION & REGULATORY UPDATES Carousel Card Item Click" href="/news/legal/24/11/42177984/joe-biden-how-about-pardoning-non-violent-cannabis-prisoners-along-with-those-thanksgiving-turkeys" target="_blank" width="300"><div class="sc-iPYwOE hspwUF"><div class="sc-bnRclF hAXDhr title">Joe Biden, How About Pardoning Non-Violent Cannabis Prisoners Along With Those Thanksgiving Turkeys?</div></div><div class="sc-hPnoVK hliDyh carousel-item-thumbnail" height="197" width="300"><span style="background:none;border:0;box-sizing:border-box;display:block;height:initial;margin:0;opacity:1;overflow:hidden;padding:0;width:initial;position:absolute;top:0;left:0;bottom:0;right:0"><img alt="" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" style="border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:cover"/><noscript><img alt="" sizes="100vw" src="https://cdn.benzinga.com/files/images/story/2024/11/25/Photo-from-Nat--Turkey-Association.jpeg?optimize=medium&dpr=2&auto=webp&width=340" srcSet="https://cdn.benzinga.com/files/images/story/2024/11/25/Photo-from-Nat--Turkey-Association.jpeg?optimize=medium&dpr=2&auto=webp&width=340 640w, https://cdn.benzinga.com/files/images/story/2024/11/25/Photo-from-Nat--Turkey-Association.jpeg?optimize=medium&dpr=2&auto=webp&width=340 750w, https://cdn.benzinga.com/files/images/story/2024/11/25/Photo-from-Nat--Turkey-Association.jpeg?optimize=medium&dpr=2&auto=webp&width=340 828w, https://cdn.benzinga.com/files/images/story/2024/11/25/Photo-from-Nat--Turkey-Association.jpeg?optimize=medium&dpr=2&auto=webp&width=340 1080w, https://cdn.benzinga.com/files/images/story/2024/11/25/Photo-from-Nat--Turkey-Association.jpeg?optimize=medium&dpr=2&auto=webp&width=340 1200w, https://cdn.benzinga.com/files/images/story/2024/11/25/Photo-from-Nat--Turkey-Association.jpeg?optimize=medium&dpr=2&auto=webp&width=340 1920w, https://cdn.benzinga.com/files/images/story/2024/11/25/Photo-from-Nat--Turkey-Association.jpeg?optimize=medium&dpr=2&auto=webp&width=340 2048w, https://cdn.benzinga.com/files/images/story/2024/11/25/Photo-from-Nat--Turkey-Association.jpeg?optimize=medium&dpr=2&auto=webp&width=340 3840w" decoding="async" loading="lazy" style="border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:cover"/></noscript></span></div></a></li><li class="splide__slide"><a class="sc-dxRmzR gXQkGo carousel-item-wrapper item" data-action="MARIJUANA LEGISLATION, LEGALIZATION & REGULATORY UPDATES Carousel Card Item Click" href="/24/11/42173101/dea-denies-allegations-of-unlawful-talks-with-anti-marijuana-group" target="_blank" width="300"><div class="sc-iPYwOE hspwUF"><div class="sc-bnRclF hAXDhr title">DEA Denies Allegations Of Colluding With Anti-Marijuana Group While Involved In Cannabis Rescheduling Process</div></div><div class="sc-hPnoVK hliDyh carousel-item-thumbnail" height="197" width="300"><span style="background:none;border:0;box-sizing:border-box;display:block;height:initial;margin:0;opacity:1;overflow:hidden;padding:0;width:initial;position:absolute;top:0;left:0;bottom:0;right:0"><img alt="" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" style="border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:cover"/><noscript><img alt="" sizes="100vw" src="https://cdn.benzinga.com/files/images/story/2024/11/25/Marijuana-DEA.png?optimize=medium&dpr=2&auto=webp&width=340" srcSet="https://cdn.benzinga.com/files/images/story/2024/11/25/Marijuana-DEA.png?optimize=medium&dpr=2&auto=webp&width=340 640w, https://cdn.benzinga.com/files/images/story/2024/11/25/Marijuana-DEA.png?optimize=medium&dpr=2&auto=webp&width=340 750w, https://cdn.benzinga.com/files/images/story/2024/11/25/Marijuana-DEA.png?optimize=medium&dpr=2&auto=webp&width=340 828w, https://cdn.benzinga.com/files/images/story/2024/11/25/Marijuana-DEA.png?optimize=medium&dpr=2&auto=webp&width=340 1080w, https://cdn.benzinga.com/files/images/story/2024/11/25/Marijuana-DEA.png?optimize=medium&dpr=2&auto=webp&width=340 1200w, https://cdn.benzinga.com/files/images/story/2024/11/25/Marijuana-DEA.png?optimize=medium&dpr=2&auto=webp&width=340 1920w, https://cdn.benzinga.com/files/images/story/2024/11/25/Marijuana-DEA.png?optimize=medium&dpr=2&auto=webp&width=340 2048w, https://cdn.benzinga.com/files/images/story/2024/11/25/Marijuana-DEA.png?optimize=medium&dpr=2&auto=webp&width=340 3840w" decoding="async" loading="lazy" style="border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:cover"/></noscript></span></div></a></li><li class="splide__slide"><a class="sc-dxRmzR gXQkGo carousel-item-wrapper item" data-action="MARIJUANA LEGISLATION, LEGALIZATION & REGULATORY UPDATES Carousel Card Item Click" href="/news/legal/24/11/42163528/gop-takeover-and-trumps-return-vs-chuck-schumers-last-ditch-cannabis-banking-reform-push" target="_blank" width="300"><div class="sc-iPYwOE hspwUF"><div class="sc-bnRclF hAXDhr title">GOP Takeover, Trump's Return Vs. Chuck Schumer's Last-Ditch Cannabis Banking Reform Push</div></div><div class="sc-hPnoVK hliDyh carousel-item-thumbnail" height="197" width="300"><span style="background:none;border:0;box-sizing:border-box;display:block;height:initial;margin:0;opacity:1;overflow:hidden;padding:0;width:initial;position:absolute;top:0;left:0;bottom:0;right:0"><img alt="" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" style="border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:cover"/><noscript><img alt="" sizes="100vw" src="https://cdn.benzinga.com/files/images/story/2024/11/25/Chuck-Schumer-copy.jpeg?optimize=medium&dpr=2&auto=webp&width=340" srcSet="https://cdn.benzinga.com/files/images/story/2024/11/25/Chuck-Schumer-copy.jpeg?optimize=medium&dpr=2&auto=webp&width=340 640w, https://cdn.benzinga.com/files/images/story/2024/11/25/Chuck-Schumer-copy.jpeg?optimize=medium&dpr=2&auto=webp&width=340 750w, https://cdn.benzinga.com/files/images/story/2024/11/25/Chuck-Schumer-copy.jpeg?optimize=medium&dpr=2&auto=webp&width=340 828w, https://cdn.benzinga.com/files/images/story/2024/11/25/Chuck-Schumer-copy.jpeg?optimize=medium&dpr=2&auto=webp&width=340 1080w, https://cdn.benzinga.com/files/images/story/2024/11/25/Chuck-Schumer-copy.jpeg?optimize=medium&dpr=2&auto=webp&width=340 1200w, https://cdn.benzinga.com/files/images/story/2024/11/25/Chuck-Schumer-copy.jpeg?optimize=medium&dpr=2&auto=webp&width=340 1920w, https://cdn.benzinga.com/files/images/story/2024/11/25/Chuck-Schumer-copy.jpeg?optimize=medium&dpr=2&auto=webp&width=340 2048w, https://cdn.benzinga.com/files/images/story/2024/11/25/Chuck-Schumer-copy.jpeg?optimize=medium&dpr=2&auto=webp&width=340 3840w" decoding="async" loading="lazy" style="border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:cover"/></noscript></span></div></a></li><li class="splide__slide"><a class="sc-dxRmzR gXQkGo carousel-item-wrapper item" data-action="MARIJUANA LEGISLATION, LEGALIZATION & REGULATORY UPDATES Carousel Card Item Click" href="/24/11/42145406/nebraskas-cannabis-legalization-faces-courtroom-showdown-over-alleged-fraud" target="_blank" width="300"><div class="sc-iPYwOE hspwUF"><div class="sc-bnRclF hAXDhr title">Nebraska's Cannabis Legalization Faces Courtroom Showdown Over Alleged Fraud</div></div><div class="sc-hPnoVK hliDyh carousel-item-thumbnail" height="197" width="300"><span style="background:none;border:0;box-sizing:border-box;display:block;height:initial;margin:0;opacity:1;overflow:hidden;padding:0;width:initial;position:absolute;top:0;left:0;bottom:0;right:0"><img alt="" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" style="border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:cover"/><noscript><img alt="" sizes="100vw" src="https://cdn.benzinga.com/files/images/story/2024/11/22/1-19.png?optimize=medium&dpr=2&auto=webp&width=340" srcSet="https://cdn.benzinga.com/files/images/story/2024/11/22/1-19.png?optimize=medium&dpr=2&auto=webp&width=340 640w, https://cdn.benzinga.com/files/images/story/2024/11/22/1-19.png?optimize=medium&dpr=2&auto=webp&width=340 750w, https://cdn.benzinga.com/files/images/story/2024/11/22/1-19.png?optimize=medium&dpr=2&auto=webp&width=340 828w, https://cdn.benzinga.com/files/images/story/2024/11/22/1-19.png?optimize=medium&dpr=2&auto=webp&width=340 1080w, https://cdn.benzinga.com/files/images/story/2024/11/22/1-19.png?optimize=medium&dpr=2&auto=webp&width=340 1200w, https://cdn.benzinga.com/files/images/story/2024/11/22/1-19.png?optimize=medium&dpr=2&auto=webp&width=340 1920w, https://cdn.benzinga.com/files/images/story/2024/11/22/1-19.png?optimize=medium&dpr=2&auto=webp&width=340 2048w, https://cdn.benzinga.com/files/images/story/2024/11/22/1-19.png?optimize=medium&dpr=2&auto=webp&width=340 3840w" decoding="async" loading="lazy" style="border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:cover"/></noscript></span></div></a></li><li class="splide__slide"><a class="sc-dxRmzR gXQkGo carousel-item-wrapper item" data-action="MARIJUANA LEGISLATION, LEGALIZATION & REGULATORY UPDATES Carousel Card Item Click" href="/24/11/42144540/dea-slammed-over-unlawful-talks-with-cannabis-opponents-the-plot-thickens" target="_blank" width="300"><div class="sc-iPYwOE hspwUF"><div class="sc-bnRclF hAXDhr title">DEA Slammed For Unlawful Talks With Cannabis Opponents - The Plot Thickens</div></div><div class="sc-hPnoVK hliDyh carousel-item-thumbnail" height="197" width="300"><span style="background:none;border:0;box-sizing:border-box;display:block;height:initial;margin:0;opacity:1;overflow:hidden;padding:0;width:initial;position:absolute;top:0;left:0;bottom:0;right:0"><img alt="" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" style="border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:cover"/><noscript><img alt="" sizes="100vw" src="https://cdn.benzinga.com/files/images/story/2024/11/22/DEA.png?optimize=medium&dpr=2&auto=webp&width=340" srcSet="https://cdn.benzinga.com/files/images/story/2024/11/22/DEA.png?optimize=medium&dpr=2&auto=webp&width=340 640w, https://cdn.benzinga.com/files/images/story/2024/11/22/DEA.png?optimize=medium&dpr=2&auto=webp&width=340 750w, https://cdn.benzinga.com/files/images/story/2024/11/22/DEA.png?optimize=medium&dpr=2&auto=webp&width=340 828w, https://cdn.benzinga.com/files/images/story/2024/11/22/DEA.png?optimize=medium&dpr=2&auto=webp&width=340 1080w, https://cdn.benzinga.com/files/images/story/2024/11/22/DEA.png?optimize=medium&dpr=2&auto=webp&width=340 1200w, https://cdn.benzinga.com/files/images/story/2024/11/22/DEA.png?optimize=medium&dpr=2&auto=webp&width=340 1920w, https://cdn.benzinga.com/files/images/story/2024/11/22/DEA.png?optimize=medium&dpr=2&auto=webp&width=340 2048w, https://cdn.benzinga.com/files/images/story/2024/11/22/DEA.png?optimize=medium&dpr=2&auto=webp&width=340 3840w" decoding="async" loading="lazy" style="border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:cover"/></noscript></span></div></a></li><li class="splide__slide"><a class="sc-dxRmzR gXQkGo carousel-item-wrapper item" data-action="MARIJUANA LEGISLATION, LEGALIZATION & REGULATORY UPDATES Carousel Card Item Click" href="/24/11/42144192/texas-ag-ken-paxton-sues-dallas-over-voter-approved-marijuana-reform" target="_blank" width="300"><div class="sc-iPYwOE hspwUF"><div class="sc-bnRclF hAXDhr title">Texas AG Ken Paxton Sues Dallas Over Cannabis Decriminalization Reform</div></div><div class="sc-hPnoVK hliDyh carousel-item-thumbnail" height="197" width="300"><span style="background:none;border:0;box-sizing:border-box;display:block;height:initial;margin:0;opacity:1;overflow:hidden;padding:0;width:initial;position:absolute;top:0;left:0;bottom:0;right:0"><img alt="" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" style="border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:cover"/><noscript><img alt="" sizes="100vw" src="https://cdn.benzinga.com/files/images/story/2024/11/22/texashemp.png?optimize=medium&dpr=2&auto=webp&width=340" srcSet="https://cdn.benzinga.com/files/images/story/2024/11/22/texashemp.png?optimize=medium&dpr=2&auto=webp&width=340 640w, https://cdn.benzinga.com/files/images/story/2024/11/22/texashemp.png?optimize=medium&dpr=2&auto=webp&width=340 750w, https://cdn.benzinga.com/files/images/story/2024/11/22/texashemp.png?optimize=medium&dpr=2&auto=webp&width=340 828w, https://cdn.benzinga.com/files/images/story/2024/11/22/texashemp.png?optimize=medium&dpr=2&auto=webp&width=340 1080w, https://cdn.benzinga.com/files/images/story/2024/11/22/texashemp.png?optimize=medium&dpr=2&auto=webp&width=340 1200w, https://cdn.benzinga.com/files/images/story/2024/11/22/texashemp.png?optimize=medium&dpr=2&auto=webp&width=340 1920w, https://cdn.benzinga.com/files/images/story/2024/11/22/texashemp.png?optimize=medium&dpr=2&auto=webp&width=340 2048w, https://cdn.benzinga.com/files/images/story/2024/11/22/texashemp.png?optimize=medium&dpr=2&auto=webp&width=340 3840w" decoding="async" loading="lazy" style="border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:cover"/></noscript></span></div></a></li><li class="splide__slide"><a class="sc-dxRmzR gXQkGo carousel-item-wrapper item" data-action="MARIJUANA LEGISLATION, LEGALIZATION & REGULATORY UPDATES Carousel Card Item Click" href="/news/legal/24/11/42143770/trumps-pick-for-attorney-general-is-no-matt-gaetz-when-it-comes-to-cannabis-reform" target="_blank" width="300"><div class="sc-iPYwOE hspwUF"><div class="sc-bnRclF hAXDhr title">Trump's Pick for Attorney General Is No Matt Gaetz When It Comes To Cannabis Reform</div></div><div class="sc-hPnoVK hliDyh carousel-item-thumbnail" height="197" width="300"><span style="background:none;border:0;box-sizing:border-box;display:block;height:initial;margin:0;opacity:1;overflow:hidden;padding:0;width:initial;position:absolute;top:0;left:0;bottom:0;right:0"><img alt="" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" style="border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:cover"/><noscript><img alt="" sizes="100vw" src="https://cdn.benzinga.com/files/images/story/2024/11/22/cannabis-reform-5-second-Studio-and-Eigh.jpeg?optimize=medium&dpr=2&auto=webp&width=340" srcSet="https://cdn.benzinga.com/files/images/story/2024/11/22/cannabis-reform-5-second-Studio-and-Eigh.jpeg?optimize=medium&dpr=2&auto=webp&width=340 640w, https://cdn.benzinga.com/files/images/story/2024/11/22/cannabis-reform-5-second-Studio-and-Eigh.jpeg?optimize=medium&dpr=2&auto=webp&width=340 750w, https://cdn.benzinga.com/files/images/story/2024/11/22/cannabis-reform-5-second-Studio-and-Eigh.jpeg?optimize=medium&dpr=2&auto=webp&width=340 828w, https://cdn.benzinga.com/files/images/story/2024/11/22/cannabis-reform-5-second-Studio-and-Eigh.jpeg?optimize=medium&dpr=2&auto=webp&width=340 1080w, https://cdn.benzinga.com/files/images/story/2024/11/22/cannabis-reform-5-second-Studio-and-Eigh.jpeg?optimize=medium&dpr=2&auto=webp&width=340 1200w, https://cdn.benzinga.com/files/images/story/2024/11/22/cannabis-reform-5-second-Studio-and-Eigh.jpeg?optimize=medium&dpr=2&auto=webp&width=340 1920w, https://cdn.benzinga.com/files/images/story/2024/11/22/cannabis-reform-5-second-Studio-and-Eigh.jpeg?optimize=medium&dpr=2&auto=webp&width=340 2048w, https://cdn.benzinga.com/files/images/story/2024/11/22/cannabis-reform-5-second-Studio-and-Eigh.jpeg?optimize=medium&dpr=2&auto=webp&width=340 3840w" decoding="async" loading="lazy" style="border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:cover"/></noscript></span></div></a></li><li class="splide__slide"><a class="sc-dxRmzR gXQkGo carousel-item-wrapper item" data-action="MARIJUANA LEGISLATION, LEGALIZATION & REGULATORY UPDATES Carousel Card Item Click" href="/news/legal/24/11/42143419/challenging-cannabis-prohibition-lawyer-behind-same-sex-marriage-takes-on-federal-policy-citing-justice-thomas-critique" target="_blank" width="300"><div class="sc-iPYwOE hspwUF"><div class="sc-bnRclF hAXDhr title">Challenging Cannabis Prohibition: Lawyer Behind Same-Sex Marriage Takes On Federal Policy, Citing Justice Thomas' Critique</div></div><div class="sc-hPnoVK hliDyh carousel-item-thumbnail" height="197" width="300"><span style="background:none;border:0;box-sizing:border-box;display:block;height:initial;margin:0;opacity:1;overflow:hidden;padding:0;width:initial;position:absolute;top:0;left:0;bottom:0;right:0"><img alt="" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" style="border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:cover"/><noscript><img alt="" sizes="100vw" src="https://cdn.benzinga.com/files/images/story/2024/11/22/Boies-Cannabis-Josh-Schiller.png?optimize=medium&dpr=2&auto=webp&width=340" srcSet="https://cdn.benzinga.com/files/images/story/2024/11/22/Boies-Cannabis-Josh-Schiller.png?optimize=medium&dpr=2&auto=webp&width=340 640w, https://cdn.benzinga.com/files/images/story/2024/11/22/Boies-Cannabis-Josh-Schiller.png?optimize=medium&dpr=2&auto=webp&width=340 750w, https://cdn.benzinga.com/files/images/story/2024/11/22/Boies-Cannabis-Josh-Schiller.png?optimize=medium&dpr=2&auto=webp&width=340 828w, https://cdn.benzinga.com/files/images/story/2024/11/22/Boies-Cannabis-Josh-Schiller.png?optimize=medium&dpr=2&auto=webp&width=340 1080w, https://cdn.benzinga.com/files/images/story/2024/11/22/Boies-Cannabis-Josh-Schiller.png?optimize=medium&dpr=2&auto=webp&width=340 1200w, https://cdn.benzinga.com/files/images/story/2024/11/22/Boies-Cannabis-Josh-Schiller.png?optimize=medium&dpr=2&auto=webp&width=340 1920w, https://cdn.benzinga.com/files/images/story/2024/11/22/Boies-Cannabis-Josh-Schiller.png?optimize=medium&dpr=2&auto=webp&width=340 2048w, https://cdn.benzinga.com/files/images/story/2024/11/22/Boies-Cannabis-Josh-Schiller.png?optimize=medium&dpr=2&auto=webp&width=340 3840w" decoding="async" loading="lazy" style="border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:cover"/></noscript></span></div></a></li><li class="splide__slide"><a class="sc-dxRmzR gXQkGo carousel-item-wrapper item" data-action="MARIJUANA LEGISLATION, LEGALIZATION & REGULATORY UPDATES Carousel Card Item Click" href="/general/health-care/24/11/42138055/kentucky-gov-beshear-go-online-and-find-your-medical-marijuana-practitioner-on-dec-1" target="_blank" width="300"><div class="sc-iPYwOE hspwUF"><div class="sc-bnRclF hAXDhr title">Kentucky Gov. Beshear: 'Go Online And Find' Your Medical Marijuana Practitioner On Dec. 1</div></div><div class="sc-hPnoVK hliDyh carousel-item-thumbnail" height="197" width="300"><span style="background:none;border:0;box-sizing:border-box;display:block;height:initial;margin:0;opacity:1;overflow:hidden;padding:0;width:initial;position:absolute;top:0;left:0;bottom:0;right:0"><img alt="" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" style="border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:cover"/><noscript><img alt="" sizes="100vw" src="https://cdn.benzinga.com/files/images/story/2024/11/22/Andy-Beshear-Team-Kentucky-address.jpeg?optimize=medium&dpr=2&auto=webp&width=340" srcSet="https://cdn.benzinga.com/files/images/story/2024/11/22/Andy-Beshear-Team-Kentucky-address.jpeg?optimize=medium&dpr=2&auto=webp&width=340 640w, https://cdn.benzinga.com/files/images/story/2024/11/22/Andy-Beshear-Team-Kentucky-address.jpeg?optimize=medium&dpr=2&auto=webp&width=340 750w, https://cdn.benzinga.com/files/images/story/2024/11/22/Andy-Beshear-Team-Kentucky-address.jpeg?optimize=medium&dpr=2&auto=webp&width=340 828w, https://cdn.benzinga.com/files/images/story/2024/11/22/Andy-Beshear-Team-Kentucky-address.jpeg?optimize=medium&dpr=2&auto=webp&width=340 1080w, https://cdn.benzinga.com/files/images/story/2024/11/22/Andy-Beshear-Team-Kentucky-address.jpeg?optimize=medium&dpr=2&auto=webp&width=340 1200w, https://cdn.benzinga.com/files/images/story/2024/11/22/Andy-Beshear-Team-Kentucky-address.jpeg?optimize=medium&dpr=2&auto=webp&width=340 1920w, https://cdn.benzinga.com/files/images/story/2024/11/22/Andy-Beshear-Team-Kentucky-address.jpeg?optimize=medium&dpr=2&auto=webp&width=340 2048w, https://cdn.benzinga.com/files/images/story/2024/11/22/Andy-Beshear-Team-Kentucky-address.jpeg?optimize=medium&dpr=2&auto=webp&width=340 3840w" decoding="async" loading="lazy" style="border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:cover"/></noscript></span></div></a></li><li class="splide__slide"><a class="sc-dxRmzR gXQkGo carousel-item-wrapper item" data-action="MARIJUANA LEGISLATION, LEGALIZATION & REGULATORY UPDATES Carousel Card Item Click" href="/news/legal/24/11/42115861/alabama-lawsuit-against-cannabis-regulator-over-medical-marijuana-licensing-moves-forward" target="_blank" width="300"><div class="sc-iPYwOE hspwUF"><div class="sc-bnRclF hAXDhr title">Alabama Lawsuit Against Cannabis Regulator Over Medical Marijuana Licensing Moves Forward</div></div><div class="sc-hPnoVK hliDyh carousel-item-thumbnail" height="197" width="300"><span style="background:none;border:0;box-sizing:border-box;display:block;height:initial;margin:0;opacity:1;overflow:hidden;padding:0;width:initial;position:absolute;top:0;left:0;bottom:0;right:0"><img alt="" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" style="border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:cover"/><noscript><img alt="" sizes="100vw" src="https://cdn.benzinga.com/files/images/story/2024/11/21/Cannabisl-Regulation-EKATERINA-BOLOVTSOV.jpeg?optimize=medium&dpr=2&auto=webp&width=340" srcSet="https://cdn.benzinga.com/files/images/story/2024/11/21/Cannabisl-Regulation-EKATERINA-BOLOVTSOV.jpeg?optimize=medium&dpr=2&auto=webp&width=340 640w, https://cdn.benzinga.com/files/images/story/2024/11/21/Cannabisl-Regulation-EKATERINA-BOLOVTSOV.jpeg?optimize=medium&dpr=2&auto=webp&width=340 750w, https://cdn.benzinga.com/files/images/story/2024/11/21/Cannabisl-Regulation-EKATERINA-BOLOVTSOV.jpeg?optimize=medium&dpr=2&auto=webp&width=340 828w, https://cdn.benzinga.com/files/images/story/2024/11/21/Cannabisl-Regulation-EKATERINA-BOLOVTSOV.jpeg?optimize=medium&dpr=2&auto=webp&width=340 1080w, https://cdn.benzinga.com/files/images/story/2024/11/21/Cannabisl-Regulation-EKATERINA-BOLOVTSOV.jpeg?optimize=medium&dpr=2&auto=webp&width=340 1200w, https://cdn.benzinga.com/files/images/story/2024/11/21/Cannabisl-Regulation-EKATERINA-BOLOVTSOV.jpeg?optimize=medium&dpr=2&auto=webp&width=340 1920w, https://cdn.benzinga.com/files/images/story/2024/11/21/Cannabisl-Regulation-EKATERINA-BOLOVTSOV.jpeg?optimize=medium&dpr=2&auto=webp&width=340 2048w, https://cdn.benzinga.com/files/images/story/2024/11/21/Cannabisl-Regulation-EKATERINA-BOLOVTSOV.jpeg?optimize=medium&dpr=2&auto=webp&width=340 3840w" decoding="async" loading="lazy" style="border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:cover"/></noscript></span></div></a></li></ul></div><div class="carousel-pagination"><div class="splide__arrows"><button class="sc-kiTBBF giYyj primary md splide__arrow splide__arrow--prev page-left-button" type="button"><span><div><svg aria-hidden="true" class="leading-none" stroke="currentColor" stroke-width="1" style="height:1em;width:1em" viewBox="0 0 320 512" xmlns="http://www.w3.org/2000/svg"><path d="M15 239c-9.4 9.4-9.4 24.6 0 33.9L207 465c9.4 9.4 24.6 9.4 33.9 0s9.4-24.6 0-33.9L65.9 256 241 81c9.4-9.4 9.4-24.6 0-33.9s-24.6-9.4-33.9 0L15 239z" fill="currentColor"></path></svg></div></span></button><button class="sc-kiTBBF giYyj primary md splide__arrow splide__arrow--next page-right-button" type="button"><span><div><svg aria-hidden="true" class="leading-none" stroke="currentColor" stroke-width="1" style="height:1em;width:1em" viewBox="0 0 320 512" xmlns="http://www.w3.org/2000/svg"><path d="M305 239c9.4 9.4 9.4 24.6 0 33.9L113 465c-9.4 9.4-24.6 9.4-33.9 0s-9.4-24.6 0-33.9l175-175L79 81c-9.4-9.4-9.4-24.6 0-33.9s24.6-9.4 33.9 0L305 239z" fill="currentColor"></path></svg></div></span></button></div></div></div></div></div></div></div><div class="sc-hzJlkW eGMBfQ calendars-widget-block"><div id="calendar-widget" class="sc-hVwoBy kafOiN"><div class="sc-fehoED kxoPLy calendar-wrapper"><h5 class="sc-fIiAAZ TiiOD">Calendar</h5><div class="sc-izxAxU jPywwb"><div class="sc-fQffii fZlzMk top-tabs-wrapper"><div class="top-tabs"><button class="top-tabs__tab top-tabs__tab--active">Earnings</button><button class="top-tabs__tab" id="tab-ratings">Analyst Ratings</button><button class="top-tabs__tab" id="tab-option_activity">Options</button><button class="top-tabs__tab" id="tab-dividends">Dividends</button><button class="top-tabs__tab" id="tab-ipos">IPOs</button></div></div></div><div class="sc-lmVGTp bCfCnu"><div class="sc-bCcCHF jjVqAK benzinga-core-virtualized-table-container"><div class="relative"><div class="benzinga-core-virtualized-table-wrapper overflow-x-auto relative"><div class="flex items-center justify-center absolute w-full h-full text-sm"><div class="sc-gpielE eJquqN"><div class="loader-wrapper"><div class="loader-wrapper__loader "><div style="display:block"><svg aria-hidden="true" class="leading-none" stroke="currentColor" stroke-width="1" style="height:1em;width:1em" viewBox="0 0 512 512" xmlns="http://www.w3.org/2000/svg"><path d="M288 32a32 32 0 1 0 -64 0 32 32 0 1 0 64 0zm0 448a32 32 0 1 0 -64 0 32 32 0 1 0 64 0zM448 256a32 32 0 1 0 64 0 32 32 0 1 0 -64 0zM32 288a32 32 0 1 0 0-64 32 32 0 1 0 0 64zM75 437a32 32 0 1 0 45.3-45.3A32 32 0 1 0 75 437zm316.8 0A32 32 0 1 0 437 391.8 32 32 0 1 0 391.8 437zM75 75a32 32 0 1 0 45.3 45.3A32 32 0 1 0 75 75z" fill="currentColor"></path></svg></div></div></div></div></div><table class="sc-iWlszP ipuYMQ benzinga-core-virtualized-table min-w-[600px] relative"><thead class="sc-gtQWWF hHZIFV benzinga-core-virtualized-table-thead whitespace-nowrap"><tr><th class="benzinga-virtualized-table-th capitalize" colSpan="1" style="width:100px"><div class="flex justify-between cursor-pointer select-none">Date<div aria-label="Sort by field: date, in undefined order" class="header-sort-icons flex flex-col"><span class="header-sort-icon header-sort-icon__up h-1.5 text-[6px] ml-1 " role="presentation">▲</span><span class="header-sort-icon header-sort-icon__down h-1.5 text-[6px] ml-1 " role="presentation">▼</span></div></div></th><th class="benzinga-virtualized-table-th capitalize" colSpan="1" style="width:90px"><div class="flex justify-between cursor-pointer select-none">ticker<div aria-label="Sort by field: ticker, in undefined order" class="header-sort-icons flex flex-col"><span class="header-sort-icon header-sort-icon__up h-1.5 text-[6px] ml-1 " role="presentation">▲</span><span class="header-sort-icon header-sort-icon__down h-1.5 text-[6px] ml-1 " role="presentation">▼</span></div></div></th><th class="benzinga-virtualized-table-th capitalize" colSpan="1" style="width:200px"><div class="flex justify-between cursor-pointer select-none">name<div aria-label="Sort by field: name, in undefined order" class="header-sort-icons flex flex-col"><span class="header-sort-icon header-sort-icon__up h-1.5 text-[6px] ml-1 " role="presentation">▲</span><span class="header-sort-icon header-sort-icon__down h-1.5 text-[6px] ml-1 " role="presentation">▼</span></div></div></th><th class="benzinga-virtualized-table-th capitalize" colSpan="1" style="width:110px"><div class="flex justify-between cursor-pointer select-none">Actual EPS<div aria-label="Sort by field: eps, in undefined order" class="header-sort-icons flex flex-col"><span class="header-sort-icon header-sort-icon__up h-1.5 text-[6px] ml-1 " role="presentation">▲</span><span class="header-sort-icon header-sort-icon__down h-1.5 text-[6px] ml-1 " role="presentation">▼</span></div></div></th><th class="benzinga-virtualized-table-th capitalize" colSpan="1" style="width:120px"><div class="flex justify-between cursor-pointer select-none">EPS Surprise<div aria-label="Sort by field: eps_surprise_percent, in undefined order" class="header-sort-icons flex flex-col"><span class="header-sort-icon header-sort-icon__up h-1.5 text-[6px] ml-1 " role="presentation">▲</span><span class="header-sort-icon header-sort-icon__down h-1.5 text-[6px] ml-1 " role="presentation">▼</span></div></div></th><th class="benzinga-virtualized-table-th capitalize" colSpan="1" style="width:110px"><div class="flex justify-between cursor-pointer select-none">Actual Rev<div aria-label="Sort by field: revenue, in undefined order" class="header-sort-icons flex flex-col"><span class="header-sort-icon header-sort-icon__up h-1.5 text-[6px] ml-1 " role="presentation">▲</span><span class="header-sort-icon header-sort-icon__down h-1.5 text-[6px] ml-1 " role="presentation">▼</span></div></div></th><th class="benzinga-virtualized-table-th capitalize" colSpan="1" style="width:110px"><div class="flex justify-between cursor-pointer select-none">Rev Surprise<div aria-label="Sort by field: revenue_surprise_percent, in undefined order" class="header-sort-icons flex flex-col"><span class="header-sort-icon header-sort-icon__up h-1.5 text-[6px] ml-1 " role="presentation">▲</span><span class="header-sort-icon header-sort-icon__down h-1.5 text-[6px] ml-1 " role="presentation">▼</span></div></div></th></tr></thead><tbody class="sc-eHtwCI iSuQrx benzinga-core-virtualized-table-tbody whitespace-nowrap"></tbody></table></div><div class="sc-khoNTN ccHFLQ"></div></div></div><div class="sc-ekHxab cianqS"><a data-action="Calendars Widget See More Click" href="https://www.benzinga.com/calendars/earnings" rel="noreferrer" target="_blank">Click to see more Earnings updates</a><div class="sc-huOXlg cbJLow"><div><svg aria-hidden="true" class="leading-none" stroke="currentColor" stroke-width="1" style="height:1em;width:1em" viewBox="0 0 320 512" xmlns="http://www.w3.org/2000/svg"><path d="M299.3 244.7c6.2 6.2 6.2 16.4 0 22.6l-192 192c-6.2 6.2-16.4 6.2-22.6 0s-6.2-16.4 0-22.6L265.4 256 84.7 75.3c-6.2-6.2-6.2-16.4 0-22.6s16.4-6.2 22.6 0l192 192z" fill="currentColor"></path></svg></div></div></div><div class="absolute top-1/3 w-full"><div class="sc-ibLMv hrLfRc earnings"><div class="banner"><div class="content"><h2>Earnings Calendar</h2><h3>Never Miss Important Catalysts</h3><p>Sort by estimates, projected upside, profit surprises, and more to easily find new stocks to invest in or check up on your portfolio.</p></div><div class="button-wrapper"><div class="logo"><svg fill="none" viewBox="0 0 96 9" xmlns="http://www.w3.org/2000/svg"><path d="M10.3078 8.9578H16.7882V7.28699H12.272V5.23708H16.014V3.56627H12.272V1.67081H16.8169V0H10.3078V8.9578ZM24.5877 5.64426L20.3438 0H17.4191L18.3366 1.13728V8.98588H20.2865V3.10294L24.6737 8.9578H26.5518V0H24.5877V5.64426ZM7.35437 4.35254C8.2146 4.19809 8.93146 3.41183 8.93146 2.30263C8.93146 1.10919 8.04255 0 6.27908 0H0.601562L1.49047 1.10919V8.97184H6.4798C8.24328 8.97184 9.16085 7.89073 9.16085 6.54285C9.11784 5.43365 8.34364 4.4789 7.35437 4.35254ZM3.44032 1.68485H5.89198C6.55149 1.68485 6.96727 2.06395 6.96727 2.62556C6.96727 3.18718 6.55149 3.56627 5.89198 3.56627H3.44032V1.68485ZM5.978 7.30103H3.44032V5.23708H5.978C6.72354 5.23708 7.13931 5.70042 7.13931 6.26204C7.13931 6.9079 6.69486 7.28699 5.978 7.30103ZM55.1975 5.64426H56.2155V6.69729C55.685 7.1185 55.0255 7.35719 54.3373 7.37123C52.7028 7.37123 51.5559 6.14971 51.5559 4.50698C51.5559 2.86425 52.7172 1.64273 54.3373 1.64273C55.1832 1.64273 55.9717 2.07799 56.4305 2.78001L57.9789 1.93758C57.3194 0.912628 56.1581 0 54.323 0C51.7279 0 49.5774 1.75505 49.5774 4.4789C49.5774 7.20275 51.6992 8.9578 54.323 8.9578C55.7567 8.98588 57.1187 8.38214 58.0649 7.34315V4.02961H53.8785L55.1975 5.64426ZM46.3801 5.64426L42.122 0H39.2116L40.1148 1.13728V8.98588H42.079V3.10294L46.4662 8.9578H48.33V0H46.3801V5.64426ZM64.5453 0H60.7747L61.6779 1.13728L61.5202 1.57253L58.5954 8.98588H60.8033L61.3768 7.46952H65.3196L65.8931 8.98588H68.101L64.5453 0ZM61.8786 5.78466L63.3124 1.92354L64.7461 5.78466H61.8786ZM36.1147 0H38.0789V8.99992H36.1147V0ZM34.552 1.54445V0H27.6558V1.67081H31.9856L27.6558 7.42739V8.9578H34.6237V7.28699H30.1935L34.552 1.54445Z" fill="white"></path><path d="M67.2051 0H96.0045V8.99992H70.8051L67.2051 0Z" fill="#3F83F8"></path><path d="M92.5942 7.11658H88.8926L90.0454 1.88574H93.747L93.5274 2.84251H90.9473L90.7042 3.97964H93.2294L93.0176 4.93641H90.4846L90.2179 6.15197H92.7981L92.5942 7.11658Z" fill="white"></path><path d="M83.498 4.86616C83.498 3.10163 84.8312 1.7998 86.6428 1.7998C87.7564 1.7998 88.4779 2.40366 88.7995 3.07026L87.7721 3.50943C87.5839 3.0781 87.0663 2.78794 86.486 2.78794C85.5135 2.78794 84.6587 3.65059 84.6587 4.79557C84.6587 5.58765 85.2155 6.22288 86.1331 6.22288C86.5801 6.22288 86.9251 6.05035 87.1918 5.82292L87.3251 5.18769H86.7702L86.1488 4.23093H88.6505L88.1956 6.25425C87.6859 6.85811 86.933 7.21101 86.0703 7.21101C84.643 7.21101 83.498 6.30914 83.498 4.86616Z" fill="white"></path><path d="M78.772 1.88574H80.7953C81.9559 1.88574 83.0617 2.77977 83.0617 4.13649C83.0617 5.5089 82.1285 7.11658 79.6738 7.11658H77.6191L78.772 1.88574ZM78.9523 6.13629H79.8777C81.1403 6.13629 81.9011 5.2501 81.9011 4.20707C81.9011 3.44637 81.3599 2.86603 80.5835 2.86603H79.6738L78.9523 6.13629Z" fill="white"></path><path d="M76.7485 7.11658H73.0469L74.1997 1.88574H77.9013L77.6817 2.84251H75.1016L74.8585 3.97964H77.3837L77.1719 4.93641H74.6389L74.3722 6.15197H76.9524L76.7485 7.11658Z" fill="white"></path></svg></div><button>Click to Join</button></div></div><div class="banner-bg-end"></div></div></div></div></div></div></div><div class="sc-dTaEtF fBnIMc"><div class="sc-gFYmAs hzOZJg carousel-block reverse"><div class="sc-dkXDdO cXVRMB section-title bordered" href=""><h3>CANADA CANNABIS</h3></div><div class="sc-hrmvde iavXuM carousel-container"><div class="splide" aria-label="Carousel"><div class="splide-track-wrapper"><div class="splide__track"><ul class="splide__list"><li class="splide__slide"><a class="sc-dxRmzR gXQkGo carousel-item-wrapper item" data-action="CANADA CANNABIS Carousel Card Item Click" href="/news/retail-sales/24/11/42199358/aurora-cannabis-reveals-latest-product-innovations-ultra-high-potency-indicas-and-strains-for-veterans" target="_blank" width="300"><div class="sc-iPYwOE hspwUF"><div class="sc-bnRclF hAXDhr title">Aurora Cannabis Reveals Latest Product Innovations: Ultra-High Potency Indicas And Strains For Veterans</div></div><div class="sc-hPnoVK hliDyh carousel-item-thumbnail" height="197" width="300"><span style="background:none;border:0;box-sizing:border-box;display:block;height:initial;margin:0;opacity:1;overflow:hidden;padding:0;width:initial;position:absolute;top:0;left:0;bottom:0;right:0"><img alt="" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" style="border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:cover"/><noscript><img alt="" sizes="100vw" src="https://cdn.benzinga.com/files/images/story/2024/11/26/wesley-gibbs-NxRx7-mPdEk-unsplash.jpeg?optimize=medium&dpr=2&auto=webp&width=340" srcSet="https://cdn.benzinga.com/files/images/story/2024/11/26/wesley-gibbs-NxRx7-mPdEk-unsplash.jpeg?optimize=medium&dpr=2&auto=webp&width=340 640w, https://cdn.benzinga.com/files/images/story/2024/11/26/wesley-gibbs-NxRx7-mPdEk-unsplash.jpeg?optimize=medium&dpr=2&auto=webp&width=340 750w, https://cdn.benzinga.com/files/images/story/2024/11/26/wesley-gibbs-NxRx7-mPdEk-unsplash.jpeg?optimize=medium&dpr=2&auto=webp&width=340 828w, https://cdn.benzinga.com/files/images/story/2024/11/26/wesley-gibbs-NxRx7-mPdEk-unsplash.jpeg?optimize=medium&dpr=2&auto=webp&width=340 1080w, https://cdn.benzinga.com/files/images/story/2024/11/26/wesley-gibbs-NxRx7-mPdEk-unsplash.jpeg?optimize=medium&dpr=2&auto=webp&width=340 1200w, https://cdn.benzinga.com/files/images/story/2024/11/26/wesley-gibbs-NxRx7-mPdEk-unsplash.jpeg?optimize=medium&dpr=2&auto=webp&width=340 1920w, https://cdn.benzinga.com/files/images/story/2024/11/26/wesley-gibbs-NxRx7-mPdEk-unsplash.jpeg?optimize=medium&dpr=2&auto=webp&width=340 2048w, https://cdn.benzinga.com/files/images/story/2024/11/26/wesley-gibbs-NxRx7-mPdEk-unsplash.jpeg?optimize=medium&dpr=2&auto=webp&width=340 3840w" decoding="async" loading="lazy" style="border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:cover"/></noscript></span></div></a></li><li class="splide__slide"><a class="sc-dxRmzR gXQkGo carousel-item-wrapper item" data-action="CANADA CANNABIS Carousel Card Item Click" href="/markets/cannabis/24/11/42169374/canadian-cannabis-producer-cannara-reports-43-yoy-revenue-growth-boosts-market-share-and-profitability" target="_blank" width="300"><div class="sc-iPYwOE hspwUF"><div class="sc-bnRclF hAXDhr title">Canadian Cannabis Producer Cannara Reports 43% YoY Revenue Growth, Boosts Market Share And Profitability</div></div><div class="sc-hPnoVK hliDyh carousel-item-thumbnail" height="197" width="300"><span style="background:none;border:0;box-sizing:border-box;display:block;height:initial;margin:0;opacity:1;overflow:hidden;padding:0;width:initial;position:absolute;top:0;left:0;bottom:0;right:0"><img alt="" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" style="border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:cover"/><noscript><img alt="" sizes="100vw" src="https://cdn.benzinga.com/files/images/story/2024/11/25/elsa-olofsson-12-Zs1xIEtA-unsplash25.jpeg?optimize=medium&dpr=2&auto=webp&width=340" srcSet="https://cdn.benzinga.com/files/images/story/2024/11/25/elsa-olofsson-12-Zs1xIEtA-unsplash25.jpeg?optimize=medium&dpr=2&auto=webp&width=340 640w, https://cdn.benzinga.com/files/images/story/2024/11/25/elsa-olofsson-12-Zs1xIEtA-unsplash25.jpeg?optimize=medium&dpr=2&auto=webp&width=340 750w, https://cdn.benzinga.com/files/images/story/2024/11/25/elsa-olofsson-12-Zs1xIEtA-unsplash25.jpeg?optimize=medium&dpr=2&auto=webp&width=340 828w, https://cdn.benzinga.com/files/images/story/2024/11/25/elsa-olofsson-12-Zs1xIEtA-unsplash25.jpeg?optimize=medium&dpr=2&auto=webp&width=340 1080w, https://cdn.benzinga.com/files/images/story/2024/11/25/elsa-olofsson-12-Zs1xIEtA-unsplash25.jpeg?optimize=medium&dpr=2&auto=webp&width=340 1200w, https://cdn.benzinga.com/files/images/story/2024/11/25/elsa-olofsson-12-Zs1xIEtA-unsplash25.jpeg?optimize=medium&dpr=2&auto=webp&width=340 1920w, https://cdn.benzinga.com/files/images/story/2024/11/25/elsa-olofsson-12-Zs1xIEtA-unsplash25.jpeg?optimize=medium&dpr=2&auto=webp&width=340 2048w, https://cdn.benzinga.com/files/images/story/2024/11/25/elsa-olofsson-12-Zs1xIEtA-unsplash25.jpeg?optimize=medium&dpr=2&auto=webp&width=340 3840w" decoding="async" loading="lazy" style="border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:cover"/></noscript></span></div></a></li><li class="splide__slide"><a class="sc-dxRmzR gXQkGo carousel-item-wrapper item" data-action="CANADA CANNABIS Carousel Card Item Click" href="/government/regulations/24/11/42146896/exclusive-how-equa-tackles-stigma-in-cannabis-insurance-with-tailored-solutions" target="_blank" width="300"><div class="sc-iPYwOE hspwUF"><div class="sc-bnRclF hAXDhr title">EXCLUSIVE: How EQUA Tackles Stigma In Cannabis Insurance With Tailored Solutions</div></div><div class="sc-hPnoVK hliDyh carousel-item-thumbnail" height="197" width="300"><span style="background:none;border:0;box-sizing:border-box;display:block;height:initial;margin:0;opacity:1;overflow:hidden;padding:0;width:initial;position:absolute;top:0;left:0;bottom:0;right:0"><img alt="" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" style="border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:cover"/><noscript><img alt="" sizes="100vw" src="https://cdn.benzinga.com/files/images/story/2024/11/22/equaloretta.png?optimize=medium&dpr=2&auto=webp&width=340" srcSet="https://cdn.benzinga.com/files/images/story/2024/11/22/equaloretta.png?optimize=medium&dpr=2&auto=webp&width=340 640w, https://cdn.benzinga.com/files/images/story/2024/11/22/equaloretta.png?optimize=medium&dpr=2&auto=webp&width=340 750w, https://cdn.benzinga.com/files/images/story/2024/11/22/equaloretta.png?optimize=medium&dpr=2&auto=webp&width=340 828w, https://cdn.benzinga.com/files/images/story/2024/11/22/equaloretta.png?optimize=medium&dpr=2&auto=webp&width=340 1080w, https://cdn.benzinga.com/files/images/story/2024/11/22/equaloretta.png?optimize=medium&dpr=2&auto=webp&width=340 1200w, https://cdn.benzinga.com/files/images/story/2024/11/22/equaloretta.png?optimize=medium&dpr=2&auto=webp&width=340 1920w, https://cdn.benzinga.com/files/images/story/2024/11/22/equaloretta.png?optimize=medium&dpr=2&auto=webp&width=340 2048w, https://cdn.benzinga.com/files/images/story/2024/11/22/equaloretta.png?optimize=medium&dpr=2&auto=webp&width=340 3840w" decoding="async" loading="lazy" style="border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:cover"/></noscript></span></div></a></li><li class="splide__slide"><a class="sc-dxRmzR gXQkGo carousel-item-wrapper item" data-action="CANADA CANNABIS Carousel Card Item Click" href="/24/11/42137701/canadian-cannabis-co-decibel-reports-12-yoy-drop-in-q3-revenue-but-increases-gross-margin-to-53" target="_blank" width="300"><div class="sc-iPYwOE hspwUF"><div class="sc-bnRclF hAXDhr title">Canadian Cannabis Co. Decibel Reports 12% YoY Drop In Q3 Revenue But Increases Gross Margin To 53%</div></div><div class="sc-hPnoVK hliDyh carousel-item-thumbnail" height="197" width="300"><span style="background:none;border:0;box-sizing:border-box;display:block;height:initial;margin:0;opacity:1;overflow:hidden;padding:0;width:initial;position:absolute;top:0;left:0;bottom:0;right:0"><img alt="" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" style="border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:cover"/><noscript><img alt="" sizes="100vw" src="https://cdn.benzinga.com/files/images/story/2024/11/22/pexels-kindelmedia-76680491.jpeg?optimize=medium&dpr=2&auto=webp&width=340" srcSet="https://cdn.benzinga.com/files/images/story/2024/11/22/pexels-kindelmedia-76680491.jpeg?optimize=medium&dpr=2&auto=webp&width=340 640w, https://cdn.benzinga.com/files/images/story/2024/11/22/pexels-kindelmedia-76680491.jpeg?optimize=medium&dpr=2&auto=webp&width=340 750w, https://cdn.benzinga.com/files/images/story/2024/11/22/pexels-kindelmedia-76680491.jpeg?optimize=medium&dpr=2&auto=webp&width=340 828w, https://cdn.benzinga.com/files/images/story/2024/11/22/pexels-kindelmedia-76680491.jpeg?optimize=medium&dpr=2&auto=webp&width=340 1080w, https://cdn.benzinga.com/files/images/story/2024/11/22/pexels-kindelmedia-76680491.jpeg?optimize=medium&dpr=2&auto=webp&width=340 1200w, https://cdn.benzinga.com/files/images/story/2024/11/22/pexels-kindelmedia-76680491.jpeg?optimize=medium&dpr=2&auto=webp&width=340 1920w, https://cdn.benzinga.com/files/images/story/2024/11/22/pexels-kindelmedia-76680491.jpeg?optimize=medium&dpr=2&auto=webp&width=340 2048w, https://cdn.benzinga.com/files/images/story/2024/11/22/pexels-kindelmedia-76680491.jpeg?optimize=medium&dpr=2&auto=webp&width=340 3840w" decoding="async" loading="lazy" style="border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:cover"/></noscript></span></div></a></li><li class="splide__slide"><a class="sc-dxRmzR gXQkGo carousel-item-wrapper item" data-action="CANADA CANNABIS Carousel Card Item Click" href="/markets/cannabis/24/11/42127287/whats-happening-with-canopy-growth-is-it-time-to-buy" target="_blank" width="300"><div class="sc-iPYwOE hspwUF"><div class="sc-bnRclF hAXDhr title">What's Happening With Canopy Growth: Is It Time To Buy?</div></div><div class="sc-hPnoVK hliDyh carousel-item-thumbnail" height="197" width="300"><span style="background:none;border:0;box-sizing:border-box;display:block;height:initial;margin:0;opacity:1;overflow:hidden;padding:0;width:initial;position:absolute;top:0;left:0;bottom:0;right:0"><img alt="" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" style="border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:cover"/><noscript><img alt="" sizes="100vw" src="https://cdn.benzinga.com/files/images/story/2024/11/21/Fibo-Canopy.png?optimize=medium&dpr=2&auto=webp&width=340" srcSet="https://cdn.benzinga.com/files/images/story/2024/11/21/Fibo-Canopy.png?optimize=medium&dpr=2&auto=webp&width=340 640w, https://cdn.benzinga.com/files/images/story/2024/11/21/Fibo-Canopy.png?optimize=medium&dpr=2&auto=webp&width=340 750w, https://cdn.benzinga.com/files/images/story/2024/11/21/Fibo-Canopy.png?optimize=medium&dpr=2&auto=webp&width=340 828w, https://cdn.benzinga.com/files/images/story/2024/11/21/Fibo-Canopy.png?optimize=medium&dpr=2&auto=webp&width=340 1080w, https://cdn.benzinga.com/files/images/story/2024/11/21/Fibo-Canopy.png?optimize=medium&dpr=2&auto=webp&width=340 1200w, https://cdn.benzinga.com/files/images/story/2024/11/21/Fibo-Canopy.png?optimize=medium&dpr=2&auto=webp&width=340 1920w, https://cdn.benzinga.com/files/images/story/2024/11/21/Fibo-Canopy.png?optimize=medium&dpr=2&auto=webp&width=340 2048w, https://cdn.benzinga.com/files/images/story/2024/11/21/Fibo-Canopy.png?optimize=medium&dpr=2&auto=webp&width=340 3840w" decoding="async" loading="lazy" style="border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:cover"/></noscript></span></div></a></li><li class="splide__slide"><a class="sc-dxRmzR gXQkGo carousel-item-wrapper item" data-action="CANADA CANNABIS Carousel Card Item Click" href="/general/market-summary/24/11/42100955/the-u-s-cannabis-strategy-no-ones-talking-about-inside-canopys-300m-plan" target="_blank" width="300"><div class="sc-iPYwOE hspwUF"><div class="sc-bnRclF hAXDhr title">The U.S. Cannabis Strategy No One's Talking About: Inside Canopy's $300M Plan</div></div><div class="sc-hPnoVK hliDyh carousel-item-thumbnail" height="197" width="300"><span style="background:none;border:0;box-sizing:border-box;display:block;height:initial;margin:0;opacity:1;overflow:hidden;padding:0;width:initial;position:absolute;top:0;left:0;bottom:0;right:0"><img alt="" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" style="border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:cover"/><noscript><img alt="" sizes="100vw" src="https://cdn.benzinga.com/files/images/story/2024/11/20/AI-Generated-Image_1.jpeg?optimize=medium&dpr=2&auto=webp&width=340" srcSet="https://cdn.benzinga.com/files/images/story/2024/11/20/AI-Generated-Image_1.jpeg?optimize=medium&dpr=2&auto=webp&width=340 640w, https://cdn.benzinga.com/files/images/story/2024/11/20/AI-Generated-Image_1.jpeg?optimize=medium&dpr=2&auto=webp&width=340 750w, https://cdn.benzinga.com/files/images/story/2024/11/20/AI-Generated-Image_1.jpeg?optimize=medium&dpr=2&auto=webp&width=340 828w, https://cdn.benzinga.com/files/images/story/2024/11/20/AI-Generated-Image_1.jpeg?optimize=medium&dpr=2&auto=webp&width=340 1080w, https://cdn.benzinga.com/files/images/story/2024/11/20/AI-Generated-Image_1.jpeg?optimize=medium&dpr=2&auto=webp&width=340 1200w, https://cdn.benzinga.com/files/images/story/2024/11/20/AI-Generated-Image_1.jpeg?optimize=medium&dpr=2&auto=webp&width=340 1920w, https://cdn.benzinga.com/files/images/story/2024/11/20/AI-Generated-Image_1.jpeg?optimize=medium&dpr=2&auto=webp&width=340 2048w, https://cdn.benzinga.com/files/images/story/2024/11/20/AI-Generated-Image_1.jpeg?optimize=medium&dpr=2&auto=webp&width=340 3840w" decoding="async" loading="lazy" style="border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:cover"/></noscript></span></div></a></li><li class="splide__slide"><a class="sc-dxRmzR gXQkGo carousel-item-wrapper item" data-action="CANADA CANNABIS Carousel Card Item Click" href="/24/11/42017405/medical-marijuana-footprint-grows-in-florida-as-legalization-push-fizzles-and-other-new-cannabis-stores-that-launched-sales" target="_blank" width="300"><div class="sc-iPYwOE hspwUF"><div class="sc-bnRclF hAXDhr title">Medical Marijuana Footprint Grows In Florida As Legalization Push Fizzles, And Other New Cannabis Stores</div></div><div class="sc-hPnoVK hliDyh carousel-item-thumbnail" height="197" width="300"><span style="background:none;border:0;box-sizing:border-box;display:block;height:initial;margin:0;opacity:1;overflow:hidden;padding:0;width:initial;position:absolute;top:0;left:0;bottom:0;right:0"><img alt="" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" style="border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:cover"/><noscript><img alt="" sizes="100vw" src="https://cdn.benzinga.com/files/images/story/2024/11/15/jan-zwarthoed-24C4MlZRqeI-unsplash.jpeg?optimize=medium&dpr=2&auto=webp&width=340" srcSet="https://cdn.benzinga.com/files/images/story/2024/11/15/jan-zwarthoed-24C4MlZRqeI-unsplash.jpeg?optimize=medium&dpr=2&auto=webp&width=340 640w, https://cdn.benzinga.com/files/images/story/2024/11/15/jan-zwarthoed-24C4MlZRqeI-unsplash.jpeg?optimize=medium&dpr=2&auto=webp&width=340 750w, https://cdn.benzinga.com/files/images/story/2024/11/15/jan-zwarthoed-24C4MlZRqeI-unsplash.jpeg?optimize=medium&dpr=2&auto=webp&width=340 828w, https://cdn.benzinga.com/files/images/story/2024/11/15/jan-zwarthoed-24C4MlZRqeI-unsplash.jpeg?optimize=medium&dpr=2&auto=webp&width=340 1080w, https://cdn.benzinga.com/files/images/story/2024/11/15/jan-zwarthoed-24C4MlZRqeI-unsplash.jpeg?optimize=medium&dpr=2&auto=webp&width=340 1200w, https://cdn.benzinga.com/files/images/story/2024/11/15/jan-zwarthoed-24C4MlZRqeI-unsplash.jpeg?optimize=medium&dpr=2&auto=webp&width=340 1920w, https://cdn.benzinga.com/files/images/story/2024/11/15/jan-zwarthoed-24C4MlZRqeI-unsplash.jpeg?optimize=medium&dpr=2&auto=webp&width=340 2048w, https://cdn.benzinga.com/files/images/story/2024/11/15/jan-zwarthoed-24C4MlZRqeI-unsplash.jpeg?optimize=medium&dpr=2&auto=webp&width=340 3840w" decoding="async" loading="lazy" style="border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:cover"/></noscript></span></div></a></li><li class="splide__slide"><a class="sc-dxRmzR gXQkGo carousel-item-wrapper item" data-action="CANADA CANNABIS Carousel Card Item Click" href="/24/11/41982261/im-cannabis-achieves-66-revenue-growth-in-germany-narrows-ebitda-loss-in-q3" target="_blank" width="300"><div class="sc-iPYwOE hspwUF"><div class="sc-bnRclF hAXDhr title">IM Cannabis: 66% Revenue Growth In Germany, Narrows EBITDA Loss In Q3</div></div><div class="sc-hPnoVK hliDyh carousel-item-thumbnail" height="197" width="300"><span style="background:none;border:0;box-sizing:border-box;display:block;height:initial;margin:0;opacity:1;overflow:hidden;padding:0;width:initial;position:absolute;top:0;left:0;bottom:0;right:0"><img alt="" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" style="border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:cover"/><noscript><img alt="" sizes="100vw" src="https://cdn.benzinga.com/files/images/story/2024/11/14/elsa-olofsson-12-Zs1xIEtA-unsplash23.jpeg?optimize=medium&dpr=2&auto=webp&width=340" srcSet="https://cdn.benzinga.com/files/images/story/2024/11/14/elsa-olofsson-12-Zs1xIEtA-unsplash23.jpeg?optimize=medium&dpr=2&auto=webp&width=340 640w, https://cdn.benzinga.com/files/images/story/2024/11/14/elsa-olofsson-12-Zs1xIEtA-unsplash23.jpeg?optimize=medium&dpr=2&auto=webp&width=340 750w, https://cdn.benzinga.com/files/images/story/2024/11/14/elsa-olofsson-12-Zs1xIEtA-unsplash23.jpeg?optimize=medium&dpr=2&auto=webp&width=340 828w, https://cdn.benzinga.com/files/images/story/2024/11/14/elsa-olofsson-12-Zs1xIEtA-unsplash23.jpeg?optimize=medium&dpr=2&auto=webp&width=340 1080w, https://cdn.benzinga.com/files/images/story/2024/11/14/elsa-olofsson-12-Zs1xIEtA-unsplash23.jpeg?optimize=medium&dpr=2&auto=webp&width=340 1200w, https://cdn.benzinga.com/files/images/story/2024/11/14/elsa-olofsson-12-Zs1xIEtA-unsplash23.jpeg?optimize=medium&dpr=2&auto=webp&width=340 1920w, https://cdn.benzinga.com/files/images/story/2024/11/14/elsa-olofsson-12-Zs1xIEtA-unsplash23.jpeg?optimize=medium&dpr=2&auto=webp&width=340 2048w, https://cdn.benzinga.com/files/images/story/2024/11/14/elsa-olofsson-12-Zs1xIEtA-unsplash23.jpeg?optimize=medium&dpr=2&auto=webp&width=340 3840w" decoding="async" loading="lazy" style="border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:cover"/></noscript></span></div></a></li><li class="splide__slide"><a class="sc-dxRmzR gXQkGo carousel-item-wrapper item" data-action="CANADA CANNABIS Carousel Card Item Click" href="/news/financing/24/11/41947919/high-tide-closes-final-tranche-of-15m-debt-plans-retail-growth" target="_blank" width="300"><div class="sc-iPYwOE hspwUF"><div class="sc-bnRclF hAXDhr title">High Tide Closes Final Tranche Of $15M Debt, Plans Retail Growth</div></div><div class="sc-hPnoVK hliDyh carousel-item-thumbnail" height="197" width="300"><span style="background:none;border:0;box-sizing:border-box;display:block;height:initial;margin:0;opacity:1;overflow:hidden;padding:0;width:initial;position:absolute;top:0;left:0;bottom:0;right:0"><img alt="" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" style="border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:cover"/><noscript><img alt="" sizes="100vw" src="https://cdn.benzinga.com/files/images/story/2024/11/13/Captura-de-pantalla-2024-11-13-113617-1.png?optimize=medium&dpr=2&auto=webp&width=340" srcSet="https://cdn.benzinga.com/files/images/story/2024/11/13/Captura-de-pantalla-2024-11-13-113617-1.png?optimize=medium&dpr=2&auto=webp&width=340 640w, https://cdn.benzinga.com/files/images/story/2024/11/13/Captura-de-pantalla-2024-11-13-113617-1.png?optimize=medium&dpr=2&auto=webp&width=340 750w, https://cdn.benzinga.com/files/images/story/2024/11/13/Captura-de-pantalla-2024-11-13-113617-1.png?optimize=medium&dpr=2&auto=webp&width=340 828w, https://cdn.benzinga.com/files/images/story/2024/11/13/Captura-de-pantalla-2024-11-13-113617-1.png?optimize=medium&dpr=2&auto=webp&width=340 1080w, https://cdn.benzinga.com/files/images/story/2024/11/13/Captura-de-pantalla-2024-11-13-113617-1.png?optimize=medium&dpr=2&auto=webp&width=340 1200w, https://cdn.benzinga.com/files/images/story/2024/11/13/Captura-de-pantalla-2024-11-13-113617-1.png?optimize=medium&dpr=2&auto=webp&width=340 1920w, https://cdn.benzinga.com/files/images/story/2024/11/13/Captura-de-pantalla-2024-11-13-113617-1.png?optimize=medium&dpr=2&auto=webp&width=340 2048w, https://cdn.benzinga.com/files/images/story/2024/11/13/Captura-de-pantalla-2024-11-13-113617-1.png?optimize=medium&dpr=2&auto=webp&width=340 3840w" decoding="async" loading="lazy" style="border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:cover"/></noscript></span></div></a></li><li class="splide__slide"><a class="sc-dxRmzR gXQkGo carousel-item-wrapper item" data-action="CANADA CANNABIS Carousel Card Item Click" href="/analyst-ratings/analyst-color/24/11/41925770/three-paths-to-cannabis-profits-village-farms-green-thumb-and-jushi-show-divergent-" target="_blank" width="300"><div class="sc-iPYwOE hspwUF"><div class="sc-bnRclF hAXDhr title">Three Paths To Cannabis Profits: Village Farms, Green Thumb, And Jushi Show Divergent Strategies—Which Will Deliver?</div></div><div class="sc-hPnoVK hliDyh carousel-item-thumbnail" height="197" width="300"><span style="background:none;border:0;box-sizing:border-box;display:block;height:initial;margin:0;opacity:1;overflow:hidden;padding:0;width:initial;position:absolute;top:0;left:0;bottom:0;right:0"><img alt="" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" style="border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:cover"/><noscript><img alt="" sizes="100vw" src="https://cdn.benzinga.com/files/images/story/2024/11/12/AI-Generated-Image.jpeg?optimize=medium&dpr=2&auto=webp&width=340" srcSet="https://cdn.benzinga.com/files/images/story/2024/11/12/AI-Generated-Image.jpeg?optimize=medium&dpr=2&auto=webp&width=340 640w, https://cdn.benzinga.com/files/images/story/2024/11/12/AI-Generated-Image.jpeg?optimize=medium&dpr=2&auto=webp&width=340 750w, https://cdn.benzinga.com/files/images/story/2024/11/12/AI-Generated-Image.jpeg?optimize=medium&dpr=2&auto=webp&width=340 828w, https://cdn.benzinga.com/files/images/story/2024/11/12/AI-Generated-Image.jpeg?optimize=medium&dpr=2&auto=webp&width=340 1080w, https://cdn.benzinga.com/files/images/story/2024/11/12/AI-Generated-Image.jpeg?optimize=medium&dpr=2&auto=webp&width=340 1200w, https://cdn.benzinga.com/files/images/story/2024/11/12/AI-Generated-Image.jpeg?optimize=medium&dpr=2&auto=webp&width=340 1920w, https://cdn.benzinga.com/files/images/story/2024/11/12/AI-Generated-Image.jpeg?optimize=medium&dpr=2&auto=webp&width=340 2048w, https://cdn.benzinga.com/files/images/story/2024/11/12/AI-Generated-Image.jpeg?optimize=medium&dpr=2&auto=webp&width=340 3840w" decoding="async" loading="lazy" style="border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:cover"/></noscript></span></div></a></li><li class="splide__slide"><a class="sc-dxRmzR gXQkGo carousel-item-wrapper item" data-action="CANADA CANNABIS Carousel Card Item Click" href="/news/earnings/24/11/41852707/auxly-cannabis-co-q3-net-revenue-climbs-18-yoy-adjusted-ebitda-soars" target="_blank" width="300"><div class="sc-iPYwOE hspwUF"><div class="sc-bnRclF hAXDhr title">Auxly Cannabis Co.: Q3 Net Revenue Climbs 18% YoY, Adjusted EBITDA Soars</div></div><div class="sc-hPnoVK hliDyh carousel-item-thumbnail" height="197" width="300"><span style="background:none;border:0;box-sizing:border-box;display:block;height:initial;margin:0;opacity:1;overflow:hidden;padding:0;width:initial;position:absolute;top:0;left:0;bottom:0;right:0"><img alt="" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" style="border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:cover"/><noscript><img alt="" sizes="100vw" src="https://cdn.benzinga.com/files/images/story/2024/11/08/dmytro-demidko-eBWzFKahEaU-unsplash1.jpeg?optimize=medium&dpr=2&auto=webp&width=340" srcSet="https://cdn.benzinga.com/files/images/story/2024/11/08/dmytro-demidko-eBWzFKahEaU-unsplash1.jpeg?optimize=medium&dpr=2&auto=webp&width=340 640w, https://cdn.benzinga.com/files/images/story/2024/11/08/dmytro-demidko-eBWzFKahEaU-unsplash1.jpeg?optimize=medium&dpr=2&auto=webp&width=340 750w, https://cdn.benzinga.com/files/images/story/2024/11/08/dmytro-demidko-eBWzFKahEaU-unsplash1.jpeg?optimize=medium&dpr=2&auto=webp&width=340 828w, https://cdn.benzinga.com/files/images/story/2024/11/08/dmytro-demidko-eBWzFKahEaU-unsplash1.jpeg?optimize=medium&dpr=2&auto=webp&width=340 1080w, https://cdn.benzinga.com/files/images/story/2024/11/08/dmytro-demidko-eBWzFKahEaU-unsplash1.jpeg?optimize=medium&dpr=2&auto=webp&width=340 1200w, https://cdn.benzinga.com/files/images/story/2024/11/08/dmytro-demidko-eBWzFKahEaU-unsplash1.jpeg?optimize=medium&dpr=2&auto=webp&width=340 1920w, https://cdn.benzinga.com/files/images/story/2024/11/08/dmytro-demidko-eBWzFKahEaU-unsplash1.jpeg?optimize=medium&dpr=2&auto=webp&width=340 2048w, https://cdn.benzinga.com/files/images/story/2024/11/08/dmytro-demidko-eBWzFKahEaU-unsplash1.jpeg?optimize=medium&dpr=2&auto=webp&width=340 3840w" decoding="async" loading="lazy" style="border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:cover"/></noscript></span></div></a></li><li class="splide__slide"><a class="sc-dxRmzR gXQkGo carousel-item-wrapper item" data-action="CANADA CANNABIS Carousel Card Item Click" href="/news/earnings/24/11/41843751/canopy-growth-q2-net-revenue-drops-9-yoy-projects-positive-earnings-ahead" target="_blank" width="300"><div class="sc-iPYwOE hspwUF"><div class="sc-bnRclF hAXDhr title">Canopy Growth: Q2 Net Revenue Drops 9% YoY, Projects Positive Earnings Ahead</div></div><div class="sc-hPnoVK hliDyh carousel-item-thumbnail" height="197" width="300"><span style="background:none;border:0;box-sizing:border-box;display:block;height:initial;margin:0;opacity:1;overflow:hidden;padding:0;width:initial;position:absolute;top:0;left:0;bottom:0;right:0"><img alt="" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" style="border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:cover"/><noscript><img alt="" sizes="100vw" src="https://cdn.benzinga.com/files/images/story/2024/11/08/cannabis-debt-NikolayFrolochkin-and-ganj.jpeg?optimize=medium&dpr=2&auto=webp&width=340" srcSet="https://cdn.benzinga.com/files/images/story/2024/11/08/cannabis-debt-NikolayFrolochkin-and-ganj.jpeg?optimize=medium&dpr=2&auto=webp&width=340 640w, https://cdn.benzinga.com/files/images/story/2024/11/08/cannabis-debt-NikolayFrolochkin-and-ganj.jpeg?optimize=medium&dpr=2&auto=webp&width=340 750w, https://cdn.benzinga.com/files/images/story/2024/11/08/cannabis-debt-NikolayFrolochkin-and-ganj.jpeg?optimize=medium&dpr=2&auto=webp&width=340 828w, https://cdn.benzinga.com/files/images/story/2024/11/08/cannabis-debt-NikolayFrolochkin-and-ganj.jpeg?optimize=medium&dpr=2&auto=webp&width=340 1080w, https://cdn.benzinga.com/files/images/story/2024/11/08/cannabis-debt-NikolayFrolochkin-and-ganj.jpeg?optimize=medium&dpr=2&auto=webp&width=340 1200w, https://cdn.benzinga.com/files/images/story/2024/11/08/cannabis-debt-NikolayFrolochkin-and-ganj.jpeg?optimize=medium&dpr=2&auto=webp&width=340 1920w, https://cdn.benzinga.com/files/images/story/2024/11/08/cannabis-debt-NikolayFrolochkin-and-ganj.jpeg?optimize=medium&dpr=2&auto=webp&width=340 2048w, https://cdn.benzinga.com/files/images/story/2024/11/08/cannabis-debt-NikolayFrolochkin-and-ganj.jpeg?optimize=medium&dpr=2&auto=webp&width=340 3840w" decoding="async" loading="lazy" style="border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:cover"/></noscript></span></div></a></li></ul></div><div class="carousel-pagination"><div class="splide__arrows"><button class="sc-kiTBBF giYyj primary md splide__arrow splide__arrow--prev page-left-button" type="button"><span><div><svg aria-hidden="true" class="leading-none" stroke="currentColor" stroke-width="1" style="height:1em;width:1em" viewBox="0 0 320 512" xmlns="http://www.w3.org/2000/svg"><path d="M15 239c-9.4 9.4-9.4 24.6 0 33.9L207 465c9.4 9.4 24.6 9.4 33.9 0s9.4-24.6 0-33.9L65.9 256 241 81c9.4-9.4 9.4-24.6 0-33.9s-24.6-9.4-33.9 0L15 239z" fill="currentColor"></path></svg></div></span></button><button class="sc-kiTBBF giYyj primary md splide__arrow splide__arrow--next page-right-button" type="button"><span><div><svg aria-hidden="true" class="leading-none" stroke="currentColor" stroke-width="1" style="height:1em;width:1em" viewBox="0 0 320 512" xmlns="http://www.w3.org/2000/svg"><path d="M305 239c9.4 9.4 9.4 24.6 0 33.9L113 465c-9.4 9.4-24.6 9.4-33.9 0s-9.4-24.6 0-33.9l175-175L79 81c-9.4-9.4-9.4-24.6 0-33.9s24.6-9.4 33.9 0L305 239z" fill="currentColor"></path></svg></div></span></button></div></div></div></div></div></div></div><div class="sc-fCzvdW kTbgNs news-list-group-block"><div class="sc-fKFgrF icxwYm news-list-group-wrapper"><div class="sc-kSsGea iOEnob news-list-wrapper"><div class="sc-nbCPO hyiaGS content-feed "><div class="sc-dkXDdO cXVRMB section-title news-block-title bordered" href=""><h3>Partner Content</h3></div><div class="content-feed-container"><div class="content-feed-list"><div class="sc-hmzteu ddclwE news-block primary"><div class="news-block-headline"><div class="flex"><div><span class="news-item-sponsored-tag">Sponsored</span><a data-action="Article Click" href="/general/biotech/24/02/36979898/cannara-biotech-q1-results-revenue-net-income-and-market-share-up-quarter-also-marks-companys-fir"><div class="sc-ceLTrZ bjJtVr article-title"><span>Cannara Biotech Q1 Results: Revenue, Net Income And Market Share Up, Quarter Also Marks Company's First Export Sale</span></div></a><div><div class="flex items-center"></div></div></div></div></div><div class="sc-bUsiPH gNYhnT ticker-list"><div class="ticker-list-container"><div class="sc-dVraiA dDLddz ticker-box-wrapper"><a aria-label="Go to Quote Page for LOVFF" rel="dofollow" class="items-end ticker-link-wrapper inline-flex" href="/quote/lovff" target="_blank"><span class="sc-gUDIDV jYfzbt">LOVFF</span></a></div></div></div></div><div class="sc-hmzteu ddclwE news-block primary"><div class="news-block-headline"><div class="flex"><div><span class="news-item-sponsored-tag">Sponsored</span><a data-action="Article Click" href="/markets/cannabis/23/12/36195597/cannara-biotech-market-share-gains-result-in-record-setting-fourth-quarter"><div class="sc-ceLTrZ bjJtVr article-title"><span>Cannara Biotech Market Share Gains Result In Record-Setting Fourth Quarter</span></div></a><div><div class="flex items-center"></div></div></div></div></div><div class="sc-bUsiPH gNYhnT ticker-list"><div class="ticker-list-container"><div class="sc-dVraiA dDLddz ticker-box-wrapper"><a aria-label="Go to Quote Page for LOVFF" rel="dofollow" class="items-end ticker-link-wrapper inline-flex" href="/quote/lovff" target="_blank"><span class="sc-gUDIDV jYfzbt">LOVFF</span></a></div></div></div></div><div class="sc-hmzteu ddclwE news-block primary"><div class="news-block-headline"><div class="flex"><div><span class="news-item-sponsored-tag">Sponsored</span><a data-action="Article Click" href="/general/biotech/23/12/36175332/inmeds-nasdaq-inm-latest-research-demonstrates-potential-in-treating-alzheimers-with-a-rare-canna"><div class="sc-ceLTrZ bjJtVr article-title"><span>InMed's (NASDAQ: INM) Latest Research Demonstrates Potential In Treating Alzheimer's With A Rare Cannabinoid Analog</span></div></a><div><div class="flex items-center"></div></div></div></div></div><div class="sc-bUsiPH gNYhnT ticker-list"><div class="ticker-list-container"><div class="sc-dVraiA dDLddz ticker-box-wrapper"><a aria-label="Go to Quote Page for INM" rel="dofollow" class="items-end ticker-link-wrapper inline-flex" href="/quote/inm" target="_blank"><span class="sc-gUDIDV jYfzbt">INM</span></a></div></div></div></div><div class="sc-hmzteu ddclwE news-block primary"><div class="news-block-headline"><div class="flex"><div><span class="news-item-sponsored-tag">Sponsored</span><a data-action="Article Click" href="/general/biotech/23/10/35488296/how-rexis-biotech-aims-to-become-the-nvidia-of-the-consumer-products-industry"><div class="sc-ceLTrZ bjJtVr article-title"><span>How Rexis Biotech Aims To Become The Nvidia Of The Consumer Products Industry</span></div></a><div><div class="flex items-center"></div></div></div></div></div><div class="sc-bUsiPH gNYhnT ticker-list"><div class="ticker-list-container"><div class="sc-dVraiA dDLddz ticker-box-wrapper"><a aria-label="Go to Quote Page for INTC" rel="dofollow" class="items-end ticker-link-wrapper inline-flex" href="/quote/intc" target="_blank"><span class="sc-gUDIDV jYfzbt">INTC</span></a></div><div class="sc-dVraiA dDLddz ticker-box-wrapper"><a aria-label="Go to Quote Page for NVDA" rel="dofollow" class="items-end ticker-link-wrapper inline-flex" href="/quote/nvda" target="_blank"><span class="sc-gUDIDV jYfzbt">NVDA</span></a></div></div></div></div></div></div></div></div><div class="sc-kSsGea iOEnob news-list-wrapper"><div class="sc-nbCPO hyiaGS content-feed "><a class="sc-dkXDdO cXVRMB section-title news-block-title bordered contains-right-slot" aria-label="Click here to see more Trading Ideas content" data-action="Trading Ideas See More Click" href="https://www.benzinga.com/trading-ideas"><h3>Trading Ideas</h3><span class="right-slot"><span class="see-more">See more</span></span></a><div class="content-feed-container"><div class="content-feed-list"><div class="sc-hmzteu ddclwE news-block primary"><div class="news-block-headline"><div class="flex"><div><a data-action="Article Click" href="/24/11/42196285/aurora-cannabis-stock-analysis-key-levels-and-trading-opportunities"><div class="sc-ceLTrZ bjJtVr article-title"><span>Aurora Cannabis Stock Analysis: Key Levels And Trading Opportunities</span></div></a><div><div class="flex items-center"><div class="sc-ekaoJE fACrUT"></div></div></div></div></div></div><div class="sc-bUsiPH gNYhnT ticker-list"><div class="ticker-list-container"><div class="sc-dVraiA dDLddz ticker-box-wrapper"><a aria-label="Go to Quote Page for ACB" rel="dofollow" class="items-end ticker-link-wrapper inline-flex" href="/quote/acb" target="_blank"><span class="sc-gUDIDV jYfzbt">ACB</span></a></div><div class="sc-dVraiA dDLddz ticker-box-wrapper"><a aria-label="Go to Quote Page for CGC" rel="dofollow" class="items-end ticker-link-wrapper inline-flex" href="/quote/cgc" target="_blank"><span class="sc-gUDIDV jYfzbt">CGC</span></a></div></div></div></div><div class="sc-hmzteu ddclwE news-block primary"><div class="news-block-headline"><div class="flex"><div><a data-action="Article Click" href="/general/market-summary/24/11/42147417/80-leverage-5-5x-ebitda-is-cresco-the-high-risk-high-reward-play-investors-need"><div class="sc-ceLTrZ bjJtVr article-title"><span>80% Leverage, 5.5x EBITDA: Is Cresco The High-Risk, High-Reward Play Investors Need?</span></div></a><div><div class="flex items-center"><div class="sc-ekaoJE fACrUT"></div></div></div></div></div></div><div class="sc-bUsiPH gNYhnT ticker-list"><div class="ticker-list-container"><div class="sc-dVraiA dDLddz ticker-box-wrapper"><a aria-label="Go to Quote Page for CRLBF" rel="dofollow" class="items-end ticker-link-wrapper inline-flex" href="/quote/crlbf" target="_blank"><span class="sc-gUDIDV jYfzbt">CRLBF</span></a></div><div class="sc-dVraiA dDLddz ticker-box-wrapper"><a aria-label="Go to Quote Page for CURLF" rel="dofollow" class="items-end ticker-link-wrapper inline-flex" href="/quote/curlf" target="_blank"><span class="sc-gUDIDV jYfzbt">CURLF</span></a></div><div class="sc-dVraiA dDLddz ticker-box-wrapper"><a aria-label="Go to Quote Page for GTBIF" rel="dofollow" class="items-end ticker-link-wrapper inline-flex" href="/quote/gtbif" target="_blank"><span class="sc-gUDIDV jYfzbt">GTBIF</span></a></div><div class="sc-hwTdGM hBTmYJ"><div class="other-tickers-label">2 others</div><div class="other-tickers"><div><div class="sc-dVraiA dDLddz ticker-box-wrapper"><a aria-label="Go to Quote Page for TCNNF" rel="dofollow" class="items-end ticker-link-wrapper inline-flex" href="/quote/tcnnf" target="_blank"><span class="sc-gUDIDV jYfzbt">TCNNF</span></a></div></div><div><div class="sc-dVraiA dDLddz ticker-box-wrapper"><a aria-label="Go to Quote Page for VRNOF" rel="dofollow" class="items-end ticker-link-wrapper inline-flex" href="/quote/vrnof" target="_blank"><span class="sc-gUDIDV jYfzbt">VRNOF</span></a></div></div></div></div></div></div></div><div class="sc-hmzteu ddclwE news-block primary"><div class="news-block-headline"><div class="flex"><div><a data-action="Article Click" href="/general/market-summary/24/11/42146751/jupiters-burnout-can-tilt-holdings-reverse-its-five-year-vape-decline"><div class="sc-ceLTrZ bjJtVr article-title"><span>Jupiter's Burnout: Can TILT Holdings Reverse Its Five-Year Vape Decline?</span></div></a><div><div class="flex items-center"><div class="sc-ekaoJE fACrUT"></div></div></div></div></div></div><div class="sc-bUsiPH gNYhnT ticker-list"><div class="ticker-list-container"><div class="sc-dVraiA dDLddz ticker-box-wrapper"><a aria-label="Go to Quote Page for TLLTF" rel="dofollow" class="items-end ticker-link-wrapper inline-flex" href="/quote/tlltf" target="_blank"><span class="sc-gUDIDV jYfzbt">TLLTF</span></a></div></div></div></div><div class="sc-hmzteu ddclwE news-block primary"><div class="news-block-headline"><div class="flex"><div><a data-action="Article Click" href="/general/market-summary/24/11/42100955/the-u-s-cannabis-strategy-no-ones-talking-about-inside-canopys-300m-plan"><div class="sc-ceLTrZ bjJtVr article-title"><span>The U.S. Cannabis Strategy No One's Talking About: Inside Canopy's $300M Plan</span></div></a><div><div class="flex items-center"><div class="sc-ekaoJE fACrUT"></div></div></div></div></div></div><div class="sc-bUsiPH gNYhnT ticker-list"><div class="ticker-list-container"><div class="sc-dVraiA dDLddz ticker-box-wrapper"><a aria-label="Go to Quote Page for CGC" rel="dofollow" class="items-end ticker-link-wrapper inline-flex" href="/quote/cgc" target="_blank"><span class="sc-gUDIDV jYfzbt">CGC</span></a></div><div class="sc-dVraiA dDLddz ticker-box-wrapper"><a aria-label="Go to Quote Page for TSNDF" rel="dofollow" class="items-end ticker-link-wrapper inline-flex" href="/quote/tsndf" target="_blank"><span class="sc-gUDIDV jYfzbt">TSNDF</span></a></div></div></div></div></div></div></div></div></div></div><div style="display:inline"> <style> .page-header-container .header-wrapper { display: inline-flex; } .page-header-container { text-align: center; } </style> </div><p></p></div></div><div><div class="sc-cSxRuM dbntgF layout-sidebar flex-none justify-between"><div class="lazyload-wrapper "><div class="lazyload-placeholder"></div></div></div></div></div></div></div></div></div><div class="footer"><div class="footer-top-section"><div class="benzinga-links-section"><div class="logo-and-socials-wrapper"><span class="sc-hiTDLB hSWwyX benzinga-logo light presentation"><svg height="100%" role="img" viewBox="0 0 471.1 63.8" width="100%" xmlns="http://www.w3.org/2000/svg"><path d="M67.7 63.8h45.2V51.9H81.4V37.3h26.1V25.4H81.4V11.9h31.7V0H67.7zm99.6-23.6L137.7 0h-20.4l6.4 8.1V64h13.6V22.1l30.6 41.7H181V0h-13.7zM47.1 31c6-1.1 11-6.7 11-14.6C58.1 7.9 51.9 0 39.6 0H0l6.2 7.9v56H41c12.3 0 18.7-7.7 18.7-17.3-.3-7.9-5.7-14.7-12.6-15.6zM19.8 12h17.1c4.6 0 7.5 2.7 7.5 6.7s-2.9 6.7-7.5 6.7H19.8V12zm17.7 40H19.8V37.3h17.7c5.2 0 8.1 3.3 8.1 7.3 0 4.6-3.1 7.3-8.1 7.4zm343.3-11.8h7.1v7.5c-3.7 3-8.3 4.7-13.1 4.8-11.4 0-19.4-8.7-19.4-20.4s8.1-20.4 19.4-20.4c5.9 0 11.4 3.1 14.6 8.1l10.8-6C395.6 6.5 387.5 0 374.7 0c-18.1 0-33.1 12.5-33.1 31.9s14.8 31.9 33.1 31.9c10 .2 19.5-4.1 26.1-11.5V28.7h-29.2l9.2 11.5zm-61.5 0L289.6 0h-20.3l6.3 8.1V64h13.7V22.1l30.6 41.7h13V0h-13.6zM446 0h-26.3l6.3 8.1-1.1 3.1L404.5 64h15.4l4-10.8h27.5l4 10.8h15.4L446 0zm-18.6 41.2l10-27.5 10 27.5h-20zM247.7 0h13.7v64.1h-13.7zm-10.9 11V0h-48.1v11.9h30.2l-30.2 41v10.9h48.6V51.9h-30.9z" fill="#FFFFFF"></path></svg></span><div class="social-sites-list"><a aria-label="Click to check out Benzinga's facebook" class="sc-gHWSBU ggmtMZ facebook" color="#3b5998" href="https://web.facebook.com/Benzinga/?_rdc=1&_rdr" target="_blank"><div><svg aria-hidden="true" class="leading-none" stroke="currentColor" stroke-width="1" style="height:1em;width:1em" viewBox="0 0 448 512" xmlns="http://www.w3.org/2000/svg"><path d="M64 32C28.7 32 0 60.7 0 96V416c0 35.3 28.7 64 64 64h98.2V334.2H109.4V256h52.8V222.3c0-87.1 39.4-127.5 125-127.5c16.2 0 44.2 3.2 55.7 6.4V172c-6-.6-16.5-1-29.6-1c-42 0-58.2 15.9-58.2 57.2V256h83.6l-14.4 78.2H255V480H384c35.3 0 64-28.7 64-64V96c0-35.3-28.7-64-64-64H64z" fill="currentColor"></path></svg></div></a><a aria-label="Click to check out Benzinga's instagram" class="sc-gHWSBU efaIqf instagram" color="#e1306c" href="https://www.instagram.com/benzinga/?hl=en" target="_blank"><div><svg aria-hidden="true" class="leading-none" stroke="currentColor" stroke-width="1" style="height:1em;width:1em" viewBox="0 0 448 512" xmlns="http://www.w3.org/2000/svg"><path d="M224.1 141c-63.6 0-114.9 51.3-114.9 114.9s51.3 114.9 114.9 114.9S339 319.5 339 255.9 287.7 141 224.1 141zm0 189.6c-41.1 0-74.7-33.5-74.7-74.7s33.5-74.7 74.7-74.7 74.7 33.5 74.7 74.7-33.6 74.7-74.7 74.7zm146.4-194.3c0 14.9-12 26.8-26.8 26.8-14.9 0-26.8-12-26.8-26.8s12-26.8 26.8-26.8 26.8 12 26.8 26.8zm76.1 27.2c-1.7-35.9-9.9-67.7-36.2-93.9-26.2-26.2-58-34.4-93.9-36.2-37-2.1-147.9-2.1-184.9 0-35.8 1.7-67.6 9.9-93.9 36.1s-34.4 58-36.2 93.9c-2.1 37-2.1 147.9 0 184.9 1.7 35.9 9.9 67.7 36.2 93.9s58 34.4 93.9 36.2c37 2.1 147.9 2.1 184.9 0 35.9-1.7 67.7-9.9 93.9-36.2 26.2-26.2 34.4-58 36.2-93.9 2.1-37 2.1-147.8 0-184.8zM398.8 388c-7.8 19.6-22.9 34.7-42.6 42.6-29.5 11.7-99.5 9-132.1 9s-102.7 2.6-132.1-9c-19.6-7.8-34.7-22.9-42.6-42.6-11.7-29.5-9-99.5-9-132.1s-2.6-102.7 9-132.1c7.8-19.6 22.9-34.7 42.6-42.6 29.5-11.7 99.5-9 132.1-9s102.7-2.6 132.1 9c19.6 7.8 34.7 22.9 42.6 42.6 11.7 29.5 9 99.5 9 132.1s2.7 102.7-9 132.1z" fill="currentColor"></path></svg></div></a><a aria-label="Click to check out Benzinga's linkedin" class="sc-gHWSBU hErREj linkedin" color="#0072b1" href="https://www.linkedin.com/company/benzinga" target="_blank"><div><svg aria-hidden="true" class="leading-none" stroke="currentColor" stroke-width="1" style="height:1em;width:1em" viewBox="0 0 448 512" xmlns="http://www.w3.org/2000/svg"><path d="M416 32H31.9C14.3 32 0 46.5 0 64.3v383.4C0 465.5 14.3 480 31.9 480H416c17.6 0 32-14.5 32-32.3V64.3c0-17.8-14.4-32.3-32-32.3zM135.4 416H69V202.2h66.5V416zm-33.2-243c-21.3 0-38.5-17.3-38.5-38.5S80.9 96 102.2 96c21.2 0 38.5 17.3 38.5 38.5 0 21.3-17.2 38.5-38.5 38.5zm282.1 243h-66.4V312c0-24.8-.5-56.7-34.5-56.7-34.6 0-39.9 27-39.9 54.9V416h-66.4V202.2h63.7v29.2h.9c8.9-16.8 30.6-34.5 62.9-34.5 67.2 0 79.7 44.3 79.7 101.9V416z" fill="currentColor"></path></svg></div></a><a aria-label="Click to check out Benzinga's soundcloud" class="sc-gHWSBU cwvTpL soundcloud" color="#fe5000" href="https://soundcloud.com/bztv" target="_blank"><div><svg aria-hidden="true" class="leading-none" stroke="currentColor" stroke-width="1" style="height:1em;width:1em" viewBox="0 0 640 512" xmlns="http://www.w3.org/2000/svg"><path d="M111.4 256.3l5.8 65-5.8 68.3c-.3 2.5-2.2 4.4-4.4 4.4s-4.2-1.9-4.2-4.4l-5.6-68.3 5.6-65c0-2.2 1.9-4.2 4.2-4.2 2.2 0 4.1 2 4.4 4.2zm21.4-45.6c-2.8 0-4.7 2.2-5 5l-5 105.6 5 68.3c.3 2.8 2.2 5 5 5 2.5 0 4.7-2.2 4.7-5l5.8-68.3-5.8-105.6c0-2.8-2.2-5-4.7-5zm25.5-24.1c-3.1 0-5.3 2.2-5.6 5.3l-4.4 130 4.4 67.8c.3 3.1 2.5 5.3 5.6 5.3 2.8 0 5.3-2.2 5.3-5.3l5.3-67.8-5.3-130c0-3.1-2.5-5.3-5.3-5.3zM7.2 283.2c-1.4 0-2.2 1.1-2.5 2.5L0 321.3l4.7 35c.3 1.4 1.1 2.5 2.5 2.5s2.2-1.1 2.5-2.5l5.6-35-5.6-35.6c-.3-1.4-1.1-2.5-2.5-2.5zm23.6-21.9c-1.4 0-2.5 1.1-2.5 2.5l-6.4 57.5 6.4 56.1c0 1.7 1.1 2.8 2.5 2.8s2.5-1.1 2.8-2.5l7.2-56.4-7.2-57.5c-.3-1.4-1.4-2.5-2.8-2.5zm25.3-11.4c-1.7 0-3.1 1.4-3.3 3.3L47 321.3l5.8 65.8c.3 1.7 1.7 3.1 3.3 3.1 1.7 0 3.1-1.4 3.1-3.1l6.9-65.8-6.9-68.1c0-1.9-1.4-3.3-3.1-3.3zm25.3-2.2c-1.9 0-3.6 1.4-3.6 3.6l-5.8 70 5.8 67.8c0 2.2 1.7 3.6 3.6 3.6s3.6-1.4 3.9-3.6l6.4-67.8-6.4-70c-.3-2.2-2-3.6-3.9-3.6zm241.4-110.9c-1.1-.8-2.8-1.4-4.2-1.4-2.2 0-4.2.8-5.6 1.9-1.9 1.7-3.1 4.2-3.3 6.7v.8l-3.3 176.7 1.7 32.5 1.7 31.7c.3 4.7 4.2 8.6 8.9 8.6s8.6-3.9 8.6-8.6l3.9-64.2-3.9-177.5c-.4-3-2-5.8-4.5-7.2zm-26.7 15.3c-1.4-.8-2.8-1.4-4.4-1.4s-3.1.6-4.4 1.4c-2.2 1.4-3.6 3.9-3.6 6.7l-.3 1.7-2.8 160.8s0 .3 3.1 65.6v.3c0 1.7.6 3.3 1.7 4.7 1.7 1.9 3.9 3.1 6.4 3.1 2.2 0 4.2-1.1 5.6-2.5 1.7-1.4 2.5-3.3 2.5-5.6l.3-6.7 3.1-58.6-3.3-162.8c-.3-2.8-1.7-5.3-3.9-6.7zm-111.4 22.5c-3.1 0-5.8 2.8-5.8 6.1l-4.4 140.6 4.4 67.2c.3 3.3 2.8 5.8 5.8 5.8 3.3 0 5.8-2.5 6.1-5.8l5-67.2-5-140.6c-.2-3.3-2.7-6.1-6.1-6.1zm376.7 62.8c-10.8 0-21.1 2.2-30.6 6.1-6.4-70.8-65.8-126.4-138.3-126.4-17.8 0-35 3.3-50.3 9.4-6.1 2.2-7.8 4.4-7.8 9.2v249.7c0 5 3.9 8.6 8.6 9.2h218.3c43.3 0 78.6-35 78.6-78.3.1-43.6-35.2-78.9-78.5-78.9zm-296.7-60.3c-4.2 0-7.5 3.3-7.8 7.8l-3.3 136.7 3.3 65.6c.3 4.2 3.6 7.5 7.8 7.5 4.2 0 7.5-3.3 7.5-7.5l3.9-65.6-3.9-136.7c-.3-4.5-3.3-7.8-7.5-7.8zm-53.6-7.8c-3.3 0-6.4 3.1-6.4 6.7l-3.9 145.3 3.9 66.9c.3 3.6 3.1 6.4 6.4 6.4 3.6 0 6.4-2.8 6.7-6.4l4.4-66.9-4.4-145.3c-.3-3.6-3.1-6.7-6.7-6.7zm26.7 3.4c-3.9 0-6.9 3.1-6.9 6.9L227 321.3l3.9 66.4c.3 3.9 3.1 6.9 6.9 6.9s6.9-3.1 6.9-6.9l4.2-66.4-4.2-141.7c0-3.9-3-6.9-6.9-6.9z" fill="currentColor"></path></svg></div></a><a aria-label="Click to check out Benzinga's twitter" class="sc-gHWSBU cwwMnJ twitter" color="#000000" href="https://twitter.com/benzinga" target="_blank"><div><svg aria-hidden="true" class="leading-none" stroke="currentColor" stroke-width="1" style="height:1em;width:1em" viewBox="0 0 448 512" xmlns="http://www.w3.org/2000/svg"><path d="M64 32C28.7 32 0 60.7 0 96V416c0 35.3 28.7 64 64 64H384c35.3 0 64-28.7 64-64V96c0-35.3-28.7-64-64-64H64zm297.1 84L257.3 234.6 379.4 396H283.8L209 298.1 123.3 396H75.8l111-126.9L69.7 116h98l67.7 89.5L313.6 116h47.5zM323.3 367.6L153.4 142.9H125.1L296.9 367.6h26.3z" fill="currentColor"></path></svg></div></a><a aria-label="Click to check out Benzinga's youtube" class="sc-gHWSBU ikwCNR youtube" color="red" href="https://www.youtube.com/benzinga" target="_blank"><div><svg aria-hidden="true" class="leading-none" stroke="currentColor" stroke-width="1" style="height:1em;width:1em" viewBox="0 0 576 512" xmlns="http://www.w3.org/2000/svg"><path d="M549.655 124.083c-6.281-23.65-24.787-42.276-48.284-48.597C458.781 64 288 64 288 64S117.22 64 74.629 75.486c-23.497 6.322-42.003 24.947-48.284 48.597-11.412 42.867-11.412 132.305-11.412 132.305s0 89.438 11.412 132.305c6.281 23.65 24.787 41.5 48.284 47.821C117.22 448 288 448 288 448s170.78 0 213.371-11.486c23.497-6.321 42.003-24.171 48.284-47.821 11.412-42.867 11.412-132.305 11.412-132.305s0-89.438-11.412-132.305zm-317.51 213.508V175.185l142.739 81.205-142.739 81.201z" fill="currentColor"></path></svg></div></a></div></div><div class="app-store-wrapper"><a aria-label="Click to download the Benzinga app" class="sc-cmfnrN cIhrRX google-play-store-button-wrapper button-wrapper" data-action="Download on Google Play Store Click" href="https://play.google.com/store/apps/details?id=com.benzinga.app&hl=en_NZ&gl=US"><svg clip-rule="evenodd" fill-rule="evenodd" height="39px" stroke-linejoin="round" stroke-miterlimit="2" viewBox="0 0 120 36" width="130px" xmlns="http://www.w3.org/2000/svg"><path d="M2863.6 530.6c-36.3 0-66.9-12.7-91.1-37.7-24-24.3-37.4-57.8-36.8-92 0-36.5 12.4-67.4 36.8-91.9 24.1-25 54.7-37.7 91-37.7 35.9 0 66.5 12.7 91.1 37.7 24.4 25.3 36.8 56.2 36.8 91.9-.4 36.6-12.8 67.5-36.8 91.9-24.1 25.2-54.7 37.8-91 37.8zm-1080.1 0c-35.5 0-66.3-12.5-91.5-37.2-25-24.6-37.7-55.7-37.7-92.4s12.7-67.8 37.7-92.4c24.7-24.7 55.5-37.2 91.5-37.2a127.533 127.533 0 0151.1 10.6c16.1 6.9 29.2 16.3 38.9 27.8l2.4 2.9-27.1 26.6-2.8-3.3c-15.3-18.2-35.8-27.1-62.9-27.1-24.2 0-45.3 8.6-62.7 25.6-17.5 17.1-26.4 39.5-26.4 66.6 0 27.1 8.9 49.5 26.4 66.6 17.4 17 38.5 25.6 62.7 25.6 25.8 0 47.5-8.6 64.4-25.6 10-10 16.2-24 18.4-41.7H1779v-37.4h124.2l.5 3.4c.9 6.3 1.8 12.8 1.8 18.8 0 34.5-10.4 62.4-31 83-23.4 24.4-54 36.8-91 36.8zm1436.1-5.3h-38.3L3064 337.6l1 33.8v153.8h-38.3V276.7h43.7l1.2 1.9 110.3 176.8-1-33.7v-145h38.7v248.6zm-643.8 0H2537V314.1h-67.3v-37.4H2643v37.4h-67.3v211.2h.1zm-137.7 0h-38.7V276.7h38.7v248.6zm-217.5 0h-38.7V314.1h-67.3v-37.4h173.3v37.4h-67.3v211.2zm-130.5-.4h-148.4V276.7h148.4v37.4h-109.6v68.2h98.9v37h-98.9v68.2h109.6v37.4zm710.8-57.7c17.3 17.3 38.3 26 62.7 26 25.1 0 45.6-8.5 62.7-26 17-17 25.6-39.3 25.6-66.2 0-26.9-8.6-49.3-25.5-66.2-17.3-17.3-38.4-26-62.7-26-25.1 0-45.6 8.5-62.6 26-17 17-25.6 39.3-25.6 66.2 0 26.9 8.5 49.3 25.4 66.2zM2732.1 872.4c-94.5 0-171.1 71.7-171.1 170.6 0 98 77.1 170.6 171.1 170.6 94.5 0 171.1-72.2 171.1-170.6 0-98.9-76.6-170.6-171.1-170.6zm0 273.6c-51.7 0-96.2-42.8-96.2-103.4 0-61.5 44.6-103.4 96.2-103.4 51.7 0 96.2 41.9 96.2 103.4.1 61-44.5 103.4-96.2 103.4zm-373.3-273.6c-94.5 0-171.1 71.7-171.1 170.6 0 98 77.1 170.6 171.1 170.6 94.5 0 171.1-72.2 171.1-170.6 0-98.9-76.7-170.6-171.1-170.6zm0 273.6c-51.7 0-96.2-42.8-96.2-103.4 0-61.5 44.6-103.4 96.2-103.4 51.7 0 96.2 41.9 96.2 103.4 0 61-44.5 103.4-96.2 103.4zm-444.2-221.5v72.2h173.3c-5.3 40.5-18.7 70.4-39.2 90.9-25.4 25.4-64.6 53-133.7 53-106.5 0-189.8-86-189.8-192.5s83.3-192.5 189.8-192.5c57.5 0 99.4 22.7 130.5 51.7l51.2-51.2c-43.2-41.4-100.7-73.1-181.3-73.1-146.1 0-268.7 119-268.7 264.7 0 146.1 122.5 264.7 268.7 264.7 78.9 0 138.1-25.8 184.9-74.4 47.7-47.7 62.8-115 62.8-169.3 0-16.9-1.3-32.1-4-45h-244.6c.1-.1.1.8.1.8zm1816.9 56.2C3717.2 942.4 3674 872 3585.4 872c-87.8 0-160.8 69.1-160.8 170.6 0 95.8 72.2 170.6 169.3 170.6 78 0 123.4-47.7 142.1-75.7l-57.9-38.8c-19.2 28.5-45.9 47.2-83.8 47.2-38.3 0-65.1-17.4-82.9-51.7l228.1-94.5c0 .1-8-19-8-19zm-232.6 57c-1.8-65.9 51.2-99.4 89.1-99.4 29.9 0 54.8 14.7 63.3 36.1l-152.4 63.3zM3313.6 1203h74.9V701.8h-74.9V1203zm-123-292.7h-2.7c-16.9-20.1-49-38.3-90-38.3-85.1 0-163.5 74.9-163.5 171.1 0 95.8 78 169.8 163.5 169.8 40.5 0 73.1-18.3 90-38.8h2.7v24.5c0 65.1-34.8 100.2-90.9 100.2-45.9 0-74.4-33-86-60.6l-65.1 27.2c18.7 45 68.6 100.7 151 100.7 87.8 0 162.2-51.7 162.2-177.8V882.2H3191v28.1h-.4zm-86 235.7c-51.7 0-94.9-43.2-94.9-102.9 0-60.2 43.2-103.8 94.9-103.8 51.2 0 90.9 44.1 90.9 103.8.5 59.7-39.6 102.9-90.9 102.9zm977.6-444.2h-179.1V1203h74.9v-189.8h104.3c82.9 0 164.4-60.1 164.4-155.5s-81.2-155.9-164.5-155.9zm2.2 241.4h-106.5v-172h106.5c56.1 0 87.8 46.3 87.8 86 0 39.3-32.1 86-87.8 86zm462.5-71.7c-54.4 0-110.5 24.1-133.7 76.6l66.4 27.6c14.3-27.6 40.5-37 68.2-37 38.8 0 78 23.2 78.9 64.6v5.3c-13.4-7.6-42.8-19.2-78-19.2-71.7 0-144.4 39.2-144.4 112.7 0 67.3 58.8 110.5 124.3 110.5 50.3 0 78-22.7 95.3-49h2.7v38.8h72.2v-192c0-89.4-66.4-138.9-151.9-138.9zm-9.4 274.5c-24.5 0-58.8-12-58.8-42.8 0-38.8 42.8-53.5 79.3-53.5 33 0 48.6 7.1 68.2 16.9-5.4 45-43.4 79-88.7 79.4zm424.7-263.8l-86 217.4h-2.7l-89.1-217.4h-80.6l133.7 303.9-76.2 168.9h78L5045 882.2h-82.8zM4288 1203h74.9V701.8H4288V1203zM418.4 302.1c-11.6 12.5-18.3 31.6-18.3 56.6v886.7c0 25 6.7 44.1 18.7 56.1l3.1 2.7 496.8-496.8v-11.1L421.5 299.4l-3.1 2.7z" fill="#0C2140" fill-rule="nonzero" transform="scale(.02208)"></path><path d="M1084 973.5L918.3 807.8v-11.6L1084 630.5l3.6 2.2 196 111.4c56.1 31.6 56.1 83.8 0 115.8l-196 111.4-3.6 2.2z" fill="#0C2140" fill-rule="nonzero" transform="scale(.02208)"></path><path d="M1087.6 971.3L918.3 802l-499.9 499.9c18.3 19.6 49 21.8 83.3 2.7l585.9-333.3M1087.6 632.7L501.7 299.9c-34.3-19.6-65.1-16.9-83.3 2.7L918.3 802l169.3-169.3z" fill="#0C2140" fill-rule="nonzero" transform="scale(.02208)"></path></svg></a><a aria-label="Click to download the Benzinga app" class="sc-cmfnrN cIhrRX apple-app-store-button-wrapper button-wrapper" data-action="Download on Apple App Store Click" href="https://apps.apple.com/us/app/benzinga-stock-news-tracker/id688949481"><svg fill="#0c2140" height="43.3px" stroke-linejoin="round" stroke-miterlimit="2" viewBox="0 0 120 40" width="130px" xmlns="http://www.w3.org/2000/svg"><path d="M24.997 19.889a5.15 5.15 0 012.45-4.317 5.27 5.27 0 00-4.15-2.244c-1.746-.183-3.439 1.045-4.329 1.045-.907 0-2.277-1.027-3.753-.997a5.534 5.534 0 00-4.651 2.837c-2.011 3.482-.511 8.6 1.416 11.414.963 1.378 2.09 2.918 3.564 2.863 1.442-.06 1.981-.919 3.722-.919 1.725 0 2.231.919 3.734.885 1.548-.026 2.523-1.385 3.453-2.776a11.366 11.366 0 001.579-3.216 4.98 4.98 0 01-3.035-4.575zm-2.841-8.412a5.066 5.066 0 001.159-3.63 5.153 5.153 0 00-3.335 1.726 4.82 4.82 0 00-1.19 3.495 4.265 4.265 0 003.366-1.591zM42.302 27.14h-4.734l-1.136 3.356h-2.005l4.483-12.418h2.083l4.484 12.418h-2.039l-1.136-3.356zm-4.243-1.549h3.752l-1.85-5.447h-.052l-1.85 5.447zm17.1.379c0 2.813-1.506 4.621-3.778 4.621a3.076 3.076 0 01-2.849-1.584h-.043v4.484h-1.858V21.442h1.799v1.506h.034a3.216 3.216 0 012.883-1.6c2.298 0 3.812 1.816 3.812 4.622zm-1.91 0c0-1.833-.947-3.038-2.393-3.038-1.419 0-2.375 1.23-2.375 3.038 0 1.824.956 3.046 2.375 3.046 1.446 0 2.393-1.197 2.393-3.046zm11.876 0c0 2.813-1.507 4.621-3.779 4.621a3.076 3.076 0 01-2.849-1.584h-.043v4.484h-1.858V21.442h1.799v1.506h.034a3.216 3.216 0 012.883-1.6c2.297 0 3.813 1.816 3.813 4.622zm-1.911 0c0-1.833-.947-3.038-2.393-3.038-1.42 0-2.375 1.23-2.375 3.038 0 1.824.955 3.046 2.375 3.046 1.446 0 2.393-1.197 2.393-3.046zm8.495 1.066c.138 1.232 1.334 2.04 2.969 2.04 1.567 0 2.694-.808 2.694-1.919 0-.964-.68-1.541-2.289-1.936l-1.61-.388c-2.28-.551-3.339-1.617-3.339-3.348 0-2.142 1.867-3.614 4.518-3.614 2.625 0 4.424 1.472 4.484 3.614H77.26c-.112-1.239-1.136-1.987-2.634-1.987s-2.521.757-2.521 1.858c0 .878.654 1.395 2.255 1.79l1.368.336c2.548.603 3.605 1.626 3.605 3.443 0 2.323-1.849 3.778-4.793 3.778-2.753 0-4.613-1.421-4.733-3.667h1.902zM83.346 19.3v2.142h1.722v1.472h-1.722v4.991c0 .776.345 1.137 1.102 1.137.204-.004.408-.018.611-.043v1.463c-.34.063-.686.092-1.032.086-1.833 0-2.548-.689-2.548-2.445v-5.189h-1.316v-1.472h1.316V19.3h1.867zm2.718 6.67c0-2.849 1.678-4.639 4.294-4.639 2.625 0 4.295 1.79 4.295 4.639 0 2.856-1.661 4.638-4.295 4.638s-4.294-1.782-4.294-4.638zm6.695 0c0-1.954-.895-3.108-2.401-3.108s-2.401 1.162-2.401 3.108c0 1.962.895 3.106 2.401 3.106s2.401-1.144 2.401-3.106zm3.426-4.528h1.773v1.541h.043a2.164 2.164 0 012.177-1.635c.214-.001.428.022.637.069v1.738a2.62 2.62 0 00-.835-.112l-.076-.002a1.883 1.883 0 00-1.873 1.873 1.87 1.87 0 00.012.212v5.37h-1.858v-9.054zm13.198 6.395c-.25 1.643-1.85 2.771-3.898 2.771-2.634 0-4.269-1.764-4.269-4.595 0-2.84 1.644-4.682 4.191-4.682 2.505 0 4.08 1.721 4.08 4.466v.637h-6.395v.112l-.009.208a2.37 2.37 0 002.358 2.358l.087-.002a2.05 2.05 0 002.091-1.273h1.764zm-6.282-2.702h4.526l.004-.121a2.19 2.19 0 00-2.177-2.178l-.047.001a2.306 2.306 0 00-2.306 2.292v.006zM37.826 8.731l.189-.007a2.653 2.653 0 012.64 2.64 2.63 2.63 0 01-.021.332c0 1.906-1.03 3.002-2.808 3.002h-2.155V8.731h2.155zm-1.228 5.123h1.125l.112.003a1.884 1.884 0 001.875-1.876 1.79 1.79 0 00-.02-.273c.012-.085.018-.17.018-.256a1.89 1.89 0 00-1.881-1.881l-.104.003h-1.125v4.28zm5.083-1.41a2.143 2.143 0 012.123-2.336c1.17 0 2.133.963 2.133 2.133l-.009.203.01.207c0 1.171-.963 2.134-2.134 2.134s-2.133-.963-2.133-2.134l.01-.207zm3.333 0c0-.976-.439-1.547-1.208-1.547s-1.207.571-1.207 1.547c0 .984.434 1.551 1.207 1.551s1.208-.571 1.208-1.551zm6.559 2.254h-.922l-.93-3.317h-.071l-.926 3.317h-.913l-1.242-4.503h.902l.806 3.436h.067l.926-3.436h.852l.926 3.436h.07l.803-3.436h.889l-1.237 4.503zm2.281-4.503h.855v.715h.066a1.35 1.35 0 011.344-.802l.11-.004a1.472 1.472 0 011.449 1.679v2.915h-.889v-2.692c0-.724-.314-1.084-.972-1.084l-.048-.001a1.04 1.04 0 00-1.033 1.033.98.98 0 00.006.109v2.635h-.888v-4.503zm5.24-1.758h.889v6.261h-.889zm2.124 4.007a2.144 2.144 0 012.124-2.336c1.171 0 2.133.963 2.133 2.133l-.01.203a2.05 2.05 0 01.01.207c0 1.17-.963 2.134-2.133 2.134s-2.134-.964-2.134-2.134l.01-.207zm3.333 0c0-.976-.439-1.547-1.208-1.547s-1.207.571-1.207 1.547c0 .984.434 1.551 1.207 1.551s1.208-.571 1.208-1.551zm1.85.98c0-.81.603-1.278 1.675-1.344l1.219-.07v-.389c0-.475-.314-.744-.921-.744-.497 0-.84.182-.939.5h-.86c.091-.773.818-1.269 1.84-1.269 1.128 0 1.765.562 1.765 1.513v3.077h-.855v-.633h-.071a1.52 1.52 0 01-1.352.707 1.33 1.33 0 01-.141.007c-.744 0-1.357-.61-1.36-1.355zm2.894-.384v-.377l-1.099.07c-.62.042-.902.253-.902.65 0 .405.352.641.835.641a.97.97 0 00.107.005c.556 0 1.022-.435 1.059-.989zm2.053-.596c0-1.423.732-2.324 1.869-2.324a1.486 1.486 0 011.381.79h.067V8.437h.888v6.261h-.851v-.712h-.071a1.565 1.565 0 01-1.414.786c-1.145 0-1.869-.901-1.869-2.328zm.918 0c0 .955.45 1.53 1.203 1.53s1.212-.583 1.212-1.526-.468-1.53-1.212-1.53-1.203.579-1.203 1.526zm6.964 0l-.01-.203c0-1.17.963-2.133 2.134-2.133s2.133.963 2.133 2.133l-.01.203a2.05 2.05 0 01.01.207c0 1.171-.963 2.134-2.133 2.134s-2.134-.963-2.134-2.134l.01-.207zm3.333 0c0-.976-.438-1.547-1.208-1.547s-1.207.571-1.207 1.547c0 .984.435 1.551 1.207 1.551s1.208-.571 1.208-1.551zm2.106-2.249h.856v.715h.066a1.35 1.35 0 011.344-.802l.11-.004a1.47 1.47 0 011.464 1.464c0 .072-.005.144-.015.215v2.915h-.889v-2.692c0-.724-.314-1.084-.972-1.084l-.048-.001a1.04 1.04 0 00-1.033 1.033.98.98 0 00.006.109v2.635h-.889v-4.503zm8.846-1.121v1.141h.976v.749h-.976v2.315c0 .472.194.679.637.679.113-.001.226-.008.339-.021v.74c-.16.029-.322.044-.484.046-.988 0-1.381-.348-1.381-1.216v-2.543h-.715v-.749h.715V9.074h.889zm2.19-.637h.88v2.481h.071c.241-.53.792-.853 1.373-.806l.08-.002a1.49 1.49 0 011.484 1.483c0 .066-.005.132-.013.198v2.907h-.89V12.01c0-.719-.335-1.084-.963-1.084l-.086-.003a1.06 1.06 0 00-1.052 1.052l.004.093v2.63h-.888V8.437zm9.056 5.045a1.833 1.833 0 01-1.951 1.303h-.054a2.055 2.055 0 01-2.026-2.325 2.086 2.086 0 012.058-2.352c1.271 0 2.027.856 2.027 2.27v.31h-3.18v.05a1.1 1.1 0 00-.004.1c0 .653.537 1.19 1.19 1.19a1.09 1.09 0 001.085-.546h.855zm-3.126-1.451h2.275l.003-.081c0-.596-.491-1.086-1.087-1.086h-.025a1.16 1.16 0 00-1.166 1.152v.015z"></path></svg></a></div></div><div class="sc-EFWon hMLEoT footer-row"><div class="sc-fYlSAf cbhZCu"><h3>Popular Channels</h3><ul><li class="sc-ejCKsa gTjEzu footer-link"><a href="https://www.benzinga.com/premarket-prep/" class="sc-ldgOGP gHhitR">PreMarket Prep</a></li><li class="sc-ejCKsa gTjEzu footer-link"><a href="https://www.benzinga.com/pressreleases" class="sc-ldgOGP gHhitR">Press Releases</a></li><li class="sc-ejCKsa gTjEzu footer-link"><a href="https://www.benzinga.com/analyst-stock-ratings" class="sc-ldgOGP gHhitR">Analyst Ratings</a></li><li class="sc-ejCKsa gTjEzu footer-link"><a href="https://www.benzinga.com/news" class="sc-ldgOGP gHhitR">News</a></li><li class="sc-ejCKsa gTjEzu footer-link"><a href="https://www.benzinga.com/markets/options" class="sc-ldgOGP gHhitR">Options</a></li><li class="sc-ejCKsa gTjEzu footer-link"><a href="https://www.benzinga.com/etfs" class="sc-ldgOGP gHhitR">ETFs</a></li></ul></div><div class="sc-fYlSAf cbhZCu"><h3>Tools & Features</h3><ul><li class="sc-ejCKsa gTjEzu footer-link"><a href="https://pro.benzinga.com/" class="sc-ldgOGP gHhitR">Real Time Feed</a></li><li class="sc-ejCKsa gTjEzu footer-link"><a href="https://www.benzinga.com/feeds/list" class="sc-ldgOGP gHhitR">Public RSS Feeds</a></li><li class="sc-ejCKsa gTjEzu footer-link"><a href="https://www.benzinga.com/contact" class="sc-ldgOGP gHhitR">Submit News Tips</a></li><li class="sc-ejCKsa gTjEzu footer-link"><a href="https://pro.benzinga.com/blog/" class="sc-ldgOGP gHhitR">Blog</a></li><li class="sc-ejCKsa gTjEzu footer-link"><a href="https://www.benzinga.com/widgets" class="sc-ldgOGP gHhitR">Embeddable Finance Widgets & Tools</a></li><li class="sc-ejCKsa gTjEzu footer-link"><a href="https://www.benzinga.com/catalyst" class="sc-ldgOGP gHhitR">Benzinga Catalyst</a></li></ul></div><div class="sc-fYlSAf cbhZCu"><h3>Partners & Contributors</h3><ul><li class="sc-ejCKsa gTjEzu footer-link"><a href="https://app.impact.com/campaign-promo-signup/Benzinga1659111587301.brand?execution=e1s1" class="sc-ldgOGP gHhitR">Affiliate Program</a></li><li class="sc-ejCKsa gTjEzu footer-link"><a href="https://contributor.benzinga.com/contributor-onboarding" class="sc-ldgOGP gHhitR">Contributor Portal</a></li><li class="sc-ejCKsa gTjEzu footer-link"><a href="https://www.benzinga.com/apis/" class="sc-ldgOGP gHhitR">Licensing & Syndication</a></li><li class="sc-ejCKsa gTjEzu footer-link"><a href="https://www.benzinga.com/reach/" class="sc-ldgOGP gHhitR">Sponsored Content</a></li><li class="sc-ejCKsa gTjEzu footer-link"><a href="https://advertise.benzinga.com/" class="sc-ldgOGP gHhitR">Advertise With Us</a></li><li class="sc-ejCKsa gTjEzu footer-link"><a href="https://www.benzinga.com/contact/" class="sc-ldgOGP gHhitR">Lead Generation & SEO</a></li></ul></div><div class="sc-fYlSAf cbhZCu"><h3>About Benzinga</h3><ul><li class="sc-ejCKsa gTjEzu footer-link"><a href="https://www.benzinga.com/about" class="sc-ldgOGP gHhitR">About Us</a></li><li class="sc-ejCKsa gTjEzu footer-link"><a href="https://jobs.benzinga.com/" class="sc-ldgOGP gHhitR">Careers</a></li><li class="sc-ejCKsa gTjEzu footer-link"><a href="https://www.benzinga.com/inthenews" class="sc-ldgOGP gHhitR">In The News</a></li><li class="sc-ejCKsa gTjEzu footer-link"><a href="https://www.benzinga.com/events/" class="sc-ldgOGP gHhitR">Events</a></li><li class="sc-ejCKsa gTjEzu footer-link"><a href="https://www.benzinga.com/contact" class="sc-ldgOGP gHhitR">Contact Us</a></li></ul></div></div></div><div class="footer-bottom-section"><ul><li class="sc-ejCKsa gTjEzu footer-link"><a href="https://www.benzinga.com/terms-and-conditions" class="sc-ldgOGP gHhitR">Terms & Conditions </a></li><li class="sc-ejCKsa gTjEzu footer-link"><a href="https://www.benzinga.com/page/privacy" class="sc-ldgOGP gHhitR"> Do Not Sell My Personal Data/Privacy Policy</a></li><li class="sc-ejCKsa gTjEzu footer-link"><a href="https://www.benzinga.com/disclaimer" class="sc-ldgOGP gHhitR">Disclaimer </a></li><li class="sc-ejCKsa gTjEzu footer-link"><a href="http://www.benzingastatus.com" class="sc-ldgOGP gHhitR">Service Status</a></li><li class="sc-ejCKsa gTjEzu footer-link"><a href="https://www.benzinga.com/sitemap" class="sc-ldgOGP gHhitR">Sitemap</a></li></ul><div class="copyright-section text-center w-full whitespace-nowrap mt-2">© 2024 Benzinga | All Rights Reserved</div></div></div></div><script id="__NEXT_DATA__" type="application/json">{"props":{"pageProps":{"brokerWidget":{"id":154603,"title":"Compare Brokers Table – Benzinga.com","type":"widget","dynamic":false,"blocks":[{"blockName":"acf/call-to-action","attrs":{"name":"acf/call-to-action","data":{"link_type":"internal","internal_link":"https://www.benzinga.com/go/benzinga-pro","external_link":"","align":null,"display":"horizontal","cta_title":"Find Stocks Tailored to Your Trading Interests","image":{"image_id":58610,"attachment_id":58610,"title":"benzingaproreview-1-1280x720","caption":"","sizes":{"original":{"height":506,"width":900,"url":"https://cdnwp-s3.benzinga.com/wp-content/uploads/2020/02/05155651/benzingaproreview-1-1280x720-1.jpg"},"medium":{"height":169,"width":300,"url":"https://cdnwp-s3.benzinga.com/wp-content/uploads/2020/02/05155651/benzingaproreview-1-1280x720-1-300x169.jpg"},"thumbnail":{"height":150,"width":150,"url":"https://cdnwp-s3.benzinga.com/wp-content/uploads/2020/02/05155651/benzingaproreview-1-1280x720-1-150x150.jpg"},"medium_large":{"height":432,"width":768,"url":"https://cdnwp-s3.benzinga.com/wp-content/uploads/2020/02/05155651/benzingaproreview-1-1280x720-1-768x432.jpg"}},"url":"https://cdnwp-s3.benzinga.com/wp-content/uploads/2020/02/05155651/benzingaproreview-1-1280x720-1.jpg"},"cta_text":"Try it Today!","cta_button_text":"Try it Today!","cta_description":"Benzinga Pro offers a real-time newsfeed as headlines break on earnings releases, analyst ratings, rumors, the biggest movers, and many more actionable alerts.","disclosure":"","placement_country":"","cta_lock":false,"media_type":"","media_select":"","video_url":"","call_to_action_customize":false},"align":"","mode":"edit"},"innerBlocks":[],"innerHTML":"","campaign":{"id":58591,"title":"Find Stocks Tailored to Your Trading Interests","image":{"image_id":58610,"attachment_id":58610,"title":"benzingaproreview-1-1280x720","caption":"","sizes":{"original":{"height":506,"width":900,"url":"https://cdnwp-s3.benzinga.com/wp-content/uploads/2020/02/05155651/benzingaproreview-1-1280x720-1.jpg"},"medium":{"height":169,"width":300,"url":"https://cdnwp-s3.benzinga.com/wp-content/uploads/2020/02/05155651/benzingaproreview-1-1280x720-1-300x169.jpg"},"thumbnail":{"height":150,"width":150,"url":"https://cdnwp-s3.benzinga.com/wp-content/uploads/2020/02/05155651/benzingaproreview-1-1280x720-1-150x150.jpg"},"medium_large":{"height":432,"width":768,"url":"https://cdnwp-s3.benzinga.com/wp-content/uploads/2020/02/05155651/benzingaproreview-1-1280x720-1-768x432.jpg"}}},"description":"Benzinga Pro offers a real-time newsfeed as headlines break on earnings releases, analyst ratings, rumors, the biggest movers, and many more actionable alerts.","button_text":"Try it Today!","link_type":"internal","link":"https://www.benzinga.com/go/benzinga-pro/","disclosure":""}},{"blockName":"core/spacer","attrs":{"height":"20px","data":[]},"innerBlocks":[],"innerHTML":"\n\u003cdiv style=\"height:20px\" aria-hidden=\"true\" class=\"wp-block-spacer\"\u003e\u003c/div\u003e\n"},{"blockName":"core/heading","attrs":{"data":[]},"innerBlocks":[],"innerHTML":"\n\u003ch2\u003eCompare Benzinga's Favorite Brokers\u003c/h2\u003e\n","tag":"h2","id":"compare-benzingas-favorite-brokers","html":"Compare Benzinga's Favorite Brokers"},{"blockName":"core/paragraph","attrs":{"data":[]},"innerBlocks":[],"innerHTML":"\n\u003cp\u003e\u003cstrong\u003e\u003ca href=\"https://share.hsforms.com/1kQ-soZmmTRqplsRXp5Zfpw1npzh\"\u003eClaim Exclusive Offers\u003c/a\u003e\u003c/strong\u003e\u003c/p\u003e\n","html":"\u003cstrong\u003e\u003ca href=\"https://share.hsforms.com/1kQ-soZmmTRqplsRXp5Zfpw1npzh\"\u003eClaim Exclusive Offers\u003c/a\u003e\u003c/strong\u003e","tag":"p"},{"blockName":"acf/widget-container","attrs":{"name":"acf/widget-container","data":{"widget":{"ID":69793,"post_author":"5911","post_date":"2020-05-19 14:49:49","post_date_gmt":"2020-05-19 18:49:49","post_content":"\u003c!-- wp:paragraph {\"align\":\"left\"} --\u003e\n\u003cp class=\"has-text-align-left\"\u003e\u003cstrong\u003e\u003ca href=\"https://share.hsforms.com/1kQ-soZmmTRqplsRXp5Zfpw1npzh\"\u003eClaim Exclusive Offers\u003c/a\u003e\u003c/strong\u003e\u003c/p\u003e\n\u003c!-- /wp:paragraph --\u003e\n\n\u003c!-- wp:acf/compare-products {\"name\":\"acf/compare-products\",\"data\":{\"compare_products\":[\"218220\",\"27392\",\"63970\",\"772\",\"91816\"],\"_compare_products\":\"block_compare_products\",\"show_product_names\":\"0\",\"_show_product_names\":\"show_product_names\",\"default_open_description\":\"0\",\"_default_open_description\":\"default_open_description\",\"disable_block\":\"0\",\"_disable_block\":\"field_disable_block\"},\"align\":\"\",\"mode\":\"edit\"} /--\u003e\n\n\u003c!-- wp:paragraph --\u003e\n\u003cp\u003e\u003c/p\u003e\n\u003c!-- /wp:paragraph --\u003e","post_title":"Compare Investing Brokers (USE THIS ONE)","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"compare-brokers","to_ping":"","pinged":"","post_modified":"2024-11-04 07:44:48","post_modified_gmt":"2024-11-04 12:44:48","post_content_filtered":"","post_parent":0,"guid":"https://www.benzinga.com/?post_type=widget\u0026#038;p=69793","menu_order":0,"post_type":"widget","post_mime_type":"","comment_count":"0","filter":"raw"}},"align":"","mode":"edit"},"innerBlocks":[],"innerHTML":"","dynamic":false,"blocks":[{"blockName":"core/paragraph","attrs":{"align":"left","data":[]},"innerBlocks":[],"innerHTML":"\n\u003cp class=\"has-text-align-left\"\u003e\u003cstrong\u003e\u003ca href=\"https://share.hsforms.com/1kQ-soZmmTRqplsRXp5Zfpw1npzh\"\u003eClaim Exclusive Offers\u003c/a\u003e\u003c/strong\u003e\u003c/p\u003e\n","html":"\u003cstrong\u003e\u003ca href=\"https://share.hsforms.com/1kQ-soZmmTRqplsRXp5Zfpw1npzh\"\u003eClaim Exclusive Offers\u003c/a\u003e\u003c/strong\u003e","tag":"p"},{"blockName":"acf/compare-products","attrs":{"name":"acf/compare-products","data":{"compare_products":[218220,27392,63970,772,91816],"style":"","show_product_names":false,"opened":false},"align":"","mode":"edit"},"innerBlocks":[],"innerHTML":"","products":[{"id":218220,"image":"https://cdnwp-s3.benzinga.com/wp-content/uploads/2017/07/15102926/ib-logo-stacked-1200x627-1-768x401.png","square_image":null,"best_for":"Active and Global Traders","teaser":"","filters":[],"name":"IBKR Stocks","link":"https://www.benzinga.com/go/ibkr-stocks","rating":5,"review":"https://www.benzinga.com/money/interactive-brokers-review","insurance_types_of_plans":"","hide_securely_through":false,"trust":"Securely through Interactive Brokers’ website","current_promotion":null,"disclosure":"","button_text":"get started","product_badge_image":"https://cdnwp-s3.benzinga.com/wp-content/uploads/2022/12/14143408/Best-Day-Trading-Software-Interactive-Brokers.png","go_link_id":218219,"company_id":107,"company_name":"Interactive Brokers","tune_offer_id":"","go_link_dofollow":0,"details":{"desc":"\u003cp\u003e\u003cspan style=\"font-weight: 400;\"\u003eInteractive Brokers is a comprehensive trading platform that gives you access to a massive range of securities at affordable prices. You can buy assets from all around the world from the comfort of your home or office with access to over 150 global markets. Options, futures, forex and fund trading are also available, and most traders won’t pay a commission on any purchase or sale. \u003c/span\u003e\u003c/p\u003e\n\u003cp\u003e\u003cspan style=\"font-weight: 400;\"\u003eIBKR is geared primarily toward experienced traders and investors but now with the availability of free trades with IBKR Lite, casual traders can also acclimate to IBKR’s offerings.\u003c/span\u003e\u003c/p\u003e\n","pros":["IB SmartRouting provides significant price improvement vs. industry","Fractional trading allows investing regardless of share price","Industry's lowest margin rates","Earn more by lending your fuly-paid shares"],"cons":["Beginner investors might prefer a broker that offers a bit more hand-holding and educational resources"],"best_for":["Access to international markets","Active traders","Detailed mobile app that makes trading simple","Wide range of available account types and tradeable assets"],"custom_sec":[]},"phone":"","data":{}},{"id":27392,"image":"https://cdnwp-s3.benzinga.com/wp-content/uploads/2018/12/16153923/plus500_source-5c5b58f746e0fb0001ca8550-768x294.png","square_image":null,"best_for":"Stock CFDs","teaser":"","filters":[],"name":"Plus500 Yield","link":"https://www.benzinga.com/go/plus500-cc-link-a","rating":4,"review":"https://www.benzinga.com/money/plus500-review","insurance_types_of_plans":"","hide_securely_through":false,"trust":"securely through Plus500 Yield's website","current_promotion":"","disclosure":"\u003cp\u003e82% of retail accounts lose money\u003c/p\u003e\n","button_text":"get started","product_badge_image":false,"go_link_id":250291,"company_id":27390,"company_name":"Plus500","tune_offer_id":"","go_link_dofollow":0,"details":{"desc":"\u003cp\u003e\u003cspan style=\"font-weight: 400;\"\u003e\u003cstrong\u003e82% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you can afford to take the high risk of losing your money.\u003c/strong\u003e\u003c/span\u003e\u003c/p\u003e\n\u003cp\u003e\u003cspan style=\"font-weight: 400;\"\u003ePlus500 is an online CFD broker focusing on contracts for difference (CFDs). CFDs are similar to binary options in the U.S. where traders take all-or-nothing speculation on the prices of certain securities like indices, commodities or currencies. While not legal to trade in the U.S., CFDs are legal in many jurisdictions across the globe and Plus500 offers a wide array of tradable markets using these instruments. \u003c/span\u003e\u003c/p\u003e\n\u003cp\u003e\u003cspan style=\"font-weight: 400;\"\u003ePlus500 doesn’t charge commission and only profits off the spread, which is the difference between the buy and sell price of a specific security. But Plus500 is not a broker for beginners — the education materials are sparse and CFDs are risky derivatives capable of sapping out all of an investor’s capital. Only trade these instruments if you understand how they operate and the risks involved with buying them.\u003c/span\u003e\u003c/p\u003e\n","pros":["Great mobile app","Low spreads and commissions","Unlimited demo account"],"cons":["Only derivatives are available","Not open to U.S. residents"],"best_for":["Traders looking for a smooth mobile experience"],"custom_sec":[]},"phone":"","data":{}},{"id":63970,"image":"https://cdnwp-s3.benzinga.com/wp-content/uploads/2023/06/01170410/public-logo.png","square_image":null,"best_for":"Trading Ideas","teaser":"","filters":[],"name":"public.com","link":"https://www.benzinga.com/go/public","rating":4.5,"review":"https://www.benzinga.com/money/public-com-review","insurance_types_of_plans":"","hide_securely_through":false,"trust":"securely through public.com's website","current_promotion":"","disclosure":"","button_text":"get started","product_badge_image":false,"go_link_id":64439,"company_id":63967,"company_name":"public.com","tune_offer_id":"","go_link_dofollow":0,"details":{"desc":"\u003cp\u003e\u003cspan style=\"font-weight: 400;\"\u003ePublic is the only investing platform that lets you trade stocks, ETFs, crypto, bonds, options and alternative assets—like fine art and collectibles—all in one place. Public also provides access to custom company metrics, live shows about the markets, and insights from a community of millions of investors, creators, and analysts.\u003c/span\u003e\u003c/p\u003e\n\u003cp\u003e\u003cspan style=\"font-weight: 400;\"\u003eToday, Public provides more ways to create a diversified portfolio than nearly any other online broker. Members can engage in sophisticated investing strategies and access a wealth of investing insights—from company-specific analysis to live audio shows and town hall-style Q\u0026amp;As. In addition, Public offers a premium membership tier with unique company KPIs, detailed performance metrics, and institutional-grade research. \u003c/span\u003e\u003c/p\u003e\n\u003cp\u003e\u0026nbsp;\u003c/p\u003e\n","pros":["Commission-free stock and ETF trading","Fractional share investing","Advanced data, tools, and insights with Public Premium"],"cons":["You can't transfer crypto to another wallet","No mutual funds or precious metals","At this time, only offers individual brokerage accounts and not IRAs"],"best_for":["Stock and ETF investors","Crypto investors","Investors looking to diversify with alternative assets or bonds and options"],"custom_sec":[]},"phone":"","data":{}},{"id":772,"image":"https://cdnwp-s3.benzinga.com/wp-content/uploads/2017/08/30201651/robinhood.png","square_image":null,"best_for":"Beginners","teaser":"","filters":[],"name":"Robinhood","link":"https://www.benzinga.com/go/robinhood","rating":4.5,"review":"https://www.benzinga.com/money/robinhood-review","insurance_types_of_plans":"","hide_securely_through":false,"trust":"securely through Robinhood's website","current_promotion":"Refer friends and get FREE stock","disclosure":"","button_text":"get started","product_badge_image":false,"go_link_id":11199,"company_id":773,"company_name":"Robinhood","tune_offer_id":"","go_link_dofollow":0,"details":{"desc":"\u003cp style=\"font-weight: 400;\"\u003e\u003cspan style=\"font-weight: 400;\"\u003eRobinhood is a popular trading platform known for its commission-free trades and user-friendly mobile app. Ideal for novice investors, Robinhood makes it easy to buy and sell stocks, ETFs and cryptocurrencies. The platform offers a straightforward, no-frills experience, making it accessible for users new to investing. With features like fractional shares and a sleek interface, Robinhood lowers the barriers to entry for investing, allowing users to start with just a few dollars. It lacks the advanced tools and research options that more experienced investors might seek. Overall, Robinhood is a great choice for beginners seeking a simple way to invest.\u003c/span\u003e\u003c/p\u003e\n","pros":["User-friendly mobile app","Instant double","Cash management","Access to cryptocurrencies"],"cons":["Limited research tools","No mutual funds available","Basic customer support options"],"best_for":["Beginners looking for simplicity","Mobile-first investors","Commission-free trades"],"custom_sec":[]},"phone":"","data":{}},{"id":91816,"image":"https://cdnwp-s3.benzinga.com/wp-content/uploads/2020/11/07101028/IMG_5065-768x135.png","square_image":null,"best_for":"Global Broker for Short Selling","teaser":"","filters":[],"name":"TradeZero","link":"https://www.benzinga.com/go/tradezero","rating":4.5,"review":"https://www.benzinga.com/money/tradezero-review","insurance_types_of_plans":"","hide_securely_through":false,"trust":"securely through TradeZero's website","current_promotion":"","disclosure":"","button_text":"get started","product_badge_image":"https://cdnwp-s3.benzinga.com/wp-content/uploads/2020/11/14143059/Best-Brokerage-for-Short-Selling-TradeZero.png","go_link_id":38233,"company_id":91824,"company_name":"TradeZero","tune_offer_id":"","go_link_dofollow":0,"details":{"desc":"\u003cp\u003e\u003cspan style=\"font-weight: 400;\"\u003eTradeZero is an online broker and free stock trading platform that provides everything you need to successfully share and trade, including round-the-clock customer support. TradeZero provides four different trading state-of-the-art software programs with its services, a locator for sourcing shares for shorting, commission-free trades, and real-time streaming, to name a few of the features promoted on their website. The software is a unique and (potentially) affordable option for anyone interested in stock trading.\u003c/span\u003e\u003c/p\u003e\n","pros":["24/7 live customer support","Uses ZeroWeb technology, a powerful level 2 online platform with direct market access","Mobile app allows users to access stocks and trade in real-time while on the go"],"cons":["Enforces Pattern Day Trading restrictions (accounts need to maintain a daily equity balance of at least $25k)","Mobile app could offer more features"],"best_for":["Traders seeking high transparency and mobility in a stock trading program","Those attracted to commission-free trades","Those seeking a free version of a high-quality trading program"],"custom_sec":[]},"phone":"","data":{}}]},{"blockName":"core/paragraph","attrs":{"data":[]},"innerBlocks":[],"innerHTML":"\n\u003cp\u003e\u003c/p\u003e\n","html":"","tag":"p"}]},{"blockName":"core/spacer","attrs":{"height":"32px","data":[]},"innerBlocks":[],"innerHTML":"\n\u003cdiv style=\"height:32px\" aria-hidden=\"true\" class=\"wp-block-spacer\"\u003e\u003c/div\u003e\n"},{"blockName":"core/heading","attrs":{"data":[]},"innerBlocks":[],"innerHTML":"\n\u003ch2\u003eCompare Benzinga's Favorite Cryptocurrency Brokers\u003c/h2\u003e\n","tag":"h2","id":"compare-benzingas-favorite-cryptocurrency-brokers","html":"Compare Benzinga's Favorite Cryptocurrency Brokers"},{"blockName":"core/spacer","attrs":{"height":"16px","data":[]},"innerBlocks":[],"innerHTML":"\n\u003cdiv style=\"height:16px\" aria-hidden=\"true\" class=\"wp-block-spacer\"\u003e\u003c/div\u003e\n"},{"blockName":"acf/widget-container","attrs":{"name":"acf/widget-container","data":{"widget":{"ID":162618,"post_author":"5911","post_date":"2021-12-14 16:20:54","post_date_gmt":"2021-12-14 21:20:54","post_content":"\u003c!-- wp:acf/compare-products {\"name\":\"acf/compare-products\",\"data\":{\"compare_products\":[\"81064\",\"302335\",\"125386\",\"279501\",\"24544\",\"128031\"],\"_compare_products\":\"block_compare_products\",\"show_product_names\":\"0\",\"_show_product_names\":\"show_product_names\",\"default_open_description\":\"0\",\"_default_open_description\":\"default_open_description\",\"disable_block\":\"0\",\"_disable_block\":\"field_disable_block\"},\"align\":\"\",\"mode\":\"edit\"} /--\u003e\n\n\u003c!-- wp:paragraph --\u003e\n\u003cp\u003e\u003c/p\u003e\n\u003c!-- /wp:paragraph --\u003e","post_title":"Compare Crypto Brokers Homepage","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"compare-crypto-brokers-homepage","to_ping":"","pinged":"","post_modified":"2024-11-04 07:41:17","post_modified_gmt":"2024-11-04 12:41:17","post_content_filtered":"","post_parent":0,"guid":"https://www.benzinga.com/?post_type=widget\u0026#038;p=162618","menu_order":0,"post_type":"widget","post_mime_type":"","comment_count":"0","filter":"raw"}},"align":"","mode":"edit"},"innerBlocks":[],"innerHTML":"","dynamic":false,"blocks":[{"blockName":"acf/compare-products","attrs":{"name":"acf/compare-products","data":{"compare_products":[81064,302335,125386,279501,24544,128031],"style":"","show_product_names":false,"opened":false},"align":"","mode":"edit"},"innerBlocks":[],"innerHTML":"","products":[{"id":81064,"image":"https://cdnwp-s3.benzinga.com/wp-content/uploads/2020/08/26115547/binance.png","square_image":null,"best_for":"Altcoin Traders","teaser":"","filters":[],"name":"Binance NON US","link":"https://www.benzinga.com/go/binance-non-us","rating":5,"review":"https://www.benzinga.com/money/binance-review","insurance_types_of_plans":"","hide_securely_through":false,"trust":"securely through Binance NON US's website","current_promotion":"","disclosure":"","button_text":"get started","product_badge_image":false,"go_link_id":110529,"company_id":81065,"company_name":"Binance","tune_offer_id":null,"go_link_dofollow":0,"details":{"desc":"","pros":["Low Fees"],"cons":["Limited U.S accessibility"],"best_for":["Altcoin Traders"],"custom_sec":[]},"phone":"","data":{}},{"id":302335,"image":"https://cdnwp-s3.benzinga.com/wp-content/uploads/2018/12/16153923/plus500_source-5c5b58f746e0fb0001ca8550-768x294.png","square_image":null,"best_for":"Crypto Futures","teaser":"","filters":[],"name":"Plus500 Crypto","link":"https://www.benzinga.com/go/plus-500-crypto-in-content","rating":5,"review":"https://www.benzinga.com/money/plus500-review","insurance_types_of_plans":"","hide_securely_through":false,"trust":"securely through Plus500 Crypto's website","current_promotion":null,"disclosure":"\u003cp\u003e82% of retail CFD accounts lose money.\u003c/p\u003e\n","button_text":"Get Started","product_badge_image":false,"go_link_id":302320,"company_id":27390,"company_name":"Plus500","tune_offer_id":"","go_link_dofollow":0,"details":{"desc":"\u003cp\u003ePlus500 is a multiasset platform that allows you to trade in everything from crypto and CFDs or forex to future, options and more. You can build a crypto portfolio, learn about each token and grow your holdings all in one place.\u003c/p\u003e\n","pros":["Quality web-based application","Quality information on all assets","Fast execution"],"cons":["CFDS are not legal everywhere"],"best_for":["Crypto CFDs","Multiasset trading","Easy to build a portfolio"],"custom_sec":[]},"phone":"","data":{}},{"id":125386,"image":"https://cdnwp-s3.benzinga.com/wp-content/uploads/2019/05/20154335/Webull.png","square_image":null,"best_for":"Low Minimums","teaser":"","filters":[],"name":"Webull Crypto","link":"https://www.benzinga.com/go/webull-crypto","rating":4.5,"review":"https://www.benzinga.com/money/webull-review","insurance_types_of_plans":"","hide_securely_through":false,"trust":"securely through Webull Crypto's website","current_promotion":null,"disclosure":"","button_text":"get started","product_badge_image":false,"go_link_id":109494,"company_id":38061,"company_name":"Webull","tune_offer_id":null,"go_link_dofollow":0,"details":{"desc":"\u003cp\u003eWebull, founded in 2017, is a mobile app-based brokerage that features commission-free stock and exchange-traded fund (ETF) trading. It’s regulated by the Securities and Exchange Commission (SEC) and the Financial Industry Regulatory Authority (FINRA).\u003c/p\u003e\n\u003cp\u003eWebull offers active traders technical indicators, economic calendars, ratings from research agencies, margin trading and short-selling. Webull’s trading platform is designed for intermediate and experienced traders, although beginning traders can also benefit.\u003c/p\u003e\n\u003cp\u003eWebull is widely considered one of the best Robinhood alternatives.\u003c/p\u003e\n","pros":["No charges to open and maintain an account","No account maintenance fees or software platform fees","Intuitive trading platform with technical and fundamental analysis tools"],"cons":["Only offers 14 coins"],"best_for":["Active traders","Intermediate traders"],"custom_sec":[]},"phone":"","data":{}},{"id":279501,"image":"https://cdnwp-s3.benzinga.com/wp-content/uploads/2023/11/02123632/logo10-Fxglory-ltd.png","square_image":null,"best_for":"Fixed Spreads","teaser":"","filters":[],"name":"FxGlory","link":"https://www.benzinga.com/go/fxglory","rating":4.5,"review":"https://www.benzinga.com/money/fxglory-review","insurance_types_of_plans":"","hide_securely_through":false,"trust":"securely through FxGlory's website","current_promotion":null,"disclosure":"","button_text":"","product_badge_image":false,"go_link_id":279490,"company_id":279499,"company_name":"FxGlory","tune_offer_id":"","go_link_dofollow":0,"details":{"desc":"\u003cp\u003e\u003c!-- wp:paragraph --\u003e\u003c/p\u003e\n\u003cp\u003eThe \u003ca href=\"https://www.benzinga.com/money/how-to-trade-forex\" data-lasso-id=\"49246\"\u003eforex market\u003c/a\u003e can present an excellent avenue for active investors and traders seeking investment prospects that offer the potential for profitability. These include \u003ca href=\"https://www.benzinga.com/money/pattern-day-trader\" data-lasso-id=\"49247\"\u003epattern day traders\u003c/a\u003e, \u003ca href=\"https://www.benzinga.com/money/what-is-forex-scalping\" data-lasso-id=\"49248\"\u003escalpers\u003c/a\u003e and \u003ca href=\"https://www.benzinga.com/money/how-to-swing-trade\" data-lasso-id=\"49249\"\u003eswing traders\u003c/a\u003e. However, to capitalize on the market\u0026#8217;s opportunities, you require access to a brokerage platform that provides a conducive trading environment and a wide range of essential tools for creating a successful trading strategy. FXGlory facilitates straightforward access to the forex market, enabling you to potentially earn returns.\u003c/p\u003e\n\u003cp\u003e\u003c!-- /wp:paragraph --\u003e \u003c!-- wp:paragraph --\u003e\u003c/p\u003e\n\u003cp\u003eThe brokerage was established by a team of financial experts aiming to deliver an exceptional online trading experience with high leverage, zero commissions, low spread and quick executions using the MT4/MT5 trading platform. Besides forex, you can also trade cryptocurrencies and commodities, including gold, silver, platinum and palladium. Additionally, traders can gain valuable insight into the forex market or trading through the knowledge base and stay updated with the global forex news.\u003c/p\u003e\n\u003cp\u003e\u003c!-- /wp:paragraph --\u003e \u003c!-- wp:paragraph --\u003e\u003c/p\u003e\n\u003cp\u003eMoreover, FXGlory offers round-the-clock customer support, meaning traders can receive assistance, ask questions and resolve problems at any hour of the day or night, enhancing the overall trading experience and providing peace of mind. Read on for a comprehensive review of FXGlory, its features, fees and customer service.\u003c/p\u003e\n\u003cp\u003e\u003c!-- /wp:paragraph --\u003e\u003c/p\u003e\n","pros":["Impressive leverage of up to 1:3000","Free remote VPS for seamless trading anywhere and anytime ","Competitive and fixed spread providing steady and predictable costs","A low minimum deposit of $1","Swap free account for interest-free trade","Excellent educational and research tools","Multiple trading platforms beginner-friendly MT4 and advanced MT5 platform ","Risk-free demo account to facilitate practice and learning","Round-the-clock customer support services for seamless trading guidance ","User-friendly mobile app for streamlined trading on the go","Generous and tradable deposit bonuses ","Supports micro-lot and automated trading","Accepts U.S. clients"],"cons":["You pay extra for added functionality"],"best_for":["Beginner traders seeking a conducive and user-friendly environment to learn and practice forex trading","Experienced traders who prefer an intuitive and straightforward platform for efficient trade execution without unnecessary complexities","Traders seeking an easy-to-use mobile app with access to diverse financial instruments to enhance their online trading experience and enjoy the flexibility and convenience of trading on the go","Traders looking for brokerages that offer high leverages, fixed and low spreads, cutting-edge trading platforms and excellent customer service experience"],"custom_sec":[]},"phone":"","data":{}},{"id":24544,"image":"https://cdnwp-s3.benzinga.com/wp-content/uploads/2018/10/09230805/eToro-Logo.png","square_image":null,"best_for":"Social Investing","teaser":"","filters":[],"name":"eToro","link":"https://www.benzinga.com/go/etoro","rating":4.5,"review":"https://www.benzinga.com/money/etoro-review","insurance_types_of_plans":"","hide_securely_through":false,"trust":"securely through eToro's website","current_promotion":"","disclosure":"\u003cp class=\"s28\"\u003e\u003cspan class=\"s34\"\u003eCryptocurrency is offered by \u003c/span\u003e\u003cspan class=\"s34\"\u003eeToro\u003c/span\u003e\u003cspan class=\"s34\"\u003e USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a rec- ommendation, and is not a guarantee of future performance. [website domain name] is not an affiliate and may be compensated if you access certain products or services offered by the MSB.\u003c/span\u003e\u003c/p\u003e\n\u003cp\u003eeToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.\u003c/p\u003e\n\u003cp\u003eDon’t invest unless you’re prepared to lose all the money you invest. This is a high-risk investment and you should not expect to be protected if something goes wrong.\u003c/p\u003e\n\u003cp\u003ePlease note that Ripple (XRP), Cardano (ADA) and Tron (TRX) are not available for US users.\u003c/p\u003e\n","button_text":"get started","product_badge_image":false,"go_link_id":34691,"company_id":24545,"company_name":"eToro","tune_offer_id":"","go_link_dofollow":0,"details":{"desc":"\u003cp\u003eeToro is headquartered in Cyprus, England and Israel. A major eToro plus is its social trading operations, which allows new clients to copy trade the platform’s best performers. Its social trading features are top notch, but eToro loses points for its underwhelming research and customer service features.\u003c/p\u003e\n","pros":["Several major cryptocurrencies and altcoins","Expansive network of social trading features","Large client base for new traders to imitate"],"cons":["Only 21 coins available in the US but over 30 globally","PayPal and Credit Card are not available for UK and FCA users"],"best_for":["Investors looking to CopyTrade other traders","Simple user interface"],"custom_sec":[]},"phone":"","data":{}},{"id":128031,"image":"https://cdnwp-s3.benzinga.com/wp-content/uploads/2020/09/01135644/uphold.png","square_image":null,"best_for":"A Fast Trading Experience","teaser":"","filters":[],"name":"Uphold Crypto","link":"https://www.benzinga.com/go/uphold-crypto-convertor","rating":4.5,"review":"https://www.benzinga.com/money/uphold-review","insurance_types_of_plans":"","hide_securely_through":false,"trust":"securely through Uphold Crypto's website","current_promotion":null,"disclosure":"\u003cp\u003e\u003cem\u003eTerms Apply. Cryptoassets are highly volatile. Your capital is at risk.\u003c/em\u003e\u003c/p\u003e\n","button_text":"get started","product_badge_image":false,"go_link_id":81724,"company_id":81722,"company_name":"Uphold","tune_offer_id":"","go_link_dofollow":0,"details":{"desc":"\u003cp\u003eUphold is a unique broker that makes it easier than ever for you to trade on the crypto market, with quite a lot of information and access to cryptocurrencies that will help diversify your portfolio.\u003c/p\u003e\n\u003cp\u003eUniquely, Uphold just released the option for a Trailing Stop Order. Unlike a Stop Order, which only protects you from losses based on purchase price, a Trailing Stop Order readjusts to the highest price after you buy. Therefore, you will follow the market up while the “going’s good” and get out if the price starts falling further than you’d like.\u003c/p\u003e\n\u003cp\u003eAlso, ATOM is now a Tier 3 token, meaning that you can make deposits and withdrawals to and from the Cosmos Network.\u003c/p\u003e\n","pros":[],"cons":[],"best_for":[],"custom_sec":[]},"phone":"","data":{}}]},{"blockName":"core/paragraph","attrs":{"data":[]},"innerBlocks":[],"innerHTML":"\n\u003cp\u003e\u003c/p\u003e\n","html":"","tag":"p"}]}]},"latestNews":[{"assets":[{"type":"image","title":"High-Sicence-Thumbnail-2","alt":"high science cannabis series","source":"","mime":"image/jpeg","primary":true,"attributes":{"fid":"901911","filename":"High-Sicence-Thumbnail-2.jpeg","filepath":"files/images/story/2024/11/26/High-Sicence-Thumbnail-2.jpeg","filesize":0,"image_attributes":{"resolution":{"height":0,"width":0,"dpi":0}}}}],"author":"Franca Quarneti","channels":[{"tid":123430,"vid":1,"name":"Cannabis"},{"tid":831970,"vid":1,"name":"Entertainment","description":"Entertainment"},{"tid":138079,"vid":1,"name":"Top Stories"},{"tid":2,"vid":1,"name":"Markets"},{"tid":18467,"vid":1,"name":"General"}],"created":"2024-11-26T22:57:13Z","createdAt":"2024-11-26T22:57:13Z","id":42204210,"image":"https://www.benzinga.com/files/images/story/2024/11/26/High-Sicence-Thumbnail-2.jpeg","isBzPost":true,"isBzProPost":true,"meta":{"SectorV2":{},"Partner":null,"PartnerTaxonomy":null,"SEC":null,"Author":null,"Authors":[{"uid":"0","name":""}],"Flags":{"ShowCopyrightNotice":true,"EvergreenContent":false,"ShowAdvertiserDisclosure":false,"ContributedContent":false,"AddGoogleStandoutMetaTag":false,"MediaSiteDNDOverride":false,"SendToYahooFinance":false,"SendToRobinhood":true,"SendToMSN":true},"Reach":{"Disclosure":{}},"Reference":null,"Ext":null,"wp_post_meta":{"campaign_strategy":"Default","post_id":666252,"post_path":"24/11/42204210/why-youtubes-high-science-is-a-must-watch-for-cannabis-enthusiasts","post_type":"post"}},"nodeId":42204210,"stocks":[],"storyId":"6746523db6cb720001ab238a","tags":[{"tid":799159,"vid":3,"name":"Clear Cannabis Inc"},{"tid":945713,"vid":3,"name":"Ed Leclere"},{"tid":937282,"vid":3,"name":"High Science"},{"tid":631239,"vid":3,"name":"medical cannabis"},{"tid":945711,"vid":3,"name":"Rich Batenburg Jr"},{"tid":945712,"vid":3,"name":"Rick Batenburg III"}],"teaser":"Explore High Science, a new YouTube series launching Nov. 27. Dive into cannabis innovations, pioneers, and its potential as medicine.","teaserText":"Explore High Science, a new YouTube series launching Nov. 27. Dive into cannabis innovations, pioneers, and its potential as medicine.","tickers":[],"title":"YouTube\u0026#39;s High Science Is A Must-Watch For Cannabis Enthusiasts","updated":"2024-11-26T22:57:13Z","updatedAt":"2024-11-26T22:57:13Z","url":"https://www.benzinga.com/24/11/42204210/why-youtubes-high-science-is-a-must-watch-for-cannabis-enthusiasts"},{"assets":[{"type":"image","title":"AI-Generated Image","alt":"weed marijuana cannabis kentucky","source":"AI-Generated Image ","mime":"","primary":true,"attributes":{"fid":"901909","filename":"AI-Generated-Image_1.jpeg","filepath":"files/images/story/2024/11/26/AI-Generated-Image_1.jpeg","filesize":0,"image_attributes":{"resolution":{"height":0,"width":0,"dpi":0}}}}],"author":"Nicolás Jose Rodriguez","channels":[{"tid":123430,"vid":1,"name":"Cannabis"},{"tid":26029,"vid":1,"name":"Government"},{"tid":57,"vid":1,"name":"News"},{"tid":144213,"vid":1,"name":"Regulations"},{"tid":140295,"vid":1,"name":"Health Care"},{"tid":29619,"vid":1,"name":"Legal"},{"tid":2,"vid":1,"name":"Markets"}],"created":"2024-11-26T22:28:35Z","createdAt":"2024-11-26T22:28:35Z","id":42203777,"image":"https://www.benzinga.com/files/images/story/2024/11/26/AI-Generated-Image_1.jpeg","isBzPost":true,"isBzProPost":true,"meta":{"SectorV2":{},"Partner":null,"PartnerTaxonomy":null,"SEC":null,"Author":null,"Authors":[{"uid":"0","name":""}],"Flags":{"ShowCopyrightNotice":true,"EvergreenContent":false,"ShowAdvertiserDisclosure":false,"ContributedContent":false,"AddGoogleStandoutMetaTag":false,"MediaSiteDNDOverride":false,"SendToYahooFinance":false,"SendToRobinhood":true,"SendToMSN":false},"Reach":{"Disclosure":{}},"Reference":null,"Ext":null,"wp_post_meta":{"campaign_strategy":"Default","post_id":666214,"post_path":"24/11/42203777/kentucky-awards-first-medical-cannabis-dispensary-licenses","post_type":"post"}},"nodeId":42203777,"stocks":[],"storyId":"67464b87b6cb720001ab21d3","tags":[{"tid":907081,"vid":3,"name":"cannabis licenses"},{"tid":933911,"vid":3,"name":"Cannabis Lottery"},{"tid":857126,"vid":3,"name":"Gov. Andy Beshear"},{"tid":861845,"vid":3,"name":"Governor Andy Beshear"},{"tid":155693,"vid":3,"name":"Hemp"},{"tid":841380,"vid":3,"name":"Kentucky cannabis"},{"tid":945709,"vid":3,"name":"Kentucky Office of medical cannabis"},{"tid":844051,"vid":3,"name":"retail cannabis"},{"tid":927289,"vid":3,"name":"Sam Flynn"}],"teaser":"The Kentucky Office of Medical Cannabis received nearly 5,000 applications, with 4,075 specifically for dispensaries.","teaserText":"The Kentucky Office of Medical Cannabis received nearly 5,000 applications, with 4,075 specifically for dispensaries.","tickers":[],"title":"Kentucky Awards First Medical Cannabis Dispensary Licenses","updated":"2024-11-26T22:28:35Z","updatedAt":"2024-11-26T22:28:35Z","url":"https://www.benzinga.com/24/11/42203777/kentucky-awards-first-medical-cannabis-dispensary-licenses"},{"assets":[{"type":"image","title":"Cannabis,Plant,With,Green,Leaves,And,White,Flowers,,With,Trichomes,","alt":"Cannabis,Plant,With,Green,Leaves,And,White,Flowers,,With,Trichomes,","source":"Photo: Courtesy of Plateresca via Shutterstock ","mime":"image/jpeg","primary":true,"attributes":{"fid":"901908","filename":"Cannabis-Plant-With-Green-Leaves-And-Whi.jpeg","filepath":"files/images/story/2024/11/26/Cannabis-Plant-With-Green-Leaves-And-Whi.jpeg","filesize":0,"image_attributes":{"resolution":{"height":0,"width":0,"dpi":0}}}}],"author":"Nina Zdinjak","channels":[{"tid":123430,"vid":1,"name":"Cannabis"},{"tid":57,"vid":1,"name":"News"},{"tid":125557,"vid":1,"name":"Eurozone"}],"created":"2024-11-26T22:26:57Z","createdAt":"2024-11-26T22:26:57Z","id":42203747,"image":"https://www.benzinga.com/files/images/story/2024/11/26/Cannabis-Plant-With-Green-Leaves-And-Whi.jpeg","isBzPost":true,"isBzProPost":true,"meta":{"SectorV2":{},"Partner":null,"PartnerTaxonomy":null,"SEC":null,"Author":null,"Authors":[{"uid":"0","name":""}],"Flags":{"ShowCopyrightNotice":true,"EvergreenContent":false,"ShowAdvertiserDisclosure":false,"ContributedContent":false,"AddGoogleStandoutMetaTag":false,"MediaSiteDNDOverride":false,"SendToYahooFinance":false,"SendToRobinhood":true,"SendToMSN":true},"Reach":{"Disclosure":{}},"Reference":null,"Ext":null,"wp_post_meta":{"campaign_strategy":"Default","post_id":665071,"post_path":"markets/cannabis/24/11/42203747/berlins-justice-senator-says-cannabis-law-benefits-mafia-like-structures-and-that-it-should-be-repealed","post_type":"post"}},"nodeId":42203747,"stocks":[],"storyId":"67464b26b6cb720001ab21ae","tags":[{"tid":945708,"vid":3,"name":"Felor Badenberg"},{"tid":842661,"vid":3,"name":"Germany Cannabis"}],"teaser":" ","teaserText":" ","tickers":[],"title":"Berlin\u0026#39;s Justice Senator Says Cannabis Law Benefits Mafia-Like Structures And It Should Be Repealed","updated":"2024-11-26T22:26:58Z","updatedAt":"2024-11-26T22:26:58Z","url":"https://www.benzinga.com/markets/cannabis/24/11/42203747/berlins-justice-senator-says-cannabis-law-benefits-mafia-like-structures-and-that-it-should-be-repealed"},{"assets":[{"type":"image","title":"joe_biden_cannabis_liberty_adam_schultz_on_wikimedia_commons_and_david_smart_on_shutterstock.jpg_copy copy","alt":"joe_biden_cannabis_liberty_adam_schultz_on_wikimedia_commons_and_david_smart_on_shutterstock.jpg_copy copy","source":"","mime":"","primary":true,"attributes":{"fid":"901901","filename":"joe-biden-cannabis-liberty-adam-schultz-.jpeg","filepath":"files/images/story/2024/11/26/joe-biden-cannabis-liberty-adam-schultz-.jpeg","filesize":0,"image_attributes":{"resolution":{"height":0,"width":0,"dpi":0}}}}],"author":"Maureen Meehan","channels":[{"tid":123430,"vid":1,"name":"Cannabis"},{"tid":26029,"vid":1,"name":"Government"},{"tid":57,"vid":1,"name":"News"},{"tid":16779,"vid":1,"name":"Politics"},{"tid":29619,"vid":1,"name":"Legal"}],"created":"2024-11-26T21:42:49Z","createdAt":"2024-11-26T21:42:49Z","id":42202403,"image":"https://www.benzinga.com/files/images/story/2024/11/26/joe-biden-cannabis-liberty-adam-schultz-.jpeg","isBzPost":true,"isBzProPost":true,"meta":{"SectorV2":{},"Partner":null,"PartnerTaxonomy":null,"SEC":null,"Author":null,"Authors":[{"uid":"0","name":""}],"Flags":{"ShowCopyrightNotice":true,"EvergreenContent":false,"ShowAdvertiserDisclosure":false,"ContributedContent":false,"AddGoogleStandoutMetaTag":false,"MediaSiteDNDOverride":false,"SendToYahooFinance":false,"SendToRobinhood":true,"SendToMSN":true},"Reach":{"Disclosure":{}},"Reference":null,"Ext":null,"wp_post_meta":{"campaign_strategy":"Default","post_id":666215,"post_path":"news/legal/24/11/42202403/elizabeth-warren-bernie-sanders-12-congress-members-to-biden-issue-clemency-and-pardons-for-cannabis-prisoners","post_type":"post"}},"nodeId":42202403,"stocks":[],"storyId":"674640cdb6cb720001ab1b73","tags":[{"tid":731964,"vid":3,"name":"cannabis legalization"},{"tid":858850,"vid":3,"name":"Cannabis pardons"},{"tid":945703,"vid":3,"name":"Congress Members"},{"tid":22004,"vid":3,"name":"Joe Biden"},{"tid":913345,"vid":3,"name":"Stories That Matter"}],"teaser":"While Biden pardoned individuals with federal marijuana possession convictions, these measures have resulted in no prison releases.","teaserText":"While Biden pardoned individuals with federal marijuana possession convictions, these measures have resulted in no prison releases.","tickers":[],"title":"Elizabeth Warren, Bernie Sanders \u0026amp; 12 Congress Members To Biden: Issue Clemency And Pardons For Cannabis Prisoners","updated":"2024-11-26T21:42:49Z","updatedAt":"2024-11-26T21:42:49Z","url":"https://www.benzinga.com/news/legal/24/11/42202403/elizabeth-warren-bernie-sanders-12-congress-members-to-biden-issue-clemency-and-pardons-for-cannabis-prisoners"}],"latestNewsQuery":{"channels":[123430],"excludeAutomated":true,"excludeSponsored":true},"meta":{"title":"Cannabis News - Benzinga Cannabis","description":"The latest cannabis news on Benzinga Cannabis. 30+ daily articles on cannabis stocks + hemp, CBD \u0026 psychedelics finance, business, politics and culture.","image":null,"author":"Benzinga","authorSlug":"benzinga","postId":232396,"publishedDate":"2023-03-10T09:19:44.000000Z","modifiedDate":"2024-03-07T11:44:13.000000Z","verifiedUserSlug":null,"verifiedBy":null,"editedUserSlug":null,"editedBy":null,"hrefLanguage":"en","dimensions":{"authorName":"Benzinga","contentType":"channel"}},"newsletter":{"hubspotFormId":"483fc5b0-377c-4e74-be45-84189ce44f17","subtitle":"Sign up for daily updates on the burgeoning cannabis industry:","title":"Benzinga Cannabis Newsletter"},"page":{"id":232396,"title":"Latest Cannabis News","post_type":"page","robots":"","intro":null,"slug":"cannabis","template":"page","canonical_link":"https://www.benzinga.com/cannabis","image":null,"taxonomies":[{"term_taxonomy_id":190,"term_id":190,"taxonomy":"page-type","description":"","parent":0,"count":83,"term":{"term_id":190,"name":"Full Width","slug":"full-width"}}],"parent":[],"meta":{"title":"Cannabis News - Benzinga Cannabis","description":"The latest cannabis news on Benzinga Cannabis. 30+ daily articles on cannabis stocks + hemp, CBD \u0026 psychedelics finance, business, politics and culture.","image":null,"author":"Benzinga","authorSlug":"benzinga","postId":232396,"publishedDate":"2023-03-10T09:19:44.000000Z","modifiedDate":"2024-03-07T11:44:13.000000Z","verifiedUserSlug":null,"verifiedBy":null,"editedUserSlug":null,"editedBy":null,"hrefLanguage":"en"},"breadcrumbs":[{"id":232396,"href":"/cannabis","name":"Latest Cannabis News"}],"blocks":[{"blockName":"acf/page-title","attrs":{"name":"acf/page-title","data":{"title":"Complete Cannabis News","page_action_link":"https://elplanteo.com/","page_action_link_text":"CAMBIAR A ESPAÑOL"},"align":"","mode":"edit"},"innerBlocks":[],"innerHTML":"","type":"default"},{"blockName":"acf/news-featured-section","attrs":{"name":"acf/news-featured-section","data":{"news_selection_mode":"query","display_more_featured_news":true,"query_and_options":{"options":{"displayOutput":"abstract","limit":7,"excludeAutomated":true,"excludeSponsored":true},"query":{"primaryChannel":"123430","channelAndTagQueryOperator":"and"}}},"align":"","mode":"edit"},"innerBlocks":[],"innerHTML":"","featuredNews":[{"assets":[{"type":"image","title":"High-Sicence-Thumbnail-2","alt":"high science cannabis series","source":"","mime":"image/jpeg","primary":true,"attributes":{"fid":"901911","filename":"High-Sicence-Thumbnail-2.jpeg","filepath":"files/images/story/2024/11/26/High-Sicence-Thumbnail-2.jpeg","filesize":0,"image_attributes":{"resolution":{"height":0,"width":0,"dpi":0}}}}],"author":"Franca Quarneti","channels":[{"tid":123430,"vid":1,"name":"Cannabis"},{"tid":831970,"vid":1,"name":"Entertainment","description":"Entertainment"},{"tid":138079,"vid":1,"name":"Top Stories"},{"tid":2,"vid":1,"name":"Markets"},{"tid":18467,"vid":1,"name":"General"}],"created":"2024-11-26T22:57:13Z","createdAt":"2024-11-26T22:57:13Z","id":42204210,"image":"https://www.benzinga.com/files/images/story/2024/11/26/High-Sicence-Thumbnail-2.jpeg","isBzPost":true,"isBzProPost":true,"meta":{"SectorV2":{},"Partner":null,"PartnerTaxonomy":null,"SEC":null,"Author":null,"Authors":[{"uid":"0","name":""}],"Flags":{"ShowCopyrightNotice":true,"EvergreenContent":false,"ShowAdvertiserDisclosure":false,"ContributedContent":false,"AddGoogleStandoutMetaTag":false,"MediaSiteDNDOverride":false,"SendToYahooFinance":false,"SendToRobinhood":true,"SendToMSN":true},"Reach":{"Disclosure":{}},"Reference":null,"Ext":null,"wp_post_meta":{"campaign_strategy":"Default","post_id":666252,"post_path":"24/11/42204210/why-youtubes-high-science-is-a-must-watch-for-cannabis-enthusiasts","post_type":"post"}},"nodeId":42204210,"stocks":[],"storyId":"6746523db6cb720001ab238a","tags":[{"tid":799159,"vid":3,"name":"Clear Cannabis Inc"},{"tid":945713,"vid":3,"name":"Ed Leclere"},{"tid":937282,"vid":3,"name":"High Science"},{"tid":631239,"vid":3,"name":"medical cannabis"},{"tid":945711,"vid":3,"name":"Rich Batenburg Jr"},{"tid":945712,"vid":3,"name":"Rick Batenburg III"}],"teaser":"Explore High Science, a new YouTube series launching Nov. 27. Dive into cannabis innovations, pioneers, and its potential as medicine.","teaserText":"Explore High Science, a new YouTube series launching Nov. 27. Dive into cannabis innovations, pioneers, and its potential as medicine.","tickers":[],"title":"YouTube\u0026#39;s High Science Is A Must-Watch For Cannabis Enthusiasts","updated":"2024-11-26T22:57:13Z","updatedAt":"2024-11-26T22:57:13Z","url":"https://www.benzinga.com/24/11/42204210/why-youtubes-high-science-is-a-must-watch-for-cannabis-enthusiasts"},{"assets":[{"type":"image","title":"AI-Generated Image","alt":"weed marijuana cannabis kentucky","source":"AI-Generated Image ","mime":"","primary":true,"attributes":{"fid":"901909","filename":"AI-Generated-Image_1.jpeg","filepath":"files/images/story/2024/11/26/AI-Generated-Image_1.jpeg","filesize":0,"image_attributes":{"resolution":{"height":0,"width":0,"dpi":0}}}}],"author":"Nicolás Jose Rodriguez","channels":[{"tid":123430,"vid":1,"name":"Cannabis"},{"tid":26029,"vid":1,"name":"Government"},{"tid":57,"vid":1,"name":"News"},{"tid":144213,"vid":1,"name":"Regulations"},{"tid":140295,"vid":1,"name":"Health Care"},{"tid":29619,"vid":1,"name":"Legal"},{"tid":2,"vid":1,"name":"Markets"}],"created":"2024-11-26T22:28:35Z","createdAt":"2024-11-26T22:28:35Z","id":42203777,"image":"https://www.benzinga.com/files/images/story/2024/11/26/AI-Generated-Image_1.jpeg","isBzPost":true,"isBzProPost":true,"meta":{"SectorV2":{},"Partner":null,"PartnerTaxonomy":null,"SEC":null,"Author":null,"Authors":[{"uid":"0","name":""}],"Flags":{"ShowCopyrightNotice":true,"EvergreenContent":false,"ShowAdvertiserDisclosure":false,"ContributedContent":false,"AddGoogleStandoutMetaTag":false,"MediaSiteDNDOverride":false,"SendToYahooFinance":false,"SendToRobinhood":true,"SendToMSN":false},"Reach":{"Disclosure":{}},"Reference":null,"Ext":null,"wp_post_meta":{"campaign_strategy":"Default","post_id":666214,"post_path":"24/11/42203777/kentucky-awards-first-medical-cannabis-dispensary-licenses","post_type":"post"}},"nodeId":42203777,"stocks":[],"storyId":"67464b87b6cb720001ab21d3","tags":[{"tid":907081,"vid":3,"name":"cannabis licenses"},{"tid":933911,"vid":3,"name":"Cannabis Lottery"},{"tid":857126,"vid":3,"name":"Gov. Andy Beshear"},{"tid":861845,"vid":3,"name":"Governor Andy Beshear"},{"tid":155693,"vid":3,"name":"Hemp"},{"tid":841380,"vid":3,"name":"Kentucky cannabis"},{"tid":945709,"vid":3,"name":"Kentucky Office of medical cannabis"},{"tid":844051,"vid":3,"name":"retail cannabis"},{"tid":927289,"vid":3,"name":"Sam Flynn"}],"teaser":"The Kentucky Office of Medical Cannabis received nearly 5,000 applications, with 4,075 specifically for dispensaries.","teaserText":"The Kentucky Office of Medical Cannabis received nearly 5,000 applications, with 4,075 specifically for dispensaries.","tickers":[],"title":"Kentucky Awards First Medical Cannabis Dispensary Licenses","updated":"2024-11-26T22:28:35Z","updatedAt":"2024-11-26T22:28:35Z","url":"https://www.benzinga.com/24/11/42203777/kentucky-awards-first-medical-cannabis-dispensary-licenses"},{"assets":[{"type":"image","title":"Cannabis,Plant,With,Green,Leaves,And,White,Flowers,,With,Trichomes,","alt":"Cannabis,Plant,With,Green,Leaves,And,White,Flowers,,With,Trichomes,","source":"Photo: Courtesy of Plateresca via Shutterstock ","mime":"image/jpeg","primary":true,"attributes":{"fid":"901908","filename":"Cannabis-Plant-With-Green-Leaves-And-Whi.jpeg","filepath":"files/images/story/2024/11/26/Cannabis-Plant-With-Green-Leaves-And-Whi.jpeg","filesize":0,"image_attributes":{"resolution":{"height":0,"width":0,"dpi":0}}}}],"author":"Nina Zdinjak","channels":[{"tid":123430,"vid":1,"name":"Cannabis"},{"tid":57,"vid":1,"name":"News"},{"tid":125557,"vid":1,"name":"Eurozone"}],"created":"2024-11-26T22:26:57Z","createdAt":"2024-11-26T22:26:57Z","id":42203747,"image":"https://www.benzinga.com/files/images/story/2024/11/26/Cannabis-Plant-With-Green-Leaves-And-Whi.jpeg","isBzPost":true,"isBzProPost":true,"meta":{"SectorV2":{},"Partner":null,"PartnerTaxonomy":null,"SEC":null,"Author":null,"Authors":[{"uid":"0","name":""}],"Flags":{"ShowCopyrightNotice":true,"EvergreenContent":false,"ShowAdvertiserDisclosure":false,"ContributedContent":false,"AddGoogleStandoutMetaTag":false,"MediaSiteDNDOverride":false,"SendToYahooFinance":false,"SendToRobinhood":true,"SendToMSN":true},"Reach":{"Disclosure":{}},"Reference":null,"Ext":null,"wp_post_meta":{"campaign_strategy":"Default","post_id":665071,"post_path":"markets/cannabis/24/11/42203747/berlins-justice-senator-says-cannabis-law-benefits-mafia-like-structures-and-that-it-should-be-repealed","post_type":"post"}},"nodeId":42203747,"stocks":[],"storyId":"67464b26b6cb720001ab21ae","tags":[{"tid":945708,"vid":3,"name":"Felor Badenberg"},{"tid":842661,"vid":3,"name":"Germany Cannabis"}],"teaser":" ","teaserText":" ","tickers":[],"title":"Berlin\u0026#39;s Justice Senator Says Cannabis Law Benefits Mafia-Like Structures And It Should Be Repealed","updated":"2024-11-26T22:26:58Z","updatedAt":"2024-11-26T22:26:58Z","url":"https://www.benzinga.com/markets/cannabis/24/11/42203747/berlins-justice-senator-says-cannabis-law-benefits-mafia-like-structures-and-that-it-should-be-repealed"},{"assets":[{"type":"image","title":"joe_biden_cannabis_liberty_adam_schultz_on_wikimedia_commons_and_david_smart_on_shutterstock.jpg_copy copy","alt":"joe_biden_cannabis_liberty_adam_schultz_on_wikimedia_commons_and_david_smart_on_shutterstock.jpg_copy copy","source":"","mime":"","primary":true,"attributes":{"fid":"901901","filename":"joe-biden-cannabis-liberty-adam-schultz-.jpeg","filepath":"files/images/story/2024/11/26/joe-biden-cannabis-liberty-adam-schultz-.jpeg","filesize":0,"image_attributes":{"resolution":{"height":0,"width":0,"dpi":0}}}}],"author":"Maureen Meehan","channels":[{"tid":123430,"vid":1,"name":"Cannabis"},{"tid":26029,"vid":1,"name":"Government"},{"tid":57,"vid":1,"name":"News"},{"tid":16779,"vid":1,"name":"Politics"},{"tid":29619,"vid":1,"name":"Legal"}],"created":"2024-11-26T21:42:49Z","createdAt":"2024-11-26T21:42:49Z","id":42202403,"image":"https://www.benzinga.com/files/images/story/2024/11/26/joe-biden-cannabis-liberty-adam-schultz-.jpeg","isBzPost":true,"isBzProPost":true,"meta":{"SectorV2":{},"Partner":null,"PartnerTaxonomy":null,"SEC":null,"Author":null,"Authors":[{"uid":"0","name":""}],"Flags":{"ShowCopyrightNotice":true,"EvergreenContent":false,"ShowAdvertiserDisclosure":false,"ContributedContent":false,"AddGoogleStandoutMetaTag":false,"MediaSiteDNDOverride":false,"SendToYahooFinance":false,"SendToRobinhood":true,"SendToMSN":true},"Reach":{"Disclosure":{}},"Reference":null,"Ext":null,"wp_post_meta":{"campaign_strategy":"Default","post_id":666215,"post_path":"news/legal/24/11/42202403/elizabeth-warren-bernie-sanders-12-congress-members-to-biden-issue-clemency-and-pardons-for-cannabis-prisoners","post_type":"post"}},"nodeId":42202403,"stocks":[],"storyId":"674640cdb6cb720001ab1b73","tags":[{"tid":731964,"vid":3,"name":"cannabis legalization"},{"tid":858850,"vid":3,"name":"Cannabis pardons"},{"tid":945703,"vid":3,"name":"Congress Members"},{"tid":22004,"vid":3,"name":"Joe Biden"},{"tid":913345,"vid":3,"name":"Stories That Matter"}],"teaser":"While Biden pardoned individuals with federal marijuana possession convictions, these measures have resulted in no prison releases.","teaserText":"While Biden pardoned individuals with federal marijuana possession convictions, these measures have resulted in no prison releases.","tickers":[],"title":"Elizabeth Warren, Bernie Sanders \u0026amp; 12 Congress Members To Biden: Issue Clemency And Pardons For Cannabis Prisoners","updated":"2024-11-26T21:42:49Z","updatedAt":"2024-11-26T21:42:49Z","url":"https://www.benzinga.com/news/legal/24/11/42202403/elizabeth-warren-bernie-sanders-12-congress-members-to-biden-issue-clemency-and-pardons-for-cannabis-prisoners"},{"assets":[{"type":"image","title":"wesley-gibbs-NxRx7_mPdEk-unsplash","alt":"Cannabis strains","source":"Photo: Courtesy of Wesley Gibbs on Unsplash","mime":"","primary":true,"attributes":{"fid":"901890","filename":"wesley-gibbs-NxRx7-mPdEk-unsplash.jpeg","filepath":"files/images/story/2024/11/26/wesley-gibbs-NxRx7-mPdEk-unsplash.jpeg","filesize":0,"image_attributes":{"resolution":{"height":0,"width":0,"dpi":0}}}}],"author":"Jelena Martinovic","channels":[{"tid":123430,"vid":1,"name":"Cannabis"},{"tid":57,"vid":1,"name":"News"},{"tid":30777,"vid":1,"name":"Retail Sales"}],"created":"2024-11-26T20:00:33Z","createdAt":"2024-11-26T20:00:33Z","id":42199358,"image":"https://www.benzinga.com/files/images/story/2024/11/26/wesley-gibbs-NxRx7-mPdEk-unsplash.jpeg","isBzPost":true,"isBzProPost":true,"meta":{"SectorV2":{"SIC":[{"IndustryCode":3741,"Industry":"Pharmaceutical and Medicine Industry","IndustryGroup":374,"MajorGroup":37,"Division":""}],"NAICS":[{"NationalIndustryCode":325411,"NationalIndustry":"Medicinal and Botanical Manufacturing ","IndustryCode":32541,"Industry":"Pharmaceutical and Medicine Manufacturing","IndustryGroupCode":3254,"IndustryGroup":"Pharmaceutical and Medicine Manufacturing","SubSectorCode":325,"SubSector":"Chemical Manufacturing","SectorCode":32,"Sector":"Manufacturing"}],"Morningstar":[{"IndustryCode":20620020,"Industry":"Drug Manufacturers—Specialty \u0026 Generic","IndustryGroupCode":20620,"IndustryGroup":"Drug Manufacturers","SectorCode":206,"Sector":"Healthcare","SuperSectorCode":2,"SuperSector":"Defensive"}]},"Partner":null,"PartnerTaxonomy":null,"SEC":null,"Author":null,"Authors":[{"uid":"0","name":""}],"Flags":{"ShowCopyrightNotice":true,"EvergreenContent":false,"ShowAdvertiserDisclosure":false,"ContributedContent":false,"AddGoogleStandoutMetaTag":false,"MediaSiteDNDOverride":false,"SendToYahooFinance":false,"SendToRobinhood":true,"SendToMSN":false},"Reach":{"Disclosure":{}},"Reference":null,"Ext":null,"wp_post_meta":{"campaign_strategy":"Default","post_id":665914,"post_path":"news/retail-sales/24/11/42199358/aurora-cannabis-reveals-latest-product-innovations-ultra-high-potency-indicas-and-strains-for-veterans","post_type":"post"}},"nodeId":42199358,"stocks":[{"tid":158152,"vid":2,"name":"ACB","primary":true},{"tid":677735,"vid":2,"name":"TSX:ACB","primary":true}],"storyId":"674628deb6cb720001ab0cd9","tags":[{"tid":805836,"vid":3,"name":"Aurora Coast"},{"tid":712759,"vid":3,"name":"Canada Cannabis"},{"tid":829110,"vid":3,"name":"cannabis strains"},{"tid":904489,"vid":3,"name":"Lana Culley"},{"tid":838712,"vid":3,"name":"marijuana products"}],"teaser":"Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), announced on Tuesday developments in cannabis science from Aurora\u0026#39;s research and genetics facility, Aurora Coast.\u0026#34;As a company committed to leading the way in terms of cannabis innovation, we are dedicated to putting patients first by harnessing the innovative solutions developed by our top researchers at Aurora Coast, our unique global research facility,\u0026#34; Lana Culley, vice president of science and innovation at Aurora. \u0026#34;We strive to continuously raise the bar on product superiority and overall user experience so that we can deliver on our mission of providing patients with access to the very best medical cannabis.\u0026#34;","teaserText":"Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), announced on Tuesday developments in cannabis science from Aurora\u0026#39;s research and genetics facility, Aurora Coast.\u0026#34;As a company committed to leading the way in terms of cannabis innovation, we are dedicated to putting patients first by harnessing the innovative solutions developed by our top researchers at Aurora Coast, our unique global research facility,\u0026#34; Lana Culley, vice president of science and innovation at Aurora. \u0026#34;We strive to continuously raise the bar on product superiority and overall user experience so that we can deliver on our mission of providing patients with access to the very best medical cannabis.\u0026#34;","tickers":[{"tid":158152,"vid":2,"name":"ACB","primary":true},{"tid":677735,"vid":2,"name":"TSX:ACB","primary":true}],"title":"Aurora Cannabis Reveals Latest Product Innovations: Ultra-High Potency Indicas And Strains For Veterans","updated":"2024-11-26T20:00:34Z","updatedAt":"2024-11-26T20:00:34Z","url":"https://www.benzinga.com/news/retail-sales/24/11/42199358/aurora-cannabis-reveals-latest-product-innovations-ultra-high-potency-indicas-and-strains-for-veterans"},{"assets":[{"type":"image","title":"2-12","alt":"2-12","source":"","mime":"","primary":true,"attributes":{"fid":"901883","filename":"2-12.png","filepath":"files/images/story/2024/11/26/2-12.png","filesize":0,"image_attributes":{"resolution":{"height":0,"width":0,"dpi":0}}}}],"author":"Juan Spínelli","channels":[{"tid":123430,"vid":1,"name":"Cannabis"},{"tid":26029,"vid":1,"name":"Government"},{"tid":57,"vid":1,"name":"News"},{"tid":748887,"vid":1,"name":"Psychedelics","description":"Coverage of Psychedelics."}],"created":"2024-11-26T19:38:13Z","createdAt":"2024-11-26T19:38:13Z","id":42198858,"image":"https://www.benzinga.com/files/images/story/2024/11/26/2-12.png","isBzPost":true,"isBzProPost":true,"meta":{"SectorV2":{},"Partner":null,"PartnerTaxonomy":null,"SEC":null,"Author":null,"Authors":[{"uid":"0","name":""}],"Flags":{"ShowCopyrightNotice":true,"EvergreenContent":false,"ShowAdvertiserDisclosure":false,"ContributedContent":false,"AddGoogleStandoutMetaTag":false,"MediaSiteDNDOverride":false,"SendToYahooFinance":false,"SendToRobinhood":true,"SendToMSN":true},"Reach":{"Disclosure":{}},"Reference":null,"Ext":null,"wp_post_meta":{"campaign_strategy":"Default","post_id":665893,"post_path":"markets/cannabis/24/11/42198858/veteran-access-to-psychedelic-mental-health-therapies-stalls-in-virginia","post_type":"post"}},"nodeId":42198858,"stocks":[],"storyId":"67462399b6cb720001ab0a64","tags":[{"tid":945687,"vid":3,"name":"Anthony Mijares"},{"tid":945688,"vid":3,"name":"Ghazala Hashmi"},{"tid":536746,"vid":3,"name":"Michael Jones"},{"tid":130601,"vid":3,"name":"military veterans"},{"tid":745828,"vid":3,"name":"Psilocybin"},{"tid":934818,"vid":3,"name":"Psychedelic Assisted Therapies"},{"tid":696405,"vid":3,"name":"PTSD"},{"tid":557442,"vid":3,"name":"Veterans Affairs"},{"tid":27644,"vid":3,"name":"virginia"},{"tid":945689,"vid":3,"name":"virginia psilocybin"}],"teaser":"Virginia lawmakers fail to advance legislation to explore psychedelic therapies like psilocybin, leaving future treatment uncertain.","teaserText":"Virginia lawmakers fail to advance legislation to explore psychedelic therapies like psilocybin, leaving future treatment uncertain.","tickers":[],"title":"Veteran Access To Psychedelic Mental Health Therapies Stalls In Virginia","updated":"2024-11-26T19:38:13Z","updatedAt":"2024-11-26T19:38:13Z","url":"https://www.benzinga.com/markets/cannabis/24/11/42198858/veteran-access-to-psychedelic-mental-health-therapies-stalls-in-virginia"},{"assets":[{"type":"image","title":"DEA hearing","alt":"Dea hearing","source":"AI generated image","mime":"","primary":true,"attributes":{"fid":"901882","filename":"DEA-hearing.png","filepath":"files/images/story/2024/11/26/DEA-hearing.png","filesize":0,"image_attributes":{"resolution":{"height":0,"width":0,"dpi":0}}}}],"author":"Rolando García","channels":[{"tid":123430,"vid":1,"name":"Cannabis"},{"tid":26029,"vid":1,"name":"Government"},{"tid":57,"vid":1,"name":"News"},{"tid":144213,"vid":1,"name":"Regulations"},{"tid":16779,"vid":1,"name":"Politics"},{"tid":2,"vid":1,"name":"Markets"}],"created":"2024-11-26T19:33:59Z","createdAt":"2024-11-26T19:33:59Z","id":42198793,"image":"https://www.benzinga.com/files/images/story/2024/11/26/DEA-hearing.png","isBzPost":true,"isBzProPost":true,"meta":{"SectorV2":{"SIC":[{"IndustryCode":152,"Industry":"Other Vegetable Farms","IndustryGroup":152,"MajorGroup":15,"Division":""}],"NAICS":[{"NationalIndustryCode":111219,"NationalIndustry":"Other Vegetable (except Potato) and Melon Farming ","IndustryCode":11121,"Industry":"Vegetable and Melon Farming","IndustryGroupCode":1112,"IndustryGroup":"Vegetable and Melon Farming","SubSectorCode":111,"SubSector":"Crop Production","SectorCode":11,"Sector":"Agriculture, Forestry, Fishing and Hunting"}],"Morningstar":[{"IndustryCode":20525020,"Industry":"Farm Products","IndustryGroupCode":20525,"IndustryGroup":"Consumer Packaged Goods","SectorCode":205,"Sector":"Consumer Defensive","SuperSectorCode":2,"SuperSector":"Defensive"}]},"Partner":null,"PartnerTaxonomy":null,"SEC":null,"Author":null,"Authors":[{"uid":"0","name":""}],"Flags":{"ShowCopyrightNotice":true,"EvergreenContent":false,"ShowAdvertiserDisclosure":false,"ContributedContent":false,"AddGoogleStandoutMetaTag":false,"MediaSiteDNDOverride":false,"SendToYahooFinance":false,"SendToRobinhood":true,"SendToMSN":true},"Reach":{"Disclosure":{}},"Reference":null,"Ext":null,"wp_post_meta":{"campaign_strategy":"Default","post_id":665998,"post_path":"government/regulations/24/11/42198793/prohibitionist-group-denies-collusion-allegations-ahead-of-dea-cannabis-rescheduling-hearing","post_type":"post"}},"nodeId":42198793,"stocks":[{"tid":367997,"vid":2,"name":"VFF","primary":true}],"storyId":"6746229cb6cb720001ab0a05","tags":[{"tid":907579,"vid":3,"name":"cannabis rescheduling"},{"tid":39013,"vid":3,"name":"DEA"},{"tid":736500,"vid":3,"name":"Hearing"},{"tid":829169,"vid":3,"name":"Hemp for Victory"},{"tid":945686,"vid":3,"name":"Judge John Mulrooney"},{"tid":19365,"vid":3,"name":"lawsuit"},{"tid":740629,"vid":3,"name":"Village Farms International"}],"teaser":"SAM denies collusion with the DEA amid cannabis rescheduling hearing allegations, calling the claims baseless distractions from the issue\u0026#39;s merits.","teaserText":"SAM denies collusion with the DEA amid cannabis rescheduling hearing allegations, calling the claims baseless distractions from the issue\u0026#39;s merits.","tickers":[{"tid":367997,"vid":2,"name":"VFF","primary":true}],"title":"Prohibitionist Group Denies Collusion Allegations Ahead Of DEA Cannabis Rescheduling Hearing","updated":"2024-11-26T19:34:00Z","updatedAt":"2024-11-26T19:34:00Z","url":"https://www.benzinga.com/government/regulations/24/11/42198793/prohibitionist-group-denies-collusion-allegations-ahead-of-dea-cannabis-rescheduling-hearing"}],"type":"default"},{"blockName":"acf/news-list-group","attrs":{"name":"acf/news-list-group","data":{"groups":[{"title":"Popular","title_case":false,"link":"","style":"","type":"parsely_news_list","loadMoreButton":true,"showSponsoredContent":false,"query_and_options":{"query":{"channelAndTagQueryOperator":"and"}},"query":{"channelAndTagQueryOperator":"and"},"parsely_query":{"limit":"50","section":"Cannabis","author":"","tag":""},"loadMoreDevice":"all","reachContent":{"placementIndex":3,"repeatIndex":5,"preload":true},"nodes":[{"id":42202403,"author":"Maureen Meehan","created":"Tue, 26 Nov 2024 17:42:49 -0400","updated":"Tue, 26 Nov 2024 17:42:49 -0400","title":"Elizabeth Warren, Bernie Sanders \u0026 12 Congress Members To Biden: Issue Clemency And Pardons For Cannabis Prisoners","teaser":"While Biden pardoned individuals with federal marijuana possession convictions, these measures have resulted in no prison releases.","body":"\u003cp\u003eA group of 14 Democratic lawmakers is urging President \u003cstrong\u003eJoe Biden\u003c/strong\u003e to expand his marijuana pardons and deprioritize federal cannabis prosecutions before the end of his term. \u003c/p\u003e\n\n\n\n\u003cp\u003eIn a letter addressed to \u003cstrong\u003eBiden\u003c/strong\u003e and VP \u003cstrong\u003eKamala Harris\u003c/strong\u003e, Senators \u003cstrong\u003eElizabeth Warren\u003c/strong\u003e (D-MA), \u003cstrong\u003eBarbara Lee\u003c/strong\u003e (D-CA), \u003cstrong\u003eBernie Sanders \u003c/strong\u003e(I-VT) as well as Reps. \u003cstrong\u003eEarl Blumenauer\u003c/strong\u003e (D-OR) and \u003cstrong\u003eIlhan Omar\u003c/strong\u003e (D-MN), along with nine more colleagues applauded Biden for getting the ball rolling on cannabis rescheduling but that more needs to be done before he leaves office.\u003c/p\u003e\n\n\n\n\u003ch2 class=\"wp-block-heading\"\u003e\u003cstrong\u003eRescheduling Cannabis Is Not Enough\u003c/strong\u003e\u003c/h2\u003e\n\n\n\n\u003cp\u003e\"Moving marijuana to Schedule III represents progress, and we urge the Drug Enforcement Administration to complete that process as soon as possible. But it will not end federal criminalization, resolve its harms, or meaningfully address the gap between federal and state cannabis policy,\" the lawmakers said in the letter, which was first \u003ca href=\"https://www.rollingstone.com/politics/politics-features/dems-biden-decriminalize-weed-trump-1235181464/\"\u003ereported\u003c/a\u003e by Rolling Stone. \"Possession and use of recreational marijuana—and much state-legal medical marijuana—will continue to be a violation of federal law.\"\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eRead Also\u003c/strong\u003e: \u003ca href=\"https://www.benzinga.com/news/legal/24/11/42177984/joe-biden-how-about-pardoning-non-violent-cannabis-prisoners-along-with-those-thanksgiving-turkeys\"\u003e\u003cstrong\u003eJoe Biden, How About Pardoning Non-Violent Cannabis Prisoners Along With Those Thanksgiving Turkeys?\u003c/strong\u003e\u003c/a\u003e\u003c/p\u003e\n\n\n\n\u003cp\u003eWhile lawmakers credited Biden for pardoning individuals with federal marijuana possession convictions, they rightly pointed out that these measures have resulted in no prison releases.\u003c/p\u003e\n\n\n\n\u003cp\u003e\"President Biden should issue broader clemency — including another round of pardons and commutations to reduce sentences or end terms of incarceration — for individuals convicted of other cannabis-related offenses,\" the lawmakers wrote. \"Additionally, the President should again urge state governors to expand marijuana clemency and decriminalize low-level marijuana conduct under state law.\"\u003c/p\u003e\n\n\n\n\u003cp\u003eThe congress members urged the Biden administration to grant broader clemency, including additional pardons and sentence commutations; they encouraged governors to extend similar pardons at the state level.\u003c/p\u003e\n\n\n\n\u003ch2 class=\"wp-block-heading\"\u003e\u003cstrong\u003eFederal Convictions Still Persist\u003c/strong\u003e\u003c/h2\u003e\n\n\n\n\u003cp\u003eThe second part of their request focused on issuing a memorandum to deprioritize federal enforcement against state-legal cannabis activity. Despite declining federal cannabis prosecutions due to state-level legalizations, the lawmakers noted that the threat of federal convictions persists. \u003c/p\u003e\n\n\n\n\u003cp\u003eThen there are the racial disparities in enforcement, the letter pointed out and further cited recent incidents where Customs and Border Protection (CBP) seized state-legal cannabis, including cases in New Mexico.\u003c/p\u003e\n\n\n\n\u003cp\u003eSignatories also include \u003cstrong\u003eCory Booker\u003c/strong\u003e (D-NJ), \u003cstrong\u003eRon Wyden\u003c/strong\u003e (D-OR), \u003cstrong\u003eJohn Hickenlooper\u003c/strong\u003e (D-CO), \u003cstrong\u003eKirsten Gillibrand\u003c/strong\u003e (D-NY) and \u003cstrong\u003eBen Ray Lujan \u003c/strong\u003e(D-NM) as well as Reps. \u003cstrong\u003eJan Schakowsky\u003c/strong\u003e (D-IL), \u003cstrong\u003eDina Titus\u003c/strong\u003e (D-NV), \u003cstrong\u003eJim McGovern\u003c/strong\u003e (D-MA) and \u003cstrong\u003eEleanor Holmes Norton\u003c/strong\u003e (D-DC).\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eNow Read:\u003c/strong\u003e\u003c/p\u003e\n\n\n\n\u003cul\u003e\n\u003cli\u003e\u003ca href=\"https://www.benzinga.com/markets/cannabis/24/11/42087262/president-biden-people-are-still-in-jail-for-marijuana-despite-your-promise-cannabis-clemency-advocates-call-for-change\"\u003e\u003cstrong\u003ePresident Biden, People Are Still In Jail For Marijuana Despite Your Promise, Cannabis Clemency Advocates Call For Change\u003c/strong\u003e\u003c/a\u003e\u003c/li\u003e\n\u003c/ul\u003e\n\n\n\n\u003cp\u003e\u003cem\u003ePhoto: Benzinga edit Adam Schultz on Wikimedia Commons and David Smart on Shutterstock\u003c/em\u003e\u003ca href=\"https://www.benzinga.com/apis?utm_source=benzinga.com\u0026amp;utm_campaign=article-bottom\" target=\"_blank\" rel=\"noreferrer noopener\"\u003e\u003c/a\u003e\u003c/p\u003e","url":"https://www.benzinga.com/news/legal/24/11/42202403/elizabeth-warren-bernie-sanders-12-congress-members-to-biden-issue-clemency-and-pardons-for-cannabis-prisoners","image":[{"size":"thumb","url":"https://cdn.benzinga.com/files/imagecache/250x187xUP/images/story/2024/11/26/joe-biden-cannabis-liberty-adam-schultz-.jpeg"},{"size":"small","url":"https://cdn.benzinga.com/files/imagecache/1024x768xUP/images/story/2024/11/26/joe-biden-cannabis-liberty-adam-schultz-.jpeg"},{"size":"large","url":"https://cdn.benzinga.com/files/imagecache/2048x1536xUP/images/story/2024/11/26/joe-biden-cannabis-liberty-adam-schultz-.jpeg"}],"channels":[{"name":"Cannabis"},{"name":"Government"},{"name":"News"},{"name":"Politics"},{"name":"Legal"}],"stocks":[],"tags":[{"name":"cannabis legalization"},{"name":"Cannabis pardons"},{"name":"Congress Members"},{"name":"Joe Biden"},{"name":"Stories That Matter"}]},{"id":42077935,"author":"Maureen Meehan","created":"Tue, 19 Nov 2024 19:28:00 -0400","updated":"Tue, 19 Nov 2024 19:28:01 -0400","title":"Trump Picks Dr. Oz, Who Says Seniors Should Give Medical Marijuana A Try, To Lead Centers For Medicare And Medicaid Services","teaser":"Trump to nominate TV personality Dr. Oz as administrator Centers for Medicare and Medicaid Services. Oz, known for his TV show, will work with RFK Jr. to take on the illness industrial complex.","body":"\u003cp\u003ePresident-elect Donald J. Trump \u003ca href=\"https://www.benzinga.com/general/health-care/24/11/42077057/trump-picks-dr-oz-as-centers-for-medicare-and-medicaid-services-administrator\"\u003eannounced on Tuesday afternoon\u003c/a\u003e that he will nominate TV personality Dr. \u003cstrong\u003eMehmet Oz\u003c/strong\u003e to serve as the administrator of the Centers for \u003ca href=\"https://www.benzinga.com/etfs/24/11/42044642/trump-appears-frustrated-as-elon-musk-chimes-in-on-treasury-secretary-adds-more-names-to-a-list-of-potential-picks\" target=\"_blank\" rel=\"noreferrer noopener\"\u003eMedicare and Medicaid Services (CMS)\u003c/a\u003e. The appointment is among a string of TV hosts — mostly from Fox News — to be chosen to join Trump's cabinet.\u003c/p\u003e\n\n\n\n\u003cp\u003eIn a statement, Trump said the celebrity TV host will \"work closely with Robert F. Kennedy Jr. to take on the illness industrial complex.\"\u003c/p\u003e\n\n\n\n\u003cp\u003eThough a household name due to his long-running \u0026#8220;\u003cstrong\u003eThe Dr. Oz Show\u003c/strong\u003e\" (2009-2022), Oz got into politics when he \u003ca href=\"https://www.benzinga.com/markets/cannabis/22/06/27558526/dr-oz-to-face-john-fetterman-in-unprecedented-unpredictable-pa-senate-race-and-cannabis-is-on-th\"\u003eunsuccessfully ran for Senate\u003c/a\u003e against now Sen. \u003cstrong\u003eJohn Fetterman\u003c/strong\u003e (D-Penn.) in 2022, during which time the good doctor seemed to forge an alliance with Trump.\u003c/p\u003e\n\n\n\n\u003cp\u003eAt the time,\u003cstrong\u003e Scientific American\u003c/strong\u003e\u0026nbsp;\u003ca href=\"https://www.scientificamerican.com/article/dr-oz-shouldnt-be-a-senator-or-a-doctor/\" target=\"_blank\" rel=\"noreferrer noopener\"\u003ewrote \u003c/a\u003eDr. Oz should not\u0026nbsp;be a senator or a doctor, noting that his misinformation had already tarnished medicine and would do much worse in the halls of Congress.\u0026nbsp;\"Dr. Oz\u0026nbsp;has long pushed misleading, science-free and unproven alternative therapies such as homeopathy, as well as fad diets, detoxes and cleanses.\"\u003c/p\u003e\n\n\n\n\u003ch1 class=\"wp-block-heading\"\u003e\u003cstrong\u003eDonald Trump Begs To Differ\u003c/strong\u003e\u003c/h1\u003e\n\n\n\n\u003cp\u003eNews outlets are quick to\u003ca href=\"https://www.axios.com/2024/11/19/trump-dr-oz-cms-cabinet\"\u003e point out\u003c/a\u003e that Dr. Oz has no experience running a large government body like the CMS but that seems to not matter because, according to the President-elect.\u003c/p\u003e\n\n\n\n\u003cp\u003e\u0026#8220;There may be no Physician more qualified and capable than Dr. Oz to Make America Healthy Again,\u0026#8221; Trump said in a statement, referring to the words of \u003ca href=\"https://www.benzinga.com/topic/robert-f-kennedy-jr\"\u003eRobert Kennedy Jr\u003c/a\u003e. who will, if confirmed run the \u003cstrong\u003eDept. of Health and Human Services\u003c/strong\u003e.\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eRead Also: \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/11/42036132/trump-wants-matt-gaetz-confirmed-100-so-does-the-cannabis-industry\"\u003eTrump Wants Matt Gaetz Confirmed \u0026#8216;100%,\u0026#8217; So Does The Cannabis Industry\u003c/a\u003e\u003c/strong\u003e\u003c/p\u003e\n\n\n\n\u003ch1 class=\"wp-block-heading\"\u003e\u003cstrong\u003eDr. Oz On Cannabis\u003c/strong\u003e\u003c/h1\u003e\n\n\n\n\u003cp\u003eThe multimillionaire TV host initially called cannabis a \u0026#8220;mixed bag for easing pain.\u0026#8221; But a recent discussion with\u0026nbsp;\u003cstrong\u003eMichael Roizen,\u0026nbsp;\u003c/strong\u003eM.D., of the Wellness Institute at the Cleveland Clinic, Dr. \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/08/40492959/trump-endorsed-dr-oz-on-medical-marijuana-and-pain-give-it-a-try\"\u003eOz said\u003c/a\u003e, \u0026#8220;Our advice: If your physician recommends it to manage pain, especially if you\u0026#8217;re 65 and older, give it a try.\u0026#8221;\u003c/p\u003e\n\n\n\n\u003cp\u003eWhile Dr. Oz cautions against cannabis consumption for recreational purposes, he said he believes marijuana for pain represents a \"safer solution than, for example, narcotics in many cases.\"\u003c/p\u003e\n\n\n\n\u003cp\u003eDuring his Senate race, Dr. Oz often criticized Fetterman\u0026#8217;s support for cannabis legalization though several years earlier he himself \u003ca href=\"https://www.marijuanamoment.net/dr-oz-claims-dea-and-fda-blame-each-other-for-keeping-marijuana-illegal/\"\u003ereferred to cannabis\u003c/a\u003e\u0026nbsp;as \"one of the most underused tools in America\" and that the U.S. should\u0026nbsp;\"completely change our policy on marijuana.\"\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eNow Read:\u003c/strong\u003e\u003c/p\u003e\n\n\n\n\u003cul\u003e\n\u003cli\u003e\u003ca href=\"https://www.benzinga.com/markets/cannabis/24/11/42069004/how-trumps-election-could-revolutionize-cannabis-and-cryptocurrency-ceo-says\"\u003eHow Trump\u0026#8217;s Election Could Revolutionize Cannabis And Cryptocurrency, CEO Says\u003c/a\u003e\u003c/li\u003e\n\u003c/ul\u003e","url":"https://www.benzinga.com/general/health-care/24/11/42077935/trump-picks-dr-oz-who-says-seniors-should-give-medical-marijuana-a-try-to-lead-centers-for-medicare-and-medicaid-services","image":[{"size":"thumb","url":"https://cdn.benzinga.com/files/imagecache/250x187xUP/images/story/2024/11/19/Dr--Oz-weed.jpeg"},{"size":"small","url":"https://cdn.benzinga.com/files/imagecache/1024x768xUP/images/story/2024/11/19/Dr--Oz-weed.jpeg"},{"size":"large","url":"https://cdn.benzinga.com/files/imagecache/2048x1536xUP/images/story/2024/11/19/Dr--Oz-weed.jpeg"}],"channels":[{"name":"Cannabis"},{"name":"Government"},{"name":"News"},{"name":"Health Care"},{"name":"Politics"},{"name":"Top Stories"}],"stocks":[],"tags":[{"name":"Centers For Medicare And Medicaid Services"},{"name":"Donald Trump"},{"name":"Dr. Dr. Mehmet Oz"},{"name":"Robert F. Kennedy Jr."}]},{"id":42190193,"author":"Nina Zdinjak","created":"Tue, 26 Nov 2024 10:11:32 -0400","updated":"Tue, 26 Nov 2024 10:11:33 -0400","title":"Tilray Introduces New Indica Strain With 'Potent THC And A Unique Terpene Profile'","teaser":" ","body":"\u003cp\u003e\u003cstrong\u003eCannabis giant Tilray Brands, Inc.\u003c/strong\u003e (NASDAQ:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/TLRY#NASDAQ\"\u003eTLRY\u003c/a\u003e) announced the latest small batch indica strain by its craft cannabis brand, \u003cstrong\u003eBroken Coast: Platinum Pavé\u003c/strong\u003e. This new cultivar is one of the first from Broken Coast\u0026#8217;s state-of-the-art Vancouver Island, BC facility. Platinum Pavé is grown under optimized conditions in single-strain, laboratory-grade rooms. Each batch is precisely pruned, slowly cold cured and rigorously inspected for purity.\u003c/p\u003e\n\n\n\n\u003cp\u003e\"We're excited for consumers to get their hands on this exceptional indica,\" stated \u003cstrong\u003eKevin Anderson,\u003c/strong\u003e master grower at Broken Coast. \"After phenohunting over 500 seeds, we're extremely proud to cultivate a strain with potent THC and a unique terpene profile. With our slow cold curing process, we take pride in preserving trichome density, delivering the purest expression of the Spritzer x Pavé cross to deliver something special.\"\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eRead Also: \u003c/strong\u003e\u003ca href=\"https://www.benzinga.com/analyst-ratings/analyst-color/24/11/41811378/aurora-vs-canopy-tilray-which-nasdaq-listed-cannabis-stock-offers-the-best-growth-p\"\u003eAurora vs. Canopy \u0026amp; Tilray: Which NASDAQ-Listed Cannabis Stock Offers The Best Growth Potential?\u003c/a\u003e\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cem\u003e\u003cstrong\u003eGet Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter \u003ca href=\"https://newsletteremail.benzinga.com/subscribe\" target=\"_blank\" rel=\"noreferrer noopener\"\u003ehere\u003c/a\u003e. If you're serious about the business, you can't afford to miss out.\u003c/strong\u003e\u003c/em\u003e\u003c/p\u003e\n\n\n\n\u003ch2 class=\"wp-block-heading\"\u003ePlatinum Pavé Higlights\u003c/h2\u003e\n\n\n\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003eLineage:\u003c/strong\u003e Spritzer x Pavé.\u003c/li\u003e\n\n\n\n\u003cli\u003e\u003cstrong\u003eAromas:\u003c/strong\u003e Sweet, earthy with a potent hint of diesel.\u003c/li\u003e\n\n\n\n\u003cli\u003e\u003cstrong\u003eRich terpene profile featuring:\u003c/strong\u003e Limonene, Caryophyllene, Linalool.\u003c/li\u003e\n\n\n\n\u003cli\u003e\u003cstrong\u003eTHC range:\u003c/strong\u003e\u0026nbsp;Potent and suitable for winding down after a long day or enjoying socially.\u003c/li\u003e\n\u003c/ul\u003e\n\n\n\n\u003cp\u003eDespite the laborious process, the team is dedicated to thoughtfully choosing strains and refining their growing and curing techniques to develop the best product possible. Platinum Pavé joins Broken Coast's renowned craft cannabis portfolio, including Cherry Cheesecake, EmergenZ, Sour OG, Holy Grail Kush, Amnesia Haze, and most recent fan favorite, Milk \u0026amp; Cookies.\u003c/p\u003e\n\n\n\n\u003cp\u003eCraft flower enthusiasts can experience the handcrafted genetics of Broken Coast\u0026#8217;s Platinum Pavé, available in 7g exclusively in British Columbia, with 3.5g whole flower, and in pre-rolls – 3\u0026#215;0.5g and 5\u0026#215;0.5g multipacks coming to Ontario and Alberta in the new year.\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003ePrice Action\u003c/strong\u003e\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eTilray shares traded flat at $1.42 during Tuesday's pre-market session.\u003c/strong\u003e\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eRead Next:\u003c/strong\u003e\u003c/p\u003e\n\n\n\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003e\u003ca href=\"https://www.benzinga.com/markets/cannabis/24/11/41997646/tilray-joins-german-cannabis-fiesta-with-first-locally-grown-strains\"\u003eTilray Joins German Cannabis Fiesta With First Locally Grown Strains\u003c/a\u003e\u003c/strong\u003e\u003c/li\u003e\n\u003c/ul\u003e\n\n\n\n\u003cp\u003e\u003cem\u003eCourtesy photo \u003c/em\u003e\u003c/p\u003e","url":"https://www.benzinga.com/markets/cannabis/24/11/42190193/tilray-introduces-new-indica-strain-with-potent-thc-and-a-unique-terpene-profile","image":[{"size":"thumb","url":"https://cdn.benzinga.com/files/imagecache/250x187xUP/images/story/2024/11/26/New-Project-173.jpeg"},{"size":"small","url":"https://cdn.benzinga.com/files/imagecache/1024x768xUP/images/story/2024/11/26/New-Project-173.jpeg"},{"size":"large","url":"https://cdn.benzinga.com/files/imagecache/2048x1536xUP/images/story/2024/11/26/New-Project-173.jpeg"}],"channels":[{"name":"Cannabis"},{"name":"News"}],"stocks":[{"name":"TLRY"}],"tags":[{"name":"Kevin Anderson"},{"name":"premium"}]},{"id":42152643,"author":"Maureen Meehan","created":"Sat, 23 Nov 2024 13:30:25 -0400","updated":"Sat, 23 Nov 2024 13:30:25 -0400","title":"DEA Banned From Random Airport Searches After Scathing Justice Department Report Uncovers Corruption","teaser":"The DEA has been barred from conducting random searches of travelers\u0026#39; belongings at airports and transit hubs following a Justice Department investigation that exposed corrupt practices.","body":"\u003cp\u003eThe \u003ca href=\"https://www.benzinga.com/topic/dea\"\u003eDrug Enforcement Administration \u003c/a\u003e(DEA) has been barred from conducting random searches of travelers\u0026#8217; belongings at airports and transit hubs following a \u003cstrong\u003eJustice Department\u003c/strong\u003e investigation that exposed corrupt practices. The investigation, led by Inspector General \u003cstrong\u003eMichael Horowitz\u003c/strong\u003e, uncovered failures to properly document searches, potential racial profiling and questionable partnerships with airline employees. \u003c/p\u003e\n\n\n\n\u003cp\u003eOne airline worker reportedly received tens of thousands of dollars over several years as a kickback for flagging passengers based on travel patterns, such as purchasing last-minute tickets. \u003c/p\u003e\n\n\n\n\u003cp\u003e\"The DOJ Office of the Inspector General (OIG) found that the DEA has repeatedly failed to comply with its own policies, creating significant operational and legal risks,\" according to the \u003ca href=\"https://oig.justice.gov/news/doj-oig-releases-management-alert-identifying-concerns-deas-transportation-interdiction\"\u003ereport\u003c/a\u003e.\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eRead Also: \u003ca href=\"https://www.benzinga.com/markets/cannabis/23/07/33156524/dea-turns-50-unveiling-the-ineffectiveness-of-the-ongoing-war-on-drugs-now-what\"\u003e$1 Trillion And 50 Years Later, Is The DEA\u0026#8217;s War On Drugs A Failure?\u003c/a\u003e\u003c/strong\u003e\u003c/p\u003e\n\n\n\n\u003cp\u003eThe decision to suspend the searches was issued on November 12 by the deputy attorney general after reviewing the draft report. The Justice Department's memo restricts DEA agents from engaging in consensual encounters at transit locations unless tied to active investigations or approved under special circumstances.\u003c/p\u003e\n\n\n\n\u003ch2 class=\"wp-block-heading\"\u003e\u003cstrong\u003eSystemic Corruption\u003c/strong\u003e\u003c/h2\u003e\n\n\n\n\u003cp\u003eThe report follows a widely circulated video released by the \u003ca href=\"https://ij.org/press-release/department-of-justice-suspends-controversial-airport-interdictions-after-viral-footage-showing-dea-agents-threatening-abusing-innocent-traveler/\"\u003eInstitute for Justice\u003c/a\u003e (IJ), a nonprofit civil rights organization. One case cited in the memo involved a traveler approached by a DEA Task Force Officer at an airport. The video shows a traveler, identified as David C., refusing to consent to a search at an airport. Despite his objections, agents took his backpack, claimed a drug-detection dog alerted them and conducted the search, which yielded no illegal items. The delay, which caused David to miss his flight, resulted in widespread public criticism.\u003c/p\u003e\n\n\n\n\u003cp\u003eFurther investigation revealed systemic issues. The DEA rarely documents its searches unless they result in seizures or arrests, making it impossible to determine how many travelers have been impacted. In one case, musician Brian Moore had $8,500 seized at an airport, money intended for a music video project. He was never charged with a crime but spent a year and $15,000 in legal fees to recover his funds. Moore said the experience ruined his music career.\u003c/p\u003e\n\n\n\n\u003cp\u003eA 2016 \u003ca href=\"https://www.usatoday.com/story/news/2016/08/10/dea-travel-record-airport-seizures/88474282/\"\u003eUSA Today investigation\u003c/a\u003e found that DEA agents seized over $209 million from more than 5,200 travelers at 15 major airports over a decade, with most funds shared with local police. Critics argue these practices incentivize unconstitutional searches for profit.\u003c/p\u003e\n\n\n\n\u003cp\u003eThe Institute for Justice has since sued the DEA and TSA, advocating for legislation to eliminate these financial incentives. The DEA has yet to respond to the findings.\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eNow Read:\u003c/strong\u003e\u003c/p\u003e\n\n\n\n\u003cul\u003e\n\u003cli\u003e\u003ca href=\"https://www.benzinga.com/markets/cannabis/24/08/40586896/dea-can-still-make-cannabis-arrests-in-legal-weed-states-like-ohio-but-its-not-our-goal\"\u003e\u003cstrong\u003eDEA Can Still Make Cannabis Arrests In Legal Weed States Like Ohio, But It\u0026#8217;s Not \u0026#8216;Our Goal\u0026#8217;\u003c/strong\u003e\u003c/a\u003e\u003c/li\u003e\n\u003c/ul\u003e\n\n\n\n\u003cp\u003e\u003cem\u003ePhoto: Courtesy of DEA\u003c/em\u003e\u003c/p\u003e","url":"https://www.benzinga.com/markets/cannabis/24/11/42152643/dea-banned-from-random-airport-searches-after-scathing-justice-department-report-uncovers-corruption","image":[{"size":"thumb","url":"https://cdn.benzinga.com/files/imagecache/250x187xUP/images/story/2024/11/23/DEA-MM.jpeg"},{"size":"small","url":"https://cdn.benzinga.com/files/imagecache/1024x768xUP/images/story/2024/11/23/DEA-MM.jpeg"},{"size":"large","url":"https://cdn.benzinga.com/files/imagecache/2048x1536xUP/images/story/2024/11/23/DEA-MM.jpeg"}],"channels":[{"name":"Cannabis"},{"name":"Government"},{"name":"News"},{"name":"Top Stories"}],"stocks":[],"tags":[{"name":"DEA"},{"name":"Dept. Of Justice"},{"name":"Inspector General Michael Horowitz"},{"name":"Institute for Justice"}]},{"id":42167296,"author":"Javier Hasse","created":"Mon, 25 Nov 2024 11:42:19 -0400","updated":"Mon, 25 Nov 2024 11:42:19 -0400","title":"Did Elon Musk Really Use A Meme Of Pablo Escobar Smoking Weed To Celebrate Trump's Election Victory? What Does It Even Mean?","teaser":"Elon Musk\u0026#39;s tweet featuring Pablo Escobar smoking weed to celebrate Trump\u0026#39;s reelection sparks debate. What does it mean?","body":"\u003cp\u003e\u003cstrong\u003eElon Musk\u003c/strong\u003e recently set social media abuzz with a tweet featuring a clip from \u003cstrong\u003eNetflix\u0026#8217;s \u0026#8220;Narcos,\u0026#8221;\u003c/strong\u003e where \u003cstrong\u003ePablo Escobar,\u003c/strong\u003e portrayed by actor \u003cstrong\u003eWagner Moura,\u003c/strong\u003e is seen smoking a joint. Musk captioned the post, \u0026#8220;Actual footage of me after @realDonaldTrump won,\u0026#8221; referring to \u003ca href=\"https://www.benzinga.com/news/24/11/41768178/donald-trump-defeats-kamala-harris-to-win-2024-election\"\u003eDonald Trump\u0026#8217;s 2024 victory\u003c/a\u003e. The tweet\u0026#8217;s provocative nature, tying a drug kingpin character to a political celebration, triggered a range of reactions online.\u003c/p\u003e\n\n\n\n\u003cfigure class=\"wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter\"\u003e\u003cdiv class=\"wp-block-embed__wrapper\"\u003e\n\u003cblockquote class=\"twitter-tweet\" data-width=\"500\" data-dnt=\"true\"\u003e\u003cp lang=\"en\" dir=\"ltr\"\u003eActual footage of me after \u003ca href=\"https://twitter.com/realDonaldTrump?ref_src=twsrc%5Etfw\"\u003e@realDonaldTrump\u003c/a\u003e won \u003ca href=\"https://t.co/PhPJjzaw0J\"\u003epic.twitter.com/PhPJjzaw0J\u003c/a\u003e\u003c/p\u003e\u0026mdash; Elon Musk (@elonmusk) \u003ca href=\"https://twitter.com/elonmusk/status/1860475842800812347?ref_src=twsrc%5Etfw\"\u003eNovember 24, 2024\u003c/a\u003e\u003c/blockquote\u003e\u003cscript async src=\"https://platform.twitter.com/widgets.js\" charset=\"utf-8\"\u003e\u003c/script\u003e\n\u003c/div\u003e\u003c/figure\u003e\n\n\n\n\u003ch3 class=\"wp-block-heading\"\u003e\u003cstrong\u003eMusk's Cannabis Advocacy And Public Persona\u003c/strong\u003e\u003c/h3\u003e\n\n\n\n\u003cp\u003eMusk's selection of a cannabis-themed scene aligns with his public stance on marijuana and psychedelics. In 2018, Musk famously smoked a joint during a live appearance on \u0026#8220;The Joe Rogan Experience,\u0026#8221; sparking both cultural fascination and corporate scrutiny. The incident even prompted NASA to review SpaceX's workplace practices.\u003c/p\u003e\n\n\n\n\u003cp\u003eBeyond this, Musk has consistently supported the legalization of \u003ca href=\"https://www.benzinga.com/cannabis\"\u003ecannabis\u003c/a\u003e and the therapeutic use of \u003ca href=\"https://www.benzinga.com/topic/psychedelics\"\u003epsychedelics\u003c/a\u003e, recently describing them as \"pretty helpful\" for conditions like PTSD and depression. His tweet juxtaposes this advocacy with a tongue-in-cheek nod to cannabis culture, though some critics have questioned the appropriateness of invoking Escobar\u0026#8217;s likeness in the context of drug reform.\u003c/p\u003e\n\n\n\n\u003ch3 class=\"wp-block-heading\"\u003e\u003cstrong\u003eMusk's Role In Trump's Reelection And Political Context\u003c/strong\u003e\u003c/h3\u003e\n\n\n\n\u003cp\u003eThe tweet coincides with Musk's increasing prominence in U.S. politics. As co-leader of the \u003cstrong\u003eDepartment of Government Efficiency (DOGE)\u003c/strong\u003e, a special initiative within President-elect Donald Trump's upcoming administration, Musk is tasked with identifying waste in federal operations and driving cost-cutting measures.\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003e\u003cem\u003eSee also: \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/11/41951578/trump-taps-cannabis-supporters-elon-musk-vivek-ramaswamy-to-slash-government-spending\"\u003eTrump Taps Cannabis Supporters Elon Musk, Vivek Ramaswamy To Slash Government Spending\u003c/a\u003e\u003c/em\u003e\u003c/strong\u003e\u003c/p\u003e\n\n\n\n\u003cp\u003eThe role cements Musk's alignment with Trump's deregulatory platform, but his cannabis-friendly public image contrasts sharply with conservative perspectives on drug policy.\u003c/p\u003e\n\n\n\n\u003ch3 class=\"wp-block-heading\"\u003e\u003cstrong\u003eWagner Moura's Political Views And Social Media Irony\u003c/strong\u003e\u003c/h3\u003e\n\n\n\n\u003cp\u003eWagner Moura, the Brazilian actor known for his portrayal of Escobar in \u0026#8220;Narcos,\u0026#8221; holds progressive political views that contrast with Musk's alignment with Trump. Moura has openly \u003ca href=\"https://www.yahoo.com/entertainment/wagner-moura-chasing-truth-100000406.html?utm_source=chatgpt.com\u0026amp;guccounter=1\u0026amp;guce_referrer=aHR0cHM6Ly9jaGF0Z3B0LmNvbS8\u0026amp;guce_referrer_sig=AQAAAHyPGwAKPhq_ebbbAr72fKnwcPnvJS6EpQAlbqiXcPZejVhUfydhaxYD39x4-d1Xi4IZ9CYMdVNt30qS4HKVbbOP2T71GtilDmAimDnHraRNLm8zAuS3LxtiLjwBvSDS9Veg3PKX0XNT33KTYuXeq4qsqFCIZYHrN8nkqE3v-2vh\"\u003esupported\u003c/a\u003e leftist causes in Brazil and has been an outspoken critic of authoritarianism. While he has not directly criticized Trump on record, his advocacy for democratic values and opposition to leaders like Brazil's former president \u003cstrong\u003eJair Bolsonaro\u003c/strong\u003e suggest ideological differences with Trump's approach.\u003c/p\u003e\n\n\n\n\u003cp\u003eThis clash between Moura and Musk was not lost on social media. One Twitter user noted, \"This actor is Brazilian. He hates Donald Trump and loves Fidel Castro,\" while another added, \"This actor is Brazilian, liberal, and deeply hates you, Elon.\" Moura has not publicly commented on the incident, but the online reactions pointed out the irony of Musk's use of the clip\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cem\u003ePhoto by \u003ca href=\"https://commons.wikimedia.org/wiki/User:Dmoberhaus\"\u003eDaniel Oberhaus\u003c/a\u003e via \u003ca href=\"https://commons.wikimedia.org/wiki/File:Elon_Musk_at_a_Press_Conference.jpg\"\u003eWikimedia Commons\u003c/a\u003e, edited by Benzinga\u003c/em\u003e\u003c/p\u003e","url":"https://www.benzinga.com/general/social-media/24/11/42167296/did-elon-musk-really-use-a-meme-of-pablo-escobar-smoking-weed-to-celebrate-trumps-reelection-what-does-it-even-mean","image":[{"size":"thumb","url":"https://cdn.benzinga.com/files/imagecache/250x187xUP/images/story/2024/11/25/Portadas-Javi-Benzinga57.png"},{"size":"small","url":"https://cdn.benzinga.com/files/imagecache/1024x768xUP/images/story/2024/11/25/Portadas-Javi-Benzinga57.png"},{"size":"large","url":"https://cdn.benzinga.com/files/imagecache/2048x1536xUP/images/story/2024/11/25/Portadas-Javi-Benzinga57.png"}],"channels":[{"name":"Cannabis"},{"name":"News"},{"name":"Social Media"},{"name":"Politics"},{"name":"Top Stories"}],"stocks":[],"tags":[{"name":"Donald Trump"},{"name":"Elon Musk"},{"name":"Narcos on Netflix"},{"name":"Wagner Moura"}]},{"id":42086839,"author":"Nina Zdinjak","created":"Wed, 20 Nov 2024 09:11:28 -0400","updated":"Wed, 20 Nov 2024 09:11:29 -0400","title":"After Four Weeks, New Drug Shows Promising Results In Boosting Life Skills For Down Syndrome Patients","teaser":" ","body":"\u003cp\u003eFrench biotech company \u003cstrong\u003eAelis Farma\u003c/strong\u003e, specializing in the treatment of brain disorders announced positive results Monday from a \u003ca href=\"https://www.benzinga.com/markets/cannabis/22/11/29769327/aelis-farmas-drug-candidate-for-the-treatment-of-cognitive-disorders-authorized-for-the-first-tr\"\u003ePhase 1/2 trial of its drug candidate AEF0217\u003c/a\u003e in young adults with Down syndrome. The study, conducted in Spain, assessed the safety, tolerability and potential efficacy of AEF0217, a selective CB1 receptor inhibitor targeting cognitive and behavioral impairments.\u003c/p\u003e\n\n\n\n\u003cp\u003eThe study successfully met its safety (primary), pharmacokinetics (secondary) and efficacy (secondary and exploratory) objectives. AEF0217 was well tolerated and no safety concerns were observed. The drug improved adaptive behavior in areas such as communication, daily living skills and socialization.\u003c/p\u003e\n\n\n\n\u003cp\u003e\"The promising and impressive results of this study generate a real hope to develop an efficacious and safe treatment for the cognitive disabilities of people with Down syndrome,\" stated \u003cstrong\u003eProf. Rafael de la Torre Fornell\u003c/strong\u003e, the trial's principal investigator.\u003cem\u003e \"\u003c/em\u003eParticularly striking are the efficacy data, which addresses crucial domains of adaptation, such as expression and writing abilities as well as certain daily living skills and societal interactions. These types of effects, especially because obtained after only four weeks of treatment, are certainly a first in the field of Down syndrome and represent a major step towards the development of a treatment that could significantly improve the autonomy and adaptation of people with Down syndrome. I would like to take this occasion to also send my warmest thanks to the participants, their families and family associations who supported this innovative project and helped us to complete this pioneering clinical trial.\"\u003c/p\u003e\n\n\n\n\u003cp\u003eIt is noteworthy that AEF0217 seemed to induce larger improvements in participants with the greater impairments before starting the treatment.\u003c/p\u003e\n\n\n\n\u003cp\u003eMoreover, adaptive behavior and cognition were assessed after just four weeks of treatment, whereas experts generally believe several months are needed to modify these functions in neurodevelopmental disabilities.\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eRead Also: \u003ca href=\"http://a/\"\u003eCan THC Turn Back The Clock? Cannabis Reverses Brain Aging, Boosts Mental Capacity, New Study Suggests\u003c/a\u003e\u003c/strong\u003e\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cem\u003e\u003cstrong\u003eGet Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter \u003ca href=\"https://newsletteremail.benzinga.com/subscribe\" target=\"_blank\" rel=\"noreferrer noopener\"\u003ehere\u003c/a\u003e. If you're serious about the business, you can't afford to miss out.\u003c/strong\u003e\u003c/em\u003e\u003c/p\u003e\n\n\n\n\u003ch2 class=\"wp-block-heading\"\u003ePaving The Way For Treating Other Cognitive Disorders\u003c/h2\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003ePier Vincenzo Piazza, \u003c/strong\u003eCEO of Aelis Farma, concluded, \"We see this accomplishment as a milestone in the development of a promising therapy that could significantly improve the autonomy and quality of life of people with Down syndrome. It is also, more generally, the first evidence of the positive impact of AEF0217 on cognition, which could pave the way for the treatment of other cognitive disorders.\"\u003c/p\u003e\n\n\n\n\u003cp\u003ePiazza also highlighted that these results offer a supplementary validation of the safety of the new pharmacological class developed by the company \u0026#8211; Signaling Specific inhibitors of the CB\u003csub\u003e1\u003c/sub\u003e receptor (CB\u003csub\u003e1\u003c/sub\u003e-Ssi). \"We believe that the CB\u003csub\u003e1\u003c/sub\u003e-SSi represent a major innovation in pharmacology that will allow to generate inhibitors not only efficacious but also safe and well tolerated, opening the way to new treatments of conditions without treatment today,\" he concluded.\u003c/p\u003e\n\n\n\n\u003cp\u003eFollowing these results, Aelis Farma plans a Phase 2 international study in 2025 to further evaluate its efficacy and adaptative behavior improvements.\u003c/p\u003e\n\n\n\n\u003cp\u003eThe clinical development of AEF0217, the phase 1 program in healthy volunteers, the phase 1/2 just completed and the next phase 2 in people with Down syndrome are part of the European H2020 ICOD project (Improving COgnition in Down syndrome, Grant Agreement ID 899986). The ICOD project received €6 million ($6.33 million) of fundings from the European Commission and involves partners in Spain, France and Italy.\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eRead Next: \u003c/strong\u003e\u003ca href=\"https://www.benzinga.com/markets/cannabis/24/09/40722274/french-biotech-candidate-for-cannabis-use-disorder-fails-phase-2b-clinical-trial-indivior-will-n\"\u003e\u003cstrong\u003eFrench Biotech Candidate For Cannabis Use Disorder Fails Phase 2B Clinical Trial, Indivior Will Not Exercise Option\u003c/strong\u003e\u003c/a\u003e\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cem\u003ePhoto generated with AI \u003c/em\u003e\u003c/p\u003e","url":"https://www.benzinga.com/markets/cannabis/24/11/42086839/after-four-weeks-new-drug-shows-promising-results-in-boosting-life-skills-for-down-syndrome-patients","image":[{"size":"thumb","url":"https://cdn.benzinga.com/files/imagecache/250x187xUP/images/story/2024/11/20/A-visually-engaging-digital-illustration.jpeg"},{"size":"small","url":"https://cdn.benzinga.com/files/imagecache/1024x768xUP/images/story/2024/11/20/A-visually-engaging-digital-illustration.jpeg"},{"size":"large","url":"https://cdn.benzinga.com/files/imagecache/2048x1536xUP/images/story/2024/11/20/A-visually-engaging-digital-illustration.jpeg"}],"channels":[{"name":"Cannabis"},{"name":"News"}],"stocks":[],"tags":[{"name":"Aelis Farma"},{"name":"Down Syndrome"},{"name":"Pier Vincenzo Piazza"},{"name":"premium"},{"name":"Torre Fornell"}]},{"id":42193953,"author":"Javier Hasse","created":"Tue, 26 Nov 2024 12:02:33 -0400","updated":"Tue, 26 Nov 2024 12:02:33 -0400","title":"Thrive Capital, Tiger Global-Backed Cannabis Wholesale Platform LeafLink Buys Leaf Trade: Co. Will Process ~$9B In Annual GMV","teaser":"LeafLink acquires Leaf Trade, creating a $9B cannabis wholesale platform and expanding industry-leading tools.","body":"\u003cp\u003e\u003cstrong\u003eLeafLink\u003c/strong\u003e, a cannabis wholesale platform, has announced its acquisition of \u003cstrong\u003eLeaf Trade\u003c/strong\u003e, a specialized marketplace catering to multi-state operators (MSOs) and enterprise cannabis businesses. The combined entity is poised to process nearly $9 billion in annual gross merchandise value (GMV). The price tag or conditions of the transaction were not disclosed.\u003c/p\u003e\n\n\n\n\u003ch3 class=\"wp-block-heading\"\u003e\u003cstrong\u003eStreamlining Cannabis Operations\u003c/strong\u003e\u003c/h3\u003e\n\n\n\n\u003cp\u003eThis strategic acquisition aligns with LeafLink's mission to optimize cannabis operations through advanced technology and financial solutions. \u0026#8220;Leaf Trade has been the clear industry leader serving the MSO and enterprise segment, and we are thrilled to welcome the Leaf Trade team to LeafLink. Our mission is to help the regulated cannabis industry reach its greatest potential by streamlining operational processes and improving financial performance,\u0026#8221; said LeafLink's president and CEO, \u003cstrong\u003eArtie Minson\u003c/strong\u003e.\u003c/p\u003e\n\n\n\n\u003cp\u003eThe merger combines Leaf Trade's expertise in the MSO sector with LeafLink's tools, offering solutions tailored to both small-scale businesses and large enterprises. While the two platforms will initially operate independently, plans are in place for a comprehensive integration.\u003c/p\u003e\n\n\n\n\u003ch3 class=\"wp-block-heading\"\u003e\u003cstrong\u003eExpanding The Toolbox For Cannabis Businesses\u003c/strong\u003e\u003c/h3\u003e\n\n\n\n\u003cp\u003eThe acquisition adds considerable depth to LeafLink's suite of offerings, which now includes tools for B2B marketplace transactions, business banking and advertising, as well as fintech solutions like Payment on Sell-Through. This innovative tool addresses the pervasive issue of delinquent payments in the cannabis sector, providing a financial lifeline to businesses struggling with cash flow.\u003c/p\u003e\n\n\n\n\u003cp\u003eLeaf Trade\u0026#8217;s CEO, \u003cstrong\u003eBrian Ward\u003c/strong\u003e, highlighted the benefits for customers. \"This acquisition is an incredible win for our team, our customers, and the advancement of the cannabis industry. With LeafLink's acquisition, we're unifying our strengths to create innovative solutions that drive growth and value across the supply chain.\"\u003c/p\u003e\n\n\n\n\u003cp\u003eFollowing this transaction, \u003cstrong\u003eSweed\u003c/strong\u003e, a logistics partner under \u003cstrong\u003eLeaf Trade's High Tech Holdings,\u003c/strong\u003e will remain independent. This separation allows Sweed to capitalize on its momentum and continue building smarter tools for operational efficiency.\u003c/p\u003e\n\n\n\n\u003ch3 class=\"wp-block-heading\"\u003e\u003cstrong\u003eFinancial Momentum And Industry Innovations\u003c/strong\u003e\u003c/h3\u003e\n\n\n\n\u003cp\u003eLeafLink has experienced remarkable growth, driven by its expanding product portfolio and strategic acquisitions like \u003cstrong\u003eDama Financial,\u003c/strong\u003e which bolsters its cannabis banking capabilities. Its Series D fundraising round, recently upsized from $100 million to $125 million, attracted high-profile investors such as \u003cstrong\u003eTiger Global Management\u003c/strong\u003e, a global leader in tech and growth equity, and \u003cstrong\u003eThrive Capital\u003c/strong\u003e, renowned for backing companies like \u003cstrong\u003eStripe\u003c/strong\u003e and \u003cstrong\u003eInstagram.\u003c/strong\u003e\u003c/p\u003e\n\n\n\n\u003cp\u003eAs the cannabis industry faces increasing regulatory and financial pressures, LeafLink's unified platform aims to address critical pain points, creating a more seamless and reliable infrastructure for operators. By leveraging synergies from the Leaf Trade acquisition, the company is positioning itself as the definitive B2B operating system for the cannabis industry.\u003c/p\u003e\n\n\n\n\u003cp\u003eCover image by Benzinga\u003c/p\u003e","url":"https://www.benzinga.com/markets/cannabis/24/11/42193953/thrive-capital-tiger-global-backed-cannabis-wholesale-platform-leaflink-buys-leaf-trade-co-will-process-9b-in-annual-gmv","image":[{"size":"thumb","url":"https://cdn.benzinga.com/files/imagecache/250x187xUP/images/story/2024/11/26/Leaflink-Leaf-Trade.png"},{"size":"small","url":"https://cdn.benzinga.com/files/imagecache/1024x768xUP/images/story/2024/11/26/Leaflink-Leaf-Trade.png"},{"size":"large","url":"https://cdn.benzinga.com/files/imagecache/2048x1536xUP/images/story/2024/11/26/Leaflink-Leaf-Trade.png"}],"channels":[{"name":"Cannabis"},{"name":"M\u0026A"},{"name":"News"}],"stocks":[],"tags":[{"name":"Leaf Trade"},{"name":"LeafLink"},{"name":"Sweed"},{"name":"thrive capital"},{"name":"Tiger Global"}]},{"id":42127287,"author":"Rolando García","created":"Thu, 21 Nov 2024 20:07:58 -0400","updated":"Thu, 21 Nov 2024 20:07:59 -0400","title":"What's Happening With Canopy Growth: Is It Time To Buy?","teaser":"Canopy Growth (NASDAQ: CGC) hovers near $3.93. Fibonacci levels suggest key resistance at $6.36 and support at $3.86. Is it worth the risk?","body":"\u003cp\u003e\u003cstrong\u003eCanopy Growth Corporation\u003c/strong\u003e\u0026#8216;s (NASDAQ:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/CGC#NASDAQ\"\u003eCGC\u003c/a\u003e) stock has fallen significantly from its recent highs in May 2024.\u003c/p\u003e\n\n\n\n\u003cp\u003eAfter reaching a peak of $16.41, the stock now trades around $3.93, raising questions about its potential for recovery and long-term investment viability. In this article, we take a closer look at Canopy\u0026#8217;s medium-term performance and provide insights for investors who might be curious about this key industry player.\u003c/p\u003e\n\n\n\n\u003ch3 class=\"wp-block-heading\"\u003e\u003cstrong\u003eFibonacci Analysis: Key Resistance And Support Levels\u003c/strong\u003e\u003c/h3\u003e\n\n\n\n\u003cp\u003eA Fibonacci retracement analysis shows that the stock has retraced to the\u0026nbsp;\u003cstrong\u003e78.6% level \u003c/strong\u003e(circa $3.86), a critical support point. Holding above this level could trigger a potential bounce, while failure to do so risks further declines toward the pre-rally starting point of\u0026nbsp;\u003cstrong\u003e$2.57\u003c/strong\u003e.\u003c/p\u003e\n\n\n\n\u003cp\u003eOn the upside, the\u0026nbsp;\u003cstrong\u003e61.8% retracement level \u003c/strong\u003e(circa $6.36)\u0026nbsp;represents a significant resistance zone. The stock tested this level twice: once during the last week of October and again during the first week of November. Breaking through this resistance would signal renewed investor confidence and could open the door to testing the\u0026nbsp;\u003cstrong\u003e50% level ($8.50)\u003c/strong\u003e \u0026#8211; a psychologically important milestone.\u003c/p\u003e\n\n\n\n\u003cp\u003eThe company reported\u0026nbsp;\u003cstrong\u003e$1.23 billion in total assets\u003c/strong\u003e\u0026nbsp;for the \u003ca href=\"https://www.benzinga.com/news/earnings/24/11/41843751/canopy-growth-q2-net-revenue-drops-9-yoy-projects-positive-earnings-ahead\"\u003emost recent quarter\u003c/a\u003e, with\u0026nbsp;\u003cstrong\u003e$509.668 million in shareholder equity\u003c/strong\u003e\u0026nbsp;and a\u0026nbsp;\u003cstrong\u003emarket capitalization of $396.154 million\u003c/strong\u003e.\u003c/p\u003e\n\n\n\n\u003cfigure class=\"wp-block-image size-large\"\u003e\u003cimg loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"781\" src=\"https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/21175121/Captura-de-pantalla-2024-11-21-a-las-19.50.57-1024x781.png\" alt=\"\" class=\"wp-image-659928\" srcset=\"https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/21175121/Captura-de-pantalla-2024-11-21-a-las-19.50.57-1024x781.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/21175121/Captura-de-pantalla-2024-11-21-a-las-19.50.57-300x229.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/21175121/Captura-de-pantalla-2024-11-21-a-las-19.50.57-768x586.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/21175121/Captura-de-pantalla-2024-11-21-a-las-19.50.57.png 1416w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" /\u003e\u003c/figure\u003e\n\n\n\n\u003cp\u003eChart created using \u003ca href=\"https://pro.benzinga.com/dashboard\"\u003eBenzinga Pro\u003c/a\u003e\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eRead Next: \u003ca href=\"https://www.benzinga.com/analyst-ratings/analyst-color/24/10/41230957/why-canopys-brand-first-strategy-could-set-it-apart-from-tilray-and-aurora-heres-wh\"\u003eWhy Canopy\u0026#8217;s \u0026#8216;Brand-First\u0026#8217; Strategy Could Set It Apart From Tilray And Aurora – Here\u0026#8217;s What Investors Should Watch\u003c/a\u003e\u003c/strong\u003e\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003e\u003cem\u003eGet Benzinga\u0026#8217;s exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter\u0026nbsp;\u003ca href=\"https://newsletteremail.benzinga.com/subscribe\" target=\"_blank\" rel=\"noreferrer noopener\"\u003ehere\u003c/a\u003e. You can't afford to miss out if you\u0026#8217;re serious about the business.\u003c/em\u003e\u003c/strong\u003e\u003c/p\u003e\n\n\n\n\u003ch3 class=\"wp-block-heading\"\u003e\u003cstrong\u003eIs Canopy A Good Investment?\u003c/strong\u003e\u003c/h3\u003e\n\n\n\n\u003cp\u003eAt current levels, Canopy Growth presents a high-risk, high-reward profile, similar to other \u003ca href=\"https://www.benzinga.com/topic/cannabis-stocks\"\u003ecannabis companies\u003c/a\u003e. The\u0026nbsp;78.6% retracement support\u0026nbsp;makes it appealing for speculative investors betting on a recovery. However, if the stock falls below $3.86, further declines could follow, raising concerns about profitability and long-term sustainability.\u003c/p\u003e\n\n\n\n\u003cp\u003eIn the short term, there may be trading opportunities, but careful monitoring of other technical indicators is necessary.\u003c/p\u003e\n\n\n\n\u003cp\u003eFor long-term investors, Canopy's future depends on its ability to\u003ca href=\"https://www.benzinga.com/general/market-summary/24/11/42100955/the-u-s-cannabis-strategy-no-ones-talking-about-inside-canopys-300m-plan\"\u003e grow revenue\u003c/a\u003e,\u003ca href=\"https://www.benzinga.com/markets/cannabis/24/10/41381387/canopy-growth-slashes-debt-with-100m-loan-prepayment-saves-14m-in-interest\"\u003e reduce debt\u003c/a\u003e, and capitalize on the U.S. market: something that the company seems to be \u003ca href=\"https://www.benzinga.com/general/market-summary/24/11/42100955/the-u-s-cannabis-strategy-no-ones-talking-about-inside-canopys-300m-plan\"\u003eset to do\u003c/a\u003e. But, from a technical standpoint, until the stock breaks above\u0026nbsp;circa \u003cstrong\u003e$6.36\u003c/strong\u003e, signaling a broader reversal, caution is recommended.\u003c/p\u003e\n\n\n\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003eRead Also: \u003ca href=\"https://www.benzinga.com/general/market-summary/24/11/42100955/the-u-s-cannabis-strategy-no-ones-talking-about-inside-canopys-300m-plan\"\u003eThe U.S. Cannabis Strategy No One\u0026#8217;s Talking About: Inside Canopy\u0026#8217;s $300M Plan\u003c/a\u003e\u003c/strong\u003e\u003c/li\u003e\n\u003c/ul\u003e\n\n\n\n\u003cp\u003e\u003cem\u003eCover: Benzinga Pro\u003c/em\u003e\u003c/p\u003e","url":"https://www.benzinga.com/markets/cannabis/24/11/42127287/whats-happening-with-canopy-growth-is-it-time-to-buy","image":[{"size":"small","url":"https://cdn.benzinga.com/files/imagecache/1024x768xUP/images/story/2024/11/21/Fibo-Canopy.png"},{"size":"large","url":"https://cdn.benzinga.com/files/imagecache/2048x1536xUP/images/story/2024/11/21/Fibo-Canopy.png"},{"size":"thumb","url":"https://cdn.benzinga.com/files/imagecache/250x187xUP/images/story/2024/11/21/Fibo-Canopy.png"}],"channels":[{"name":"Cannabis"},{"name":"News"},{"name":"Markets"}],"stocks":[{"name":"CGC"}],"tags":[{"name":"Canada Cannabis"},{"name":"Fibonacci Analysis"},{"name":"technical analysis"}]},{"id":42163528,"author":"Maureen Meehan","created":"Mon, 25 Nov 2024 09:57:02 -0400","updated":"Mon, 25 Nov 2024 09:57:03 -0400","title":"GOP Takeover, Trump's Return Vs. Chuck Schumer's Last-Ditch Cannabis Banking Reform Push","teaser":"Between new anti-weed Senate Majority leader John Thune \u0026amp; House Speaker Mike Johnson, the path to cannabis reform just got a lot narrower.","body":"\u003cp\u003eWith just six weeks left in 2024, Senate Majority Leader \u003cstrong\u003e\u003ca href=\"https://www.benzinga.com/topic/chuck-schumer\"\u003eChuck Schumer\u003c/a\u003e\u003c/strong\u003e (D-NY) faces mounting criticism for failing to deliver on his \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/03/37526202/chuck-schumer-senate-will-work-very-hard-to-pass-cannabis-banking-bill-before-upcoming-elections\"\u003elong-standing promise\u003c/a\u003e of achieving cannabis banking reform. Now, he\u0026#8217;s mounting a Hail Mary effort to get it across the finish line before the term ends.\u003c/p\u003e\n\n\n\n\u003cp\u003eSenators on Capitol \u003ca href=\"https://login.politicopro.com/?redirect=https://subscriber.politicopro.com/newsletter/2024/11/weed-banking-hopes-rise-again-00190071\"\u003etold\u003c/a\u003e Politico they \u0026#8220;still have hopes the cannabis banking bill can get done in the lame duck, despite the odds.\u0026#8221; \u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eWhat Happened\u003c/strong\u003e: Schumer, who brought the \u003ca href=\"https://www.benzinga.com/topic/secure-and-fair-enforcement-safe-banking-act\" target=\"_blank\" rel=\"noreferrer noopener\"\u003eSecure and Fair Enforcement Regulation (SAFER) Banking Act\u003c/a\u003e (SAFER) to a \u003ca href=\"https://www.benzinga.com/markets/cannabis/23/09/34929327/breaking-senate-committee-approves-cannabis-banking-reform-in-historic-vote\"\u003ecommittee hearing\u003c/a\u003e in September 2023, had intended to advance the bill by attaching it to must-pass legislation before the midterms. However, despite his vocal support, he did not call the bill for a full Senate vote, citing insufficient Republican backing to overcome filibuster rules. This hesitation, coupled with Democrats\u0026#8217; shifting priorities after this month's \u003ca href=\"https://www.benzinga.com/news/24/11/41768178/donald-trump-defeats-kamala-harris-to-win-2024-election\"\u003eRepublican electoral surge,\u003c/a\u003e has all but killed hopes for cannabis banking reform during the lame-duck session.\u003c/p\u003e\n\n\n\n\u003cp\u003eAnd now, Senate Democrats are scrambling to address more immediate legislative tasks, including passing budget bills to avoid a looming \u003ca href=\"https://www.benzinga.com/news/24/09/40931809/house-republicans-reject-their-own-funding-bill-as-government-shutdown-looms-mike-johnson-says-we-ha\"\u003eDec. 20 government shutdown\u003c/a\u003e and finalizing judicial appointments before relinquishing control in January.\u003c/p\u003e\n\n\n\n\u003ch2 class=\"wp-block-heading\"\u003e\u003cstrong\u003eHigh Stakes As GOP Takes Congress\u003c/strong\u003e\u003c/h2\u003e\n\n\n\n\u003cp\u003eSenator \u003cstrong\u003e\u003ca href=\"https://www.benzinga.com/politics/24/11/41950681/trump-once-said-political-career-over-about-john-thune-now-senate-majority-leader-working-with-him-to-pass-gop-agenda\"\u003eJohn Thune\u003c/a\u003e\u003c/strong\u003e of South Dakota who opposes marijuana legalization, is set to replace Sen. \u003cstrong\u003e\u003ca href=\"https://www.benzinga.com/topic/mitch-mcconnell\" target=\"_blank\" rel=\"noreferrer noopener\"\u003eMitch McConnell\u003c/a\u003e \u003c/strong\u003eas Senate majority leader. With Thune and conservative House Speaker \u003cstrong\u003eMike Johnson\u003c/strong\u003e at the helm, the path to cannabis reform becomes even narrower. Johnson \u003ca href=\"https://www.benzinga.com/markets/cannabis/23/10/35428675/buzz-kill-mike-johnsons-election-as-new-house-speaker-does-not-bode-well-for-cannabis-legalizati\"\u003ehas consistently voted against\u003c/a\u003e most cannabis-related legislation, including banking reform.\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eRead Also:\u003c/strong\u003e \u003cstrong\u003e\u003ca href=\"https://www.benzinga.com/markets/cannabis/24/11/41982165/new-gop-senate-leader-john-thune-opposes-marijuana-legalization-implications-for-banking-access-and-more\"\u003eNew GOP Senate Leader John Thune Opposes Marijuana Legalization: Implications For Banking Access And More\u003c/a\u003e\u003c/strong\u003e\u003c/p\u003e\n\n\n\n\u003cp\u003eCritics argue that Democrats, despite their rhetoric or best efforts, have fallen short of delivering substantive cannabis reform. Their missed opportunity leaves the industry bracing for continued financial instability.\u003c/p\u003e\n\n\n\n\u003cp\u003eMeanwhile, \u003ca href=\"https://www.benzinga.com/24/11/42125955/cannabis-stocks-feel-the-burn-as-gaetz-bows-out-msos-in-focus\"\u003ecannabis stocks tanked\u003c/a\u003e last Thursday after pro-marijuana\u0026nbsp;\u003cstrong\u003eMatt Gaetz\u003c/strong\u003e\u0026nbsp;\u003ca href=\"https://www.benzinga.com/24/11/42119848/matt-gaetz-withdraws-name-from-ag-nomination-calls-sex-trafficking-controversy-a-distraction\" target=\"_blank\" rel=\"noreferrer noopener\"\u003ewithdrew his nomination\u003c/a\u003e\u0026nbsp;for U.S. Attorney General and was replaced by the far less weed-friendly nominee \u003cstrong\u003ePam Bondi\u003c/strong\u003e, a close associate of President-elect \u003ca href=\"https://www.benzinga.com/topic/donald-trump\"\u003e\u003cstrong\u003eDonald Trump\u003c/strong\u003e\u003c/a\u003e.\u003c/p\u003e\n\n\n\n\u003ch2 class=\"wp-block-heading\"\u003e\u003cstrong\u003eLooking Ahead\u003c/strong\u003e\u003c/h2\u003e\n\n\n\n\u003cp\u003eAs the likelihood of meaningful cannabis reform fades under the outgoing Democratic administration, advocates are left with no choice but to turn to the incoming Republican leadership, hoping they embrace the stance candidate \u003cstrong\u003eDonald Trump\u003c/strong\u003e \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/08/40561136/trump-dislikes-having-people-in-jail-for-cannabis-will-he-legalize-if-elected-or-just-trying-to-\"\u003eexpressed back in August\u003c/a\u003e at his Mar-a-Lago residence. \u003c/p\u003e\n\n\n\n\u003cp\u003e\u0026#8220;As we legalize it, I start to agree a lot more because it\u0026#8217;s being legalized all over the country,\u0026#8221; the president-elect said.\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eNow Read: \u003c/strong\u003e\u003c/p\u003e\n\n\n\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003e\u003ca href=\"https://www.benzinga.com/news/legal/24/11/42143770/trumps-pick-for-attorney-general-is-no-matt-gaetz-when-it-comes-to-cannabis-reform\"\u003eTrump\u0026#8217;s Pick for Attorney General Is No Matt Gaetz When It Comes To Cannabis Reform\u003c/a\u003e\u003c/strong\u003e\u003c/li\u003e\n\u003c/ul\u003e\n\n\n\n\u003cp\u003e\u003cem\u003ePhoto via Shutterstock\u003c/em\u003e\u003c/p\u003e","url":"https://www.benzinga.com/news/legal/24/11/42163528/gop-takeover-and-trumps-return-vs-chuck-schumers-last-ditch-cannabis-banking-reform-push","image":[{"size":"large","url":"https://cdn.benzinga.com/files/imagecache/2048x1536xUP/images/story/2024/11/25/Chuck-Schumer-copy.jpeg"},{"size":"thumb","url":"https://cdn.benzinga.com/files/imagecache/250x187xUP/images/story/2024/11/25/Chuck-Schumer-copy.jpeg"},{"size":"small","url":"https://cdn.benzinga.com/files/imagecache/1024x768xUP/images/story/2024/11/25/Chuck-Schumer-copy.jpeg"}],"channels":[{"name":"Cannabis"},{"name":"Government"},{"name":"News"},{"name":"Politics"},{"name":"Legal"},{"name":"Top Stories"}],"stocks":[],"tags":[{"name":"cannabis banking reform"},{"name":"Chuck Schumer"},{"name":"John Thune"},{"name":"Mike Johnson"}]},{"id":42194365,"author":"Juan Spínelli","created":"Tue, 26 Nov 2024 12:20:17 -0400","updated":"Tue, 26 Nov 2024 12:20:18 -0400","title":"DMT: The Hidden 'Spirit Molecule' Within Your Body","teaser":"DMT, known as the \u0026#34;spirit molecule,\u0026#34; could be key to understanding dreams, near-death experiences, and spiritual awakenings.","body":"\u003cp\u003e\u003ca href=\"https://www.benzinga.com/topic/dmt\"\u003e\u003cstrong\u003eDMT\u003c/strong\u003e\u003c/a\u003e, or dimethyltryptamine, has intrigued researchers and psychedelic enthusiasts for its profound effects on consciousness. Known for inducing otherworldly visions, from \u0026#8220;machine elves\u0026#8221; to mystical figures, some scientists now propose that DMT may play a key role in extraordinary experiences like vivid dreams, near-death encounters and spiritual awakenings. \u003c/p\u003e\n\n\n\n\u003ch3 class=\"wp-block-heading\"\u003e\u003cstrong\u003eDMT: A Naturally Occurring Substance In Humans\u003c/strong\u003e\u003c/h3\u003e\n\n\n\n\u003cp\u003eDMT is a naturally occurring compound found in plants, animals and humans. First identified in humans in the 1950s, it gained attention in the 1990s through \u003ca href=\"https://www.benzinga.com/markets/cannabis/20/12/18522764/more-real-than-real-a-psychiatrist-discusses-dmt\"\u003e\u003cstrong\u003eRick Strassman\u003c/strong\u003e\u003c/a\u003e's research, where he coined the term ‘the spirit molecule' in \u003ca href=\"https://psychiatryonline.org/doi/10.1176/appi.ajp.159.8.1448\"\u003ehis 2000 book\u003c/a\u003e. Strassman proposed that DMT could induce spiritual experiences and might be produced by the \u003ca href=\"https://en.wikipedia.org/wiki/File:Pineal_gland.png\"\u003epineal gland\u003c/a\u003e. While found in the pineal gland of rats, in humans, DMT is only detectable in urine, blood and cerebrospinal fluid, making it difficult to study.\u003c/p\u003e\n\n\n\n\u003cp\u003eStrassman's theory, as Double Blind \u003ca href=\"https://doubleblindmag.com/our-brains-make-dmt/\"\u003ereports\u003c/a\u003e, proposed that DMT could be responsible for the vivid visions and transcendental experiences often associated with both near-death encounters and extreme psychological states. \u0026#8220;When Strassman called DMT ‘the spirit molecule,' he meant it rather literally: Its function in the brain, he argued, is simply to elicit psychological states that we call spiritual,\u0026#8221; \u003ca href=\"https://www.vox.com/the-highlight/379914/dmt-psychedelics-drug-neuroscience-consciousness-ayahuasca\"\u003ewrote\u003c/a\u003e journalist \u003cstrong\u003eOshan Jarow\u003c/strong\u003e in Vox.\u003c/p\u003e\n\n\n\n\u003ch3 class=\"wp-block-heading\"\u003e\u003cstrong\u003eDMT And Near-Death Experiences\u003c/strong\u003e\u003c/h3\u003e\n\n\n\n\u003cp\u003eOne of the most compelling aspects of DMT research is its potential connection to \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/08/40528986/psychedelic-trips-resemble-near-death-experiences-new-study-shows-what-does-it-mean\"\u003enear-death experiences\u003c/a\u003e. A 2019 study found that DMT levels spike in rat brains during cardiac arrest, suggesting it may play a role in the vivid, transformative experiences reported during near-death encounters. This has led some researchers to speculate that DMT's release during extreme stress could trigger the mystical visions often experienced in such situations.\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eDr. Ede Frecska\u003c/strong\u003e, a researcher from the University of Debrecen in Hungary, proposed that DMT could be released in response to the brain's need to preserve itself during near-death situations. \"Extrapolating from this finding, one might be tempted to hypothesize that this sudden flood of DMT may provoke the mystical encounters on the border between life and death,\" Frecska wrote in his work with Strassman.\u003c/p\u003e\n\n\n\n\u003cp\u003eWhile this hypothesis remains speculative, it is part of a broader effort to understand how DMT could influence human consciousness during moments of extreme distress or transition.\u003c/p\u003e\n\n\n\n\u003ch3 class=\"wp-block-heading\"\u003e\u003cstrong\u003eDMT And Dream States\u003c/strong\u003e\u003c/h3\u003e\n\n\n\n\u003cp\u003eIn addition to its connection with near-death experiences, DMT's potential role in dreams has also intrigued researchers. Some believe it could explain the vivid, spiritual quality of dreams. A 2018 \u003ca href=\"https://cosmosandhistory.org/index.php/journal/article/view/734/1200\"\u003estudy\u003c/a\u003e published in The Journal of Natural and Social Philosophy suggests DMT may be released during sleep, making dreams feel more real. Its small molecular structure allows it to cross the blood-brain barrier, altering perception and possibly contributing to closed-eye visions or hallucinations in darkness or sensory deprivation.\u003c/p\u003e\n\n\n\n\u003ch3 class=\"wp-block-heading\"\u003e\u003cstrong\u003eThe Elusive Nature Of DMT Research\u003c/strong\u003e\u003c/h3\u003e\n\n\n\n\u003cp\u003eDespite the growing interest in DMT, much about the molecule remains a mystery. While researchers have identified the necessary enzymes for DMT synthesis in the brain, its exact role in human consciousness is still unclear. As neuroscientist \u003cstrong\u003eJimo Borjigin\u003c/strong\u003e from the University of Michigan noted, \"We know nothing—seriously!—about the role of endogenous DMT.\" The challenges of studying DMT, particularly because it is quickly metabolized in the body, have made it difficult to draw definitive conclusions.\u003c/p\u003e\n\n\n\n\u003cp\u003eWhile early research raised concerns about a potential link between elevated DMT levels and psychiatric conditions like schizophrenia, studies have since debunked this theory. \"If you've got really high levels of psychedelics that your body is making, maybe that's conferring hallucinations and delusions,\" \u003ca href=\"https://lettersandsciencemag.ucdavis.edu/feature/exploring-psychedelics-within-us\"\u003esaid\u003c/a\u003e \u003cstrong\u003eCassandra Hatzipantelis\u003c/strong\u003e, a postdoctoral fellow at the UC Davis Institute for Psychedelics and Neurotherapeutics. \"But they found no correlation between schizophrenia patients and endogenous psychedelic levels, and it was all thrown out.\"\u003c/p\u003e\n\n\n\n\u003cp\u003eAs research continues, scientists are beginning to uncover the potential roles of DMT in human consciousness. Whether it's playing a part in near-death experiences, enhancing the quality of dreams, or facilitating profound spiritual experiences, DMT's influence on the brain is a subject of growing interest.\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cem\u003eCover image made with AI\u003c/em\u003e\u003c/p\u003e","url":"https://www.benzinga.com/markets/cannabis/24/11/42194365/dmt-the-hidden-spirit-molecule-within-your-body","image":[{"size":"thumb","url":"https://cdn.benzinga.com/files/imagecache/250x187xUP/images/story/2024/11/26/1-23.png"},{"size":"small","url":"https://cdn.benzinga.com/files/imagecache/1024x768xUP/images/story/2024/11/26/1-23.png"},{"size":"large","url":"https://cdn.benzinga.com/files/imagecache/2048x1536xUP/images/story/2024/11/26/1-23.png"}],"channels":[{"name":"Cannabis"},{"name":"News"},{"name":"Psychedelics"}],"stocks":[],"tags":[{"name":"Cassandra Hatzipantelis"},{"name":"DMT"},{"name":"Ede Frecska"},{"name":"Psychedelic Research"},{"name":"Rick Strassman"},{"name":"SHL"}]},{"id":42173101,"author":"Rolando García","created":"Mon, 25 Nov 2024 15:41:53 -0400","updated":"Mon, 25 Nov 2024 15:41:54 -0400","title":"DEA Denies Allegations Of Colluding With Anti-Marijuana Group While Involved In Cannabis Rescheduling Process","teaser":"DEA denies allegations of improper talks with an anti-marijuana group during rescheduling, treats claims as \u0026#34;gossip\u0026#34; and requesting dismissal","body":"\u003cp\u003eThe \u003ca href=\"https://www.benzinga.com/topic/drug-enforcement-administration\"\u003eDrug Enforcement Administration\u003c/a\u003e (DEA) has denied accusations of improper communication with cannabis prohibitionist group Smart Approaches to Marijuana (SAM) during the Biden administration's \u003ca href=\"https://www.benzinga.com/topic/cannabis-rescheduling\"\u003emarijuana rescheduling process\u003c/a\u003e.\u003c/p\u003e\n\n\n\n\u003cp\u003eIn a recent filing \u003ca href=\"https://www.marijuanamoment.net/dea-says-it-didnt-conspire-with-anti-marijuana-group-dismissing-allegedly-illegal-talks-as-gossip/\"\u003ereported\u003c/a\u003e by Marijuana Moment, the agency dismissed these allegations as \"gossip.\" While the DEA admitted to the communication, it argued they were no unlawful ex parte and that no harm was done and therefore, the motion by\u003ca href=\"https://www.benzinga.com/markets/cannabis/24/11/41726679/village-farms-is-only-cannabis-operator-selected-to-represent-weed-industry-at-dea-rescheduling-\"\u003e Village Farms International\u003c/a\u003e (NASDAQ:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/VFF#NASDAQ\"\u003eVFF\u003c/a\u003e) and \u003cstrong\u003eHemp for Victory\u003c/strong\u003e should be dismissed.\u003c/p\u003e\n\n\n\n\u003ch3 class=\"wp-block-heading\"\u003e\u003cstrong\u003eAllegations Of Misconduct\u003c/strong\u003e\u003c/h3\u003e\n\n\n\n\u003cp\u003ePart of the accusations stem from social media posts by SAM president and CEO \u003cstrong\u003eKevin Sabet\u003c/strong\u003e.\u003c/p\u003e\n\n\n\n\u003cp\u003eIn a post May 6, 2024 on X, Sabet admitted to having conversations with \u0026#8220;two confidential sources inside DEA.\u0026#8221; Sabet said these discussions provided inside information about the agency's stance on marijuana rescheduling, including a claim that DEA Administrator\u003cstrong\u003e Anne Milgram\u003c/strong\u003e would not approve a proposed rule.\u003c/p\u003e\n\n\n\n\u003cp\u003eThis post was presented as evidence by \u003ca href=\"https://www.benzinga.com/cannabis\"\u003ecannabis\u003c/a\u003e advocacy groups to support their broader claim that \u003ca href=\"https://www.benzinga.com/topic/dea-cannabis\"\u003ethe DEA\u003c/a\u003e holds a contradictory position, alleging the agency is acting as both judge and participant in the cannabis rescheduling process.\u003c/p\u003e\n\n\n\n\u003cp\u003eThe post by Sabet admitting to the conversations with insider sources is still on X. \u003c/p\u003e\n\n\n\n\u003cfigure class=\"wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter\"\u003e\u003cdiv class=\"wp-block-embed__wrapper\"\u003e\n\u003cblockquote class=\"twitter-tweet\" data-width=\"500\" data-dnt=\"true\"\u003e\u003cp lang=\"en\" dir=\"ltr\"\u003eBIG: I can now say with full confidence that the Administrator of DEA, Anne Milgram, did NOT sign the rescheduling order, breaking with five decades of precedent and established law and regulations (two confidential sources inside DEA and another outside DEA with intimate…\u003c/p\u003e\u0026mdash; Kevin Sabet (@KevinSabet) \u003ca href=\"https://twitter.com/KevinSabet/status/1787569052782846142?ref_src=twsrc%5Etfw\"\u003eMay 6, 2024\u003c/a\u003e\u003c/blockquote\u003e\u003cscript async src=\"https://platform.twitter.com/widgets.js\" charset=\"utf-8\"\u003e\u003c/script\u003e\n\u003c/div\u003e\u003c/figure\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eRead Also: \u003ca href=\"https://www.benzinga.com/24/11/42144540/dea-slammed-over-unlawful-talks-with-cannabis-opponents-the-plot-thickens\"\u003eDEA Slammed For Unlawful Talks With Cannabis Opponents \u0026#8211; The Plot Thickens\u003c/a\u003e\u003c/strong\u003e\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cem\u003e\u003cstrong\u003eGet Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter\u0026nbsp;\u003ca href=\"https://newsletteremail.benzinga.com/subscribe\" target=\"_blank\" rel=\"noreferrer noopener\"\u003ehere\u003c/a\u003e. If you're serious about the business, you can't afford to miss out.\u003c/strong\u003e\u003c/em\u003e\u003c/p\u003e\n\n\n\n\u003ch3 class=\"wp-block-heading\"\u003e\u003cstrong\u003eDEA's Defense\u003c/strong\u003e\u003c/h3\u003e\n\n\n\n\u003cp\u003eAccording to the DEA's filing, the cannabis organizations' evidence is not proof of \u003ca href=\"https://www.benzinga.com/24/11/42144540/dea-slammed-over-unlawful-talks-with-cannabis-opponents-the-plot-thickens\"\u003emisconduct\u003c/a\u003e. \u0026#8220;Movants' own evidence fails to demonstrate that any unlawful ex parte communication took place,\" the agency said. A movant is any party that makes a motion in a case.\u003c/p\u003e\n\n\n\n\u003cp\u003eThe DEA flatly rejected accusations of bias or impropriety, emphasizing that the submitted evidence amounts to little more than hearsay. \u003c/p\u003e\n\n\n\n\u003cp\u003e\"The Movants would have this tribunal embark on a fishing expedition in search of evidence to support these sweeping, unsupported claims, which at best can be categorized as gossip, not ex parte communications,\" the DEA stated.\u003c/p\u003e\n\n\n\n\u003cp\u003eIt also dismissed calls for the \u003ca href=\"https://www.benzinga.com/24/11/42144540/dea-slammed-over-unlawful-talks-with-cannabis-opponents-the-plot-thickens\"\u003eagency's removal \u003c/a\u003efrom the rescheduling process, arguing that there is no legal precedent for such action. \u003c/p\u003e\n\n\n\n\u003cp\u003e\"The only authority cited by the Movants on this point simply supports the notion that specific individuals may be removed from the proceeding under the appropriate circumstances,\" per the filing.\u003c/p\u003e\n\n\n\n\u003cp\u003eAdditionally, the DEA pointed out that no misconduct has been alleged against its attorneys involved in the proceedings, further undermining the motion's validity.\u003c/p\u003e\n\n\n\n\u003cp\u003eAs a consequence, the DEA requested the motion's dismissal. \"The tribunal correctly questions the seriousness of the remedies sought by the Movants and as such, should deny the motion,\" the agency concluded. \u003c/p\u003e\n\n\n\n\u003cp\u003eVillage Farms International is \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/11/41726679/village-farms-is-only-cannabis-operator-selected-to-represent-weed-industry-at-dea-rescheduling-\"\u003ethe only cannabis operator\u003c/a\u003e selected to represent the industry at the\u003ca href=\"https://www.benzinga.com/markets/cannabis/24/11/41726679/village-farms-is-only-cannabis-operator-selected-to-represent-weed-industry-at-dea-rescheduling-\"\u003e \u003c/a\u003eupcoming hearing on December 2. \u003c/p\u003e\n\n\n\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003eRead Next: \u003ca href=\"https://www.benzinga.com/24/11/42169153/dea-judge-blocks-researchers-motion-in-cannabis-rescheduling-case\"\u003eDEA Judge Blocks Researcher\u0026#8217;s Motion In Cannabis Rescheduling Case\u003c/a\u003e\u003c/strong\u003e\u003c/li\u003e\n\u003c/ul\u003e\n\n\n\n\u003cp\u003e\u003cem\u003eCover: AI generated image\u003c/em\u003e\u003c/p\u003e","url":"https://www.benzinga.com/24/11/42173101/dea-denies-allegations-of-unlawful-talks-with-anti-marijuana-group","image":[{"size":"thumb","url":"https://cdn.benzinga.com/files/imagecache/250x187xUP/images/story/2024/11/25/Marijuana-DEA.png"},{"size":"small","url":"https://cdn.benzinga.com/files/imagecache/1024x768xUP/images/story/2024/11/25/Marijuana-DEA.png"},{"size":"large","url":"https://cdn.benzinga.com/files/imagecache/2048x1536xUP/images/story/2024/11/25/Marijuana-DEA.png"}],"channels":[{"name":"Cannabis"},{"name":"Government"},{"name":"News"},{"name":"Regulations"},{"name":"Politics"},{"name":"Legal"},{"name":"Markets"}],"stocks":[{"name":"VFF"}],"tags":[{"name":"Anne Milgram"},{"name":"DEA"},{"name":"Hemp for Victory"},{"name":"Kevin Sabet"},{"name":"lawsuit"},{"name":"Smart Approaches to Marijuana"},{"name":"Village Farms International"}]},{"id":42196285,"author":"Rolando García","created":"Tue, 26 Nov 2024 13:37:15 -0400","updated":"Tue, 26 Nov 2024 13:37:15 -0400","title":"Aurora Cannabis Stock Analysis: Key Levels And Trading Opportunities","teaser":"Aurora Cannabis (NASDAQ: ACB) stock finds support at $4.16 amid Fibonacci analysis and bullish divergence. Learn key levels for traders.","body":"\u003cp\u003eCannabis stocks have faced significant \u003ca href=\"https://www.benzinga.com/24/11/42125955/cannabis-stocks-feel-the-burn-as-gaetz-bows-out-msos-in-focus\"\u003echallenges\u003c/a\u003e recently, driven by \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/11/41782344/tilray-trulieve-and-other-cannabis-stocks-nosediving-as-industry-faces-new-wave-of-political-unc\"\u003epolitical uncertainty\u003c/a\u003e that has further weighed on a sector still struggling to regain its footing since the overhyped all-time highs of 2021. \u003c/p\u003e\n\n\n\n\u003cp\u003eTo help investors navigate the long-term outlook for key \u003ca href=\"https://www.benzinga.com/topic/marijuana-stocks\"\u003ecannabis companies\u003c/a\u003e, we are introducing a series of in-depth technical analyses, focusing on actionable insights from technical indicators to support informed financial decisions.\u003c/p\u003e\n\n\n\n\u003cp\u003eAfter analyzing Canadian cannabis giant \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/11/42127287/whats-happening-with-canopy-growth-is-it-time-to-buy\"\u003eCanopy Growth\u003c/a\u003e (NASDAQ:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/CGC#NASDAQ\"\u003eCGC\u003c/a\u003e), it's time to turn our attention to another heavyweight: Aurora Cannabis (NASDAQ:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/ACB#NASDAQ\"\u003eACB\u003c/a\u003e). \u003c/p\u003e\n\n\n\n\u003cp\u003eBased in Alberta, Aurora remains a key player in the sector and a major contender for Canopy. So, grab a seat as we dive into the technical setup and explore what the future might hold for this heavy-weight cannabis company.\u003c/p\u003e\n\n\n\n\u003cp\u003eWe will use Fibonacci Retracement, a popular tool in technical analysis that helps traders identify key levels where a stock might reverse or stabilize. In Aurora's case, the tool is applied from the March low of $2.7 to the April high of $8.96. In the case of Canopy, the starting point was May.\u003c/p\u003e\n\n\n\n\u003ch3 class=\"wp-block-heading\"\u003e\u003cstrong\u003eFor Mid-Term Traders And Holders\u003c/strong\u003e\u003c/h3\u003e\n\n\n\n\u003cp\u003eThese levels highlight critical zones where buyer or seller momentum tends to shift.\u003c/p\u003e\n\n\n\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003eCurrent Support\u003c/strong\u003e: Aurora is hovering around the\u0026nbsp;\u003cstrong\u003e78.6% retracement level at $4.16\u003c/strong\u003e: the \"final line of defense\" for bulls.\u003c/li\u003e\n\n\n\n\u003cli\u003e\u003cstrong\u003eResistance Ahead\u003c/strong\u003e: If this support holds, the next key levels are\u0026nbsp;\u003cstrong\u003e$5.26 (61.8%)\u003c/strong\u003e\u0026nbsp;and\u0026nbsp;\u003cstrong\u003e$6.04 (50%)\u003c/strong\u003e, which could act as mid-term targets.\u003c/li\u003e\n\n\n\n\u003cli\u003eBreaking above $6.04 would indicate stronger bullish momentum and possibly a trend reversal.\u003c/li\u003e\n\u003c/ul\u003e\n\n\n\n\u003cp\u003eFor short-term traders, $5.26 is a natural profit-taking zone, while holders might look for sustained moves above $6.04 as a sign of long-term recovery. \u003c/p\u003e\n\n\n\n\u003cp\u003eIf the price falls below $4.16, the next significant support lies near $2.7, the March low, which would invalidate the bullish scenario.\u003c/p\u003e\n\n\n\n\u003cfigure class=\"wp-block-image size-large is-resized\"\u003e\u003cimg loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"395\" src=\"https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/26114152/ACB-cannabis-Fibo-1024x395.png\" alt=\"Aurora Stock\" class=\"wp-image-665843\" style=\"width:695px;height:auto\" srcset=\"https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/26114152/ACB-cannabis-Fibo-1024x395.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/26114152/ACB-cannabis-Fibo-300x116.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/26114152/ACB-cannabis-Fibo-768x296.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/26114152/ACB-cannabis-Fibo-1536x592.png 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/26114152/ACB-cannabis-Fibo.png 1805w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" /\u003e\u003c/figure\u003e\n\n\n\n\u003cp\u003eChart \u003ca href=\"https://pro.benzinga.com/dashboard\"\u003ecreated using Benzinga Pro\u003c/a\u003e\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eRead Also: \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/11/42127287/whats-happening-with-canopy-growth-is-it-time-to-buy\"\u003eWhat\u0026#8217;s Happening With Canopy Growth: Is It Time To Buy?\u003c/a\u003e\u003c/strong\u003e\u003c/p\u003e\n\n\n\n\u003ch3 class=\"wp-block-heading\"\u003e\u003cstrong\u003eFor Daily Traders \u003c/strong\u003e\u003c/h3\u003e\n\n\n\n\u003cp\u003eIf you look for recent price action in the daily chart you\u0026#8217;ll see signs of rebounding momentum as a \u003cstrong\u003ebullish divergence\u003c/strong\u003e\u0026nbsp;is emerging. While the stock has been printing lower lows, the Relative Strength Index (RSI) has shown\u0026nbsp;\u003cstrong\u003ehigher lows\u003c/strong\u003e. This divergence suggests weakening selling pressure and the potential for a rebound.\u003c/p\u003e\n\n\n\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003eValidation Point\u003c/strong\u003e: A break above $5.26, accompanied by rising RSI, would confirm the divergence and support a recovery.\u003c/li\u003e\n\n\n\n\u003cli\u003e\u003cstrong\u003eInvalidation Point\u003c/strong\u003e: A fall below $4.16 would negate the divergence and signal continued downward pressures\u003c/li\u003e\n\u003c/ul\u003e\n\n\n\n\u003cp\u003eBeware that divergences alone are not foolproof. They require confirmation through price action, volume or additional indicators like moving averages or candlestick patterns. Without these, the divergence may fail and the downtrend could continue.\u003c/p\u003e\n\n\n\n\u003ch3 class=\"wp-block-heading\"\u003e\u003cstrong\u003eFundamentals: A Stock Trading Below Book Value\u003c/strong\u003e\u003c/h3\u003e\n\n\n\n\u003cp\u003eBeyond the charts, Aurora Cannabis has interesting fundamentals. With\u0026nbsp;\u003cstrong\u003equarterly total assets of $808.77 million\u003c/strong\u003e\u0026nbsp;and a \u003cstrong\u003ebook value per share of $7.10\u003c/strong\u003e, the company's stock trades significantly below its intrinsic value. This could indicate an undervalued opportunity for long-term investors willing to weather the volatility.\u003c/p\u003e\n\n\n\n\u003cp\u003eFor now, traders should watch price action near $4.16 and $5.26, while holders may see a more compelling story above $6.04. Both groups should keep an eye on volume, which can confirm whether the bulls are stepping back in.\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cem\u003eDISCLAIMER: The content of this article is not financial or investment advice and does not constitute an offer or solicitation to offer or recommendation of any investment product. The author holds no position on the mentioned stocks. \u003c/em\u003e\u003c/p\u003e\n\n\n\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003eRead Next: \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/11/41782344/tilray-trulieve-and-other-cannabis-stocks-nosediving-as-industry-faces-new-wave-of-political-unc\"\u003eTilray, Trulieve And Other Cannabis Stocks Nosediving As Industry Faces New Wave Of Political Uncertainty\u003c/a\u003e\u003c/strong\u003e\u003c/li\u003e\n\u003c/ul\u003e\n\n\n\n\u003cp\u003eCOVER\u003cem\u003e: AI-generated image\u003c/em\u003e\u003c/p\u003e","url":"https://www.benzinga.com/24/11/42196285/aurora-cannabis-stock-analysis-key-levels-and-trading-opportunities","image":[{"size":"thumb","url":"https://cdn.benzinga.com/files/imagecache/250x187xUP/images/story/2024/11/26/Aurora-Stock.png"},{"size":"small","url":"https://cdn.benzinga.com/files/imagecache/1024x768xUP/images/story/2024/11/26/Aurora-Stock.png"},{"size":"large","url":"https://cdn.benzinga.com/files/imagecache/2048x1536xUP/images/story/2024/11/26/Aurora-Stock.png"}],"channels":[{"name":"Cannabis"},{"name":"News"},{"name":"Small Cap"},{"name":"Markets"},{"name":"Trading Ideas"}],"stocks":[{"name":"ACB"},{"name":"CGC"}],"tags":[{"name":"Aurora Cannabis"},{"name":"Cannabis Investing"},{"name":"Fibonacci Retracement"}]},{"id":42169153,"author":"Rolando García","created":"Mon, 25 Nov 2024 12:48:13 -0400","updated":"Mon, 25 Nov 2024 12:48:14 -0400","title":"DEA Judge Blocks Researcher's Motion In Cannabis Rescheduling Case,","teaser":"DEA denies MedPharm\u0026#39;s motion to join marijuana rescheduling hearing, raising concerns over exclusion and bias favoring prohibitionists.","body":"\u003cp\u003eA \u003ca href=\"https://www.google.com/url?sa=t\u0026amp;source=web\u0026amp;rct=j\u0026amp;opi=89978449\u0026amp;url=https://www.benzinga.com/topic/dea-cannabis\u0026amp;ved=2ahUKEwi-55vk7veJAxX8IbkGHctZFHAQFnoECBkQAQ\u0026amp;usg=AOvVaw2exrY_OTgOJ9N-asMwoMUl\"\u003eDEA\u003c/a\u003e administrative law judge has denied MedPharm's motion to participate in the December 2 marijuana rescheduling hearing, deferring to DEA Administrator \u003cstrong\u003eAnne Milgram'\u003c/strong\u003es authority. \u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eMedPharm\u003c/strong\u003e, a DEA-registered research firm, criticized the exclusion of marijuana researchers and the inclusion of prohibitionist organizations, calling the process biased.\u003c/p\u003e\n\n\n\n\u003ch3 class=\"wp-block-heading\"\u003e\u003cstrong\u003eMedPharm\u0026#8217;s Motion And Criticism\u003c/strong\u003e\u003c/h3\u003e\n\n\n\n\u003cp\u003eMedPharm filed a motion to intervene after being excluded from the witness list, arguing the fact that no DEA-licensed marijuana researchers were included.\u003c/p\u003e\n\n\n\n\u003cp\u003e\"The deck appears to be stacked against those in favor\" of rescheduling marijuana from Schedule I to Schedule III of the Controlled Substances Act (CSA), MedPharm noted.\u003c/p\u003e\n\n\n\n\u003cp\u003eIt also alleged that the witness list, which included the anti-cannabis prohibitionist group \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/05/38733313/anti-cannabis-group-raises-money-to-scuttle-dea-rescheduling-effort\"\u003eSmart Approaches to Marijuana\u003c/a\u003e (SAM), undermines the legitimacy of the process, describing the decision as an attempt to \u0026#8220;thwart a legitimate process,\u0026#8221; as \u003ca href=\"https://www.marijuanamoment.net/dea-judge-denies-agency-registered-drug-companys-request-to-join-marijuana-rescheduling-hearing/\"\u003ereported\u003c/a\u003e Marijuana Moment.\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eRead Also: \u003ca href=\"https://www.benzinga.com/24/11/42144540/dea-slammed-over-unlawful-talks-with-cannabis-opponents-the-plot-thickens\"\u003eDEA Slammed For Unlawful Talks With Cannabis Opponents \u0026#8211; The Plot Thickens\u003c/a\u003e\u003c/strong\u003e\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cem\u003e\u003cstrong\u003eGet Benzinga\u0026#8217;s exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter\u0026nbsp;\u003ca href=\"https://newsletteremail.benzinga.com/subscribe\" target=\"_blank\" rel=\"noreferrer noopener\"\u003ehere\u003c/a\u003e. If you\u0026#8217;re serious about the business, you can\u0026#8217;t afford to miss out.\u003c/strong\u003e\u003c/em\u003e\u003c/p\u003e\n\n\n\n\u003ch3 class=\"wp-block-heading\"\u003e\u003cstrong\u003eJudge Mulrooney's Decision\u003c/strong\u003e\u003c/h3\u003e\n\n\n\n\u003cp\u003eDEA Administrative Law Judge \u003cstrong\u003eJohn Mulrooney\u003c/strong\u003e denied MedPharm's motion, citing statutory limits on his authority. \u003c/p\u003e\n\n\n\n\u003cp\u003e\"The Administrator exercised her discretion to fix the number of participants,\" Mulrooney said, adding that expanding the list would exceed his role under the Administrative Procedures Act.\u003c/p\u003e\n\n\n\n\u003cp\u003eMulrooney acknowledged the value of wider input but noted that the DEA prioritizes participants who can demonstrate adverse impacts from the proposed policy change, which becomes apparent by viewing the \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/11/41726679/village-farms-is-only-cannabis-operator-selected-to-represent-weed-industry-at-dea-rescheduling-\"\u003ebiased list\u003c/a\u003e.\u003c/p\u003e\n\n\n\n\u003cp\u003eThe exclusion of key scientific voices has \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/11/41726679/village-farms-is-only-cannabis-operator-selected-to-represent-weed-industry-at-dea-rescheduling-\"\u003eraised concerns\u003c/a\u003e about the process's fairness, particularly as the \u003cstrong\u003eDepartment of Health and Human Services\u003c/strong\u003e (HHS) and the DEA\u0026#8217;s Office of Legal Counsel support rescheduling.\u003c/p\u003e\n\n\n\n\u003cp\u003eThe upcoming hearing will allow cross-examination of witnesses from both sides, but critics warn the imbalance could skew outcomes. Mulrooney is leading another case where the DEA is accused of engaging in \u003ca href=\"https://www.benzinga.com/24/11/42144540/dea-slammed-over-unlawful-talks-with-cannabis-opponents-the-plot-thickens\"\u003eunlawful conversations\u003c/a\u003e with anti-cannabis groups ahead of the December 2 hearing.\u003c/p\u003e\n\n\n\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003eRead Next: \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/11/42093641/dea-is-compromised-doj-should-replace-it-in-cannabis-rescheduling-claims-joint-motion\"\u003eDEA Is Compromised, DOJ Should Replace It In Cannabis Rescheduling, Claims Joint Motion\u003c/a\u003e\u003c/strong\u003e\u003c/li\u003e\n\u003c/ul\u003e\n\n\n\n\u003cp\u003e\u003cem\u003eCover: AI generated image\u003c/em\u003e\u003c/p\u003e","url":"https://www.benzinga.com/24/11/42169153/dea-judge-blocks-researchers-motion-in-cannabis-rescheduling-case","image":[{"size":"large","url":"https://cdn.benzinga.com/files/imagecache/2048x1536xUP/images/story/2024/11/25/DEA.png"},{"size":"thumb","url":"https://cdn.benzinga.com/files/imagecache/250x187xUP/images/story/2024/11/25/DEA.png"},{"size":"small","url":"https://cdn.benzinga.com/files/imagecache/1024x768xUP/images/story/2024/11/25/DEA.png"}],"channels":[{"name":"Cannabis"},{"name":"Government"},{"name":"News"},{"name":"Politics"},{"name":"Markets"}],"stocks":[],"tags":[{"name":"Cannabis Lawsuit"},{"name":"cannabis rescheduling"},{"name":"DEA"},{"name":"MedPharm"}]},{"id":42165010,"author":"Nina Zdinjak","created":"Mon, 25 Nov 2024 10:30:24 -0400","updated":"Mon, 25 Nov 2024 10:30:25 -0400","title":"Mike Tyson's Cannabis Infused Pre-Rolls And Vapes Reach Jamaica Via Kaya Group Partnership","teaser":" ","body":"\u003cp\u003e\u003cstrong\u003eMike Tyson\u003c/strong\u003e's cannabis brand \u003cstrong\u003eTYSON 2.0 \u003c/strong\u003ewill debut in Jamaica, the brand's holding company, \u003cstrong\u003eCarma HoldCo Inc,\u003c/strong\u003e confirmed Friday. In partnership with \u003cstrong\u003eNUGL Inc's \u003c/strong\u003e(OTC:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/NUGL#OTC\"\u003eNUGL\u003c/a\u003e) \u003cstrong\u003eKaya Group\u003c/strong\u003e, TYSON 2.0 will bring its popular line of infused pre-rolls, vapes, pre-packaged flower and concentrates to Jamaican consumers.\u003c/p\u003e\n\n\n\n\u003cp\u003eKaya is one of Jamaica's leading medical marijuana companies. Kaya\u0026#8217;s diverse operations include a licensed cultivation facility, processing facility, 3 retail herb houses and one ganja franchise in Punta Del Este, Uruguay. Kaya was the first medicinal Ganja Herb House in the Caribbean. This partnership marks TYSON 2.0\u0026#8217;s entrance into the Caribbean.\u003c/p\u003e\n\n\n\n\u003cp\u003eInitially, TYSON products will be available at Kaya Herb House locations in St. Ann, Falmouth and in Kingston, with plans to expand into additional retail outlets across Jamaica.\u003c/p\u003e\n\n\n\n\u003cp\u003e\"Bringing TYSON 2.0 to Jamaica is about more than expansion; it\u0026#8217;s about honoring the island's deep-rooted relationship with cannabis,\" stated \u003cstrong\u003eMike Tyson\u003c/strong\u003e, co-founder and chief brand officer of TYSON 2.0. \"Jamaican consumers can now experience the same high quality and dedication we put into every TYSON 2.0 product. I'm excited to share this journey with them.\"\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eRead Also: \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/11/41685387/mike-tysons-marijuana-brand-tyson-2-0-expands-to-arizona-via-partnership-with-desert-fairways\"\u003eMike Tyson\u0026#8217;s Marijuana Brand TYSON 2.0 Expands To Arizona Via Partnership With Desert Fairways\u003c/a\u003e\u003c/strong\u003e\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cem\u003e\u003cstrong\u003eGet Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter \u003ca href=\"https://newsletteremail.benzinga.com/subscribe\" target=\"_blank\" rel=\"noreferrer noopener\"\u003ehere\u003c/a\u003e. If you're serious about the business, you can't afford to miss out.\u003c/strong\u003e\u003c/em\u003e\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eAdam Wilks\u003c/strong\u003e, CEO of Carma HoldCo, added, \"Expanding into Jamaica is another big win for TYSON 2.0 and Carma HoldCo. Like Amsterdam, Jamaica is a global leader in cannabis culture, making it the perfect destination for our next chapter. Partnering with Kaya Group allows us to merge our premium product lineup with a rich heritage, providing discerning consumers with an unmatched cannabis experience.\"\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eBali Vaswani\u003c/strong\u003e, CEO of Kaya Group and NUGL, remarked on the partnership's significance: \"Our collaboration with TYSON is another defining moment for Jamaica\u0026#8217;s ganja industry. By combining our local expertise in cultivation, processing and our commitment to quality with TYSON 2.0's global reach, we're creating one-of-a-kind ganja experiences. Every herb has a story, and together we're bringing those stories to life, connecting our community to the world.\"\u003c/p\u003e\n\n\n\n\u003cp\u003eSince its debut in 2021, TYSON 2.0 expanded beyond the U.S. and into 16 countries and broadened its portfolio to include other premium product categories, cementing its reputation for crafting memorable experiences.\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eRead Next:\u003c/strong\u003e\u003c/p\u003e\n\n\n\n\u003cul\u003e\n\u003cli\u003e\u003ca href=\"https://www.benzinga.com/markets/cannabis/24/07/39612472/mike-tyson-to-open-first-branded-retail-store-in-amsterdam-a-city-that-always-held-a-special-pla\"\u003eMike Tyson To Open First Branded Retail Store In Amsterdam, A City That Always Held A Special Place In His Heart\u003c/a\u003e\u003c/li\u003e\n\n\n\n\u003cli\u003e\u003ca href=\"https://www.benzinga.com/markets/cannabis/24/11/41693389/exclusive-mike-tyson-and-st-ndenglass-unveil-the-tyson-2-0-mod-l-dok-travel-set\"\u003eEXCLUSIVE: Mike Tyson And Stündenglass Unveil The TYSON 2.0 Modül + Dok Travel Set\u003c/a\u003e\u003c/li\u003e\n\u003c/ul\u003e\n\n\n\n\u003cp\u003e\u003cem\u003eCourtesy Photo \u003c/em\u003e\u003c/p\u003e","url":"https://www.benzinga.com/markets/cannabis/24/11/42165010/mike-tysons-cannabis-infused-pre-rolls-and-vapes-reach-jamaica-via-kaya-group-partnership","image":[{"size":"thumb","url":"https://cdn.benzinga.com/files/imagecache/250x187xUP/images/story/2024/11/25/New-Project-172.jpeg"},{"size":"small","url":"https://cdn.benzinga.com/files/imagecache/1024x768xUP/images/story/2024/11/25/New-Project-172.jpeg"},{"size":"large","url":"https://cdn.benzinga.com/files/imagecache/2048x1536xUP/images/story/2024/11/25/New-Project-172.jpeg"}],"channels":[{"name":"Cannabis"},{"name":"News"}],"stocks":[{"name":"NUGL"}],"tags":[{"name":"Adam Wilks"},{"name":"Carma HoldCo"},{"name":"Kaya Group"},{"name":"MIke Tyson"},{"name":"premium"},{"name":"Tyson 2.0"}]},{"id":42143770,"author":"Maureen Meehan","created":"Fri, 22 Nov 2024 13:37:16 -0400","updated":"Fri, 22 Nov 2024 13:37:17 -0400","title":"Trump's Pick for Attorney General Is No Matt Gaetz When It Comes To Cannabis Reform","teaser":"Trump picks Pam Bondi as new attorney general nominee, shifting focus to her record. Bondi\u0026#39;s tough stance on cannabis contrasts with the pro-reform views of former choice, Matt Gaetz.","body":"\u003cp\u003eJust hours after former Rep. \u003cstrong\u003eMatt Gaetz\u003c/strong\u003e (R-Fla.) \u003ca href=\"https://www.benzinga.com/24/11/42119848/matt-gaetz-withdraws-name-from-ag-nomination-calls-sex-trafficking-controversy-a-distraction\"\u003ewithdrew\u003c/a\u003e from consideration for attorney general, President-elect \u003cstrong\u003eDonald Trump\u003c/strong\u003e \u003ca href=\"https://www.benzinga.com/news/24/11/42130207/trump-picks-former-florida-ag-pam-bondi-for-justice-department-after-matt-gaetz-withdraws\"\u003eannounced his new nominee\u003c/a\u003e: former Florida Attorney General \u003cstrong\u003ePam Bondi\u003c/strong\u003e. \u003c/p\u003e\n\n\n\n\u003cp\u003eThe selection shifts the spotlight to Bondi's record, especially her stance on cannabis reform, which contrasts starkly with Gaetz's pro-legalization views.\u003c/p\u003e\n\n\n\n\u003cp\u003eDespite the \u003ca href=\"https://www.benzinga.com/news/24/11/42026047/gaetz-nomination-in-peril-due-to-gop-resistance\"\u003eunsavory allegations\u003c/a\u003e\u003ca href=\"https://www.benzinga.com/24/11/42119848/matt-gaetz-withdraws-name-from-ag-nomination-calls-sex-trafficking-controversy-a-distraction\"\u003e \u003c/a\u003eagainst Gaetz's personal behavior, he\u0026#8217;s been an \u003ca href=\"https://www.benzinga.com/markets/cannabis/23/07/33127611/rep-matt-gaetz-wants-to-end-cannabis-testing-for-us-military-citing-recruitment-crisis\"\u003eadvocate for cannabis reform\u003c/a\u003e and was expected to adopt a lenient approach toward legalization if appointed. In contrast, Bondi had a tougher stance on medical marijuana during her tenure as Florida's Attorney General (2011-2019).\u003c/p\u003e\n\n\n\n\u003ch1 class=\"wp-block-heading\"\u003e\u003cstrong\u003eBondi While Florida\u0026#8217;s AG\u003c/strong\u003e\u003c/h1\u003e\n\n\n\n\u003cp\u003eFor example, in 2013, Bondi\u0026#8217;s office \u003ca href=\"https://www.huffpost.com/entry/florida-medical-marijuana_n_4159849\"\u003efiled a 57-page challenge\u003c/a\u003e to the proposed ballot initiative that was seeking to put medical marijuana (MMJ) on the ballot the following year. Once medical marijuana was approved, she defended state laws restricting cannabis use, including a ban on publicly smoking it. Bondi argued at the time that the ban was justified due to concerns over secondhand smoke exposure. \u003c/p\u003e\n\n\n\n\u003cp\u003eA state judge later ruled the ban to be inconsistent with Florida's constitutional amendment that legalized medical cannabis in 2014. The restriction was eventually overturned under Gov. Ron DeSantis who \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/06/39346531/desantis-cant-get-past-the-odor-of-weed-to-smell-the-flowers-specifically-430m-annually-in-canna\"\u003ewent on the warpath\u003c/a\u003e against smoking in public.\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eRead Also: \u003ca href=\"https://www.benzinga.com/24/11/42125955/cannabis-stocks-feel-the-burn-as-gaetz-bows-out-msos-in-focus\"\u003eCannabis Stocks Feel The Burn: Matt Gaetz Bows Out As Trump\u0026#8217;s Attorney General Nominee\u003c/a\u003e\u003c/strong\u003e\u003c/p\u003e\n\n\n\n\u003ch1 class=\"wp-block-heading\"\u003e\u003cstrong\u003eTrump's Drug Addiction Commission\u003c/strong\u003e\u003c/h1\u003e\n\n\n\n\u003cp\u003eBondi's role on Trump's Commission on Combating Drug Addiction and the Opioid Crisis during his first term in the White House could further complicate her position on cannabis. \u003c/p\u003e\n\n\n\n\u003cp\u003eThe commission, which was chaired by former New Jersey Gov. \u003ca href=\"https://www.benzinga.com/topic/chris-christie\"\u003eChris Christie\u003c/a\u003e, was skeptical about cannabis as a treatment for chronic pain or opioid addiction, citing studies suggesting a potential link between marijuana use and opioid abuse. Authoritative \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/01/36578723/huge-study-reveals-cannabis-provides-similar-pain-relief-benefits-as-opioids-without-negative-co\"\u003estudies\u003c/a\u003e have since shown the contrary to be the case.\u003c/p\u003e\n\n\n\n\u003cp\u003eThough Bondi's track record has raised concerns among some cannabis reform advocates, industry leader \u003cstrong\u003eKim Rivers\u003c/strong\u003e, CEO of \u003cstrong\u003eTrulieve Cannabis Corp\u003c/strong\u003e (OTC:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/TCNNF#OTC\"\u003eTCNNF\u003c/a\u003e), described Bondi on X as \"straightforward and very fair,\" \u003ca href=\"https://www.marijuanamoment.net/trumps-new-attorney-general-pick-opposed-legalizing-medical-marijuana-in-florida/\"\u003ereported\u003c/a\u003e Marijuana Moment.\u003c/p\u003e\n\n\n\n\u003cp\u003e\"She is passionate about ending the opioid crisis and did great work shutting down pill mills in Florida. She is an advocate for safe, regulated markets and I believe she will bring the same energy to end the fentanyl issues our country is facing,\" Rivers said.\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eNow Read:\u003ca href=\"https://www.benzinga.com/general/health-care/24/11/42138055/kentucky-gov-beshear-go-online-and-find-your-medical-marijuana-practitioner-on-dec-1\"\u003e \u003c/a\u003e\u003cbr\u003e • \u003ca href=\"https://www.benzinga.com/general/health-care/24/11/42138055/kentucky-gov-beshear-go-online-and-find-your-medical-marijuana-practitioner-on-dec-1\"\u003eKentucky Gov. Beshear: \u0026#8216;Go Online And Find\u0026#8217; Your Medical Marijuana Practitioner On Dec. 1\u003c/a\u003e\u003c/strong\u003e\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cem\u003ePhoto: Shutterstock\u003c/em\u003e\u003c/p\u003e","url":"https://www.benzinga.com/news/legal/24/11/42143770/trumps-pick-for-attorney-general-is-no-matt-gaetz-when-it-comes-to-cannabis-reform","image":[{"size":"small","url":"https://cdn.benzinga.com/files/imagecache/1024x768xUP/images/story/2024/11/22/cannabis-reform-5-second-Studio-and-Eigh.jpeg"},{"size":"large","url":"https://cdn.benzinga.com/files/imagecache/2048x1536xUP/images/story/2024/11/22/cannabis-reform-5-second-Studio-and-Eigh.jpeg"},{"size":"thumb","url":"https://cdn.benzinga.com/files/imagecache/250x187xUP/images/story/2024/11/22/cannabis-reform-5-second-Studio-and-Eigh.jpeg"}],"channels":[{"name":"Cannabis"},{"name":"Government"},{"name":"News"},{"name":"Politics"},{"name":"Legal"}],"stocks":[{"name":"TCNNF"}],"tags":[{"name":"Donald Trump"},{"name":"Florida"},{"name":"Kim Rivers"},{"name":"Matt Gaetz"},{"name":"Pam Bondi"}]},{"id":42193387,"author":"Nicolás Jose Rodriguez","created":"Tue, 26 Nov 2024 11:45:19 -0400","updated":"Tue, 26 Nov 2024 11:45:19 -0400","title":"Federal Policy Could Add $3 Billion To Cannabis Industry: On Track To Reach $55 Billion By 2030","teaser":"According to LeafLink, over the next 2-3 years, 5,000 non-MSO retailers are projected to open in key states, increasing store counts by 70%.","body":"\u003cp\u003eThe U.S. cannabis industry continues its impressive growth, generating over $32 billion in annual retail sales as of 2024, according to data from \u003cstrong\u003eLeafLink\u003c/strong\u003e. This marks a 10.8% year-over-year increase, with $2.8 billion in sales recorded in October 2024 alone. From its humble beginnings, cannabis now operates in 41 states, with over 80% of Americans having access to it. \u003c/p\u003e\n\n\n\n\u003cp\u003eDespite challenges like price declines, margin pressures and operational inefficiencies, the industry is on track to reach $55 billion by 2030, driven by regional growth and federal policy changes.\u003c/p\u003e\n\n\n\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003e\u003cem\u003eGet Benzinga\u0026#8217;s exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter\u0026nbsp;\u003ca href=\"https://newsletteremail.benzinga.com/subscribe\" target=\"_blank\" rel=\"noreferrer noopener\"\u003ehere\u003c/a\u003e. You can't afford to miss out if you\u0026#8217;re serious about the business.\u003c/em\u003e\u003c/strong\u003e\u003c/li\u003e\n\u003c/ul\u003e\n\n\n\n\u003ch2 class=\"wp-block-heading\"\u003e\u003cstrong\u003eKey Growth Drivers \u003c/strong\u003e\u003c/h2\u003e\n\n\n\n\u003cp\u003eNear-term growth will be fueled by rapid licensing and retail expansion in emerging markets such as New York, New Jersey and Ohio. Over the next 2-3 years, 5,000 non-MSO retailers are projected to open in key states, increasing store counts by 70%.\u003c/p\u003e\n\n\n\n\u003cp\u003eFederal policy reform, notably the potential reclassification of cannabis to Schedule III in 2025, could relieve the current 280E tax burden and inject $2-3 billion annually into the industry, boosting profitability.\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eRead Also: \u003ca href=\"https://www.benzinga.com/government/regulations/24/11/42068539/billion-dollar-strike-farm-bill-amendment-could-change-the-hemp-industry\"\u003eBillion-Dollar Strike: Farm Bill Amendment Could Change The Hemp Industry\u003c/a\u003e\u003c/strong\u003e\u003c/p\u003e\n\n\n\n\u003ch2 class=\"wp-block-heading\"\u003e\u003cstrong\u003eState-Specific Insights: Strong Performers and Untapped Potential\u003c/strong\u003e\u003c/h2\u003e\n\n\n\n\u003cp\u003eThe cannabis market shows significant variance across states.\u003c/p\u003e\n\n\n\n\u003ch3 class=\"wp-block-heading\"\u003eTop Performers\u003c/h3\u003e\n\n\n\n\u003cul\u003e\n\u003cli\u003eAlaska leads in sales per resident, driven by tourism, followed by Michigan and Nevada, with the latter benefiting from \u003ca href=\"https://www.benzinga.com/24/11/42148169/formula-1-drivers-react-to-cannabis-smell-at-las-vegas-grand-prix-everyone-would-test-positive\"\u003eLas Vegas tourism\u003c/a\u003e, achieving the highest sales per dispensary.\u003c/li\u003e\n\u003c/ul\u003e\n\n\n\n\u003ch3 class=\"wp-block-heading\"\u003eRoom For Growth\u003c/h3\u003e\n\n\n\n\u003cul\u003e\n\u003cli\u003eCalifornia leads in overall sales but lags in per capita sales. \u003ca href=\"https://www.benzinga.com/topic/illinois-cannabis\"\u003eIllinois\u003c/a\u003e and \u003ca href=\"https://www.benzinga.com/topic/florida-cannabis\"\u003eFlorida\u003c/a\u003e show strong sales but lower per capita, signaling opportunities for deeper market penetration. Florida is poised for growth once recreational cannabis is legalized.\u003c/li\u003e\n\u003c/ul\u003e\n\n\n\n\u003ch3 class=\"wp-block-heading\"\u003eEmerging Markets\u003c/h3\u003e\n\n\n\n\u003cul\u003e\n\u003cli\u003e\u003ca href=\"https://www.benzinga.com/topic/new-york-cannabis\"\u003eNew York\u003c/a\u003e and \u003ca href=\"https://www.benzinga.com/topic/ohio-cannabis\"\u003eOhio\u003c/a\u003e show lower sales per resident but have large population bases and expanding retail infrastructures, making them prime candidates for long-term growth.\u003c/li\u003e\n\n\n\n\u003cli\u003eCannabis companies operating in New York include\u003cstrong\u003e Curaleaf Holdings, Inc. \u003c/strong\u003e(OTC:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/CURLF#OTC\"\u003eCURLF\u003c/a\u003e), \u003cstrong\u003eAyr Wellness Inc.\u003c/strong\u003e (OTC:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/AYRWF#OTC\"\u003eAYRWF\u003c/a\u003e), \u003cstrong\u003eGreen Thumb Industries\u003c/strong\u003e (OTC:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/GTBIF#OTC\"\u003eGTBIF\u003c/a\u003e), \u003cstrong\u003eTrulieve Cannabis Corp.\u003c/strong\u003e (OTC:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/TCNNF#OTC\"\u003eTCNNF\u003c/a\u003e), \u003cstrong\u003eVerano Holdings Corp.\u003c/strong\u003e (OTC:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/VRNOF#OTC\"\u003eVRNOF\u003c/a\u003e), and \u003cstrong\u003eAscend Wellness Holdings\u003c/strong\u003e (CSE:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/AAWH#CSE\"\u003eAAWH\u003c/a\u003e, OTC:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/AAWHF#OTC\"\u003eAAWHF\u003c/a\u003e). In Ohio, key players include\u003cstrong\u003e Vext Science \u003c/strong\u003e(OTC:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/VEXTF#OTC\"\u003eVEXTF\u003c/a\u003e), \u003cstrong\u003eThe Green Organic Dutchman\u003c/strong\u003e (OTC:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/TGODF#OTC\"\u003eTGODF\u003c/a\u003e), \u003cstrong\u003eCresco Labs Inc.\u003c/strong\u003e (OTC:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/CRLBF#OTC\"\u003eCRLBF\u003c/a\u003e), and \u003cstrong\u003eHarvest Health \u0026amp; Recreation\u003c/strong\u003e (OTC:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/HRVSF#OTC\"\u003eHRVSF\u003c/a\u003e), which is now part of Trulieve.\u003c/li\u003e\n\u003c/ul\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eRead Also:\u003ca href=\"https://www.benzinga.com/24/11/42130001/green-wednesdays-biggest-weed-buyers-the-surprising-archetypes-driving-sales\"\u003e Green Wednesday\u0026#8217;s Biggest Weed Buyers: The Surprising Archetypes Driving Sales\u003c/a\u003e\u003c/strong\u003e\u003c/p\u003e\n\n\n\n\u003ch2 class=\"wp-block-heading\"\u003e\u003cstrong\u003eStrategic Opportunities\u003c/strong\u003e\u003c/h2\u003e\n\n\n\n\u003cp\u003eWholesale cannabis sales are projected to reach $11.7 billion in 2024, an 11% increase from 2023. However, monthly fluctuations require strategic planning for both sellers and buyers. In October 2024, wholesale sales dipped 2% from the previous month but rose 9.6% year-over-year.\u003c/p\u003e\n\n\n\n\u003ch3 class=\"wp-block-heading\"\u003e\u003cstrong\u003eSeller Impact\u003c/strong\u003e\u003c/h3\u003e\n\n\n\n\u003cul\u003e\n\u003cli\u003eSellers in \u003ca href=\"https://www.benzinga.com/topic/massachusetts-cannabis\"\u003eMassachusetts\u003c/a\u003e, \u003ca href=\"https://www.benzinga.com/topic/michigan-cannabis\"\u003eMichigan\u003c/a\u003e, and Illinois see robust demand, while those in Maryland and Michigan face pricing pressure, with Maryland\u0026#8217;s prices falling 23.2% and Michigan\u0026#8217;s dropping 14.1%.\u003c/li\u003e\n\u003c/ul\u003e\n\n\n\n\u003ch3 class=\"wp-block-heading\"\u003e\u003cstrong\u003eBuyer Impact\u003c/strong\u003e\u003c/h3\u003e\n\n\n\n\u003cul\u003e\n\u003cli\u003eBuyers can capitalize on price dips, particularly as some states, such as\u003ca href=\"https://www.benzinga.com/topic/arkansas-cannabis\"\u003e Arkansas\u003c/a\u003e and Washington, saw price increases of 20.7% and 17.9%, respectively, while\u003ca href=\"https://www.benzinga.com/topic/maryland-cannabis\"\u003e Maryland\u003c/a\u003e and \u003ca href=\"https://www.benzinga.com/topic/arizona-cannabis\"\u003eArizona\u003c/a\u003e saw declines.\u003c/li\u003e\n\u003c/ul\u003e\n\n\n\n\u003ch3 class=\"wp-block-heading\"\u003ePricing\u0026nbsp;\u003c/h3\u003e\n\n\n\n\u003cul\u003e\n\u003cli\u003eIn October 2024, the average flower price was $1,065 per pound, down $100 from the summer peak of $1,152. The price drop reflects typical seasonal oversupply from outdoor harvests in states like Michigan and Arizona. At the same time, reduced cultivation in mature markets like \u003ca href=\"https://www.benzinga.com/topic/california-cannabis\"\u003eCalifornia\u003c/a\u003e, Oregon, and \u003ca href=\"https://www.benzinga.com/topic/colorado-cannabis\"\u003eColorado\u003c/a\u003e should help stabilize prices.\u003c/li\u003e\n\u003c/ul\u003e\n\n\n\n\u003cul\u003e\n\u003cli\u003eMaryland experienced a 23.2% price drop, while Arkansas saw a 20.7% price increase year-over-year. States like California and Arizona, facing oversupply issues, may see stabilization as cultivation is reduced.\u003c/li\u003e\n\u003c/ul\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eRead Also:\u003ca href=\"https://www.benzinga.com/general/market-summary/24/11/42086135/pre-rolls-the-avocado-toast-of-cannabis-why-millennials-are-spending-100m-a-month\"\u003e Pre-Rolls, The Avocado Toast Of Cannabis: Why Millennials Are Spending +$100M A Month\u003c/a\u003e\u003c/strong\u003e\u003c/p\u003e\n\n\n\n\u003ch2 class=\"wp-block-heading\"\u003e\u003cstrong\u003eEmerging Hotspots\u003c/strong\u003e\u003c/h2\u003e\n\n\n\n\u003cp\u003eMarkets like\u003ca href=\"https://www.benzinga.com/topic/missouri-cannabis\"\u003e Missouri\u003c/a\u003e and Maryland are showing strong growth. Missouri generated $6.5 million in sales per dispensary in 2024, while Maryland reached $11.6 million per retail license. Arkansas, with its limited number of permits, is generating $7.6 million per license, signaling robust demand in a limited-license environment.\u003c/p\u003e\n\n\n\n\u003cp\u003eBy contrast, Oklahoma has the lowest sales per license, at just $0.4 million, due to oversaturation with over 1,800 licenses, presenting opportunities for consolidation or increased operational efficiency.\u003c/p\u003e\n\n\n\n\u003ch3 class=\"wp-block-heading\"\u003eLong-Term Outlook: A $55 Billion Industry by 2030\u003c/h3\u003e\n\n\n\n\u003cp\u003eThe U.S. cannabis industry is projected to reach $55 billion by 2030, driven by retail expansion in states like New York, \u003ca href=\"https://www.benzinga.com/topic/new-jersey-cannabis\"\u003eNew Jersey\u003c/a\u003e, and Ohio, as well as continued growth in mature markets like Illinois and Florida.\u0026nbsp;\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eRead Next: \u003ca href=\"https://www.benzinga.com/general/market-summary/24/11/42049450/can-trumps-return-save-the-cannabis-sector-debt-mounts-as-giants-face-post-election-reckoning\"\u003eCan Trump\u0026#8217;s Return Save The Cannabis Sector? Debt Mounts As Giants Face Post-Election Reckoning\u003c/a\u003e\u003c/strong\u003e\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cem\u003e\u003cstrong\u003eSource Acknowledgment\u003c/strong\u003e: This article is based on insights from \u003ca href=\"https://www.leaflink.com/\"\u003e\u003cstrong\u003eLeafLink\u0026#8217;s Fall 2024 U.S. Cannabis Industry Report\u003c/strong\u003e \u003c/a\u003eand other relevant industry data. All projections and trends discussed are sourced directly from the report, which includes sales figures, state-specific insights, pricing trends, and wholesale dynamics for the cannabis sector.\u003c/em\u003e\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cem\u003e\u003cstrong\u003eDisclaimer\u003c/strong\u003e: The projections and data shared in this article are based on the most current information available as of the Fall 2024 report. Results may vary, and the cannabis industry is subject to ongoing regulatory changes, market fluctuations, and shifts in federal policy.\u003c/em\u003e\u003c/p\u003e","url":"https://www.benzinga.com/news/retail-sales/24/11/42193387/federal-policy-could-add-3-billion-to-cannabis-industry-on-track-to-reach-55-billion-by-2030","image":[{"size":"thumb","url":"https://cdn.benzinga.com/files/imagecache/250x187xUP/images/story/2024/11/26/AI-Generated-Image_0.jpeg"},{"size":"small","url":"https://cdn.benzinga.com/files/imagecache/1024x768xUP/images/story/2024/11/26/AI-Generated-Image_0.jpeg"},{"size":"large","url":"https://cdn.benzinga.com/files/imagecache/2048x1536xUP/images/story/2024/11/26/AI-Generated-Image_0.jpeg"}],"channels":[{"name":"Cannabis"},{"name":"News"},{"name":"Retail Sales"},{"name":"Markets"}],"stocks":[{"name":"AYRWF"},{"name":"CRLBF"},{"name":"CSE:AAWH"},{"name":"CURLF"},{"name":"GTBIF"},{"name":"TCNNF"},{"name":"VEXTF"},{"name":"VRNOF"},{"name":"AAWHF"},{"name":"TGODF"},{"name":"HRVSF"}],"tags":[{"name":"cannabis retail sales"}]},{"id":42199358,"author":"Jelena Martinovic","created":"Tue, 26 Nov 2024 16:00:33 -0400","updated":"Tue, 26 Nov 2024 16:00:34 -0400","title":"Aurora Cannabis Reveals Latest Product Innovations: Ultra-High Potency Indicas And Strains For Veterans","teaser":"Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), announced on Tuesday developments in cannabis science from Aurora\u0026#39;s research and genetics facility, Aurora Coast.\u0026#34;As a company committed to leading the way in terms of cannabis innovation, we are dedicated to putting patients first by harnessing the innovative solutions developed by our top researchers at Aurora Coast, our unique global research facility,\u0026#34; Lana Culley, vice president of science and innovation at Aurora. \u0026#34;We strive to continuously raise the bar on product superiority and overall user experience so that we can deliver on our mission of providing patients with access to the very best medical cannabis.\u0026#34;","body":"\u003cp\u003e\u003cstrong\u003eAurora Cannabis Inc.\u003c/strong\u003e (NASDAQ:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/ACB#NASDAQ\"\u003eACB\u003c/a\u003e) (TSX:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/ACB#TSX\"\u003eACB\u003c/a\u003e), announced on Tuesday developments in cannabis science from Aurora\u0026#8217;s research and genetics facility, \u003cstrong\u003eAurora Coast.\u003c/strong\u003e\u003c/p\u003e\n\n\n\n\u003cp\u003eThe latest innovations from the Canadian medical cannabis giant include:\u003c/p\u003e\n\n\n\n\u003cul\u003e\n\u003cli\u003eAurora \u0026#x7C; CBD Varius (1g, 510 Cartridge);\u003c/li\u003e\n\n\n\n\u003cli\u003eMedReleaf (Strains For Heroes) \u0026#x7C; Esprit De Corps (5g and 15g); a premium sativa (THC: 20-29%, CBD: 0-1%), developed under the Strains For Heroes initiative by Aurora with direct feedback from Veteran patients;\u003c/li\u003e\n\n\n\n\u003cli\u003eMedReleaf \u0026#x7C; Sedamen (1g, 510 Cartridge) in a higher THC format;\u003c/li\u003e\n\n\n\n\u003cli\u003eMedReleaf \u0026#x7C; Noculus (5g and 15g); an ultra-high potency indica, featuring THC levels between 25-31% and CBD content from 0-1%; and\u003c/li\u003e\n\n\n\n\u003cli\u003eWMMC \u0026#x7C; Seasonal Stash \u0026#8211; Frosted Alpine (10g); a limited-grown hybrid strain (THC: 24-30%; CBD: 0-1%).\u003c/li\u003e\n\u003c/ul\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eRead Also: \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/10/41358918/aurora-cannabis-launches-innovative-thc-oil-products-in-australia-to-meet-diverse-patient-needs\"\u003eAurora Cannabis Launches Innovative THC Oil Products In Australia To Meet Diverse Patient Needs\u003c/a\u003e\u003c/strong\u003e \u003c/p\u003e\n\n\n\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003e\u003cem\u003eGet Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter \u003ca href=\"https://newsletteremail.benzinga.com/subscribe\" target=\"_blank\" rel=\"noreferrer noopener\"\u003ehere\u003c/a\u003e. If you're serious about the business, you can't afford to miss out.\u003c/em\u003e\u003c/strong\u003e\u003c/li\u003e\n\u003c/ul\u003e\n\n\n\n\u003cp\u003e\u0026#8220;As a company committed to leading the way in terms of cannabis innovation, we are dedicated to putting patients first by harnessing the innovative solutions developed by our top researchers at Aurora Coast, our unique global research facility,\u0026#8221; \u003cstrong\u003eLana Culley, \u003c/strong\u003evice president of science and innovation at Aurora. \u0026#8220;We strive to continuously raise the bar on product superiority and overall user experience so that we can deliver on our mission of providing patients with access to the very best medical cannabis.\u0026#8221;\u003c/p\u003e\n\n\n\n\u003cp\u003eThe latest update from Aurora comes on the heels of its recently revealed lineup of innovations from \u003cstrong\u003eGreybeard, San Rafael '71\u003c/strong\u003e and \u003ca href=\"https://www.benzinga.com/news/retail-sales/24/11/42098974/canopy-growth-aurora-and-another-cannabis-giant-unveil-product-innovations-heres-whats-new\"\u003e\u003cstrong\u003eTasty\u003c/strong\u003e's brands for Canadian consumers.\u003c/a\u003e\u003c/p\u003e\n\n\n\n\u003cp\u003eAurora reported its second quarter financial results, showing revenue of CA$81.1 million ($58.3 million), up from CA$63.1 million in the same \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/11/41774692/aurora-cannabis-reports-strong-q2-growth-driven-by-international-medical-marijuana-sales\"\u003eperiod last year.\u003c/a\u003e\u003c/p\u003e\n\n\n\n\u003cp\u003eThe company attributed the 29% increase from the prior period to 41% growth in its global medical cannabis business and 21% growth in its plant propagation business, slightly offset by lower quarterly revenue in its consumer cannabis business.\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eRead Next:\u003c/strong\u003e\u003c/p\u003e\n\n\n\n\u003cul\u003e\n\u003cli\u003e\u003ca href=\"https://www.benzinga.com/markets/cannabis/24/02/37365341/uk-medical-cannabis-market-gets-boost-with-aurora-and-script-assist-collaboration\"\u003e\u003cstrong\u003eUK Medical Cannabis Market Gets Boost With Aurora And Script Assist Collaboration\u003c/strong\u003e\u003c/a\u003e\u003c/li\u003e\n\u003c/ul\u003e\n\n\n\n\u003ch3 class=\"wp-block-heading\"\u003eACB Price Action\u003c/h3\u003e\n\n\n\n\u003cp\u003eAurora's shares traded 3.28% lower at $4.42 per share at the time of writing on Tuesday morning.\u003c/p\u003e","url":"https://www.benzinga.com/news/retail-sales/24/11/42199358/aurora-cannabis-reveals-latest-product-innovations-ultra-high-potency-indicas-and-strains-for-veterans","image":[{"size":"thumb","url":"https://cdn.benzinga.com/files/imagecache/250x187xUP/images/story/2024/11/26/wesley-gibbs-NxRx7-mPdEk-unsplash.jpeg"},{"size":"small","url":"https://cdn.benzinga.com/files/imagecache/1024x768xUP/images/story/2024/11/26/wesley-gibbs-NxRx7-mPdEk-unsplash.jpeg"},{"size":"large","url":"https://cdn.benzinga.com/files/imagecache/2048x1536xUP/images/story/2024/11/26/wesley-gibbs-NxRx7-mPdEk-unsplash.jpeg"}],"channels":[{"name":"Cannabis"},{"name":"News"},{"name":"Retail Sales"}],"stocks":[{"name":"ACB"},{"name":"TSX:ACB"}],"tags":[{"name":"Aurora Coast"},{"name":"Canada Cannabis"},{"name":"cannabis strains"},{"name":"Lana Culley"},{"name":"marijuana products"}]},{"id":42196557,"author":"Jelena Martinovic","created":"Tue, 26 Nov 2024 13:46:16 -0400","updated":"Tue, 26 Nov 2024 13:46:17 -0400","title":"Canopy USA's Acquisition Of Acreage Could Mean Staggering Losses For Some Shareholders","teaser":"Acreage Holdings, Inc. (CSE:ACRG.A.U, ACRG.B.U) (OTCQX: ACRHF, ACRDF) said it anticipates that Canopy USA, LLC -Canopy Growth Corporation‘s (TSX: WEED) (NASDAQ: CGC) strategy for capturing the U.S. cannabis - will complete its acquisition of Acreage by mid-December, 2024.The move could leave holders of Acreage\u0026#39;s Class E shares (fixed shares) with nothing. That is, if Canopy\u0026#39;s stock price price remains below $5 when the deal closes, Acreage said in Monday\u0026#39;s press release.","body":"\u003cp\u003e\u003cstrong\u003eAcreage Holdings, Inc\u003c/strong\u003e. (CSE:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/ACRG#CSE\"\u003eACRG\u003c/a\u003e, ACRG.B.U)) (OTCQX:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/ACRHF#OTCQX\"\u003eACRHF\u003c/a\u003e, ACRDF)) said it anticipates that \u003cstrong\u003eCanopy USA\u003c/strong\u003e, \u003cstrong\u003eLLC\u003c/strong\u003e \u0026#8211;\u003cstrong\u003eCanopy Growth Corporation\u003c/strong\u003e‘s (TSX:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/WEED#TSX\"\u003eWEED\u003c/a\u003e) (NASDAQ:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/CGC#NASDAQ\"\u003eCGC\u003c/a\u003e) strategy for capturing the U.S. cannabis market will complete its acquisition of Acreage by mid-December, 2024.\u003c/p\u003e\n\n\n\n\u003cp\u003eThe move could leave holders of Acreage\u0026#8217;s Class E shares (fixed shares) with nothing. That is, if Canopy\u0026#8217;s stock price price remains below $5 when the deal closes, Acreage pointed out in a Monday press release.\u003c/p\u003e\n\n\n\n\u003ch3 class=\"wp-block-heading\"\u003e\u003cstrong\u003eWhy?\u003c/strong\u003e\u003c/h3\u003e\n\n\n\n\u003cp\u003eThe convertible note offering completed in June caused significant dilution of Acreage's fixed shares, leaving them without any worth at Canopy\u0026#8217;s current share price.\u003c/p\u003e\n\n\n\n\u003cp\u003e\"As a result of the material impact of the Offering it is anticipated that the current holders of Fixed Shares will receive zero value upon closing of the Acquisitions,\" Acreage said.\u003c/p\u003e\n\n\n\n\u003cp\u003eCanopy's shares traded 5.06% lower at $3.9401 per share at the time of writing on Tuesday morning. Acreage shares plunged more than 90% on Monday in reaction to the news.\u003c/p\u003e\n\n\n\n\u003cp\u003eThe company also \u003ca href=\"https://www.accesswire.com/946598/acreage-provides-update-on-corporate-transactions\"\u003esaid\u003c/a\u003e holders of floating shares will get 0.045 of a Canopy share for each of their floating shares, which is a fixed exchange rate.\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eRead Also: \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/06/39185620/acreage-announces-10m-private-placement-of-units-ahead-of-acquisition-by-canopy\"\u003eAcreage Announces $10M Private Placement Of Units Ahead Of Acquisition By Canopy\u003c/a\u003e\u003c/strong\u003e\u003c/p\u003e\n\n\n\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003e\u003cem\u003eGet Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter \u003ca href=\"https://newsletteremail.benzinga.com/subscribe\" target=\"_blank\" rel=\"noreferrer noopener\"\u003ehere\u003c/a\u003e. If you're serious about the business, you can't afford to miss out.\u003c/em\u003e\u003c/strong\u003e\u003c/li\u003e\n\u003c/ul\u003e\n\n\n\n\u003cp\u003eAccording to editor-in-chief of Cultivated Daily, \u003cstrong\u003eJeremy Berke\u003c/strong\u003e, optimism around U.S. legalization of cannabis was imminent five years ago when the deal was announced.\u003c/p\u003e\n\n\n\n\u003cp\u003e\"When the deal was announced, analysts, investors, and attorneys thought legalization in the US was right around the corner — and there would be millions to be made in fees for cross-border transactions,\" Berke \u003ca href=\"https://www.cultivated.news/p/a-3-4-billion-deal-goes-to-zero\"\u003esaid\u003c/a\u003e.\u003c/p\u003e\n\n\n\n\u003cp\u003eHowever, the anticipated boom in legalization and cross-border deals are still pending, leading to disappointment in the industry, he continued.\u003c/p\u003e\n\n\n\n\u003cp\u003e\"Both US and Canadian companies have seen their valuations fall into the gutter as investors have looked to put their money elsewhere,\" Berke said, adding that Acreage was particularly hit by setbacks in the New York cannabis market in which it is substantially invested.\u003c/p\u003e\n\n\n\n\u003cp\u003eAcreage reported a 30% decrease in consolidated revenue in the third quarter and a wider net loss of s $22.2 million, up from a loss of $7.9 million in the previous year\u0026#8217;s quarter. Adjusted EBITDA came in positive at $0.6 million, representing a drop from $6.6 million \u003ca href=\"https://www.benzinga.com/24/11/42009069/canopy-growths-acquisition-target-acreage-reports-30-yoy-decline-in-q3-revenue-achieves-record-cannabis-wholesale-revenue-in-new-york\"\u003ein the third quarter of 2023.\u003c/a\u003e\u003c/p\u003e\n\n\n\n\u003ch3 class=\"wp-block-heading\"\u003e\u003cstrong\u003eBackground\u003c/strong\u003e\u003c/h3\u003e\n\n\n\n\u003cp\u003eThe Canadian cannabis giant first announced its plans to \u003ca href=\"https://www.benzinga.com/analyst-ratings/analyst-color/19/06/13951090/canopy-shareholders-approve-acreage-deal-legalization-in-focus\"\u003eacquire\u003c/a\u003e Acreage for $3.4 billion in 2019. Initially, the deal was to be undertaken should the U.S. legalize marijuana on a federal level. That deal was later restructured.\u003c/p\u003e\n\n\n\n\u003cp\u003eIn 2022 Canopy Growth created a new U.S.-domiciled holding company, Canopy USA, LLC.\u003c/p\u003e\n\n\n\n\u003cp\u003eThe move sought to streamline the company\u0026#8217;s entry into the US market by allowing it to acquire Acreage as well as two other cannabis companies \u0026#8211; \u003cstrong\u003eWana Brands\u003c/strong\u003e and\u003cstrong\u003e Jetty\u003c/strong\u003e – while also holding a minority stake in \u003cstrong\u003eTerrAscend. Corp.\u003c/strong\u003e(TSX:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/TSND#TSX\"\u003eTSND\u003c/a\u003e) (OTCQX:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/TSNDF#OTCQX\"\u003eTSNDF\u003c/a\u003e),\u003c/p\u003e\n\n\n\n\u003cp\u003eCanopy USA \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/10/41251114/cannabis-giant-canopy-expands-us-presence-with-acquisition-of-top-edibles-brand-what-it-means-fo\"\u003ecompleted\u003c/a\u003e its acquisition of Wana in October, and roughly 75% of the shares of cannabis edibles producer,\u003cstrong\u003e Lemurian, Inc. \u003c/strong\u003e(Jetty) as \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/06/39166300/canopy-growth-doubles-down-on-its-usa-strategy-announces-exercise-of-acreage-options\"\u003eannounced in June 2024.\u003c/a\u003e\u003c/p\u003e\n\n\n\n\u003cp\u003eCanopy Growth's newly appointed CEO\u003cstrong\u003e Luc Mongeau\u003c/strong\u003e, who succeeds \u003cstrong\u003eDavid Klein \u003c/strong\u003eeffective Jan. 6, 2025, will continue his legacy by expanding the company's influence in the U.S.\u003c/p\u003e\n\n\n\n\u003cp\u003e\"I am honored to lead Canopy Growth into this exciting next chapter, and I am confident that our vision, dedication to our consumers, and the commitment of our team members will continue to position us for long-term success and value creation,\" Mongeau \u003ca href=\"https://www.benzinga.com/24/11/42190387/cannabis-giant-canopy-growth-names-next-ceo-heres-who-will-succeed-david-klein-amid-us-expansion\"\u003esaid in a Tuesday statement.\u003c/a\u003e\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eRead Next:\u003c/strong\u003e\u003c/p\u003e\n\n\n\n\u003cul\u003e\n\u003cli\u003e\u003ca href=\"https://www.benzinga.com/markets/cannabis/24/11/42162875/canopy-growths-german-subsidiary-teams-up-with-portugals-gro-vida-to-expand-medical-cannabis-supply\"\u003e\u003cstrong\u003eCanopy Growth\u0026#8217;s German Subsidiary Teams Up With Portugal\u0026#8217;s Gro-Vida To Expand Medical Cannabis Supply\u003c/strong\u003e\u003c/a\u003e\u003c/li\u003e\n\u003c/ul\u003e","url":"https://www.benzinga.com/24/11/42196557/canopy-usas-acquisition-of-acreage-could-mean-loss-for-some-shareholders-heres-why","image":[{"size":"thumb","url":"https://cdn.benzinga.com/files/imagecache/250x187xUP/images/story/2024/11/26/jan-baborak-mI4Zf2ftzXo-unsplash.jpeg"},{"size":"small","url":"https://cdn.benzinga.com/files/imagecache/1024x768xUP/images/story/2024/11/26/jan-baborak-mI4Zf2ftzXo-unsplash.jpeg"},{"size":"large","url":"https://cdn.benzinga.com/files/imagecache/2048x1536xUP/images/story/2024/11/26/jan-baborak-mI4Zf2ftzXo-unsplash.jpeg"}],"channels":[{"name":"Cannabis"},{"name":"M\u0026A"},{"name":"News"},{"name":"Top Stories"}],"stocks":[{"name":"ACRDF"},{"name":"ACRHF"},{"name":"CGC"},{"name":"CSE:ACRG"},{"name":"TSNDF"},{"name":"TSX:TSND"},{"name":"TSX:WEED"},{"name":"WEED"}],"tags":[{"name":"cannabis acquisition"},{"name":"cannabis shareholders"},{"name":"Canopy USA"},{"name":"David Klein"},{"name":"Jeremy Berke"},{"name":"Jetty"},{"name":"Luc Mongeau"},{"name":"Wana Brands"}]},{"id":42043465,"author":"Nina Zdinjak","created":"Mon, 25 Nov 2024 15:13:36 -0400","updated":"Mon, 25 Nov 2024 15:13:40 -0400","title":"Czech Government Approves Draft Law That Would Legalize Cultivation Of 3 Cannabis Plants, Possession Of 50 Grams (UPDATED)","teaser":" ","body":"\u003cp\u003e\u003cem\u003eEditor\u0026#8217;s note: This article has been updated to clarify that the Czech government approved a draft bill regarding cannabis cultivation rather than having legalized marijuana cultivation and possession of 50 grams as was previously reported.\u003c/em\u003e\u003c/p\u003e\n\n\n\n\u003cp\u003eThe Czech government recently proposed a draft law that would reform criminal law regarding cannabis, with changes including relaxed rules on home cultivation and possession. The draft law now needs to be viewed by both chambers of Parliament.\u003c/p\u003e\n\n\n\n\u003cp\u003e During a press conference, Justice Minister \u003cstrong\u003ePavel Blažek\u003c/strong\u003e spoke about raising and favoring financial penalties over imprisonment for cannabis offenses.\u003c/p\u003e\n\n\n\n\u003cp\u003e\"Our punishment system is outdated and diverging from the rest of the EU, which is obviously not good,\" Blažek said, \u003ca href=\"https://www.echo24.cz/a/H5KfB/zpravy-vlada-schvalila-novela-trestniho-zakoniku-ministr-spravedlnosti-pavel-blazek-vezeni-konopi-tresty\"\u003ereported\u003c/a\u003e Echo24, according to translation.\u003c/p\u003e\n\n\n\n\u003cp\u003eUnder the proposed changes, which could take months to be approved, cultivating up to three cannabis plants and possessing up to 50 grams outside the home and 25 grams inside would be legal. Cultivating four to five plants would be treated as a minor offense, but anything more than that would be considered criminal activity.\u003c/p\u003e\n\n\n\n\u003cp\u003eThe opposition Pirate Party argued that the proposal is inadequate because allowing cultivation of several plants does not permit their harvest, as three plants could yield up to 300 grams.\u003c/p\u003e\n\n\n\n\u003cp\u003e\"Instead of legalization and additional revenue for the budget, the government presents a botched proposal,\" said former Deputy Prime Minister and ex-leader of the Pirate Party \u003cstrong\u003eIvan Bartoš.\u003c/strong\u003e \"You can grow cannabis, but you can't harvest it. Allowing the cultivation of three cannabis plants while limiting possession to 50 grams at home is absurd. It's like being allowed to keep three hens, but if they lay more than one egg, you face a fine or jail time.\"\u003c/p\u003e\n\n\n\n\u003cp\u003eBartoš further argued that proposal is complicating the situation for up to 600,000 medical marijuana patients. The Pirate Party plans to propose increasing the legal possession limit to 900 grams.\u003c/p\u003e\n\n\n\n\u003cp\u003eThe government wants to implement the approved changes before the end of its term.\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eRead Also: \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/10/41295350/czech-senate-approves-restrictions-on-sale-of-kratom-and-hhc-products\"\u003eCzech Senate Approves Restrictions On Sale Of Kratom And HHC Products\u003c/a\u003e\u003c/strong\u003e\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cem\u003e\u003cstrong\u003eGet Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter \u003ca href=\"https://newsletteremail.benzinga.com/subscribe\" target=\"_blank\" rel=\"noreferrer noopener\"\u003ehere\u003c/a\u003e. If you're serious about the business, you can't afford to miss out.\u003c/strong\u003e\u003c/em\u003e\u003c/p\u003e\n\n\n\n\u003ch2 class=\"wp-block-heading\"\u003e\u003cstrong\u003eRecent Calls For Regulated Cannabis Market\u003c/strong\u003e\u003c/h2\u003e\n\n\n\n\u003cp\u003eThe news comes several months after the governing coalition confirmed it supports cannabis cultivation, but not the establishment of a regulated marijuana market. At the same time, former National Drug Coordinator \u003cstrong\u003eJindřich Vobořil\u003c/strong\u003e shared he doesn't believe that the game is over for full legalization and \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/08/40626067/full-cannabis-legalization-not-yet-off-the-table-in-czech-republic-some-lawmakers-want-only-home\" target=\"_blank\" rel=\"noreferrer noopener\"\u003econtinues to push for it\u003c/a\u003e.\u003c/p\u003e\n\n\n\n\u003cp\u003eMeanwhile, a recent study conducted by the researchers from the Faculty of Business Economics at the University of Prague concluded that the country could be \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/09/40879273/this-european-country-could-lose-242m-a-year-if-it-doesnt-regulate-its-marijuana-market-study-fi\" target=\"_blank\" rel=\"noreferrer noopener\"\u003emissing out on hundreds of millions of euros \u003c/a\u003eannually if it doesn\u0026#8217;t establish a regulated marijuana market. As per the report a \u0026#8220;comprehensive model,\u0026#8221; incorporating self-cultivation, cannabis clubs and a fully commercial market, could result in \"total net social benefits of CZK 5.5 billion (218 million euros; $242 million) per year.\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eRead Next:\u003c/strong\u003e\u003c/p\u003e\n\n\n\n\u003cul\u003e\n\u003cli\u003e\u003ca href=\"https://www.benzinga.com/markets/cannabis/24/11/41890759/polish-parliamentary-committee-sends-cannabis-decriminalization-petition-to-prime-minister\"\u003ePolish Parliamentary Committee Sends Cannabis Decriminalization Petition To Prime Minister\u003c/a\u003e\u003c/li\u003e\n\u003c/ul\u003e\n\n\n\n\u003cp\u003e\u003cem\u003ePhoto: Courtesy of JESHOOTS.com via Pexels \u003c/em\u003e\u003c/p\u003e","url":"https://www.benzinga.com/markets/cannabis/24/11/42043465/czech-government-legalizes-cultivation-of-three-cannabis-plants-allows-possession-of-50-grams","image":[{"size":"large","url":"https://cdn.benzinga.com/files/imagecache/2048x1536xUP/images/story/2024/11/25/pexels-jeshoots-com-147458-442583.jpeg"},{"size":"thumb","url":"https://cdn.benzinga.com/files/imagecache/250x187xUP/images/story/2024/11/25/pexels-jeshoots-com-147458-442583.jpeg"},{"size":"small","url":"https://cdn.benzinga.com/files/imagecache/1024x768xUP/images/story/2024/11/25/pexels-jeshoots-com-147458-442583.jpeg"}],"channels":[{"name":"Cannabis"},{"name":"News"},{"name":"Eurozone"}],"stocks":[],"tags":[{"name":"Czech Republic cannabis"},{"name":"Pavel Blažek"},{"name":"the Czech Republic cannabis"},{"name":"The Pirate Party"}]},{"id":42017583,"author":"Javier Hasse","created":"Fri, 15 Nov 2024 15:54:58 -0400","updated":"Fri, 15 Nov 2024 15:54:59 -0400","title":"Trump's 'Go Wild On Health' Plan Puts RFK Jr. In Charge: What It Means For Cannabis And Psychedelics Reform","teaser":"President-elect Trump appoints Robert F. Kennedy Jr. (RFK Jr.) as HHS Secretary, hinting at shifts in cannabis and psychedelics policy.","body":"\u003cp\u003ePresident-elect \u003cstrong\u003eDonald Trump\u003c/strong\u003e has announced that \u003cstrong\u003eRobert F. Kennedy Jr. (RFK Jr.)\u003c/strong\u003e will serve as the \u003cstrong\u003eSecretary of Health and Human Services (HHS).\u003c/strong\u003e Trump described Kennedy's mission as one to address the \"industrial food complex\" and pharmaceutical companies, which he accused of spreading \"misinformation and disinformation.\"\u003c/p\u003e\n\n\n\n\u003cp\u003eIn his announcement, Trump emphasized that Kennedy's leadership would \"restore these agencies to the traditions of gold standard scientific research and beacons of transparency to end the chronic disease epidemic.\" He also noted that the safety and health of Americans would remain a central focus of the new administration.\u003c/p\u003e\n\n\n\n\u003cp\u003eEarlier \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/11/41828359/could-trumps-go-wild-on-health-invite-to-rfk-jr-drive-changes-for-cannabis-and-psychedelics\"\u003eremarks\u003c/a\u003e by Trump indicated that Kennedy would be given significant freedom in his role, with the president-elect stating that he would allow Kennedy to \"go wild on health\" to address systemic issues in the country's healthcare system. While the specific implications of this statement remain unclear, it reflects Trump's confidence in Kennedy's ability to tackle what he views are broad public health challenges.\u003c/p\u003e\n\n\n\n\u003ch3 class=\"wp-block-heading\"\u003e\u003cstrong\u003ePolarizing Appointment With Major Implications\u003c/strong\u003e\u003c/h3\u003e\n\n\n\n\u003cp\u003eKennedy's appointment has drawn attention due to his well-documented skepticism about vaccine safety, including his past promotion of \u003ca href=\"https://www.chop.edu/vaccine-education-center/vaccine-safety/vaccines-and-other-conditions/autism\"\u003edebunked theories linking vaccines to autism\u003c/a\u003e, claims widely rejected by the scientific community. This history raises questions about how RFK\u0026#8217;s leadership will influence key public health initiatives.\u003c/p\u003e\n\n\n\n\u003cp\u003eDespite this background, Kennedy's policy positions on \u003ca href=\"https://www.benzinga.com/cannabis\"\u003ecannabis and psychedelics\u003c/a\u003e suggest he could drive significant reforms in these areas. His advocacy for these substances has gained traction as public opinion shifts and bipartisan support grows for drug policy reform.\u003c/p\u003e\n\n\n\n\u003ch3 class=\"wp-block-heading\"\u003e\u003cstrong\u003eKennedy's Cannabis Policy Vision\u003c/strong\u003e\u003c/h3\u003e\n\n\n\n\u003cp\u003eAs HHS Secretary, Kennedy's approach to cannabis will likely be closely scrutinized. He has consistently advocated for federal decriminalization, envisioning a framework where states can regulate cannabis while the federal government collects tax revenue to fund rehabilitation centers. These centers, which RFK has proposed establishing in rural areas, would emphasize holistic recovery practices, such as gardening and forestry.\u003c/p\u003e\n\n\n\n\u003cp\u003eKennedy's broader public health goals align with this vision. He has pushed for reducing barriers to entry for cannabis businesses while addressing addiction and recovery challenges nationwide. A significant element of his policy is enabling safe banking for cannabis businesses. He has called for reforms to end the industry's reliance on cash transactions, which pose security risks and limit financial access.\u003c/p\u003e\n\n\n\n\u003ch3 class=\"wp-block-heading\"\u003e\u003cstrong\u003ePsychedelics: A Personal And Policy Frontier\u003c/strong\u003e\u003c/h3\u003e\n\n\n\n\u003cp\u003eKennedy's advocacy for psychedelics stems from both personal experiences and the growing body of research on their potential mental health benefits. He has shared how his son's use of ayahuasca helped him process grief, an experience that informed Kennedy's cautious but supportive stance on psychedelics.\u003c/p\u003e\n\n\n\n\u003cp\u003e\"My inclination would be to make them available, at least in therapeutic settings and maybe more generally, but in ways that would discourage corporate control and exploitation,\" Kennedy \u003ca href=\"https://www.benzinga.com/markets/cannabis/23/12/36289732/psychedelics-legalization-2024-election-robert-f-kennedy-jr-confirms-support-in-new-interview\"\u003esaid in an interview\u003c/a\u003e with Genius Network in 2023. His perspective suggests a focus on accessibility while resisting the commercialization of these substances, aiming to prioritize therapeutic applications.\u003c/p\u003e\n\n\n\n\u003ch3 class=\"wp-block-heading\"\u003e\u003cstrong\u003eWhat's Next For Reform?\u003c/strong\u003e\u003c/h3\u003e\n\n\n\n\u003cp\u003eKennedy's confirmation as HHS Secretary has sparked discussion about how his views will shape drug policy in the U.S. His positions on cannabis decriminalization, safe banking reforms and therapeutic uses of psychedelics align with increasing public and political support for change. However, his history of promoting discredited vaccine theories and his polarizing reputation could complicate efforts to build consensus within the administration and among public health stakeholders.\u003c/p\u003e\n\n\n\n\u003cp\u003eWhile the specifics of Kennedy's role are still emerging, his appointment signals a potential pivot in federal approaches to cannabis and psychedelics. Industry stakeholders, from advocates to investors, will be watching closely to see whether his leadership results in meaningful reform.\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cem\u003eThis content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.\u003c/em\u003e\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cem\u003ePhoto: Shutterstock\u003c/em\u003e\u003c/p\u003e","url":"https://www.benzinga.com/general/health-care/24/11/42017583/trumps-go-wild-on-health-plan-puts-rfk-jr-in-charge-what-it-means-for-cannabis-and-psychedelics-reform","image":[{"size":"large","url":"https://cdn.benzinga.com/files/imagecache/2048x1536xUP/images/story/2024/11/15/RFK---Independent-Presidential-Candidate_0.jpeg"},{"size":"thumb","url":"https://cdn.benzinga.com/files/imagecache/250x187xUP/images/story/2024/11/15/RFK---Independent-Presidential-Candidate_0.jpeg"},{"size":"small","url":"https://cdn.benzinga.com/files/imagecache/1024x768xUP/images/story/2024/11/15/RFK---Independent-Presidential-Candidate_0.jpeg"}],"channels":[{"name":"Cannabis"},{"name":"Government"},{"name":"News"},{"name":"Health Care"},{"name":"Politics"},{"name":"Top Stories"}],"stocks":[],"tags":[]},{"id":42173279,"author":"Juan Spínelli","created":"Mon, 25 Nov 2024 15:50:42 -0400","updated":"Mon, 25 Nov 2024 15:50:42 -0400","title":"COMPASS Pathways: Institutional Pressure Amid $43M Market Cap Decline, What's Next For This Psychedelics Co?","teaser":"COMPASS Pathways faces $43M market cap loss, raising concerns among institutional investors holding 30% ownership.","body":"\u003cp\u003e\u003ca href=\"https://www.benzinga.com/topic/compass-pathways\"\u003e\u003cstrong\u003eCOMPASS Pathways\u003c/strong\u003e\u003c/a\u003e (NASDAQ:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/CMPS#NASDAQ\"\u003eCMPS\u003c/a\u003e), a key player in the \u003ca href=\"https://www.benzinga.com/markets/psychedelics\"\u003epsychedelics industry\u003c/a\u003e, recently experienced a $43 million drop in market capitalization, reducing its value to $302 million. As Simply Wall St. \u003ca href=\"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-cmps/compass-pathways/news/in-the-wake-of-compass-pathways-plcs-nasdaqcmps-latest-us43m\"\u003ereported\u003c/a\u003e, this decline has placed institutional investors, who own 30% of the company's shares, under increasing pressure to act. The stock has already faced a 32% loss over the past year, raising concerns about its future trajectory.\u003c/p\u003e\n\n\n\n\u003ch3 class=\"wp-block-heading\"\u003e\u003cstrong\u003eInstitutional Ownership And Its Implications\u003c/strong\u003e\u003c/h3\u003e\n\n\n\n\u003cp\u003eInstitutional investors, often referred to as \u0026#8220;smart money,\u0026#8221; hold the largest stake in COMPASS Pathways. These entities, which include hedge funds owning 13%, are known for their active investment strategies and significant influence on stock prices. A simultaneous sell-off by large institutional shareholders could exacerbate the company's losses, making the current situation pivotal for its stability.\u003c/p\u003e\n\n\n\n\u003cp\u003eThe top nine shareholders collectively own 52% of the company, with George Goldsmith, a co-founder, holding the largest individual stake at 11%. Such concentrated ownership underscores the significant influence these stakeholders wield over the company's future.\u003c/p\u003e\n\n\n\n\u003ch3 class=\"wp-block-heading\"\u003e\u003cstrong\u003eInsider And Public Stakeholders\u003c/strong\u003e\u003c/h3\u003e\n\n\n\n\u003cp\u003eInsiders account for 15% of ownership, valued at $46 million. This level of insider investment suggests a strong alignment of interests between the company\u0026#8217;s leadership and its shareholders. However, balancing the influence of insiders with accountability remains a concern.\u003c/p\u003e\n\n\n\n\u003cp\u003eThe general public holds 25% of COMPASS Pathways, reflecting the involvement of retail investors in the company\u0026#8217;s trajectory. While this group lacks the power to dictate strategy, it plays a critical role in shaping sentiment and trading activity.\u003c/p\u003e\n\n\n\n\u003ch3 class=\"wp-block-heading\"\u003e\u003cstrong\u003ePrivate Equity And Strategic Interests\u003c/strong\u003e\u003c/h3\u003e\n\n\n\n\u003cp\u003ePrivate equity firms control 5.6% of COMPASS Pathways, signaling potential for strategic input into the company's operations. Additionally, public companies own 10% of the business, likely reflecting related business interests or a de-merger history, warranting further investigation into these relationships.\u003c/p\u003e\n\n\n\n\u003ch3 class=\"wp-block-heading\"\u003e\u003cstrong\u003eBroader Implications\u0026nbsp;\u003c/strong\u003e\u003c/h3\u003e\n\n\n\n\u003cp\u003eThe recent market cap drop highlights the challenges faced by COMPASS Pathways amid broader industry volatility. As institutions weigh their options, the potential for further sell-offs looms, which could negatively impact retail and smaller investors. Analysts will be closely monitoring the company\u0026#8217;s ability to stabilize its earnings trajectory and maintain investor confidence.\u003c/p\u003e\n\n\n\n\u003cp\u003eCompass shares traded +2.04% at $4.50 per share at the time of this publication early afternoon on Monday.\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cem\u003eCover image made with AI\u003c/em\u003e\u003c/p\u003e","url":"https://www.benzinga.com/markets/cannabis/24/11/42173279/compass-pathways-institutional-pressure-amid-43m-market-cap-decline-whats-next-for-this-psychedelics-co","image":[{"size":"thumb","url":"https://cdn.benzinga.com/files/imagecache/250x187xUP/images/story/2024/11/25/2-11.png"},{"size":"small","url":"https://cdn.benzinga.com/files/imagecache/1024x768xUP/images/story/2024/11/25/2-11.png"},{"size":"large","url":"https://cdn.benzinga.com/files/imagecache/2048x1536xUP/images/story/2024/11/25/2-11.png"}],"channels":[{"name":"Cannabis"},{"name":"News"},{"name":"Psychedelics"}],"stocks":[{"name":"CMPS"}],"tags":[{"name":"Compass Pathways"},{"name":"market cap"}]},{"id":42198793,"author":"Rolando García","created":"Tue, 26 Nov 2024 15:33:59 -0400","updated":"Tue, 26 Nov 2024 15:34:00 -0400","title":"Prohibitionist Group Denies Collusion Allegations Ahead Of DEA Cannabis Rescheduling Hearing","teaser":"SAM denies collusion with the DEA amid cannabis rescheduling hearing allegations, calling the claims baseless distractions from the issue\u0026#39;s merits.","body":"\u003cp\u003eSmart Approaches to Marijuana (SAM), an active prohibitionist group, has denied allegations of improper communications with the Drug Enforcement Administration (DEA) ahead of next week\u0026#8217;s \u003ca href=\"https://www.benzinga.com/topic/cannabis-rescheduling\"\u003ecannabis rescheduling\u003c/a\u003e hearing.\u003c/p\u003e\n\n\n\n\u003cp\u003eSAM's Nov. 25 legal response dismissed the claims as unfounded and aimed at distracting from the proceedings, \u003ca href=\"https://www.marijuanamoment.net/dea-says-it-didnt-conspire-with-anti-marijuana-group-dismissing-allegedly-illegal-talks-as-gossip/\"\u003ereported\u003c/a\u003e Marijuana Moment.\u003c/p\u003e\n\n\n\n\u003cp\u003eThe hearings, scheduled to begin Dec. 2, will explore the Department of Justice's proposed rule to reschedule cannabis from a Schedule I to a Schedule III drug under the Controlled Substances Act (CSA). The proposal follows recommendations from the U.S. Department of Health and Human Services and the Food and Drug Administration.\u003c/p\u003e\n\n\n\n\u003ch3 class=\"wp-block-heading\"\u003eSAM Pushes Back On Collusion Allegations\u003c/h3\u003e\n\n\n\n\u003cp\u003eThe allegations, raised in a \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/11/41726679/village-farms-is-only-cannabis-operator-selected-to-represent-weed-industry-at-dea-rescheduling-\"\u003ejoint motion\u003c/a\u003e by cannabis company Village Farms International (NASDAQ:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/VFF#NASDAQ\"\u003eVFF\u003c/a\u003e) and veterans group Hemp for Victory, sought to disqualify SAM and the DEA from participating in the hearings. \u003c/p\u003e\n\n\n\n\u003cp\u003eSAM, one of 25 designated participants, countered that the motion was a baseless attempt to smear its reputation.\u003c/p\u003e\n\n\n\n\u003cp\u003e\"This motion is a transparent effort to smear both SAM and the DEA,\" SAM's lawyers, \u003cstrong\u003ePatrick F. Philbin\u003c/strong\u003e and \u003cstrong\u003eChase Harrington\u003c/strong\u003e, wrote. \u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eRead Also: \u003ca href=\"https://www.benzinga.com/24/11/42169153/dea-judge-blocks-researchers-motion-in-cannabis-rescheduling-case\"\u003eDEA Judge Blocks Researcher\u0026#8217;s Motion In Cannabis Rescheduling Case\u003c/a\u003e\u003c/strong\u003e\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cem\u003e\u003cstrong\u003eGet Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter\u0026nbsp;\u003ca href=\"https://newsletteremail.benzinga.com/subscribe\" target=\"_blank\" rel=\"noreferrer noopener\"\u003ehere\u003c/a\u003e. If you're serious about the business, you can't afford to miss out.\u003c/strong\u003e\u003c/em\u003e\u003c/p\u003e\n\n\n\n\u003cp\u003eThey argued that the claims amounted to a \"sideshow\" and urged the DEA's Administrative Law Judge (ALJ) \u003cstrong\u003eJohn J. Mulrooney\u003c/strong\u003e to focus on the substance of the hearing.\u003c/p\u003e\n\n\n\n\u003cp\u003eWhile SAM denied any ex parte communications after the May 21 publication of the notice of proposed rulemaking (NPRM), it acknowledged earlier \u003ca href=\"https://www.benzinga.com/24/11/42173101/dea-denies-allegations-of-unlawful-talks-with-anti-marijuana-group\"\u003esocial media posts\u003c/a\u003e by its president, \u003cstrong\u003eKevin Sabet\u003c/strong\u003e, predicting that Attorney General Merrick Garland, rather than DEA Administrator \u003cstrong\u003eAnne Milgram\u003c/strong\u003e, would sign the NPRM.\u003c/p\u003e\n\n\n\n\u003cp\u003eCritics allege that Sabet's May 6 post referencing \"confidential sources inside DEA\" raises questions about transparency. As for that evidence, SAM's lawyers argued the post was made before the NPRM's issuance.\u003c/p\u003e\n\n\n\n\u003ch3 class=\"wp-block-heading\"\u003e\u003cstrong\u003eA Related Case\u003c/strong\u003e\u003c/h3\u003e\n\n\n\n\u003cp\u003eThe same DEA judge leading this case has recently denied the \u003ca href=\"https://www.benzinga.com/24/11/42169153/dea-judge-blocks-researchers-motion-in-cannabis-rescheduling-case\"\u003erequest\u003c/a\u003e by research company \u003ca href=\"https://www.benzinga.com/24/11/42169153/dea-judge-blocks-researchers-motion-in-cannabis-rescheduling-case\"\u003eMedPharm\u003c/a\u003e to participate in the December 2 hearing, citing his limited authority and deferring to the DEA Administrator\u0026#8217;s discretion over participant selection.\u003c/p\u003e\n\n\n\n\u003cp\u003eMedPharm criticized the exclusion of DEA-licensed marijuana researchers and the inclusion of prohibitionist groups, calling the process biased and undermining its legitimacy. \u003c/p\u003e\n\n\n\n\u003cp\u003eCritics worry the imbalance in witness selection could skew the hearing\u0026#8217;s outcomes, despite support from other federal agencies for rescheduling.\u003c/p\u003e\n\n\n\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003eRead Next: \u003ca href=\"https://www.benzinga.com/24/11/42173101/dea-denies-allegations-of-unlawful-talks-with-anti-marijuana-group\"\u003eDEA Denies Allegations Of Colluding With Anti-Marijuana Group While Involved In Cannabis Rescheduling Process\u003c/a\u003e\u003c/strong\u003e\u003c/li\u003e\n\u003c/ul\u003e\n\n\n\n\u003cp\u003e\u003cem\u003eCOVER: AI-Generated image\u003c/em\u003e\u003c/p\u003e","url":"https://www.benzinga.com/government/regulations/24/11/42198793/prohibitionist-group-denies-collusion-allegations-ahead-of-dea-cannabis-rescheduling-hearing","image":[{"size":"large","url":"https://cdn.benzinga.com/files/imagecache/2048x1536xUP/images/story/2024/11/26/DEA-hearing.png"},{"size":"thumb","url":"https://cdn.benzinga.com/files/imagecache/250x187xUP/images/story/2024/11/26/DEA-hearing.png"},{"size":"small","url":"https://cdn.benzinga.com/files/imagecache/1024x768xUP/images/story/2024/11/26/DEA-hearing.png"}],"channels":[{"name":"Cannabis"},{"name":"Government"},{"name":"News"},{"name":"Regulations"},{"name":"Politics"},{"name":"Markets"}],"stocks":[{"name":"VFF"}],"tags":[{"name":"cannabis rescheduling"},{"name":"DEA"},{"name":"Hearing"},{"name":"Hemp for Victory"},{"name":"Judge John Mulrooney"},{"name":"lawsuit"},{"name":"Village Farms International"}]},{"id":42203747,"author":"Nina Zdinjak","created":"Tue, 26 Nov 2024 18:26:57 -0400","updated":"Tue, 26 Nov 2024 18:26:58 -0400","title":"Berlin's Justice Senator Says Cannabis Law Benefits Mafia-Like Structures And It Should Be Repealed","teaser":" ","body":"\u003cp\u003eBerlin\u0026#8217;s Senator for Justice \u003cstrong\u003eFelor Badenberg\u003c/strong\u003e recently criticized Germany's cannabis law. According to Badenberg, contrary to the objectives of the law, legalization actually made the fight against the black market and organized crime more difficult, \u003ca target=\"_blank\" href=\"https://www.zeit.de/news/2024-11/26/berliner-justizsenatorin-cannabis-gesetz-aufheben\" rel=\"noreferrer noopener\"\u003ewrites\u003c/a\u003e Zeit online, according to translation.\u003c/p\u003e\n\n\n\n\u003cp\u003e\"What was touted by the federal government as a milestone in drug policy has proven in practice to be a serious mistake that will cause long-term damage to our country,\" the CDU politician told the German Press Agency. \"It has to be repealed.\"\u003c/p\u003e\n\n\n\n\u003cp\u003eOn Thursday, Nov. 28th, a conference of justice ministers of the federal states will be held and experiences with the cannabis law will be discussed.\u003c/p\u003e\n\n\n\n\u003cp\u003ePartial cannabis legalization \u003ca target=\"_blank\" href=\"https://www.benzinga.com/markets/cannabis/24/04/38023610/heres-what-you-need-to-know-about-weed-legalization-in-germany-that-just-took-effect\" rel=\"noreferrer noopener\"\u003etook effect in Germany on April 1\u003c/a\u003e, making it the third country in the European Union to legalize adult-use cannabis after \u003ca target=\"_blank\" href=\"https://www.benzinga.com/markets/cannabis/21/12/24601584/maltas-parliament-says-yes-to-cannabis-legalization-becoming-first-in-europe-to-legalize-weed\" rel=\"noreferrer noopener\"\u003eMalta and\u003c/a\u003e \u003ca target=\"_blank\" href=\"https://www.benzinga.com/markets/cannabis/23/06/33063370/another-eu-country-legalizes-weed-top-gov-official-calls-cannabis-criminalization-a-failure\" rel=\"noreferrer noopener\"\u003eLuxembourg\u003c/a\u003e. Under this first pillar of cannabis legalization, adults over 18 can legally possess up to 25 grams of dried cannabis flower and cultivate up to three marijuana plants at home. One of the biggest breakthroughs under the law is that medical cannabis is essentially \u003ca target=\"_blank\" href=\"https://www.benzinga.com/markets/cannabis/24/07/39830117/medical-marijuana-regulated-as-ibuprofen-is-one-of-the-biggest-breakthroughs-of-germanys-cannabi\" rel=\"noreferrer noopener\"\u003eregulated like ibuprofen.\u003c/a\u003e\u003c/p\u003e\n\n\n\n\u003cp\u003eHowever, Berlin's proposed resolution argues that the law has caused troubles in effort to deal with the illegal market and organized criminal activities, especially in the commercial trade in cannabis products. The issues lies in the fact that the law change disabled telephone surveillance, online searches in its usual extent. This means that not all the evidence are allowed to be used in criminal proceedings.\u0026nbsp;\u0026nbsp;\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eRead Also: \u003ca target=\"_blank\" href=\"https://www.benzinga.com/government/regulations/24/11/41885393/germanys-govt-coalition-crisis-is-cannabis-reform-at-risk\" rel=\"noreferrer noopener\"\u003eGermany\u0026#8217;s Govt. Coalition Crisis, Is Cannabis Reform At Risk?\u003c/a\u003e\u003c/strong\u003e\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003e\u003cem\u003eGet Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter \u003ca target=\"_blank\" href=\"https://newsletteremail.benzinga.com/subscribe\" rel=\"noreferrer noopener\"\u003ehere\u003c/a\u003e. If you're serious about the business, you can't afford to miss out.\u003c/em\u003e\u003c/strong\u003e\u003c/p\u003e\n\n\n\n\u003ch2 class=\"wp-block-heading\"\u003e\u003cstrong\u003eDrug Dealers As Beneficiaries Of The Law\u003c/strong\u003e\u003c/h2\u003e\n\n\n\n\u003cp\u003eOne specific case that \u003ca target=\"_blank\" href=\"https://www.benzinga.com/markets/cannabis/24/09/40697724/weed-smuggler-among-few-freed-under-germanys-new-cannabis-law\" rel=\"noreferrer noopener\"\u003erecently made headlines\u003c/a\u003e, involves a 36-year-old man who smuggled 450 kilograms (992.08 lbs) of cannabis into Germany, estimated to be worth 1.9 million euros ($2.1 million). The controversy arises from the new law, which doesn\u0026#8217;t consider cannabis-related crimes as serious crimes and therefore the prosecutors can\u0026#8217;t use encrypted chats from the provider Encrochat as evidence. The man was released, prompting Baden-Württemberg's Minister of Justice, \u003cstrong\u003eMarion Gentges\u003c/strong\u003e (CDU), to say, \"Drug dealers are beneficiaries of this law.\u0026#8221;\u003c/p\u003e\n\n\n\n\u003cp\u003eThe case was before the Mannheim Regional Court, but the court's judgment is not yet legally binding, writes the outlet. However it is raising questions among the judiciary nationwide, and cannabis opponents are using it as an argument against the reform.\u003c/p\u003e\n\n\n\n\u003cp\u003eThe German government is working on the second pillar of its cannabis legalization law \u003cstrong\u003e–\u003c/strong\u003esetting up municipal five-year pilot programs for state-controlled marijuana to be sold in licensed shops. Moreover, it was recently confirmed that \u003cstrong\u003e\u003ca href=\"https://www.benzinga.com/markets/cannabis/24/10/41662047/frankfurt-and-hannover-prepare-for-cannabis-sales-study-amid-health-alarms-over-black-market-con\" target=\"_blank\" rel=\"noreferrer noopener\"\u003erecreational cannabis sales will launch in Hannover and Frankfurt\u003c/a\u003e \u003c/strong\u003enext year under a pilot program set to last five years.\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eRead Next:\u003c/strong\u003e\u003c/p\u003e\n\n\n\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003e\u003ca href=\"https://www.benzinga.com/general/market-summary/24/11/42126680/german-cannabis-20-tons-10m-grams-and-thats-only-0-3-of-the-market-whats-missing\" target=\"_blank\" rel=\"noreferrer noopener\"\u003eGerman Cannabis: 20 Tons, 10M Grams \u0026#8211; And That\u0026#8217;s Only 0.3% Of The Market, What\u0026#8217;s Missing?\u003c/a\u003e\u003c/strong\u003e\u003c/li\u003e\n\n\n\n\u003cli\u003e\u003cstrong\u003e\u003ca href=\"https://www.benzinga.com/markets/cannabis/24/11/42069381/european-leaders-meet-in-berlin-to-discuss-cannabis-policies\" target=\"_blank\" rel=\"noreferrer noopener\"\u003eEuropean Leaders Meet In Berlin To Discuss Cannabis Policies\u003c/a\u003e\u003c/strong\u003e\u003c/li\u003e\n\u003c/ul\u003e\n\n\n\n\u003cp\u003e\u003cem\u003ePhoto: Courtesy of Plateresca via Shutterstock\u003c/em\u003e\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003c/p\u003e","url":"https://www.benzinga.com/markets/cannabis/24/11/42203747/berlins-justice-senator-says-cannabis-law-benefits-mafia-like-structures-and-that-it-should-be-repealed","image":[{"size":"large","url":"https://cdn.benzinga.com/files/imagecache/2048x1536xUP/images/story/2024/11/26/Cannabis-Plant-With-Green-Leaves-And-Whi.jpeg"},{"size":"thumb","url":"https://cdn.benzinga.com/files/imagecache/250x187xUP/images/story/2024/11/26/Cannabis-Plant-With-Green-Leaves-And-Whi.jpeg"},{"size":"small","url":"https://cdn.benzinga.com/files/imagecache/1024x768xUP/images/story/2024/11/26/Cannabis-Plant-With-Green-Leaves-And-Whi.jpeg"}],"channels":[{"name":"Cannabis"},{"name":"News"},{"name":"Eurozone"}],"stocks":[],"tags":[{"name":"Felor Badenberg"},{"name":"Germany Cannabis"}]},{"id":42126680,"author":"Nicolás Jose Rodriguez","created":"Thu, 21 Nov 2024 19:00:35 -0400","updated":"Thu, 21 Nov 2024 19:00:36 -0400","title":"German Cannabis: 20 Tons, 10M Grams - And That's Only 0.3% Of The Market, What's Missing?","teaser":"Medical cannabis users still represent less than 0.3% of the population, indicating significant potential for market expansion.","body":"\u003cp\u003eGermany\u0026#8217;s medical cannabis imports reached 20.1 tons in Q3 2024, a substantial increase from previous quarters. This surge follows the April 2024 revision of the country\u0026#8217;s narcotics law, which has facilitated greater access to medical cannabis. \u003c/p\u003e\n\n\n\n\u003cp\u003eDespite this growth, medical cannabis users still represent less than 0.3% of the population, indicating significant potential for market expansion.\u003c/p\u003e\n\n\n\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003e\u003cem\u003eGet Benzinga\u0026#8217;s exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter\u0026nbsp;\u003ca href=\"https://newsletteremail.benzinga.com/subscribe\" target=\"_blank\" rel=\"noreferrer noopener\"\u003ehere\u003c/a\u003e. You can't afford to miss out if you\u0026#8217;re serious about the business.\u003c/em\u003e\u003c/strong\u003e\u003c/li\u003e\n\u003c/ul\u003e\n\n\n\n\u003ch3 class=\"wp-block-heading\"\u003eRejection Rates And Market Dynamics\u003c/h3\u003e\n\n\n\n\u003cp\u003eHistorically, approximately 40% of imported cannabis in Germany has been either rejected or re-exported, with pharmacies purchasing about 60% of imports, according to analyst \u003ca href=\"https://zuanicgroup.com/\"\u003ePablo Zuanic\u003c/a\u003e of \u003cstrong\u003eZuanic and Associates\u003c/strong\u003e.\u003c/p\u003e\n\n\n\n\u003cp\u003eIn Q3 2024, as importers rushed to build inventories, rejection rates likely increased, potentially resulting in pharmacies purchasing between 50% and 55% of imports. \u003c/p\u003e\n\n\n\n\u003cp\u003eThis suggests that out of the 20.1 tons imported, pharmacies acquired between 10 and 11 tons, doubling the levels seen before the April reforms.\u003c/p\u003e\n\n\n\n\u003ch3 class=\"wp-block-heading\"\u003eShifts In Exporter Market Shares\u003c/h3\u003e\n\n\n\n\u003cp\u003e\u003ca href=\"https://www.benzinga.com/topic/canada-cannabis\"\u003eCanada\u003c/a\u003e remains the largest supplier, exporting 8.1 tons to\u003ca href=\"https://www.benzinga.com/topic/germany-cannabis\"\u003e Germany\u003c/a\u003e in Q3 2024. However, its market share declined to 40% from 59% in Q1.\u0026nbsp;Several Canadian companies actively operate in Germany's cannabis market, including \u003cstrong\u003eAurora Cannabis Inc.\u003c/strong\u003e (NASDAQ:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/ACB#NASDAQ\"\u003eACB\u003c/a\u003e), \u003cstrong\u003eCanopy Growth Corporation\u003c/strong\u003e (NASDAQ:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/CGC#NASDAQ\"\u003eCGC\u003c/a\u003e), and \u003cstrong\u003eTilray Brands Inc. \u003c/strong\u003e(NASDAQ:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/TLRY#NASDAQ\"\u003eTLRY\u003c/a\u003e), leveraging their expertise in cultivation and distribution to meet the growing demand.\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003ca href=\"https://www.benzinga.com/topic/portugal-cannabis\"\u003ePortugal\u003c/a\u003e\u0026#8216;s share increased to 21%, with \u003ca href=\"https://www.benzinga.com/topic/denmark\"\u003eDenmark\u003c/a\u003e at 13%, and Spain and Uruguay each contributing 5%. Notably, the Netherlands\u0026#8217; share dropped to 2% from 8% in 2023.\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eRead Also: \u003ca href=\"https://www.benzinga.com/general/market-summary/24/11/42100955/the-u-s-cannabis-strategy-no-ones-talking-about-inside-canopys-300m-plan\"\u003eThe U.S. Cannabis Strategy No One\u0026#8217;s Talking About: Inside Canopy\u0026#8217;s $300M Plan\u003c/a\u003e\u003c/strong\u003e\u003c/p\u003e\n\n\n\n\u003ch3 class=\"wp-block-heading\"\u003eImplications For The Market\u003c/h3\u003e\n\n\n\n\u003cp\u003eThe annualized value of Germany\u0026#8217;s medical cannabis market is estimated at €352 million (US$375 million). According to Zuanic, \"With less than 0.3% of the population currently using medical cannabis, the market remains underdeveloped but has immense growth potential.\"\u003c/p\u003e\n\n\n\n\u003cp\u003eZuanic explains that if Germany reaches a 1% penetration rate, similar to Canada\u0026#8217;s, \"that would imply more than 4-5x upside.\" However, achieving this growth will require \u003ca href=\"https://www.benzinga.com/general/biotech/24/08/40298228/think-you-can-do-it-all-20-000-reasons-why-automation-outperforms-a-broad-approach-in-cannabis\"\u003eaddressing key challenges\u003c/a\u003e. \"More consistent and ample supplies across price and quality spectrums, new formats being allowed, and streamlined prescription systems.\"\u003c/p\u003e\n\n\n\n\u003cp\u003eDespite these hurdles, Zuanic says he is still optimistic. \"It is still early days, but the German medical cannabis market could accelerate as these issues along the supply chain improve,\" he added, signaling the potential for significant expansion in this nascent market.\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eRead Next: \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/11/41997646/tilray-joins-german-cannabis-fiesta-with-first-locally-grown-strains\"\u003eTilray Joins German Cannabis Fiesta With First Locally Grown Strains\u003c/a\u003e\u003c/strong\u003e\u003c/p\u003e","url":"https://www.benzinga.com/general/market-summary/24/11/42126680/german-cannabis-20-tons-10m-grams-and-thats-only-0-3-of-the-market-whats-missing","image":[{"size":"thumb","url":"https://cdn.benzinga.com/files/imagecache/250x187xUP/images/story/2024/11/21/AI-Generated-Image_2.jpeg"},{"size":"small","url":"https://cdn.benzinga.com/files/imagecache/1024x768xUP/images/story/2024/11/21/AI-Generated-Image_2.jpeg"},{"size":"large","url":"https://cdn.benzinga.com/files/imagecache/2048x1536xUP/images/story/2024/11/21/AI-Generated-Image_2.jpeg"}],"channels":[{"name":"Cannabis"},{"name":"Market Summary"},{"name":"News"},{"name":"Emerging Markets"},{"name":"Entrepreneurship"},{"name":"Eurozone"},{"name":"Retail Sales"},{"name":"Success Stories"},{"name":"Markets"}],"stocks":[{"name":"ACB"},{"name":"CGC"},{"name":"TLRY"}],"tags":[{"name":"Germany Cannabis"},{"name":"Pablo Zuanic"}]},{"id":42177984,"author":"Maureen Meehan","created":"Mon, 25 Nov 2024 18:50:24 -0400","updated":"Mon, 25 Nov 2024 18:50:24 -0400","title":"Joe Biden, How About Pardoning Non-Violent Cannabis Prisoners Along With Those Thanksgiving Turkeys?","teaser":"President Joe Biden pardoned the lucky turkeys, marking the start of the holiday season. Advocates urge him to pardon non-violent cannabis prisoners as well.","body":"\u003cp\u003eThe two lucky turkeys this year, Peach and Blossom from Minnesota, escaped the hatchet when President Joe Biden pardoned them in the annual pre-Thanksgiving tradition at the White House Monday.\u003c/p\u003e\n\n\n\n\u003cp\u003e\u0026#8220;This event marks the official start of the holiday season here in Washington,\u0026#8221; Biden \u003ca href=\"https://abcnews.go.com/Politics/peach-blossom-continue-white-house-turkey-tradition/story?id=116182776\"\u003esaid\u003c/a\u003e to a crowd of 2,500 gathered on the South Lawn. \u0026#8220;It\u0026#8217;s also my last time to speak here as your president during this season and give thanks and gratitude. So let me say to you, it\u0026#8217;s been the honor of my life. I\u0026#8217;m forever grateful.\u0026#8221;\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eRead Also:\u003c/strong\u003e \u003ca href=\"https://www.benzinga.com/government/regulations/24/11/42173811/hemp-and-thanksgiving-from-the-mayflower-to-independence-the-crop-that-helped-build-a-nation\"\u003e\u003cstrong\u003eHemp And Thanksgiving: From The Mayflower To Independence, The Crop That Helped Build A Nation\u003c/strong\u003e\u003c/a\u003e\u003c/p\u003e\n\n\n\n\u003ch1 class=\"wp-block-heading\"\u003e\u003cstrong\u003eDon't Forget Those Others You Promised To Pardon\u003c/strong\u003e\u003c/h1\u003e\n\n\n\n\u003cp\u003eIt's been over two years since\u0026nbsp;\u003ca href=\"https://www.benzinga.com/topic/joe-biden\" target=\"_blank\" rel=\"noreferrer noopener\"\u003eBiden\u003c/a\u003e\u0026#8216;s announcement to pardon all prior federal offenses\u0026nbsp;\u003ca href=\"https://www.benzinga.com/markets/cannabis/22/10/29175510/breaking-biden-announces-pardons-for-all-federal-marijuana-possession-convictions\" target=\"_blank\" rel=\"noreferrer noopener\"\u003eof simple marijuana possession\u003c/a\u003e. It must be pointed out that not one single person among the approximately 3,000 people incarcerated for federal cannabis offenses has been released.\u003c/p\u003e\n\n\n\n\u003cp\u003eTo remedy that situation, the\u0026nbsp;\u003ca href=\"https://www.benzinga.com/topic/last-prisoner-project\" target=\"_blank\" rel=\"noreferrer noopener\"\u003e\u003cstrong\u003eLast Prisoner Project\u003c/strong\u003e\u003c/a\u003e\u0026nbsp;(LPP) has a great idea for the soon-to-be-retired president: release those prisoners immediately. \u003c/p\u003e\n\n\n\n\u003cp\u003eIn its \u003cstrong\u003ePeople Not Poultry\u003c/strong\u003e project, the LPP is calling on Biden to free the thousands of non-violent cannabis prisoners still incarcerated for offenses that are now legal in more than half the country. Last week, the LPP joined a chorus of advocates and over 60 Congress members in\u0026nbsp;\u003ca href=\"https://www.benzinga.com/markets/cannabis/24/11/42122853/67-lawmakers-urge-biden-to-grant-clemency-to-people-still-in-jail-for-cannabis-offenses\"\u003esending a letter\u003c/a\u003e\u0026nbsp;to Biden seeking clemency so families can be reunited for the holidays.\u003c/p\u003e\n\n\n\n\u003cp\u003eIn a press conference on the capitol steps, LPP Director of Strategic Initiatives \u003cstrong\u003eJason Ortiz\u003c/strong\u003e, said, \"Sadly, as of today, President Biden has given freedom to more turkeys than he has to people [incarcerated for cannabis]. This is a gross injustice and an injustice that President Biden can correct with a stroke of a\u0026nbsp;pen.\"\u0026nbsp;\u003c/p\u003e\n\n\n\n\u003ch1 class=\"wp-block-heading\"\u003e\u003cstrong\u003eThink Of Your Legacy, President Biden\u003c/strong\u003e\u003c/h1\u003e\n\n\n\n\u003cp\u003e\u0026#8220;But time is running out for President Biden to use this power effectively,\" LPP wrote in a press statement shared with Benzinga in October. \u0026#8220;As President Biden approaches the final months of his presidency, he has the unique opportunity to correct the injustices of the War on Drugs that he once helped champion. By commuting the sentences of those still incarcerated for cannabis, he can take a bold stand for justice, equity and healing.\u0026#8221;\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eNow Read:\u003c/strong\u003e\u003c/p\u003e\n\n\n\n\u003cul\u003e\n\u003cli\u003e\u003ca href=\"https://www.benzinga.com/24/11/42130001/green-wednesdays-biggest-weed-buyers-the-surprising-archetypes-driving-sales\"\u003e\u003cstrong\u003eGreen Wednesday\u0026#8217;s Biggest Weed Buyers: The Surprising Archetypes Driving Sales\u003c/strong\u003e\u003c/a\u003e\u003c/li\u003e\n\u003c/ul\u003e\n\n\n\n\u003cp\u003e\u003cem\u003eCourtesy photo of National Turkey Federation with NTF chairman John Zimmerman and his son with President Joe Biden\u003c/em\u003e\u003c/p\u003e","url":"https://www.benzinga.com/news/legal/24/11/42177984/joe-biden-how-about-pardoning-non-violent-cannabis-prisoners-along-with-those-thanksgiving-turkeys","image":[{"size":"thumb","url":"https://cdn.benzinga.com/files/imagecache/250x187xUP/images/story/2024/11/25/Photo-from-Nat--Turkey-Association.jpeg"},{"size":"small","url":"https://cdn.benzinga.com/files/imagecache/1024x768xUP/images/story/2024/11/25/Photo-from-Nat--Turkey-Association.jpeg"},{"size":"large","url":"https://cdn.benzinga.com/files/imagecache/2048x1536xUP/images/story/2024/11/25/Photo-from-Nat--Turkey-Association.jpeg"}],"channels":[{"name":"Cannabis"},{"name":"Government"},{"name":"News"},{"name":"Legal"}],"stocks":[],"tags":[{"name":"Cannabis Prisoners"},{"name":"Joe Biden"},{"name":"Last Prisoner Project"},{"name":"Thanksgiving"}]},{"id":42173811,"author":"Nicolás Jose Rodriguez","created":"Mon, 25 Nov 2024 16:23:55 -0400","updated":"Mon, 25 Nov 2024 16:23:56 -0400","title":"Hemp And Thanksgiving: From The Mayflower To Independence, The Crop That Helped Build A Nation","teaser":"When the Mayflower set sail in 1620, it relied on hemp, a plant that now holds the potential for a U.S.-based industrial revolution.","body":"\u003cp\u003eHemp has long been a cornerstone of American industry, from its vital role in the Mayflower's journey to its symbolic importance in the fight for independence. As we celebrate Thanksgiving, it\u0026#8217;s fitting to reflect on how this versatile crop helped build the foundation of the U.S., in the past as well as in the modern era. From the early days of colonial America to its potential role in today's economy, hemp continues to shape the story of American resilience and innovation.\u003c/p\u003e\n\n\n\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003e\u003cem\u003eGet Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter\u0026nbsp;\u003ca href=\"https://newsletteremail.benzinga.com/subscribe\" target=\"_blank\" rel=\"noreferrer noopener\"\u003ehere\u003c/a\u003e. You can\u0026#8217;t afford to miss out if you're serious about the business.\u003c/em\u003e\u003c/strong\u003e\u003c/li\u003e\n\u003c/ul\u003e\n\n\n\n\u003ch3 class=\"wp-block-heading\"\u003e\u003cstrong\u003eHemp: From Sailcloth To Sovereignty\u003c/strong\u003e\u003c/h3\u003e\n\n\n\n\u003cp\u003eWhen the \u003cstrong\u003eMayflower\u003c/strong\u003e set sail in 1620, carrying Pilgrims across the Atlantic, it relied on hemp, a material essential for survival and symbolic of resilience. \u003ca href=\"https://www.benzinga.com/topic/hemp\"\u003eHemp's strength\u003c/a\u003e, durability and water resistance made it crucial for crafting the ship\u0026#8217;s sails, ropes and rigging, ensuring the ship could withstand the journey. \u003c/p\u003e\n\n\n\n\u003cp\u003eThe Pilgrims, English settlers who established Plymouth Colony in Massachusetts, brought knowledge of hemp cultivation from Europe, but their immediate focus was survival. It wasn't until the English government began encouraging hemp farming that its true importance was realized. As \u003cstrong\u003eErnest\u003c/strong\u003e \u003cstrong\u003eAbel\u003c/strong\u003e (1980) notes, in 1611, \u003cstrong\u003eKing James I\u003c/strong\u003e ordered hemp cultivation in Jamestown, Virginia, aiming to reduce reliance on imports. Over time, hemp became a critical crop for the colonies.\u003c/p\u003e\n\n\n\n\u003ch3 class=\"wp-block-heading\"\u003e\u003cstrong\u003eHemp And Seeds Of Rebellion\u003c/strong\u003e\u003c/h3\u003e\n\n\n\n\u003cp\u003eAs colonial America grew, hemp shifted from a practical crop to a symbol of resistance against British economic control. \u003cstrong\u003eThe Wool Act of 1699\u003c/strong\u003e banned exports of colonial wool and textiles, forcing reliance on British imports. Hemp offered a vital alternative, allowing colonists to secure materials and defy \u003ca href=\"https://www.benzinga.com/topic/uk-cannabis\"\u003eBritish trade\u003c/a\u003e restrictions.\u003c/p\u003e\n\n\n\n\u003cp\u003eDuring the political unrest following the \u003cstrong\u003eStamp Act of 1765\u003c/strong\u003e, the symbolic power of hemp grew. Families across the colonies began producing their textiles, including osnaburgs \u0026#8211; a coarse linen made from hemp and flax. These homespun fabrics kept colonists warm during harsh winters and represented an act of rebellion against British control over colonial economies. \u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eGeorge Washington \u003c/strong\u003ehimself championed the crop, producing over 1,300 yards of hemp and flax fabric annually at Mount Vernon by 1767. Soon, America's first innovators expanded hemp's use beyond textiles. It became legal tender in \u003ca href=\"https://www.benzinga.com/topic/virginia-cannabis\"\u003eVirginia \u003c/a\u003e(1682), \u003ca href=\"https://www.benzinga.com/topic/maryland-cannabis\"\u003eMaryland \u003c/a\u003e(1683) and \u003ca href=\"https://www.benzinga.com/topic/pennsylvania-cannabis\"\u003ePennsylvania\u003c/a\u003e (1706), strengthening local economies and reducing reliance on British currency.\u003c/p\u003e\n\n\n\n\u003cp\u003eIn the northern colonies, where hemp was in high demand for shipbuilding, merchants purchased every available fiber. This material \u0026#8211; essential for crafting ropes, sails and fishing nets \u0026#8211; became the lifeblood of New England's maritime industries.\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eRead Also: \u003ca href=\"https://www.benzinga.com/government/regulations/24/11/42068539/billion-dollar-strike-farm-bill-amendment-could-change-the-hemp-industry\"\u003eBillion-Dollar Strike: Farm Bill Amendment Could Change The Hemp Industry\u003c/a\u003e\u003c/strong\u003e\u003c/p\u003e\n\n\n\n\u003ch3 class=\"wp-block-heading\"\u003e\u003cstrong\u003eHemp In Maritime And Industrial Expansion\u003c/strong\u003e\u003c/h3\u003e\n\n\n\n\u003cp\u003eRopewalks, factories dedicated to twisting \u003ca href=\"https://www.benzinga.com/topic/hemp\"\u003ehemp fibers\u003c/a\u003e into ropes were first established in Salem in 1635 and later in Boston by 1642, when English rope maker John Harrison introduced advanced techniques. \u003c/p\u003e\n\n\n\n\u003cp\u003eEarly ropewalks were simple open fields with posts for twisting fibers, but they evolved into enclosed factories powered by steam engines. By the time of the \u003cstrong\u003eAmerican Revolution\u003c/strong\u003e, \u003ca href=\"https://www.benzinga.com/topic/massachusetts-cannabis\"\u003eBoston\u003c/a\u003e alone had 14 ropewalks, underscoring hemp's critical role in the colonies' economic infrastructure.\u003c/p\u003e\n\n\n\n\u003cp\u003eDespite its importance, hemp production often lagged behind demand due to its labor-intensive cultivation and processing requirements. Both George Washington and \u003cstrong\u003eThomas Jefferson\u003c/strong\u003e, advocates of hemp farming, struggled to make it a profitable venture. The shortages of hemp fiber, especially in New England, highlighted the challenges of scaling production to meet industrial needs.\u003c/p\u003e\n\n\n\n\u003ch3 class=\"wp-block-heading\"\u003e\u003cstrong\u003eCenturies Later, Hemp Is Regulated Then Later Banned\u003c/strong\u003e\u003c/h3\u003e\n\n\n\n\u003cp\u003eBy 1937, hemp was heavily regulated in the U.S. under the \u003cstrong\u003eMarihuana Tax Act\u003c/strong\u003e, making it difficult for farmers to produce. During World War II, the U.S. faced a significant decline in domestic hemp production due to the loss of foreign sources, such as the Philippines, which were under Japanese control. \u003c/p\u003e\n\n\n\n\u003cp\u003eIn response, the U.S. government initiated the \u003cstrong\u003eWar Hemp Program\u003c/strong\u003e to ramp up domestic cultivation for \u003ca href=\"https://www.benzinga.com/general/biotech/24/02/37271000/u-s-army-invests-1-9m-to-develop-hemp-manufactured-buildings-for-military-operations\"\u003emilitary and industrial needs\u003c/a\u003e. This program successfully increased hemp acreage to supply the materials necessary for the war effort, including ropes, uniforms and parachutes.\u003c/p\u003e\n\n\n\n\u003cp\u003eHemp was then prohibited by the \u003cstrong\u003eControlled Substances Act \u003c/strong\u003eof 1970, which classified it as a Schedule I controlled substance. This classification remained in place until the \u003cstrong\u003e2018 Farm Bill\u003c/strong\u003e, which\u003ca href=\"https://www.benzinga.com/markets/cannabis/24/10/41406637/top-5-cannabis-legalization-missteps-in-recent-u-s-history-a-selection\"\u003e legalized hemp \u003c/a\u003ecultivation once again.\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eRead Also: \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/11/41831831/no-middleman-no-markup-how-red-mesa-is-slashing-costs-with-around-the-clock-hemp-refinement\"\u003eNo Middleman, No Markup: How Red Mesa Is Slashing Costs With Around-The-Clock Hemp Refinement\u003c/a\u003e\u003c/strong\u003e\u003c/p\u003e\n\n\n\n\u003ch3 class=\"wp-block-heading\"\u003e\u003cstrong\u003eHemp Belongs In America\u0026#8217;s Industry \u003c/strong\u003e\u003c/h3\u003e\n\n\n\n\u003cp\u003eIn the northern colonies, \u003ca href=\"https://www.benzinga.com/topic/hemp\"\u003ehemp\u003c/a\u003e was once the foundation of thriving industries, creating jobs and driving American ingenuity. Today, hemp holds the \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/11/42041965/usda-extends-hemp-testing-flexibility-postpones-dea-lab-certification-rule\"\u003epotential \u003c/a\u003eto ignite the next great industrial revolution.\u003c/p\u003e\n\n\n\n\u003cp\u003eNo longer limited to niche markets or the controversial world of \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/10/41382006/hemp-thrives-in-texas-shops-near-schools-why-this-company-bet-on-the-countrys-most-regulated-can\" target=\"_blank\" rel=\"noreferrer noopener\"\u003eDelta-8 THC\u003c/a\u003e, hemp can once again \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/10/41561269/texas-smoke-shop-owners-sue-dea-over-intimidation-and-bullying-tactics-in-raid-of-legal-retail-s\"\u003ereclaim its place\u003c/a\u003e among America's industry and agricultural sectors.\u003c/p\u003e\n\n\n\n\u003cp\u003eFrom textiles to bioplastics to advanced construction materials, hemp has always been part of the industrious spirit of the American Revolution, fueled by resourcefulness and hard work.\u003c/p\u003e\n\n\n\n\u003cp\u003eIt\u0026#8217;s time to strengthen American industry, one fiber at a time. \u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eRead Next: \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/10/41579897/exclusive-how-hemp-certifications-bridge-regulatory-gaps-while-debunking-myths\"\u003eEXCLUSIVE: How Hemp Certifications Bridge Regulatory Gaps While Debunking Myths\u003c/a\u003e\u003c/strong\u003e\u003c/p\u003e","url":"https://www.benzinga.com/government/regulations/24/11/42173811/hemp-and-thanksgiving-from-the-mayflower-to-independence-the-crop-that-helped-build-a-nation","image":[{"size":"thumb","url":"https://cdn.benzinga.com/files/imagecache/250x187xUP/images/story/2024/11/25/AI-Generated-Image.jpeg"},{"size":"small","url":"https://cdn.benzinga.com/files/imagecache/1024x768xUP/images/story/2024/11/25/AI-Generated-Image.jpeg"},{"size":"large","url":"https://cdn.benzinga.com/files/imagecache/2048x1536xUP/images/story/2024/11/25/AI-Generated-Image.jpeg"}],"channels":[{"name":"Cannabis"},{"name":"Government"},{"name":"News"},{"name":"Regulations"},{"name":"Emerging Markets"},{"name":"Politics"},{"name":"Exclusives"},{"name":"Markets"},{"name":"General"}],"stocks":[],"tags":[{"name":"George Washington"},{"name":"Hemp"},{"name":"Mayflower"},{"name":"Thanksgiving"},{"name":"Thomas Jefferson"}]},{"id":42192294,"author":"Nina Zdinjak","created":"Tue, 26 Nov 2024 11:12:59 -0400","updated":"Tue, 26 Nov 2024 11:13:00 -0400","title":"Cannabinoid Drug For Agitation In Alzheimer's Yields Cognitive Improvements In Clinical Trial","teaser":" ","body":"\u003cp\u003e\u003cstrong\u003eIGC Pharma, Inc.(NYSE:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/IGC#NYSE\"\u003eIGC\u003c/a\u003e) \u003c/strong\u003ereported additional interim data from its ongoing Phase 2 clinical trial evaluating IGC-AD1 for agitation in dementia associated with Alzheimer's disease. IGC-AD1 targets neuro-inflammation and CB1 receptor dysfunction,. The investigational drug contains THC as one of two active pharmaceutical agents. \u003c/p\u003e\n\n\n\n\u003cp\u003eInterim data analysis reveals cognitive improvements in the active treatment group versus the placebo group, marking a meaningful step toward developing a therapy that may influence underlying disease progression.\u003c/p\u003e\n\n\n\n\u003cp\u003eThese findings \u003ca href=\"https://www.benzinga.com/general/biotech/24/04/38275005/igc-pharma-says-cannabinoid-based-drug-candidate-provides-fast-relief-with-fewer-side-effects-for\" target=\"_blank\" rel=\"noreferrer noopener\"\u003ealign with previously announced preclinical data\u003c/a\u003e, which showed a reduction in amyloid plaque aggregation by approximately 20% and improved spatial memory by about 50% in Alzheimer\u0026#8217;s cell lines and mouse models, respectively.\u003c/p\u003e\n\n\n\n\u003cp\u003e\u0026#8220;The cognitive improvements observed in our interim results align with preclinical evidence of IGC-AD1\u0026#8217;s active pharmaceutical ingredients\u0026#8217; impact on amyloid plaques and spatial memory,\" stated \u003cstrong\u003eRam Mukunda\u003c/strong\u003e, CEO of IGC Pharma. \"While agitation remains the primary focus of the Phase 2 trial, these exploratory findings strengthen our confidence in IGC-AD1\u0026#8217;s potential to address the broader pathology of Alzheimer\u0026#8217;s disease. For patients and caregivers, this potentially represents hope for improved care, and for our investors, it signifies a compelling opportunity in a growing market.\u0026#8221;\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eRead Also: \u003c/strong\u003e\u003ca target=\"_blank\" href=\"https://www.benzinga.com/partner/biotech/24/05/38699585/6-7-million-americans-live-with-alzheimers-igc-pharma-believes-they-deserve-treatment-options-wit\" rel=\"noreferrer noopener\"\u003e6.7 Million Americans Live With Alzheimer\u0026#8217;s – IGC Pharma Believes They Deserve Treatment Options Without Black Box Warnings\u003c/a\u003e\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003e\u003cem\u003eGet Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter \u003ca target=\"_blank\" href=\"https://newsletteremail.benzinga.com/subscribe\" rel=\"noreferrer noopener\"\u003ehere\u003c/a\u003e. If you're serious about the business, you can't afford to miss out.\u003c/em\u003e\u003c/strong\u003e\u003c/p\u003e\n\n\n\n\u003ch2 class=\"wp-block-heading\"\u003e\u003cstrong\u003eCognitive Improvements\u0026nbsp;\u0026nbsp;\u003c/strong\u003e\u003c/h2\u003e\n\n\n\n\u003cp\u003eCognitive decline in Alzheimer\u0026#8217;s disease reflects the deterioration of memory, attention, language and reasoning due to underlying pathological changes, such as amyloid plaques and tau tangles. Interim results from the trial demonstrated that the active treatment group receiving IGC-AD1 twice daily for six weeks showed an average improvement of about 8% on the Mini-Mental State Examination, a validated clinical tool for assessing cognitive function. By contrast, the placebo group showed no improvement over the same period.\u003c/p\u003e\n\n\n\n\u003cp\u003eThese results and the preclinical data provide a robust foundation for future trials focusing on cognition as the primary endpoint and exploring IGC-AD1\u0026#8217;s disease-modifying potential.\u003c/p\u003e\n\n\n\n\u003ch2 class=\"wp-block-heading\"\u003e\u003cstrong\u003ePrimary Outcome: Agitation Reduction in Alzheimer\u0026#8217;s Patients\u003c/strong\u003e\u003c/h2\u003e\n\n\n\n\u003cp\u003eAgitation, a debilitating symptom affecting up to 76% of Alzheimer\u0026#8217;s patients, accelerates disease progression, increases caregiver burden, and drives hospitalization rates. As previously disclosed, interim results showed that IGC-AD1 significantly reduced agitation compared to placebo, with improvements observed as early as two weeks. Unlike the existing therapy, which often takes up about 6–10 weeks to show results and carries a black box warning, IGC-AD1 offers rapid symptom relief with a favorable safety profile, making it a highly differentiated potential medication for managing agitation in Alzheimer\u0026#8217;s.\u003c/p\u003e\n\n\n\n\u003cp\u003eAlzheimer\u0026#8217;s disease affects 6.7 million Americans, with the global Alzheimer\u0026#8217;s treatment market projected to exceed $50 billion by 2025.\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003ePrice Action\u003c/strong\u003e\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eIGC shares closed Monday market session 5.34% higher at $0.38 per share.\u003c/strong\u003e\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eRead Next:\u003c/strong\u003e\u003c/p\u003e\n\n\n\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003e\u003ca href=\"https://www.benzinga.com/markets/cannabis/24/11/42086839/after-four-weeks-new-drug-shows-promising-results-in-boosting-life-skills-for-down-syndrome-patients\" target=\"_blank\" rel=\"noreferrer noopener\"\u003eAfter Four Weeks, New Drug Shows Promising Results In Boosting Life Skills For Down Syndrome Patients\u003c/a\u003e\u003c/strong\u003e\u003c/li\u003e\n\n\n\n\u003cli\u003e\u003ca href=\"https://www.benzinga.com/markets/cannabis/24/11/42127698/long-term-study-reveals-cannabis-may-slow-cognitive-decline-everything-you-need-to-know\" target=\"_blank\" rel=\"noreferrer noopener\"\u003e\u003cstrong\u003eLong-Term Study Reveals Cannabis May Slow Cognitive Decline: Everything You Need To Know\u003c/strong\u003e\u003c/a\u003e\u003c/li\u003e\n\u003c/ul\u003e\n\n\n\n\u003cp\u003e\u003cem\u003ePhoto: Courtesy of fizkes via Shutterstock \u003c/em\u003e\u003c/p\u003e","url":"https://www.benzinga.com/markets/cannabis/24/11/42192294/cannabiniod-drug-for-agitation-in-alzheimers-yields-cognitive-improvements-in-clinical-trial-interim-data","image":[{"size":"thumb","url":"https://cdn.benzinga.com/files/imagecache/250x187xUP/images/story/2024/11/26/Gp-In-White-Coat-Talk-To-Patient-Seated-.jpeg"},{"size":"small","url":"https://cdn.benzinga.com/files/imagecache/1024x768xUP/images/story/2024/11/26/Gp-In-White-Coat-Talk-To-Patient-Seated-.jpeg"},{"size":"large","url":"https://cdn.benzinga.com/files/imagecache/2048x1536xUP/images/story/2024/11/26/Gp-In-White-Coat-Talk-To-Patient-Seated-.jpeg"}],"channels":[{"name":"Cannabis"},{"name":"News"},{"name":"Health Care"}],"stocks":[{"name":"IGC"}],"tags":[{"name":"alzheimer's"},{"name":"Alzheimer's cannabinoid-based drug"},{"name":"Alzheimer's cannabis"},{"name":"Alzheimer's THC"},{"name":"IGC-AD1"},{"name":"premium"},{"name":"Ram Mukunda"}]},{"id":42041336,"author":"Rolando García","created":"Mon, 18 Nov 2024 12:04:42 -0400","updated":"Mon, 18 Nov 2024 12:04:43 -0400","title":"AdvisorShares Announces Reverse Split For MSOS Daily Leveraged ETF, What Investors Need To Know","teaser":"AdvisorShares announces a 1-for-20 reverse split for its MSOS Daily Leveraged ETF (MSOX), impacting share count without changing value.","body":"\u003cp\u003e\u003ca href=\"https://www.benzinga.com/quote/MSOS\"\u003eAdvisorShares\u003c/a\u003e has \u003ca href=\"https://www.prnewswire.com/news-releases/advisorshares-announces-reverse-split-of-etf-302307466.html\"\u003eannounced\u003c/a\u003e a reverse split for its MSOS Daily Leveraged ETF (NYSE:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/MSOX#NYSE\"\u003eMSOX\u003c/a\u003e), \u003cstrong\u003eeffective November 26, 2024. \u003c/strong\u003e\u003c/p\u003e\n\n\n\n\u003cp\u003eA reverse split reduces the number of its outstanding shares, increasing the share price proportionally. In this case, the split will be 1-for-20, with\u003cstrong\u003e \u003c/strong\u003eevery 20 shares of MSOX consolidated into one share.\u003c/p\u003e\n\n\n\n\u003ch3 class=\"wp-block-heading\"\u003eKey Details:\u003c/h3\u003e\n\n\n\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003eShare Consolidation\u003c/strong\u003e: If you own 1,000 shares at $10 per share (worth $10,000), post-split you will hold 50 shares at $200 per share, still totaling $10,000. Your investment value remains unchanged, only the number of shares and price per share adjust.\u003c/li\u003e\n\n\n\n\u003cli\u003e\u003cstrong\u003eNew CUSIP\u003c/strong\u003e: The ETF\u0026#8217;s identifier (CUSIP) will change to reflect the reverse split, so investors should take note of the updated CUSIP.\u003c/li\u003e\n\n\n\n\u003cli\u003e\u003cstrong\u003eImpact on Trading\u003c/strong\u003e: MSOX will start trading on a split-adjusted basis on November 26, with the share price expected to be roughly 20 times higher.\u003c/li\u003e\n\u003c/ul\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003e\u003cem\u003eGet Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter\u0026nbsp;\u003ca href=\"https://newsletteremail.benzinga.com/subscribe\" target=\"_blank\" rel=\"noreferrer noopener\"\u003ehere\u003c/a\u003e. You can\u0026#8217;t afford to miss out if you're serious about the business.\u003c/em\u003e\u003c/strong\u003e\u003c/p\u003e\n\n\n\n\u003ch3 class=\"wp-block-heading\"\u003eWhy It Matters:\u003c/h3\u003e\n\n\n\n\u003cp\u003eThe reverse split is aimed at reducing the number of outstanding shares, potentially improving liquidity and making the ETF more attractive for institutional trading. However, this \u003ca href=\"https://www.benzinga.com/topic/cannabis-etf\"\u003eETF\u003c/a\u003e is specifically designed for active, sophisticated traders seeking leveraged exposure to the cannabis industry. It targets twice the exposure of its underlying assets but may not always hit this exact leverage.\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eRead Also: \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/11/41793174/cannabis-stocks-collapse-after-trump-win-major-players-see-double-digit-declines-at-wednesdays-c\"\u003eCannabis Stocks Collapse After Trump Win: Major Players See Double-Digit Declines At Wednesday\u0026#8217;s Close\u003c/a\u003e\u003c/strong\u003e\u003c/p\u003e\n\n\n\n\u003ch3 class=\"wp-block-heading\"\u003eTax Consideration\u003c/h3\u003e\n\n\n\n\u003cp\u003eInvestors could end up with fractional shares due to the split. Since fractional shares cannot be traded, they will be redeemed for cash, which might trigger a taxable gain or loss.\u003c/p\u003e\n\n\n\n\u003cp\u003eIn summary, the \u003ca href=\"https://www.benzinga.com/news/stock-split\"\u003ereverse split\u003c/a\u003e will not affect the overall value of your investment, but it does change the share count and price. It's important for investors to consult their financial advisor if they have questions about potential tax implications or the ETF\u0026#8217;s risk profile.\u003c/p\u003e\n\n\n\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003eRead Next: \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/10/41489067/advisorshares-msos-climbs-8-as-cannabis-rescheduling-sparks-investor-interest\"\u003eAdvisorShares MSOS Climbs 8% As Cannabis Rescheduling Sparks Investor Interest\u003c/a\u003e\u003c/strong\u003e\u003c/li\u003e\n\u003c/ul\u003e\n\n\n\n\u003cp\u003e\u003cem\u003eCover: AI Generated image\u003c/em\u003e\u003c/p\u003e","url":"https://www.benzinga.com/news/stock-split/24/11/42041336/advisorshares-announces-reverse-split-for-msos-daily-leveraged-etf-what-investors-need-to-know","image":[{"size":"thumb","url":"https://cdn.benzinga.com/files/imagecache/250x187xUP/images/story/2024/11/18/AdvisorShares-ETF.png"},{"size":"small","url":"https://cdn.benzinga.com/files/imagecache/1024x768xUP/images/story/2024/11/18/AdvisorShares-ETF.png"},{"size":"large","url":"https://cdn.benzinga.com/files/imagecache/2048x1536xUP/images/story/2024/11/18/AdvisorShares-ETF.png"}],"channels":[{"name":"Cannabis"},{"name":"News"},{"name":"Stock Split"},{"name":"Markets"}],"stocks":[{"name":"MSOX"}],"tags":[{"name":"Cannabis ETF"},{"name":"MSOX"},{"name":"reverse split"},{"name":"stocks"}]},{"id":42127698,"author":"Franca Quarneti","created":"Thu, 21 Nov 2024 21:00:38 -0400","updated":"Thu, 21 Nov 2024 21:00:38 -0400","title":"Long-Term Study Reveals Cannabis May Slow Cognitive Decline: Everything You Need To Know","teaser":"A Danish study found no link between cannabis use and cognitive decline in men over decades, challenging common myths.","body":"\u003cp\u003eA decades-long Danish study has found no significant link between cannabis use and increased age-related cognitive decline in men, challenging persistent \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/09/40989263/long-term-medical-cannabis-use-has-no-significant-harmful-effects-on-memory-or-impulse-control-n\"\u003estereotypes about cannabis consumers.\u003c/a\u003e\u003c/p\u003e\n\n\n\n\u003ch3 class=\"wp-block-heading\"\u003e\u003cstrong\u003eKey Findings\u003c/strong\u003e\u003c/h3\u003e\n\n\n\n\u003cp\u003eResearchers from the University of Copenhagen followed 5,162 men over an average of 44 years, examining cognitive aging from early adulthood to late midlife.\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eSee Also: \u003ca href=\"https://www.benzinga.com/24/11/42122260/study-reveals-psychedelic-ritual-cocktail-in-ancient-egyptian-mug\"\u003eStudy Reveals Psychedelic Ritual Cocktail In Ancient Egyptian Mug\u003c/a\u003e\u003c/strong\u003e\u003c/p\u003e\n\n\n\n\u003cp\u003eContrary to common assumptions, the study revealed that cannabis users experienced slightly less cognitive decline than non-users. The average cognitive decline across the participants was 6.2 IQ points, with cannabis users showing 1.3 fewer IQ points of decline compared to non-users.\u003c/p\u003e\n\n\n\n\u003cp\u003eThe findings, \u003ca href=\"https://onlinelibrary.wiley.com/doi/10.1002/brb3.70136\"\u003epublished\u003c/a\u003e in the journal Brain and Behavior, align with prior studies suggesting cannabis use is not associated with greater cognitive impairment in adulthood. \u003c/p\u003e\n\n\n\n\u003cp\u003eHowever, the researchers caution that further investigations are necessary to determine if these results indicate no adverse long-term effects or if the effects of \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/08/40536603/can-thc-turn-back-the-clock-cannabis-reverses-brain-aging-boosts-mental-capacity-new-study-sugge\"\u003ecannabis use dissipate over time.\u003c/a\u003e\u003c/p\u003e\n\n\n\n\u003ch3 class=\"wp-block-heading\"\u003e\u003cstrong\u003eExpert Reactions\u003c/strong\u003e\u003c/h3\u003e\n\n\n\n\u003cp\u003e\"These results contradict one of the more prominent and longstanding stereotypes about cannabis and cannabis consumers,\u0026#8221; said \u003cstrong\u003ePaul Armentano\u003c/strong\u003e, deputy director of the National Organization for the Reform of Marijuana Laws (NORML).\u003c/p\u003e\n\n\n\n\u003cp\u003e\"It is even more unfortunate that studies refuting these long-held stereotypes seldom receive the type of mainstream attention they deserve.\"\u003c/p\u003e\n\n\n\n\u003ch3 class=\"wp-block-heading\"\u003e\u003cstrong\u003eContext And Broader Implications\u003c/strong\u003e\u003c/h3\u003e\n\n\n\n\u003cp\u003eWhile this study adds to evidence refuting claims of significant cognitive decline in cannabis users, it is essential to note the distinction between adult and adolescent cannabis exposure. \u003c/p\u003e\n\n\n\n\u003cp\u003eThe US Centers for Disease Control and Prevention (CDC) warns that heavy cannabis use during adolescence may cause permanent changes to the developing brain, which continues to mature until approximately age 25.\u003c/p\u003e\n\n\n\n\u003cp\u003eIn contrast, a separate recent study found \u003ca href=\"https://www.benzinga.com/markets/cannabis/23/03/31293224/study-asserts-long-term-cannabis-use-leads-to-hippocampal-shrinkage-lower-iq-poor-learning-abil-\"\u003eno adverse effects\u003c/a\u003e on brain structure or cognitive function among adult medical cannabis users after a year of consistent use.\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eRead Next:\u003c/strong\u003e\u003c/p\u003e\n\n\n\n\u003cul\u003e\n\u003cli\u003e\u003ca href=\"https://www.benzinga.com/markets/cannabis/24/11/42072269/cbd-based-drug-reduces-pericarditis-pain-and-inflammation-shows-new-clinical-study\"\u003eCBD-Based Drug Reduces Pericarditis Pain And Inflammation, Shows New Clinical Study\u003c/a\u003e\u003c/li\u003e\n\u003c/ul\u003e","url":"https://www.benzinga.com/markets/cannabis/24/11/42127698/long-term-study-reveals-cannabis-may-slow-cognitive-decline-everything-you-need-to-know","image":[{"size":"thumb","url":"https://cdn.benzinga.com/files/imagecache/250x187xUP/images/story/2024/11/21/DALLE-2024-11-21-19-27.jpeg"},{"size":"small","url":"https://cdn.benzinga.com/files/imagecache/1024x768xUP/images/story/2024/11/21/DALLE-2024-11-21-19-27.jpeg"},{"size":"large","url":"https://cdn.benzinga.com/files/imagecache/2048x1536xUP/images/story/2024/11/21/DALLE-2024-11-21-19-27.jpeg"}],"channels":[{"name":"Cannabis"},{"name":"News"},{"name":"Markets"}],"stocks":[],"tags":[{"name":"cannabis and health"},{"name":"cognitive health"},{"name":"NORML"},{"name":"Paul Armentano"},{"name":"US Centers for Disease and Prevention"}]},{"id":42162875,"author":"Nina Zdinjak","created":"Mon, 25 Nov 2024 09:34:58 -0400","updated":"Mon, 25 Nov 2024 09:34:59 -0400","title":"Canopy Growth's German Subsidiary Teams Up With Portugal's Gro-Vida To Expand Medical Cannabis Supply","teaser":" ","body":"\u003cp\u003ePortugal-based medical marijuana grower \u003cstrong\u003eGro-Vida\u003c/strong\u003e teamed up with \u003cstrong\u003eCanopy Growth Germany GmbH\u003c/strong\u003e, a subsidiary of cannabis giant \u003cstrong\u003eCanopy Growth Corporation\u003c/strong\u003e (NASDAQ:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/CGC#NASDAQ\"\u003eCGC\u003c/a\u003e). This agreement is a key step for Gro-Vida to position itself in Germany\u0026#8217;s growing medical marijuana market while supporting Canopy Growth GmbH\u0026#8217;s strategy of securing EU-based supply through an asset-light approach in addition to existing supply from the company's Canadian GMP production platform.\u003c/p\u003e\n\n\n\n\u003cp\u003e\"We are incredibly proud to be working with Canopy Growth Germany,\" stated \u003cstrong\u003eMallory Bodna\u003c/strong\u003er, managing director at Gro-Vida. \"It is a remarkable honor to have a global leader recognize the exceptional quality of cannabis produced here in Portugal. This is not only a testament to our hard work but points to the promising future of Portuguese-grown cannabis on the world stage.\"\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eRead Also: \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/11/41997646/tilray-joins-german-cannabis-fiesta-with-first-locally-grown-strains\"\u003eTilray Joins German Cannabis Fiesta With First Locally Grown Strains\u003c/a\u003e\u003c/strong\u003e\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cem\u003e\u003cstrong\u003eGet Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter \u003ca href=\"https://newsletteremail.benzinga.com/subscribe\" target=\"_blank\" rel=\"noreferrer noopener\"\u003ehere\u003c/a\u003e. If you're serious about the business, you can't afford to miss out.\u003c/strong\u003e\u003c/em\u003e\u003c/p\u003e\n\n\n\n\u003cp\u003eThe supply agreement represents an opportunity to drive growth for both companies, blending Gro-Vida's cultivation expertise and EU-GMP production partnerships with Canopy Growth GmbH's extensive network and in-market expertise. Under the terms of the supply agreement, Gro-Vida will cultivate a range of exclusive medicinal cannabis flower for Canopy Growth GmbH, with the products slated for release\u003cstrong\u003e \u003c/strong\u003eunder the Tweed brand.\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003e\u003ca href=\"https://www.benzinga.com/markets/cannabis/23/05/32592244/motherhood-brought-her-to-marijuana-now-shes-in-a-c-suite-at-a-global-weed-brand\"\u003eTara Rozalowsky\u003c/a\u003e,\u003c/strong\u003e chief growth officer and president, International, Canopy Growth, says this move is part of the company's larger plans for international expansion. \"Part of our global strategy is ensuring a diverse and high-quality supply chain, and Gro-Vida is an important piece of this strategy. Sourcing EU-GMP flower from Portugal, alongside our EU-GMP Canadian-grown cannabis flower, allows us to offer a versatile and competitive product portfolio in the German market while advancing our asset light strategy for growth.\"\u003c/p\u003e\n\n\n\n\u003cp\u003eProducts will be available via prescription and can be requested by patients nationwide in Germany from their healthcare practitioner beginning in calendar Q1 of 2025.\u003c/p\u003e\n\n\n\n\u003ch2 class=\"wp-block-heading\"\u003e\u003cstrong\u003eCannabis In Germany\u003c/strong\u003e\u003c/h2\u003e\n\n\n\n\u003cp\u003eA recent \u003ca href=\"https://prohibitionpartners.com/reports/the-german-cannabis-report/\" target=\"_blank\" rel=\"noreferrer noopener\"\u003ereport\u003c/a\u003e on Germany\u0026#8217;s cannabis market by Prohibition Partners revealed that German medical marijuana sales are projected to reach €420 million in 2024 ($260.66 million) reaching €1 billion by 2028.\u003c/p\u003e\n\n\n\n\u003cp\u003eThe report comes several months after major cannabis reform in Germany with the implementation of the Cannabis Act (CanG) and the associated MedCanG Act. Partial cannabis legalization \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/04/38023610/heres-what-you-need-to-know-about-weed-legalization-in-germany-that-just-took-effect\" target=\"_blank\" rel=\"noreferrer noopener\"\u003etook effect in Germany on April 1\u003c/a\u003e, allowing people over 18 to legally possess up to 25 grams of dried cannabis and cultivate up to three plants at home. One of the biggest breakthroughs under the law is that medical cannabis is essentially \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/07/39830117/medical-marijuana-regulated-as-ibuprofen-is-one-of-the-biggest-breakthroughs-of-germanys-cannabi\" target=\"_blank\" rel=\"noreferrer noopener\"\u003eregulated like ibuprofen\u003c/a\u003e.\u003c/p\u003e\n\n\n\n\u003ch2 class=\"wp-block-heading\"\u003e\u003cstrong\u003ePrice Action\u003c/strong\u003e\u003c/h2\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eCanopy Growth shares closed Friday's market session 1.04% higher at $3.9 per share.\u003c/strong\u003e\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eRead Next:\u003c/strong\u003e\u003c/p\u003e\n\n\n\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003e\u003ca href=\"https://www.benzinga.com/general/market-summary/24/11/42126680/german-cannabis-20-tons-10m-grams-and-thats-only-0-3-of-the-market-whats-missing\"\u003eGerman Cannabis: 20 Tons, 10M Grams \u0026#8211; And That\u0026#8217;s Only 0.3% Of The Market, What\u0026#8217;s Missing?\u003c/a\u003e\u003c/strong\u003e\u003c/li\u003e\n\u003c/ul\u003e\n\n\n\n\u003cp\u003e\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cem\u003ePhoto: Courtesy of OMfotovideocontent on Shutterstock\u003c/em\u003e\u003c/p\u003e","url":"https://www.benzinga.com/markets/cannabis/24/11/42162875/canopy-growths-german-subsidiary-teams-up-with-portugals-gro-vida-to-expand-medical-cannabis-supply","image":[{"size":"small","url":"https://cdn.benzinga.com/files/imagecache/1024x768xUP/images/story/2024/11/25/medical-marijuana-OMfotovideocontent-on-.jpeg"},{"size":"large","url":"https://cdn.benzinga.com/files/imagecache/2048x1536xUP/images/story/2024/11/25/medical-marijuana-OMfotovideocontent-on-.jpeg"},{"size":"thumb","url":"https://cdn.benzinga.com/files/imagecache/250x187xUP/images/story/2024/11/25/medical-marijuana-OMfotovideocontent-on-.jpeg"}],"channels":[{"name":"Cannabis"},{"name":"News"},{"name":"Eurozone"}],"stocks":[{"name":"CGC"}],"tags":[{"name":"Germany Cannabis"},{"name":"Gro-Vida"},{"name":"Mallory Bodna"},{"name":"premium"},{"name":"Tara Rozalowsky"},{"name":"Tweed"}]},{"id":42190387,"author":"Jelena Martinovic","created":"Tue, 26 Nov 2024 10:16:42 -0400","updated":"Tue, 26 Nov 2024 10:16:43 -0400","title":"Canopy Growth Names New CEO Who Will Succeed David Klein Amid US Expansion","teaser":"Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC) announced on Tuesday its board of directors has named Luc Mongeau as the company\u0026#39;s next chief executive officer, effective Jan. 6, 2025.Mongeau, a CPG veteran and current board member at the Canadian cannabis giant, succeeds CEO David Klein, who announced his plans to retire in August.Klein, who joined Canopy Growth in January 2020, led the Ontario-based company through transformation and development to meet opportunities within the global cannabis market.","body":"\u003cp\u003e\u003cstrong\u003eCanopy Growth Corporation\u003c/strong\u003e (TSX:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/WEED#TSX\"\u003eWEED\u003c/a\u003e) (NASDAQ:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/CGC#NASDAQ\"\u003eCGC\u003c/a\u003e) announced on Tuesday that its board of directors has named \u003cstrong\u003eLuc Mongeau\u003c/strong\u003e as the company's next chief executive officer, effective Jan. 6, 2025.\u003c/p\u003e\n\n\n\n\u003cp\u003eMongeau, a CPG veteran and board member at the Canadian cannabis giant, succeeds CEO \u003cstrong\u003eDavid Klein\u003c/strong\u003e, who announced his plans to retire in August.\u003c/p\u003e\n\n\n\n\u003cp\u003eKlein, who \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/08/40417074/head-of-canadian-cannabis-giant-canopy-growth-to-retire-at-the-end-of-this-fy\"\u003ejoined\u003c/a\u003e Canopy Growth in January 2020, led the Ontario-based company through transformation and development to meet opportunities within the global cannabis market.\u003c/p\u003e\n\n\n\n\u003cp\u003e\u0026#8220;Under his leadership, the company established a foundation for multi-market cannabis leadership through its transformation to an asset-light model in Canada and across a range of international markets, including Germany,\u0026#8221; the company said in a press release. \u0026#8220;In addition, Mr. Klein oversaw the launch and advancement of Canopy USA as a first-of-its-kind structure to offer the Company's shareholders unique exposure to the rapid growth and opportunity presented by the U.S. cannabis market ahead of federal permissibility.\u0026#8221;\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eRead Also: \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/08/40419783/canopy-growth-ceo-departure-leaves-nasdaq-listed-company-poised-for-profit-surge-what-investors-\"\u003eCanopy Growth CEO Departure Leaves Nasdaq-Listed Company Poised For Profit Surge \u0026#8211; What Investors Need To Know\u003c/a\u003e\u003c/strong\u003e\u003c/p\u003e\n\n\n\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003e\u003cem\u003eGet Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter \u003ca href=\"https://newsletteremail.benzinga.com/subscribe\" target=\"_blank\" rel=\"noreferrer noopener\"\u003ehere\u003c/a\u003e. If you're serious about the business, you can't afford to miss out.\u003c/em\u003e\u003c/strong\u003e\u003c/li\u003e\n\u003c/ul\u003e\n\n\n\n\u003ch3 class=\"wp-block-heading\"\u003eNew CEO\u003c/h3\u003e\n\n\n\n\u003cp\u003eMongeau, who has over 25 years\u0026#8217; experience as a senior executive, has most recently served as the CEO of North America\u0026#8217;s e-commerce provider for residential and commercial furniture \u003cstrong\u003eESolutions Furniture, \u003c/strong\u003eformerly Bestar-Bush. He previously held the role of president for Weston Foods as well as president of \u003cstrong\u003eMars Petcare North America.\u003c/strong\u003e\u003c/p\u003e\n\n\n\n\u003cp\u003eMongeau joined Canopy as an observer in early 2023 and as a board member in Feb. 2024.\u003c/p\u003e\n\n\n\n\u003cp\u003eThe new appointment comes simultaneously with the company's influence extending in the U.S. via \u003cstrong\u003eCanopy USA, LLC.\u003c/strong\u003e\u003c/p\u003e\n\n\n\n\u003cp\u003eThe new U.S.-domiciled holding company \u003ca href=\"https://www.benzinga.com/analyst-ratings/analyst-color/22/10/29418334/this-is-how-its-done-why-is-canopys-us-consolidation-plan-blueprint-for-other-canad\"\u003efirst introduced\u003c/a\u003e in 2022, represents Canopy Growth's strategy for capturing the U.S. cannabis market. The business strategy, which included acquisitions of\u003cstrong\u003e Wana Brands\u003c/strong\u003e and\u003cstrong\u003e Jetty\u003c/strong\u003e, as well as holding a minority stake in \u003cstrong\u003eTerrAscend Corp.\u003c/strong\u003e (TSX:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/TSND#TSX\"\u003eTSND\u003c/a\u003e) (OTCQX:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/TSNDF#OTCQX\"\u003eTSNDF\u003c/a\u003e), also includes the acquisition of \u003cstrong\u003eAcreage Holdings, Inc.\u003c/strong\u003e (CSE:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/ACRG#CSE\"\u003eACRG\u003c/a\u003e, ACRG.B.U)) (OTCQX:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/ACRHF#OTCQX\"\u003eACRHF\u003c/a\u003e, ACRDF)) which is expected to close in early 2025, according to Canopy.\u003c/p\u003e\n\n\n\n\u003ch3 class=\"wp-block-heading\"\u003eWhat's Next\u003c/h3\u003e\n\n\n\n\u003cp\u003eMongeau will continue serving as a member of the board in his new role as CEO.\u003c/p\u003e\n\n\n\n\u003cp\u003eTo support an efficient transition, Klein will continue in his role as CEO and a director on the board until the effective date of Mongeau\u0026#8217;s appointment as CEO.\u003c/p\u003e\n\n\n\n\u003cp\u003eOn Jan. 6, 2025, Klein will step down as a member of the board and will shift into a special advisor role until Aug. 31, 2025.\u003c/p\u003e\n\n\n\n\u003cp\u003e\u0026#8220;I am honored to lead Canopy Growth into this exciting next chapter, and I am confident that our vision, dedication to our consumers, and the commitment of our team members will continue to position us for long-term success and value creation,\u0026#8221; Mongeau said.\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eRead Next:\u003c/strong\u003e\u003c/p\u003e\n\n\n\n\u003cul\u003e\n\u003cli\u003e\u003ca href=\"https://www.benzinga.com/general/market-summary/24/11/42100955/the-u-s-cannabis-strategy-no-ones-talking-about-inside-canopys-300m-plan\"\u003e\u003cstrong\u003eThe U.S. Cannabis Strategy No One\u0026#8217;s Talking About: Inside Canopy\u0026#8217;s $300M Plan\u003c/strong\u003e\u003c/a\u003e\u003c/li\u003e\n\u003c/ul\u003e\n\n\n\n\u003ch3 class=\"wp-block-heading\"\u003eCGC Price Action\u003c/h3\u003e\n\n\n\n\u003cp\u003eCanopy Growth's shares traded 0.2120% lower at $4.1412 per share during the pre-market session on Tuesday morning.\u003c/p\u003e","url":"https://www.benzinga.com/24/11/42190387/cannabis-giant-canopy-growth-names-next-ceo-heres-who-will-succeed-david-klein-amid-us-expansion","image":[{"size":"large","url":"https://cdn.benzinga.com/files/imagecache/2048x1536xUP/images/story/2024/11/26/ben-rosett-WdJkXFQ4VHY-unsplash2.jpeg"},{"size":"thumb","url":"https://cdn.benzinga.com/files/imagecache/250x187xUP/images/story/2024/11/26/ben-rosett-WdJkXFQ4VHY-unsplash2.jpeg"},{"size":"small","url":"https://cdn.benzinga.com/files/imagecache/1024x768xUP/images/story/2024/11/26/ben-rosett-WdJkXFQ4VHY-unsplash2.jpeg"}],"channels":[{"name":"Cannabis"},{"name":"News"}],"stocks":[{"name":"ACRHF"},{"name":"CGC"},{"name":"CSE:ACRG"},{"name":"TSNDF"},{"name":"TSX:TSND"},{"name":"TSX:WEED"},{"name":"WEED"}],"tags":[{"name":"cannabis appointment"},{"name":"Cannabis executives"},{"name":"Canopy USA"},{"name":"David Klein"},{"name":"Luc Mongeau"}]},{"id":37221610,"author":"Nicolás Jose Rodriguez","created":"Tue, 20 Feb 2024 18:03:26 -0400","updated":"Tue, 20 Feb 2024 18:03:27 -0400","title":"How Many Joints A Day Are Safe? Researchers Identify Methods For Weed Consumption Within Healthy Limits","teaser":"How much is too much? What constitutes a healthy habit? What are the long-term effects? When should one start using cannabis? How does potency factor in?","body":"\u003cp\u003eHow much is too much? What constitutes\u0026nbsp;a healthy habit? What are the long-term effects? When should one start using cannabis? How does potency factor in?\u003c/p\u003e\r\n\r\n\u003cp\u003eA team of researchers led by \u003cstrong\u003eDr.\u0026nbsp;Benedikt Fischer\u003c/strong\u003e from \u003cstrong\u003eSimon Fraser University\u003c/strong\u003e in Canada delved into these questions, producing \u003cstrong\u003eLower-Risk Cannabis Use Guidelines (LRCUG)\u003c/strong\u003e based on scientific findings.\u003c/p\u003e\r\n\r\n\u003cp\u003eThe study revealed twelve recommendation clusters and three precautionary statements to mitigate cannabis-related health risks.\u003c/p\u003e\r\n\r\n\u003cp\u003eRecommendations stess delaying cannabis use until after \u003ca href=\"https://www.benzinga.com/markets/cannabis/21/12/24632406/cannabis-use-among-teens-drastically-declined-confirms-government-funded-study\"\u003eadolescence\u003c/a\u003e, avoiding high-potency products\u0026nbsp;and opting for legal, \u003ca href=\"https://www.benzinga.com/markets/cannabis/23/12/36394288/cannabis-2024-experts-weigh-in-what-to-expect-from-dc-and-business-outlook-exciting-point-in-tim\"\u003eregulated options \u003c/a\u003ewhere available.\u003c/p\u003e\r\n\r\n\u003ch3\u003eSteer Clear Of Mixing\u003c/h3\u003e\r\n\r\n\u003cp\u003eCombining cannabis with substances like tobacco or alcohol can amplify health risks significantly. The unpredictable interactions may lead to various complications, including problematic use, circulatory issues\u0026nbsp;and long-term health problems such as asthma.\u003c/p\u003e\r\n\r\n\u003ch3\u003eExploring Inhalation Methods\u003c/h3\u003e\r\n\r\n\u003cp\u003eTraditional methods of cannabis consumption, such as smoking, can expose users to harmful substances.\u003c/p\u003e\r\n\r\n\u003cp\u003e\u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/34465496/\"\u003eLRCUG \u003c/a\u003esuggests exploring alternative inhalation methods like \u003ca href=\"https://www.benzinga.com/analyst-ratings/analyst-color/23/10/35297411/us-vape-market-insights-pricing-trends-rise-of-all-in-ones-and-in-house-brands\"\u003evaporizers\u003c/a\u003e or \u003ca href=\"https://www.benzinga.com/analyst-ratings/analyst-color/23/10/35228569/whos-who-among-cannabis-hardware-vaping-suppliers-zuanic-associates-take-a-deep-div\"\u003ebongs \u003c/a\u003ewith activated charcoal filters to minimize respiratory harm.\u003c/p\u003e\r\n\r\n\u003ch3\u003eQuality Control\u003c/h3\u003e\r\n\r\n\u003cp\u003eEnsuring the quality of \u003ca href=\"https://www.benzinga.com/general/biotech/23/10/35300227/from-cbn-cbg-to-thcv-consumer-centric-brands-embrace-rare-cannabinoids-for-differentiation\"\u003ecannabis products \u003c/a\u003eis paramount to preventing potential health hazards. Users are advised to inspect products for signs of contamination or\u003ca href=\"https://www.benzinga.com/markets/cannabis/23/09/34122583/oregon-court-halts-zero-tolerance-aspergillus-mold-testing-cannabis-cultivators-find-respite\"\u003e mold\u003c/a\u003e, as these can lead to poisoning and/or respiratory complications.\u003c/p\u003e\r\n\r\n\u003ch3\u003eConsiderations For Health Conditions\u003c/h3\u003e\r\n\r\n\u003cp\u003eIndividuals with pre-existing health conditions such as \u003ca href=\"https://www.benzinga.com/markets/cannabis/23/12/36228666/the-kids-are-alright-government-study-finds-teen-cannabis-use-holds-steady-despite-increased-sta\"\u003edepression\u003c/a\u003e or cardiovascular disease are urged in the \u003ca href=\"https://news.yahoo.com/high-healthy-addiction-experts-smoke-172729032.html?guccounter=1\u0026amp;guce_referrer=aHR0cHM6Ly93d3cuZ29vZ2xlLmNvbS8\u0026amp;guce_referrer_sig=AQAAAIXyMQJqvuN9eD5OcGjs-sD324sToMySvNGUxWERcqqGgAJSIKe1lQ43Db7YME63SxBRF5v5Ef2ym40PCfCTTSq4MHH6-tVAhxcVME4IGht4uYMLbR3Ds6lWUL_CFKsDdK3iEBpMFRUx0RgufLLrim6y0GZj9i8Xig1MI5xCRx-p\"\u003estudy\u003c/a\u003e to exercise caution or refrain from cannabis use altogether. The study cautions that\u0026nbsp;cannabis consumption can exacerbate symptoms or cause adverse effects in these populations.\u003c/p\u003e\r\n\r\n\u003ch3\u003eEdibles: Start Low, Go Slow\u003c/h3\u003e\r\n\r\n\u003cp\u003eWhen consuming cannabis-infused edibles, starting with lower doses is recommended due to the delayed onset and prolonged effects. Researchers behind the\u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/34465496/\"\u003e study \u003c/a\u003erecommend avoiding immediate re-dosing to prevent accidental overconsumption and its associated risks.\u003c/p\u003e\r\n\r\n\u003ch3\u003eModeration And Timing: How Many Joints A Day?\u0026nbsp;\u003c/h3\u003e\r\n\r\n\u003cp\u003eThe frequency of cannabis use plays a crucial role in determining associated health risks. According to LRCUG, limiting consumption to one or two days a week at most is advisable.\u003c/p\u003e\r\n\r\n\u003cp\u003eAdditionally, delaying the onset of cannabis use until after \u003ca href=\"https://www.benzinga.com/markets/cannabis/22/07/27928906/adolescents-three-times-more-prone-to-marijuana-addiction-than-adults-new-study-reveals\"\u003eadolescence\u003c/a\u003e is highly recommended, as early exposure may adversely affect brain development and cognitive function.\u003c/p\u003e\r\n\r\n\u003ch3\u003eStudy Methodology\u003c/h3\u003e\r\n\r\n\u003cp\u003eResearchers conducted targeted searches in 2016 to identify \u003ca href=\"https://www.benzinga.com/markets/cannabis/23/02/30809400/surprising-results-weed-affects-adults-teens-equally-cbd-does-not-mitigate-thcs-immediate-effect\"\u003ekey risk factors\u003c/a\u003e for adverse health outcomes from cannabis use. They expanded their scope based on past guidelines and recent evidence, prioritizing systematic reviews and important individual studies. Findings were then summarized to inform expert-driven recommendations.\u003c/p\u003e\r\n\r\n\u003cp\u003e\u003cem\u003eJoin the\u0026nbsp;\u003ca href=\"https://cannabismarketspotlight.com/\" rel=\"noreferrer noopener\" target=\"_blank\"\u003eBenzinga Cannabis Market Spotlight: California\u003c/a\u003e, and unlock the future of cannabis at the premier networking event in Culver City on February 22. Connect with top industry leaders, gain insider insights into the investment landscape, and shape the evolving markets in California and beyond. Don\u0026rsquo;t miss this chance to be at the forefront of the cannabis industry\u0026rsquo;s growth and innovation!\u0026nbsp;\u003ca href=\"https://cannabismarketspotlight.com/\" rel=\"noreferrer noopener\" target=\"_blank\"\u003eJoin now\u003c/a\u003e.\u0026nbsp;\u003c/em\u003e\u003c/p\u003e\r\n\r\n\u003cp\u003e\u003cem\u003ePhoto: AI-Generated Image.\u0026nbsp;\u003c/em\u003e\u003c/p\u003e\r\n","url":"https://www.benzinga.com/markets/cannabis/24/02/37221610/how-many-joints-a-day-are-safe-researchers-identify-methods-for-weed-consumption-within-healthy-","image":[{"size":"thumb","url":"https://cdn.benzinga.com/files/imagecache/250x187xUP/images/story/2024/02/20/dalle_cannabis_use_study.jpg"},{"size":"small","url":"https://cdn.benzinga.com/files/imagecache/1024x768xUP/images/story/2024/02/20/dalle_cannabis_use_study.jpg"},{"size":"large","url":"https://cdn.benzinga.com/files/imagecache/2048x1536xUP/images/story/2024/02/20/dalle_cannabis_use_study.jpg"}],"channels":[{"name":"Cannabis"},{"name":"News"},{"name":"Education"},{"name":"Health Care"},{"name":"Psychology"},{"name":"Markets"},{"name":"General"}],"stocks":[],"tags":[{"name":"cannabis risks"},{"name":"Cannabis teens"},{"name":"Dr. Benedikt Fischer"},{"name":"Lower-Risk Cannabis Use Guidelines"},{"name":"Simon Fraser University"}]},{"id":42163673,"author":"Nina Zdinjak","created":"Mon, 25 Nov 2024 10:00:15 -0400","updated":"Mon, 25 Nov 2024 10:00:16 -0400","title":"Enveric Biosciences Advances Non-Hallucinogenic DMT Analog Drug With Promising Preclinical Results","teaser":" ","body":"\u003cp\u003ePsychedelics biotech company \u003cstrong\u003eEnveric Biosciences \u003c/strong\u003e(NASDAQ:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/ENVB#NASDAQ\"\u003eENVB\u003c/a\u003e) completed preclinical pharmacokinetic (PK) studies for its leading drug candidate EB-003 aimed at treating depression and anxiety without causing hallucinations. EB-003 is a neuroplastic and non-hallucinogenic N, N-Dimethyltryptamine (DMT) analog drug candidate\u003cstrong\u003e.\u003c/strong\u003e\u003cstrong\u003e,\u003c/strong\u003e such as ataxia or hyperthermia.\u003c/p\u003e\n\n\n\n\u003cp\u003e\"Completion of these animal PK studies further supports our efforts to develop conveniently delivered, orally-available drugs with the potential to harness neuroplastic properties without inducing hallucinations,\" stated \u003cstrong\u003eJoseph Tucker\u003c/strong\u003e, Ph.D., CEO of Enveric. \"The additional data gained in these animal studies enhances our understanding of the preclinical profile of this drug candidate and brings us a step closer to finalizing the data package for the EB-003 Investigational New Drug (IND) application, which we anticipate submitting to the U.S. Food and Drug Administration in the second half of 2025.\"\u003c/p\u003e\n\n\n\n\u003cp\u003eAdditionally, significant brain penetration was demonstrated in the rat model with a brain/plasma ratio of about 5-6, which is significantly higher than in previous mouse studies. This suggests enhanced efficacy, lower doses and less off-target side effects if these findings are confirmed in clinical trials.\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eRead Also: \u003ca href=\"https://www.benzinga.com/news/earnings/24/11/42039385/enveric-biosciences-trims-losses-eyes-key-drug-approval-for-difficult-to-treat-mental-health-disorders\"\u003eEnveric Biosciences Trims Losses, Eyes Key Drug Approval For Difficult-To-Treat Mental Health Disorders\u003c/a\u003e\u003c/strong\u003e\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cem\u003e\u003cstrong\u003eGet Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter \u003ca href=\"https://newsletteremail.benzinga.com/subscribe\" target=\"_blank\" rel=\"noreferrer noopener\"\u003ehere\u003c/a\u003e. If you're serious about the business, you can't afford to miss out.\u003c/strong\u003e\u003c/em\u003e\u003c/p\u003e\n\n\n\n\u003cp\u003e\"Mental health disorders like depression and anxiety are on the rise, with approximately one billion people globally expected to experience a neuropsychiatric disorder at some time in their lives,\u0026#8221; Tucker continued. \u0026#8220;Despite the prevalence of these conditions, currently approved treatments fail to provide adequate relief for half of the patients who try them, resulting in widespread challenges to the psychiatric community. The market opportunity for neuroplastogens is estimated to exceed $35 billion by 2030, with the potential to offer low side-effects, strong efficacy, and potential synergies with current drugs, which could help drive demand for new and innovative treatment options.\"\u003c/p\u003e\n\n\n\n\u003cp\u003eThis update on EB-003 follows the company's announcement of\u003ca href=\"https://www.benzinga.com/general/biotech/24/11/41714040/enveric-biosciences-expands-mental-health-patent-portfolio-with-5-new-additions\"\u003e securing five new U.S. patents\u003c/a\u003e for its EVM301 \u003ca href=\"https://www.benzinga.com/cannabis\" target=\"_blank\" rel=\"noreferrer noopener\"\u003eportfolio.\u003c/a\u003e These latest additions bring Enveric\u0026#8217;s total to nine issued U.S. patents, enhancing the intellectual property surrounding its library of neuroplasticity-focused compounds aimed at mental health conditions.\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003ePrice Action\u003c/strong\u003e\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eEnveric Biosciences shares closed Friday's market session 0.24% higher at 33 cents per share.\u003c/strong\u003e\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eRead Next:\u003c/strong\u003e\u003c/p\u003e\n\n\n\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003e\u003ca href=\"https://www.benzinga.com/24/11/42146118/how-to-navigate-difficult-psychedelic-journeys-research-insights\"\u003eHow To Navigate Difficult Psychedelic Journeys: Research Insights\u003c/a\u003e\u003c/strong\u003e\u003c/li\u003e\n\u003c/ul\u003e\n\n\n\n\u003cp\u003e\u003cem\u003ePhoto via Shutterstock\u003c/em\u003e\u003c/p\u003e","url":"https://www.benzinga.com/markets/cannabis/24/11/42163673/enveric-biosciences-advances-non-hallucinogenic-dmt-analog-drug-with-promising-preclinical-results","image":[{"size":"thumb","url":"https://cdn.benzinga.com/files/imagecache/250x187xUP/images/story/2024/11/25/Genetic-Research-And-Biotech-Science-Con.jpeg"},{"size":"small","url":"https://cdn.benzinga.com/files/imagecache/1024x768xUP/images/story/2024/11/25/Genetic-Research-And-Biotech-Science-Con.jpeg"},{"size":"large","url":"https://cdn.benzinga.com/files/imagecache/2048x1536xUP/images/story/2024/11/25/Genetic-Research-And-Biotech-Science-Con.jpeg"}],"channels":[{"name":"Cannabis"},{"name":"News"},{"name":"Psychedelics"}],"stocks":[{"name":"ENVB"}],"tags":[{"name":"EB-003"},{"name":"Joseph Tucker"},{"name":"premium"}]},{"id":42170000,"author":"Juan Spínelli","created":"Mon, 25 Nov 2024 13:19:06 -0400","updated":"Mon, 25 Nov 2024 13:19:07 -0400","title":"Instagram Suspends Pro-Cannabis Veterans Group Without Explanation, Raising Censorship Concerns","teaser":"Instagram suspends pro-cannabis veterans group without explanation, sparking debates over censorship and challenges for cannabis advocacy online.","body":"\u003cp\u003eInstagram recently suspended the account of \u003cstrong\u003eService Disabled Veterans in Cannabis\u003c/strong\u003e, a group advocating for \u003ca href=\"https://www.benzinga.com/topic/military-veterans\"\u003emilitary veterans\u003c/a\u003e in the cannabis industry, according to co-founder \u003cstrong\u003eOsbert Orduna\u003c/strong\u003e. As New York Post \u003ca href=\"https://nypost.com/2024/11/24/us-news/pro-marijuana-veterans-group-claims-it-was-suspended-from-instagram-in-act-of-censorship/\"\u003ereported\u003c/a\u003e, the suspension occurred on November 21, 2024, without prior notice or explanation, despite the group\u0026#8217;s adherence to Instagram's terms of service and community guidelines.\u003c/p\u003e\n\n\n\n\u003cp\u003eThe group's name, which includes the word \"cannabis,\" and its logo, featuring a marijuana leaf, are suspected by Orduna to have triggered the suspension. However, \u003ca href=\"https://www.benzinga.com/topic/instagram\"\u003eInstagram\u003c/a\u003e has not provided clarity. \"We have diligently adhered to Instagram's terms of service and community guidelines, and we believe this suspension to be unjustified,\" Orduna said in a statement to The NY Post. The Meta (NASDAQ:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/META#NASDAQ\"\u003eMETA\u003c/a\u003e) platform informed the group they have 180 days to appeal the decision, stating, \"If we find your account does follow our community standards, you'll be able to use Instagram again. If not, it will be permanently disabled.\"\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eRead Also: \u003ca href=\"https://www.benzinga.com/general/social-media/24/11/42167296/did-elon-musk-really-use-a-meme-of-pablo-escobar-smoking-weed-to-celebrate-trumps-reelection-what-does-it-even-mean\"\u003eDid Elon Musk Really Use A Meme Of Pablo Escobar Smoking Weed To Celebrate Trump\u0026#8217;s Election Victory? What Does It Even Mean?\u003c/a\u003e\u003c/strong\u003e\u003c/p\u003e\n\n\n\n\u003ch3 class=\"wp-block-heading\"\u003e\u003cstrong\u003eFree Speech Debate in Social Media\u003c/strong\u003e\u003c/h3\u003e\n\n\n\n\u003cp\u003eThe suspension has reignited discussions about censorship on social media, particularly for cannabis-related content. Cannabis advocates argue that platforms like Instagram apply their content moderation policies inconsistently, impacting organizations focused on advocacy and education.\u003c/p\u003e\n\n\n\n\u003cp\u003eMeanwhile, the group has maintained its presence on X, with Orduna praising the platform's owner, \u003cstrong\u003eElon Musk\u003c/strong\u003e, for a \"rational position on cannabis.\" On X, the group criticized Instagram's actions, stating, \"Where are the class action lawyers? Who else is tired of @Meta @instagram censorship of the word ‘CANNABIS'?\"\u003c/p\u003e\n\n\n\n\u003cp\u003eOrduna also expressed frustration over Instagram's handling of the matter, accusing the platform of acting as \"judge, jury, and executioner.\"\u003c/p\u003e\n\n\n\n\u003ch3 class=\"wp-block-heading\"\u003e\u003cstrong\u003eBroader Implications For Cannabis Industry\u003c/strong\u003e\u003c/h3\u003e\n\n\n\n\u003cp\u003eThis incident highlights the ongoing struggles faced by cannabis organizations operating within the confines of major tech platforms. Despite \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/08/40121092/medical-cannabis-patients-increased-sixfold-in-six-years-declined-in-states-where-recreational-u\"\u003ewidespread legalization\u003c/a\u003e and growing societal acceptance, cannabis-related groups frequently encounter hurdles due to outdated or overly cautious content policies.\u003c/p\u003e\n\n\n\n\u003cp\u003eMeta has yet to comment on this specific suspension, leaving industry professionals and advocates to question whether such actions are part of a broader trend of suppressing cannabis-related content or an isolated misstep.\u003c/p\u003e\n\n\n\n\u003cp\u003eWhile Meta declined to comment on the issue, the \u003ca href=\"https://www.benzinga.com/cannabis\"\u003ecannabis industry\u003c/a\u003e continues to grow, and the question remains: Can advocacy groups rely on mainstream social media platforms to amplify their message, or must they seek alternative spaces that accommodate the realities of a legal but still controversial market?\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eRead Now\u003c/strong\u003e: \u003c/p\u003e\n\n\n\n\u003cul\u003e\n\u003cli\u003e\u003ca href=\"https://www.benzinga.com/general/social-media/24/11/42074616/expert-tips-to-create-effective-cannabis-content-on-instagram-tiktok-and-more-focus-on-the-content-not-the-packaging\"\u003e\u003cstrong\u003eExpert Tips To Create Effective Cannabis Content On Instagram, TikTok And More: Focus On Content, Not Packaging\u003c/strong\u003e\u003c/a\u003e\u003c/li\u003e\n\u003c/ul\u003e\n\n\n\n\u003cp\u003e\u003cem\u003eCover image made with AI\u003c/em\u003e\u003c/p\u003e","url":"https://www.benzinga.com/markets/cannabis/24/11/42170000/instagram-suspends-pro-cannabis-veterans-group-without-explanation-raising-censorship-concerns","image":[{"size":"thumb","url":"https://cdn.benzinga.com/files/imagecache/250x187xUP/images/story/2024/11/25/1-21.png"},{"size":"small","url":"https://cdn.benzinga.com/files/imagecache/1024x768xUP/images/story/2024/11/25/1-21.png"},{"size":"large","url":"https://cdn.benzinga.com/files/imagecache/2048x1536xUP/images/story/2024/11/25/1-21.png"}],"channels":[{"name":"Cannabis"},{"name":"News"},{"name":"Psychedelics"}],"stocks":[{"name":"META"}],"tags":[{"name":"Cannabis advocacy"},{"name":"Cannabis Veterans"},{"name":"Elon Musk"},{"name":"Instagram"},{"name":"Meta"},{"name":"military veterans"},{"name":"Osbert Orduna"},{"name":"Service Disabled Veterans in Cannabis"}]},{"id":42169374,"author":"Jelena Martinovic","created":"Mon, 25 Nov 2024 12:57:45 -0400","updated":"Mon, 25 Nov 2024 12:57:45 -0400","title":"Canadian Cannabis Producer Cannara Reports 43% YoY Revenue Growth, Boosts Market Share And Profitability","teaser":"Vertically integrated cannabis producer Cannara Biotech Inc. (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB0) announced on Monday its fourth quarter and full fiscal 2024 financial and operating results ended Aug. 31. The Montreal, Canada-based company revealed a 43% year-over-year revenue growth in 2024 to CA$82.2 million ($58.8 million). Gross profit for the full year grew by 32% over the same period, reaching CA$27.9 million, with a gross margin of 34% before fair value adjustments. Positive operating cash flow increased by 81% to CA$10.7 million, while free cash flow turned positive at CA$3.2 million, a CA$7.2 million turnaround from 2023.","body":"\u003cp\u003eVertically integrated cannabis producer \u003cstrong\u003eCannara Biotech Inc\u003c/strong\u003e. (TSXV:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/LOVE#TSXV\"\u003eLOVE\u003c/a\u003e) (OTCQB:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/LOVFF#OTCQB\"\u003eLOVFF\u003c/a\u003e) (FRA: 8CB0) announced its fourth quarter and full fiscal 2024 financial and operating results on Monday ended Aug. 31.\u003c/p\u003e\n\n\n\n\u003cp\u003eThe Montreal-based company revealed a 43% year-over-year revenue growth in 2024 to CA$82.2 million ($58.8 million).\u003c/p\u003e\n\n\n\n\u003cp\u003eGross profit for the full year grew by 32% over the same period, reaching CA$27.9 million, with a gross margin of 34% before fair value adjustments.\u003c/p\u003e\n\n\n\n\u003cp\u003ePositive operating cash flow increased by 81% to CA$10.7 million, while free cash flow turned positive at CA$3.2 million, a CA$7.2 million turnaround from 2023.\u003c/p\u003e\n\n\n\n\u003cp\u003e\"Fiscal 2024 was a transformative year for Cannara, showcasing the resilience of our business model and the strength of our execution strategy,\" said \u003cstrong\u003eZohar Krivorot, \u003c/strong\u003epresident and CEO. \"With a 3.2% national market share and a leading position in Québec, we have proven our ability to deliver sustained growth in a challenging cannabis market. By investing in our state-of-the-art production facilities, powered by the lowest-cost electricity in the country, we continue to produce premium cannabis products at an unmatched value.\"\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eRead Also: \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/07/39914893/cannara-biotech-reports-6-yoy-drop-in-q3-gross-profit-22-revenue-increase-as-it-enhances-sales-f\"\u003eCannara Biotech Reports 6% YoY Drop In Q3 Gross Profit, 22% Revenue Increase As It Enhances Sales Force And Infrastructure\u003c/a\u003e\u003c/strong\u003e \u003c/p\u003e\n\n\n\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003e\u003cem\u003eGet Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter \u003ca href=\"https://newsletteremail.benzinga.com/subscribe\" target=\"_blank\" rel=\"noreferrer noopener\"\u003ehere\u003c/a\u003e. If you're serious about the business, you can't afford to miss out.\u003c/em\u003e\u003c/strong\u003e\u003c/li\u003e\n\u003c/ul\u003e\n\n\n\n\u003ch3 class=\"wp-block-heading\"\u003eQ4 2024 Financial Highlights\u003c/h3\u003e\n\n\n\n\u003cul\u003e\n\u003cli\u003eRevenue saw a 28% increase year-over-year, totaling CA$23.4 million.\u003c/li\u003e\n\n\n\n\u003cli\u003eGross profit before fair value adjustments was CA$7 million, a 2% year-over-year increase. The gross profit percentage before fair value adjustments was 30%. Gross profit after fair value adjustments was 46%.\u003c/li\u003e\n\n\n\n\u003cli\u003eOperating income was CA$5 million, compared to operating income of CA$5.8 million in the same quarter of 2023.\u003c/li\u003e\n\n\n\n\u003cli\u003eAdjusted EBITDA came in positive at CA$3.7 million or 16% of net revenues compared to an adjusted EBITDA gain of CA$4.9 million in the same period of the prior year.\u003c/li\u003e\n\n\n\n\u003cli\u003eNet income totaled CA$5.8 million compared to CA$ 4.6 million in the prior year's period.\u003c/li\u003e\n\n\n\n\u003cli\u003ePositive operating cash flows of CA$3.2 million, compared to CA$2.9 million in the same period of fiscal 2023.\u003c/li\u003e\n\n\n\n\u003cli\u003eFree cash flow increased to CA$2.7 million from CA$1.1 million in the fourth quarter of 2023, representing a year-over-year increase of 143%.\u003c/li\u003e\n\u003c/ul\u003e\n\n\n\n\u003ch3 class=\"wp-block-heading\"\u003eFY 2024 Financial Highlights\u003c/h3\u003e\n\n\n\n\u003cul\u003e\n\u003cli\u003eOperating income was CA$10.1 million, compared to operating income of CA$11.9 million for 2023.\u003c/li\u003e\n\n\n\n\u003cli\u003eAdjusted EBITDA amounted to CA$15.1 million, representing a 10% increase compared to the prior year.\u003c/li\u003e\n\n\n\n\u003cli\u003eNet income was CA$6.4 million, compared to CA$6.9 million in 2023.\u003c/li\u003e\n\n\n\n\u003cli\u003eThe company's national market share rose to 3.2% in the fourth quarter, up from 2.3% in the same period of 2023.\u003c/li\u003e\n\n\n\n\u003cli\u003eCannara also saw strong growth in Québec, with market share increasing to 12.6% in October.\u003c/li\u003e\n\u003c/ul\u003e\n\n\n\n\u003ch3 class=\"wp-block-heading\"\u003eOutlook\u003c/h3\u003e\n\n\n\n\u003cp\u003eCannara reported that it plans to launch over 20 new products in fiscal 2025, with innovative formats like all-in-one vape devices and premium infused pre-rolls.\u003c/p\u003e\n\n\n\n\u003cp\u003eFor fiscal 2025, the company aims to activate two more zones, adding 50,000 sq. ft. of active canopy, while its 24-zone facility allows scalable production in lockstep with demand.\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eRead Next:\u003c/strong\u003e\u003c/p\u003e\n\n\n\n\u003cul\u003e\n\u003cli\u003e\u003ca href=\"https://www.benzinga.com/markets/cannabis/24/05/38563458/cannara-biotech-reports-51-yoy-revenue-increase-in-q2-wider-net-loss\"\u003e\u003cstrong\u003eCannara Biotech Reports 51% YoY Revenue Increase In Q2, Wider Net Loss\u003c/strong\u003e\u003c/a\u003e\u003c/li\u003e\n\u003c/ul\u003e","url":"https://www.benzinga.com/markets/cannabis/24/11/42169374/canadian-cannabis-producer-cannara-reports-43-yoy-revenue-growth-boosts-market-share-and-profitability","image":[{"size":"thumb","url":"https://cdn.benzinga.com/files/imagecache/250x187xUP/images/story/2024/11/25/elsa-olofsson-12-Zs1xIEtA-unsplash25.jpeg"},{"size":"small","url":"https://cdn.benzinga.com/files/imagecache/1024x768xUP/images/story/2024/11/25/elsa-olofsson-12-Zs1xIEtA-unsplash25.jpeg"},{"size":"large","url":"https://cdn.benzinga.com/files/imagecache/2048x1536xUP/images/story/2024/11/25/elsa-olofsson-12-Zs1xIEtA-unsplash25.jpeg"}],"channels":[{"name":"Cannabis"},{"name":"News"}],"stocks":[{"name":"LOVE"},{"name":"LOVFF"},{"name":"TSXV:LOVE"}],"tags":[{"name":"Canada Cannabis"},{"name":"Cannabis Earnings"},{"name":"earnings report"},{"name":"fourth quarter financials"},{"name":"Zohar Krivorot"}]},{"id":42086135,"author":"Nicolás Jose Rodriguez","created":"Wed, 20 Nov 2024 08:54:16 -0400","updated":"Wed, 20 Nov 2024 08:54:16 -0400","title":"Pre-Rolls, The Avocado Toast Of Cannabis: Why Millennials Are Spending +$100M A Month","teaser":"Millennials dominate the pre-roll market, accounting for 44.6% of purchases in September 2024, totaling $103.9 million. ","body":"\u003cp\u003eToo busy paying rent to roll joints? For Millennials, pre-rolls are a $3 billion solution, claiming 44.6% of the market. Convenient and ready to go, these tidy joints have become a coping mechanism for a time-strapped generation. A white paper from \u003cstrong\u003eCustom Cones USA \u003c/strong\u003eand data firm \u003cstrong\u003eHeadset\u003c/strong\u003e provides a detailed look at the modern pre-roll consumer, combining insights from over 900 cannabis users with extensive sales data.\u003c/p\u003e\n\n\n\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003e\u003cem\u003eGet Benzinga\u0026#8217;s exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter\u0026nbsp;\u003ca href=\"https://newsletteremail.benzinga.com/subscribe\" target=\"_blank\" rel=\"noreferrer noopener\"\u003ehere\u003c/a\u003e. You can't afford to miss out if you\u0026#8217;re serious about the business.\u003c/em\u003e\u003c/strong\u003e\u003c/li\u003e\n\u003c/ul\u003e\n\n\n\n\u003ch3 class=\"wp-block-heading\"\u003ePre-Roll Popularity Outpaces Other Cannabis Products\u003c/h3\u003e\n\n\n\n\u003cp\u003ePre-rolls have become the third-largest and fastest-growing category in the cannabis market, with sales reaching $4.1 billion from 2023 to mid-2024. Revenue grew 11.9% year-over-year between June 2023 and June 2024, outpacing other categories in dispensaries.\u0026nbsp;\u003c/p\u003e\n\n\n\n\u003cp\u003eConsumers increasingly prefer pre-rolls as convenient add-ons, especially when purchasing cannabis flower, which remains the top category.\u003c/p\u003e\n\n\n\n\u003cp\u003eNearly 82% of \u003ca href=\"https://customconesusa.com/pre-roll-consumer-report/\"\u003esurvey respondents reported \u003c/a\u003ebuying pre-rolls, with 94.2% listing joints as their favorite cannabis consumption method. Vape pens (67.3%), edibles (66.1%), and bowls (64.6%) followed, underscoring the dominance of flower consumption among cannabis users.\u003c/p\u003e\n\n\n\n\u003ch3 class=\"wp-block-heading\"\u003e\u003cstrong\u003eWho\u0026#8217;s Buying Pre-Rolls?\u003c/strong\u003e\u003c/h3\u003e\n\n\n\n\u003cp\u003eMillennials dominate the pre-roll market, accounting for 44.6% of purchases in September 2024, totaling $103.9 million.\u0026nbsp;\u003c/p\u003e\n\n\n\n\u003cp\u003eGeneration X follows at 24.3% ($56.7 million), with Gen Z contributing 18.5% ($43.2 million), and Baby Boomers rounding out the demographic at 12.5% ($29.2 million).\u0026nbsp;\u003c/p\u003e\n\n\n\n\u003cp\u003eMen outpace women in every generational group, with Millennial men leading at 28% of total revenue and 26.8% of units sold.\u003c/p\u003e\n\n\n\n\u003cp\u003eWhile Millennials are the largest market segment, the report also reveals a broad consumer base: the average pre-roll buyer is 43 years old, with most respondents using cannabis multiple times daily and having smoked for over 20 years.\u0026nbsp;\u003c/p\u003e\n\n\n\n\u003cp\u003eNotably, the survey revealed a near-even gender distribution, which aligns with broader consumption trends reported by New Frontier Data in 2023.\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eRead Also:\u003ca href=\"https://www.benzinga.com/general/social-media/24/11/41996222/how-reddits-cannabis-critics-are-helping-brands-spot-market-trends-before-they-hit-dispensar\"\u003e How Reddit\u0026#8217;s Cannabis Critics Are Helping Brands Spot Market Trends Before They Hit Dispensaries\u003c/a\u003e\u003c/strong\u003e\u003c/p\u003e\n\n\n\n\u003ch3 class=\"wp-block-heading\"\u003e\u003cstrong\u003eWhat Matters Most To Pre-Roll Consumers?\u003c/strong\u003e\u003c/h3\u003e\n\n\n\n\u003cp\u003ePotency remains the leading factor for pre-roll buyers, with more than 70% of respondents ranking it as the most important consideration. Price came second, followed by brand loyalty. Producers, however, view consumer priorities differently, ranking price first, potency second, and strain third.\u0026nbsp;\u003c/p\u003e\n\n\n\n\u003cp\u003eThis discrepancy highlights a potential gap between what consumers value and how producers position their products.\u003c/p\u003e\n\n\n\n\u003ch3 class=\"wp-block-heading\"\u003e\u003cstrong\u003ePre-Roll Trends By Consumption Frequency\u003c/strong\u003e\u003c/h3\u003e\n\n\n\n\u003cp\u003eThe frequency of cannabis use is a key factor in \u003ca href=\"https://www.benzinga.com/topic/cannabis-marketing\"\u003epre-roll purchasing behavior\u003c/a\u003e. Nearly 80% of pre-roll smokers use cannabis multiple times daily, while 11.7% consume it once per day. This high frequency contrasts with purchasing habits: only 16% of dispensary visits include pre-rolls, suggesting many consumers roll their joints or use pre-rolls for specific occasions.\u003c/p\u003e\n\n\n\n\u003cp\u003eThe multi-pack format continues to dominate, with 31.1% of consumers preferring multi-packs over single pre-rolls.\u0026nbsp;\u003c/p\u003e\n\n\n\n\u003cp\u003eAmong these, 47.5% favor packs of full-gram pre-rolls, though Headset data shows that half-gram multi-packs account for the majority of top-selling products.\u003c/p\u003e\n\n\n\n\u003ch3 class=\"wp-block-heading\"\u003e\u003cstrong\u003ePremium Pre-Rolls \u003c/strong\u003e\u003c/h3\u003e\n\n\n\n\u003cp\u003eInnovation is driving the popularity of premium pre-rolls.\u003ca href=\"https://www.benzinga.com/analyst-ratings/analyst-color/23/12/36268367/u-s-cannabis-market-premium-products\"\u003e Infused products \u003c/a\u003enow account for 44.4% of market share, up from 34.4% in 2019.\u0026nbsp;\u003c/p\u003e\n\n\n\n\u003cp\u003eKief remains the most popular infusion (78.3%), followed by live resin (77.3%).\u0026nbsp;\u003c/p\u003e\n\n\n\n\u003cp\u003eRespondents also showed enthusiasm for premium filter tips, with 59% having purchased pre-rolls featuring materials like glass or wood. While these are typically reserved for special occasions, 21.4% of buyers purchase them weekly, willing to pay $2 to $5 extra for the enhanced experience.\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eRead Also:\u003ca href=\"https://www.benzinga.com/general/health-care/24/11/41959233/yougov-poll-reveals-what-women-want-with-weed-relax-mindfulness-and-great-deals\"\u003e YouGov Poll Reveals What Women Want With Weed: Relax, Mindfulness And Great Deals\u003c/a\u003e\u003c/strong\u003e\u003c/p\u003e\n\n\n\n\u003ch3 class=\"wp-block-heading\"\u003e\u003cstrong\u003eMarket Trends Across States\u003c/strong\u003e\u003c/h3\u003e\n\n\n\n\u003cp\u003e\u003ca href=\"https://www.benzinga.com/topic/michigan-cannabis\"\u003eMichigan\u003c/a\u003e leads in pre-roll unit sales, moving 94.6 million units between September 2023 and September 2024, aided by the nation's lowest average price of $5.57. California follows with 52.1 million units sold, while\u003ca href=\"https://www.benzinga.com/topic/new-york-cannabis\"\u003e New York\u003c/a\u003e claims the highest per-gram price at $13.74. Regional price differences underscore the impact of market maturity, with newer markets commanding higher prices.\u003c/p\u003e\n\n\n\n\u003ch3 class=\"wp-block-heading\"\u003e\u003cstrong\u003eThe Lion's Share \u003c/strong\u003e\u003c/h3\u003e\n\n\n\n\u003cp\u003eJeeter leads the pre-roll market with 8.8% of all sales, generating $504.2 million. The brand's dominance is reflected in the fact that 13 of the top 20 best-selling products belong to Jeeter. STIIIZY follows with $320.9 million in sales, and Dogwalkers (OTC:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/GTBIF#OTC\"\u003eGTBIF\u003c/a\u003e), known for their mini pre-rolls, rounds out the top three with $141.6 million in revenue. Despite Jeeter's stronghold, regional brands like Michigan's Cali-Blaze highlight the importance of competitive pricing in driving sales volume.\u003c/p\u003e\n\n\n\n\u003ch3 class=\"wp-block-heading\"\u003e\u003cstrong\u003eMethodology \u003c/strong\u003e\u003c/h3\u003e\n\n\n\n\u003cp\u003eThe \u003ca href=\"https://customconesusa.com/pre-roll-consumer-report/\"\u003ereport employed a mixed-methods approach\u003c/a\u003e, integrating self-selected survey data with dispensary loyalty program analytics. This combination offers both consumer-reported preferences and objective sales figures. While the survey data may reflect the views of more engaged users, its findings are consistent with broader research. This alignment suggests that the mixed-methods approach provides a comprehensive and nuanced understanding of consumer behavior.\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eRead Next:\u003ca href=\"https://www.benzinga.com/markets/cannabis/24/10/41176039/whats-the-difference-between-medical-and-recreational-cannabis-users-new-survey-reveals-market-t\"\u003e What\u0026#8217;s The Difference Between Medical And Recreational Cannabis Users? New Survey Reveals Market Trends\u003c/a\u003e\u003c/strong\u003e\u003c/p\u003e","url":"https://www.benzinga.com/general/market-summary/24/11/42086135/pre-rolls-the-avocado-toast-of-cannabis-why-millennials-are-spending-100m-a-month","image":[{"size":"thumb","url":"https://cdn.benzinga.com/files/imagecache/250x187xUP/images/story/2024/11/20/AI-Generated-Image.jpeg"},{"size":"small","url":"https://cdn.benzinga.com/files/imagecache/1024x768xUP/images/story/2024/11/20/AI-Generated-Image.jpeg"},{"size":"large","url":"https://cdn.benzinga.com/files/imagecache/2048x1536xUP/images/story/2024/11/20/AI-Generated-Image.jpeg"}],"channels":[{"name":"Cannabis"},{"name":"Market Summary"},{"name":"News"},{"name":"Retail Sales"},{"name":"Success Stories"},{"name":"Startups"},{"name":"Small Business"},{"name":"Markets"},{"name":"General"}],"stocks":[{"name":"GTBIF"}],"tags":[{"name":"Cannabis Branding"},{"name":"cannabis edibles"},{"name":"cannabis infused pre-rolls"},{"name":"Cannabis Marketing"},{"name":"Cannabis Markets"},{"name":"cannabis pre-rolls"},{"name":"Cannabis Retail"},{"name":"Cannabis Retail Market"},{"name":"cannabis retail sales"},{"name":"cannabis sales"},{"name":"cannabis vapes"},{"name":"Custom Cones USA"},{"name":"Dogwalkers"},{"name":"Headset.io"},{"name":"Infused Pre-Rolls"},{"name":"Jeeter"},{"name":"pre-rolls"},{"name":"Stiiizy LLC"}]},{"id":25694419,"author":"Grassdoor","created":"Wed, 24 May 2023 07:07:07 -0400","updated":"Wed, 24 May 2023 07:12:12 -0400","title":"6 Easy Ways To Eliminate Marijuana From Your System","teaser":"This article, originally from Grassdoor, appeared here with permission first in February 2022. ","body":"\u003cp\u003e\u003cstrong\u003eThis article, originally from \u003ca href=\"https://grassdoor.com/blog/how-to-get-weed-out-of-your-system/\"\u003eGrassdoor\u003c/a\u003e, appeared here with permission first in February 2022. \u003c/strong\u003e\u003c/p\u003e\r\n\r\n\u003cp\u003eChanges in law and more research on marijuana\u0026rsquo;s medicinal and recreational value have increased its use. Sometimes people desire to get the tetrahydrocannabinol (THC) out of their system to pass a drug test or eliminate toxins out of their bodies. Detoxification is the primary and most effective method of removing \u003ca href=\"https://elplanteo.com/que-es-weed-que-significa-en-espanol/\"\u003eweed\u003c/a\u003e from the bloodstream.\u003c/p\u003e\r\n\r\n\u003cp\u003eTaking a drug test can be scary for people who consume weed often. Today, the internet contains a lot of information for different audiences on how to flush away \u003ca href=\"https://elplanteo.com/como-hacer-una-desintoxicacion-de-thc/\"\u003eTHC\u003c/a\u003e. However, marijuana users should be cautious because some information can be false or just confusing.\u003c/p\u003e\r\n\r\n\u003cp\u003eTo help you get started on the right foot, here\u0026rsquo;s a clear, helpful guide to getting weed out of your system as efficiently as possible.\u0026nbsp;\u003c/p\u003e\r\n\r\n\u003ch3\u003e\u003cstrong\u003eHow long does cannabis stay in your system?\u003c/strong\u003e\u003c/h3\u003e\r\n\r\n\u003cp\u003eBefore determining how to get weed out of your system, you should understand how long the THC stays in your bloodstream. When a person consumes marijuana, they feel the effects immediately. However, the marijuana metabolites remain in their bodies even after the effects disappear.\u003c/p\u003e\r\n\r\n\u003cp\u003eAfter ingesting or smoking weed, the liver mobilizes it into hydroxyl and carboxy-metabolites, which later leave the body through urine. Additionally, various body tissues absorb it and release it to the bloodstream. The plants\u0026rsquo; remnants, called cannabinoids, are detectable in the saliva, urine, and blood.\u003c/p\u003e\r\n\r\n\u003cp\u003eDrug tests can detect it in the blood tests up to thirty days after use. However, how long weed stays in the body depends on various factors, such as the dosage or amount consumed, THC levels in the drug, age, hydration, body mass index (BMI), and the frequency of ingestion. Some factors like age might not be related to weed, but they influence how the body metabolizes it.\u003c/p\u003e\r\n\r\n\u003cp\u003eOther factors like dosage determine the time that the body requires to eliminate the THC from the system. For example, people who consume weed more often and in higher doses are likely to have longer detection times of up to months. Additionally, ingested weed stays in the individual\u0026rsquo;s body longer than smoked weed.\u003c/p\u003e\r\n\r\n\u003cul\u003e\r\n\t\u003cli\u003e\u003cstrong\u003eTHC Dose:\u003c/strong\u003e\u0026nbsp;THC effects are cumulative. That means that smoking frequently or taking more\u0026nbsp;edibles\u0026nbsp;increases the THC levels in the body. For example, a person who smokes daily is likely to test positive for weed for more months than a person who smokes weekly or monthly.\u003c/li\u003e\r\n\u003c/ul\u003e\r\n\r\n\u003cul\u003e\r\n\t\u003cli\u003e\u003cstrong\u003eBMI or Body Fat:\u003c/strong\u003e\u0026nbsp;When healthcare experts are searching for the correct answer for the question \u0026ldquo;how long is weed in your system,\u0026rdquo; they consider the individual\u0026rsquo;s BMI. The fat in the body stores marijuana, meaning that having more fat concentration or a higher BMI prevents the body from metabolizing the THC faster. Therefore, the weed is likely to stay longer in a fat person\u0026rsquo;s body than a slimmer person.\u003c/li\u003e\r\n\u003c/ul\u003e\r\n\r\n\u003cul\u003e\r\n\t\u003cli\u003e\u003cstrong\u003eMetabolism:\u003c/strong\u003e\u0026nbsp;Weed stays longer in the bloodstream of people with slower metabolism because their bodies eliminate the THC and other metabolic chemicals slower.\u003c/li\u003e\r\n\u003c/ul\u003e\r\n\r\n\u003cul\u003e\r\n\t\u003cli\u003e\u003cstrong\u003eGender:\u0026nbsp;\u003c/strong\u003eWeed is likely to stay longer in men\u0026rsquo;s bodies than women\u0026rsquo;s bodies because the former have less body fat and metabolize the marijuana slower. The detection periods also depend on the type of drug test. Research indicates that urine tests can detect weed for up to ninety days, while a saliva test can detect cannabinoids up to three days after consumption. The duration of the hair test is ninety days for regular users.\u003c/li\u003e\r\n\u003c/ul\u003e\r\n\r\n\u003ch3\u003e\u003cstrong\u003eHow to get weed out of your system?\u003c/strong\u003e\u003c/h3\u003e\r\n\r\n\u003cp\u003eAfter smoking or ingesting weed, the body requires time to break it down. However, several strategies can help the body to metabolize it faster. The best ways to detoxify the body include:\u003c/p\u003e\r\n\r\n\u003ch3\u003eExercise\u003c/h3\u003e\r\n\r\n\u003cp\u003eWhen a person exercises, they lose toxins through sweat. Working out detoxifies the body, increasing the body\u0026rsquo;s rate of THC metabolization. Another advantage of physical activities is that they lower BMI and stimulate fat cells to release more THC. To get rid of more marijuana within a shorter period, the person should lift weight and do cardio training. Combining these activities burns more fat and causes one to sweat more.\u003c/p\u003e\r\n\r\n\u003ch3\u003eTake a mixture of Water and Lemon Juice\u003c/h3\u003e\r\n\r\n\u003cp\u003eWellness experts approve of lemon juice as a detox drink. Lemons and limes have high amounts of antioxidants, vitamins, and minerals. These contents enable the juice to eliminate the THC metabolites from the patient\u0026rsquo;s system.\u003c/p\u003e\r\n\r\n\u003cp\u003eTo make it more efficient, the person should mix one tablespoon of the juice with half a liter of water. Additionally, they should drink the mixture approximately seven times a day. The amount consumed also depends on the vaping frequency. However, one should avoid taking too much of the juice to avoid damaging their digestive system with the acidic contents of lemon.\u003c/p\u003e\r\n\r\n\u003ch3\u003eDrink A Lot of Water\u003c/h3\u003e\r\n\r\n\u003cp\u003ePlain water is an excellent detoxifier. It is natural and appropriate for people whose digestive systems cannot take the acidic elements of lemon juice. Water hydrates the body, eliminates the toxins from the body, and dilutes the urine. Taking a lot of water causes the frequent urge to urinate and clear the body\u0026rsquo;s systems.\u003c/p\u003e\r\n\r\n\u003ch3\u003eDrink Tea or Coffee\u003c/h3\u003e\r\n\r\n\u003cp\u003eTaking tea or coffee is an effective method of detoxifying the body. Like water, it causes a person to urinate more frequently, hence flushing THC and other toxins out of the body. Besides being a stimulant, coffee also contains antioxidants that detoxify the body naturally.\u003c/p\u003e\r\n\r\n\u003cp\u003eMixing the coffee with water and taking vitamin B supplements helps it cleanse the body faster. Green and dandelion teas contain low caffeine levels and boost the body\u0026rsquo;s metabolism. Therefore, people planning to take a drug test should consider taking more espresso several days before the test to ensure that their bodies are weed-free.\u003c/p\u003e\r\n\r\n\u003ch3\u003eUse Apple Cider Vinegar\u003c/h3\u003e\r\n\r\n\u003cp\u003eApple cider vinegar is a natural and popular alternative to commercial detoxifying products. Natural wellness enthusiasts use it as a health tonic. It works by boosting the person\u0026rsquo;s metabolism and allowing the cannabinoids to pass through the system faster.\u003c/p\u003e\r\n\r\n\u003cp\u003eThis detox drink also possesses antimicrobial qualities that assist in removing sludge toxins from the human body. However, it is advisable to avoid taking this detox solution straight because it has acidic properties and easily damages the mouth\u0026rsquo;s lining. Instead, mix several teaspoons of the juice with water and drink the solution.\u003c/p\u003e\r\n\r\n\u003ch3\u003eAdopt a \u0026ldquo;Green\u0026rdquo; Diet\u003c/h3\u003e\r\n\r\n\u003cp\u003eEating various green vegetables, such as kale, spinach, and broccoli can effectively flush weed out of the bloodstream. They provide the body with different minerals and vitamins which hasten metabolism.\u003c/p\u003e\r\n\r\n\u003ch3\u003e\u003cstrong\u003eConclusion\u003c/strong\u003e\u003c/h3\u003e\r\n\r\n\u003cp\u003ePeople seek to eliminate weed from their systems for different reasons. THC\u0026rsquo;s duration of time in the system depends on factors such as metabolism, weed dosage, and body fat. Detoxification is the most effective method of getting marijuana out of the bloodstream. Exercising and taking water, lemon juice, coffee, tea, and apple cider vinegar may not guarantee a negative drug test, but they do help to cleanse the body naturally.\u003c/p\u003e\r\n","url":"https://www.benzinga.com/markets/cannabis/22/02/25694419/get-weed-out-of-your-system-1","image":[{"size":"thumb","url":"https://cdn.benzinga.com/files/imagecache/250x187xUP/images/story/2012/photo-1534365315265-920d6de1f31d.jpg"},{"size":"small","url":"https://cdn.benzinga.com/files/imagecache/1024x768xUP/images/story/2012/photo-1534365315265-920d6de1f31d.jpg"},{"size":"large","url":"https://cdn.benzinga.com/files/imagecache/2048x1536xUP/images/story/2012/photo-1534365315265-920d6de1f31d.jpg"}],"channels":[{"name":"Cannabis"},{"name":"Markets"}],"stocks":[],"tags":[{"name":"contributors"},{"name":"Eliminate THC"},{"name":"ICYMI"},{"name":"metabolism"},{"name":"Nina's Picks"}]},{"id":42165932,"author":"Nina Zdinjak","created":"Mon, 25 Nov 2024 11:00:51 -0400","updated":"Mon, 25 Nov 2024 11:00:51 -0400","title":"More Paid Holidays For Cannabis Workers At Zen Leaf Dispensary Through Agreement With Teamsters","teaser":" ","body":"\u003cp\u003eCannabis advisors and agents-in-charge at the Zen Leaf cannabis dispensary in Evanston, Illinois unanimously ratified their first collective bargaining agreement with Teamsters Local 777. Zen Leaf is a subsidiary of the multi-state operator \u003cstrong\u003eVerano Holdings\u003c/strong\u003e (OTCQX:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/VRNOF#OTCQX\"\u003eVRNOF\u003c/a\u003e).\u003c/p\u003e\n\n\n\n\u003cp\u003e\"We successfully negotiated and ratified this collective bargaining agreement in less than three months, which is probably the fastest turnaround we've had for a first contract in this industry,\" stated \u003cstrong\u003eJim Glimco\u003c/strong\u003e, president of Local 777. \"We're organizing and winning contracts faster than ever before because everyone in this field recognizes we're a force to be reckoned with. Congratulations to all of the workers who stuck together to demand a contract with the same high standards we've secured for other multi-state cannabis operators in Illinois.\"\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eRead Also: \u003c/strong\u003e\u003ca href=\"https://www.benzinga.com/markets/cannabis/24/11/42067867/illinois-launches-cannabis-research-institute-with-7m-in-funding\"\u003eIllinois Launches Cannabis Research Institute With $7M In Funding\u003c/a\u003e\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cem\u003e\u003cstrong\u003eGet Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter \u003ca href=\"https://newsletteremail.benzinga.com/subscribe\" target=\"_blank\" rel=\"noreferrer noopener\"\u003ehere\u003c/a\u003e. If you're serious about the business, you can't afford to miss out.\u003c/strong\u003e\u003c/em\u003e\u003c/p\u003e\n\n\n\n\u003cp\u003eThe three-year contract includes a number of changes including more paid holidays, a minimum 14% wage increase over the lifetime of the agreement, due process during disciplinary matters, and a guarantee that a successor employer will assume the contract if another company buys the dispensary. Workers also receive retirement benefits, something that is only available to union members at the company.\u003c/p\u003e\n\n\n\n\u003cp\u003e\"Cannabis workers are organizing and bargaining better contracts faster because they know a Teamsters contract brings stability to their jobs and respect from the industry for the work they do,\" said \u003cstrong\u003eJesse Case\u003c/strong\u003e, Teamsters food processing division director.\u003c/p\u003e\n\n\n\n\u003cp\u003eThe news comes after workers at \u003cstrong\u003ePharmaCann\u003c/strong\u003e, one of the largest vertically integrated cannabis companies in the U.S., \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/11/41887709/prices-up-50-wages-barely-moved-says-pharmacann-worker-and-new-teamster-member\"\u003ejoined Teamsters Local 337\u003c/a\u003e following an overwhelming unionization vote at the company's Michigan facility.\u003c/p\u003e\n\n\n\n\u003cp\u003eIn recent years, Teamsters have worked to unionize workers in the emerging cannabis industry. Efforts included \u003cstrong\u003ethe Cannabist Company (OTCQX:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/CBSTF#OTCQX\"\u003eCBSTF\u003c/a\u003e) \u003c/strong\u003ein \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/05/38669949/cannabis-workers-in-l-a-join-teamsters-to-improve-pay-working-conditions-and-have-a-voice\" target=\"_blank\" rel=\"noreferrer noopener\"\u003eCalifornia\u003c/a\u003e,\u003cstrong\u003e Cresco Labs (OTCQX:\u003c/strong\u003eCRLBF) in \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/05/38585820/teamsters-unionize-cannabis-workers-at-another-cresco-labs-dispensary-in-illinois-it-feels-good\" target=\"_blank\" rel=\"noreferrer noopener\"\u003eIllinois\u003c/a\u003e,\u003cstrong\u003e Grassdoor \u003c/strong\u003ein \u003ca href=\"https://www.benzinga.com/markets/cannabis/23/03/31477358/workers-at-two-more-cannabis-companies-unionize-with-teamsters-and-ufcw\" target=\"_blank\" rel=\"noreferrer noopener\"\u003eCalifornia\u003c/a\u003e, \u003cstrong\u003eNabis\u003c/strong\u003e in \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/05/38797830/84-cannabis-warehouse-workers-and-drivers-in-california-join-teamsters-for-contracts-reflecting-\"\u003eCalifornia\u003c/a\u003e and\u003cstrong\u003e Verano Holdings in\u003c/strong\u003e\u003ca href=\"https://www.benzinga.com/markets/cannabis/22/08/28566870/veranos-firing-of-union-supporters-flops-zen-leaf-chicago-workers-join-teamsters-local-777\" target=\"_blank\" rel=\"noreferrer noopener\"\u003eChicago\u003c/a\u003e.\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eRead Next:\u003c/strong\u003e\u003c/p\u003e\n\n\n\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003e\u003ca href=\"https://www.benzinga.com/markets/cannabis/24/10/41176622/teamsters-added-50-000-new-members-in-less-than-3-years-partly-due-to-cannabis-industry-growth\"\u003eTeamsters Added 50,000 New Members In Less Than 3 Years, Partly Due To Cannabis Industry Growth\u003c/a\u003e\u003c/strong\u003e\u003c/li\u003e\n\u003c/ul\u003e\n\n\n\n\u003cp\u003e\u003cem\u003ePhoto: Benzinga edit with images by lexandros Michailidisand Oleksandrum via Shutterstock\u003c/em\u003e\u003c/p\u003e","url":"https://www.benzinga.com/markets/cannabis/24/11/42165932/more-paid-holidays-for-cannabis-workers-at-zen-leaf-dispensary-through-agreement-with-teamsters","image":[{"size":"thumb","url":"https://cdn.benzinga.com/files/imagecache/250x187xUP/images/story/2024/11/25/cannabis-union--workers---syndicate-Alex.jpeg"},{"size":"small","url":"https://cdn.benzinga.com/files/imagecache/1024x768xUP/images/story/2024/11/25/cannabis-union--workers---syndicate-Alex.jpeg"},{"size":"large","url":"https://cdn.benzinga.com/files/imagecache/2048x1536xUP/images/story/2024/11/25/cannabis-union--workers---syndicate-Alex.jpeg"}],"channels":[{"name":"Cannabis"},{"name":"News"}],"stocks":[{"name":"CBSTF"},{"name":"VRNOF"}],"tags":[{"name":"Jesse Case"},{"name":"Jim Glimco"},{"name":"premium"},{"name":"Teamsters"},{"name":"zen leaf"}]},{"id":16412908,"author":"WeedMaps News","created":"Fri, 23 Sep 2022 17:13:07 -0400","updated":"Fri, 23 Sep 2022 17:14:25 -0400","title":"How Many Grams Are In An Eighth Of Weed - And Other Useful Cannabis Conversions","teaser":"By Weedmaps, provided exclusively to Benzinga Cannabis.","body":"\u003cp\u003e\u003cem\u003e\u003cstrong\u003eBy \u003ca href=\"https://weedmaps.com/learn/products-and-how-to-consume/how-much-is-an-eighth/\"\u003eWeedmaps\u003c/a\u003e, provided exclusively to \u003ca href=\"http://www.benzinga.com/cannabis/\"\u003eBenzinga Cannabis\u003c/a\u003e.\u003c/strong\u003e\u003c/em\u003e\u003c/p\u003e\r\n\r\n\r\n\r\n\u003cdiv class=\"wm-article-content\"\u003e\r\n\u003cp\u003eSimilar to asking a flight attendant for a glass of alcohol, purchasing cannabis can be awkward when you don\u0026#39;t know how to ask for the right amount for your purposes. If you\u0026#39;ve managed to reach adulthood unscathed by social anxiety, feel free to skip this article and \u003ca href=\"https://weedmaps.com/\" rel=\"noopener noreferrer\" target=\"_blank\"\u003emake your way to a licensed dispensary\u003c/a\u003e where a budtender can walk you through the rest.\u003c/p\u003e\r\n\r\n\u003cp\u003eIf not, know that an eighth of weed is the most common amount consumers purchase. Why? Cannabis brands, dispensaries, and delivery services all measure \u003ca href=\"https://weedmaps.com/learn/products-and-how-to-consume/cannabis-flower\" rel=\"noopener noreferrer\" target=\"_blank\"\u003edried flower\u003c/a\u003e in grams and ounces. An eighth is simply shorthand for an eighth of an ounce, or 3.5 grams, of weed.\u003c/p\u003e\r\n\r\n\u003cdiv class=\"wm-article-table-of-contents-header-container\"\u003e\r\n\u003ch2 class=\"wm-article-table-of-contents-header\" id=\"what-is-a-gram-and-how-much-is-it-exactly\"\u003eWhat is a gram and how much is it exactly?\u003c/h2\u003e\r\n\r\n\u003cp\u003eA gram, sometimes colloquially referred to as a dime bag or dub, is the smallest measurement of dried flower. How much weed you need is entirely dependent on how much weed you plan on consuming per day, but for the purposes of rolling one sizable joint, 1 gram is plenty.\u0026nbsp;\u003c/p\u003e\r\n\r\n\u003cp\u003eDepending on the \u003ca href=\"https://weedmaps.com/learn/dictionary/nug/\" rel=\"noopener noreferrer\" target=\"_blank\"\u003edensity of the nugs\u003c/a\u003e, a gram of weed can range in size from a walnut to a kumquat. So, if someone tries to sell you a gram of weed the size of a tiny organic blueberry, ask them to pull out a scale and weigh it again.\u003c/p\u003e\r\n\u003cimg alt=\"\" src=\"https://weedmaps.com/learn/wp-content/uploads/2021/02/ezgif-1-305684bd5837.gif\" style=\"height:351px; width:624px\" /\u003e\r\n\u003cp\u003eAn eighth is simply shorthand for an eighth of an ounce, or 3.5 grams, of weed.\u003cbr /\u003e\r\n\u003cem\u003ePhoto by: Gina Coleman/Weedmaps\u003c/em\u003e\u003c/p\u003e\r\n\u003c/div\u003e\r\n\r\n\u003cdiv class=\"wm-article-table-of-contents-header-container\"\u003e\r\n\u003ch2 class=\"wm-article-table-of-contents-header\" id=\"how-much-is-an-eighth-in-comparison-to-a-gram\"\u003eHow much is an eighth in comparison to a gram?\u003c/h2\u003e\r\n\r\n\u003cp\u003eGo to any dispensary and you\u0026#39;ll see rows and rows of jars of weed with an eighth in them. But how much is an eighth, exactly? As mentioned above, the term eighth refers to an eighth of an ounce or 3.5 grams. Those savvy with measurements (and Google) know that one-eighth of an ounce is actually 3.543603875 grams.\u0026nbsp;\u003c/p\u003e\r\n\r\n\u003cp\u003eIn more practical terms, an eighth of weed can provide you with three full-gram joints and one half-gram joint or seven smaller, half-gram joints. With an eighth of weed, you\u0026#39;ll be able to roll \u003ca href=\"https://weedmaps.com/learn/dictionary/blunt/\" rel=\"noopener noreferrer\" target=\"_blank\"\u003etwo to three blunts\u003c/a\u003e or a handful of spliffs. You can \u003ca href=\"https://weedmaps.com/learn/products-and-how-to-consume/make-canna-butter\" rel=\"noopener noreferrer\" target=\"_blank\"\u003emake a potent batch of cannabutter\u003c/a\u003e or pack at least half a dozen bowls. The weed math possibilities are practically endless.\u003c/p\u003e\r\n\r\n\u003cp\u003eWhether you\u0026#39;re \u003ca href=\"https://weedmaps.com/listings/in/united-states/california/los-angeles\" rel=\"noopener noreferrer\" target=\"_blank\"\u003eshopping in Los Angeles\u003c/a\u003e, \u003ca href=\"https://weedmaps.com/listings/in/united-states/colorado/denver\" rel=\"noopener noreferrer\" target=\"_blank\"\u003edowntown Denver\u003c/a\u003e, or \u003ca href=\"https://weedmaps.com/dispensaries/in/united-states/maine\" rel=\"noopener noreferrer\" target=\"_blank\"\u003ethe wilds of Maine\u003c/a\u003e the average price of an eighth of weed can range anywhere from $30 to $70. To find the most cost-effective weed for your needs, compare dispensary menus and shop around. Or, since you\u0026#39;re already here at Weedmaps, you can simply browse our sales page to \u003ca href=\"https://weedmaps.com/sale\" rel=\"noopener noreferrer\" target=\"_blank\"\u003efind deals in your area\u003c/a\u003e.\u0026nbsp;\u003c/p\u003e\r\n\r\n\u003cp\u003e\u003ca href=\"https://weedmaps.com/learn/introduction/how-to-use-weedmaps/\" rel=\"noopener noreferrer\" target=\"_blank\"\u003e\u003cstrong\u003e\u003cem\u003eRelated: How to use Weedmaps\u003c/em\u003e\u003c/strong\u003e\u003c/a\u003e\u003c/p\u003e\r\n\r\n\u003cp\u003eOn the topic of deals, have you ever seen or heard the term 5-gram eighth and wondered how dispensaries get away with rewriting the metric system? The good news is they\u0026#39;re not trying to gaslight you. They\u0026#39;re simply trying to give you extra weed. Five-gram eighths describe the price point for the amount of cannabis. For instance, a customer who selects a 5-gram eighth will receive 5 grams of cannabis for the price of that strain\u0026#39;s eighth. Any eighth that\u0026#39;s more than 3.5 grams is basically bonus weed.\u003c/p\u003e\r\n\r\n\u003cp\u003eFun fact: eighths are also known as a half-quarter or a slice. The more you know.\u0026nbsp;\u003c/p\u003e\r\n\u003cimg alt=\"\" src=\"https://weedmaps.com/learn/wp-content/uploads/2021/02/CRTV-3983_January-Learn_2-1.gif\" style=\"height:351px; width:624px\" /\u003e\r\n\u003cp\u003eA quarter of weed \u0026mdash; aka a quarter of an ounce of weed \u0026mdash; clocks in at 7 grams.\u003cbr /\u003e\r\n\u003cem\u003ePhoto by: Gina Coleman/Weedmaps\u003c/em\u003e\u003c/p\u003e\r\n\u003c/div\u003e\r\n\r\n\u003cdiv class=\"wm-article-table-of-contents-header-container\"\u003e\r\n\u003ch2 class=\"wm-article-table-of-contents-header\" id=\"retail-weights\"\u003eRetail weights\u003c/h2\u003e\r\n\r\n\u003cp\u003eOK, so an eighth of weed is the most standard weight cannabis consumers can expect to come across. But step behind the counter and you may find yourself dealing with much larger amounts of weed and a whole new set of terms.\u0026nbsp;\u003c/p\u003e\r\n\r\n\u003ch3\u003e\u003cstrong\u003eQuarter\u003c/strong\u003e\u003c/h3\u003e\r\n\r\n\u003cp\u003eA quarter of weed \u0026mdash; aka a quarter of an ounce of weed \u0026mdash; clocks in at 7 grams. To put that into perspective, a quarter-ounce of marijuana is enough for five to seven blunts and an arsenal of joints. Double that and you get a half-ounce, or 14 grams. This quantity is also referred to as a half or half O. With a half-ounce, you can roll seven to 14 blunts or enough joints to make you dizzy.\u0026nbsp;\u003c/p\u003e\r\n\r\n\u003ch3\u003e\u003cstrong\u003eOunce\u003c/strong\u003e\u003c/h3\u003e\r\n\r\n\u003cp\u003eAn ounce weighs in at 28 grams. That\u0026#39;s four quarters or eight eighths, hence the descriptors quarter and eighth. Colloquially, you may hear some refer to an ounce as a zip or an O. You\u0026#39;ll also see ounces show up in legislation describing possession limits \u0026mdash; aka how much weed you can possess at one time or purchase per month in a given state.\u003c/p\u003e\r\n\r\n\u003ch3\u003e\u003cstrong\u003eQuarter-pound\u003c/strong\u003e\u003c/h3\u003e\r\n\r\n\u003cp\u003eNo, we\u0026#39;re not talking burgers. A quarter-pound of weed is 113.4 grams. With 16 ounces in a pound, you can also think of a quarter-pound as four ounces. (Are you impressed with our math skills, yet?) And because stoners have a slang term for everything, quarter-pounds are often called QP for short.\u003c/p\u003e\r\n\r\n\u003ch3\u003e\u003cstrong\u003eHalf-pound\u003c/strong\u003e\u003c/h3\u003e\r\n\r\n\u003cp\u003eThe clue is certainly in the name with this weed weight. The next step up from the quarter-pound, a half-pound weighs in at 226.8 grams. A half-pound, or eight ounces of cannabis, is also known casually as a half-pack or half-pounder.\u003c/p\u003e\r\n\r\n\u003ch3\u003e\u003cstrong\u003ePound\u003c/strong\u003e\u003c/h3\u003e\r\n\r\n\u003cp\u003eThe rarest and most coveted weed weight of them all, one pound is equivalent to roughly 453 grams or 16 ounces. That\u0026#39;s enough weed to satisfy the typical cannabis consumer for a year \u0026mdash; and put a serious dent in their bank account. A pound of cannabis flower can cost as much as $3,000 and can be called a pack or an elbow.\u003c/p\u003e\r\n\u003c/div\u003e\r\n\r\n\u003cdiv class=\"wm-article-table-of-contents-header-container\"\u003e\r\n\u003ch2 class=\"wm-article-table-of-contents-header\" id=\"how-to-order-like-a-local\"\u003eHow to order like a local\u003c/h2\u003e\r\n\r\n\u003cp\u003eGrams may be the universal weed measurement, but how you refer to different cannabis weights may change based on your location. Unsurprisingly, countries all over the world use different slang terms to refer to marijuana as well. So, if you want to shop like a local, it\u0026#39;s best to talk like one, too.\u0026nbsp;\u003c/p\u003e\r\n\r\n\u003cp\u003eDepending on the age of the consumer, North Americans refer to cannabis as flower, weed, pot, reefer, marijuana, Mary Jane, and a host of other words \u0026mdash; not to mention \u003ca href=\"https://weedmaps.com/strains\" rel=\"noopener noreferrer\" target=\"_blank\"\u003estrain names\u003c/a\u003e. \u003ca href=\"https://weedmaps.com/learn/laws-and-regulations/australia/\" rel=\"noopener noreferrer\" target=\"_blank\"\u003eAustralians use slang terms\u003c/a\u003e like hooch and choof, while \u003ca href=\"https://weedmaps.com/learn/laws-and-regulations/jamaica/\" rel=\"noopener noreferrer\" target=\"_blank\"\u003ecannabis enthusiasts in Jamaica\u003c/a\u003e say dagga. And while you\u0026#39;re doing some research on ordering like a local in your vacation destination, be sure to check up on the \u003ca href=\"https://weedmaps.com/learn/laws-and-regulations/\" rel=\"noopener noreferrer\" target=\"_blank\"\u003elaws and regulations\u003c/a\u003e before you go.\u003c/p\u003e\r\n\u003cimg alt=\"How much is an eighth of weed?\" src=\"https://weedmaps.com/learn/wp-content/uploads/2020/09/CRTV-3983_January-Learn1447_16x9-768x432.jpg\" style=\"height:351px; width:624px\" title=\"Click to see a larger version of the image\" /\u003e\r\n\u003cp\u003e3.5 grams of weed next to 3.5 grams of popcorn for scale.\u0026nbsp;\u003c/p\u003e\r\nPhoto by: Gina Coleman/Weedmaps\u003c/div\u003e\r\n\r\n\u003cdiv class=\"wm-article-table-of-contents-header-container\"\u003e\r\n\u003ch2 class=\"wm-article-table-of-contents-header\" id=\"faq\"\u003eFAQ\u003c/h2\u003e\r\n\r\n\u003ch3\u003e\u003cstrong\u003eHow many bowls can I get with 1 gram?\u003c/strong\u003e\u003c/h3\u003e\r\n\r\n\u003cp\u003eHow many bowls you can get from a gram of cannabis depends more on the size of the bowl you\u0026#39;re smoking out of than the weed itself. On average, one gram of cannabis will pack two to three average-size bowls. If you figure out how to stretch 1 gram beyond three bowls, please let us know how you did it.\u003c/p\u003e\r\n\r\n\u003ch3\u003e\u003cstrong\u003eHow many grams is the average bowl?\u003c/strong\u003e\u003c/h3\u003e\r\n\r\n\u003cp\u003eAgain, glass bowls vary widely in size, but the average bowl holds 0.3 to 0.5 grams of cannabis.\u003c/p\u003e\r\n\r\n\u003ch3\u003e\u003cstrong\u003eHow many bowls are in an eighth of weed?\u003c/strong\u003e\u003c/h3\u003e\r\n\r\n\u003cp\u003eSimple math shows you can get seven half-gram bowls out of an eighth of cannabis. The smaller the bowl, the more bowls you\u0026#39;ll get out of an eighth of weed.\u0026nbsp;\u003c/p\u003e\r\n\r\n\u003ch3\u003e\u003cstrong\u003eHow many bowls are in an ounce?\u003c/strong\u003e\u003c/h3\u003e\r\n\r\n\u003cp\u003eAn ounce is roughly 28 grams, which means you\u0026#39;ll get 56 half-gram bowls out of an ounce of weed. And that\u0026#39;s if you pack those bowls to the brim.\u0026nbsp;\u003c/p\u003e\r\n\r\n\u003ch3\u003e\u003cstrong\u003eHow many hits are in a bowl?\u003c/strong\u003e\u003c/h3\u003e\r\n\r\n\u003cp\u003eHow many hits you can expect to get out of a fresh bowl depends entirely on the size of the hit you take. Everyone inhales differently, so a bowl can last anywhere from three to eight hits depending on the size of the bowl and how much you and/or those in \u003ca href=\"https://weedmaps.com/learn/dictionary/session/\" rel=\"noopener noreferrer\" target=\"_blank\"\u003eyour sesh\u003c/a\u003e inhale.\u003c/p\u003e\r\n\r\n\u003ch3\u003e\u003cstrong\u003eWhat\u0026#39;s a 10 sack?\u003c/strong\u003e\u003c/h3\u003e\r\n\r\n\u003cp\u003eA 10 sack refers to a bag of weed that costs $10. It usually amounts to about a bowl\u0026#39;s worth of weed or enough for one joint.\u0026nbsp;\u003c/p\u003e\r\n\r\n\u003ch3\u003e\u003cstrong\u003eHow much is a dub?\u003c/strong\u003e\u003c/h3\u003e\r\n\r\n\u003cp\u003eDub is a term that refers to a 20 sack of weed. On the unlicensed market, a dub costs $20 and usually contains between 1 and 2 grams of weed, sometimes more depending on where you get it. We recommend you \u003ca href=\"https://weedmaps.com/dispensaries/in/united-states\" rel=\"noopener noreferrer\" target=\"_blank\"\u003eshop from licensed retailers for better deals\u003c/a\u003e and better weed.\u0026nbsp;\u003c/p\u003e\r\n\r\n\u003ch3\u003e\u003cstrong\u003eWhat is the usual amount for a 25 sack?\u003c/strong\u003e\u003c/h3\u003e\r\n\r\n\u003cp\u003eA 25 sack on the unlicensed market could contain 2.5 to 3.5 grams, or roughly an eighth of weed. But again, we recommend shopping from licensed retailers to know for sure what you\u0026#39;re getting for your money.\u0026nbsp;\u0026nbsp;\u003c/p\u003e\r\n\r\n\u003ch3\u003e\u003cstrong\u003eHow long does a quarter ounce typically last?\u003c/strong\u003e\u003c/h3\u003e\r\n\r\n\u003cp\u003eHow long a quarter ounce of cannabis will last depends largely on the frequency and method of consumption you choose. A quarter ounce of weed, also known as a quarter, is 7 grams. That could mean one large joint per day for a week, enough cannabutter to see you through the month, or just enough weed to get you through the workday depending on your tolerance and job description.\u003c/p\u003e\r\n\r\n\u003ch3\u003e\u003cstrong\u003eHow do people around the world weigh weed?\u003c/strong\u003e\u003c/h3\u003e\r\n\r\n\u003cp\u003eEvery country except Myanmar, Liberia, and the United States has adopted the metric system, more formally known as the International System of Units. Despite some countries being reluctant to get with the program, cannabis is typically measured in grams no matter where you go.\u003c/p\u003e\r\n\u003c/div\u003e\r\n\u003c/div\u003e\r\n\r\n\u003cdiv class=\"wm-article-meta\"\u003e\r\n\u003cp class=\"wm-article-contributor\"\u003eReviewed by \u003ca href=\"https://weedmaps.com/learn/subject-matter-expert/lnickus\"\u003eLesley Nickus\u003c/a\u003e on\u0026nbsp;3/10/21\u003c/p\u003e\r\n\u003c/div\u003e\r\n\r\n\u003cp\u003e\u003cstrong\u003e\u0026#547462301479416; \u003c/strong\u003e\u003ca href=\"https://elplanteo.com/cuantos-gramos-tiene-una-onza-conversiones-marihuana-utiles/\"\u003eMarihuana: Cuántos Gramos Tiene una Onza y Otras Conversiones Cannábicas Útiles\u003c/a\u003e\u003c/p\u003e\r\n","url":"https://www.benzinga.com/markets/cannabis/21/05/16412908/how-many-grams-are-in-an-eighth-of-weed","image":[{"size":"thumb","url":"https://cdn.benzinga.com/files/imagecache/250x187xUP/images/story/2012/screen_shot_2020-06-28_at_13.53.00.png"},{"size":"small","url":"https://cdn.benzinga.com/files/imagecache/1024x768xUP/images/story/2012/screen_shot_2020-06-28_at_13.53.00.png"},{"size":"large","url":"https://cdn.benzinga.com/files/imagecache/2048x1536xUP/images/story/2012/screen_shot_2020-06-28_at_13.53.00.png"}],"channels":[{"name":"Cannabis"},{"name":"Markets"},{"name":"General"}],"stocks":[],"tags":[{"name":"grams"},{"name":"ICYMI"},{"name":"ounce"}]},{"id":42148169,"author":"Franca Quarneti","created":"Fri, 22 Nov 2024 17:22:43 -0400","updated":"Fri, 22 Nov 2024 17:22:43 -0400","title":"Formula 1 Drivers React To Cannabis Smell At Las Vegas Grand Prix: 'Everyone Would Test Positive'","teaser":"Formula 1 drivers, including Franco Colapinto, joke about the strong cannabis scent lingering around the circuit at the Las Vegas Grand Prix.","body":"\u003cp\u003eThe Las Vegas Grand Prix kicked off with an unexpected twist this week at \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/04/38181178/exclusive-fifteen-new-f1-hybrid-cannabis-strains-to-hit-shelves-in-us-for-420-under-new-partners\"\u003eFormula 1\u003c/a\u003e. During the second free practice session, it wasn't the usual track talk about lap times or track conditions being discussed by the drivers. Instead, they were commenting on the pervasive cannabis aroma filling the air around the circuit.\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eSee Also: \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/10/41403643/cannabis-can-be-a-great-tool-in-dealing-with-adversity-says-former-nfl-star-ricky-williams\"\u003eCannabis Can Be A \u0026#8216;Great Tool In Dealing With Adversity,\u0026#8217; Says Former NFL Star Ricky Williams\u003c/a\u003e\u003c/strong\u003e\u003c/p\u003e\n\n\n\n\u003cp\u003eThe first to bring it up was young Argentine driver \u003cstrong\u003e Colapinto\u003c/strong\u003e. After his media interview following practice, he made a candid observation that quickly went viral.\u003c/p\u003e\n\n\n\n\u003cp\u003e\"Yes, there was a smell of weed. If they do a doping test on the drivers now, I think everyone would test positive, I swear,\" Colapinto joked. \u003c/p\u003e\n\n\n\n\u003cp\u003e\"When we all test positive, it'll be a mess,\" the 21-year-old William\u0026#8217;s driver said in a playful tone.\u003c/p\u003e\n\n\n\n\u003cfigure class=\"wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio\"\u003e\u003cdiv class=\"wp-block-embed__wrapper\"\u003e\n\u003ciframe loading=\"lazy\" title=\"Insólito comentario de Colapinto: \u0026quot;Sí, había olor a porro\u0026quot; \u0026#x7C; Cadena 3 Argentina\" width=\"500\" height=\"281\" src=\"https://www.youtube.com/embed/Gta2uN9RYpg?feature=oembed\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share\" referrerpolicy=\"strict-origin-when-cross-origin\" allowfullscreen\u003e\u003c/iframe\u003e\n\u003c/div\u003e\u003c/figure\u003e\n\n\n\n\u003cp\u003eColapinto wasn't alone in noticing the cannabis scent. Red Bull's \u003cstrong\u003eSergio \u0026#8220;Checo\u0026#8221; Pérez\u003c/strong\u003e also weighed in, concerned about the track conditions: \u0026#8220;Practice 1 was a total disaster, the track was very dirty.\u0026#8221;\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003ca href=\"https://www.infobae.com/deportes/2024/11/22/habia-olor-a-porro-la-desopilante-revelacion-de-franco-colapinto-tras-sus-primeras-vueltas-en-el-gran-premio-de-las-vegas/\"\u003eAccording \u003c/a\u003eto Infobae, he quickly added: \"What's really noticeable around the whole circuit is the smell of marijuana all night long. I'm a little tired of it, the amount of odor is unbelievable. It's something that all the drivers will surely talk about.\"\u003c/p\u003e\n\n\n\n\u003ch3 class=\"wp-block-heading\"\u003eCannabis In Las Vegas: What You Need to Know\u003c/h3\u003e\n\n\n\n\u003cp\u003eSince recreational cannabis became legal in Nevada in 2017, adults 21 and over can legally possess up to 2.5 ounces of cannabis flower or 0.25 ounces of THC concentrate, including edibles. \u003c/p\u003e\n\n\n\n\u003cp\u003eHowever, while cannabis use is widespread in the city, public consumption remains off-limits. Smoking or using cannabis in public places is prohibited, with consumption confined to private residences or licensed lounges.\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eRead Next: \u003c/strong\u003e\u003c/p\u003e\n\n\n\n\u003cul\u003e\n\u003cli\u003e\u003ca href=\"https://www.benzinga.com/markets/cannabis/24/08/40558915/will-cannabis-be-a-game-changer-for-athletes-nfls-1m-study-suggests-it-could\"\u003eWill Cannabis Be A Game-Changer For Athletes? NFL\u0026#8217;s $1M Study Suggests It Could\u003c/a\u003e\u003c/li\u003e\n\u003c/ul\u003e\n\n\n\n\u003cp\u003e\u003cem\u003eImage created using photos from Shutterstock and Unsplash.\u003c/em\u003e\u003c/p\u003e","url":"https://www.benzinga.com/24/11/42148169/formula-1-drivers-react-to-cannabis-smell-at-las-vegas-grand-prix-everyone-would-test-positive","image":[{"size":"thumb","url":"https://cdn.benzinga.com/files/imagecache/250x187xUP/images/story/2024/11/22/Shutterstock-2542649645-1.jpeg"},{"size":"small","url":"https://cdn.benzinga.com/files/imagecache/1024x768xUP/images/story/2024/11/22/Shutterstock-2542649645-1.jpeg"},{"size":"large","url":"https://cdn.benzinga.com/files/imagecache/2048x1536xUP/images/story/2024/11/22/Shutterstock-2542649645-1.jpeg"}],"channels":[{"name":"Cannabis"},{"name":"News"},{"name":"Sports"},{"name":"Markets"},{"name":"General"}],"stocks":[],"tags":[{"name":"F1"},{"name":"Formula 1"},{"name":"Franco Colapinto"},{"name":"Las Vegas"},{"name":"Las Vegas Grand Prix"},{"name":"Red Bull Racing"},{"name":"Sergio"},{"name":"sports and cannabis"},{"name":"Williams Racing"}]},{"id":42118372,"author":"Jelena Martinovic","created":"Thu, 21 Nov 2024 13:01:06 -0400","updated":"Thu, 21 Nov 2024 13:01:06 -0400","title":"NASDAQ-Traded Cannabis Co. Agrify Secures $25.9M Via Private Placement, Here's How They'll Spend It","teaser":"Agrify Corporation (NASDAQ: AGFY) announced on Thursday a $25.9 million non-brokered private placement.The company said it has entered into securities purchase agreements with institutional and accredited investors in a non-brokered private placement priced at $22.30 per share.The placement is set to close on Thursday, Nov. 21, subject to customary closing conditions.","body":"\u003cp\u003e\u003cstrong\u003eAgrify Corporation\u003c/strong\u003e (NASDAQ:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/AGFY#NASDAQ\"\u003eAGFY\u003c/a\u003e) announced Thursday that is has secured a $25.9 million non-brokered private placement.\u003c/p\u003e\n\n\n\n\u003ch3 class=\"wp-block-heading\"\u003eWhat Happened\u003c/h3\u003e\n\n\n\n\u003cp\u003eThe company said it has entered into securities purchase agreements with institutional and accredited investors in a non-brokered private placement priced at $22.30 per share.\u003c/p\u003e\n\n\n\n\u003cp\u003eThe placement is set to close on Thursday, Nov. 21, subject to customary closing conditions.\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eBenjamin Kovler, \u003c/strong\u003echairman and interim CEO, participated in the private placement to purchase 10,000 shares of common stock at $38.76.\u003c/p\u003e\n\n\n\n\u003cp\u003eThe news comes on the heels of the company's board of directors having \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/11/41760263/marijuana-growing-solution-provider-agrify-gets-20m-boost-from-green-thumb-to-power-up-cannabis-\"\u003eapproved\u003c/a\u003e a $20 million convertible secured note. Of that sum $10 million will be drawn upon at closing, from a wholly-owned subsidiary of Green Thumb Industries Inc., Agrify said in a press release.\u003c/p\u003e\n\n\n\n\u003cp\u003eBefore this, the Green Thumb subsidiary acquired an ownership stake in Agrify through the purchase of common stock and warrants from its outgoing chairman and CEO \u003cstrong\u003eRaymond Chang \u003c/strong\u003eand outgoing director\u003cstrong\u003e I-Tseng Jenny Chan.\u003c/strong\u003e\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eRead Also: \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/05/38876948/cannabis-cultivation-solutions-provider-agrify-and-californias-natures-miracle-sign-definitive-m\"\u003eCannabis Cultivation Solutions Provider Agrify And California\u0026#8217;s Nature\u0026#8217;s Miracle Sign Definitive Merger Deal\u003c/a\u003e\u003c/strong\u003e\u003c/p\u003e\n\n\n\n\u003ch3 class=\"wp-block-heading\"\u003eWhy It Matters\u003c/h3\u003e\n\n\n\n\u003cp\u003eAgrify plans to use the proceeds from the private placement for general corporate purposes, including, among other things, working capital and business development. It intends to allocate capital to opportunities in the cannabis and hemp industries.\u003c/p\u003e\n\n\n\n\u003cp\u003e\"This funding is a strong move for Agrify and our shareholders as we were able to raise approximately $26 million in a non-brokered deal (gross equals net),\" Kovler said. \"We plan to allocate this capital into opportunities within our circle of competence to benefit stockholders. We are excited about the opportunity set and current consumer trends in cannabis and hemp. The team continues to work hard to close the previously announced Señorita transaction, and it remains on track for closing at or around year-end.\"\u003c/p\u003e\n\n\n\n\u003cp\u003eAgrify reported its third quarter 2024 financial results on Nov. 14, revealing a $1.9 million revenue, down from $3.1 million a year ago. The company posted a net loss of $18.6 million, largely driven by a $15 million change in the \u003ca href=\"https://www.benzinga.com/news/earnings/24/11/41998220/agrifys-q3-revenue-drop-18-6m-loss-amid-new-leadership\"\u003efair value of warrant liabilities.\u003c/a\u003e\u003c/p\u003e\n\n\n\n\u003ch3 class=\"wp-block-heading\"\u003eAGFY Price Action\u003c/h3\u003e\n\n\n\n\u003cp\u003eAgrify's shares traded 25.15% lower at $29.01 per share at the time of writing on Thursday.\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eRead Next:\u003c/strong\u003e\u003c/p\u003e\n\n\n\n\u003cul\u003e\n\u003cli\u003e\u003ca href=\"https://www.benzinga.com/markets/cannabis/24/06/39271387/cannabis-cultivation-solutions-provider-agrify-announces-500k-turnkey-extraction-equipment-deal-\"\u003e\u003cstrong\u003eCannabis Cultivation Solutions Provider Agrify Announces $500K Turnkey Extraction Equipment Deal With This NJ Co.\u003c/strong\u003e\u003c/a\u003e\u003c/li\u003e\n\u003c/ul\u003e","url":"https://www.benzinga.com/24/11/42118372/nasdaq-traded-cannabis-co-agrify-secures-259m-through-non-brokered-private-placement-ceo-reveals-where-money-would-go","image":[{"size":"thumb","url":"https://cdn.benzinga.com/files/imagecache/250x187xUP/images/story/2024/11/21/vitaly-taranov-OCrPJce6GPk-unsplash2.jpeg"},{"size":"small","url":"https://cdn.benzinga.com/files/imagecache/1024x768xUP/images/story/2024/11/21/vitaly-taranov-OCrPJce6GPk-unsplash2.jpeg"},{"size":"large","url":"https://cdn.benzinga.com/files/imagecache/2048x1536xUP/images/story/2024/11/21/vitaly-taranov-OCrPJce6GPk-unsplash2.jpeg"}],"channels":[{"name":"Cannabis"},{"name":"News"},{"name":"Financing"}],"stocks":[{"name":"AGFY"}],"tags":[{"name":"Benjamin Kovler"},{"name":"Cannabis financing"},{"name":"cannabis private placement"},{"name":"I-Tseng Jenny Chan"},{"name":"Raymond Chang"}]},{"id":41910180,"author":"Javier Hasse","created":"Tue, 12 Nov 2024 16:16:57 -0400","updated":"Wed, 13 Nov 2024 16:50:20 -0400","title":"EXCLUSIVE: Chris Christie Says Trump Will Remove Federal Restrictions On Marijuana, Find 'Sweet Spot' For Crypto Regulation (UPDATED)","teaser":"Chris Christie sees Trump descheduling cannabis and easing crypto regulation. Here\u0026#39;s what it could mean for investors and business owners alike.","body":"\u003cp\u003e\u003cem\u003eEditor\u0026#8217;s note: This story has been updated to more accurately report a quote from Chris Christie that states he is not in favor of cannabis descheduling.\u003c/em\u003e\u003c/p\u003e\n\n\n\n\u003cp\u003e\"The U.S. government has got to get its act together and decide what it really thinks on this issue,\" says \u003cstrong\u003e\u003ca href=\"https://www.benzinga.com/topic/chris-christie\"\u003eChris Christie\u003c/a\u003e,\u003c/strong\u003e former New Jersey governor and longtime conservative voice, addressing the state of cannabis in America under a new Trump administration. \u003c/p\u003e\n\n\n\n\u003cp\u003eIn an exclusive conversation with \u003ca href=\"https://www.benzinga.com/cannabis\"\u003eBenzinga Cannabis\u003c/a\u003e facilitated by \u003ca href=\"https://www.covers.com/politics/us-election-betting-odds\"\u003eCovers.com\u003c/a\u003e, Christie outlines his perspectives on the future of cannabis regulation and cryptocurrency adoption, framing both within a broader trend of deregulation he expects to see under Trump's leadership. As the country moves forward, Christie believes cannabis and crypto are poised to experience significant changes though each industry will need to navigate its own unique challenges.\u003c/p\u003e\n\n\n\n\u003ch2 class=\"wp-block-heading\"\u003e\u003cstrong\u003eChristie On Cannabis: \u0026#8216;Trump Will Attempt To Deschedule\u0026#8217;\u003c/strong\u003e\u003c/h2\u003e\n\n\n\n\u003cp\u003eChristie begins by tackling the complexities surrounding cannabis regulation, a topic he's been openly conservative about throughout his political career. Although he's traditionally opposed to federal legalization, Christie notes a potential shift under President-elect \u003cstrong\u003e\u003ca href=\"https://www.benzinga.com/topic/donald-trump\"\u003eDonald Trump\u003c/a\u003e\u003c/strong\u003e. \"What I suspect he would really like to do is get it downgraded by the DEA so that it\u0026#8217;s not illegal,\" Christie says. Cannabis remains a Schedule I substance, making it federally illegal despite a growing wave of state-level legalization. For Christie, the legal status presents an obstacle for the industry, particularly regarding banking and financial services. \"The trouble the cannabis industry has now is that a lot of people still won't do business with them, because the proceeds are tainted by the fact they are created through a drug that is illegal in the United States.\"\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003e\u003cem\u003eSee also: \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/11/41828359/could-trumps-go-wild-on-health-invite-to-rfk-jr-drive-changes-for-cannabis-and-psychedelics\"\u003eCould Trump\u0026#8217;s \u0026#8216;Go Wild On Health\u0026#8217; Invite To RFK Jr. Drive Changes For Cannabis And Psychedelics?\u003c/a\u003e\u003c/em\u003e\u003c/strong\u003e\u003c/p\u003e\n\n\n\n\u003cp\u003eChristie suggests that descheduling cannabis—removing it from the DEA's list of controlled substances—could provide a workable solution. By changing its classification, he believes, the federal government could make way for legitimate business operations without directly endorsing legalization. \"What I think Trump will attempt to do, which I don't favor, is change marijuana to a non-scheduled drug that wouldn\u0026#8217;t be illegal, and then banks and other institutions would be more free to do business with cannabis store owners and entrepreneurs,\" he says. This stance marks a shift in Christie's approach, where he appears to reconcile his conservative views on cannabis with a pragmatic view of the industry's needs.\u003c/p\u003e\n\n\n\n\u003ch2 class=\"wp-block-heading\"\u003e\u003cstrong\u003eChristie On Crypto: Finding A \u0026#8216;Sweet Spot\u0026#8217;\u003c/strong\u003e\u003c/h2\u003e\n\n\n\n\u003cp\u003eBeyond cannabis, Christie also weighs in on another hot-button topic: cryptocurrency. Known for its volatility and potential for high returns, crypto has seen a significant uptick in adoption over recent years. With Trump heading to the White House, Christie predicts a favorable environment for crypto's continued expansion. \"I think it will develop because he\u0026#8217;ll not be in favor of doing a lot of regulating on it,\" he says, suggesting that Trump's general stance on deregulation could encourage further growth in the crypto sector.\u003c/p\u003e\n\n\n\n\u003cp\u003eHowever, Christie is quick to add a note of caution. \"He\u0026#8217;s got to be careful because when real people start to lose their money, and if that were to happen with crypto, they\u0026#8217;re going to want the government to step in.\" For Christie, the challenge lies in striking a balance between fostering innovation and protecting the public. He stresses what he calls the \"sweet spot\" where regulation is minimal enough to allow growth, yet sufficient to shield investors from potential losses. \"He\u0026#8217;s got to try to find a sweet spot where he can regulate it enough so that grandma is not getting ripped off, but not so much that he puts a cap on its ability to grow and be a driver of America\u0026#8217;s economy.\"\u003c/p\u003e\n\n\n\n\u003ch2 class=\"wp-block-heading\"\u003e\u003cstrong\u003eAre Christie\u0026#8217;s Evolving Views A Reflection Of GOP\u0026#8217;s Evolution?\u003c/strong\u003e\u003c/h2\u003e\n\n\n\n\u003cp\u003eChristie's pragmatic approach to cannabis and cryptocurrency reflects a broader trend within the GOP: a preference for state-led decision-making combined with cautious federal oversight. On cannabis, he continues to support a state-by-state approach, emphasizing that each state should have the freedom to regulate or prohibit cannabis as it sees fit. \"The decision should be left to each individual state on cannabis regulation.\" This perspective aligns with Christie's conservative stance, although he acknowledges that a federal descheduling effort might make life easier for the industry.\u003c/p\u003e\n\n\n\n\u003cp\u003eWith the potential \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/11/41828359/could-trumps-go-wild-on-health-invite-to-rfk-jr-drive-changes-for-cannabis-and-psychedelics\"\u003eappointment of figures like RFK Jr. to key health positions\u003c/a\u003e under a Trump administration, the regulatory landscape for both cannabis and crypto could evolve rapidly over the next four years. As Christie sees it, the approach Trump takes will shape not only the cannabis and crypto markets but also public sentiment and investor confidence. His vision, rooted in deregulation with a careful dose of oversight, aims to balance the drive for innovation with a commitment to public safety—a delicate act in today's rapidly shifting political and economic landscape.\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cem\u003ePhoto via Shutterstock\u003c/em\u003e\u003c/p\u003e","url":"https://www.benzinga.com/markets/cannabis/24/11/41910180/exclusive-chris-christie-says-trump-will-remove-federal-restrictions-on-marijuana-find-sweet-spot-for-crypto-regulation","image":[{"size":"thumb","url":"https://cdn.benzinga.com/files/imagecache/250x187xUP/images/story/2024/11/13/Washington-Township--Nj---November-15--2.jpeg"},{"size":"small","url":"https://cdn.benzinga.com/files/imagecache/1024x768xUP/images/story/2024/11/13/Washington-Township--Nj---November-15--2.jpeg"},{"size":"large","url":"https://cdn.benzinga.com/files/imagecache/2048x1536xUP/images/story/2024/11/13/Washington-Township--Nj---November-15--2.jpeg"}],"channels":[{"name":"Cannabis"},{"name":"Cryptocurrency"},{"name":"News"},{"name":"Politics"},{"name":"Top Stories"},{"name":"Exclusives"},{"name":"Interview"}],"stocks":[],"tags":[{"name":"cannabis descheduling"},{"name":"Chris Christie"},{"name":"Donald Trump"}]},{"id":39069357,"author":"Abbey Higginbotham","created":"Wed, 29 May 2024 12:47:41 -0400","updated":"Wed, 29 May 2024 12:47:41 -0400","title":"Cannabis Now Surpasses Alcohol: 'This Trend Will Continue for Decades,' Says Expert","teaser":"Cannabis consumption has surpassed daily alcohol use for the first time in the US, with 17.7M daily users. Experts predict impact on market and call for diverse product offerings.","body":"\u003cp\u003eFor the first time in U.S. history, the number of people \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/05/38976556/daily-cannabis-consumption-outpaces-daily-alcohol-use-in-the-us-for-the-first-time-new-study-sho\"\u003econsuming cannabis daily or almost daily\u003c/a\u003e has overtaken those who drink alcohol with the same frequency, according to a new study published in the journal \u003cstrong\u003eSociety for the Study of Addiction.\u003c/strong\u003e \u003c/p\u003e\n\n\n\n\u003cp\u003eThis landmark shift has substantial implications for the cannabis market, as detailed by a few industry experts who will be speaking at the fall \u003cstrong\u003e\u003ca href=\"https://www.benzinga.com/events/cannabis-conference/\"\u003eBenzinga Cannabis Capital Conference\u003c/a\u003e\u003c/strong\u003e in Chicago this October.\u003c/p\u003e\n\n\n\n\u003ch1 class=\"wp-block-heading\"\u003e\u003cstrong\u003eCannabis Consumption On The Rise\u003c/strong\u003e\u003c/h1\u003e\n\n\n\n\u003cp\u003eThe study highlights a dramatic increase in cannabis use over the past three decades. Since 1992, the per capita rate of daily cannabis consumption in the U.S. has surged nearly fifteenfold. \u003c/p\u003e\n\n\n\n\u003cp\u003eBy 2022, approximately 17.7 million people reported using marijuana daily or near-daily, compared to 14.7 million who reported the same frequency for alcohol use. This data was derived from the \u003cstrong\u003eNational Survey on Drug Use and Health\u003c/strong\u003e, a federally funded survey considered a reliable source for self-reported substance use statistics in the country.\u003c/p\u003e\n\n\n\n\u003ch1 class=\"wp-block-heading\"\u003e\u003cstrong\u003eIndustry Experts On Market Impact\u003c/strong\u003e\u003c/h1\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eAaron Grey\u003c/strong\u003e, managing director at \u003cstrong\u003eAlliance Global Partners\u003c/strong\u003e, emphasized the importance of this trend among younger adults. \u003c/p\u003e\n\n\n\n\u003cp\u003e\"Our bigger takeaway is that the shift to cannabis [from alcohol] is greater for young adults — implying that this trend will continue for decades to come as younger adults age and continue their legacy consumption habits,\" Grey said. \u003c/p\u003e\n\n\n\n\u003cp\u003e\"We believe large CPG operators in categories struggling for volume growth will turn to cannabis once federally permissible, in our view, as we have already seen in Canada — leaving operators with the ability to succeed in the market today well-positioned not only for institutional investors but also for strategic investments/acquisitions from these large CPG companies.\"\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eJesse Redmond\u003c/strong\u003e, head of cannabis at \u003cstrong\u003eWater Tower Research\u003c/strong\u003e, pointed out that a small percentage of consumers drive the majority of cannabis sales.\u003c/p\u003e\n\n\n\n\u003cp\u003e\"The Pareto principle states that 80% of consequences come from 20% of actions. I've found in the cannabis industry that 10% of consumers use 90% of the cannabis — it is the daily consumer who drives revenue. The high amount of daily consumption should expand this ‘apex cannabis consumer' segment and drive more revenue for cannabis companies. Businesses should design loyalty programs that reward regular users.\"\u003c/p\u003e\n\n\n\n\u003ch1 class=\"wp-block-heading\"\u003e\u003cstrong\u003eConsumer Preferences and Business Strategies\u003c/strong\u003e\u003c/h1\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eJamie Pearson\u003c/strong\u003e, president of \u003cstrong\u003eNew Holland Group\u003c/strong\u003e, shared her perspective on the impact. \u003c/p\u003e\n\n\n\n\u003cp\u003e\"We will see more money and M\u0026amp;A activity enter the industry from the alcohol sector as they hedge lost market share. I predict we will also see more CPG companies looking for access points to the industry,\u0026#8221; said Pearson. \u003c/p\u003e\n\n\n\n\u003cp\u003e\u0026#8220;The most critical will be to focus on the growth of profitability rather than just growth for growth's sake. The more people use cannabis and grow accustomed to having it in their neighborhoods, the less powerful the stigma becomes. I expect legislation and reform efforts to continue as public knowledge and support grows.\"\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eLaurie Parfitt\u003c/strong\u003e, founder and CEO of \u003cstrong\u003eLKP Impact Consulting\u003c/strong\u003e, believed the surge in daily cannabis use will lead to increased demand for diverse product offerings. \u003c/p\u003e\n\n\n\n\u003cp\u003e\"The shift towards increased daily cannabis use is likely to have an impact on the cannabis market. First and foremost, we can expect a surge in demand across various product categories, particularly in consumables such as edibles and vapes, which tend to be popular for their ease of use and discretion. This uptick in daily usage could lead to greater retail sales and potentially higher profits for cannabis businesses.\"\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eJoseph Lustberg\u003c/strong\u003e, CEO of\u003cstrong\u003e Upwise Capital,\u003c/strong\u003e expects higher daily use to push for more lenient regulations and broader legalization efforts. He emphasized the need for product innovation and robust marketing strategies to capitalize on this trend. \u003c/p\u003e\n\n\n\n\u003cp\u003e\"To capitalize on this trend, businesses should focus on product innovation and quality. Creating unique, high-quality products that cater to various consumer preferences can set a brand apart. Additionally, investing in robust marketing strategies and consumer education will be crucial to attract and retain customers.\"\u003c/p\u003e\n\n\n\n\u003ch1 class=\"wp-block-heading\"\u003e\u003cstrong\u003eRegulatory and Public Perception Shifts\u003c/strong\u003e\u003c/h1\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eWill Bowden\u003c/strong\u003e, founder and CEO of \u003cstrong\u003eGrasshopper Farms\u003c/strong\u003e, saw this shift as an opportunity to enhance education and transparency in the industry. \u003c/p\u003e\n\n\n\n\u003cp\u003e\"This is an exciting time in which demand is literally creating job and business opportunities. This is also an excellent time to appreciate the amount of medicinal use and relief being provided, perhaps more directly. We really need to start helping each other with business plans, real SOPs, and market analysis. There is plenty of business for all who want to run a viable business.\"\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003e\u003cstrong\u003eDan Ahrens\u003c/strong\u003e\u003c/strong\u003e, portfolio manager of \u003cstrong\u003eAdvisorShares\u003c/strong\u003e, noted the increasing acceptance and use of cannabis reflect a broader cultural shift. \u003c/p\u003e\n\n\n\n\u003cp\u003e\"We're not surprised by the increase in cannabis use; we think this is a trend that will continue in the U.S. as more states allow for regulated, safe access to legal cannabis. Nearly 75% of Americans live in a state where marijuana is legal for either recreational or medical use, and we see that number as only growing larger. The more people learn about cannabis as a relatively safe alternative to alcohol or other substances, we expect greater normalization and increased use.\"\u003c/p\u003e\n\n\n\n\u003cp\u003eAs daily cannabis consumption becomes more prevalent, the industry must adapt to changing consumer behaviors and regulatory landscapes, positioning itself for continued growth and acceptance. The insights from these experts at the upcoming \u003cstrong\u003e\u003ca href=\"https://www.benzinga.com/events/cannabis-conference/\"\u003eBenzinga Cannabis Capital Conference\u003c/a\u003e\u003c/strong\u003e in Chicago will be crucial for businesses managing this evolving market.\u003c/p\u003e\n\n\n\n\u003chr class=\"wp-block-separator has-alpha-channel-opacity\"/\u003e\n\n\n\n\u003cp\u003e\u003cem\u003eCannabis rescheduling seems to be right around the corner. Want to understand what this means for the future of the industry? Hear directly for top executives, investors and policymakers at the \u003cstrong\u003e19th Benzinga Cannabis Capital Conference,\u003c/strong\u003e coming to Chicago this Oct. 8-9. \u003ca href=\"https://www.eventbrite.com/e/benzinga-capital-conference-cannabis-fall-2024-tickets-858948065787?aff=oddtdtcreator\" target=\"_blank\" rel=\"noreferrer noopener\"\u003eGet your tickets now\u003c/a\u003e before prices surge by following \u003ca href=\"https://www.eventbrite.com/e/benzinga-capital-conference-cannabis-fall-2024-tickets-858948065787?aff=oddtdtcreator\" target=\"_blank\" rel=\"noreferrer noopener\"\u003ethis link\u003c/a\u003e.\u003c/em\u003e\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cem\u003ePhoto: Benzinga\u003c/em\u003e\u003c/p\u003e","url":"https://www.benzinga.com/markets/cannabis/24/05/39069357/cannabis-now-surpasses-alcohol-this-trend-will-continue-for-decades-says-expert","image":[{"size":"thumb","url":"https://cdn.benzinga.com/files/imagecache/250x187xUP/images/story/2024/05/29/Alcohol-Cannabis.png"},{"size":"small","url":"https://cdn.benzinga.com/files/imagecache/1024x768xUP/images/story/2024/05/29/Alcohol-Cannabis.png"},{"size":"large","url":"https://cdn.benzinga.com/files/imagecache/2048x1536xUP/images/story/2024/05/29/Alcohol-Cannabis.png"}],"channels":[{"name":"Cannabis"},{"name":"Events"},{"name":"Exclusives"},{"name":"Interview"}],"stocks":[],"tags":[{"name":"Aaron Grey"},{"name":"AdvisorShares"},{"name":"alcohol"},{"name":"Alliance Global Partners"},{"name":"Benzinga Cannabis Capital Conference"},{"name":"Cannabis"},{"name":"CCC"},{"name":"Dan Ahrens"},{"name":"Expert Ideas"},{"name":"Grasshopper Farms"},{"name":"Jamie Pearson"},{"name":"Jesse Redmond"},{"name":"Joseph Lustberg"},{"name":"Laurie Parfitt"},{"name":"LKP Impact Consulting"},{"name":"New Holland Group"},{"name":"Stories That Matter"},{"name":"Upwise Capital"},{"name":"Water Tower Research"},{"name":"Will Bowden"}]},{"id":42177732,"author":"Rolando García","created":"Mon, 25 Nov 2024 18:35:53 -0400","updated":"Mon, 25 Nov 2024 18:35:54 -0400","title":"Minnesota's Cannabis License Lottery Faces Legal Delays Over Rejections Dispute","teaser":"Minnesota: cannabis license lottery is delayed following lawsuits from rejected applicants, raising concerns about the state\u0026#39;s timeline","body":"\u003cp\u003eMinnesota\u0026#8217;s journey toward a recreational cannabis market hit a roadblock Monday when a local judge delayed the state's first lottery for cannabis business licenses.\u003c/p\u003e\n\n\n\n\u003cp\u003eThe decision follows lawsuits filed by applicants who claim they were unfairly excluded from the process, \u003ca href=\"https://www.startribune.com/minnesotas-first-lottery-for-cannabis-business-licenses-delayed-amid-litigation/601186596\"\u003ereported\u003c/a\u003e The Minnesota Star Tribune. \u003c/p\u003e\n\n\n\n\u003cp\u003eJudge \u003cstrong\u003eStephen Smith\u003c/strong\u003e ordered the state's \u003cstrong\u003eOffice of Cannabis Management\u003c/strong\u003e (OCM) to postpone the Tuesday lottery for social equity applicants. The delay aims to provide the Court of Appeals time to address legal challenges raised by the rejected applicants.\u003c/p\u003e\n\n\n\n\u003cp\u003eThe lottery is set to grant 282 social equity applicants pre-approval for cannabis business licenses. This move may impact the timeline for launching Minnesota's retail cannabis market.\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eRead Also:\u003ca href=\"https://www.benzinga.com/markets/cannabis/24/08/40149945/minnesota-cannabis-update-as-industry-prepares-to-launch-retail-sales\"\u003e Minnesota Cannabis Update As Industry Prepares To Launch Retail Sales\u003c/a\u003e\u003c/strong\u003e\u003c/p\u003e\n\n\n\n\u003ch3 class=\"wp-block-heading\"\u003e\u003cstrong\u003eRejections Spark Lawsuits\u003c/strong\u003e\u003c/h3\u003e\n\n\n\n\u003cp\u003eOut of \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/08/40518244/minnesota-prepares-for-historic-social-equity-lottery-with-1-817-applications-for-280-cannabis-l\"\u003e1,817 applicants\u003c/a\u003e, 1,169 were denied entry into the lottery. The OCM cited failures to meet qualifying standards or submit proper documentation as reasons for rejection. However, rejected applicants argue the process lacked transparency and clarity.\u003c/p\u003e\n\n\n\n\u003cp\u003eAttorney\u003cstrong\u003e Courtney Ernston\u003c/strong\u003e, representing one of the plaintiffs, criticized the vague nature of rejection notices. \"Simply saying the word ‘fail' is not a reason,\" Ernston said, adding that her client received no detailed explanation for her exclusion. Applicants and their legal representatives contend that the lack of transparency undermines their ability to contest or correct the rejections.\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003e\u003cem\u003eGet Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter\u0026nbsp;\u003ca href=\"https://newsletteremail.benzinga.com/subscribe\" target=\"_blank\" rel=\"noreferrer noopener\"\u003ehere\u003c/a\u003e. You can\u0026#8217;t afford to miss out if you're serious about the business.\u003c/em\u003e\u003c/strong\u003e\u003c/p\u003e\n\n\n\n\u003ch3 class=\"wp-block-heading\"\u003e\u003cstrong\u003eImplications For Minnesota's Cannabis Market\u003c/strong\u003e\u003c/h3\u003e\n\n\n\n\u003cp\u003eThe delayed lottery raises concerns about potential setbacks in establishing \u003ca href=\"https://www.benzinga.com/topic/minnesota-cannabis\"\u003eMinnesota's\u003c/a\u003e cannabis market.\u003c/p\u003e\n\n\n\n\u003cp\u003eThe program\u0026#8217;s social equity focus aims to prioritize individuals disproportionately affected by past cannabis prohibition, Gov. \u003cstrong\u003eTim Walz\u003c/strong\u003e \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/02/37164553/gov-waltz-stresses-importance-of-social-equity-in-minnesotas-cannabis-market-marginalized-commun\"\u003epointed out\u003c/a\u003e in an interview in February.\u003c/p\u003e\n\n\n\n\u003cp\u003e\u0026#8220;Philosophically our goal is to make sure the equity piece was a big part of this. We certainly want to stay within the parameters of the law of who we can give help to. But I think the idea was, too often marginalized communities are left to the side. They\u0026#8217;re left back,\u0026#8221; Walz said.\u003c/p\u003e\n\n\n\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003eRead Next: \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/08/40541485/exclusive-can-minnesota-keep-its-cannabis-industry-local-amid-out-of-state-pressure-legal-expert\"\u003eEXCLUSIVE: Can Minnesota Keep Its Cannabis Industry Local Amid Out-Of-State Pressure? Legal Expert Weighs In\u003c/a\u003e\u003c/strong\u003e\u003c/li\u003e\n\u003c/ul\u003e\n\n\n\n\u003cp\u003e\u003cem\u003eCover: Photo by \u003ca href=\"https://www.pexels.com/es-es/foto/vehiculos-en-la-carretera-cerca-de-edificios-altos-3859774/\"\u003eJosh Hild\u003c/a\u003e via Pexels\u003c/em\u003e\u003c/p\u003e","url":"https://www.benzinga.com/24/11/42177732/minnesota-cannabis-social-equity-license-lottery-faces-legal-delays-over-rejections-dispute","image":[{"size":"thumb","url":"https://cdn.benzinga.com/files/imagecache/250x187xUP/images/story/2024/11/25/Minnesota-Cannabis.png"},{"size":"small","url":"https://cdn.benzinga.com/files/imagecache/1024x768xUP/images/story/2024/11/25/Minnesota-Cannabis.png"},{"size":"large","url":"https://cdn.benzinga.com/files/imagecache/2048x1536xUP/images/story/2024/11/25/Minnesota-Cannabis.png"}],"channels":[{"name":"Cannabis"},{"name":"Government"},{"name":"News"},{"name":"Regulations"},{"name":"Politics"},{"name":"Markets"}],"stocks":[],"tags":[{"name":"Judge Stephen Smith"},{"name":"Minnesota cannabis"},{"name":"Social Equity Licenses"},{"name":"Social Equity Lottery"}]},{"id":42144102,"author":"Nina Zdinjak","created":"Fri, 22 Nov 2024 13:48:43 -0400","updated":"Mon, 25 Nov 2024 02:15:22 -0400","title":"California Has The Finest Weed In The World, Says Lab Expert, And How To Save Its Struggling Market","teaser":" ","body":"\u003cp\u003eCalifornia, known for its ideal climate and rich cannabis history, is regarded as one of the best places to grow weed. The state has also led U.S. cannabis reform, from the first legalization ballot initiative in 1972 to becoming the first state to legalize medical marijuana in 1996. A decade later, in 2016, it legalized recreational use. Since then, California, home to the world's largest cannabis market, has faced significant challenges.\u003c/p\u003e\n\n\n\n\u003cp\u003eSmall pot farms in regions like the Emerald Triangle have struggled to survive due to oversupply and falling prices, \u003ca href=\"https://www.sfgate.com/cannabis/article/california-cannabis-farms-struggle-19907579.php\"\u003ewrites\u003c/a\u003e SF Gate. Issues like \u003ca href=\"https://anresco.com/exclusive-we-tested-top-california-prerolls-for-potency-inflation/\"\u003einappropriate labeling\u003c/a\u003e, lab shopping, and a \u003ca href=\"https://www.benzinga.com/top-stories/24/06/39487551/pesticide-contamination-poses-serious-health-risks-in-californias-cannabis-industry\"\u003epesticide scandal\u003c/a\u003e have also plagued the industry. While legal cannabis sales \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/06/39195663/legal-california-cannabis-market-on-the-verge-of-collapse-while-illegal-growers-thrive-destroyin\"\u003edecline\u003c/a\u003e, cartel operations \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/06/39188435/californias-cartel-cannabis-flourishes-in-national-parks-weed-grown-on-public-lands-accounts-for\"\u003ethrive in national parks\u003c/a\u003e.\u003c/p\u003e\n\n\n\n\u003cp\u003eTo explore these challenges, we spoke to \u003cstrong\u003eJosh Wurzer\u003c/strong\u003e, chief compliance officer and co-founder of \u003cstrong\u003eSC Labs\u003c/strong\u003e, one of the first to raise concerns about pesticide testing. \"From the beginning, our goal has been to be the most science-focused testing laboratory in the cannabis industry,\" Wurzer told Benzinga.\u003c/p\u003e\n\n\n\n\u003cp\u003e\"We are committed to promoting safe cannabis consumption by ensuring the quality and safety of cannabis cultivation and product manufacturing. Our passion for the plant drives us to support research into its chemical composition, exploring how these compounds influence the flavor, aroma, and unique effects of different strains.\"\u003c/p\u003e\n\n\n\n\u003cfigure class=\"wp-block-image size-large\"\u003e\u003cimg loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"585\" src=\"https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/25011149/New-Project-171-1024x585.jpg\" alt=\"\" class=\"wp-image-662681\" srcset=\"https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/25011149/New-Project-171-1024x585.jpg 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/25011149/New-Project-171-300x171.jpg 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/25011149/New-Project-171-768x439.jpg 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/25011149/New-Project-171.jpg 1261w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" /\u003e\u003c/figure\u003e\n\n\n\n\u003ch2 class=\"wp-block-heading\"\u003e\u003cstrong\u003eP\u003c/strong\u003e\u003cstrong\u003eesticides, Inaccurate Labeling And Lab Shopping\u003c/strong\u003e\u003c/h2\u003e\n\n\n\n\u003cp\u003eIn 2023, there was a \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/06/39505507/cannabis-recall-in-california-after-investigation-finds-dangerous-pesticides-in-popular-weed-pro\"\u003ecannabis recall\u003c/a\u003e after an investigation found dangerous pesticides in popular weed products and a lawsuit against \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/06/39533403/california-lawsuit-takes-aim-at-cannabis-lab-shopping-as-dangerous-pesticides-end-up-in-popular-\"\u003ecannabis lab shopping\u003c/a\u003e. According to Wurzer, who is also a board member of multiple cannabis industry organizations, including the U.S. Pharmacopeial Convention (USP), lab shopping has become a significant issue within the testing industry.\u003c/p\u003e\n\n\n\n\u003cp\u003e\"This problem primarily stems from the fact that the THC concentration in cannabis and cannabis concentrates has become a key factor in determining the wholesale price of these products. This creates a strong incentive for growers and manufacturers to seek out laboratories that report the highest THC concentrations, regardless of the accuracy of the data,\" he said.\u003c/p\u003e\n\n\n\n\u003cp\u003eHe added that cannabis is vulnerable to pests like spider mites and fungal pathogens like powdery mildew. With no approved pesticides and strict testing requirements, managing these threats is challenging and expensive. Some producers bypass detection by using lenient labs.\u003c/p\u003e\n\n\n\n\u003cp\u003eWhile regulators are in charge of overseeing the quality of lab testing, growers and producers are those financially impacted by unfavorable results, Wurzer adds. Without the enforcement of penalties for these actions, \"unethical behavior is incentivized.\"\u003c/p\u003e\n\n\n\n\u003cp\u003e\"I certainly don\u0026#8217;t envy our regulators,\" he said. \"Many of them are working hard to do the best they can within the constraints of the current rules and restrictions. It\u0026#8217;s no small task to try and organize an industry that has been so fragmented, especially when so many people are struggling financially, and there are numerous competing interests at play.\"\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eRead Also: \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/10/41573828/mold-lead-e-coli-and-other-deadly-contaminants-found-in-90-of-illegal-cannabis-samples-in-uk\"\u003eMold, Lead, E.Coli And Other Deadly Contaminants Found In 90% Of Illegal Cannabis Samples In UK\u003c/a\u003e\u003c/strong\u003e\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cem\u003e\u003cstrong\u003eGet Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter \u003ca href=\"https://newsletteremail.benzinga.com/subscribe\" target=\"_blank\" rel=\"noreferrer noopener\"\u003ehere\u003c/a\u003e. If you're serious about the business, you can't afford to miss out.\u003c/strong\u003e\u003c/em\u003e\u003c/p\u003e\n\n\n\n\u003ch2 class=\"wp-block-heading\"\u003eCannabis Will Likely Always Be Affected By HLVd\u003c/h2\u003e\n\n\n\n\u003cp\u003eIn 2019, a hop-latent viroid (HLVd) was identified as an infectious pathogen devastating cannabis farms in California by infiltrating plants and ruining entire crops just before they're ready for harvest. According to a 2021 estimate, it affected 90% of California cannabis crops.\u003c/p\u003e\n\n\n\n\u003cp\u003eWurzer explained that cannabis will likely always be affected by HLVd, the same way that potato farmers are continuously plagued with the Mosai Virus. However, the cannabis industry has developed a support system that enables growers to mitigate HLVd\u0026#8217;s effects. This has enabled the breeding of resistant strains, improving hygiene practices in nurseries and conducting regular monitoring through testing.\u003c/p\u003e\n\n\n\n\u003ch2 class=\"wp-block-heading\"\u003e\u003cstrong\u003eFixing Some Of The Challenges\u003c/strong\u003e\u003c/h2\u003e\n\n\n\n\u003cp\u003eIn view of HLVd, dangerous pesticides and inaccurate labeling, the question is: have California consumers lost trust in the state\u0026#8217;s legal cannabis products? This could be one of the reasons why the illicit market is still thriving; consumers are turning to cheaper products. Wurzer notes that the price difference between regulated and black markets is significant.\u003c/p\u003e\n\n\n\n\u003cp\u003eAnother challenge comes from the hemp market and the confusion about what is and is not legal. To save the industry, regulators need to address the competition from intoxicating cannabinoids in the hemp market, which is currently mostly unregulated and flooded with dangerous synthetic chemicals, he explains.\u003c/p\u003e\n\n\n\n\u003cp\u003eWurzer suggests reducing taxes and regulatory burdens on growers and producers without compromising the quality and safety of products. Profiteers selling unsafe products need to be disincentivized, and ultimately, \"the path forward must include federal legalization.\"\u003c/p\u003e\n\n\n\n\u003ch2 class=\"wp-block-heading\"\u003e\u003cstrong\u003eF\u003c/strong\u003e\u003cstrong\u003einest Cannabis In The World\u003c/strong\u003e\u003c/h2\u003e\n\n\n\n\u003cp\u003eWurzer believes there's no other place on earth that can match the quality of cannabis grown in California, and \"as long as that remains true, we have a real opportunity to fix this mess.\"\u003c/p\u003e\n\n\n\n\u003cp\u003eOnce cannabis is allowed to cross state lines, California will have a significant advantage, he adds. \"No one will want to purchase inferior synthetic THC flowers from other states when they can get high-quality sun-grown flowers from Mendocino, Humboldt, and Santa Cruz. I\u0026#8217;ll confidently put our sun-grown flowers up against the best indoor cannabis produced anywhere else in the world, and I have the lab data to back up those claims.\"\u003c/p\u003e\n\n\n\n\u003cp\u003eIn April 2023, SC Labs partnered with another major laboratory network to develop the \u003ca href=\"https://www.benzinga.com/markets/cannabis/23/04/31680816/sc-labs-and-act-laboratories-launch-trust-in-testing-certification-to-set-a-higher-standard-for-\"\u003eTrust in Testing Certification\u003c/a\u003e a set of enhanced national standards for cannabis testing. This program is \"designed to address some of the gaps in state regulations that have allowed unscrupulous labs to produce questionable data or manipulate the system,\" Wurzer details. There's been a significant interest from retailers looking for a trustmark that provides confidence in the products they offer. SC Lab's goal is to establish a group of laboratories dedicated to doing things the right way.\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eRead Next\u003c/strong\u003e:\u003c/p\u003e\n\n\n\n\u003cul\u003e\n\u003cli\u003e\u003ca href=\"https://www.benzinga.com/government/regulations/24/11/42127449/colorados-marijuana-sales-tax-revenue-slump-amid-hemp-competition\"\u003eColorado\u0026#8217;s Marijuana Sales, Tax Revenue Slump Amid Hemp Competition\u003c/a\u003e\u003c/li\u003e\n\u003c/ul\u003e\n\n\n\n\u003cp\u003e\u003cem\u003ePhoto: Courtesy SC Labs\u003c/em\u003e\u003c/p\u003e","url":"https://www.benzinga.com/markets/cannabis/24/11/42144102/california-has-the-finest-weed-in-the-world-says-lab-expert-and-how-to-save-its-struggling-market","image":[{"size":"thumb","url":"https://cdn.benzinga.com/files/imagecache/250x187xUP/images/story/2024/11/25/Microbiology-Testing-PCR-5.jpeg"},{"size":"small","url":"https://cdn.benzinga.com/files/imagecache/1024x768xUP/images/story/2024/11/25/Microbiology-Testing-PCR-5.jpeg"},{"size":"large","url":"https://cdn.benzinga.com/files/imagecache/2048x1536xUP/images/story/2024/11/25/Microbiology-Testing-PCR-5.jpeg"}],"channels":[{"name":"Cannabis"},{"name":"News"},{"name":"Exclusives"},{"name":"Interview"}],"stocks":[],"tags":[{"name":"California cannabis labs"},{"name":"California illegal cannabis"},{"name":"Josh Wurzer"},{"name":"lab shopping"},{"name":"SC Labs"}]},{"id":42144540,"author":"Rolando García","created":"Fri, 22 Nov 2024 14:07:35 -0400","updated":"Fri, 22 Nov 2024 14:07:36 -0400","title":"DEA Slammed For Unlawful Talks With Cannabis Opponents - The Plot Thickens","teaser":"DEA faces legal pressure over alleged unlawful communications with SAM during cannabis rescheduling process.","body":"\u003cp\u003eThe Drug Enforcement Administration (DEA) is facing legal heat following \u003cstrong\u003eaccusations of unlawful communication with Smart Approaches to Marijuana (SAM\u003c/strong\u003e), a leading opponent of the Biden administration\u0026#8217;s plan to reschedule marijuana from Schedule I to Schedule III under the Controlled Substances Act (CSA). Now, a judge has given both DEA and SAM until November 25 to respond.\u003c/p\u003e\n\n\n\n\u003cp\u003eHere\u0026#8217;s what we know.\u003c/p\u003e\n\n\n\n\u003ch3 class=\"wp-block-heading\"\u003e\u003cstrong\u003eThe Facts\u003c/strong\u003e\u003c/h3\u003e\n\n\n\n\u003cp\u003eOn November 20, DEA Administrative Law Judge (ALJ)\u003cstrong\u003e John Mulrooney \u003c/strong\u003eissued an order responding to \u003ca href=\"https://www.benzinga.com/partner/emerging-markets/24/11/42136266/reliance-global-now-adjusted-ebitda-positive-with-growing-revenue-reflecting-potential-b\"\u003ea motion\u003c/a\u003e filed by cannabis organizations \u003cstrong\u003eVillage Farms International\u003c/strong\u003e and \u003cstrong\u003eHemp for Victory\u003c/strong\u003e. The motion disputes the DEA's role as a \"proponent\" of the rescheduling rule, alleging conflicts of interest.\u003c/p\u003e\n\n\n\n\u003cp\u003eThe motion argues that the DEA's advocacy for the rescheduling rule violates impartiality principles:\u003c/p\u003e\n\n\n\n\u003cp\u003e\u0026#8220;Not once in its history as an agency had DEA ever rejected an HHS scheduling recommendation. This time, however, DEA did not just disagree with HHS\u0026#8217;s views, it opposed them so vehemently that the Attorney General had to refer the interagency dispute to the Office of Legal Counsel for resolution.\u0026#8221;\u003c/p\u003e\n\n\n\n\u003cp\u003eAs a result, Mulrooney has set a deadline for the DEA to respond by November 25, 2024. Part of the argument is that the DEA engaged in unlawful communications with the anti-cannabis group SAM, \u003cstrong\u003ethus indicating its bias on the cannabis issue.\u003c/strong\u003e\u003c/p\u003e\n\n\n\n\u003cp\u003eThe plot thickened and legal tension escalated the very next day, on November 21, when Mulrooney extended the invitation for SAM to address allegations of unlawful ex parte communications with the DEA.\u003c/p\u003e\n\n\n\n\u003cp\u003e\"As such, it is herein ORDERED, that in addition to the Government, should Smart Approaches to Marijuana (and by this order only that Designated Participant) elect to respond to the Motion it may do so no later than 2:00 P.M. Eastern Time on November 25, 2024,\u0026#8221; stated his last order, as \u003ca href=\"https://www.marijuanamoment.net/dea-judge-invites-prohibitionist-group-to-explain-allegedly-unlawful-talks-with-agency-amid-marijuana-rescheduling-review/\"\u003ereported\u003c/a\u003e Marijuana Moment.\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eRead Also: \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/11/42093641/dea-is-compromised-doj-should-replace-it-in-cannabis-rescheduling-claims-joint-motion\"\u003eDEA Is Compromised, DOJ Should Replace It In Cannabis Rescheduling, Claims Joint Motion\u003c/a\u003e\u003c/strong\u003e\u003c/p\u003e\n\n\n\n\u003ch3 class=\"wp-block-heading\"\u003eThe Arguments And SAM\u0026#8217;s Alleged Role\u003c/h3\u003e\n\n\n\n\u003cp\u003eThe motion, filed on November 18, claims that the \u003cstrong\u003eDEA's actions contradict its traditional role\u003c/strong\u003e. \u003c/p\u003e\n\n\n\n\u003cp\u003eThe groups argue that the DEA, which enforces controlled substances law, should not also be advocating for changes to that law.\u003c/p\u003e\n\n\n\n\u003cp\u003eThe motion also points out that the DEA's strong opposition to the rescheduling proposal, despite the Department of Health and Human Services (HHS) recommendation, raises concerns about the agency's neutrality. The involvement of SAM in this process, especially regarding alleged unlawful communications, has become a key issue in the case.\u003c/p\u003e\n\n\n\n\u003cp\u003eThat is the reason why \u003cstrong\u003eMulrooney has ordered both the DEA and SAM to respond to the allegations\u003c/strong\u003e, something they have failed to do so far.\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cem\u003e\u003cstrong\u003eGet Benzinga\u0026#8217;s exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter\u0026nbsp;\u003ca href=\"https://newsletteremail.benzinga.com/subscribe\" target=\"_blank\" rel=\"noreferrer noopener\"\u003ehere\u003c/a\u003e. If you\u0026#8217;re serious about the business, you can\u0026#8217;t afford to miss out.\u003c/strong\u003e\u003c/em\u003e\u003c/p\u003e\n\n\n\n\u003ch3 class=\"wp-block-heading\"\u003eLegal And Political Implications\u003c/h3\u003e\n\n\n\n\u003cp\u003eAs the \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/08/40567326/dea-delays-cannabis-rescheduling-decision-until-after-november-presidential-election\"\u003eDecember 2\u003c/a\u003e, hearing approaches, the stakes in this legal battle continue to rise. The \u003cstrong\u003eoutcome\u003c/strong\u003e \u003cstrong\u003ecould significantly affect cannabis policy in the United States\u003c/strong\u003e. Cannabis advocates, \u003ca href=\"https://www.benzinga.com/news/legal/24/11/41923948/dea-faces-lawsuit-alleging-bias-in-marijuana-rescheduling-process\"\u003eresearchers\u003c/a\u003e and veterans groups are calling for a fair and transparent process.\u003c/p\u003e\n\n\n\n\u003cp\u003eThese groups have raised concerns about the list of approved participants for the hearing, pointing out that Village Farms is the \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/11/41726679/village-farms-is-only-cannabis-operator-selected-to-represent-weed-industry-at-dea-rescheduling-\"\u003eonly cannabis company selected \u003c/a\u003eby the DEA. Additionally, despite over \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/07/39932698/deas-call-for-public-input-on-cannabis-garnered-42-000-comments-majority-want-total-legalization\"\u003e42,000 public comments\u003c/a\u003e supporting rescheduling or delisting cannabis, the DEA's list is dominated by anti-cannabis groups.\u003c/p\u003e\n\n\n\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003eRead Next: \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/11/41726679/village-farms-is-only-cannabis-operator-selected-to-represent-weed-industry-at-dea-rescheduling-\"\u003eVillage Farms Is Only Cannabis Operator Selected To Represent Weed Industry At DEA Rescheduling Hearing\u003c/a\u003e\u003c/strong\u003e\u003c/li\u003e\n\u003c/ul\u003e\n\n\n\n\u003cp\u003e\u003cem\u003eCover: AI Generated Image\u003c/em\u003e\u003c/p\u003e","url":"https://www.benzinga.com/24/11/42144540/dea-slammed-over-unlawful-talks-with-cannabis-opponents-the-plot-thickens","image":[{"size":"thumb","url":"https://cdn.benzinga.com/files/imagecache/250x187xUP/images/story/2024/11/22/DEA.png"},{"size":"small","url":"https://cdn.benzinga.com/files/imagecache/1024x768xUP/images/story/2024/11/22/DEA.png"},{"size":"large","url":"https://cdn.benzinga.com/files/imagecache/2048x1536xUP/images/story/2024/11/22/DEA.png"}],"channels":[{"name":"Cannabis"},{"name":"Government"},{"name":"News"},{"name":"Regulations"},{"name":"Politics"},{"name":"Legal"},{"name":"Top Stories"},{"name":"Markets"}],"stocks":[],"tags":[{"name":"cannabis rescheduling"},{"name":"DEA Cannabis"},{"name":"DOJ"},{"name":"John Mulrooney"},{"name":"lawsuit"}]},{"id":41996222,"author":"Nicolás Jose Rodriguez","created":"Thu, 14 Nov 2024 19:06:55 -0400","updated":"Fri, 15 Nov 2024 10:37:07 -0400","title":"How Reddit's Cannabis Critics Are Helping Brands Spot Market Trends Before They Hit Dispensaries","teaser":"Reddit\u0026#39;s cannabis critics help brands spot emerging trends and identify top strains before they reach dispensaries.\n\nFrom the early days of internet forums to today\u0026#39;s thriving Reddit communities, cannabis discussions have transformed, offering unprecedented visibility into consumer preferences. ","body":"\u003cp\u003eReddit\u0026#39;s cannabis critics help brands spot emerging trends and identify top strains before they reach dispensaries.\u003c/p\u003e\r\n\r\n\u003cp\u003eFrom the early days of internet forums to today\u0026#39;s thriving Reddit communities, cannabis discussions have transformed, offering unprecedented visibility into consumer preferences.\u0026nbsp;\u003c/p\u003e\r\n\r\n\u003cp\u003e\u003cstrong\u003eCaleb Chen\u003c/strong\u003e, founder of \u003cstrong\u003eThe Highest Critic\u003c/strong\u003e and a key moderator on Reddit\u0026#39;s largest cannabis community, has harnessed this evolution, creating a platform that fills a crucial gap: providing unfiltered, ground-level reviews at a time when the industry is dominated by dispensary marketing. \u0026ldquo;Reviewers on \u003ca href=\"https://thehighestcritic.com/\"\u003eThe Highest Critic \u003c/a\u003earen\u0026#39;t just casual users\u0026mdash;they\u0026#39;re connoisseurs buying the best cannabis, whether it\u0026#39;s from the legal market or the underground scene,\u0026rdquo; Chen shared with Benzinga Cannabis.\u0026nbsp;\u0026ldquo;Their insights offer an early look at trends, often predicting which strains will become the next big thing in dispensaries.\u0026rdquo;\u003c/p\u003e\r\n\r\n\u003cp\u003eThis approach of gathering authentic, ground-level feedback mirrors the spirit of early online cannabis forums, where enthusiasts first connected over shared experiences.\u003c/p\u003e\r\n\r\n\u003cul\u003e\r\n\t\u003cli\u003e\u003cstrong\u003e\u003cem\u003eGet Benzinga\u0026#39;s exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter\u0026nbsp;\u003ca href=\"https://newsletteremail.benzinga.com/subscribe\" rel=\"noreferrer noopener\" target=\"_blank\"\u003ehere\u003c/a\u003e. You can\u0026rsquo;t afford to miss out if you\u0026#39;re serious about the business.\u003c/em\u003e\u003c/strong\u003e\u003c/li\u003e\r\n\u003c/ul\u003e\r\n\r\n\u003ch3 class=\"wp-block-heading\"\u003eFrom Usenet To Reddit: The Evolution Of Cannabis Conversations\u003c/h3\u003e\r\n\r\n\u003cp\u003eChen traces the history of online cannabis discussions back to the earliest days of the internet. \u0026ldquo;Cannabis has been part of the online conversation since the ARPANET era. At the dawn of the internet, one of the first discussions was about weed,\u0026rdquo; he explained. This legacy began with Usenet, an early online network launched in the 1980s that allowed users to exchange messages in public forums.\u0026nbsp;\u003c/p\u003e\r\n\r\n\u003cp\u003eUsenet was a precursor to today\u0026#39;s social media, where cannabis enthusiasts shared growing tips, strain reviews, and underground market insights. The collaborative spirit of these early forums laid the groundwork for modern platforms like Reddit, where communities continue to exchange authentic, crowd-sourced information about cannabis products.\u003c/p\u003e\r\n\r\n\u003ch3 class=\"wp-block-heading\"\u003eA Window Into Consumer Preferences\u003c/h3\u003e\r\n\r\n\u003cp\u003eChen pointed out how Reddit\u0026#39;s \u003ca href=\"https://www.reddit.com/r/trees/wiki/index/?rdt=49055\"\u003er/trees subreddit offers a unique opportunity for brands\u003c/a\u003e to gauge market trends early on. \u0026ldquo;Reviewers often get their hands on tester products from breeders before they hit\u003ca href=\"https://www.benzinga.com/analyst-ratings/analyst-color/24/11/41725186/with-200-new-dispensaries-and-four-states-voting-on-legalizing-cannabis-could-marke\"\u003e dispensaries\u003c/a\u003e,\u0026rdquo; Chen noted. \u0026ldquo;This early feedback loop can predict which cultivars will become top sellers two or three years down the line. It\u0026#39;s a real-time look at what heavy users are seeking.\u0026rdquo;\u003c/p\u003e\r\n\r\n\u003cp\u003eFor brands, this is invaluable. Chen explains that while dispensaries often focus on THC levels as a selling point, Reddit users are more interested in specific effects and unique terpene profiles.\u003c/p\u003e\r\n\r\n\u003cp\u003e\u0026ldquo;Reddit users often look beyond the THC percentage. They want to know what\u0026#39;s good, what\u0026#39;s worth their money, and what provides the medicinal effects they\u0026#39;re looking for,\u0026rdquo; Chen said. \u0026ldquo;This kind of feedback can help brands refine their offerings and focus on quality, rather than just chasing the highest THC numbers.\u0026rdquo; In addition, the Insights shared on The Highest Critic go beyond typical \u003ca href=\"https://www.benzinga.com/topic/cannabis-marketing\"\u003edispensary marketing\u003c/a\u003e, delving into what consumers truly want.\u003c/p\u003e\r\n\r\n\u003cp\u003e\u003cstrong\u003eRead Also:\u003ca href=\"https://www.benzinga.com/general/health-care/24/11/41959233/yougov-poll-reveals-what-women-want-with-weed-relax-mindfulness-and-great-deals\"\u003e YouGov Poll Reveals What Women Want With Weed: Relax, Mindfulness And Great Deals\u003c/a\u003e\u003c/strong\u003e\u003c/p\u003e\r\n\r\n\u003ch3 class=\"wp-block-heading\"\u003eModerator Challenges\u003c/h3\u003e\r\n\r\n\u003cp\u003e\u0026ldquo;A lot of the moderation involves banning underage users and handling posts from people looking to buy weed illegally,\u0026rdquo; Chen said. \u0026ldquo;It\u0026#39;s a collective effort. Other moderators have been quoted in articles before, responding to inquiries through the official mod mail.\u0026rdquo;\u003c/p\u003e\r\n\r\n\u003cp\u003eFor cannabis brands, Reddit\u0026#39;s communities offer a unique advantage in \u003ca href=\"https://www.benzinga.com/topic/cannabis-branding\"\u003eunderstanding market trends\u003c/a\u003e, particularly the premiumization of cannabis.\u003c/p\u003e\r\n\r\n\u003ch3 class=\"wp-block-heading\"\u003eHow Cannabis Brands Can Leverage Reddit For Market Insights\u003c/h3\u003e\r\n\r\n\u003cp\u003eChen explained how Reddit has become a trusted resource for identifying new cultivars and genetics before they reach mainstream dispensaries.\u003c/p\u003e\r\n\r\n\u003cp\u003e\u0026ldquo;Many of the reviews we publish are based on tester strains from breeders or small-batch growers. These are the strains that often end up being the next big thing in dispensaries,\u0026rdquo; Chen noted. \u0026ldquo;By paying attention to what reviewers are excited about, brands can get ahead of the curve and focus on strains that have a\u003ca href=\"https://www.benzinga.com/markets/cannabis/24/09/40860336/marijuana-sales-hit-record-highs-in-these-6-us-states-is-marijuana-outpacing-alcohol\"\u003e strong demand\u003c/a\u003e among connoisseurs.\u0026rdquo;\u003c/p\u003e\r\n\r\n\u003cp\u003eChen also pointed out that Reddit\u0026#39;s cannabis forums retain a grassroots, user-driven ethos. While the community provides honest feedback, brands cannot simply buy their way into the conversation.\u003c/p\u003e\r\n\r\n\u003cp\u003e\u0026ldquo;Brands need to engage authentically,\u0026rdquo; Chen concluded. \u0026ldquo;The community can spot a marketing ploy from a mile away. What resonates more is when a brand listens to user feedback and makes adjustments based on what people are saying on the forum.\u0026rdquo;\u003c/p\u003e\r\n\r\n\u003cp\u003e\u003cstrong\u003eRead Next: \u003ca href=\"https://www.benzinga.com/news/legal/24/11/41959036/trump-nominates-another-cannabis-supporter-to-cabinet-rep-matt-gaetz-for-attorney-general\"\u003eTrump Nominates Another Cannabis Supporter To Cabinet: Rep. Matt Gaetz For Attorney General\u003c/a\u003e\u003c/strong\u003e\u003c/p\u003e\r\n","url":"https://www.benzinga.com/general/social-media/24/11/41996222/how-reddits-cannabis-critics-are-helping-brands-spot-market-trends-before-they-hit-dispensar","image":[{"size":"thumb","url":"https://cdn.benzinga.com/files/imagecache/250x187xUP/images/story/2024/11/14/AI-Generated-Image.jpeg"},{"size":"small","url":"https://cdn.benzinga.com/files/imagecache/1024x768xUP/images/story/2024/11/14/AI-Generated-Image.jpeg"},{"size":"large","url":"https://cdn.benzinga.com/files/imagecache/2048x1536xUP/images/story/2024/11/14/AI-Generated-Image.jpeg"}],"channels":[{"name":"Cannabis"},{"name":"News"},{"name":"Social Media"},{"name":"Entrepreneurship"},{"name":"Retail Sales"},{"name":"Exclusives"},{"name":"Markets"},{"name":"Tech"},{"name":"Media"},{"name":"Interview"}],"stocks":[],"tags":[{"name":"Caleb Chen"},{"name":"Cannabis Branding"},{"name":"Cannabis Dispensaries"},{"name":"Cannabis Genetics"},{"name":"Cannabis Marketing"},{"name":"Cannabis Markets"},{"name":"Cannabis Retail"},{"name":"cannabis sales"},{"name":"Consumer Behavior"},{"name":"r/trees subreddit"},{"name":"Reddit"},{"name":"Reddit cannabis posts"},{"name":"Reddit Inc"},{"name":"The Highest Critic"}]},{"id":42146896,"author":"Patricio Liddle","created":"Fri, 22 Nov 2024 16:30:27 -0400","updated":"Fri, 22 Nov 2024 16:30:27 -0400","title":"EXCLUSIVE: How EQUA Tackles Stigma In Cannabis Insurance With Tailored Solutions","teaser":"Discover how EQUA tackles stigma in cannabis insurance in Canada with tailored solutions, education, and advocacy to help businesses thrive.","body":"\u003cp\u003e\u003cstrong\u003eEQUA Specialty Risk Partners\u003c/strong\u003e, a Canadian-owned insurance brokerage, is taking on one of the cannabis industry's most pervasive challenges: stigma. Through education, advocacy and innovative risk management strategies, EQUA seeks to transform how \u003ca href=\"http://benzinga.com/cannabis\"\u003ecannabis\u003c/a\u003e businesses access insurance.\u0026nbsp;\u003c/p\u003e\n\n\n\n\u003cp\u003eIn an exclusive conversation with Benzinga, \u003cstrong\u003eLoretta Eldridge\u003c/strong\u003e, EQUA's director of marketing, communications and strategic partnerships, and \u003cstrong\u003eMatt Jardine\u003c/strong\u003e, cannabis client executive, spoke about the company's mission to create insurance solutions without stigma.\u003c/p\u003e\n\n\n\n\u003ch3 class=\"wp-block-heading\"\u003e\u003cstrong\u003eUncovering The Impact Of Stigma On Canada\u0026#8217;s Cannabis Operators\u003c/strong\u003e\u003c/h3\u003e\n\n\n\n\u003cp\u003eEQUA was founded in 2020 as a specialty brokerage for complex commercial risks. Initially focusing on industries like construction and technology, the company ventured into cannabis after Eldridge, a lifelong cannabis advocate and former director of marketing at \u003cstrong\u003eAmple Organics\u003c/strong\u003e, joined the team. \u0026#8220;I\u0026#8217;m transparently a lifelong consumer, a medical patient. I am really dedicated to the cannabis community because it is my community,\u0026#8221; Eldridge said.\u003c/p\u003e\n\n\n\n\u003cp\u003eThe shift began when Eldridge continued attending cannabis events and noticed a pressing need for insurance solutions. Business owners approached her with urgent requests for help. \u0026#8220;It got to the point where in one of those conversations a woman I was chatting to started to get emotional. The one woman said, \u0026#8216;I met you for a reason today. I need help,'\u0026#8221; Eldridge recalled.\u003c/p\u003e\n\n\n\n\u003cp\u003eThese interactions prompted \u003cstrong\u003etwo years of in-depth research involving nearly 60 industry leaders across 20 sub-sectors\u003c/strong\u003e. What the EQUA team found was alarming. Canadian cannabis operators faced inflated premiums, limited market capacity and policies riddled with exclusions.\u003c/p\u003e\n\n\n\n\u003cp\u003eJardine elaborated on the practical impacts of stigma, particularly for cultivators and processors. \u0026#8220;You could have a neighboring risk that\u0026#8217;s a greenhouse and they would have completely different premiums for the exact same size facilities\u0026#8230; We have coined that the cannabis surcharge,\u0026#8221; he noted.\u003c/p\u003e\n\n\n\n\u003ch3 class=\"wp-block-heading\"\u003e\u003cstrong\u003eEQUA's Strategy: Education, Collaboration \u0026amp; Customized Solutions\u003c/strong\u003e\u003c/h3\u003e\n\n\n\n\u003cp\u003eHowever, EQUA has taken a proactive approach to dismantle these barriers, rooted in education and collaboration. Eldridge highlighted the importance of connecting cannabis operators directly with underwriters to dismantle biases. \"We invite underwriters to tour facilities, see the stringent security measures and understand the hyper-regulated nature of the industry,\" she explained. These efforts have led to the entry of new insurance markets, gradually alleviating stigma.\u003c/p\u003e\n\n\n\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003e\u003cem\u003eGet Benzinga\u0026#8217;s exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter \u003c/em\u003e\u003c/strong\u003e\u003ca href=\"https://newsletteremail.benzinga.com/subscribe\"\u003e\u003cstrong\u003e\u003cem\u003ehere\u003c/em\u003e\u003c/strong\u003e\u003c/a\u003e\u003cstrong\u003e\u003cem\u003e. If you\u0026#8217;re serious about the business, you can\u0026#8217;t afford to miss out.\u003c/em\u003e\u003c/strong\u003e\u003c/li\u003e\n\u003c/ul\u003e\n\n\n\n\u003cp\u003eCustomization lies at the heart of EQUA\u0026#8217;s strategy. By deeply understanding each client\u0026#8217;s unique needs, they tailor insurance packages accordingly. Jardine shared an example where EQUA reduced a client's stock coverage to align with actual inventory needs, saving thousands of dollars. \"We personalize every policy, ensuring it matches the operator's specific requirements and eliminates unnecessary costs,\" Jardine said.\u003c/p\u003e\n\n\n\n\u003ch3 class=\"wp-block-heading\"\u003e\u003cstrong\u003eU.S. Laws Limit Cannabis Insurance Access\u003c/strong\u003e Globally\u003c/h3\u003e\n\n\n\n\u003cp\u003eLimited global insurance capacity due to \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/11/42093641/dea-is-compromised-doj-should-replace-it-in-cannabis-rescheduling-claims-joint-motion\"\u003eU.S. federal illegality\u003c/a\u003e further complicates problems, leaving Canadian businesses with fewer competitive options. This limits market capacity and sustains high premiums. Eldridge described the situation as a funnel, with stigma and legal barriers narrowing options at every level.\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eRead Also: \u003c/strong\u003e\u003ca href=\"https://www.benzinga.com/markets/cannabis/24/09/40900626/legal-medical-cannabis-could-save-us-healthcare-29b-annually-new-study-finds\"\u003e\u003cstrong\u003eLegal Medical Cannabis Could Save US Healthcare $29B Annually, New Study Finds\u003c/strong\u003e\u003c/a\u003e\u003c/p\u003e\n\n\n\n\u003cp\u003eShe also emphasized the importance of global outreach: \u0026#8220;We don\u0026#8217;t have to just go to the United States, we educate and engage with underwriters wherever those underwriters are legally allowed to offer these services to Canadian businesses.\u0026#8221;\u003c/p\u003e\n\n\n\n\u003ch3 class=\"wp-block-heading\"\u003e\u003cstrong\u003e‘Cannabis Surcharge' Also Hits Ancillary Companies\u003c/strong\u003e\u003c/h3\u003e\n\n\n\n\u003cp\u003eAnd the challenges don't stop at plant-touching businesses. Eldridge pointed out that \u003ca href=\"https://www.benzinga.com/markets/cannabis/23/09/34985762/exclusive-unlocking-potential-of-ancillary-companies-in-cannabis-industry\"\u003eancillary companies\u003c/a\u003e, such as equipment manufacturers and technology providers, also face inflated premiums simply for serving cannabis clients. EQUA's role, she explained, includes educating underwriters to separate perceived risks from actual risks and advocating for fairer practices across the supply chain.\u003c/p\u003e\n\n\n\n\u003ch3 class=\"wp-block-heading\"\u003e\u003cstrong\u003eOvercoming Canada's Complex Cannabis Regulations\u003c/strong\u003e\u003c/h3\u003e\n\n\n\n\u003cp\u003eMoreover, navigating Canada's fragmented regulatory landscape is another area where EQUA\u0026#8217;s tailored solutions provide critical support. Each province imposes unique insurance requirements, from product recall policies to liability limits. \u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eRead Also: \u003c/strong\u003e\u003ca href=\"https://www.benzinga.com/markets/cannabis/24/08/40591338/canadas-cannabis-growth-slowed-due-to-federal-gov-inaction-key-industry-leader-says\"\u003e\u003cstrong\u003eCanada\u0026#8217;s Cannabis Growth Slowed Due To Federal Gov Inaction, Key Industry Leader Says\u003c/strong\u003e\u003c/a\u003e\u003c/p\u003e\n\n\n\n\u003cp\u003eJardine noted that non-compliance can void policies, making EQUA's role in reviewing agreements and ensuring alignment indispensable for multi-province cannabis operators.\u003c/p\u003e\n\n\n\n\u003ch3 class=\"wp-block-heading\"\u003e\u003cstrong\u003eEQUA's Vision For Industry Transformation\u003c/strong\u003e\u003c/h3\u003e\n\n\n\n\u003cp\u003eWhen asked about their views on the future evolution of cannabis insurance, Eldridge expressed optimism. \"The industry is waking up and wanting to support these companies because it's the right thing to do,\" she said. Jardine echoed this sentiment, predicting that increased competition and nuanced underwriting will lead to fairer premiums within the next two years.\u0026nbsp;\u0026nbsp;\u003c/p\u003e\n\n\n\n\u003cp\u003eWith its focus on advocacy, education and tailored solutions, EQUA is reshaping how insurance is perceived in the cannabis industry. As Eldridge put it, \"We're just at the beginning of the precipice of change and we're proud to be leading the charge.\"\u0026nbsp;\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eRead Next:\u003c/strong\u003e\u003c/p\u003e\n\n\n\n\u003cul\u003e\n\u003cli\u003e\u003ca href=\"https://www.benzinga.com/24/11/42130221/the-best-and-worst-performing-states-for-cannabis-sales-in-2024-ytd-winners-and-losers\"\u003e\u003cstrong\u003eBest And Worst Performing States For Cannabis Sales In 2024: YTD Winners \u0026amp; Losers\u003c/strong\u003e\u003c/a\u003e\u003c/li\u003e\n\u003c/ul\u003e\n\n\n\n\u003cp\u003e\u003cem\u003eImage courtesy of EQUA.\u003c/em\u003e\u003c/p\u003e","url":"https://www.benzinga.com/government/regulations/24/11/42146896/exclusive-how-equa-tackles-stigma-in-cannabis-insurance-with-tailored-solutions","image":[{"size":"thumb","url":"https://cdn.benzinga.com/files/imagecache/250x187xUP/images/story/2024/11/22/equaloretta.png"},{"size":"small","url":"https://cdn.benzinga.com/files/imagecache/1024x768xUP/images/story/2024/11/22/equaloretta.png"},{"size":"large","url":"https://cdn.benzinga.com/files/imagecache/2048x1536xUP/images/story/2024/11/22/equaloretta.png"}],"channels":[{"name":"Cannabis"},{"name":"News"},{"name":"Regulations"},{"name":"Top Stories"},{"name":"Exclusives"},{"name":"Interview"},{"name":"Insurance"}],"stocks":[],"tags":[{"name":"Canada Cannabis"},{"name":"Cannabis Insurance"},{"name":"EQUA"},{"name":"EQUA Specialty Risk Partners"},{"name":"Loretta Eldridge"},{"name":"Matt Jardine"}]},{"id":42198858,"author":"Juan Spínelli","created":"Tue, 26 Nov 2024 15:38:13 -0400","updated":"Tue, 26 Nov 2024 15:38:13 -0400","title":"Veteran Access To Psychedelic Mental Health Therapies Stalls In Virginia","teaser":"Virginia lawmakers fail to advance legislation to explore psychedelic therapies like psilocybin, leaving future treatment uncertain.","body":"\u003cp\u003eLegislative progress on providing veterans with access to \u003ca href=\"https://www.benzinga.com/topic/psychedelic-assisted-therapies\"\u003epsychedelic therapies\u003c/a\u003e like psilocybin, found in magic mushrooms, hit a roadblock last week as Virginia lawmakers decided not to advance a bill aimed at expanding mental health treatments for veterans. \u003c/p\u003e\n\n\n\n\u003cp\u003eAs Henrico Citizen \u003ca href=\"https://www.henricocitizen.com/veteran-use-of-psychedelics-for-mental-health-care-still-up-in-the-air/\"\u003ereported\u003c/a\u003e, the bill, introduced by Sen.\u003cstrong\u003e Ghazala Hashmi\u003c/strong\u003e (D-Richmond) and Del. \u003cstrong\u003eMichael Jones\u003c/strong\u003e (D-Richmond), sought to create an advisory council that would study how breakthrough therapies could be used to help \u003ca href=\"https://www.benzinga.com/24/11/41881842/why-do-veterans-deserve-access-to-psychedelic-therapy\"\u003ereduce veteran suicide rates and treat mental health disorders\u003c/a\u003e, including post-traumatic stress disorder (PTSD). However, without further action from lawmakers, the bill was left in committee as of November 18, the deadline for bills to be considered from the previous General Assembly session.\u003c/p\u003e\n\n\n\n\u003ch3 class=\"wp-block-heading\"\u003e\u003cstrong\u003eThe Bill\u003c/strong\u003e\u003c/h3\u003e\n\n\n\n\u003cp\u003eThe \u003ca href=\"https://lis.virginia.gov/bill-details/20251/HB80?\"\u003elegislation\u003c/a\u003e proposed a deep dive into federal regulations and licensing requirements for breakthrough therapies, which would include substances like \u003ca href=\"https://www.benzinga.com/topic/psilocybin\"\u003epsilocybin\u003c/a\u003e. While the bill did not explicitly mention psilocybin, it is recognized as a potential breakthrough therapy due to its promising effects on mental health. Studies, including research from \u003cstrong\u003eJohns Hopkins Medicine\u003c/strong\u003e, have found that psilocybin helps alleviate symptoms of depression, anxiety and PTSD, and even aids in smoking cessation.\u003c/p\u003e\n\n\n\n\u003ch3 class=\"wp-block-heading\"\u003e\u003cstrong\u003eChallenges In Rescheduling Psilocybin For Medicinal Use\u003c/strong\u003e\u003c/h3\u003e\n\n\n\n\u003cp\u003eDespite \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/10/41216395/could-psilocybin-be-a-game-changer-for-millions-battling-depression-new-study-says-yes\"\u003eevidence supporting psilocybin\u0026#8217;s therapeutic potential\u003c/a\u003e, it remains a \u003ca href=\"https://www.benzinga.com/topic/federal-schedule-i\"\u003eSchedule I substance\u003c/a\u003e in Virginia, limiting its medical use. In 2023, a \u003ca href=\"https://legacylis.virginia.gov/cgi-bin/legp604.exe?231+sum+SB932=\u0026amp;\"\u003ebill\u003c/a\u003e to reschedule it to Schedule III failed. This classification is controversial, especially considering fentanyl, another Schedule I drug, is responsible for most overdose deaths in Virginia, while psilocybin has no overdose-related fatalities.\u003c/p\u003e\n\n\n\n\u003ch3 class=\"wp-block-heading\"\u003e\u003cstrong\u003eVeterans Call For Better Mental Health Care And Treatment Access\u003c/strong\u003e\u003c/h3\u003e\n\n\n\n\u003cp\u003eDel. Jones, whose father was a Vietnam War veteran, voiced frustration at the lack of action. \"Veterans deserve any form of effective mental health care they need,\" said Jones, emphasizing that improving mental health support for veterans should be a priority. He stressed the importance of exploring all treatment options for veterans, acknowledging the struggles some face just getting through daily life. \"Every day isn't easy for everybody,\" Jones remarked. \"For some people getting up on Thursday morning is hard as hell, and so, how do we soften that burden?\"\u003c/p\u003e\n\n\n\n\u003cp\u003eVeterans have \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/10/41320243/massachusetts-veterans-advocate-for-psilocybin-legalization-will-voters-support-them\"\u003elong advocated for the use of psychedelics\u003c/a\u003e to address mental health issues, particularly PTSD, which affects a significant portion of those who have served in the military. Army veteran \u003cstrong\u003eAnthony Mijares\u003c/strong\u003e shared his personal testimony about the benefits of psilocybin, stating that it helped him overcome depression and reliance on prescription drugs after his military service. \"The military trained me to save people, but it failed to train me on how to heal myself,\" Mijares said during a 2023 testimony in favor of psilocybin legislation.\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003e\u003cem\u003eRead Also:\u0026nbsp;\u003ca href=\"https://www.benzinga.com/24/11/41881842/why-do-veterans-deserve-access-to-psychedelic-therapy\"\u003eVeterans Deserve Access To Life-Changing Psychedelics Therapy: A Vital Solution For PTSD And Healing\u003c/a\u003e\u003c/em\u003e\u003c/strong\u003e\u003c/p\u003e\n\n\n\n\u003ch3 class=\"wp-block-heading\"\u003e\u003cstrong\u003eVA Funds Research On Psychedelic Treatments\u003c/strong\u003e\u003c/h3\u003e\n\n\n\n\u003cp\u003eIn response to mounting interest in psychedelic therapies, the Department of Veterans Affairs announced in January that it \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/01/36523540/veterans-affairs-after-decades-will-fund-psychedelic-research-for-vets-with-ptsd-and-depression\"\u003ewould fund research into the use of psychedelics\u003c/a\u003e like psilocybin to treat PTSD and depression. representing the first such VA-supported research since the 1960s.\u003c/p\u003e\n\n\n\n\u003ch3 class=\"wp-block-heading\"\u003e\u003cstrong\u003eThe Future Of Psychedelic Treatment For Veterans In Virginia\u003c/strong\u003e\u003c/h3\u003e\n\n\n\n\u003cp\u003eDespite setbacks at the state level, Jones remains hopeful that future legislative efforts will prioritize veteran mental health and continue to advance research into psychedelic treatments. \"We need to be bold,\" he said, urging that any future administration support scientific research that could improve the lives of veterans.\u003c/p\u003e\n\n\n\n\u003cp\u003eWhether the issue will resurface in the upcoming legislative session is still uncertain, as neither Jones nor Hashmi have confirmed plans to reintroduce the bill.\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cem\u003eCover image made with AI\u003c/em\u003e\u003c/p\u003e","url":"https://www.benzinga.com/markets/cannabis/24/11/42198858/veteran-access-to-psychedelic-mental-health-therapies-stalls-in-virginia","image":[{"size":"thumb","url":"https://cdn.benzinga.com/files/imagecache/250x187xUP/images/story/2024/11/26/2-12.png"},{"size":"small","url":"https://cdn.benzinga.com/files/imagecache/1024x768xUP/images/story/2024/11/26/2-12.png"},{"size":"large","url":"https://cdn.benzinga.com/files/imagecache/2048x1536xUP/images/story/2024/11/26/2-12.png"}],"channels":[{"name":"Cannabis"},{"name":"Government"},{"name":"News"},{"name":"Psychedelics"}],"stocks":[],"tags":[{"name":"Anthony Mijares"},{"name":"Ghazala Hashmi"},{"name":"Michael Jones"},{"name":"military veterans"},{"name":"Psilocybin"},{"name":"Psychedelic Assisted Therapies"},{"name":"PTSD"},{"name":"Veterans Affairs"},{"name":"virginia"},{"name":"virginia psilocybin"}]},{"id":42122260,"author":"Juan Spínelli","created":"Thu, 21 Nov 2024 16:09:19 -0400","updated":"Thu, 21 Nov 2024 16:09:19 -0400","title":"Study Reveals Psychedelic Ritual Cocktail In Ancient Egyptian Mug","teaser":"A 2,000-year-old Egyptian mug reveals a psychedelic cocktail used in fertility rituals, uncovering ancient Egyptians\u0026#39; advanced ceremonial practices.","body":"\u003cp\u003eA 2,000-year-old Egyptian mug, known as a Bes mug, was used to consume a potent concoction of \u003ca href=\"https://www.benzinga.com/markets/psychedelics\"\u003epsychedelic substances\u003c/a\u003e, alcohol and human bodily fluids, according to new research. The \u003ca href=\"https://www.nature.com/articles/s41598-024-78721-8\"\u003estudy\u003c/a\u003e, published in Scientific Reports, utilized advanced chemical and DNA analysis to uncover the complex composition of the mug\u0026#8217;s last contents.\u003c/p\u003e\n\n\n\n\u003ch4 class=\"wp-block-heading\"\u003e\u003cstrong\u003eThe Mug And Its Mythical Connection\u003c/strong\u003e\u003c/h4\u003e\n\n\n\n\u003cp\u003eThe artifact, housed at the Tampa Museum of Art, features the head of Bes, an Egyptian deity linked to protection, fertility and joy. During the Ptolemaic period (330–30 BCE), Bes also took on mystical and oracular roles, often associated with transformative rituals.\u003c/p\u003e\n\n\n\n\u003cp\u003eResearchers analyzed residues scraped from the inner walls of the mug and identified psychoactive substances such as \u003cstrong\u003ePeganum harmala\u003c/strong\u003e (Syrian rue) and \u003cstrong\u003eNymphaea caerulea\u003c/strong\u003e (blue water lily). Syrian rue contains alkaloids like harmine and harmaline, known for inducing dream-like visions, while blue water lily is linked to mild sedative and euphoric effects.\u003c/p\u003e\n\n\n\n\u003ch4 class=\"wp-block-heading\"\u003e\u003cstrong\u003eRitual And Symbolism\u003c/strong\u003e\u003c/h4\u003e\n\n\n\n\u003cp\u003eResearchers said the mug was used in fertility-related rituals reenacting Egyptian myths. \u0026#8220;These substances reveal the sophistication of ancient Egyptian ritual practices,\u0026#8221; \u003ca href=\"https://www.newsweek.com/ancient-egyptians-drank-cocktail-psychedelic-body-fluid-alcohol-1987914\"\u003esaid\u003c/a\u003e study author \u003cstrong\u003eEnrico Greco\u003c/strong\u003e to Newsweek. \u0026#8220;Their use highlights a deliberate attempt to connect with the divine through physical and spiritual transformation.\u0026#8221;\u003c/p\u003e\n\n\n\n\u003cp\u003eIn addition to \u003ca href=\"https://www.benzinga.com/markets/cannabis/22/02/25568274/entheogens-and-plant-medicine-an-introduction\"\u003epsychoactive plants\u003c/a\u003e, the mixture contained fermented alcoholic liquids, honey, sesame seeds, pine nuts, licorice and grapes. Unexpectedly, the analysis also revealed proteins from human bodily fluids such as blood, vaginal mucus and breast milk, which Greco described as \u0026#8220;highly symbolic elements emphasizing themes of life, fertility, and regeneration.\u0026#8221;\u003c/p\u003e\n\n\n\n\u003ch4 class=\"wp-block-heading\"\u003e\u003cstrong\u003eAdvanced Analysis Techniques\u003c/strong\u003e\u003c/h4\u003e\n\n\n\n\u003cp\u003e\u0026#8220;This is the first comprehensive scientific analysis of a Bes mug\u0026#8217;s organic residues,\u0026#8221; explained \u003cstrong\u003eDavide Tanasi\u003c/strong\u003e, lead author from the University of South Florida. \u0026#8220;For the first time, we were able to identify all the chemical signatures of the components of the liquid concoction.\u0026#8221;\u003c/p\u003e\n\n\n\n\u003cp\u003eThe study underscores the Egyptians\u0026#8217; advanced understanding of natural resources and their effects on the human mind. \u0026#8220;The identified substances likely induced dream-like visions, heightened meditative states, and possibly euphoria,\u0026#8221; said Greco.\u003c/p\u003e\n\n\n\n\u003ch4 class=\"wp-block-heading\"\u003e\u003cstrong\u003eExpanding Understanding Of Egyptian Rituals\u003c/strong\u003e\u003c/h4\u003e\n\n\n\n\u003cp\u003eThe Bes mug was not merely decorative or utilitarian but played a critical role in complex ceremonial practices. The findings provide tangible evidence of how ancient Egyptians used psychotropic substances to achieve altered states of consciousness in rituals involving fertility, prophecy, and spiritual transformation.\u003c/p\u003e\n\n\n\n\u003cp\u003e\u0026#8220;This study reveals that Bes mugs were more than decorative—they were integral to mystical and ritualistic practices,\u0026#8221; Greco concluded.\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cem\u003eCover image made with AI\u003c/em\u003e\u003c/p\u003e","url":"https://www.benzinga.com/24/11/42122260/study-reveals-psychedelic-ritual-cocktail-in-ancient-egyptian-mug","image":[{"size":"thumb","url":"https://cdn.benzinga.com/files/imagecache/250x187xUP/images/story/2024/11/21/2-9.png"},{"size":"small","url":"https://cdn.benzinga.com/files/imagecache/1024x768xUP/images/story/2024/11/21/2-9.png"},{"size":"large","url":"https://cdn.benzinga.com/files/imagecache/2048x1536xUP/images/story/2024/11/21/2-9.png"}],"channels":[{"name":"Cannabis"},{"name":"News"},{"name":"Psychedelics"}],"stocks":[],"tags":[{"name":"Blue Water Lily"},{"name":"Davide Tanasi"},{"name":"Enrico Greco"},{"name":"Psychedelics Research"},{"name":"Syrian Rue"}]}]},{"title":"Latest","title_case":false,"link":"","style":"","type":"latest_news_list","loadMoreButton":true,"showSponsoredContent":false,"query_and_options":{"options":{"displayOutput":"abstract","limit":4,"excludeSponsored":true},"query":{"primaryChannel":"123430","channelAndTagQueryOperator":"and"}},"query":{"displayOutput":"abstract","limit":4,"excludeSponsored":true,"primaryChannel":"123430","channelAndTagQueryOperator":"and"},"parsely_query":{"limit":"","author":"","tag":""},"loadMoreDevice":"all","reachContent":{"placementIndex":3,"repeatIndex":5,"preload":true},"nodes":[{"assets":[{"type":"image","title":"High-Sicence-Thumbnail-2","alt":"high science cannabis series","source":"","mime":"image/jpeg","primary":true,"attributes":{"fid":"901911","filename":"High-Sicence-Thumbnail-2.jpeg","filepath":"files/images/story/2024/11/26/High-Sicence-Thumbnail-2.jpeg","filesize":0,"image_attributes":{"resolution":{"height":0,"width":0,"dpi":0}}}}],"author":"Franca Quarneti","channels":[{"tid":123430,"vid":1,"name":"Cannabis"},{"tid":831970,"vid":1,"name":"Entertainment","description":"Entertainment"},{"tid":138079,"vid":1,"name":"Top Stories"},{"tid":2,"vid":1,"name":"Markets"},{"tid":18467,"vid":1,"name":"General"}],"created":"2024-11-26T22:57:13Z","createdAt":"2024-11-26T22:57:13Z","id":42204210,"image":"https://www.benzinga.com/files/images/story/2024/11/26/High-Sicence-Thumbnail-2.jpeg","isBzPost":true,"isBzProPost":true,"meta":{"SectorV2":{},"Partner":null,"PartnerTaxonomy":null,"SEC":null,"Author":null,"Authors":[{"uid":"0","name":""}],"Flags":{"ShowCopyrightNotice":true,"EvergreenContent":false,"ShowAdvertiserDisclosure":false,"ContributedContent":false,"AddGoogleStandoutMetaTag":false,"MediaSiteDNDOverride":false,"SendToYahooFinance":false,"SendToRobinhood":true,"SendToMSN":true},"Reach":{"Disclosure":{}},"Reference":null,"Ext":null,"wp_post_meta":{"campaign_strategy":"Default","post_id":666252,"post_path":"24/11/42204210/why-youtubes-high-science-is-a-must-watch-for-cannabis-enthusiasts","post_type":"post"}},"nodeId":42204210,"stocks":[],"storyId":"6746523db6cb720001ab238a","tags":[{"tid":799159,"vid":3,"name":"Clear Cannabis Inc"},{"tid":945713,"vid":3,"name":"Ed Leclere"},{"tid":937282,"vid":3,"name":"High Science"},{"tid":631239,"vid":3,"name":"medical cannabis"},{"tid":945711,"vid":3,"name":"Rich Batenburg Jr"},{"tid":945712,"vid":3,"name":"Rick Batenburg III"}],"teaser":"Explore High Science, a new YouTube series launching Nov. 27. Dive into cannabis innovations, pioneers, and its potential as medicine.","teaserText":"Explore High Science, a new YouTube series launching Nov. 27. Dive into cannabis innovations, pioneers, and its potential as medicine.","tickers":[],"title":"YouTube\u0026#39;s High Science Is A Must-Watch For Cannabis Enthusiasts","updated":"2024-11-26T22:57:13Z","updatedAt":"2024-11-26T22:57:13Z","url":"https://www.benzinga.com/24/11/42204210/why-youtubes-high-science-is-a-must-watch-for-cannabis-enthusiasts"},{"assets":[{"type":"image","title":"AI-Generated Image","alt":"weed marijuana cannabis kentucky","source":"AI-Generated Image ","mime":"","primary":true,"attributes":{"fid":"901909","filename":"AI-Generated-Image_1.jpeg","filepath":"files/images/story/2024/11/26/AI-Generated-Image_1.jpeg","filesize":0,"image_attributes":{"resolution":{"height":0,"width":0,"dpi":0}}}}],"author":"Nicolás Jose Rodriguez","channels":[{"tid":123430,"vid":1,"name":"Cannabis"},{"tid":26029,"vid":1,"name":"Government"},{"tid":57,"vid":1,"name":"News"},{"tid":144213,"vid":1,"name":"Regulations"},{"tid":140295,"vid":1,"name":"Health Care"},{"tid":29619,"vid":1,"name":"Legal"},{"tid":2,"vid":1,"name":"Markets"}],"created":"2024-11-26T22:28:35Z","createdAt":"2024-11-26T22:28:35Z","id":42203777,"image":"https://www.benzinga.com/files/images/story/2024/11/26/AI-Generated-Image_1.jpeg","isBzPost":true,"isBzProPost":true,"meta":{"SectorV2":{},"Partner":null,"PartnerTaxonomy":null,"SEC":null,"Author":null,"Authors":[{"uid":"0","name":""}],"Flags":{"ShowCopyrightNotice":true,"EvergreenContent":false,"ShowAdvertiserDisclosure":false,"ContributedContent":false,"AddGoogleStandoutMetaTag":false,"MediaSiteDNDOverride":false,"SendToYahooFinance":false,"SendToRobinhood":true,"SendToMSN":false},"Reach":{"Disclosure":{}},"Reference":null,"Ext":null,"wp_post_meta":{"campaign_strategy":"Default","post_id":666214,"post_path":"24/11/42203777/kentucky-awards-first-medical-cannabis-dispensary-licenses","post_type":"post"}},"nodeId":42203777,"stocks":[],"storyId":"67464b87b6cb720001ab21d3","tags":[{"tid":907081,"vid":3,"name":"cannabis licenses"},{"tid":933911,"vid":3,"name":"Cannabis Lottery"},{"tid":857126,"vid":3,"name":"Gov. Andy Beshear"},{"tid":861845,"vid":3,"name":"Governor Andy Beshear"},{"tid":155693,"vid":3,"name":"Hemp"},{"tid":841380,"vid":3,"name":"Kentucky cannabis"},{"tid":945709,"vid":3,"name":"Kentucky Office of medical cannabis"},{"tid":844051,"vid":3,"name":"retail cannabis"},{"tid":927289,"vid":3,"name":"Sam Flynn"}],"teaser":"The Kentucky Office of Medical Cannabis received nearly 5,000 applications, with 4,075 specifically for dispensaries.","teaserText":"The Kentucky Office of Medical Cannabis received nearly 5,000 applications, with 4,075 specifically for dispensaries.","tickers":[],"title":"Kentucky Awards First Medical Cannabis Dispensary Licenses","updated":"2024-11-26T22:28:35Z","updatedAt":"2024-11-26T22:28:35Z","url":"https://www.benzinga.com/24/11/42203777/kentucky-awards-first-medical-cannabis-dispensary-licenses"},{"assets":[{"type":"image","title":"Cannabis,Plant,With,Green,Leaves,And,White,Flowers,,With,Trichomes,","alt":"Cannabis,Plant,With,Green,Leaves,And,White,Flowers,,With,Trichomes,","source":"Photo: Courtesy of Plateresca via Shutterstock ","mime":"image/jpeg","primary":true,"attributes":{"fid":"901908","filename":"Cannabis-Plant-With-Green-Leaves-And-Whi.jpeg","filepath":"files/images/story/2024/11/26/Cannabis-Plant-With-Green-Leaves-And-Whi.jpeg","filesize":0,"image_attributes":{"resolution":{"height":0,"width":0,"dpi":0}}}}],"author":"Nina Zdinjak","channels":[{"tid":123430,"vid":1,"name":"Cannabis"},{"tid":57,"vid":1,"name":"News"},{"tid":125557,"vid":1,"name":"Eurozone"}],"created":"2024-11-26T22:26:57Z","createdAt":"2024-11-26T22:26:57Z","id":42203747,"image":"https://www.benzinga.com/files/images/story/2024/11/26/Cannabis-Plant-With-Green-Leaves-And-Whi.jpeg","isBzPost":true,"isBzProPost":true,"meta":{"SectorV2":{},"Partner":null,"PartnerTaxonomy":null,"SEC":null,"Author":null,"Authors":[{"uid":"0","name":""}],"Flags":{"ShowCopyrightNotice":true,"EvergreenContent":false,"ShowAdvertiserDisclosure":false,"ContributedContent":false,"AddGoogleStandoutMetaTag":false,"MediaSiteDNDOverride":false,"SendToYahooFinance":false,"SendToRobinhood":true,"SendToMSN":true},"Reach":{"Disclosure":{}},"Reference":null,"Ext":null,"wp_post_meta":{"campaign_strategy":"Default","post_id":665071,"post_path":"markets/cannabis/24/11/42203747/berlins-justice-senator-says-cannabis-law-benefits-mafia-like-structures-and-that-it-should-be-repealed","post_type":"post"}},"nodeId":42203747,"stocks":[],"storyId":"67464b26b6cb720001ab21ae","tags":[{"tid":945708,"vid":3,"name":"Felor Badenberg"},{"tid":842661,"vid":3,"name":"Germany Cannabis"}],"teaser":" ","teaserText":" ","tickers":[],"title":"Berlin\u0026#39;s Justice Senator Says Cannabis Law Benefits Mafia-Like Structures And It Should Be Repealed","updated":"2024-11-26T22:26:58Z","updatedAt":"2024-11-26T22:26:58Z","url":"https://www.benzinga.com/markets/cannabis/24/11/42203747/berlins-justice-senator-says-cannabis-law-benefits-mafia-like-structures-and-that-it-should-be-repealed"},{"assets":[{"type":"image","title":"joe_biden_cannabis_liberty_adam_schultz_on_wikimedia_commons_and_david_smart_on_shutterstock.jpg_copy copy","alt":"joe_biden_cannabis_liberty_adam_schultz_on_wikimedia_commons_and_david_smart_on_shutterstock.jpg_copy copy","source":"","mime":"","primary":true,"attributes":{"fid":"901901","filename":"joe-biden-cannabis-liberty-adam-schultz-.jpeg","filepath":"files/images/story/2024/11/26/joe-biden-cannabis-liberty-adam-schultz-.jpeg","filesize":0,"image_attributes":{"resolution":{"height":0,"width":0,"dpi":0}}}}],"author":"Maureen Meehan","channels":[{"tid":123430,"vid":1,"name":"Cannabis"},{"tid":26029,"vid":1,"name":"Government"},{"tid":57,"vid":1,"name":"News"},{"tid":16779,"vid":1,"name":"Politics"},{"tid":29619,"vid":1,"name":"Legal"}],"created":"2024-11-26T21:42:49Z","createdAt":"2024-11-26T21:42:49Z","id":42202403,"image":"https://www.benzinga.com/files/images/story/2024/11/26/joe-biden-cannabis-liberty-adam-schultz-.jpeg","isBzPost":true,"isBzProPost":true,"meta":{"SectorV2":{},"Partner":null,"PartnerTaxonomy":null,"SEC":null,"Author":null,"Authors":[{"uid":"0","name":""}],"Flags":{"ShowCopyrightNotice":true,"EvergreenContent":false,"ShowAdvertiserDisclosure":false,"ContributedContent":false,"AddGoogleStandoutMetaTag":false,"MediaSiteDNDOverride":false,"SendToYahooFinance":false,"SendToRobinhood":true,"SendToMSN":true},"Reach":{"Disclosure":{}},"Reference":null,"Ext":null,"wp_post_meta":{"campaign_strategy":"Default","post_id":666215,"post_path":"news/legal/24/11/42202403/elizabeth-warren-bernie-sanders-12-congress-members-to-biden-issue-clemency-and-pardons-for-cannabis-prisoners","post_type":"post"}},"nodeId":42202403,"stocks":[],"storyId":"674640cdb6cb720001ab1b73","tags":[{"tid":731964,"vid":3,"name":"cannabis legalization"},{"tid":858850,"vid":3,"name":"Cannabis pardons"},{"tid":945703,"vid":3,"name":"Congress Members"},{"tid":22004,"vid":3,"name":"Joe Biden"},{"tid":913345,"vid":3,"name":"Stories That Matter"}],"teaser":"While Biden pardoned individuals with federal marijuana possession convictions, these measures have resulted in no prison releases.","teaserText":"While Biden pardoned individuals with federal marijuana possession convictions, these measures have resulted in no prison releases.","tickers":[],"title":"Elizabeth Warren, Bernie Sanders \u0026amp; 12 Congress Members To Biden: Issue Clemency And Pardons For Cannabis Prisoners","updated":"2024-11-26T21:42:49Z","updatedAt":"2024-11-26T21:42:49Z","url":"https://www.benzinga.com/news/legal/24/11/42202403/elizabeth-warren-bernie-sanders-12-congress-members-to-biden-issue-clemency-and-pardons-for-cannabis-prisoners"}]}]},"align":"","mode":"edit"},"innerBlocks":[],"innerHTML":"","type":"default"},{"blockName":"core/image","attrs":{"id":180447,"sizeSlug":"large","linkDestination":"custom","data":[]},"innerBlocks":[],"innerHTML":"\n\u003cfigure class=\"wp-block-image size-large\"\u003e\u003ca href=\"https://www.benzinga.com/psychedelics\" data-lasso-id=\"103\"\u003e\u003cimg src=\"https://benzinga.com/wp-content/uploads/2023/02/Copy-of-April-2022-Psychedelics-Ad-728x90-1.png\" alt=\"\" class=\"wp-image-180447\"/\u003e\u003c/a\u003e\u003c/figure\u003e\n","image":{"image_id":180447,"attachment_id":180447,"title":"Copy-of-April-2022-Psychedelics-Ad-728x90-1","caption":null,"sizes":{"original":{"height":111,"width":900,"url":"https://cdnwp-s3.benzinga.com/wp-content/uploads/2022/04/29135419/Copy-of-April-2022-Psychedelics-Ad-728x90-1.png"},"medium":{"height":37,"width":300,"url":"https://cdnwp-s3.benzinga.com/wp-content/uploads/2022/04/29135419/Copy-of-April-2022-Psychedelics-Ad-728x90-1-300x37.png"},"thumbnail":{"height":111,"width":150,"url":"https://cdnwp-s3.benzinga.com/wp-content/uploads/2022/04/29135419/Copy-of-April-2022-Psychedelics-Ad-728x90-1-150x111.png"},"medium_large":{"height":95,"width":768,"url":"https://cdnwp-s3.benzinga.com/wp-content/uploads/2022/04/29135419/Copy-of-April-2022-Psychedelics-Ad-728x90-1-768x95.png"},"Multi Rating Pro Thumbnail":{"height":100,"width":100,"url":"https://cdnwp-s3.benzinga.com/wp-content/uploads/2022/04/29135419/Copy-of-April-2022-Psychedelics-Ad-728x90-1-100x100.png"},"web-stories-poster-portrait":{"height":111,"width":640,"url":"https://cdnwp-s3.benzinga.com/wp-content/uploads/2022/04/29135419/Copy-of-April-2022-Psychedelics-Ad-728x90-1-640x111.png"},"web-stories-publisher-logo":{"height":96,"width":96,"url":"https://cdnwp-s3.benzinga.com/wp-content/uploads/2022/04/29135419/Copy-of-April-2022-Psychedelics-Ad-728x90-1-96x96.png"},"web-stories-thumbnail":{"height":19,"width":150,"url":"https://cdnwp-s3.benzinga.com/wp-content/uploads/2022/04/29135419/Copy-of-April-2022-Psychedelics-Ad-728x90-1-150x19.png"}}},"href":"https://www.benzinga.com/psychedelics","type":"default"},{"blockName":"acf/carousel-news","attrs":{"name":"acf/carousel-news","data":{"title":" Cannabis Interviews \u0026 Exclusives","link":"/cannabis/interviews","variant":"reverse","layout":"default","options":{"show_arrows_only_on_overflow":false,"slides_per_page":"","height":"197","width":"300","object_fit":"cover","title_case":false,"background_color":""},"query_and_options":{"options":{"displayOutput":"abstract","limit":12},"query":{"primaryChannel":"123430","channels":[165347,145889],"channelAndTagQueryOperator":"and"}},"default_image":null,"initialItems":[{"href":"/government/regulations/24/11/42173811/hemp-and-thanksgiving-from-the-mayflower-to-independence-the-crop-that-helped-build-a-nation","id":42173811,"image":"https://cdn.benzinga.com/files/images/story/2024/11/25/AI-Generated-Image.jpeg","isBzPost":true,"isBzProPost":true,"title":"Hemp And Thanksgiving: From The Mayflower To Independence, The Crop That Helped Build A Nation"},{"href":"/general/market-summary/24/11/42147417/80-leverage-5-5x-ebitda-is-cresco-the-high-risk-high-reward-play-investors-need","id":42147417,"image":"https://cdn.benzinga.com/files/images/story/2024/11/22/AI-Generated-Image_1.jpeg","isBzPost":true,"isBzProPost":true,"title":"80% Leverage, 5.5x EBITDA: Is Cresco The High-Risk, High-Reward Play Investors Need?"},{"href":"/government/regulations/24/11/42146896/exclusive-how-equa-tackles-stigma-in-cannabis-insurance-with-tailored-solutions","id":42146896,"image":"https://cdn.benzinga.com/files/images/story/2024/11/22/equaloretta.png","isBzPost":true,"isBzProPost":true,"title":"EXCLUSIVE: How EQUA Tackles Stigma In Cannabis Insurance With Tailored Solutions"},{"href":"/general/market-summary/24/11/42146751/jupiters-burnout-can-tilt-holdings-reverse-its-five-year-vape-decline","id":42146751,"image":"https://cdn.benzinga.com/files/images/story/2024/11/22/AI-Generated-Image_0.jpeg","isBzPost":true,"isBzProPost":true,"title":"Jupiter\u0026#39;s Burnout: Can TILT Holdings Reverse Its Five-Year Vape Decline?"},{"href":"/24/11/42145274/the-most-authentic-celebrity-story-in-cannabis-building-trust-through-real-connections","id":42145274,"image":"https://cdn.benzinga.com/files/images/story/2024/11/22/Wiz-Khalifa-Duki.png","isBzPost":true,"isBzProPost":true,"title":"\u0026#39;The Most Authentic Celebrity Story In Cannabis\u0026#39;: Khalifa Kush Exec"},{"href":"/markets/cannabis/24/11/42144102/california-has-the-finest-weed-in-the-world-says-lab-expert-and-how-to-save-its-struggling-market","id":42144102,"image":"https://cdn.benzinga.com/files/images/story/2024/11/25/Microbiology-Testing-PCR-5.jpeg","isBzPost":true,"isBzProPost":true,"title":"California Has The Finest Weed In The World, Says Lab Expert, And How To Save Its Struggling Market"},{"href":"/24/11/42130221/the-best-and-worst-performing-states-for-cannabis-sales-in-2024-ytd-winners-and-losers","id":42130221,"image":"https://cdn.benzinga.com/files/images/story/2024/11/21/AI-Generated-Image_4.jpeg","isBzPost":true,"isBzProPost":true,"title":"Best And Worst Performing States For Cannabis Sales In 2024: YTD Winners \u0026amp; Losers"},{"href":"/24/11/42130001/green-wednesdays-biggest-weed-buyers-the-surprising-archetypes-driving-sales","id":42130001,"image":"https://cdn.benzinga.com/files/images/story/2024/11/21/AI-Generated-Image_3.jpeg","isBzPost":true,"isBzProPost":true,"title":"Green Wednesday\u0026#39;s Biggest Weed Buyers: The Surprising Archetypes Driving Sales"},{"href":"/24/11/42117877/innovation-starts-at-the-farm-how-cannabis-brands-balance-quality-with-consumer-demand","id":42117877,"image":"https://cdn.benzinga.com/files/images/story/2024/11/21/AI-Generated-Image_0.jpeg","isBzPost":true,"isBzProPost":true,"title":"\u0026#39;Innovation Starts At The Farm\u0026#39;: How Cannabis Brands Balance Quality With Consumer Demand"},{"href":"/general/biotech/24/11/42116309/traceable-reliable-stable-seeds-dutch-passion-the-cannabis-biotech-you-didnt-know-you-needed","id":42116309,"image":"https://cdn.benzinga.com/files/images/story/2024/11/21/Courtesy-of-Dutch-Passion-Seeds.jpeg","isBzPost":true,"isBzProPost":true,"title":"Traceable, Reliable, Stable Seeds: Dutch Passion, The Cannabis Biotech You Didn\u0026#39;t Know You Needed"},{"href":"/24/11/42111313/exclusive-fluent-launches-new-cannabis-concentrates-line-for-medical-marijuana-patients-in-florida","id":42111313,"image":"https://cdn.benzinga.com/files/images/story/2024/11/21/Cannabis-Concentrate--High-Thc--Pieces-O.jpeg","isBzPost":true,"isBzProPost":true,"title":"FLUENT Launches New Cannabis Concentrates Line For Medical Marijuana Patients In Florida"},{"href":"/24/11/42098929/culture-is-not-something-you-can-buy-why-genuine-engagement-matters-in-cannabis","id":42098929,"image":"https://cdn.benzinga.com/files/images/story/2024/11/20/cannabis-ai3-copy.jpeg","isBzPost":true,"isBzProPost":true,"title":"\u0026#39;Culture Is Not Something You Can Buy\u0026#39;: Why Genuine Engagement Matters In Cannabis"}]},"align":"","mode":"edit"},"innerBlocks":[],"innerHTML":"","type":"default"},{"blockName":"acf/google-ad-placement","attrs":{"name":"acf/google-ad-placement","data":{"slot_placement_id":"4107070","slot_width":"","slot_height":"","slot_google_ad_id":"DotCom_Leaderboard","display":"all-devices","dynamic_height":false,"size_mapping":[{"viewport":[1300,768],"sizes":[[728,90],[970,250]]},{"viewport":[1072,764],"sizes":[[300,50]]},{"viewport":[900,768],"sizes":[[300,50],[300,250],[728,90],[970,250]]}]},"align":"","mode":"edit"},"innerBlocks":[],"innerHTML":"","type":"default"},{"blockName":"acf/news-list-group","attrs":{"name":"acf/news-list-group","data":{"groups":[{"title":"Earnings","title_case":false,"link":"https://www.benzinga.com/cannabis/earnings","style":"","type":"default","loadMoreButton":false,"showSponsoredContent":false,"query_and_options":{"options":{"displayOutput":"full","limit":4},"query":{"primaryChannel":"123430","channels":[16888],"channelAndTagQueryOperator":"and"}},"query":{"displayOutput":"full","limit":4,"primaryChannel":"123430","channels":[16888],"channelAndTagQueryOperator":"and"},"parsely_query":{"limit":"","author":"","tag":""},"reachContent":{"placementIndex":3,"repeatIndex":5,"preload":true},"nodes":[{"assets":[{"type":"image","title":"pexels-kindelmedia-7668049(1)","alt":"Cannabis earnings","source":"Photo: Courtesy of Kindel Media","mime":"","primary":true,"attributes":{"fid":"901001","filename":"pexels-kindelmedia-76680491.jpeg","filepath":"files/images/story/2024/11/22/pexels-kindelmedia-76680491.jpeg","filesize":0,"image_attributes":{"resolution":{"height":0,"width":0,"dpi":0}}}}],"author":"Jelena Martinovic","body":"\u003cp\u003e\u003cstrong\u003eDecibel Cannabis Company Inc.\u003c/strong\u003e (TSXV:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/DB#TSXV\"\u003eDB\u003c/a\u003e) (OTCQB:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/DBCCF#OTCQB\"\u003eDBCCF\u003c/a\u003e) announced its unaudited interim financial results on Thursday for the third quarter ending Sept. 30, 2024.\u003c/p\u003e\n\n\n\n\u003cp\u003e\u0026#8220;Decibel has been very deliberate about reducing our current liabilities, by ~5mm this quarter,\" CEO \u003cstrong\u003eBenjamin Sze\u003c/strong\u003e said.\u0026nbsp;\"Maintaining discipline over time will result in a stronger balance sheet.\u0026nbsp; This marks the last quarter where our primary focus is on Canadian domestic recreational sales. While we continue to integrate AgMedica into our portfolio, it is encouraging to see significant demand internationally for Decibel flower.\u0026#8221;\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eRead Also: \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/08/40369534/decibel-cannabis-reports-22-yoy-decrease-in-q2-net-revenue-plans-to-benefit-with-new-product-lau\"\u003eDecibel Cannabis Reports 22% YoY Decrease In Q2 Net Revenue, Plans To Benefit With New Product Launches\u003c/a\u003e\u003c/strong\u003e\u003c/p\u003e\n\n\n\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003e\u003cem\u003eGet Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter \u003ca href=\"https://newsletteremail.benzinga.com/subscribe\" target=\"_blank\" rel=\"noreferrer noopener\"\u003ehere\u003c/a\u003e. If you're serious about the business, you can't afford to miss out.\u003c/em\u003e\u003c/strong\u003e\u003c/li\u003e\n\u003c/ul\u003e\n\n\n\n\u003ch3 class=\"wp-block-heading\"\u003eQ3 Financial Highlights\u003c/h3\u003e\n\n\n\n\u003cul\u003e\n\u003cli\u003eNet revenue totaled CA$24.1 million ($17.2 million), representing a 9% increase sequentially, but a 12% decrease year-over-year.\u003c/li\u003e\n\n\n\n\u003cli\u003eGross profit before fair value adjustments was CA$12.7 million, compared to roughly CA$12 million in the prior year's period.\u003c/li\u003e\n\n\n\n\u003cli\u003eGross margin before fair value adjustments reached 53% in the third quarter, up from 44% in the prior year's period, reflecting improved operational efficiency.\u003c/li\u003e\n\n\n\n\u003cli\u003eAdjusted EBITDA was positive at CA$5.1 million, representing a 31% increase from the previous quarter but a 21% decrease year over year.\u003c/li\u003e\n\n\n\n\u003cli\u003eNet loss and comprehensive loss amounted to CA$585 000, compared to a net income and comprehensive income of CA$413 000.\u003c/li\u003e\n\n\n\n\u003cli\u003eGenerated positive free cash flow of $1.8 million, up 75% year-over-year.\u003c/li\u003e\n\u003c/ul\u003e\n\n\n\n\u003cp\u003eThe company said that it's seeing significant demand for its flower internationally as it continues to integrate\u003cstrong\u003e \u003c/strong\u003eAgMedica.\u003c/p\u003e\n\n\n\n\u003cp\u003eDecibel \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/10/41600492/decibel-acquires-agmedica-announces-private-placement-and-third-quarter-guidance\"\u003eclosed the acquisition\u003c/a\u003e of \u003cstrong\u003eAgMedica Bioscience Ltd\u003c/strong\u003e. in October. The transaction was arranged through an agreement with Callisto Capital Corp. and was made in exchange for a $6.3 million unsecured convertible debenture.\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eRead Next:\u003c/strong\u003e\u003c/p\u003e\n\n\n\n\u003cul\u003e\n\u003cli\u003e\u003ca href=\"https://www.benzinga.com/analyst-ratings/analyst-color/24/08/40577591/decibels-10m-strategy-how-it-could-enhance-your-canadian-cannabis-portfolio\"\u003e\u003cstrong\u003eDecibel\u0026#8217;s $10M Strategy: How It Could Enhance Your Canadian Cannabis Portfolio\u003c/strong\u003e\u003c/a\u003e\u003c/li\u003e\n\u003c/ul\u003e\n\n\n\n\u003ch3 class=\"wp-block-heading\"\u003eDBCCF Price Action\u003c/h3\u003e\n\n\n\n\u003cp\u003eDecibel's shares traded 5.54% higher at $0.0495 per share after the market close on Thursday afternoon.\u003c/p\u003e","channels":[{"tid":123430,"vid":1,"name":"Cannabis"},{"tid":16888,"vid":1,"name":"Earnings"},{"tid":57,"vid":1,"name":"News"}],"created":"2024-11-22T13:54:23Z","createdAt":"2024-11-22T13:54:23Z","id":42137701,"image":"https://www.benzinga.com/files/images/story/2024/11/22/pexels-kindelmedia-76680491.jpeg","isBzPost":true,"isBzProPost":true,"meta":{"SectorV2":{"SIC":[{"IndustryCode":3741,"Industry":"Pharmaceutical and Medicine Industry","IndustryGroup":374,"MajorGroup":37,"Division":""}],"NAICS":[{"NationalIndustryCode":325412,"NationalIndustry":"Pharmaceutical Preparation Manufacturing ","IndustryCode":32541,"Industry":"Pharmaceutical and Medicine Manufacturing","IndustryGroupCode":3254,"IndustryGroup":"Pharmaceutical and Medicine Manufacturing","SubSectorCode":325,"SubSector":"Chemical Manufacturing","SectorCode":32,"Sector":"Manufacturing"}],"Morningstar":[{"IndustryCode":10320020,"Industry":"Banks—Regional","IndustryGroupCode":10320,"IndustryGroup":"Banks","SectorCode":103,"Sector":"Financial Services","SuperSectorCode":1,"SuperSector":"Cyclical"},{"IndustryCode":20620020,"Industry":"Drug Manufacturers—Specialty \u0026 Generic","IndustryGroupCode":20620,"IndustryGroup":"Drug Manufacturers","SectorCode":206,"Sector":"Healthcare","SuperSectorCode":2,"SuperSector":"Defensive"}]},"Partner":null,"PartnerTaxonomy":null,"SEC":null,"Author":null,"Authors":[{"uid":"0","name":""}],"Flags":{"ShowCopyrightNotice":true,"EvergreenContent":false,"ShowAdvertiserDisclosure":false,"ContributedContent":false,"AddGoogleStandoutMetaTag":false,"MediaSiteDNDOverride":false,"SendToYahooFinance":false,"SendToRobinhood":true,"SendToMSN":false},"Reach":{"Disclosure":{}},"Reference":null,"Ext":null,"wp_post_meta":{"campaign_strategy":"Default","post_id":660753,"post_path":"24/11/42137701/canadian-cannabis-co-decibel-reports-12-yoy-drop-in-q3-revenue-but-increases-gross-margin-to-53","post_type":"post"}},"nodeId":42137701,"stocks":[{"tid":14243,"vid":2,"name":"DB","description":"Deutsche Bank Ag"},{"tid":769655,"vid":2,"name":"DBCCF","description":"Decibel Cannabis Co"},{"tid":769656,"vid":2,"name":"TSXV:DB"}],"storyId":"67408d03b6cb720001aa1066","tags":[{"tid":945494,"vid":3,"name":"AgMedica"},{"tid":927015,"vid":3,"name":"Benjamin Sze"},{"tid":712759,"vid":3,"name":"Canada Cannabis"},{"tid":734058,"vid":3,"name":"Cannabis Earnings"},{"tid":20107,"vid":3,"name":"earnings report"},{"tid":914018,"vid":3,"name":"third quarter financial results"}],"teaser":"Decibel Cannabis Company Inc. (TSXV: DB) (OTCQB: DBCCF) announced on Thursday its unaudited interim financial results for the third quarter ending Sept. 30, 2024. \u0026#34;Decibel has been very deliberate about reducing our current liabilities, by ~5mm this quarter,\u0026#34; CEO Benjamin Sze said. \u0026#34;Maintaining discipline over time will result in a stronger balance sheet. This marks the last quarter where our primary focus is on Canadian domestic recreational sales. While we continue to integrate AgMedica into our portfolio, it is encouraging to see significant demand internationally for Decibel flower.\u0026#34;","teaserText":"Decibel Cannabis Company Inc. (TSXV: DB) (OTCQB: DBCCF) announced on Thursday its unaudited interim financial results for the third quarter ending Sept. 30, 2024. \u0026#34;Decibel has been very deliberate about reducing our current liabilities, by ~5mm this quarter,\u0026#34; CEO Benjamin Sze said. \u0026#34;Maintaining discipline over time will result in a stronger balance sheet. This marks the last quarter where our primary focus is on Canadian domestic recreational sales. While we continue to integrate AgMedica into our portfolio, it is encouraging to see significant demand internationally for Decibel flower.\u0026#34;","tickers":[{"tid":14243,"vid":2,"name":"DB","description":"Deutsche Bank Ag"},{"tid":769655,"vid":2,"name":"DBCCF","description":"Decibel Cannabis Co"},{"tid":769656,"vid":2,"name":"TSXV:DB"}],"title":"Canadian Cannabis Co. Decibel Reports 12% YoY Drop In Q3 Revenue But Increases Gross Margin To 53%","updated":"2024-11-22T13:54:23Z","updatedAt":"2024-11-22T13:54:23Z","url":"https://www.benzinga.com/24/11/42137701/canadian-cannabis-co-decibel-reports-12-yoy-drop-in-q3-revenue-but-increases-gross-margin-to-53"},{"assets":[{"type":"image","title":"cannabis, stock market, trading, earnings Business,Cannabis,Leaves,Marijuana,Stock,Exchange,Market,Or,Trading,Analysis","alt":"cannabis, stock market, trading, earnings Business,Cannabis,Leaves,Marijuana,Stock,Exchange,Market,Or,Trading,Analysis","source":"Photo: Courtesy of C.Aphirak via Shutterstock","mime":"","primary":true,"attributes":{"fid":"900867","filename":"cannabis--stock-market--trading--earning.jpeg","filepath":"files/images/story/2024/11/21/cannabis--stock-market--trading--earning.jpeg","filesize":0,"image_attributes":{"resolution":{"height":0,"width":0,"dpi":0}}}}],"author":"Patricio Liddle","body":"\u003cp\u003e\u003cstrong\u003eInnocan Pharma Corporation \u003c/strong\u003e(OTC:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/INNPF#OTC\"\u003eINNPF\u003c/a\u003e), an Israel-based \u003ca href=\"http://benzinga.com/cannabis\"\u003ecannabinoids-focused\u003c/a\u003e pharmaceutical company, reported a 174% year-over-year revenue growth, reaching $24 million for the first nine months of 2024. Quarterly revenues rose 111% YoY to $8.6 million, driven by robust sales from its subsidiary, \u003cstrong\u003eBI Sky Global Ltd.\u003c/strong\u003e\u003c/p\u003e\n\n\n\n\u003ch4 class=\"wp-block-heading\"\u003e\u003cstrong\u003eQ3 2024 Financial Highlights\u003c/strong\u003e\u003c/h4\u003e\n\n\n\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003eRevenue was $8.6 million for the third quarter\u003c/strong\u003e, up 111% year-over-year, and $24 million for the nine-month period, up 174% year-over-year.\u003c/li\u003e\n\n\n\n\u003cli\u003e\u003cstrong\u003eNet income was $0.3 million\u003c/strong\u003e, an increase of $2.1 million compared to a net loss of $1.8 million in Q3 2023.\u003c/li\u003e\n\n\n\n\u003cli\u003e\u003cstrong\u003eAdjusted EBITDA \u003c/strong\u003ewas not stated in the press release.\u003c/li\u003e\n\n\n\n\u003cli\u003e\u003cstrong\u003eGross profit was $7.8 million for the third quarter\u003c/strong\u003e, up 112% year-over-year.\u003c/li\u003e\n\u003c/ul\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eGross profit surged 183% YoY for the nine-month period\u003c/strong\u003e, totaling $21.8 million, while Q3 gross profit grew 112% to $7.8 million. Operating profit turned positive, reaching $0.4 million, reversing a $1.2 million loss in Q3 2023.\u0026nbsp;\u003c/p\u003e\n\n\n\n\u003cp\u003eNet profit also improved significantly, increasing by $2.1 million to $0.3 million for the quarter.\u003c/p\u003e\n\n\n\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003e\u003cem\u003eGet Benzinga\u0026#8217;s exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter \u003c/em\u003e\u003c/strong\u003e\u003ca href=\"https://newsletteremail.benzinga.com/subscribe\"\u003e\u003cstrong\u003e\u003cem\u003ehere\u003c/em\u003e\u003c/strong\u003e\u003c/a\u003e\u003cstrong\u003e\u003cem\u003e. If you\u0026#8217;re serious about the business, you can\u0026#8217;t afford to miss out.\u003c/em\u003e\u003c/strong\u003e\u003c/li\u003e\n\u003c/ul\u003e\n\n\n\n\u003ch3 class=\"wp-block-heading\"\u003e\u003cstrong\u003eManagement Commentary\u003c/strong\u003e\u003c/h3\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eIris Bincovich\u003c/strong\u003e, Innocan's CEO, attributed the strong performance to the company's dual focus on pharmaceutical innovation and wellness. She highlighted the company's progress in developing LPT-CBD, a proprietary non-opioid chronic pain management solution targeting both human and animal care. \"Innocan is bringing strong value for shareholders,\" Bincovich \u003ca href=\"https://www.newswire.ca/news-releases/innocan-pharma-reports-third-quarter-2024-financial-results-849241974.html\"\u003esaid\u003c/a\u003e, emphasizing the company's commitment to addressing chronic pain.\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eRead Also: \u003c/strong\u003e\u003ca href=\"https://www.benzinga.com/general/market-summary/24/11/42049450/can-trumps-return-save-the-cannabis-sector-debt-mounts-as-giants-face-post-election-reckoning\"\u003e\u003cstrong\u003eCan Trump\u0026#8217;s Return Save The Cannabis Sector? Debt Mounts As Giants Face Post-Election Reckoning\u003c/strong\u003e\u003c/a\u003e\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eRoni Kamhi\u003c/strong\u003e, of BI Sky Global and COO of Innocan Pharma, highlighted the company\u0026#8217;s consistent growth. \u0026#8220;We are pleased to report nine consecutive quarters of continuous revenue growth,\u0026#8221; he stated. He credited new product launches and enhanced brand awareness for the success.\u003c/p\u003e\n\n\n\n\u003cp\u003eInnocan's financial gains underscore its strategic focus on innovation and market expansion, positioning the company as a rising player in the pharmaceutical sector. The company's results signal ongoing growth potential amid increasing demand for non-opioid pain management solutions.\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eRead Next:\u003c/strong\u003e\u003c/p\u003e\n\n\n\n\u003cul\u003e\n\u003cli\u003e\u003ca href=\"https://www.benzinga.com/news/earnings/24/11/42039385/enveric-biosciences-trims-losses-eyes-key-drug-approval-for-difficult-to-treat-mental-health-disorders\"\u003e\u003cstrong\u003eEnveric Biosciences Trims Losses, Eyes Key Drug Approval For Difficult-To-Treat Mental Health Disorders\u003c/strong\u003e\u003c/a\u003e\u003c/li\u003e\n\u003c/ul\u003e","channels":[{"tid":123430,"vid":1,"name":"Cannabis"},{"tid":16888,"vid":1,"name":"Earnings"},{"tid":57,"vid":1,"name":"News"}],"created":"2024-11-21T20:49:09Z","createdAt":"2024-11-21T20:49:09Z","id":42122829,"image":"https://www.benzinga.com/files/images/story/2024/11/21/cannabis--stock-market--trading--earning.jpeg","isBzPost":true,"isBzProPost":true,"meta":{"SectorV2":{"SIC":[{"IndustryCode":3741,"Industry":"Pharmaceutical and Medicine Industry","IndustryGroup":374,"MajorGroup":37,"Division":""}],"NAICS":[{"NationalIndustryCode":325412,"NationalIndustry":"Pharmaceutical Preparation Manufacturing ","IndustryCode":32541,"Industry":"Pharmaceutical and Medicine Manufacturing","IndustryGroupCode":3254,"IndustryGroup":"Pharmaceutical and Medicine Manufacturing","SubSectorCode":325,"SubSector":"Chemical Manufacturing","SectorCode":32,"Sector":"Manufacturing"}],"Morningstar":[{"IndustryCode":20620020,"Industry":"Drug Manufacturers—Specialty \u0026 Generic","IndustryGroupCode":20620,"IndustryGroup":"Drug Manufacturers","SectorCode":206,"Sector":"Healthcare","SuperSectorCode":2,"SuperSector":"Defensive"}]},"Partner":null,"PartnerTaxonomy":null,"SEC":null,"Author":null,"Authors":[{"uid":"0","name":""}],"Flags":{"ShowCopyrightNotice":true,"EvergreenContent":false,"ShowAdvertiserDisclosure":false,"ContributedContent":false,"AddGoogleStandoutMetaTag":false,"MediaSiteDNDOverride":false,"SendToYahooFinance":false,"SendToRobinhood":true,"SendToMSN":false},"Reach":{"Disclosure":{}},"Reference":null,"Ext":null,"wp_post_meta":{"campaign_strategy":"Default","post_id":659381,"post_path":"24/11/42122829/cannabinoid-leader-innocan-pharma-reports-174-yoy-revenue-growth","post_type":"post"}},"nodeId":42122829,"stocks":[{"tid":737819,"vid":2,"name":"INNPF","primary":true}],"storyId":"673f9cc13f4e8b0001bb2330","tags":[{"tid":893158,"vid":3,"name":"BI Sky Global"},{"tid":734058,"vid":3,"name":"Cannabis Earnings"},{"tid":725960,"vid":3,"name":"Israel Cannabis"}],"teaser":"Innocan Pharma reports 174% YoY revenue growth in Q3 2024, driven by innovation in cannabinoids and strong sales from BI Sky Global Ltd.","teaserText":"Innocan Pharma reports 174% YoY revenue growth in Q3 2024, driven by innovation in cannabinoids and strong sales from BI Sky Global Ltd.","tickers":[{"tid":737819,"vid":2,"name":"INNPF","primary":true}],"title":"Cannabinoid Leader Innocan Pharma\u0026#39;s Q3: 174% YoY Revenue Growth","updated":"2024-11-21T20:49:09Z","updatedAt":"2024-11-21T20:49:09Z","url":"https://www.benzinga.com/24/11/42122829/cannabinoid-leader-innocan-pharma-reports-174-yoy-revenue-growth"},{"assets":[{"type":"image","title":"elsa-olofsson-ZYEk3w9q2DM-unsplash(3)","alt":"Cannabis earnings","source":"Photo: Courtesy of Elsa Olofsson on Unsplash","mime":"","primary":true,"attributes":{"fid":"900715","filename":"elsa-olofsson-ZYEk3w9q2DM-unsplash3.jpeg","filepath":"files/images/story/2024/11/21/elsa-olofsson-ZYEk3w9q2DM-unsplash3.jpeg","filesize":0,"image_attributes":{"resolution":{"height":0,"width":0,"dpi":0}}}}],"author":"Jelena Martinovic","body":"\u003cp\u003eCannabis operator with vertical operations in Arizona and Ohio \u003cstrong\u003eVext Science, Inc\u003c/strong\u003e. (CSE:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/VEXT#CSE\"\u003eVEXT\u003c/a\u003e) (OTCQX:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/VEXTF#OTCQX\"\u003eVEXTF\u003c/a\u003e) reported on its financial results Thursday for the period ended Sept. 30, 2024.\u003c/p\u003e\n\n\n\n\u003cp\u003e\u0026#8220;Vext\u0026#8217;s performance in the third quarter of 2024 was a testament to the team\u0026#8217;s disciplined execution amid persistent macroeconomic headwinds,\"\u003cstrong\u003e Eric Offenberger, \u003c/strong\u003eCEO of Vext, said. \"Our solid Adjusted EBITDA results reflect both the transition to adult-use sales in Ohio, as well as our focus on maintaining strict cost control. Despite a challenging economic climate and typical third-quarter seasonality and pricing pressures in the Arizona market with the ongoing supply-demand imbalance, we\u0026#8217;re pleased to report that our economic unit volumes remain strong.\"\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eRead Also: \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/08/40463152/vext-cannabis-co-s-q2-revenue-drops-over-8-yoy-but-top-cannabis-analyst-sees-ohio-market-as-majo\"\u003eVext Cannabis Co.\u0026#8217;s Q2 Revenue Drops Over 8% YoY, But Top Cannabis Analyst Sees Ohio Market As Major Growth Driver\u003c/a\u003e\u003c/strong\u003e\u003c/p\u003e\n\n\n\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003e\u003cem\u003eGet Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter \u003ca href=\"https://newsletteremail.benzinga.com/subscribe\" target=\"_blank\" rel=\"noreferrer noopener\"\u003ehere\u003c/a\u003e. If you're serious about the business, you can't afford to miss out.\u003c/em\u003e\u003c/strong\u003e\u003c/li\u003e\n\u003c/ul\u003e\n\n\n\n\u003ch3 class=\"wp-block-heading\"\u003eQ3 2024 Financial Highlights\u003c/h3\u003e\n\n\n\n\u003cul\u003e\n\u003cli\u003eRevenue totaled roughly $9 million, up from $8 million in the prior year's period.\u003c/li\u003e\n\n\n\n\u003cli\u003eGross profit was $3.9 million, up from $2.8 million in the third quarter of last year.\u003c/li\u003e\n\n\n\n\u003cli\u003eTotal operating expenses amounted to $5.2 million, up from $4.5 million in the corresponding quarter of 2023.\u003c/li\u003e\n\n\n\n\u003cli\u003eAdjusted EBITDA amounted to approximately $2.9 million, up from $1 million in the third quarter of 2023.\u003c/li\u003e\n\n\n\n\u003cli\u003eNet loss was $2.5 million, up from $1.8 million in the prior year's period.\u003c/li\u003e\n\u003c/ul\u003e\n\n\n\n\u003ch3 class=\"wp-block-heading\"\u003eOutlook\u003c/h3\u003e\n\n\n\n\u003cp\u003eThe company noted that it's well-positioned to increase its Ohio footprint with an integrated approach.\u003c/p\u003e\n\n\n\n\u003cp\u003eVext aims to open more dispensaries in Ohio by 2025–2026, anticipating reaching the state's dispensary cap of 8.\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003ePablo Zuanic,\u003c/strong\u003e senior analyst at Zuanic \u0026amp; Associates initiated coverage of Vext Science with an Overweight rating earlier this year, highlighting the company\u0026#8217;s significant growth potential.\u003c/p\u003e\n\n\n\n\u003cp\u003eZuanic calculated that Vext has the most EBITDA torque among the twelve public multi-state operators (MSOs) in Ohio, projecting Vext\u0026#8217;s EBITDA could grow six-fold by calendar 2026, taking calendar 2023 as the base year. Recreational marijuana sales launched across Ohio on \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/08/40172821/its-official-ohio-begins-recreational-cannabis-sales-on-tuesday-heres-where-and-how-you-know-the\"\u003eTuesday, Aug. 6.\u003c/a\u003e\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eRead Next:\u003c/strong\u003e\u003c/p\u003e\n\n\n\n\u003cul\u003e\n\u003cli\u003e\u003ca href=\"https://www.benzinga.com/markets/cannabis/24/09/40761882/1b-in-26-days-this-marijuana-company-is-capitalizing-on-ohios-cannabis-surge\"\u003e\u003cstrong\u003e$1B In 26 Days: This Marijuana Company Is Capitalizing On Ohio's Cannabis Surge\u003c/strong\u003e\u003c/a\u003e\u003c/li\u003e\n\u003c/ul\u003e","channels":[{"tid":123430,"vid":1,"name":"Cannabis"},{"tid":16888,"vid":1,"name":"Earnings"},{"tid":57,"vid":1,"name":"News"},{"tid":30777,"vid":1,"name":"Retail Sales"}],"created":"2024-11-21T15:28:36Z","createdAt":"2024-11-21T15:28:36Z","id":42115532,"image":"https://www.benzinga.com/files/images/story/2024/11/21/elsa-olofsson-ZYEk3w9q2DM-unsplash3.jpeg","isBzPost":true,"isBzProPost":true,"meta":{"SectorV2":{"SIC":[{"IndustryCode":3741,"Industry":"Pharmaceutical and Medicine Industry","IndustryGroup":374,"MajorGroup":37,"Division":""}],"NAICS":[{"NationalIndustryCode":325412,"NationalIndustry":"Pharmaceutical Preparation Manufacturing ","IndustryCode":32541,"Industry":"Pharmaceutical and Medicine Manufacturing","IndustryGroupCode":3254,"IndustryGroup":"Pharmaceutical and Medicine Manufacturing","SubSectorCode":325,"SubSector":"Chemical Manufacturing","SectorCode":32,"Sector":"Manufacturing"}],"Morningstar":[{"IndustryCode":20620020,"Industry":"Drug Manufacturers—Specialty \u0026 Generic","IndustryGroupCode":20620,"IndustryGroup":"Drug Manufacturers","SectorCode":206,"Sector":"Healthcare","SuperSectorCode":2,"SuperSector":"Defensive"}]},"Partner":null,"PartnerTaxonomy":null,"SEC":null,"Author":null,"Authors":[{"uid":"0","name":""}],"Flags":{"ShowCopyrightNotice":true,"EvergreenContent":false,"ShowAdvertiserDisclosure":false,"ContributedContent":false,"AddGoogleStandoutMetaTag":false,"MediaSiteDNDOverride":false,"SendToYahooFinance":false,"SendToRobinhood":true,"SendToMSN":false},"Reach":{"Disclosure":{}},"Reference":null,"Ext":null,"wp_post_meta":{"campaign_strategy":"Default","post_id":658799,"post_path":"24/11/42115532/this-cannabis-co-is-capitalizing-on-ohios-recreational-sales-reports-165-yoy-increase-in-q3-adjusted-ebitda","post_type":"post"}},"nodeId":42115532,"stocks":[{"tid":761042,"vid":2,"name":"CSE:VEXT","primary":true},{"tid":761043,"vid":2,"name":"VEXTF","primary":true}],"storyId":"673f51a13f4e8b0001bb05ed","tags":[{"tid":734058,"vid":3,"name":"Cannabis Earnings"},{"tid":20107,"vid":3,"name":"earnings report"},{"tid":804604,"vid":3,"name":"Eric Offenberger"},{"tid":154491,"vid":3,"name":"Pablo Zuanic"},{"tid":914018,"vid":3,"name":"third quarter financial results"}],"teaser":"Cannabis operator with vertical operations in Arizona and Ohio Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) reported on Thursday its financial results for the period ended Sept. 30, 2024. \u0026#34;Vext\u0026#39;s performance in the third quarter of 2024 was a testament to the team\u0026#39;s disciplined execution amid persistent macroeconomic headwinds,\u0026#34; Eric Offenberger, CEO of Vext, said. \u0026#34;Our solid Adjusted EBITDA results reflect both the transition to adult-use sales in Ohio, as well as our focus on maintaining strict cost control. Despite a challenging economic climate and typical third-quarter seasonality and pricing pressures in the Arizona market with the ongoing supply-demand imbalance, we\u0026#39;re pleased to report that our economic unit volumes remain strong.\u0026#34;","teaserText":"Cannabis operator with vertical operations in Arizona and Ohio Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) reported on Thursday its financial results for the period ended Sept. 30, 2024. \u0026#34;Vext\u0026#39;s performance in the third quarter of 2024 was a testament to the team\u0026#39;s disciplined execution amid persistent macroeconomic headwinds,\u0026#34; Eric Offenberger, CEO of Vext, said. \u0026#34;Our solid Adjusted EBITDA results reflect both the transition to adult-use sales in Ohio, as well as our focus on maintaining strict cost control. Despite a challenging economic climate and typical third-quarter seasonality and pricing pressures in the Arizona market with the ongoing supply-demand imbalance, we\u0026#39;re pleased to report that our economic unit volumes remain strong.\u0026#34;","tickers":[{"tid":761042,"vid":2,"name":"CSE:VEXT","primary":true},{"tid":761043,"vid":2,"name":"VEXTF","primary":true}],"title":"Ohio\u0026#39;s Weed Enthusiasts Help This Cannabis Company\u0026#39;s Bottom Line: 165% YoY Increase In Q3 Adjusted EBITDA","updated":"2024-11-21T15:28:37Z","updatedAt":"2024-11-21T15:28:37Z","url":"https://www.benzinga.com/24/11/42115532/this-cannabis-co-is-capitalizing-on-ohios-recreational-sales-reports-165-yoy-increase-in-q3-adjusted-ebitda"},{"assets":[{"type":"image","title":"Enveric drug for mental health disorders","alt":"Enveric drug for mental health disorders","source":"","mime":"","primary":true,"attributes":{"fid":"899739","filename":"Enveric-drug-for-mental-health-disorders.jpeg","filepath":"files/images/story/2024/11/18/Enveric-drug-for-mental-health-disorders.jpeg","filesize":0,"image_attributes":{"resolution":{"height":0,"width":0,"dpi":0}}}}],"author":"Nina Zdinjak","body":"\u003cp\u003ePsychedelics biotech company \u003cstrong\u003eEnveric Biosciences \u003c/strong\u003e(NASDAQ:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/ENVB#NASDAQ\"\u003eENVB\u003c/a\u003e) provided a corporate update and reported financial results for the third quarter ended Sept. 30, 2024.\u003c/p\u003e\n\n\n\n\u003cp\u003e\"The third quarter of 2024 was highlighted by important progress in the development of EB-003, our neuroplastogenic molecule that is designed to address difficult-to-treat mental health disorders without inducing the hallucinogenic effect common to N,N-Dimethyltryptamine (DMT) and related analogs,\" stated \u003cstrong\u003eJoseph Tucker\u003c/strong\u003e, Ph.D., director and CEO of Enveric. \"Among the key achievements, data confirmed that EB-003 has the potential \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/07/39955483/non-hallucinogenic-psychedelic-treatment-for-mental-health-disorders-shows-potential-to-be-dosed\"\u003eto be delivered via oral administration\u003c/a\u003e and penetrate the brain at levels expected to elicit the desired therapeutic effect. Additionally, preclinical safety and pharmacology studies confirmed that EB-003 targets desired serotonergic receptors while minimizing potentially harmful, off-target interactions common to serotonin-like drug compounds. These are clear differentiators for EB-003, which we believe will add to its value potential.\"\u003c/p\u003e\n\n\n\n\u003cp\u003eTucker says that \"drug technologies that minimize or eliminate the hallucinogenic effect in molecules targeting the 5-HT2A receptor have the potential to become the gold standard in one or more neuropsychiatric indications.\" The company plans to submit an EB-003 Investigational New Drug (IND) application to the U.S. Food and Drug Administration in the second half of 2025.\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eRead Also:\u003ca href=\"https://www.benzinga.com/markets/cannabis/24/11/41901157/enveric-biosciences-out-licenses-key-program-to-mycomedica-in-62m-deal\"\u003eEnveric Biosciences Out-Licenses Key Program To MycoMedica In $62M Deal\u003c/a\u003e\u003c/strong\u003e\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cem\u003e\u003cstrong\u003eGet Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter \u003ca href=\"https://newsletteremail.benzinga.com/subscribe\" target=\"_blank\" rel=\"noreferrer noopener\"\u003ehere\u003c/a\u003e. If you're serious about the business, you can't afford to miss out.\u003c/strong\u003e\u003c/em\u003e\u003c/p\u003e\n\n\n\n\u003ch2 class=\"wp-block-heading\"\u003e\u003cstrong\u003eQ3 Financial Highlights\u003c/strong\u003e\u003c/h2\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eNet loss attributable to stockholders was $2.1 million\u003c/strong\u003e, including $500,000 in net non-cash expense, with a basic and diluted loss per share of $0.24, as compared to a net loss of $2.8 million, including $0.2 million in net non-cash income, with a basic and diluted loss per share of $1.30 for the quarter ended Sept. 30, 2023.\u003c/p\u003e\n\n\n\n\u003cp\u003eTotal operating expenses amounted to $2.08 million, compared to $3.45 million in the same period last year.\u003c/p\u003e\n\n\n\n\u003cp\u003eAt the end of the reporting period on Sept. 30, 2024, Enveric had cash-on-hand of $3.1 million, and accumulated deficit of $102.92 million.\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003ca\u003e\u003c/a\u003e In the quarterly \u003ca href=\"https://www.sec.gov/ix?doc=/Archives/edgar/data/890821/000149315224045859/form10-q.htm\"\u003ereport\u003c/a\u003e filed with the SEC, Enveric noted that \"further losses are anticipated in the development of its business. Being a research and development company, since inception, the company has not yet generated revenue and the company has incurred continuing losses from its operations. The company's operations have been funded principally through the issuance of equity. These factors raise substantial doubt about the company's ability to continue as a going concern for a period of one year from the issuance of these unaudited condensed consolidated financial statements.\"\u003c/p\u003e\n\n\n\n\u003cp\u003eTo continue as a going concern, Enveric needs to raise additional capital.\u003c/p\u003e\n\n\n\n\u003cp\u003eThe company had cash-on-hand of $3.1 million for the quarter ended September 30, 2024.\u003c/p\u003e\n\n\n\n\u003ch2 class=\"wp-block-heading\"\u003e\u003cstrong\u003eCorporate, Product and Business Development Highlights\u003c/strong\u003e\u003c/h2\u003e\n\n\n\n\u003cul\u003e\n\u003cli\u003eConfirmed oral bioavailability and significant brain exposure in preclinical studies of EB-003, supporting expedited development with IND filing and first patient dosed expected in 2025\u003c/li\u003e\n\n\n\n\u003cli\u003eAnnounced positive results from preclinical safety and pharmacology studies of EB-003, confirming the drug's selective activity with desired serotonergic neuroreceptors and ability to minimize potential adverse cardiovascular and CNS events\u003c/li\u003e\n\n\n\n\u003cli\u003ePresented foundational research involving EB-003 at the 7th Neuropsychiatric Drug Summit and the European Behavioral Pharmacology Society Biennial Workshop\u003c/li\u003e\n\n\n\n\u003cli\u003eStrengthened intellectual property estate for EVM301 portfolio and announced the issuance of five additional U.S. patents\u003c/li\u003e\n\n\n\n\u003cli\u003eExecuted licensing agreement with Aries Science \u0026amp; Technology to clinically develop and market Enveric's patented product for radiation dermatitis\u003c/li\u003e\n\u003c/ul\u003e\n\n\n\n\u003ch2 class=\"wp-block-heading\"\u003e\u003cstrong\u003ePrice Action\u003c/strong\u003e\u003c/h2\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eEnveric Biosciences shares closed Friday market session 8.06% lower at 37 cents per share.\u003c/strong\u003e\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eRead Next:\u003c/strong\u003e\u003c/p\u003e\n\n\n\n\u003cul\u003e\n\u003cli\u003e\u003ca href=\"https://www.benzinga.com/general/biotech/24/11/41714040/enveric-biosciences-expands-mental-health-patent-portfolio-with-5-new-additions\"\u003e\u003cstrong\u003eEnveric Biosciences Expands Mental Health Patent Portfolio With 5 New Additions\u003c/strong\u003e\u003c/a\u003e\u003c/li\u003e\n\u003c/ul\u003e\n\n\n\n\u003cp\u003e\u003cem\u003ePhoto created with AI\u003c/em\u003e\u003c/p\u003e","channels":[{"tid":123430,"vid":1,"name":"Cannabis"},{"tid":16888,"vid":1,"name":"Earnings"},{"tid":57,"vid":1,"name":"News"},{"tid":748887,"vid":1,"name":"Psychedelics","description":"Coverage of Psychedelics."}],"created":"2024-11-18T15:06:29Z","createdAt":"2024-11-18T15:06:29Z","id":42039385,"image":"https://www.benzinga.com/files/images/story/2024/11/18/Enveric-drug-for-mental-health-disorders.jpeg","isBzPost":true,"isBzProPost":true,"meta":{"SectorV2":{"SIC":[{"IndustryCode":2834,"Industry":"Pharmaceutical Preparations","IndustryGroup":283,"MajorGroup":28,"Division":""}],"NAICS":[{"NationalIndustryCode":541714,"NationalIndustry":"Research and Development in Biotechnology (except Nanobiotechnology)","IndustryCode":54171,"Industry":"Research and Development in the Physical, Engineering, and Life Sciences","IndustryGroupCode":5417,"IndustryGroup":"Scientific Research and Development Services","SubSectorCode":541,"SubSector":"Professional, Scientific, and Technical Services","SectorCode":54,"Sector":"Professional, Scientific, and Technical Services"}],"Morningstar":[{"IndustryCode":20610010,"Industry":"Biotechnology","IndustryGroupCode":20610,"IndustryGroup":"Biotechnology","SectorCode":206,"Sector":"Healthcare","SuperSectorCode":2,"SuperSector":"Defensive"}]},"Partner":null,"PartnerTaxonomy":null,"SEC":null,"Author":null,"Authors":[{"uid":"0","name":""}],"Flags":{"ShowCopyrightNotice":true,"EvergreenContent":false,"ShowAdvertiserDisclosure":false,"ContributedContent":false,"AddGoogleStandoutMetaTag":false,"MediaSiteDNDOverride":false,"SendToYahooFinance":false,"SendToRobinhood":true,"SendToMSN":true},"Reach":{"Disclosure":{}},"Reference":null,"Ext":null,"wp_post_meta":{"campaign_strategy":"Default","post_id":652349,"post_path":"news/earnings/24/11/42039385/enveric-biosciences-trims-losses-eyes-key-drug-approval-for-difficult-to-treat-mental-health-disorders","post_type":"post"}},"nodeId":42039385,"stocks":[{"tid":788535,"vid":2,"name":"ENVB","description":"Enveric Biosciences, Inc. - Common Stock","primary":true}],"storyId":"673b57f1d149ec00010e8434","tags":[{"tid":734058,"vid":3,"name":"Cannabis Earnings"},{"tid":794954,"vid":3,"name":"Joseph Tucker"},{"tid":28340,"vid":3,"name":"premium"},{"tid":827425,"vid":3,"name":"Psychedelics earnings"}],"teaser":" ","teaserText":" ","tickers":[{"tid":788535,"vid":2,"name":"ENVB","description":"Enveric Biosciences, Inc. - Common Stock","primary":true}],"title":"Enveric Biosciences Trims Losses, Eyes Key Drug Approval For Difficult-To-Treat Mental Health Disorders","updated":"2024-11-18T15:06:29Z","updatedAt":"2024-11-18T15:06:29Z","url":"https://www.benzinga.com/news/earnings/24/11/42039385/enveric-biosciences-trims-losses-eyes-key-drug-approval-for-difficult-to-treat-mental-health-disorders"}]},{"title":"Deals","title_case":false,"link":"https://www.benzinga.com/cannabis/deals","style":"","type":"default","loadMoreButton":false,"showSponsoredContent":false,"query_and_options":{"options":{"displayOutput":"full","limit":4},"query":{"primaryChannel":"123430","channels":[34989,34991,65,64],"channelAndTagQueryOperator":"and"}},"query":{"displayOutput":"full","limit":4,"primaryChannel":"123430","channels":[34989,34991,65,64],"channelAndTagQueryOperator":"and"},"parsely_query":{"limit":"","author":"","tag":""},"reachContent":{"placementIndex":3,"repeatIndex":5,"preload":true},"nodes":[{"assets":[{"type":"image","title":"jan-baborak-mI4Zf2ftzXo-unsplash","alt":"Cannabis news","source":"Photo: Courtesy of Jan Baborák on Unsplash","mime":"","primary":true,"attributes":{"fid":"901850","filename":"jan-baborak-mI4Zf2ftzXo-unsplash.jpeg","filepath":"files/images/story/2024/11/26/jan-baborak-mI4Zf2ftzXo-unsplash.jpeg","filesize":0,"image_attributes":{"resolution":{"height":0,"width":0,"dpi":0}}}}],"author":"Jelena Martinovic","body":"\u003cp\u003e\u003cstrong\u003eAcreage Holdings, Inc\u003c/strong\u003e. (CSE:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/ACRG#CSE\"\u003eACRG\u003c/a\u003e, ACRG.B.U)) (OTCQX:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/ACRHF#OTCQX\"\u003eACRHF\u003c/a\u003e, ACRDF)) said it anticipates that \u003cstrong\u003eCanopy USA\u003c/strong\u003e, \u003cstrong\u003eLLC\u003c/strong\u003e \u0026#8211;\u003cstrong\u003eCanopy Growth Corporation\u003c/strong\u003e‘s (TSX:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/WEED#TSX\"\u003eWEED\u003c/a\u003e) (NASDAQ:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/CGC#NASDAQ\"\u003eCGC\u003c/a\u003e) strategy for capturing the U.S. cannabis market will complete its acquisition of Acreage by mid-December, 2024.\u003c/p\u003e\n\n\n\n\u003cp\u003eThe move could leave holders of Acreage\u0026#8217;s Class E shares (fixed shares) with nothing. That is, if Canopy\u0026#8217;s stock price price remains below $5 when the deal closes, Acreage pointed out in a Monday press release.\u003c/p\u003e\n\n\n\n\u003ch3 class=\"wp-block-heading\"\u003e\u003cstrong\u003eWhy?\u003c/strong\u003e\u003c/h3\u003e\n\n\n\n\u003cp\u003eThe convertible note offering completed in June caused significant dilution of Acreage's fixed shares, leaving them without any worth at Canopy\u0026#8217;s current share price.\u003c/p\u003e\n\n\n\n\u003cp\u003e\"As a result of the material impact of the Offering it is anticipated that the current holders of Fixed Shares will receive zero value upon closing of the Acquisitions,\" Acreage said.\u003c/p\u003e\n\n\n\n\u003cp\u003eCanopy's shares traded 5.06% lower at $3.9401 per share at the time of writing on Tuesday morning. Acreage shares plunged more than 90% on Monday in reaction to the news.\u003c/p\u003e\n\n\n\n\u003cp\u003eThe company also \u003ca href=\"https://www.accesswire.com/946598/acreage-provides-update-on-corporate-transactions\"\u003esaid\u003c/a\u003e holders of floating shares will get 0.045 of a Canopy share for each of their floating shares, which is a fixed exchange rate.\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eRead Also: \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/06/39185620/acreage-announces-10m-private-placement-of-units-ahead-of-acquisition-by-canopy\"\u003eAcreage Announces $10M Private Placement Of Units Ahead Of Acquisition By Canopy\u003c/a\u003e\u003c/strong\u003e\u003c/p\u003e\n\n\n\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003e\u003cem\u003eGet Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter \u003ca href=\"https://newsletteremail.benzinga.com/subscribe\" target=\"_blank\" rel=\"noreferrer noopener\"\u003ehere\u003c/a\u003e. If you're serious about the business, you can't afford to miss out.\u003c/em\u003e\u003c/strong\u003e\u003c/li\u003e\n\u003c/ul\u003e\n\n\n\n\u003cp\u003eAccording to editor-in-chief of Cultivated Daily, \u003cstrong\u003eJeremy Berke\u003c/strong\u003e, optimism around U.S. legalization of cannabis was imminent five years ago when the deal was announced.\u003c/p\u003e\n\n\n\n\u003cp\u003e\"When the deal was announced, analysts, investors, and attorneys thought legalization in the US was right around the corner — and there would be millions to be made in fees for cross-border transactions,\" Berke \u003ca href=\"https://www.cultivated.news/p/a-3-4-billion-deal-goes-to-zero\"\u003esaid\u003c/a\u003e.\u003c/p\u003e\n\n\n\n\u003cp\u003eHowever, the anticipated boom in legalization and cross-border deals are still pending, leading to disappointment in the industry, he continued.\u003c/p\u003e\n\n\n\n\u003cp\u003e\"Both US and Canadian companies have seen their valuations fall into the gutter as investors have looked to put their money elsewhere,\" Berke said, adding that Acreage was particularly hit by setbacks in the New York cannabis market in which it is substantially invested.\u003c/p\u003e\n\n\n\n\u003cp\u003eAcreage reported a 30% decrease in consolidated revenue in the third quarter and a wider net loss of s $22.2 million, up from a loss of $7.9 million in the previous year\u0026#8217;s quarter. Adjusted EBITDA came in positive at $0.6 million, representing a drop from $6.6 million \u003ca href=\"https://www.benzinga.com/24/11/42009069/canopy-growths-acquisition-target-acreage-reports-30-yoy-decline-in-q3-revenue-achieves-record-cannabis-wholesale-revenue-in-new-york\"\u003ein the third quarter of 2023.\u003c/a\u003e\u003c/p\u003e\n\n\n\n\u003ch3 class=\"wp-block-heading\"\u003e\u003cstrong\u003eBackground\u003c/strong\u003e\u003c/h3\u003e\n\n\n\n\u003cp\u003eThe Canadian cannabis giant first announced its plans to \u003ca href=\"https://www.benzinga.com/analyst-ratings/analyst-color/19/06/13951090/canopy-shareholders-approve-acreage-deal-legalization-in-focus\"\u003eacquire\u003c/a\u003e Acreage for $3.4 billion in 2019. Initially, the deal was to be undertaken should the U.S. legalize marijuana on a federal level. That deal was later restructured.\u003c/p\u003e\n\n\n\n\u003cp\u003eIn 2022 Canopy Growth created a new U.S.-domiciled holding company, Canopy USA, LLC.\u003c/p\u003e\n\n\n\n\u003cp\u003eThe move sought to streamline the company\u0026#8217;s entry into the US market by allowing it to acquire Acreage as well as two other cannabis companies \u0026#8211; \u003cstrong\u003eWana Brands\u003c/strong\u003e and\u003cstrong\u003e Jetty\u003c/strong\u003e – while also holding a minority stake in \u003cstrong\u003eTerrAscend. Corp.\u003c/strong\u003e(TSX:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/TSND#TSX\"\u003eTSND\u003c/a\u003e) (OTCQX:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/TSNDF#OTCQX\"\u003eTSNDF\u003c/a\u003e),\u003c/p\u003e\n\n\n\n\u003cp\u003eCanopy USA \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/10/41251114/cannabis-giant-canopy-expands-us-presence-with-acquisition-of-top-edibles-brand-what-it-means-fo\"\u003ecompleted\u003c/a\u003e its acquisition of Wana in October, and roughly 75% of the shares of cannabis edibles producer,\u003cstrong\u003e Lemurian, Inc. \u003c/strong\u003e(Jetty) as \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/06/39166300/canopy-growth-doubles-down-on-its-usa-strategy-announces-exercise-of-acreage-options\"\u003eannounced in June 2024.\u003c/a\u003e\u003c/p\u003e\n\n\n\n\u003cp\u003eCanopy Growth's newly appointed CEO\u003cstrong\u003e Luc Mongeau\u003c/strong\u003e, who succeeds \u003cstrong\u003eDavid Klein \u003c/strong\u003eeffective Jan. 6, 2025, will continue his legacy by expanding the company's influence in the U.S.\u003c/p\u003e\n\n\n\n\u003cp\u003e\"I am honored to lead Canopy Growth into this exciting next chapter, and I am confident that our vision, dedication to our consumers, and the commitment of our team members will continue to position us for long-term success and value creation,\" Mongeau \u003ca href=\"https://www.benzinga.com/24/11/42190387/cannabis-giant-canopy-growth-names-next-ceo-heres-who-will-succeed-david-klein-amid-us-expansion\"\u003esaid in a Tuesday statement.\u003c/a\u003e\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eRead Next:\u003c/strong\u003e\u003c/p\u003e\n\n\n\n\u003cul\u003e\n\u003cli\u003e\u003ca href=\"https://www.benzinga.com/markets/cannabis/24/11/42162875/canopy-growths-german-subsidiary-teams-up-with-portugals-gro-vida-to-expand-medical-cannabis-supply\"\u003e\u003cstrong\u003eCanopy Growth\u0026#8217;s German Subsidiary Teams Up With Portugal\u0026#8217;s Gro-Vida To Expand Medical Cannabis Supply\u003c/strong\u003e\u003c/a\u003e\u003c/li\u003e\n\u003c/ul\u003e","channels":[{"tid":123430,"vid":1,"name":"Cannabis"},{"tid":64,"vid":1,"name":"M\u0026A"},{"tid":57,"vid":1,"name":"News"},{"tid":138079,"vid":1,"name":"Top Stories"}],"created":"2024-11-26T17:46:16Z","createdAt":"2024-11-26T17:46:16Z","id":42196557,"image":"https://www.benzinga.com/files/images/story/2024/11/26/jan-baborak-mI4Zf2ftzXo-unsplash.jpeg","isBzPost":true,"isBzProPost":true,"meta":{"SectorV2":{"SIC":[{"IndustryCode":3999,"Industry":"Manufacturing Industries N.E.C.","IndustryGroup":399,"MajorGroup":39,"Division":""},{"IndustryCode":3741,"Industry":"Pharmaceutical and Medicine Industry","IndustryGroup":374,"MajorGroup":37,"Division":""}],"NAICS":[{"NationalIndustryCode":325412,"NationalIndustry":"Pharmaceutical Preparation Manufacturing ","IndustryCode":32541,"Industry":"Pharmaceutical and Medicine Manufacturing","IndustryGroupCode":3254,"IndustryGroup":"Pharmaceutical and Medicine Manufacturing","SubSectorCode":325,"SubSector":"Chemical Manufacturing","SectorCode":32,"Sector":"Manufacturing"}],"Morningstar":[{"IndustryCode":20620020,"Industry":"Drug Manufacturers—Specialty \u0026 Generic","IndustryGroupCode":20620,"IndustryGroup":"Drug Manufacturers","SectorCode":206,"Sector":"Healthcare","SuperSectorCode":2,"SuperSector":"Defensive"}]},"Partner":null,"PartnerTaxonomy":null,"SEC":null,"Author":null,"Authors":[{"uid":"0","name":""}],"Flags":{"ShowCopyrightNotice":true,"EvergreenContent":false,"ShowAdvertiserDisclosure":false,"ContributedContent":false,"AddGoogleStandoutMetaTag":false,"MediaSiteDNDOverride":false,"SendToYahooFinance":false,"SendToRobinhood":true,"SendToMSN":false},"Reach":{"Disclosure":{}},"Reference":null,"Ext":null,"wp_post_meta":{"campaign_strategy":"Default","post_id":665747,"post_path":"24/11/42196557/canopy-usas-acquisition-of-acreage-could-mean-loss-for-some-shareholders-heres-why","post_type":"post"}},"nodeId":42196557,"stocks":[{"tid":780995,"vid":2,"name":"ACRDF","description":"Acreage Holdings"},{"tid":780672,"vid":2,"name":"ACRHF"},{"tid":22438,"vid":2,"name":"CGC","description":"Canopy Growth Corp"},{"tid":739144,"vid":2,"name":"CSE:ACRG"},{"tid":902043,"vid":2,"name":"TSNDF"},{"tid":901859,"vid":2,"name":"TSX:TSND"},{"tid":691126,"vid":2,"name":"TSX:WEED"},{"tid":670646,"vid":2,"name":"WEED"}],"storyId":"6746095cb6cb720001aaffb0","tags":[{"tid":916798,"vid":3,"name":"cannabis acquisition"},{"tid":945680,"vid":3,"name":"cannabis shareholders"},{"tid":860120,"vid":3,"name":"Canopy USA"},{"tid":659481,"vid":3,"name":"David Klein"},{"tid":761207,"vid":3,"name":"Jeremy Berke"},{"tid":843333,"vid":3,"name":"Jetty"},{"tid":927342,"vid":3,"name":"Luc Mongeau"},{"tid":159401,"vid":3,"name":"Wana Brands"}],"teaser":"Acreage Holdings, Inc. (CSE:ACRG.A.U, ACRG.B.U) (OTCQX: ACRHF, ACRDF) said it anticipates that Canopy USA, LLC -Canopy Growth Corporation‘s (TSX: WEED) (NASDAQ: CGC) strategy for capturing the U.S. cannabis - will complete its acquisition of Acreage by mid-December, 2024.The move could leave holders of Acreage\u0026#39;s Class E shares (fixed shares) with nothing. That is, if Canopy\u0026#39;s stock price price remains below $5 when the deal closes, Acreage said in Monday\u0026#39;s press release.","teaserText":"Acreage Holdings, Inc. (CSE:ACRG.A.U, ACRG.B.U) (OTCQX: ACRHF, ACRDF) said it anticipates that Canopy USA, LLC -Canopy Growth Corporation‘s (TSX: WEED) (NASDAQ: CGC) strategy for capturing the U.S. cannabis - will complete its acquisition of Acreage by mid-December, 2024.The move could leave holders of Acreage\u0026#39;s Class E shares (fixed shares) with nothing. That is, if Canopy\u0026#39;s stock price price remains below $5 when the deal closes, Acreage said in Monday\u0026#39;s press release.","tickers":[{"tid":780995,"vid":2,"name":"ACRDF","description":"Acreage Holdings"},{"tid":780672,"vid":2,"name":"ACRHF"},{"tid":22438,"vid":2,"name":"CGC","description":"Canopy Growth Corp"},{"tid":739144,"vid":2,"name":"CSE:ACRG"},{"tid":902043,"vid":2,"name":"TSNDF"},{"tid":901859,"vid":2,"name":"TSX:TSND"},{"tid":691126,"vid":2,"name":"TSX:WEED"},{"tid":670646,"vid":2,"name":"WEED"}],"title":"Canopy USA\u0026#39;s Acquisition Of Acreage Could Mean Staggering Losses For Some Shareholders","updated":"2024-11-26T17:46:17Z","updatedAt":"2024-11-26T17:46:17Z","url":"https://www.benzinga.com/24/11/42196557/canopy-usas-acquisition-of-acreage-could-mean-loss-for-some-shareholders-heres-why"},{"assets":[{"type":"image","title":"Leaflink Leaf Trade","alt":"Leaflink Leaf Trade","source":"","mime":"","primary":true,"attributes":{"fid":"901810","filename":"Leaflink-Leaf-Trade.png","filepath":"files/images/story/2024/11/26/Leaflink-Leaf-Trade.png","filesize":0,"image_attributes":{"resolution":{"height":0,"width":0,"dpi":0}}}}],"author":"Javier Hasse","body":"\u003cp\u003e\u003cstrong\u003eLeafLink\u003c/strong\u003e, a cannabis wholesale platform, has announced its acquisition of \u003cstrong\u003eLeaf Trade\u003c/strong\u003e, a specialized marketplace catering to multi-state operators (MSOs) and enterprise cannabis businesses. The combined entity is poised to process nearly $9 billion in annual gross merchandise value (GMV). The price tag or conditions of the transaction were not disclosed.\u003c/p\u003e\n\n\n\n\u003ch3 class=\"wp-block-heading\"\u003e\u003cstrong\u003eStreamlining Cannabis Operations\u003c/strong\u003e\u003c/h3\u003e\n\n\n\n\u003cp\u003eThis strategic acquisition aligns with LeafLink's mission to optimize cannabis operations through advanced technology and financial solutions. \u0026#8220;Leaf Trade has been the clear industry leader serving the MSO and enterprise segment, and we are thrilled to welcome the Leaf Trade team to LeafLink. Our mission is to help the regulated cannabis industry reach its greatest potential by streamlining operational processes and improving financial performance,\u0026#8221; said LeafLink's president and CEO, \u003cstrong\u003eArtie Minson\u003c/strong\u003e.\u003c/p\u003e\n\n\n\n\u003cp\u003eThe merger combines Leaf Trade's expertise in the MSO sector with LeafLink's tools, offering solutions tailored to both small-scale businesses and large enterprises. While the two platforms will initially operate independently, plans are in place for a comprehensive integration.\u003c/p\u003e\n\n\n\n\u003ch3 class=\"wp-block-heading\"\u003e\u003cstrong\u003eExpanding The Toolbox For Cannabis Businesses\u003c/strong\u003e\u003c/h3\u003e\n\n\n\n\u003cp\u003eThe acquisition adds considerable depth to LeafLink's suite of offerings, which now includes tools for B2B marketplace transactions, business banking and advertising, as well as fintech solutions like Payment on Sell-Through. This innovative tool addresses the pervasive issue of delinquent payments in the cannabis sector, providing a financial lifeline to businesses struggling with cash flow.\u003c/p\u003e\n\n\n\n\u003cp\u003eLeaf Trade\u0026#8217;s CEO, \u003cstrong\u003eBrian Ward\u003c/strong\u003e, highlighted the benefits for customers. \"This acquisition is an incredible win for our team, our customers, and the advancement of the cannabis industry. With LeafLink's acquisition, we're unifying our strengths to create innovative solutions that drive growth and value across the supply chain.\"\u003c/p\u003e\n\n\n\n\u003cp\u003eFollowing this transaction, \u003cstrong\u003eSweed\u003c/strong\u003e, a logistics partner under \u003cstrong\u003eLeaf Trade's High Tech Holdings,\u003c/strong\u003e will remain independent. This separation allows Sweed to capitalize on its momentum and continue building smarter tools for operational efficiency.\u003c/p\u003e\n\n\n\n\u003ch3 class=\"wp-block-heading\"\u003e\u003cstrong\u003eFinancial Momentum And Industry Innovations\u003c/strong\u003e\u003c/h3\u003e\n\n\n\n\u003cp\u003eLeafLink has experienced remarkable growth, driven by its expanding product portfolio and strategic acquisitions like \u003cstrong\u003eDama Financial,\u003c/strong\u003e which bolsters its cannabis banking capabilities. Its Series D fundraising round, recently upsized from $100 million to $125 million, attracted high-profile investors such as \u003cstrong\u003eTiger Global Management\u003c/strong\u003e, a global leader in tech and growth equity, and \u003cstrong\u003eThrive Capital\u003c/strong\u003e, renowned for backing companies like \u003cstrong\u003eStripe\u003c/strong\u003e and \u003cstrong\u003eInstagram.\u003c/strong\u003e\u003c/p\u003e\n\n\n\n\u003cp\u003eAs the cannabis industry faces increasing regulatory and financial pressures, LeafLink's unified platform aims to address critical pain points, creating a more seamless and reliable infrastructure for operators. By leveraging synergies from the Leaf Trade acquisition, the company is positioning itself as the definitive B2B operating system for the cannabis industry.\u003c/p\u003e\n\n\n\n\u003cp\u003eCover image by Benzinga\u003c/p\u003e","channels":[{"tid":123430,"vid":1,"name":"Cannabis"},{"tid":64,"vid":1,"name":"M\u0026A"},{"tid":57,"vid":1,"name":"News"}],"created":"2024-11-26T16:02:33Z","createdAt":"2024-11-26T16:02:33Z","id":42193953,"image":"https://www.benzinga.com/files/images/story/2024/11/26/Leaflink-Leaf-Trade.png","isBzPost":true,"isBzProPost":true,"meta":{"SectorV2":{},"Partner":null,"PartnerTaxonomy":null,"SEC":null,"Author":null,"Authors":[{"uid":"0","name":""}],"Flags":{"ShowCopyrightNotice":true,"EvergreenContent":false,"ShowAdvertiserDisclosure":false,"ContributedContent":false,"AddGoogleStandoutMetaTag":false,"MediaSiteDNDOverride":false,"SendToYahooFinance":false,"SendToRobinhood":true,"SendToMSN":false},"Reach":{"Disclosure":{}},"Reference":null,"Ext":null,"wp_post_meta":{"campaign_strategy":"Default","post_id":665678,"post_path":"markets/cannabis/24/11/42193953/thrive-capital-tiger-global-backed-cannabis-wholesale-platform-leaflink-buys-leaf-trade-co-will-process-9b-in-annual-gmv","post_type":"post"}},"nodeId":42193953,"stocks":[],"storyId":"6745f115b6cb720001aaf3c7","tags":[{"tid":765312,"vid":3,"name":"Leaf Trade"},{"tid":690958,"vid":3,"name":"LeafLink"},{"tid":892191,"vid":3,"name":"Sweed"},{"tid":680204,"vid":3,"name":"thrive capital"},{"tid":44349,"vid":3,"name":"Tiger Global"}],"teaser":"LeafLink acquires Leaf Trade, creating a $9B cannabis wholesale platform and expanding industry-leading tools.","teaserText":"LeafLink acquires Leaf Trade, creating a $9B cannabis wholesale platform and expanding industry-leading tools.","tickers":[],"title":"Thrive Capital, Tiger Global-Backed Cannabis Wholesale Platform LeafLink Buys Leaf Trade: Co. Will Process ~$9B In Annual GMV","updated":"2024-11-26T16:02:33Z","updatedAt":"2024-11-26T16:02:33Z","url":"https://www.benzinga.com/markets/cannabis/24/11/42193953/thrive-capital-tiger-global-backed-cannabis-wholesale-platform-leaflink-buys-leaf-trade-co-will-process-9b-in-annual-gmv"},{"assets":[{"type":"image","title":"ibrahim-rifath-OApHds2yEGQ-unsplash(8)","alt":"Cannabis financing","source":"Photo: Courtesy of Ibrahim Rifath on Unsplash","mime":"","primary":true,"attributes":{"fid":"901592","filename":"ibrahim-rifath-OApHds2yEGQ-unsplash8.jpeg","filepath":"files/images/story/2024/11/25/ibrahim-rifath-OApHds2yEGQ-unsplash8.jpeg","filesize":0,"image_attributes":{"resolution":{"height":0,"width":0,"dpi":0}}}}],"author":"Jelena Martinovic","body":"\u003cp\u003e\u003cstrong\u003eDecibel Cannabis Company Inc\u003c/strong\u003e. (OTCQB:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/DBCCF#OTCQB\"\u003eDBCCF\u003c/a\u003e) has completed the second and final closing of its previously announced non-brokered private placement of its common shares at $0.06 per common share.\u003c/p\u003e\n\n\n\n\u003ch3 class=\"wp-block-heading\"\u003e\u003cstrong\u003eWhat Happened\u003c/strong\u003e\u003c/h3\u003e\n\n\n\n\u003cp\u003eThe company said on Monday that, at the second closing of the offering, it issued 19,647,776 common shares for gross proceeds of roughly $1,178,867.\u003c/p\u003e\n\n\n\n\u003cp\u003eThe second closing was in addition to the previously announced first closing in November when Decibel issued 33,503,864 common shares for gross proceeds of approximately $2,010,232.\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eRead Also: \u003ca href=\"https://www.benzinga.com/analyst-ratings/analyst-color/24/08/40577591/decibels-10m-strategy-how-it-could-enhance-your-canadian-cannabis-portfolio\"\u003eDecibel's $10M Strategy: How It Could Enhance Your Canadian Cannabis Portfolio\u003c/a\u003e\u003c/strong\u003e\u003c/p\u003e\n\n\n\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003e\u003cem\u003eGet Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter \u003ca href=\"https://newsletteremail.benzinga.com/subscribe\" target=\"_blank\" rel=\"noreferrer noopener\"\u003ehere\u003c/a\u003e. If you're serious about the business, you can't afford to miss out.\u003c/em\u003e\u003c/strong\u003e\u003c/li\u003e\n\u003c/ul\u003e\n\n\n\n\u003ch3 class=\"wp-block-heading\"\u003e\u003cstrong\u003eWhy It Matters\u003c/strong\u003e\u003c/h3\u003e\n\n\n\n\u003cp\u003eDecibel said the proceeds of the offering will be used to work on and help integrate the integration of \u003cstrong\u003eAgMedica BioScience Inc. \u003c/strong\u003ewhich he company previously\u003ca href=\"https://www.benzinga.com/markets/cannabis/24/10/41600492/decibel-acquires-agmedica-announces-private-placement-and-third-quarter-guidance\"\u003e acquired\u003c/a\u003e. The acquisition was arranged through an agreement with\u003cstrong\u003e Callisto Capital \u003c/strong\u003eon Oct. 28 and was made in exchange for a $6.3 million unsecured convertible debenture.\u003c/p\u003e\n\n\n\n\u003cp\u003eDecibel projects that AgMedica could contribute $30 million of net revenue and $4 million of EBITDA in 2025, totaling an anticipated $130 million of net revenue and $25 million of adjusted EBITDA in 2025 on a pro forma basis.\u003c/p\u003e\n\n\n\n\u003cp\u003eThe company recently \u003ca href=\"https://www.benzinga.com/24/11/42137701/canadian-cannabis-co-decibel-reports-12-yoy-drop-in-q3-revenue-but-increases-gross-margin-to-53\"\u003eannounced\u003c/a\u003e its unaudited interim financial results on Thursday for the third quarter revealing CA$24.1 million ($17.2 million) in net revenue representing a 9% increase sequentially, but a 12% decrease year-over-year. However, gross margin before fair value adjustments reached 53% for the period, up from 44% in the prior year\u0026#8217;s period, reflecting improved operational efficiency.\u003c/p\u003e\n\n\n\n\u003ch3 class=\"wp-block-heading\"\u003e\u003cstrong\u003eWhat's Next\u003c/strong\u003e\u003c/h3\u003e\n\n\n\n\u003cp\u003eThe offering is subject to the receipt of all regulatory approvals including the final approval of the TSX Venture Exchange (TSXV).\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eNow Read:\u003c/strong\u003e\u003c/p\u003e\n\n\n\n\u003cul\u003e\n\u003cli\u003e\u003ca href=\"https://www.benzinga.com/markets/cannabis/24/08/40369534/decibel-cannabis-reports-22-yoy-decrease-in-q2-net-revenue-plans-to-benefit-with-new-product-lau\"\u003e\u003cstrong\u003eDecibel Cannabis Reports 22% YoY Decrease In Q2 Net Revenue, Plans To Benefit With New Product Launches\u003c/strong\u003e\u003c/a\u003e\u003c/li\u003e\n\u003c/ul\u003e\n\n\n\n\u003ch3 class=\"wp-block-heading\"\u003e\u003cstrong\u003eDBCCF Price Action\u003c/strong\u003e\u003c/h3\u003e\n\n\n\n\u003cp\u003eDecibel's shares traded 1.45% higher at $0.0476 per share after the market close on Friday afternoon.\u003c/p\u003e","channels":[{"tid":123430,"vid":1,"name":"Cannabis"},{"tid":57,"vid":1,"name":"News"},{"tid":34989,"vid":1,"name":"Financing"}],"created":"2024-11-25T14:20:57Z","createdAt":"2024-11-25T14:20:57Z","id":42164794,"image":"https://www.benzinga.com/files/images/story/2024/11/25/ibrahim-rifath-OApHds2yEGQ-unsplash8.jpeg","isBzPost":true,"isBzProPost":true,"meta":{"SectorV2":{"SIC":[{"IndustryCode":3741,"Industry":"Pharmaceutical and Medicine Industry","IndustryGroup":374,"MajorGroup":37,"Division":""}],"NAICS":[{"NationalIndustryCode":325412,"NationalIndustry":"Pharmaceutical Preparation Manufacturing ","IndustryCode":32541,"Industry":"Pharmaceutical and Medicine Manufacturing","IndustryGroupCode":3254,"IndustryGroup":"Pharmaceutical and Medicine Manufacturing","SubSectorCode":325,"SubSector":"Chemical Manufacturing","SectorCode":32,"Sector":"Manufacturing"}],"Morningstar":[{"IndustryCode":10320020,"Industry":"Banks—Regional","IndustryGroupCode":10320,"IndustryGroup":"Banks","SectorCode":103,"Sector":"Financial Services","SuperSectorCode":1,"SuperSector":"Cyclical"},{"IndustryCode":20620020,"Industry":"Drug Manufacturers—Specialty \u0026 Generic","IndustryGroupCode":20620,"IndustryGroup":"Drug Manufacturers","SectorCode":206,"Sector":"Healthcare","SuperSectorCode":2,"SuperSector":"Defensive"}]},"Partner":null,"PartnerTaxonomy":null,"SEC":null,"Author":null,"Authors":[{"uid":"0","name":""}],"Flags":{"ShowCopyrightNotice":true,"EvergreenContent":false,"ShowAdvertiserDisclosure":false,"ContributedContent":false,"AddGoogleStandoutMetaTag":false,"MediaSiteDNDOverride":false,"SendToYahooFinance":false,"SendToRobinhood":true,"SendToMSN":false},"Reach":{"Disclosure":{}},"Reference":null,"Ext":null,"wp_post_meta":{"campaign_strategy":"Default","post_id":663422,"post_path":"news/financing/24/11/42164794/decibel-cannabis-raises-1-18m-secures-capital-for-agmedica-bioscience-integration","post_type":"post"}},"nodeId":42164794,"stocks":[{"tid":14243,"vid":2,"name":"DB","description":"Deutsche Bank Ag","primary":true},{"tid":769655,"vid":2,"name":"DBCCF","description":"Decibel Cannabis Co","primary":true}],"storyId":"674487cdb6cb720001aa7c58","tags":[{"tid":945601,"vid":3,"name":"AgMedica BioScience Inc."},{"tid":945602,"vid":3,"name":"Callisto Capital"},{"tid":801187,"vid":3,"name":"Cannabis financing"}],"teaser":"Decibel Cannabis Company Inc. (TSXV: DB) (OTCQB: DBCCF) has completed the second and final closing of its previously announced non-brokered private placement of its common shares at $0.06 per common share. The company said on Monday that, at the second closing of the offering, it issued 19,647,776 common shares for gross proceeds of roughly $1,178,867. The second closing was in addition to the previously announced first closing in November when Decibel issued 33,503,864 common shares for gross proceeds of approximately $2,010,232.","teaserText":"Decibel Cannabis Company Inc. (TSXV: DB) (OTCQB: DBCCF) has completed the second and final closing of its previously announced non-brokered private placement of its common shares at $0.06 per common share. The company said on Monday that, at the second closing of the offering, it issued 19,647,776 common shares for gross proceeds of roughly $1,178,867. The second closing was in addition to the previously announced first closing in November when Decibel issued 33,503,864 common shares for gross proceeds of approximately $2,010,232.","tickers":[{"tid":14243,"vid":2,"name":"DB","description":"Deutsche Bank Ag","primary":true},{"tid":769655,"vid":2,"name":"DBCCF","description":"Decibel Cannabis Co","primary":true}],"title":"Decibel Cannabis Raises $1.18M, Secures Capital For AgMedica BioScience Integration","updated":"2024-11-25T22:52:50Z","updatedAt":"2024-11-25T22:52:50Z","url":"https://www.benzinga.com/news/financing/24/11/42164794/decibel-cannabis-raises-1-18m-secures-capital-for-agmedica-bioscience-integration"},{"assets":[{"type":"image","title":"AI-Generated Image","alt":"weed cannabis marijuana vape jupiter tilt stock","source":"AI-Generated Image ","mime":"","primary":true,"attributes":{"fid":"901178","filename":"AI-Generated-Image_0.jpeg","filepath":"files/images/story/2024/11/22/AI-Generated-Image_0.jpeg","filesize":0,"image_attributes":{"resolution":{"height":0,"width":0,"dpi":0}}}}],"author":"Nicolás Jose Rodriguez","body":"\u003cp\u003e\u003cstrong\u003eTILT Holdings\u003c/strong\u003e (OTC:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/TLLTF#OTC\"\u003eTLLTF\u003c/a\u003e) is at a critical juncture as it explores divesting its plant-touching business (PTB), which generates 75% of its revenue but continues to struggle with declining margins. Massachusetts operations, contributing two-thirds of revenue, are under pressure from market saturation, while Pennsylvania's wholesale arm faces reduced purchases as vertically integrated operators prioritize in-house products. \u003c/p\u003e\n\n\n\n\u003cp\u003eGross margins across TILT fell from 18% in Q1 to 14% in Q3, reflecting challenges across all divisions. Analyst \u003cstrong\u003ePablo Zuanic \u003c/strong\u003evalues the PTB between $20–$30 million, a modest sum given the company's $3 million market cap and heavy debt burden.\u003c/p\u003e\n\n\n\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003e\u003cem\u003eGet Benzinga\u0026#8217;s exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter \u003ca href=\"https://newsletteremail.benzinga.com/subscribe\" target=\"_blank\" rel=\"noreferrer noopener\"\u003ehere\u003c/a\u003e. You can't afford to miss out if you\u0026#8217;re serious about the business.\u003c/em\u003e\u003c/strong\u003e\u003c/li\u003e\n\u003c/ul\u003e\n\n\n\n\u003ch3 class=\"wp-block-heading\"\u003eDebt Remains A Major Hurdle Despite Positive Cash Flow\u003c/h3\u003e\n\n\n\n\u003cp\u003eTILT's financial health is constrained by $62 million in net debt, with $12 million due in 2025 and $38 million in 2026, alongside $44 million in lease obligations. However, \u003ca href=\"https://www.benzinga.com/topic/pablo-zuanic\"\u003eZuanic highlights\u003c/a\u003e a positive development: TILT generated $2 million in operating cash flow in Q3 2024. \u003c/p\u003e\n\n\n\n\u003ch3 class=\"wp-block-heading\"\u003eJupiter\u0026#8217;s Challenges: A Dual Front\u003c/h3\u003e\n\n\n\n\u003cp\u003e\u003ca href=\"https://www.benzinga.com/analyst-ratings/analyst-color/24/02/37083640/jupiter-research-weed-vape-cartridges-mso-brand\"\u003eJupiter, TILT's vape subsidiary\u003c/a\u003e, is contending with both operational setbacks and broader market shifts. U.S. sales dropped to $9.4 million in Q3 2024, down from $15 million in the same period last year, even after adjusting for the transition of half its sales to a 15% distribution fee model. \u003c/p\u003e\n\n\n\n\u003cp\u003eCanadian sales grew 11% to $6.4 million but saw gross margins collapse from 29% to zero. Zuanic calculates that Jupiter's distribution fees could generate $9 million annually at 100% gross margins, with the remaining $53 million in sales yielding 20% margins. This would produce $20 million in gross profit, making Jupiter potentially profitable with $10 million in EBITDA.\u0026nbsp;\u003c/p\u003e\n\n\n\n\u003cp\u003eHowever, Zuanic remains cautious about the sustainability of these projections given continued market share erosion. \u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eRead Also: \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/11/42145489/leef-brands-completes-101-share-consolidation\"\u003eLEEF Brands Completes 10:1 Share Consolidation\u003c/a\u003e\u003c/strong\u003e\u003c/p\u003e\n\n\n\n\u003ch3 class=\"wp-block-heading\"\u003eCompetitive Landscape And CCELL Partnership\u003c/h3\u003e\n\n\n\n\u003cp\u003eJupiter's long-standing partnership with CCELL is adapting to shifting market dynamics. CCELL has diversified its production outside China to mitigate geopolitical risks, while also strengthening direct U.S. customer support. Zuanic raises concerns about potential \u003ca href=\"https://www.benzinga.com/analyst-ratings/analyst-color/23/10/35228569/whos-who-among-cannabis-hardware-vaping-suppliers-zuanic-associates-take-a-deep-div\"\u003eoverlap between CCELL's direct operations and Jupiter's business\u003c/a\u003e, warning that structural changes may be necessary to preserve market leadership. \u003c/p\u003e\n\n\n\n\u003cp\u003eConsumer preferences are shifting toward all-in-one devices (AIOs), prompting Jupiter to invest in proprietary technologies and bolster its supply chain. Despite these efforts, the company has yet to reverse a five-year trend of declining market share. Zuanic underscores the importance of aligning innovation with operational efficiency to stay competitive. For a deeper dive into his methodology and projections, visit \u003ca href=\"https://zuanicgroup.com/\"\u003eZuanic \u0026amp; Associates' research portal\u003c/a\u003e.\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eRead Next:\u003ca href=\"https://www.benzinga.com/24/11/42144192/texas-ag-ken-paxton-sues-dallas-over-voter-approved-marijuana-reform\"\u003e Texas AG Ken Paxton Sues Dallas Over Cannabis Decriminalization Reform\u003c/a\u003e\u003c/strong\u003e\u003c/p\u003e","channels":[{"tid":68,"vid":1,"name":"Analyst Color"},{"tid":123430,"vid":1,"name":"Cannabis"},{"tid":927212,"vid":1,"name":"Market Summary"},{"tid":57,"vid":1,"name":"News"},{"tid":34989,"vid":1,"name":"Financing"},{"tid":34992,"vid":1,"name":"Asset Sales"},{"tid":46411,"vid":1,"name":"Small Cap"},{"tid":60,"vid":1,"name":"Management"},{"tid":145889,"vid":1,"name":"Exclusives"},{"tid":2,"vid":1,"name":"Markets"},{"tid":67,"vid":1,"name":"Analyst Ratings"},{"tid":22,"vid":1,"name":"Trading Ideas"}],"created":"2024-11-22T20:17:12Z","createdAt":"2024-11-22T20:17:12Z","id":42146751,"image":"https://www.benzinga.com/files/images/story/2024/11/22/AI-Generated-Image_0.jpeg","isBzPost":true,"isBzProPost":true,"meta":{"SectorV2":{"SIC":[{"IndustryCode":3741,"Industry":"Pharmaceutical and Medicine Industry","IndustryGroup":374,"MajorGroup":37,"Division":""}],"NAICS":[{"NationalIndustryCode":325412,"NationalIndustry":"Pharmaceutical Preparation Manufacturing ","IndustryCode":32541,"Industry":"Pharmaceutical and Medicine Manufacturing","IndustryGroupCode":3254,"IndustryGroup":"Pharmaceutical and Medicine Manufacturing","SubSectorCode":325,"SubSector":"Chemical Manufacturing","SectorCode":32,"Sector":"Manufacturing"}],"Morningstar":[{"IndustryCode":20620020,"Industry":"Drug Manufacturers—Specialty \u0026 Generic","IndustryGroupCode":20620,"IndustryGroup":"Drug Manufacturers","SectorCode":206,"Sector":"Healthcare","SuperSectorCode":2,"SuperSector":"Defensive"}]},"Partner":null,"PartnerTaxonomy":null,"SEC":null,"Author":null,"Authors":[{"uid":"0","name":""}],"Flags":{"ShowCopyrightNotice":true,"EvergreenContent":false,"ShowAdvertiserDisclosure":false,"ContributedContent":false,"AddGoogleStandoutMetaTag":false,"MediaSiteDNDOverride":false,"SendToYahooFinance":false,"SendToRobinhood":true,"SendToMSN":false},"Reach":{"Disclosure":{}},"Reference":null,"Ext":null,"wp_post_meta":{"campaign_strategy":"Default","post_id":661612,"post_path":"general/market-summary/24/11/42146751/jupiters-burnout-can-tilt-holdings-reverse-its-five-year-vape-decline","post_type":"post"}},"nodeId":42146751,"stocks":[{"tid":756432,"vid":2,"name":"TLLTF","primary":true}],"storyId":"6740e6c4b6cb720001aa34d7","tags":[{"tid":895782,"vid":3,"name":"cannabis debt"},{"tid":827747,"vid":3,"name":"cannabis debt financing"},{"tid":801187,"vid":3,"name":"Cannabis financing"},{"tid":775074,"vid":3,"name":"Cannabis Markets"},{"tid":148171,"vid":3,"name":"cannabis stocks"},{"tid":745269,"vid":3,"name":"Cannabis Vaping"},{"tid":844272,"vid":3,"name":"Jupiter Research LLC"},{"tid":154491,"vid":3,"name":"Pablo Zuanic"},{"tid":734779,"vid":3,"name":"TILT Holdings"},{"tid":758473,"vid":3,"name":"vapes"},{"tid":626169,"vid":3,"name":"Vaping"}],"teaser":"TILT\u0026#39;s financial health is constrained by $62 million in debt, along with $44 million in lease obligations.","teaserText":"TILT\u0026#39;s financial health is constrained by $62 million in debt, along with $44 million in lease obligations.","tickers":[{"tid":756432,"vid":2,"name":"TLLTF","primary":true}],"title":"Jupiter\u0026#39;s Burnout: Can TILT Holdings Reverse Its Five-Year Vape Decline?","updated":"2024-11-22T20:17:12Z","updatedAt":"2024-11-22T20:17:12Z","url":"https://www.benzinga.com/general/market-summary/24/11/42146751/jupiters-burnout-can-tilt-holdings-reverse-its-five-year-vape-decline"}]}]},"align":"","mode":"edit"},"innerBlocks":[],"innerHTML":"","type":"default"},{"blockName":"acf/carousel-news","attrs":{"name":"acf/carousel-news","data":{"title":"MARIJUANA LEGISLATION, LEGALIZATION \u0026 REGULATORY UPDATES","link":"","variant":"reverse","layout":"default","options":{"show_arrows_only_on_overflow":false,"slides_per_page":"","height":"197","width":"300","object_fit":"cover","title_case":false,"background_color":""},"query_and_options":{"options":{"displayOutput":"abstract","limit":12},"query":{"primaryChannel":"123430","channels":[29619],"channelAndTagQueryOperator":"and"}},"default_image":null,"initialItems":[{"href":"/24/11/42203777/kentucky-awards-first-medical-cannabis-dispensary-licenses","id":42203777,"image":"https://cdn.benzinga.com/files/images/story/2024/11/26/AI-Generated-Image_1.jpeg","isBzPost":true,"isBzProPost":true,"title":"Kentucky Awards First Medical Cannabis Dispensary Licenses"},{"href":"/news/legal/24/11/42202403/elizabeth-warren-bernie-sanders-12-congress-members-to-biden-issue-clemency-and-pardons-for-cannabis-prisoners","id":42202403,"image":"https://cdn.benzinga.com/files/images/story/2024/11/26/joe-biden-cannabis-liberty-adam-schultz-.jpeg","isBzPost":true,"isBzProPost":true,"title":"Elizabeth Warren, Bernie Sanders \u0026amp; 12 Congress Members To Biden: Issue Clemency And Pardons For Cannabis Prisoners"},{"href":"/news/legal/24/11/42177984/joe-biden-how-about-pardoning-non-violent-cannabis-prisoners-along-with-those-thanksgiving-turkeys","id":42177984,"image":"https://cdn.benzinga.com/files/images/story/2024/11/25/Photo-from-Nat--Turkey-Association.jpeg","isBzPost":true,"isBzProPost":true,"title":"Joe Biden, How About Pardoning Non-Violent Cannabis Prisoners Along With Those Thanksgiving Turkeys?"},{"href":"/24/11/42173101/dea-denies-allegations-of-unlawful-talks-with-anti-marijuana-group","id":42173101,"image":"https://cdn.benzinga.com/files/images/story/2024/11/25/Marijuana-DEA.png","isBzPost":true,"isBzProPost":true,"title":"DEA Denies Allegations Of Colluding With Anti-Marijuana Group While Involved In Cannabis Rescheduling Process"},{"href":"/news/legal/24/11/42163528/gop-takeover-and-trumps-return-vs-chuck-schumers-last-ditch-cannabis-banking-reform-push","id":42163528,"image":"https://cdn.benzinga.com/files/images/story/2024/11/25/Chuck-Schumer-copy.jpeg","isBzPost":true,"isBzProPost":true,"title":"GOP Takeover, Trump\u0026#39;s Return Vs. Chuck Schumer\u0026#39;s Last-Ditch Cannabis Banking Reform Push"},{"href":"/24/11/42145406/nebraskas-cannabis-legalization-faces-courtroom-showdown-over-alleged-fraud","id":42145406,"image":"https://cdn.benzinga.com/files/images/story/2024/11/22/1-19.png","isBzPost":true,"isBzProPost":true,"title":"Nebraska\u0026#39;s Cannabis Legalization Faces Courtroom Showdown Over Alleged Fraud"},{"href":"/24/11/42144540/dea-slammed-over-unlawful-talks-with-cannabis-opponents-the-plot-thickens","id":42144540,"image":"https://cdn.benzinga.com/files/images/story/2024/11/22/DEA.png","isBzPost":true,"isBzProPost":true,"title":"DEA Slammed For Unlawful Talks With Cannabis Opponents - The Plot Thickens"},{"href":"/24/11/42144192/texas-ag-ken-paxton-sues-dallas-over-voter-approved-marijuana-reform","id":42144192,"image":"https://cdn.benzinga.com/files/images/story/2024/11/22/texashemp.png","isBzPost":true,"isBzProPost":true,"title":"Texas AG Ken Paxton Sues Dallas Over Cannabis Decriminalization Reform"},{"href":"/news/legal/24/11/42143770/trumps-pick-for-attorney-general-is-no-matt-gaetz-when-it-comes-to-cannabis-reform","id":42143770,"image":"https://cdn.benzinga.com/files/images/story/2024/11/22/cannabis-reform-5-second-Studio-and-Eigh.jpeg","isBzPost":true,"isBzProPost":true,"title":"Trump\u0026#39;s Pick for Attorney General Is No Matt Gaetz When It Comes To Cannabis Reform"},{"href":"/news/legal/24/11/42143419/challenging-cannabis-prohibition-lawyer-behind-same-sex-marriage-takes-on-federal-policy-citing-justice-thomas-critique","id":42143419,"image":"https://cdn.benzinga.com/files/images/story/2024/11/22/Boies-Cannabis-Josh-Schiller.png","isBzPost":true,"isBzProPost":true,"title":"Challenging Cannabis Prohibition: Lawyer Behind Same-Sex Marriage Takes On Federal Policy, Citing Justice Thomas\u0026#39; Critique"},{"href":"/general/health-care/24/11/42138055/kentucky-gov-beshear-go-online-and-find-your-medical-marijuana-practitioner-on-dec-1","id":42138055,"image":"https://cdn.benzinga.com/files/images/story/2024/11/22/Andy-Beshear-Team-Kentucky-address.jpeg","isBzPost":true,"isBzProPost":true,"title":"Kentucky Gov. Beshear: \u0026#39;Go Online And Find\u0026#39; Your Medical Marijuana Practitioner On Dec. 1"},{"href":"/news/legal/24/11/42115861/alabama-lawsuit-against-cannabis-regulator-over-medical-marijuana-licensing-moves-forward","id":42115861,"image":"https://cdn.benzinga.com/files/images/story/2024/11/21/Cannabisl-Regulation-EKATERINA-BOLOVTSOV.jpeg","isBzPost":true,"isBzProPost":true,"title":"Alabama Lawsuit Against Cannabis Regulator Over Medical Marijuana Licensing Moves Forward"}]},"align":"","mode":"edit"},"innerBlocks":[],"innerHTML":"","type":"default"},{"blockName":"acf/calendars-widget","attrs":{"name":"acf/calendars-widget","data":{"show_logos":null,"show_title":true,"initial_tab":"earnings","tickers":["HMLSF","MJ","MJNE","YOLO","MJUS","ACRZF","APHA","ACB","CTST","CGC","CRON","CURLF","TGODF","GTBIF","GWPH","HEXO","HRVSF","ITHUF","MRMD","MMNFF","OGI","SMG","TLRY","YCBD","GNLN","IIPR","PYX","GMVP","IVITF","TBPMF","BBRRF","CNPOF","XXII","EVVLF","GSRX","CWBHF","CVSI","ACCA","CNBX","FLOOF","CBMJ","GABLF","NABIF","BGRDF","CURR","CPTRF","HERTF","CHOOF","CWWBF","ADVT","IMLFF","KSHB","VREOF","LRSNF","RMHB","HHPHF","IILBF","BHHKF","CLSH","QILFF","MDCL","ALYI","LDSYF","INSY","HZEMF","TRSSF","CADMF","VGWCF","AGEEF","APPB","HSTRF","CANN","VIVO","MMJFF","NOBDF","ACNNF","KALTF","MTEC","NWVCF","ALEAF","EMOR","ISOLF","RGI","CANX","LBUY","SVVTF","AUSAF","NTEC","KBEVF","FUAPF","CAPD","CNGGF","KAYS","RHNMF","RSSFF","GRWG","NCNNF","GEATF","EMHTF","LXRP","SUGR","GGTTF","BLEVF","WDEXF","GLDFF","BLOZF","ACRGF","ALGWF","RIV","PUFXF","JWCAF","VVCIF","EEVVF","HLIX","PKPH","CRLBF","ZYNE","DYMEF","TRPX","ORHOF","MGWFF","LVCNF","ZBISF","CBDY","CNXXF","GENE","BMMJ","NXGWF","CXXIF","CNVCF","CPHRF","HMPPF","ATTBF","KALY","HEMP","PHGRF","KHRNF","FFRMF","MBII","LQSIF","INSHF","SOLCF","BLGVF","SOL","CNTMF","INLB","MGCLF","HRVOF","GBHPF","CBWTF","OILFF","VFF","DRVD","WIZP","RLLRF","SARSF","AHGIF","CBIIF","CANVF","LIBFF","TGIFF","EVIO","ARNA","WRLD","HBOSF","ICNAF","ELLXF","GRNH","HITIF","CVHIF","FNNZF","BUGVF","MPXOF","LVRLF","CBIS","FSDDF","LNLHF","LGGCF","ZLDAF","LXLLF","LHSIF","PMD","NDVAF","LFCOF","LMLLF","VRNDF","PHOT","MXC","FLWPF","BOSQF","FFNTF","UGRO","CANN","CNBS","SNDL","ZDPY","TCNNF","PSDN","AYRWF","LIFD","AAWH","LFLY","MAPS","TLLTF","XTXXF","ayrwf","FFLWF","FFNTF","INCR","FLGC","SSIC","GRAMF","GLASF","GHBWF","AVTBF","LOVFF","CLVR",""]},"align":"","mode":"edit"},"innerBlocks":[],"innerHTML":"","type":"default"},{"blockName":"acf/carousel-news","attrs":{"name":"acf/carousel-news","data":{"title":"CANADA CANNABIS","link":"","variant":"reverse","layout":"default","options":{"show_arrows_only_on_overflow":false,"slides_per_page":"","height":"197","width":"300","object_fit":"cover","title_case":false,"background_color":""},"query_and_options":{"options":{"displayOutput":"abstract","limit":12},"query":{"primaryChannel":"123430","tags":[712759],"channelAndTagQueryOperator":"and"}},"default_image":null,"initialItems":[{"href":"/news/retail-sales/24/11/42199358/aurora-cannabis-reveals-latest-product-innovations-ultra-high-potency-indicas-and-strains-for-veterans","id":42199358,"image":"https://cdn.benzinga.com/files/images/story/2024/11/26/wesley-gibbs-NxRx7-mPdEk-unsplash.jpeg","isBzPost":true,"isBzProPost":true,"title":"Aurora Cannabis Reveals Latest Product Innovations: Ultra-High Potency Indicas And Strains For Veterans"},{"href":"/markets/cannabis/24/11/42169374/canadian-cannabis-producer-cannara-reports-43-yoy-revenue-growth-boosts-market-share-and-profitability","id":42169374,"image":"https://cdn.benzinga.com/files/images/story/2024/11/25/elsa-olofsson-12-Zs1xIEtA-unsplash25.jpeg","isBzPost":true,"isBzProPost":true,"title":"Canadian Cannabis Producer Cannara Reports 43% YoY Revenue Growth, Boosts Market Share And Profitability"},{"href":"/government/regulations/24/11/42146896/exclusive-how-equa-tackles-stigma-in-cannabis-insurance-with-tailored-solutions","id":42146896,"image":"https://cdn.benzinga.com/files/images/story/2024/11/22/equaloretta.png","isBzPost":true,"isBzProPost":true,"title":"EXCLUSIVE: How EQUA Tackles Stigma In Cannabis Insurance With Tailored Solutions"},{"href":"/24/11/42137701/canadian-cannabis-co-decibel-reports-12-yoy-drop-in-q3-revenue-but-increases-gross-margin-to-53","id":42137701,"image":"https://cdn.benzinga.com/files/images/story/2024/11/22/pexels-kindelmedia-76680491.jpeg","isBzPost":true,"isBzProPost":true,"title":"Canadian Cannabis Co. Decibel Reports 12% YoY Drop In Q3 Revenue But Increases Gross Margin To 53%"},{"href":"/markets/cannabis/24/11/42127287/whats-happening-with-canopy-growth-is-it-time-to-buy","id":42127287,"image":"https://cdn.benzinga.com/files/images/story/2024/11/21/Fibo-Canopy.png","isBzPost":true,"isBzProPost":true,"title":"What\u0026#39;s Happening With Canopy Growth: Is It Time To Buy?"},{"href":"/general/market-summary/24/11/42100955/the-u-s-cannabis-strategy-no-ones-talking-about-inside-canopys-300m-plan","id":42100955,"image":"https://cdn.benzinga.com/files/images/story/2024/11/20/AI-Generated-Image_1.jpeg","isBzPost":true,"isBzProPost":true,"title":"The U.S. Cannabis Strategy No One\u0026#39;s Talking About: Inside Canopy\u0026#39;s $300M Plan"},{"href":"/24/11/42017405/medical-marijuana-footprint-grows-in-florida-as-legalization-push-fizzles-and-other-new-cannabis-stores-that-launched-sales","id":42017405,"image":"https://cdn.benzinga.com/files/images/story/2024/11/15/jan-zwarthoed-24C4MlZRqeI-unsplash.jpeg","isBzPost":true,"isBzProPost":true,"title":"Medical Marijuana Footprint Grows In Florida As Legalization Push Fizzles, And Other New Cannabis Stores"},{"href":"/24/11/41982261/im-cannabis-achieves-66-revenue-growth-in-germany-narrows-ebitda-loss-in-q3","id":41982261,"image":"https://cdn.benzinga.com/files/images/story/2024/11/14/elsa-olofsson-12-Zs1xIEtA-unsplash23.jpeg","isBzPost":true,"isBzProPost":true,"title":"IM Cannabis: 66% Revenue Growth In Germany, Narrows EBITDA Loss In Q3"},{"href":"/news/financing/24/11/41947919/high-tide-closes-final-tranche-of-15m-debt-plans-retail-growth","id":41947919,"image":"https://cdn.benzinga.com/files/images/story/2024/11/13/Captura-de-pantalla-2024-11-13-113617-1.png","isBzPost":true,"isBzProPost":true,"title":"High Tide Closes Final Tranche Of $15M Debt, Plans Retail Growth"},{"href":"/analyst-ratings/analyst-color/24/11/41925770/three-paths-to-cannabis-profits-village-farms-green-thumb-and-jushi-show-divergent-","id":41925770,"image":"https://cdn.benzinga.com/files/images/story/2024/11/12/AI-Generated-Image.jpeg","isBzPost":true,"isBzProPost":true,"title":"Three Paths To Cannabis Profits: Village Farms, Green Thumb, And Jushi Show Divergent Strategies—Which Will Deliver?"},{"href":"/news/earnings/24/11/41852707/auxly-cannabis-co-q3-net-revenue-climbs-18-yoy-adjusted-ebitda-soars","id":41852707,"image":"https://cdn.benzinga.com/files/images/story/2024/11/08/dmytro-demidko-eBWzFKahEaU-unsplash1.jpeg","isBzPost":true,"isBzProPost":true,"title":"Auxly Cannabis Co.: Q3 Net Revenue Climbs 18% YoY, Adjusted EBITDA Soars"},{"href":"/news/earnings/24/11/41843751/canopy-growth-q2-net-revenue-drops-9-yoy-projects-positive-earnings-ahead","id":41843751,"image":"https://cdn.benzinga.com/files/images/story/2024/11/08/cannabis-debt-NikolayFrolochkin-and-ganj.jpeg","isBzPost":true,"isBzProPost":true,"title":"Canopy Growth: Q2 Net Revenue Drops 9% YoY, Projects Positive Earnings Ahead"}]},"align":"","mode":"edit"},"innerBlocks":[],"innerHTML":"","type":"default"},{"blockName":"acf/news-list-group","attrs":{"name":"acf/news-list-group","data":{"groups":[{"title":"Partner Content","title_case":false,"link":"","style":"","type":"default","loadMoreButton":false,"showSponsoredContent":false,"query_and_options":{"options":{"displayOutput":"full","limit":4},"query":{"primaryChannel":"123430","tags":[802151],"channelAndTagQueryOperator":"and"}},"query":{"displayOutput":"full","limit":4,"primaryChannel":"123430","tags":[802151],"channelAndTagQueryOperator":"and"},"parsely_query":{"limit":"","author":"","tag":""},"reachContent":{"placementIndex":3,"repeatIndex":5,"preload":true},"nodes":[{"assets":[{"type":"image","title":"Cannara Biotech Q1 Results: Revenue, Net Income And Market Share Up, Quarter Also Marks Company’s First Export Sale","alt":"Cannara Biotech Q1 Results: Revenue, Net Income And Market Share Up, Quarter Als","source":"","mime":"image/png","primary":true,"attributes":{"fid":"769463","filename":"screenshot_2024-02-07_at_8.29.35_pm.png","filepath":"files/images/story/2024/02/07/screenshot_2024-02-07_at_8.29.35_pm.png","filesize":0,"image_attributes":{"resolution":{"height":0,"width":0,"dpi":0}}}}],"author":"Meg Flippin","body":"\u003cp\u003eWith the demand for high-quality, affordably priced cannabis growing in Canada, \u003cstrong\u003eCannara Biotech Inc.\u0026#39;s \u003c/strong\u003e(OTC:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/LOVFF#OTC\"\u003eLOVFF\u003c/a\u003e) investments seem to be paying off. The vertically integrated producer of premium-grade cannabis and derivative product offerings has used investment dollars to produce quality cannabis products and increase the number of growing zones. That has resulted in Montreal-based \u003ca href=\"https://www.cannara.ca/en/\"\u003eCannara Biotech\u003c/a\u003e reporting record-setting revenue for its first quarter and forecast even more growth to come in 2024.\u0026nbsp;\u003c/p\u003e\r\n\r\n\u003cp\u003eFor the \u003ca href=\"https://www.newswire.ca/news-releases/cannara-biotech-announces-record-breaking-q1-2024-results-continued-robust-growth-and-market-expansion-856789495.html#:~:text=Q1%202024%20net%20revenues%20increased,adjustments%20generated%20in%20Q1%202023.\"\u003efirst quarter\u003c/a\u003e ending November 30, 2023, Cannara posted net revenue of $19.5 million, an 89% year-over-year increase and net income of $2.1 million, up significantly from $2,954 in the year-ago first quarter. Meanwhile, gross profit before fair value adjustments of $7.9 million was up 98% from the year-ago first quarter and earnings before interest, taxes, depreciation and amortization (EBITDA) of $5.2 million marked a 206% increase. \u0026ldquo;Our first quarter results are continued solid proof of Cannara\u0026#39;s strong financial health and strategic approach to business operations,\u0026rdquo; Nicholas Sosiak, CFO of Cannara said \u003ca href=\"https://www.newswire.ca/news-releases/cannara-biotech-announces-record-breaking-q1-2024-results-continued-robust-growth-and-market-expansion-856789495.html#:~:text=Q1%202024%20gross%20cannabis%20revenue,revenues%20generated%20in%20Q1%202023.\"\u003ewhen reporting quarterly results\u003c/a\u003e. \u0026rdquo;We have seen impressive sales increases and a steady rise in adjusted EBITDA, net income and cash flow from operations, which sets a strong base for the rest of the year.\u0026rdquo;\u003c/p\u003e\r\n\r\n\u003ch2\u003eQuality Cannabis At An Affordable Price\u0026nbsp;\u003c/h2\u003e\r\n\r\n\u003cp\u003eSince launching in 2017, Cannara Biotech has been focused on growing quality cannabis products and bringing them to the masses at an affordable price. The company operates two huge facilities spanning over 1,650,000 square feet in Quebec, where it churns out quality cannabis products en masse using its access to low-priced utilities in the province and lean operational structure to keep costs down. It then passes on those savings to its legions of customers.\u0026nbsp;\u003c/p\u003e\r\n\r\n\u003cp\u003eDuring the first quarter, the company produced from nine growing zones out of its Valleyfield Facility with a 10th growing zone added in January. All told, the company has increased its total production to about 33,500 kg of cannabis per year. That should be welcome news to its investors given sales of cannabis products in Canada are projected to grow at a \u003ca href=\"https://atbcapitalmarkets.com/insights/canadian-cannabis-market-size-forecast\"\u003eCAGR of 13.4% between 2021 and 2030\u003c/a\u003e. Underscoring that demand, Cannara said it sold 1.34 million units across its three flagship brands during the first quarter, up 99% from the 675,000 units sold in the same period a year ago. Quarter-over-quarter units sold were up 11%.\u0026nbsp;\u003c/p\u003e\r\n\r\n\u003cp\u003eThe variety of its product line is also increasing, which could drive sales further in 2024. During the quarter it increased its total national product portfolio of cannabis products by 60% to 155 SKUs from 97. It is innovating in new categories including infused pre-rolls, milled flower and budget-friendly vapes.\u0026nbsp;\u003c/p\u003e\r\n\r\n\u003ch2\u003eMarket Share Gains\u0026nbsp;\u003c/h2\u003e\r\n\r\n\u003cp\u003eAlong with an increase in sales during the quarter were market share gains, a key metric given it\u0026rsquo;s difficult to stand out in the market thanks to climates that make it hard to grow the product, regulatory hurdles and high start-up costs.\u0026nbsp;\u003c/p\u003e\r\n\r\n\u003cp\u003eIn Quebec, Canada\u0026rsquo;s largest market for cannabis, Cannara is the fourth-largest licensed producer, controlling about 8.7% of the market as of the first quarter. In Ontario, it ranks as the ninth top producer and in Alberta, its market share has increased to 2.3% from 1.2% share in the year-earlier first quarter. In British Columbia, it\u0026#39;s making inroads, with market share of just under 1%.\u0026nbsp;\u003c/p\u003e\r\n\r\n\u003cp\u003eThe company is still at the beginning of its growth, with only 35% of its production capacity activated, and operates in only five main markets in Canada, resulting in many strategies in Cannara\u0026rsquo;s toolkit to potentially increase its revenues and market share quarter over quarter.\u0026nbsp; Another milestone for Cannara during the first quarter: it completed its first intentional export sale of cannabis product to Israel. Not only does that showcase its ability to be an exporter, it highlights an additional potential revenue stream for the company.\u0026nbsp;\u003c/p\u003e\r\n\r\n\u003ch2\u003eA Bright Future Ahead?\u003c/h2\u003e\r\n\r\n\u003cp\u003eLooking out to the remainder of 2024, the company plans to increase production capabilities and sales incentives, roll out new products including new formats, release new strains, increase market penetration and continue to post positive Adjusted EBITDA. It\u0026rsquo;s confident all of that should position it for solid results this year and beyond.\u0026nbsp;\u003c/p\u003e\r\n\r\n\u003cp\u003e\u0026quot;The first quarter of 2024 has been another significant period for Cannara, with record breaking net revenues of $19.5 million, an 89% increase from the comparative quarter in 2023, and an incredible net income surge,\u0026rdquo; Zohar Krivorot, President and Chief Executive Officer, said of the first quarter results. \u0026ldquo;As we build on this momentum in 2024, our roadmap is clear, continued execution with excellence, cost efficiencies and product innovation. This strategic expansion is not just about quantity, it is about deepening our market penetration by enriching our customers\u0026rsquo; experience with high-quality products that stand out in the market. With a keen eye on evolving market trends and consumer preferences, we are committed to growing our market presence and product portfolio in a purposeful manner.\u0026quot;\u003c/p\u003e\r\n\r\n\u003cp\u003eFeatured photo courtesy of Cannara Biotech.\u003c/p\u003e\r\n\r\n\u003cp\u003e\u003cem\u003eThis post contains sponsored content. This content is for informational purposes only and not intended to be investing advice.\u003c/em\u003e\u003c/p\u003e\r\n","channels":[{"tid":19868,"vid":1,"name":"Biotech"},{"tid":123430,"vid":1,"name":"Cannabis"},{"tid":2,"vid":1,"name":"Markets"},{"tid":18467,"vid":1,"name":"General"}],"created":"2024-02-07T13:32:08Z","createdAt":"2024-02-07T13:32:08Z","id":36979898,"image":"https://www.benzinga.com/files/images/story/2024/02/07/screenshot_2024-02-07_at_8.29.35_pm.png","isBzPost":true,"isBzProPost":false,"meta":{"SectorV2":{"SIC":[{"IndustryCode":3741,"Industry":"Pharmaceutical and Medicine Industry","IndustryGroup":374,"MajorGroup":37,"Division":""}],"NAICS":[{"NationalIndustryCode":325412,"NationalIndustry":"Pharmaceutical Preparation Manufacturing ","IndustryCode":32541,"Industry":"Pharmaceutical and Medicine Manufacturing","IndustryGroupCode":3254,"IndustryGroup":"Pharmaceutical and Medicine Manufacturing","SubSectorCode":325,"SubSector":"Chemical Manufacturing","SectorCode":32,"Sector":"Manufacturing"}],"Morningstar":[{"IndustryCode":20620020,"Industry":"Drug Manufacturers—Specialty \u0026 Generic","IndustryGroupCode":20620,"IndustryGroup":"Drug Manufacturers","SectorCode":206,"Sector":"Healthcare","SuperSectorCode":2,"SuperSector":"Defensive"}]},"Partner":null,"PartnerTaxonomy":null,"SEC":null,"Author":null,"Authors":[{"uid":"0","name":""}],"Flags":{"ShowCopyrightNotice":true,"EvergreenContent":false,"ShowAdvertiserDisclosure":true,"ContributedContent":false,"AddGoogleStandoutMetaTag":false,"MediaSiteDNDOverride":true,"SendToYahooFinance":false,"SendToRobinhood":false,"SendToMSN":false},"Reach":{"Disclosure":{}},"Reference":null,"Ext":null,"wp_post_meta":null},"nodeId":36979898,"stocks":[{"vid":2,"name":"LOVFF"}],"storyId":"65c3865958a64d26a11dccd3","tags":[{"tid":831931,"vid":3,"name":"Cannara Biotech"},{"tid":802151,"vid":3,"name":"Partner Content"}],"teaser":"With the demand for high-quality, affordably priced cannabis growing in Canada, Cannara Biotech Inc.\u0026#39;s (OTCMKTS: LOVFF) investments seem to be paying off. The vertically integrated producer of premium-grade cannabis and derivative product offerings has used investment dollars to produce quality cannabis products and increase the number of growing zones.","teaserText":"With the demand for high-quality, affordably priced cannabis growing in Canada, Cannara Biotech Inc.\u0026#39;s (OTCMKTS: LOVFF) investments seem to be paying off. The vertically integrated producer of premium-grade cannabis and derivative product offerings has used investment dollars to produce quality cannabis products and increase the number of growing zones.","tickers":[{"vid":2,"name":"LOVFF"}],"title":"Cannara Biotech Q1 Results: Revenue, Net Income And Market Share Up, Quarter Also Marks Company\u0026#39;s First Export Sale","updated":"2024-02-07T13:32:10Z","updatedAt":"2024-02-07T13:32:10Z","url":"https://www.benzinga.com/general/biotech/24/02/36979898/cannara-biotech-q1-results-revenue-net-income-and-market-share-up-quarter-also-marks-companys-fir"},{"assets":[{"type":"image","title":"Cannara Biotech Market Share Gains Result In Record-Setting Fourth Quarter","alt":"Cannara Biotech Market Share Gains Result In Record-Setting Fourth Quarter","source":"","mime":"image/png","primary":true,"attributes":{"fid":"733186","filename":"untitled_design_-_2023-12-12t190932.689.png","filepath":"files/images/story/2023/12/12/untitled_design_-_2023-12-12t190932.689.png","filesize":0,"image_attributes":{"resolution":{"height":0,"width":0,"dpi":0}}}}],"author":"Meg Flippin","body":"\u003cp\u003eThanks in part to market share gains and increasing demand for high-quality cannabis at an affordable price in Canada, \u003cstrong\u003eCannara Biotech Inc.\u003c/strong\u003e (OTC:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/LOVFF#OTC\"\u003eLOVFF\u003c/a\u003e), the vertically integrated producer of premium-grade cannabis and derivative product offerings, reported record growth in revenue and net income for its fourth quarter of 2023.\u003c/p\u003e\r\n\r\n\u003cp\u003eFor its fiscal fourth quarter, Montreal-based \u003ca href=\"https://www.cannara.ca/en/\"\u003eCannara Biotech\u003c/a\u003e reported a more than 50% increase in net revenues, gross profits that rose 45% and adjusted EBITDA that was up 88% year-over-year. For the full year, adjusted EBITDA increased 140%, underscoring the company\u0026rsquo;s strength in its financial strategy and operational efficiency efforts.\u0026nbsp;\u003c/p\u003e\r\n\r\n\u003ch2\u003eBringing Efficiencies To The Market\u0026nbsp;\u003c/h2\u003e\r\n\r\n\u003cp\u003e\u0026ldquo;Net income of $4.8 million for the fourth quarter and more than $7 million for the year showcases how the company is in expansion mode\u0026rdquo;, Cannara Biotech said when reporting earnings. During the third quarter, the company was able to \u003ca href=\"https://finance.yahoo.com/news/cannara-biotech-inc-reports-record-120000449.html\"\u003eactivate three additional 25,000-square-foot grow zones ahead of schedule\u003c/a\u003e that are expected to pay off in the fourth quarter and beyond. Cannara\u0026rsquo;s one million square foot state-of-the-art Valleyfield Facility is now cultivating out of 9 of its 24 grow zones, with over 100,000 plants under cultivation between both facilities, producing over 30,000 kg of premium-grade cannabis per year. In addition to Cannara\u0026rsquo;s strength in its assets and acute focus on operational efficiencies, Cannara is also focused on innovation, bringing more than 70 new SKUs to market in 2023 driving profitability and market recognition. Cannara Biotech expects to expand its product line further to stand out in a crowded field.\u0026nbsp;\u003c/p\u003e\r\n\r\n\u003cp\u003e\u0026quot;Our net income growth \u0026ndash; 89% for the quarter and over 200% for the year \u0026ndash; signifies more than just numbers. It reflects our strategic vision and the distinct competitive edge we have as a leading Quebec-based producer,\u0026rdquo; said\u003ca href=\"https://www.cannara.ca/en/people/\"\u003e Zohar Krivorot, President and Chief Executive Officer\u003c/a\u003e when reporting earnings. \u0026ldquo;Importantly, our fourth quarter showed significant sequential growth over the third quarter of 2023, with higher revenue by 15%, operating income by 39%, Adjusted EBITDA by 23% and net income by 65%. Looking to 2024, we expect to see these figures grow even further as we continue to increase our market share across Canada.\u0026rdquo;\u003c/p\u003e\r\n\r\n\u003ch2\u003eDemand For Cannabis Growing In Canada\u0026nbsp;\u003c/h2\u003e\r\n\r\n\u003cp\u003eCannara Biotech is riding the wave of growth from the Canadian cannabis market. By 2030, it is forecast \u003ca href=\"https://atbcapitalmarkets.com/insights/canadian-cannabis-market-size-forecast\"\u003eto reach $12.2 billion\u003c/a\u003e, growing at a CAGR of 13.4% over 2021-2030. Recreational cannabis was legalized in 2018, creating a new market that saw the entrance of several players. Growth is being driven by younger consumers who have positive attitudes about cannabis and are more likely than their older counterparts to purchase recreational cannabis.\u0026nbsp;\u003c/p\u003e\r\n\r\n\u003cp\u003eStanding out in the market is tough, given brutal climates that make it difficult to grow. Plus given the regulatory hurdles and high start-up costs, the barriers to entry and the ability to succeed in the Canadian cannabis market can be difficult to accomplish, which makes Cannara\u0026rsquo;s results positive for its investors. The company operates two huge facilities spanning \u003ca href=\"https://www.cannara.ca/wp-content/uploads/2023/08/Cannara-Biotech-Investors-Deck-2023Q3_Final-.pdf\"\u003eover 1,650,000 square feet\u003c/a\u003e in Quebec, where it churns out quality cannabis products en masse using its access to low-priced utilities in the Province and lean operational structure to keep costs down.\u0026nbsp;\u003c/p\u003e\r\n\r\n\u003ch2\u003eQuality = Market Share Gains\u0026nbsp;\u003c/h2\u003e\r\n\r\n\u003cp\u003eCannara\u0026rsquo;s positive cash flow position of $2.8 million at the end of the fourth quarter and $5.4 million for fiscal 2023 allows it to expand organically and continue offering high-quality cannabis products at an affordable price. The company is still at the beginning of its growth, with only 35% of its production capacity activated, and operates in only five main markets in Canada, resulting in many strategies in Cannara\u0026rsquo;s toolkit to potentially increase its revenues and market share quarter over quarter.\u0026nbsp;\u003c/p\u003e\r\n\r\n\u003cp\u003eIn Ontario, Cannara gained enough market share to move up to the ninth spot and the company plans to improve that in 2024. Since launching in Alberta in May, the company has seen a 1,100% increase in product sales. In Quebec, Cannara has maintained its leadership position ranking as the third-biggest producer in the region. Meanwhile in British Columbia market share increased 60% in the fourth quarter compared to the third quarter.\u0026nbsp;\u003c/p\u003e\r\n\r\n\u003cp\u003e\u0026ldquo;These successes across various provinces underscore Cannara\u0026#39;s growing influence in the Canadian cannabis industry. As we cement our position as a true player in the market, our trajectory is clearly set towards becoming a leader in this competitive landscape,\u0026quot; Nicholas Sosiak, the company\u0026rsquo;s CFO said.\u003c/p\u003e\r\n\r\n\u003cp\u003e\u003cimg alt=\"screenshot_2023-12-12_at_7.06.11_pm.png\" src=\"https://www.benzinga.com/files/u240220/screenshot_2023-12-12_at_7.06.11_pm.png\" style=\"height:590px; width:650px\" /\u003e\u003c/p\u003e\r\n\r\n\u003cp\u003eFeatured photo courtesy of Cannara Biotech.\u003c/p\u003e\r\n\r\n\u003cp\u003e\u003cem\u003eThis post contains sponsored content. This content is for informational purposes only and not intended to be investing advice.\u003c/em\u003e\u003c/p\u003e\r\n","channels":[{"tid":123430,"vid":1,"name":"Cannabis"},{"tid":57,"vid":1,"name":"News"},{"tid":2,"vid":1,"name":"Markets"}],"created":"2023-12-12T13:22:20Z","createdAt":"2023-12-12T13:22:20Z","id":36195597,"image":"https://www.benzinga.com/files/images/story/2023/12/12/untitled_design_-_2023-12-12t190932.689.png","isBzPost":true,"isBzProPost":false,"meta":{"SectorV2":{"SIC":[{"IndustryCode":3741,"Industry":"Pharmaceutical and Medicine Industry","IndustryGroup":374,"MajorGroup":37,"Division":""}],"NAICS":[{"NationalIndustryCode":325412,"NationalIndustry":"Pharmaceutical Preparation Manufacturing ","IndustryCode":32541,"Industry":"Pharmaceutical and Medicine Manufacturing","IndustryGroupCode":3254,"IndustryGroup":"Pharmaceutical and Medicine Manufacturing","SubSectorCode":325,"SubSector":"Chemical Manufacturing","SectorCode":32,"Sector":"Manufacturing"}],"Morningstar":[{"IndustryCode":20620020,"Industry":"Drug Manufacturers—Specialty \u0026 Generic","IndustryGroupCode":20620,"IndustryGroup":"Drug Manufacturers","SectorCode":206,"Sector":"Healthcare","SuperSectorCode":2,"SuperSector":"Defensive"}]},"Partner":null,"PartnerTaxonomy":null,"SEC":null,"Author":null,"Authors":[{"uid":"0","name":""}],"Flags":{"ShowCopyrightNotice":true,"EvergreenContent":false,"ShowAdvertiserDisclosure":true,"ContributedContent":false,"AddGoogleStandoutMetaTag":false,"MediaSiteDNDOverride":true,"SendToYahooFinance":false,"SendToRobinhood":false,"SendToMSN":false},"Reach":{"Disclosure":{}},"Reference":null,"Ext":null,"wp_post_meta":null},"nodeId":36195597,"stocks":[{"vid":2,"name":"LOVFF"}],"storyId":"65785e8d58a64d26a1f3c193","tags":[{"tid":831931,"vid":3,"name":"Cannara Biotech"},{"tid":802151,"vid":3,"name":"Partner Content"}],"teaser":"Thanks in part to market share gains and increasing demand for high-quality cannabis at an affordable price in Canada, Cannara Biotech Inc. (OTCMKTS: LOVFF), the vertically integrated producer of premium-grade cannabis and derivative product offerings, reported record growth in revenue and net income for its fourth quarter of 2023.","teaserText":"Thanks in part to market share gains and increasing demand for high-quality cannabis at an affordable price in Canada, Cannara Biotech Inc. (OTCMKTS: LOVFF), the vertically integrated producer of premium-grade cannabis and derivative product offerings, reported record growth in revenue and net income for its fourth quarter of 2023.","tickers":[{"vid":2,"name":"LOVFF"}],"title":"Cannara Biotech Market Share Gains Result In Record-Setting Fourth Quarter","updated":"2023-12-12T13:24:59Z","updatedAt":"2023-12-12T13:24:59Z","url":"https://www.benzinga.com/markets/cannabis/23/12/36195597/cannara-biotech-market-share-gains-result-in-record-setting-fourth-quarter"},{"assets":[{"type":"image","title":"InMed’s (NASDAQ: INM) Latest Research Demonstrates Potential In Treating Alzheimer’s With A Rare Cannabinoid Analog","alt":"InMed’s (NASDAQ: INM) Latest Research Demonstrates Potential In Treating Alzheim","source":"","mime":"image/png","primary":true,"attributes":{"fid":"732539","filename":"screenshot_2023-12-11_at_6.51.29_pm.png","filepath":"files/images/story/2023/12/11/screenshot_2023-12-11_at_6.51.29_pm.png","filesize":0,"image_attributes":{"resolution":{"height":0,"width":0,"dpi":0}}}}],"author":"Meg Flippin","body":"\u003cp\u003eWhen it comes to treating degenerative diseases like Alzheimer\u0026rsquo;s, much of the current focus is on addressing the symptoms rather than repairing and regenerating the damaged tissues and cells. Some drugs and treatments may slow the progression of cognitive decline, but none can reverse the effects of Alzheimer\u0026rsquo;s.\u003c/p\u003e\r\n\r\n\u003cp\u003eThat\u0026rsquo;s bad news given Alzheimer\u0026rsquo;s is a big and growing problem. As it stands, \u003ca href=\"https://www.cdc.gov/aging/alzheimers-disease-dementia/about-alzheimers.html#:~:text=In%202023%2C%20an%20estimated%206.7,or%20older%20had%20Alzheimer's%20disease.\u0026amp;text=1-,This%20number%20is%20projected%20to%20nearly,14%20million%20people%20by%202060.\"\u003eabout 6.7 million people 65 and older\u003c/a\u003e in the U.S. suffer from the disease that attacks memory and cognitive functions. It\u0026rsquo;s only expected to get worse as the population ages \u0026ndash; by 2060, it\u0026rsquo;s projected that 14 million people in the U.S. will suffer from Alzheimer\u0026rsquo;s.\u003c/p\u003e\r\n\r\n\u003ch2\u003eThe Promise Of Cannabinoids\u003c/h2\u003e\r\n\r\n\u003cp\u003eCannabinoid research is \u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/34204237/\"\u003eone area that holds promise\u003c/a\u003e in not only slowing the progress but also reversing the effects of\u0026nbsp;Alzheimer\u0026rsquo;s thanks to the neuroprotective and regenerative properties of cannabinoids. Rare cannabinoids, like the ones identified by \u003cstrong\u003eInMed Pharmaceuticals Inc.\u003c/strong\u003e (NASDAQ:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/INM#NASDAQ\"\u003eINM\u003c/a\u003e) \u0026ndash; a leader in cannabinoids and cannabinoid analogs pharmaceutical research and development, manufacturing and commercialization \u0026ndash; have promising properties.\u0026nbsp;\u003c/p\u003e\r\n\r\n\u003cp\u003eFor instance, they are highly lipophilic and \u003ca href=\"https://www.inmedpharma.com/pharmaceutical/inm-901-for-alzheimers-disease/\"\u003ecan easily cross the blood-brain barrier\u003c/a\u003e, which is the specialized system of brain microvascular endothelial cells that serves to regulate several functions including shielding the brain from toxic substances (including viruses, bacteria and other foreign substances including many drugs), supplying brain tissues with nutrients and filtering harmful compounds from the brain back into the bloodstream. Cannabinoids\u0026#39; ability to easily breach the blood-brain barrier makes them potential pharmaceutical agents for neurological disorders. They are also capable of targeting multiple receptor systems which may prove helpful in treating complex diseases of the brain.\u0026nbsp;\u003c/p\u003e\r\n\r\n\u003ch2\u003eThe Promise Of IMN-901\u0026nbsp;\u003c/h2\u003e\r\n\r\n\u003cp\u003eInMed has just launched a new pharmaceutical drug development program called INM-901, using a rare cannabinoid analog in the treatment of Alzheimer\u0026rsquo;s. Based on early in vitro research, \u003ca href=\"https://www.inmedpharma.com/pharmaceutical/inm-901-for-alzheimers-disease/\"\u003ethe cannabinoid analog\u003c/a\u003e showed the potential to target several biological pathways associated with Alzheimer\u0026rsquo;s, providing neuroprotection to the brain neurons from beta-amyloid peptide-induced toxicity and improving neuronal function via the extension of neurite length.\u0026nbsp;\u003c/p\u003e\r\n\r\n\u003cp\u003eIn its latest \u003cem\u003ein vivo\u003c/em\u003e studies, INM-901 improved cognitive function and memory, locomotor activity, anxiety-based behavior, sound awareness and neuronal function. INM-901 also displayed neuroprotective effects by reducing cell death in an amyloid-beta-induced cytotoxicity study. Previous in vitro studies showed this rare cannabinoid provided neuroprotective effects in a population of affected neurons and promoted neurite outgrowth. That points to the potential for INM-901 to enhance neuronal function.\u003c/p\u003e\r\n\r\n\u003cp\u003e\u0026ldquo;The most recent studies of INM-901 demonstrate promising disease-modifying effects in an\u0026nbsp; Alzheimer\u0026rsquo;s disease treatment model,\u0026rdquo; said Dr. Eric Hsu, InMed\u0026rsquo;s Senior Vice President of Preclinical Research and Development in announcing the selection of INM-901 as a candidate to treat Alzheimer\u0026#39;s. \u0026ldquo;We are optimistic that the next stage of studies will continue to show how this cannabinoid analog can improve neuronal function, a potential breakthrough in\u0026nbsp; Alzheimer\u0026rsquo;s treatment.\u0026rdquo;\u003c/p\u003e\r\n\r\n\u003ch2\u003eRare Cannabinoids Could Treat Itch And Vision\u0026nbsp;\u003c/h2\u003e\r\n\r\n\u003cp\u003eInMed\u0026rsquo;s selection of INM-901 builds on the company\u0026rsquo;s \u003ca href=\"https://www.inmedpharma.com/wp-content/uploads/2023/02/InMed-Corporate-Deck-October-2023.pdf\"\u003epipeline of rare cannabinoids\u003c/a\u003e for a variety of therapeutic applications that have large unmet medical needs. Its work includes programs in dermatology, ocular conditions and Alzheimer\u0026rsquo;s disease. InMed is the first company to advance CBN, its active pharmaceutical ingredient into a phase 2 clinical trial, in the treatment of\u003ca href=\"https://www.inmedpharma.com/pharmaceutical/inm-755-for-epidermolysis-bullosa/\"\u003e epidermolysis bullosa\u003c/a\u003e. It also has 2 ocular programs underway: aINM-088 CBN eye drops, which were developed \u003ca href=\"https://www.inmedpharma.com/pharmaceutical/inm-088-for-glaucoma/\"\u003eto treat glaucoma\u003c/a\u003e, and the recently launched INM-089 program in the treatment of age-related macular degeneration (AMD)).\u003c/p\u003e\r\n\r\n\u003cp\u003eTreating Alzheimer\u0026#39;s with the existing therapeutics and the drugs on the market clearly isn\u0026rsquo;t enough. While they slow the onset and progression of this debilitating disease, unfortunately, they don\u0026rsquo;t cure it. Cannabinoids, particularly the one discovered by InMed, may change all that, someday providing relief to patients and loved ones who suffer from this widespread and growing form of dementia.\u0026nbsp;\u003c/p\u003e\r\n\r\n\u003cp\u003eTo learn more on the INM-901 program please watch their \u003ca href=\"https://www.inmedpharma.com/pharmaceutical/inm-901-for-alzheimers-disease/\"\u003eanimation video on their website\u003c/a\u003e.\u003c/p\u003e\r\n\r\n\u003cp\u003eFeatured photo by \u003ca href=\"https://unsplash.com/@averey?utm_content=creditCopyText\u0026amp;utm_medium=referral\u0026amp;utm_source=unsplash\"\u003eRobina Weermeijer\u003c/a\u003e on \u003ca href=\"https://unsplash.com/photos/brown-brain-decor-in-selective-focus-photography-3KGF9R_0oHs?utm_content=creditCopyText\u0026amp;utm_medium=referral\u0026amp;utm_source=unsplash\"\u003eUnsplash\u003c/a\u003e\u003cem\u003e.\u003c/em\u003e\u003c/p\u003e\r\n\r\n\u003cp\u003e\u003cem\u003eThis post contains sponsored content. This content is for informational purposes only and not intended to be investing advice.\u003c/em\u003e\u003c/p\u003e\r\n","channels":[{"tid":19868,"vid":1,"name":"Biotech"},{"tid":123430,"vid":1,"name":"Cannabis"},{"tid":22681,"vid":1,"name":"Penny Stocks"},{"tid":2,"vid":1,"name":"Markets"},{"tid":18467,"vid":1,"name":"General"}],"created":"2023-12-11T13:22:37Z","createdAt":"2023-12-11T13:22:37Z","id":36175332,"image":"https://www.benzinga.com/files/images/story/2023/12/11/screenshot_2023-12-11_at_6.51.29_pm.png","isBzPost":true,"isBzProPost":false,"meta":{"SectorV2":{"SIC":[{"IndustryCode":3741,"Industry":"Pharmaceutical and Medicine Industry","IndustryGroup":374,"MajorGroup":37,"Division":""}],"NAICS":[{"NationalIndustryCode":325411,"NationalIndustry":"Medicinal and Botanical Manufacturing ","IndustryCode":32541,"Industry":"Pharmaceutical and Medicine Manufacturing","IndustryGroupCode":3254,"IndustryGroup":"Pharmaceutical and Medicine Manufacturing","SubSectorCode":325,"SubSector":"Chemical Manufacturing","SectorCode":32,"Sector":"Manufacturing"}],"Morningstar":[{"IndustryCode":20610010,"Industry":"Biotechnology","IndustryGroupCode":20610,"IndustryGroup":"Biotechnology","SectorCode":206,"Sector":"Healthcare","SuperSectorCode":2,"SuperSector":"Defensive"}]},"Partner":null,"PartnerTaxonomy":null,"SEC":null,"Author":null,"Authors":[{"uid":"0","name":""}],"Flags":{"ShowCopyrightNotice":true,"EvergreenContent":false,"ShowAdvertiserDisclosure":true,"ContributedContent":false,"AddGoogleStandoutMetaTag":false,"MediaSiteDNDOverride":true,"SendToYahooFinance":false,"SendToRobinhood":false,"SendToMSN":false},"Reach":{"Disclosure":{}},"Reference":null,"Ext":null,"wp_post_meta":null},"nodeId":36175332,"stocks":[{"tid":144068,"vid":2,"name":"INM"}],"storyId":"65770d1e58a64d26a1a28a16","tags":[{"tid":817230,"vid":3,"name":"InMed Pharmaceuticals"},{"tid":802151,"vid":3,"name":"Partner Content"}],"teaser":"When it comes to treating degenerative diseases like Alzheimer’s, much of the current focus is on addressing the symptoms rather than repairing and regenerating the damaged tissues and cells. Some drugs and treatments may slow the progression of cognitive decline, but none can reverse the effects of Alzheimer’s.","teaserText":"When it comes to treating degenerative diseases like Alzheimer’s, much of the current focus is on addressing the symptoms rather than repairing and regenerating the damaged tissues and cells. Some drugs and treatments may slow the progression of cognitive decline, but none can reverse the effects of Alzheimer’s.","tickers":[{"tid":144068,"vid":2,"name":"INM"}],"title":"InMed\u0026#39;s (NASDAQ: INM) Latest Research Demonstrates Potential In Treating Alzheimer\u0026#39;s With A Rare Cannabinoid Analog","updated":"2023-12-11T13:30:16Z","updatedAt":"2023-12-11T13:30:16Z","url":"https://www.benzinga.com/general/biotech/23/12/36175332/inmeds-nasdaq-inm-latest-research-demonstrates-potential-in-treating-alzheimers-with-a-rare-canna"},{"assets":[{"type":"image","title":"How Rexis Biotech Aims To Become The Nvidia Of The Consumer Products Industry ","alt":"How Rexis Biotech Aims To Become The Nvidia Of The Consumer Products Industry ","source":"","mime":"image/png","primary":true,"attributes":{"fid":"707835","filename":"screenshot_2023-10-30_at_5.49.29_pm.png","filepath":"files/images/story/2023/10/30/screenshot_2023-10-30_at_5.49.29_pm.png","filesize":0,"image_attributes":{"resolution":{"height":0,"width":0,"dpi":0}}}}],"author":"Meg Flippin","body":"\u003cp\u003e\u003ca href=\"https://wefunder.com/rexis\"\u003e\u003cem\u003e\u003cspan style=\"font-weight: 400;\"\u003eClick here to learn more about Rexis Systems\u0026rsquo; crowdfunding raise, and how to invest\u003c/span\u003e\u003c/em\u003e\u003c/a\u003e\u003c/p\u003e\r\n\u003cp\u003e\u003cspan style=\"font-weight: 400;\"\u003eCannabis is going mainstream as more states legalize the leafy herb. That's spawning a multi-billion-dollar market for CBD and THC products, with manufacturers putting it in everything from candy to drinks. The cannabis-infused beverage category in particular is growing in popularity as people look for healthier ways to get a buzz. Last year, the cannabis drink market was valued at $0.4 billion. By 2032, it is \u003c/span\u003e\u003ca href=\"https://www.futuremarketinsights.com/reports/cannabis-drinks-market#:~:text=The%20cannabis%20drinks%20market%20is,growth%20of%2018.7%25%20in%202022.\"\u003e\u003cspan style=\"font-weight: 400;\"\u003eprojected to reach $8.3 billion\u003c/span\u003e\u003c/a\u003e\u003cspan style=\"font-weight: 400;\"\u003e at a 37.7% CAGR over 2023-2032. These drinks promise to give consumers a smoother, gentler taste with few calories and zero hangover in the morning.\u003c/span\u003e\u003c/p\u003e\r\n\u003cp\u003e\u003cstrong\u003eRexis Biotech Inc.\u003c/strong\u003e\u003cspan style=\"font-weight: 400;\"\u003e, the biotech out of Delaware, is taking the cannabis-infused beverage market to the next level with its proprietary Fused Polymorph Nano Fiber Technolog\u003c/span\u003e\u003cspan style=\"font-weight: 400;\"\u003ey\u0026trade; \u003c/span\u003e\u003cspan style=\"font-weight: 400;\"\u003ethat enhances the benefits and effects of cannabis in drinks. The current cannabis-infused drinks on the market do provide a new experience to consumers, but there are some limitations. For starters, the body can\u0026rsquo;t efficiently absorb most plant-based ingredients like CBD, THC and caffeine. As a result, consumers typically only receive 10% or less of the ingredient in their system. It also takes longer to absorb into the bloodstream, usually 45 to 90 minutes, when using oil-based infusions. These tend to give more of an edible high, as they are processed during first-pass digestion, versus the smoking high that using nanotechnology is supposed to create. Up until now, nanoemulsions have been the go-to solution to solve for faster onset, but emulsions tend to be unstable, \u003c/span\u003e\u003ca href=\"https://wefunder.com/rexis\"\u003e\u003cspan style=\"font-weight: 400;\"\u003eeasily losing 30% efficacy\u003c/span\u003e\u003c/a\u003e\u003cspan style=\"font-weight: 400;\"\u003e within the first three months. On top of that, they often leave a bitter or oily aftertaste in your mouth.\u003c/span\u003e\u003c/p\u003e\r\n\u003ch2\u003e\u003cspan style=\"font-weight: 400;\"\u003eRexis Enhances The Benefits\u0026nbsp;\u003c/span\u003e\u003c/h2\u003e\r\n\u003cp\u003e\u003cspan style=\"font-weight: 400;\"\u003eRexis Biotech reports that its proprietary drug delivery platform eliminates those undesirable aspects of nanoemulsions, allowing them to create a lineup of Hemp\u003c/span\u003e\u003cspan style=\"font-weight: 400;\"\u003e Delta 9 THC-infused beverages that both taste amazing and enhance the consumer experience. \u003c/span\u003e\u003ca href=\"https://letsgetsquared.com/\"\u003e\u003cspan style=\"font-weight: 400;\"\u003eSquared\u003c/span\u003e\u003c/a\u003e\u003cspan style=\"font-weight: 400;\"\u003e, the first beverage out of the gate for Rexis, is a lineup of better-for-you-sodas that are both delicious and nutritious. Available in a variety of flavors from their Classic Orange Pop that tastes exactly like an Orange Crush to their High Spirits Awards-winning Sparkling Grapefruit, these cannabis-infused beverages onset in about 10-15 minutes and provide a reliable effect that\u0026rsquo;s closer to the dosage on the can.\u0026nbsp;\u003c/span\u003e\u003c/p\u003e\r\n\u003cp\u003e\u003cspan style=\"font-weight: 400;\"\u003eRexis says it is able to achieve that thanks to its fast-acting nano fiber technology which enables the drink to quickly absorb through the buccal membranes in the mouth versus having to go through first-pass digestion like traditional edibles. This allows the body to absorb and process the Hemp Delta 9 THC faster and more effectively. Squared beverages are also formulated to offset in about an hour \u0026ndash; a key differentiator. It puts consumers in the driver\u0026rsquo;s seat regarding how much and how long they want to feel the effects.\u0026nbsp;\u003c/span\u003e\u003c/p\u003e\r\n\u003ch2\u003e\u003cspan style=\"font-weight: 400;\"\u003eSquared Is Just The Beginning\u0026nbsp;\u003c/span\u003e\u003c/h2\u003e\r\n\u003cp\u003e\u003cspan style=\"font-weight: 400;\"\u003eRexis is demonstrating its nanotechnology with the launch of Squared, but its vision is much bigger. It \u003c/span\u003e\u003ca href=\"https://rexissystems.com/about-us/\"\u003e\u003cspan style=\"font-weight: 400;\"\u003ewants to share its technology\u003c/span\u003e\u003c/a\u003e\u003cspan style=\"font-weight: 400;\"\u003e, aiming to be the \u003c/span\u003e\u003cstrong\u003eNvidia Corp.\u003c/strong\u003e\u003cspan style=\"font-weight: 400;\"\u003e (NASDAQ:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/NVDA#NASDAQ\"\u003eNVDA\u003c/a\u003e) or \u003c/span\u003e\u003cstrong\u003eIntel Corp.\u003c/strong\u003e\u003cspan style=\"font-weight: 400;\"\u003e (NASDAQ:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/INTC#NASDAQ\"\u003eINTC\u003c/a\u003e) of the consumer products industry. It envisions a world where brands license Rexis\u0026rsquo;s nanotechnology to enhance everything from drinks to food.\u0026nbsp;\u003c/span\u003e\u003c/p\u003e\r\n\u003cp\u003e\u003cspan style=\"font-weight: 400;\"\u003eIts partnership with \u003c/span\u003e\u003cstrong\u003e3Chi, Inc.\u003c/strong\u003e\u003cspan style=\"font-weight: 400;\"\u003e, one of the world\u0026rsquo;s largest hemp-derived consumer packaged goods manufacturers and retailers, underscores how it\u0026rsquo;s making that ambition a reality. Functional foods and beverages \u0026ldquo;Powered by Rexis\u0026rdquo; will be sold via their national distribution network, Wicked Smart Food Company, and they expect it to drive revenues of $24.6 million over the next three years. \u0026ldquo;Rexis separates itself from the competition with its technology. Their Fused Polymorph Nano Fiber is several steps above anything else that's in the marketplace right now. The quality of product that we have gotten from them is unsurpassed,\u0026rdquo; Justin Journay, 3Chi CEO, said \u003c/span\u003e\u003ca href=\"https://rexissystems.com/rexis-biotech-announces-strategic-partnership-with-3chi-wefunder-crowdfunding-equity-raise/\"\u003e\u003cspan style=\"font-weight: 400;\"\u003ewhen the deal was announced in July\u003c/span\u003e\u003c/a\u003e\u003cspan style=\"font-weight: 400;\"\u003e.\u0026nbsp;\u003c/span\u003e\u003c/p\u003e\r\n\u003cp\u003e\u003cspan style=\"font-weight: 400;\"\u003eThe cannabis-infused beverage market seems to be taking off, and Rexis wants to be a leader. As more states legalize it and consumers clamor for healthier and tastier alternatives, Rexis is betting its proprietary nanotechnology will become the engine that drives these beverages like Intel\u0026rsquo;s chips power PCs.\u0026nbsp;\u003c/span\u003e\u003c/p\u003e\r\n\u003cp\u003e\u003cspan style=\"font-weight: 400;\"\u003eFeatured photo by \u003c/span\u003e\u003ca href=\"https://www.shutterstock.com/g/Spender1\"\u003e\u003cspan style=\"font-weight: 400;\"\u003eSpender1\u003c/span\u003e\u003c/a\u003e\u003cspan style=\"font-weight: 400;\"\u003e on \u003c/span\u003e\u003ca href=\"https://www.shutterstock.com/\"\u003e\u003cspan style=\"font-weight: 400;\"\u003eShutterstock\u003c/span\u003e\u003c/a\u003e\u003cspan style=\"font-weight: 400;\"\u003e\u0026nbsp;\u003c/span\u003e\u003c/p\u003e\r\n\u003cp\u003e\u003cem\u003e\u003cspan style=\"font-weight: 400;\"\u003eThis post contains sponsored content. This content is for informational purposes only and is not intended to be investing advice.\u0026nbsp;\u003c/span\u003e\u003c/em\u003e\u003c/p\u003e ","channels":[{"tid":19868,"vid":1,"name":"Biotech"},{"tid":123430,"vid":1,"name":"Cannabis"},{"tid":2,"vid":1,"name":"Markets"},{"tid":18467,"vid":1,"name":"General"}],"created":"2023-10-30T12:20:22Z","createdAt":"2023-10-30T12:20:22Z","id":35488296,"image":"https://www.benzinga.com/files/images/story/2023/10/30/screenshot_2023-10-30_at_5.49.29_pm.png","isBzPost":true,"isBzProPost":false,"meta":{"SectorV2":{"SIC":[{"IndustryCode":3674,"Industry":"Semiconductors \u0026 Related Devices","IndustryGroup":367,"MajorGroup":36,"Division":""}],"NAICS":[{"NationalIndustryCode":334413,"NationalIndustry":"Semiconductor and Related Device Manufacturing ","IndustryCode":33441,"Industry":"Semiconductor and Other Electronic Component Manufacturing","IndustryGroupCode":3344,"IndustryGroup":"Semiconductor and Other Electronic Component Manufacturing","SubSectorCode":334,"SubSector":"Computer and Electronic Product Manufacturing","SectorCode":33,"Sector":"Manufacturing"}],"Morningstar":[{"IndustryCode":31130020,"Industry":"Semiconductors","IndustryGroupCode":31130,"IndustryGroup":"Semiconductors","SectorCode":311,"Sector":"Technology","SuperSectorCode":3,"SuperSector":"Sensitive"}]},"Partner":null,"PartnerTaxonomy":null,"SEC":null,"Author":null,"Authors":[{"uid":"0","name":""}],"Flags":{"ShowCopyrightNotice":true,"EvergreenContent":false,"ShowAdvertiserDisclosure":true,"ContributedContent":false,"AddGoogleStandoutMetaTag":false,"MediaSiteDNDOverride":true,"SendToYahooFinance":false,"SendToRobinhood":false,"SendToMSN":false},"Reach":{"Disclosure":{}},"Reference":null,"Ext":null,"wp_post_meta":null},"nodeId":35488296,"stocks":[{"tid":11827,"vid":2,"name":"INTC","description":"Intel"},{"tid":12353,"vid":2,"name":"NVDA","description":"Nvidia","primary":true}],"storyId":"653f9f876312747be0a9ded2","tags":[{"tid":802151,"vid":3,"name":"Partner Content"},{"tid":903119,"vid":3,"name":"Rexis Biotech"}],"teaser":"Click here to learn more about Rexis Systems’ crowdfunding raise, and how to invest","teaserText":"Click here to learn more about Rexis Systems’ crowdfunding raise, and how to invest","tickers":[{"tid":11827,"vid":2,"name":"INTC","description":"Intel"},{"tid":12353,"vid":2,"name":"NVDA","description":"Nvidia","primary":true}],"title":"How Rexis Biotech Aims To Become The Nvidia Of The Consumer Products Industry","updated":"2023-10-31T11:08:46Z","updatedAt":"2023-10-31T11:08:46Z","url":"https://www.benzinga.com/general/biotech/23/10/35488296/how-rexis-biotech-aims-to-become-the-nvidia-of-the-consumer-products-industry"}]},{"title":"Trading Ideas","title_case":false,"link":"https://www.benzinga.com/trading-ideas","style":"","type":"default","loadMoreButton":false,"showSponsoredContent":false,"query_and_options":{"options":{"displayOutput":"full","limit":4},"query":{"primaryChannel":"123430","channels":[22],"channelAndTagQueryOperator":"and"}},"query":{"displayOutput":"full","limit":4,"primaryChannel":"123430","channels":[22],"channelAndTagQueryOperator":"and"},"parsely_query":{"limit":"","author":"","tag":""},"reachContent":{"placementIndex":3,"repeatIndex":5,"preload":true},"nodes":[{"assets":[{"type":"image","title":"Aurora Stock","alt":"Aurora Stock","source":"AI generated image","mime":"","primary":true,"attributes":{"fid":"901845","filename":"Aurora-Stock.png","filepath":"files/images/story/2024/11/26/Aurora-Stock.png","filesize":0,"image_attributes":{"resolution":{"height":0,"width":0,"dpi":0}}}}],"author":"Rolando García","body":"\u003cp\u003eCannabis stocks have faced significant \u003ca href=\"https://www.benzinga.com/24/11/42125955/cannabis-stocks-feel-the-burn-as-gaetz-bows-out-msos-in-focus\"\u003echallenges\u003c/a\u003e recently, driven by \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/11/41782344/tilray-trulieve-and-other-cannabis-stocks-nosediving-as-industry-faces-new-wave-of-political-unc\"\u003epolitical uncertainty\u003c/a\u003e that has further weighed on a sector still struggling to regain its footing since the overhyped all-time highs of 2021. \u003c/p\u003e\n\n\n\n\u003cp\u003eTo help investors navigate the long-term outlook for key \u003ca href=\"https://www.benzinga.com/topic/marijuana-stocks\"\u003ecannabis companies\u003c/a\u003e, we are introducing a series of in-depth technical analyses, focusing on actionable insights from technical indicators to support informed financial decisions.\u003c/p\u003e\n\n\n\n\u003cp\u003eAfter analyzing Canadian cannabis giant \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/11/42127287/whats-happening-with-canopy-growth-is-it-time-to-buy\"\u003eCanopy Growth\u003c/a\u003e (NASDAQ:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/CGC#NASDAQ\"\u003eCGC\u003c/a\u003e), it's time to turn our attention to another heavyweight: Aurora Cannabis (NASDAQ:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/ACB#NASDAQ\"\u003eACB\u003c/a\u003e). \u003c/p\u003e\n\n\n\n\u003cp\u003eBased in Alberta, Aurora remains a key player in the sector and a major contender for Canopy. So, grab a seat as we dive into the technical setup and explore what the future might hold for this heavy-weight cannabis company.\u003c/p\u003e\n\n\n\n\u003cp\u003eWe will use Fibonacci Retracement, a popular tool in technical analysis that helps traders identify key levels where a stock might reverse or stabilize. In Aurora's case, the tool is applied from the March low of $2.7 to the April high of $8.96. In the case of Canopy, the starting point was May.\u003c/p\u003e\n\n\n\n\u003ch3 class=\"wp-block-heading\"\u003e\u003cstrong\u003eFor Mid-Term Traders And Holders\u003c/strong\u003e\u003c/h3\u003e\n\n\n\n\u003cp\u003eThese levels highlight critical zones where buyer or seller momentum tends to shift.\u003c/p\u003e\n\n\n\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003eCurrent Support\u003c/strong\u003e: Aurora is hovering around the\u0026nbsp;\u003cstrong\u003e78.6% retracement level at $4.16\u003c/strong\u003e: the \"final line of defense\" for bulls.\u003c/li\u003e\n\n\n\n\u003cli\u003e\u003cstrong\u003eResistance Ahead\u003c/strong\u003e: If this support holds, the next key levels are\u0026nbsp;\u003cstrong\u003e$5.26 (61.8%)\u003c/strong\u003e\u0026nbsp;and\u0026nbsp;\u003cstrong\u003e$6.04 (50%)\u003c/strong\u003e, which could act as mid-term targets.\u003c/li\u003e\n\n\n\n\u003cli\u003eBreaking above $6.04 would indicate stronger bullish momentum and possibly a trend reversal.\u003c/li\u003e\n\u003c/ul\u003e\n\n\n\n\u003cp\u003eFor short-term traders, $5.26 is a natural profit-taking zone, while holders might look for sustained moves above $6.04 as a sign of long-term recovery. \u003c/p\u003e\n\n\n\n\u003cp\u003eIf the price falls below $4.16, the next significant support lies near $2.7, the March low, which would invalidate the bullish scenario.\u003c/p\u003e\n\n\n\n\u003cfigure class=\"wp-block-image size-large is-resized\"\u003e\u003cimg loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"395\" src=\"https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/26114152/ACB-cannabis-Fibo-1024x395.png\" alt=\"Aurora Stock\" class=\"wp-image-665843\" style=\"width:695px;height:auto\" srcset=\"https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/26114152/ACB-cannabis-Fibo-1024x395.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/26114152/ACB-cannabis-Fibo-300x116.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/26114152/ACB-cannabis-Fibo-768x296.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/26114152/ACB-cannabis-Fibo-1536x592.png 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/26114152/ACB-cannabis-Fibo.png 1805w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" /\u003e\u003c/figure\u003e\n\n\n\n\u003cp\u003eChart \u003ca href=\"https://pro.benzinga.com/dashboard\"\u003ecreated using Benzinga Pro\u003c/a\u003e\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eRead Also: \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/11/42127287/whats-happening-with-canopy-growth-is-it-time-to-buy\"\u003eWhat\u0026#8217;s Happening With Canopy Growth: Is It Time To Buy?\u003c/a\u003e\u003c/strong\u003e\u003c/p\u003e\n\n\n\n\u003ch3 class=\"wp-block-heading\"\u003e\u003cstrong\u003eFor Daily Traders \u003c/strong\u003e\u003c/h3\u003e\n\n\n\n\u003cp\u003eIf you look for recent price action in the daily chart you\u0026#8217;ll see signs of rebounding momentum as a \u003cstrong\u003ebullish divergence\u003c/strong\u003e\u0026nbsp;is emerging. While the stock has been printing lower lows, the Relative Strength Index (RSI) has shown\u0026nbsp;\u003cstrong\u003ehigher lows\u003c/strong\u003e. This divergence suggests weakening selling pressure and the potential for a rebound.\u003c/p\u003e\n\n\n\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003eValidation Point\u003c/strong\u003e: A break above $5.26, accompanied by rising RSI, would confirm the divergence and support a recovery.\u003c/li\u003e\n\n\n\n\u003cli\u003e\u003cstrong\u003eInvalidation Point\u003c/strong\u003e: A fall below $4.16 would negate the divergence and signal continued downward pressures\u003c/li\u003e\n\u003c/ul\u003e\n\n\n\n\u003cp\u003eBeware that divergences alone are not foolproof. They require confirmation through price action, volume or additional indicators like moving averages or candlestick patterns. Without these, the divergence may fail and the downtrend could continue.\u003c/p\u003e\n\n\n\n\u003ch3 class=\"wp-block-heading\"\u003e\u003cstrong\u003eFundamentals: A Stock Trading Below Book Value\u003c/strong\u003e\u003c/h3\u003e\n\n\n\n\u003cp\u003eBeyond the charts, Aurora Cannabis has interesting fundamentals. With\u0026nbsp;\u003cstrong\u003equarterly total assets of $808.77 million\u003c/strong\u003e\u0026nbsp;and a \u003cstrong\u003ebook value per share of $7.10\u003c/strong\u003e, the company's stock trades significantly below its intrinsic value. This could indicate an undervalued opportunity for long-term investors willing to weather the volatility.\u003c/p\u003e\n\n\n\n\u003cp\u003eFor now, traders should watch price action near $4.16 and $5.26, while holders may see a more compelling story above $6.04. Both groups should keep an eye on volume, which can confirm whether the bulls are stepping back in.\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cem\u003eDISCLAIMER: The content of this article is not financial or investment advice and does not constitute an offer or solicitation to offer or recommendation of any investment product. The author holds no position on the mentioned stocks. \u003c/em\u003e\u003c/p\u003e\n\n\n\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003eRead Next: \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/11/41782344/tilray-trulieve-and-other-cannabis-stocks-nosediving-as-industry-faces-new-wave-of-political-unc\"\u003eTilray, Trulieve And Other Cannabis Stocks Nosediving As Industry Faces New Wave Of Political Uncertainty\u003c/a\u003e\u003c/strong\u003e\u003c/li\u003e\n\u003c/ul\u003e\n\n\n\n\u003cp\u003eCOVER\u003cem\u003e: AI-generated image\u003c/em\u003e\u003c/p\u003e","channels":[{"tid":123430,"vid":1,"name":"Cannabis"},{"tid":57,"vid":1,"name":"News"},{"tid":46411,"vid":1,"name":"Small Cap"},{"tid":2,"vid":1,"name":"Markets"},{"tid":22,"vid":1,"name":"Trading Ideas"}],"created":"2024-11-26T17:37:15Z","createdAt":"2024-11-26T17:37:15Z","id":42196285,"image":"https://www.benzinga.com/files/images/story/2024/11/26/Aurora-Stock.png","isBzPost":true,"isBzProPost":true,"meta":{"SectorV2":{"SIC":[{"IndustryCode":3741,"Industry":"Pharmaceutical and Medicine Industry","IndustryGroup":374,"MajorGroup":37,"Division":""}],"NAICS":[{"NationalIndustryCode":325411,"NationalIndustry":"Medicinal and Botanical Manufacturing ","IndustryCode":32541,"Industry":"Pharmaceutical and Medicine Manufacturing","IndustryGroupCode":3254,"IndustryGroup":"Pharmaceutical and Medicine Manufacturing","SubSectorCode":325,"SubSector":"Chemical Manufacturing","SectorCode":32,"Sector":"Manufacturing"},{"NationalIndustryCode":325412,"NationalIndustry":"Pharmaceutical Preparation Manufacturing ","IndustryCode":32541,"Industry":"Pharmaceutical and Medicine Manufacturing","IndustryGroupCode":3254,"IndustryGroup":"Pharmaceutical and Medicine Manufacturing","SubSectorCode":325,"SubSector":"Chemical Manufacturing","SectorCode":32,"Sector":"Manufacturing"}],"Morningstar":[{"IndustryCode":20620020,"Industry":"Drug Manufacturers—Specialty \u0026 Generic","IndustryGroupCode":20620,"IndustryGroup":"Drug Manufacturers","SectorCode":206,"Sector":"Healthcare","SuperSectorCode":2,"SuperSector":"Defensive"}]},"Partner":null,"PartnerTaxonomy":null,"SEC":null,"Author":null,"Authors":[{"uid":"0","name":""}],"Flags":{"ShowCopyrightNotice":true,"EvergreenContent":false,"ShowAdvertiserDisclosure":false,"ContributedContent":false,"AddGoogleStandoutMetaTag":false,"MediaSiteDNDOverride":false,"SendToYahooFinance":false,"SendToRobinhood":true,"SendToMSN":false},"Reach":{"Disclosure":{}},"Reference":null,"Ext":null,"wp_post_meta":{"campaign_strategy":"Default","post_id":665813,"post_path":"24/11/42196285/aurora-cannabis-stock-analysis-key-levels-and-trading-opportunities","post_type":"post"}},"nodeId":42196285,"stocks":[{"tid":158152,"vid":2,"name":"ACB","primary":true},{"tid":22438,"vid":2,"name":"CGC","description":"Canopy Growth Corp","primary":true}],"storyId":"6746073fb6cb720001aafe5e","tags":[{"tid":725367,"vid":3,"name":"Aurora Cannabis"},{"tid":728511,"vid":3,"name":"Cannabis Investing"},{"tid":945678,"vid":3,"name":"Fibonacci Retracement"}],"teaser":"Aurora Cannabis (NASDAQ: ACB) stock finds support at $4.16 amid Fibonacci analysis and bullish divergence. Learn key levels for traders.","teaserText":"Aurora Cannabis (NASDAQ: ACB) stock finds support at $4.16 amid Fibonacci analysis and bullish divergence. Learn key levels for traders.","tickers":[{"tid":158152,"vid":2,"name":"ACB","primary":true},{"tid":22438,"vid":2,"name":"CGC","description":"Canopy Growth Corp","primary":true}],"title":"Aurora Cannabis Stock Analysis: Key Levels And Trading Opportunities","updated":"2024-11-26T17:37:15Z","updatedAt":"2024-11-26T17:37:15Z","url":"https://www.benzinga.com/24/11/42196285/aurora-cannabis-stock-analysis-key-levels-and-trading-opportunities"},{"assets":[{"type":"image","title":"AI-Generated Image","alt":"weed marijuana cannabis stocks cresco","source":"AI-Generated Image ","mime":"","primary":true,"attributes":{"fid":"901187","filename":"AI-Generated-Image_1.jpeg","filepath":"files/images/story/2024/11/22/AI-Generated-Image_1.jpeg","filesize":0,"image_attributes":{"resolution":{"height":0,"width":0,"dpi":0}}}}],"author":"Nicolás Jose Rodriguez","body":"\u003cp\u003eDespite flat earnings and challenging market conditions, \u003cstrong\u003eCresco Labs Inc.\u003c/strong\u003e (OTC:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/CRLBF#OTC\"\u003eCRLBF\u003c/a\u003e) remains an \u0026#8220;Overweight\u0026#8221; stock, according to analysis firm \u003cstrong\u003eZuanic \u0026amp; Associates\u003c/strong\u003e. In his latest report, Zuanic underscores Cresco\u0026#8217;s strong positioning in emerging adult-use markets such as Pennsylvania and Ohio while identifying valuation advantages that set the company apart. \u003c/p\u003e\n\n\n\n\u003cp\u003eCresco trades at 5.5x forward EBITDA, below \u003cstrong\u003eGreen Thumb Industries Inc.\u003c/strong\u003e (OTC:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/GTBIF#OTC\"\u003eGTBIF\u003c/a\u003e) at 7x and \u003cstrong\u003eCuraleaf Holdings Inc. \u003c/strong\u003e(OTC:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/CURLF#OTC\"\u003eCURLF\u003c/a\u003e) at 10x. \u003c/p\u003e\n\n\n\n\u003cp\u003e\u0026#8220;This discount presents an appealing entry point for investors looking beyond short-term volatility,\u0026#8221; Zuanic writes.\u003c/p\u003e\n\n\n\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003e\u003cem\u003eGet Benzinga\u0026#8217;s exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter\u0026nbsp;\u003ca href=\"https://newsletteremail.benzinga.com/subscribe\" target=\"_blank\" rel=\"noreferrer noopener\"\u003ehere\u003c/a\u003e. You can't afford to miss out if you\u0026#8217;re serious about the business.\u003c/em\u003e\u003c/strong\u003e\u003c/li\u003e\n\u003c/ul\u003e\n\n\n\n\u003ch3 class=\"wp-block-heading\"\u003e\u003cstrong\u003eMarket Dynamics: Cresco In The Tier 1 Landscape\u003c/strong\u003e\u003c/h3\u003e\n\n\n\n\u003cp\u003eZuanic's report benchmarks Cresco against other Tier 1 multi-state operators (MSOs), including Green Thumb, \u003cstrong\u003eTrulieve Cannabis Corp.\u003c/strong\u003e (OTC:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/TCNNF#OTC\"\u003eTCNNF\u003c/a\u003e), \u003cstrong\u003eVerano Holdings Corp.\u003c/strong\u003e (OTC:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/VRNOF#OTC\"\u003eVRNOF\u003c/a\u003e), and Curaleaf.\u0026nbsp;\u003c/p\u003e\n\n\n\n\u003cp\u003eWhile Cresco\u0026#8217;s third-quarter revenue of $180 million fell 2% sequentially, the decline aligns with broader industry trends, with peers like Curaleaf and Verano posting declines of 3% and 5%, respectively. By contrast, Green Thumb achieved a 2% increase, reaching $287 million.\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003ca href=\"https://www.benzinga.com/cannabis/earnings\"\u003eAdjusted EBITDA margins \u003c/a\u003efurther illustrate Cresco's position: the company held steady at 29% in Q3, compared to Green Thumb at 31% (-200 basis points) and Trulieve at 34% (-100 basis points). However, \u003ca href=\"https://www.benzinga.com/quote/CRLBF\"\u003eCresco lags in adjusted cash flow.\u003c/a\u003e\u0026nbsp;\u003c/p\u003e\n\n\n\n\u003cp\u003eIts negative $3 million adjusted figure for the first nine months of 2024, factoring in tax liabilities, contrasts sharply with Green Thumb's $139 million (17% of sales) and Trulieve's $37 million (4% of sales). \u003ca href=\"https://www.benzinga.com/topic/pablo-zuanic\"\u003eZuanic highlights\u003c/a\u003e cash flow conversion as a critical area where Cresco \u0026#8216;lags\u0026#8217; its competitors.\u0026#8221;\u0026nbsp;\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eRead Also: \u003ca href=\"https://www.benzinga.com/24/11/42145406/nebraskas-cannabis-legalization-faces-courtroom-showdown-over-alleged-fraud\"\u003eNebraska\u0026#8217;s Cannabis Legalization Faces Courtroom Showdown Over Alleged Fraud\u003c/a\u003e\u003c/strong\u003e\u003c/p\u003e\n\n\n\n\u003ch3 class=\"wp-block-heading\"\u003e\u003cstrong\u003eValuation Analysis: Digging Into The Numbers\u003c/strong\u003e\u003c/h3\u003e\n\n\n\n\u003cp\u003eCresco's \u003ca href=\"https://www.benzinga.com/cannabis/earnings\"\u003evaluation metrics reveal potential upside\u003c/a\u003e. Its enterprise value (EV) to current sales ratio stands at 1.6x, lower than Curaleaf and Green Thumb, both at 2.2x. This discount extends to EV-to-EBITDA multiples, with Cresco trading at 5.5x compared to Green Thumb at 7x and Curaleaf at 10x.\u0026nbsp;\u003c/p\u003e\n\n\n\n\u003cp\u003eThese figures include tax liabilities, financial net debt, and other obligations. \"Cresco's lower EV multiples, alongside its gross cash holdings of $157 million, make it a compelling value play among Tier 1 operators,\" Zuanic explains.\u003c/p\u003e\n\n\n\n\u003ch3 class=\"wp-block-heading\"\u003e\u003cstrong\u003eStrategic Hurdles And Growth Catalysts\u003c/strong\u003e\u003c/h3\u003e\n\n\n\n\u003cp\u003eDespite these advantages, Zuanic identifies several hurdles. Cresco\u0026#8217;s total leverage, including financial and tax liabilities, amounts to 80% of trailing sales, the highest among Tier 1 MSOs. In contrast, Green Thumb's leverage is just 9%. Moreover, while Cresco holds promising positions in \u003ca href=\"https://www.benzinga.com/topic/pennsylvania-cannabis\"\u003ePennsylvania\u003c/a\u003e and \u003ca href=\"https://www.benzinga.com/topic/ohio-cannabis\"\u003eOhio\u003c/a\u003e, Zuanic emphasizes the need for a strategic partner to close the scale gap with peers like Green Thumb and Curaleaf. \u0026#8220;A partnership would help Cresco achieve operational efficiencies and capitalize on upcoming recreational markets,\u0026#8221; he notes.\u003c/p\u003e\n\n\n\n\u003cp\u003eZuanic\u0026#8217;s projections account for regulatory uncertainty, including delays in Pennsylvania's adult-use legalization timeline to mid-2026 and the potential impact of federal rescheduling challenges. Nonetheless, he remains optimistic about Cresco's long-term prospects. \u0026#8220;We see Cresco as a buy for investors with a one-to-two-year horizon, particularly given its discounted valuation,\u0026#8221; he concludes. \u003c/p\u003e\n\n\n\n\u003cp\u003eFor a deeper dive into his methodology and projections, \u003ca href=\"https://zuanicgroup.com/\"\u003evisit Zuanic \u0026amp; Associates' research portal\u003c/a\u003e.\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eRead Next: \u003ca href=\"https://www.benzinga.com/24/11/42144540/dea-slammed-over-unlawful-talks-with-cannabis-opponents-the-plot-thickens\"\u003eDEA Slammed For Unlawful Talks With Cannabis Opponents \u0026#8211; The Plot Thickens\u003c/a\u003e\u003c/strong\u003e\u003c/p\u003e","channels":[{"tid":68,"vid":1,"name":"Analyst Color"},{"tid":123430,"vid":1,"name":"Cannabis"},{"tid":927212,"vid":1,"name":"Market Summary"},{"tid":57,"vid":1,"name":"News"},{"tid":30777,"vid":1,"name":"Retail Sales"},{"tid":46411,"vid":1,"name":"Small Cap"},{"tid":145889,"vid":1,"name":"Exclusives"},{"tid":2,"vid":1,"name":"Markets"},{"tid":67,"vid":1,"name":"Analyst Ratings"},{"tid":22,"vid":1,"name":"Trading Ideas"}],"created":"2024-11-22T21:00:20Z","createdAt":"2024-11-22T21:00:20Z","id":42147417,"image":"https://www.benzinga.com/files/images/story/2024/11/22/AI-Generated-Image_1.jpeg","isBzPost":true,"isBzProPost":true,"meta":{"SectorV2":{"SIC":[{"IndustryCode":3741,"Industry":"Pharmaceutical and Medicine Industry","IndustryGroup":374,"MajorGroup":37,"Division":""},{"IndustryCode":2834,"Industry":"Pharmaceutical Preparations","IndustryGroup":283,"MajorGroup":28,"Division":""}],"NAICS":[{"NationalIndustryCode":325412,"NationalIndustry":"Pharmaceutical Preparation Manufacturing ","IndustryCode":32541,"Industry":"Pharmaceutical and Medicine Manufacturing","IndustryGroupCode":3254,"IndustryGroup":"Pharmaceutical and Medicine Manufacturing","SubSectorCode":325,"SubSector":"Chemical Manufacturing","SectorCode":32,"Sector":"Manufacturing"},{"NationalIndustryCode":325411,"NationalIndustry":"Medicinal and Botanical Manufacturing ","IndustryCode":32541,"Industry":"Pharmaceutical and Medicine Manufacturing","IndustryGroupCode":3254,"IndustryGroup":"Pharmaceutical and Medicine Manufacturing","SubSectorCode":325,"SubSector":"Chemical Manufacturing","SectorCode":32,"Sector":"Manufacturing"}],"Morningstar":[{"IndustryCode":20620020,"Industry":"Drug Manufacturers—Specialty \u0026 Generic","IndustryGroupCode":20620,"IndustryGroup":"Drug Manufacturers","SectorCode":206,"Sector":"Healthcare","SuperSectorCode":2,"SuperSector":"Defensive"}]},"Partner":null,"PartnerTaxonomy":null,"SEC":null,"Author":null,"Authors":[{"uid":"0","name":""}],"Flags":{"ShowCopyrightNotice":true,"EvergreenContent":false,"ShowAdvertiserDisclosure":false,"ContributedContent":false,"AddGoogleStandoutMetaTag":false,"MediaSiteDNDOverride":false,"SendToYahooFinance":false,"SendToRobinhood":true,"SendToMSN":false},"Reach":{"Disclosure":{}},"Reference":null,"Ext":null,"wp_post_meta":{"campaign_strategy":"Default","post_id":661643,"post_path":"general/market-summary/24/11/42147417/80-leverage-5-5x-ebitda-is-cresco-the-high-risk-high-reward-play-investors-need","post_type":"post"}},"nodeId":42147417,"stocks":[{"tid":735580,"vid":2,"name":"CRLBF"},{"tid":734995,"vid":2,"name":"CURLF","description":"CURALEAF HLDGS INC by Curaleaf Hldgs Inc."},{"tid":724072,"vid":2,"name":"GTBIF"},{"tid":731053,"vid":2,"name":"TCNNF"},{"tid":797063,"vid":2,"name":"VRNOF","description":"Verano Holdings"}],"storyId":"6740f0e0b6cb720001aa37e4","tags":[],"teaser":"According to Z\u0026amp;A, its enterprise value (EV) to current sales ratio stands at 1.6x, lower than Curaleaf and Green Thumb, both at 2.2x.","teaserText":"According to Z\u0026amp;A, its enterprise value (EV) to current sales ratio stands at 1.6x, lower than Curaleaf and Green Thumb, both at 2.2x.","tickers":[{"tid":735580,"vid":2,"name":"CRLBF"},{"tid":734995,"vid":2,"name":"CURLF","description":"CURALEAF HLDGS INC by Curaleaf Hldgs Inc."},{"tid":724072,"vid":2,"name":"GTBIF"},{"tid":731053,"vid":2,"name":"TCNNF"},{"tid":797063,"vid":2,"name":"VRNOF","description":"Verano Holdings"}],"title":"80% Leverage, 5.5x EBITDA: Is Cresco The High-Risk, High-Reward Play Investors Need?","updated":"2024-11-22T21:00:21Z","updatedAt":"2024-11-22T21:00:21Z","url":"https://www.benzinga.com/general/market-summary/24/11/42147417/80-leverage-5-5x-ebitda-is-cresco-the-high-risk-high-reward-play-investors-need"},{"assets":[{"type":"image","title":"AI-Generated Image","alt":"weed cannabis marijuana vape jupiter tilt stock","source":"AI-Generated Image ","mime":"","primary":true,"attributes":{"fid":"901178","filename":"AI-Generated-Image_0.jpeg","filepath":"files/images/story/2024/11/22/AI-Generated-Image_0.jpeg","filesize":0,"image_attributes":{"resolution":{"height":0,"width":0,"dpi":0}}}}],"author":"Nicolás Jose Rodriguez","body":"\u003cp\u003e\u003cstrong\u003eTILT Holdings\u003c/strong\u003e (OTC:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/TLLTF#OTC\"\u003eTLLTF\u003c/a\u003e) is at a critical juncture as it explores divesting its plant-touching business (PTB), which generates 75% of its revenue but continues to struggle with declining margins. Massachusetts operations, contributing two-thirds of revenue, are under pressure from market saturation, while Pennsylvania's wholesale arm faces reduced purchases as vertically integrated operators prioritize in-house products. \u003c/p\u003e\n\n\n\n\u003cp\u003eGross margins across TILT fell from 18% in Q1 to 14% in Q3, reflecting challenges across all divisions. Analyst \u003cstrong\u003ePablo Zuanic \u003c/strong\u003evalues the PTB between $20–$30 million, a modest sum given the company's $3 million market cap and heavy debt burden.\u003c/p\u003e\n\n\n\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003e\u003cem\u003eGet Benzinga\u0026#8217;s exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter \u003ca href=\"https://newsletteremail.benzinga.com/subscribe\" target=\"_blank\" rel=\"noreferrer noopener\"\u003ehere\u003c/a\u003e. You can't afford to miss out if you\u0026#8217;re serious about the business.\u003c/em\u003e\u003c/strong\u003e\u003c/li\u003e\n\u003c/ul\u003e\n\n\n\n\u003ch3 class=\"wp-block-heading\"\u003eDebt Remains A Major Hurdle Despite Positive Cash Flow\u003c/h3\u003e\n\n\n\n\u003cp\u003eTILT's financial health is constrained by $62 million in net debt, with $12 million due in 2025 and $38 million in 2026, alongside $44 million in lease obligations. However, \u003ca href=\"https://www.benzinga.com/topic/pablo-zuanic\"\u003eZuanic highlights\u003c/a\u003e a positive development: TILT generated $2 million in operating cash flow in Q3 2024. \u003c/p\u003e\n\n\n\n\u003ch3 class=\"wp-block-heading\"\u003eJupiter\u0026#8217;s Challenges: A Dual Front\u003c/h3\u003e\n\n\n\n\u003cp\u003e\u003ca href=\"https://www.benzinga.com/analyst-ratings/analyst-color/24/02/37083640/jupiter-research-weed-vape-cartridges-mso-brand\"\u003eJupiter, TILT's vape subsidiary\u003c/a\u003e, is contending with both operational setbacks and broader market shifts. U.S. sales dropped to $9.4 million in Q3 2024, down from $15 million in the same period last year, even after adjusting for the transition of half its sales to a 15% distribution fee model. \u003c/p\u003e\n\n\n\n\u003cp\u003eCanadian sales grew 11% to $6.4 million but saw gross margins collapse from 29% to zero. Zuanic calculates that Jupiter's distribution fees could generate $9 million annually at 100% gross margins, with the remaining $53 million in sales yielding 20% margins. This would produce $20 million in gross profit, making Jupiter potentially profitable with $10 million in EBITDA.\u0026nbsp;\u003c/p\u003e\n\n\n\n\u003cp\u003eHowever, Zuanic remains cautious about the sustainability of these projections given continued market share erosion. \u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eRead Also: \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/11/42145489/leef-brands-completes-101-share-consolidation\"\u003eLEEF Brands Completes 10:1 Share Consolidation\u003c/a\u003e\u003c/strong\u003e\u003c/p\u003e\n\n\n\n\u003ch3 class=\"wp-block-heading\"\u003eCompetitive Landscape And CCELL Partnership\u003c/h3\u003e\n\n\n\n\u003cp\u003eJupiter's long-standing partnership with CCELL is adapting to shifting market dynamics. CCELL has diversified its production outside China to mitigate geopolitical risks, while also strengthening direct U.S. customer support. Zuanic raises concerns about potential \u003ca href=\"https://www.benzinga.com/analyst-ratings/analyst-color/23/10/35228569/whos-who-among-cannabis-hardware-vaping-suppliers-zuanic-associates-take-a-deep-div\"\u003eoverlap between CCELL's direct operations and Jupiter's business\u003c/a\u003e, warning that structural changes may be necessary to preserve market leadership. \u003c/p\u003e\n\n\n\n\u003cp\u003eConsumer preferences are shifting toward all-in-one devices (AIOs), prompting Jupiter to invest in proprietary technologies and bolster its supply chain. Despite these efforts, the company has yet to reverse a five-year trend of declining market share. Zuanic underscores the importance of aligning innovation with operational efficiency to stay competitive. For a deeper dive into his methodology and projections, visit \u003ca href=\"https://zuanicgroup.com/\"\u003eZuanic \u0026amp; Associates' research portal\u003c/a\u003e.\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eRead Next:\u003ca href=\"https://www.benzinga.com/24/11/42144192/texas-ag-ken-paxton-sues-dallas-over-voter-approved-marijuana-reform\"\u003e Texas AG Ken Paxton Sues Dallas Over Cannabis Decriminalization Reform\u003c/a\u003e\u003c/strong\u003e\u003c/p\u003e","channels":[{"tid":68,"vid":1,"name":"Analyst Color"},{"tid":123430,"vid":1,"name":"Cannabis"},{"tid":927212,"vid":1,"name":"Market Summary"},{"tid":57,"vid":1,"name":"News"},{"tid":34989,"vid":1,"name":"Financing"},{"tid":34992,"vid":1,"name":"Asset Sales"},{"tid":46411,"vid":1,"name":"Small Cap"},{"tid":60,"vid":1,"name":"Management"},{"tid":145889,"vid":1,"name":"Exclusives"},{"tid":2,"vid":1,"name":"Markets"},{"tid":67,"vid":1,"name":"Analyst Ratings"},{"tid":22,"vid":1,"name":"Trading Ideas"}],"created":"2024-11-22T20:17:12Z","createdAt":"2024-11-22T20:17:12Z","id":42146751,"image":"https://www.benzinga.com/files/images/story/2024/11/22/AI-Generated-Image_0.jpeg","isBzPost":true,"isBzProPost":true,"meta":{"SectorV2":{"SIC":[{"IndustryCode":3741,"Industry":"Pharmaceutical and Medicine Industry","IndustryGroup":374,"MajorGroup":37,"Division":""}],"NAICS":[{"NationalIndustryCode":325412,"NationalIndustry":"Pharmaceutical Preparation Manufacturing ","IndustryCode":32541,"Industry":"Pharmaceutical and Medicine Manufacturing","IndustryGroupCode":3254,"IndustryGroup":"Pharmaceutical and Medicine Manufacturing","SubSectorCode":325,"SubSector":"Chemical Manufacturing","SectorCode":32,"Sector":"Manufacturing"}],"Morningstar":[{"IndustryCode":20620020,"Industry":"Drug Manufacturers—Specialty \u0026 Generic","IndustryGroupCode":20620,"IndustryGroup":"Drug Manufacturers","SectorCode":206,"Sector":"Healthcare","SuperSectorCode":2,"SuperSector":"Defensive"}]},"Partner":null,"PartnerTaxonomy":null,"SEC":null,"Author":null,"Authors":[{"uid":"0","name":""}],"Flags":{"ShowCopyrightNotice":true,"EvergreenContent":false,"ShowAdvertiserDisclosure":false,"ContributedContent":false,"AddGoogleStandoutMetaTag":false,"MediaSiteDNDOverride":false,"SendToYahooFinance":false,"SendToRobinhood":true,"SendToMSN":false},"Reach":{"Disclosure":{}},"Reference":null,"Ext":null,"wp_post_meta":{"campaign_strategy":"Default","post_id":661612,"post_path":"general/market-summary/24/11/42146751/jupiters-burnout-can-tilt-holdings-reverse-its-five-year-vape-decline","post_type":"post"}},"nodeId":42146751,"stocks":[{"tid":756432,"vid":2,"name":"TLLTF","primary":true}],"storyId":"6740e6c4b6cb720001aa34d7","tags":[{"tid":895782,"vid":3,"name":"cannabis debt"},{"tid":827747,"vid":3,"name":"cannabis debt financing"},{"tid":801187,"vid":3,"name":"Cannabis financing"},{"tid":775074,"vid":3,"name":"Cannabis Markets"},{"tid":148171,"vid":3,"name":"cannabis stocks"},{"tid":745269,"vid":3,"name":"Cannabis Vaping"},{"tid":844272,"vid":3,"name":"Jupiter Research LLC"},{"tid":154491,"vid":3,"name":"Pablo Zuanic"},{"tid":734779,"vid":3,"name":"TILT Holdings"},{"tid":758473,"vid":3,"name":"vapes"},{"tid":626169,"vid":3,"name":"Vaping"}],"teaser":"TILT\u0026#39;s financial health is constrained by $62 million in debt, along with $44 million in lease obligations.","teaserText":"TILT\u0026#39;s financial health is constrained by $62 million in debt, along with $44 million in lease obligations.","tickers":[{"tid":756432,"vid":2,"name":"TLLTF","primary":true}],"title":"Jupiter\u0026#39;s Burnout: Can TILT Holdings Reverse Its Five-Year Vape Decline?","updated":"2024-11-22T20:17:12Z","updatedAt":"2024-11-22T20:17:12Z","url":"https://www.benzinga.com/general/market-summary/24/11/42146751/jupiters-burnout-can-tilt-holdings-reverse-its-five-year-vape-decline"},{"assets":[{"type":"image","title":"AI-Generated Image","alt":"weed marijuana cannabis canopy usa stock market","source":"AI-Generated Image ","mime":"image/jpeg","primary":true,"attributes":{"fid":"900553","filename":"AI-Generated-Image_1.jpeg","filepath":"files/images/story/2024/11/20/AI-Generated-Image_1.jpeg","filesize":0,"image_attributes":{"resolution":{"height":0,"width":0,"dpi":0}}}}],"author":"Nicolás Jose Rodriguez","body":"\u003cp\u003e\u003cstrong\u003eCanopy Growth Corporation\u003c/strong\u003e\u0026#8216;s (NASDAQ:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/CGC#NASDAQ\"\u003eCGC\u003c/a\u003e) strategy for capturing the U.S. cannabis market was the focal point of a recent fireside chat hosted by \u003cstrong\u003e\u003ca href=\"https://www.youtube.com/@ZuanicAssociates\"\u003eZuanic \u0026amp; Associates\u003c/a\u003e\u003c/strong\u003e. CEO\u003cstrong\u003e David Klein\u003c/strong\u003e and CFO\u003cstrong\u003e Judy Hong\u003c/strong\u003e provided insights into Canopy USA's (CUSA) growth strategy, financial projections and its significance for investors navigating the evolving cannabis industry.\u003c/p\u003e\n\n\n\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003e\u003cem\u003eGet Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter\u0026nbsp;\u003ca href=\"https://newsletteremail.benzinga.com/subscribe\" target=\"_blank\" rel=\"noreferrer noopener\"\u003ehere\u003c/a\u003e. You can\u0026#8217;t afford to miss out if you're serious about the business.\u003c/em\u003e\u003c/strong\u003e\u003c/li\u003e\n\u003c/ul\u003e\n\n\n\n\u003ch3 class=\"wp-block-heading\"\u003e\u003cstrong\u003eUnique Structure For U.S. Expansion\u003c/strong\u003e\u003c/h3\u003e\n\n\n\n\u003cp\u003eCUSA's innovative structure is designed to comply with NASDAQ and SEC regulations while preparing for potential federal cannabis reform. \u0026#8220;The structure allows us to keep Canopy Growth compliant while positioning CUSA to grow independently in the U.S.,\u0026#8221; Klein said.\u003c/p\u003e\n\n\n\n\u003cp\u003eThis arrangement prevents Canopy Growth from directly financing CUSA but allows for co-investments alongside third-party investors when necessary. Additionally, Canopy Growth holds a beneficial interest in CUSA through exchangeable shares, which can be converted into voting shares once regulatory conditions permit.\u003c/p\u003e\n\n\n\n\u003cp\u003eHong revealed CUSA's long-term potential, noting it could generate up to $300 million in revenue annually with EBITDA margins of approximately 20%. She emphasized the importance of maintaining operational independence until a \"federal permissibility event\" allows for broader integration.\u003c/p\u003e\n\n\n\n\u003ch3 class=\"wp-block-heading\"\u003eTerrAscend And Acreage: Growth Potential In Key States\u003c/h3\u003e\n\n\n\n\u003cp\u003eCanopy Growth's U.S. footprint includes significant stakes in key cannabis brands:\u003c/p\u003e\n\n\n\n\u003cul\u003e\n\u003cli\u003e100% ownership of Wana and Acreage Holdings upon Acreage's acquisition closure in 2025.\u003c/li\u003e\n\n\n\n\u003cli\u003e77% stake in Jetty.\u003c/li\u003e\n\n\n\n\u003cli\u003e21% beneficial interest in TerrAscend, subject to the full exercise of warrants and exchangeable shares.\u003c/li\u003e\n\u003c/ul\u003e\n\n\n\n\u003cp\u003eTerrAscend (OTC:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/TSNDF#OTC\"\u003eTSNDF\u003c/a\u003e) supports Wana's operations in \u003ca href=\"https://www.benzinga.com/topic/maryland-cannabis\"\u003eMaryland\u003c/a\u003e and \u003ca href=\"https://www.benzinga.com/topic/new-jersey-cannabis\"\u003eNew Jersey\u003c/a\u003e, generating mutual benefits for both companies. Meanwhile, Acreage is actively expanding in \u003ca href=\"https://www.benzinga.com/topic/ohio-cannabis\"\u003eOhio\u003c/a\u003e, where it operates five dispensaries and holds licenses for three more.\u003c/p\u003e\n\n\n\n\u003cp\u003e\"Acreage's transition to a wholly owned subsidiary will improve efficiency and enable cost savings,\" Hong said, adding that these changes position Acreage to better compete in states like New Jersey,\u003ca href=\"https://www.benzinga.com/topic/illinois-cannabis\"\u003e Illinois\u003c/a\u003e, and Ohio, where adult-use markets are booming.\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eRead Also: \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/11/41791053/terrascend-expands-footprint-despite-q3-losses-can-a-move-to-ohio-turn-the-tide\"\u003eTerrAscend Expands Footprint Despite Q3 Losses, Can A Move To Ohio Turn The Tide?\u003c/a\u003e\u003c/strong\u003e\u003c/p\u003e\n\n\n\n\u003ch3 class=\"wp-block-heading\"\u003e\u003cstrong\u003eGlobal Success And Local Challenges\u003c/strong\u003e\u003c/h3\u003e\n\n\n\n\u003cp\u003eCanopy Growth's influence extends beyond the U.S., with strong performance in international markets. Germany, for instance, imported 20 tons of cannabis in Q3, up from 7 tons in Q1, driven by Canadian exporters like Canopy.\u003c/p\u003e\n\n\n\n\u003cp\u003eDomestically, CUSA is addressing challenges in mature markets such as \u003ca href=\"https://www.benzinga.com/topic/colorado-cannabis\"\u003eColorado\u003c/a\u003e, where price compression and competition have intensified. Wana has proactively adjusted its supply chain to lower costs, while Jetty's focus on solventless extraction has solidified its reputation in \u003ca href=\"https://www.benzinga.com/topic/california-cannabis\"\u003eCalifornia\u003c/a\u003e and Colorado.\u003c/p\u003e\n\n\n\n\u003ch3 class=\"wp-block-heading\"\u003e\u003cstrong\u003eBrand Synergies And Market Penetration\u003c/strong\u003e\u003c/h3\u003e\n\n\n\n\u003cp\u003eCollaboration between CUSA's brands is a cornerstone of its strategy. \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/05/38671962/canopy-growth-expands-u-s-reach-by-acquiring-these-two-key-cannabis-brands\"\u003eWana and Jetty have begun joint marketing efforts\u003c/a\u003e in New York and Colorado, leveraging a consumer packaged goods (CPG) approach to cannabis sales.\u003c/p\u003e\n\n\n\n\u003cp\u003e\u0026#8220;Collaboration between \u003ca href=\"https://www.benzinga.com/topic/wana-brands\"\u003eWana\u003c/a\u003e and\u003ca href=\"https://www.benzinga.com/topic/jetty-extracts\"\u003e Jetty\u003c/a\u003e is already \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/08/40375216/jetty-extracts-teams-up-with-licensed-cannabis-wholesale-platform-sets-sights-on-nationwide-cann\"\u003eyielding results\u003c/a\u003e,\u0026#8221; Klein noted, with plans to further integrate operations once Acreage Holdings is acquired. Wana's expansion into non-dispensary channels such as liquor stores has also helped broaden its consumer base, particularly with its hemp-derived product line.\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eRead Also: \u003ca href=\"https://www.benzinga.com/24/11/42009069/canopy-growths-acquisition-target-acreage-reports-30-yoy-decline-in-q3-revenue-achieves-record-cannabis-wholesale-revenue-in-new-york\"\u003eCanopy Growth Acquisition Target Acreage Reports 30% YoY Decline In Q3, Record Cannabis Wholesale Revenue In NY\u003c/a\u003e\u003c/strong\u003e\u003c/p\u003e\n\n\n\n\u003ch3 class=\"wp-block-heading\"\u003e\u003cstrong\u003eInvestor Perception And Market Positioning\u003c/strong\u003e\u003c/h3\u003e\n\n\n\n\u003cp\u003eDespite its strategic advancements, Canopy Growth faces challenges in convincing the market of CUSA's value. \u0026#8220;It's a real business generating revenue daily, but the complexity of our structure sometimes overshadows its value,\u0026#8221; Klein acknowledged.\u003c/p\u003e\n\n\n\n\u003cp\u003eHong added that audited financial statements for CUSA expected in 2025 will provide much-needed transparency. \"This should make it easier for investors to understand CUSA's role within the broader Canopy Growth story,\" she explained.\u003c/p\u003e\n\n\n\n\u003ch3 class=\"wp-block-heading\"\u003e\u003cstrong\u003eInvestor Takeaways\u003c/strong\u003e\u003c/h3\u003e\n\n\n\n\u003cp\u003eCUSA offers investors exposure to the U.S. cannabis market without direct regulatory risk. Its portfolio, including brands like Wana and Jetty and its strategic collaborations with TerrAscend, position Canopy Growth to capitalize on evolving market opportunities.\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eRead Next:\u003ca href=\"https://www.benzinga.com/news/earnings/24/11/41843751/canopy-growth-q2-net-revenue-drops-9-yoy-projects-positive-earnings-ahead\"\u003e Canopy Growth: Q2 Net Revenue Drops 9% YoY, Projects Positive Earnings Ahead\u003c/a\u003e\u003c/strong\u003e\u003c/p\u003e","channels":[{"tid":123430,"vid":1,"name":"Cannabis"},{"tid":927212,"vid":1,"name":"Market Summary"},{"tid":57,"vid":1,"name":"News"},{"tid":30777,"vid":1,"name":"Retail Sales"},{"tid":60,"vid":1,"name":"Management"},{"tid":2,"vid":1,"name":"Markets"},{"tid":22,"vid":1,"name":"Trading Ideas"}],"created":"2024-11-20T22:50:30Z","createdAt":"2024-11-20T22:50:30Z","id":42100955,"image":"https://www.benzinga.com/files/images/story/2024/11/20/AI-Generated-Image_1.jpeg","isBzPost":true,"isBzProPost":true,"meta":{"SectorV2":{"SIC":[{"IndustryCode":3741,"Industry":"Pharmaceutical and Medicine Industry","IndustryGroup":374,"MajorGroup":37,"Division":""}],"NAICS":[{"NationalIndustryCode":325412,"NationalIndustry":"Pharmaceutical Preparation Manufacturing ","IndustryCode":32541,"Industry":"Pharmaceutical and Medicine Manufacturing","IndustryGroupCode":3254,"IndustryGroup":"Pharmaceutical and Medicine Manufacturing","SubSectorCode":325,"SubSector":"Chemical Manufacturing","SectorCode":32,"Sector":"Manufacturing"}],"Morningstar":[{"IndustryCode":20620020,"Industry":"Drug Manufacturers—Specialty \u0026 Generic","IndustryGroupCode":20620,"IndustryGroup":"Drug Manufacturers","SectorCode":206,"Sector":"Healthcare","SuperSectorCode":2,"SuperSector":"Defensive"}]},"Partner":null,"PartnerTaxonomy":null,"SEC":null,"Author":null,"Authors":[{"uid":"0","name":""}],"Flags":{"ShowCopyrightNotice":true,"EvergreenContent":false,"ShowAdvertiserDisclosure":false,"ContributedContent":false,"AddGoogleStandoutMetaTag":false,"MediaSiteDNDOverride":false,"SendToYahooFinance":false,"SendToRobinhood":true,"SendToMSN":false},"Reach":{"Disclosure":{}},"Reference":null,"Ext":null,"wp_post_meta":{"campaign_strategy":"Default","post_id":657830,"post_path":"general/market-summary/24/11/42100955/the-u-s-cannabis-strategy-no-ones-talking-about-inside-canopys-300m-plan","post_type":"post"}},"nodeId":42100955,"stocks":[{"tid":22438,"vid":2,"name":"CGC","description":"Canopy Growth Corp","primary":true},{"tid":902043,"vid":2,"name":"TSNDF","primary":true}],"storyId":"673e67b2bac836000141b1f2","tags":[{"tid":664761,"vid":3,"name":"California cannabis"},{"tid":712759,"vid":3,"name":"Canada Cannabis"},{"tid":745526,"vid":3,"name":"Cannabis Branding"},{"tid":733970,"vid":3,"name":"Cannabis Extracts"},{"tid":801187,"vid":3,"name":"Cannabis financing"},{"tid":733528,"vid":3,"name":"Cannabis M\u0026A"},{"tid":739874,"vid":3,"name":"Cannabis Marketing"},{"tid":775074,"vid":3,"name":"Cannabis Markets"},{"tid":148171,"vid":3,"name":"cannabis stocks"},{"tid":790150,"vid":3,"name":"cannabis stocks M\u0026A"},{"tid":718003,"vid":3,"name":"Colorado Cannabis"},{"tid":659481,"vid":3,"name":"David Klein"},{"tid":747823,"vid":3,"name":"Illinois cannabis"},{"tid":843333,"vid":3,"name":"Jetty"},{"tid":734243,"vid":3,"name":"Jetty Extracts"},{"tid":18481,"vid":3,"name":"Judy Hong"},{"tid":734987,"vid":3,"name":"Maryland Cannabis"},{"tid":726937,"vid":3,"name":"New Jersey Cannabis"},{"tid":733780,"vid":3,"name":"Ohio Cannabis"},{"tid":154491,"vid":3,"name":"Pablo Zuanic"},{"tid":159401,"vid":3,"name":"Wana Brands"},{"tid":936724,"vid":3,"name":"Zuanic \u0026amp; Associates LLC"}],"teaser":"Canopy USA offers investors exposure to the U.S. cannabis market without direct regulatory risk through brands like Wana and Jetty.","teaserText":"Canopy USA offers investors exposure to the U.S. cannabis market without direct regulatory risk through brands like Wana and Jetty.","tickers":[{"tid":22438,"vid":2,"name":"CGC","description":"Canopy Growth Corp","primary":true},{"tid":902043,"vid":2,"name":"TSNDF","primary":true}],"title":"The U.S. Cannabis Strategy No One\u0026#39;s Talking About: Inside Canopy\u0026#39;s $300M Plan","updated":"2024-11-20T22:50:30Z","updatedAt":"2024-11-20T22:50:30Z","url":"https://www.benzinga.com/general/market-summary/24/11/42100955/the-u-s-cannabis-strategy-no-ones-talking-about-inside-canopys-300m-plan"}]}]},"align":"","mode":"edit"},"innerBlocks":[],"innerHTML":"","type":"default"},{"blockName":"core/html","attrs":{"data":[]},"innerBlocks":[],"innerHTML":"\n\u003cstyle\u003e\n.page-header-container .header-wrapper { display: inline-flex; }\n.page-header-container { text-align: center; }\n\u003c/style\u003e\n","type":"default"},{"blockName":"core/paragraph","attrs":{"data":[]},"innerBlocks":[],"innerHTML":"\n\u003cp\u003e\u003c/p\u003e\n","html":"","tag":"p","type":"default"}],"campaigns":{"primary":[],"secondary":[],"floating":{"has_targeting":false,"placements":[],"campaigns":[],"display_y_position":400},"popup":{"has_targeting":false,"placements":[],"campaigns":[],"delay":10000},"compare_partners":{"widget":null}},"cornerstone":[],"header":{"id":62771,"title":"Cannabis Header","type":"header","blocks":[{"blockName":"acf/google-ad-placement","attrs":{"id":"block_6139f78f06a02","name":"acf/google-ad-placement","data":{"slot_placement_id":"/4107070/DotCom_728x90","slot_width":"728","slot_height":"90","slot_google_ad_id":"div-cannabis-ad-728-90","display":"all-devices","dynamic_height":null,"size_mapping":null},"align":"","mode":"edit"},"innerBlocks":[],"innerHTML":"","type":"default"},{"blockName":"core/spacer","attrs":{"height":10,"data":[]},"innerBlocks":[],"innerHTML":"\n\u003cdiv style=\"height:10px\" aria-hidden=\"true\" class=\"wp-block-spacer\"\u003e\u003c/div\u003e\n","type":"default"}]},"content_header":null,"in_content":null,"in_article_content":null,"sidebar":{"id":54194,"title":"Cannabis Sidebar","type":"sidebar","blocks":[{"blockName":"acf/widget-container","attrs":{"name":"acf/widget-container","data":{"widget":{"ID":233532,"post_author":"27","post_date":"2023-02-22 12:00:39","post_date_gmt":"2023-02-22 17:00:39","post_content":"\u003c!-- wp:acf/newsletter-subscription-box {\"name\":\"acf/newsletter-subscription-box\",\"data\":{\"title\":\"Benzinga Cannabis Daily Newsletter\",\"_title\":\"field_title\",\"form_id\":\"5e65f50d-e5c4-407b-a8e6-c6a1f2cd3858\",\"_form_id\":\"field_form_id\",\"style\":\"solid-box\",\"_style\":\"field_style\",\"mobile_only\":\"0\",\"_mobile_only\":\"field_mobile_only\",\"description\":\"\\u003cdiv class=\\u0022c-message_kit__gutter\\u0022\\u003e\\r\\n\\u003cdiv class=\\u0022c-message_kit__gutter__right\\u0022 role=\\u0022presentation\\u0022 data-qa=\\u0022message_content\\u0022\\u003e\\r\\n\\u003cdiv class=\\u0022c-message_kit__blocks c-message_kit__blocks\\u002d\\u002drich_text\\u0022\\u003e\\r\\n\\u003cdiv class=\\u0022c-message__message_blocks c-message__message_blocks\\u002d\\u002drich_text\\u0022 data-qa=\\u0022message-text\\u0022\\u003e\\r\\n\\u003cdiv class=\\u0022p-block_kit_renderer\\u0022 data-qa=\\u0022block-kit-renderer\\u0022\\u003e\\r\\n\\u003cdiv class=\\u0022p-block_kit_renderer__block_wrapper p-block_kit_renderer__block_wrapper\\u002d\\u002dfirst\\u0022\\u003e\\r\\n\\u003cdiv class=\\u0022p-rich_text_block\\u0022 dir=\\u0022auto\\u0022\\u003e\\r\\n\\u003cdiv class=\\u0022p-rich_text_section\\u0022\\u003e\\r\\n\\u003cp data-pm-slice=\\u00221 1 []\\u0022\\u003eSubscribe to \\u003cstrong\\u003eBenzinga's free daily cannabis newsletter\\u003c/strong\\u003e to get policy and market updates directly in your inbox!\\u003c/p\\u003e\\r\\n\\r\\n\\u003c/div\\u003e\\r\\n\\u003c/div\\u003e\\r\\n\\u003c/div\\u003e\\r\\n\\u003c/div\\u003e\\r\\n\\u003c/div\\u003e\\r\\n\\u003c/div\\u003e\\r\\n\\u003c/div\\u003e\\r\\n\\u003c/div\\u003e\",\"_description\":\"field_description\",\"redirect_url\":\"\",\"_redirect_url\":\"redirect_url\",\"utm_label\":\"\",\"_utm_label\":\"field_utm_label\"},\"align\":\"\",\"mode\":\"edit\"} /--\u003e","post_title":"Cannabis Newsletter Subscription Box","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"cannabis-newsletter-subscription-box","to_ping":"","pinged":"","post_modified":"2024-07-26 15:37:26","post_modified_gmt":"2024-07-26 19:37:26","post_content_filtered":"","post_parent":0,"guid":"https://www.benzinga.com/?post_type=widget\u0026#038;p=233532","menu_order":0,"post_type":"widget","post_mime_type":"","comment_count":"0","filter":"raw"}},"align":"","mode":"edit"},"innerBlocks":[],"innerHTML":"","dynamic":false,"blocks":[{"blockName":"acf/newsletter-subscription-box","attrs":{"name":"acf/newsletter-subscription-box","data":{"title":"Benzinga Cannabis Daily Newsletter","form_id":"5e65f50d-e5c4-407b-a8e6-c6a1f2cd3858","description":"\u003cdiv class=\"c-message_kit__gutter\"\u003e\n\u003cdiv class=\"c-message_kit__gutter__right\" role=\"presentation\" data-qa=\"message_content\"\u003e\n\u003cdiv class=\"c-message_kit__blocks c-message_kit__blocks--rich_text\"\u003e\n\u003cdiv class=\"c-message__message_blocks c-message__message_blocks--rich_text\" data-qa=\"message-text\"\u003e\n\u003cdiv class=\"p-block_kit_renderer\" data-qa=\"block-kit-renderer\"\u003e\n\u003cdiv class=\"p-block_kit_renderer__block_wrapper p-block_kit_renderer__block_wrapper--first\"\u003e\n\u003cdiv class=\"p-rich_text_block\" dir=\"auto\"\u003e\n\u003cdiv class=\"p-rich_text_section\"\u003e\n\u003cp data-pm-slice=\"1 1 []\"\u003eSubscribe to \u003cstrong\u003eBenzinga\u0026#8217;s free daily cannabis newsletter\u003c/strong\u003e to get policy and market updates directly in your inbox!\u003c/p\u003e\n\u003c/div\u003e\n\u003c/div\u003e\n\u003c/div\u003e\n\u003c/div\u003e\n\u003c/div\u003e\n\u003c/div\u003e\n\u003c/div\u003e\n\u003c/div\u003e\n","mobileOnly":false,"style":"solid-box","utm_label":"","redirect_url":""},"align":"","mode":"edit"},"innerBlocks":[],"innerHTML":""}]},{"blockName":"acf/advertisement-card","attrs":{"name":"acf/advertisement-card","data":{"title":"Cannabis is evolving – don’t get left behind!","description":"\u003cp\u003e\u003c!-- wp:paragraph --\u003e\u003c/p\u003e\n\u003cp\u003eCurious about what’s next for the industry and how to leverage California’s unique market?\u003c/p\u003e\n\u003cp\u003e\u003c!-- /wp:paragraph --\u003e \u003c!-- wp:paragraph --\u003e\u003c/p\u003e\n\u003cp\u003eJoin top executives, policymakers, and investors at the \u003cstrong\u003e\u003ca href=\"https://cannabismarketspotlight.com/california/anaheim-november-12/\"\u003eBenzinga Cannabis Market Spotlight\u003c/a\u003e\u003c/strong\u003e in Anaheim, CA, at the House of Blues on \u003cstrong\u003eNovember 12\u003c/strong\u003e. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!\u003c/p\u003e\n\u003cp\u003e\u003c!-- /wp:paragraph --\u003e \u003c!-- wp:paragraph --\u003e\u003c/p\u003e\n\u003cp\u003e\u003ca href=\"https://cannabismarketspotlight.com/california/anaheim-november-12/\"\u003eGet your tickets now\u003c/a\u003e to secure your spot and avoid last-minute price hikes.\u003c!-- /wp:paragraph --\u003e\u003c/p\u003e\n","image":false,"height":0,"link":"","button_text":"Get tickets now","align":"left"},"align":"","mode":"edit"},"innerBlocks":[],"innerHTML":""},{"blockName":"acf/link-group","attrs":{"name":"acf/link-group","data":{"title":"Cannabis Investor Resources","style":"box","action":"Click","links":[{"title":"Benzinga Cannabis Insider - Our Bi-Weekly Show \u0026 Podcast","url":"https://www.benzinga.com/money/podcast-show/cannabisinsider","list_icon":"fa-file-alt"},{"title":"How to Invest in Marijuana Stocks","url":"https://www.benzinga.com/money/marijuana-stocks/","list_icon":"fa-file-alt"},{"title":"What Brokerages can I use to Purchase Cannabis Stocks?","url":"https://www.benzinga.com/money/best-online-stock-broker-for-beginners/","list_icon":"fa-file-alt"}],"open_in_new_tab":false,"query":null},"align":"","mode":"edit"},"innerBlocks":[],"innerHTML":"\u003cdiv class=\"bz3-solid-box\"\u003e\u003cdiv class=\"bz3-solid-box-container\"\u003e\u003ch6 class=\"bz3-solid-box-title accent\"\u003eCannabis Investor Resources\u003c/h6\u003e\u003cdiv class=\"bz3-solid-box-link-wrapper\"\u003e\u003cdiv class=\"bz3-solid-box-item\"\u003e\u003ca href=\"https://www.benzinga.com/money/podcast-show/cannabisinsider\" \u003e Benzinga Cannabis Insider - Our Bi-Weekly Show \u0026amp; Podcast \u003c/a\u003e\u003c/div\u003e\u003cdiv class=\"bz3-solid-box-item\"\u003e\u003ca href=\"https://www.benzinga.com/money/marijuana-stocks/\" \u003e How to Invest in Marijuana Stocks \u003c/a\u003e\u003c/div\u003e\u003cdiv class=\"bz3-solid-box-item\"\u003e\u003ca href=\"https://www.benzinga.com/money/best-online-stock-broker-for-beginners/\" \u003e What Brokerages can I use to Purchase Cannabis Stocks? \u003c/a\u003e\u003c/div\u003e\u003c/div\u003e\u003c/div\u003e\u003c/div\u003e\u003cstyle\u003e .bz3-solid-box { color: #fff; margin: 1em auto; border-radius: 2px; border-width: 1px;\n}\n.bz3-solid-box-link-wrapper { font-size: 16px; font-weight: bold;\n}\n.bz3-solid-box .bz3-solid-box-container { background-color: #fff; color: #002d45; border-radius: 4px; border: solid 1px #002d45;\n}\n.bz3-solid-box .bz3-solid-box-container .bz3-solid-box-title { font-size: 1em; background-color: #2d425f; border-bottom: 1px solid #E1EBFA; font-weight: 700; padding: 0.4em 0.6em; text-transform: uppercase; margin: 0;\n}\n.bz3-solid-box .bz3-solid-box-title { text-transform: uppercase; font-weight: 800; font-family: \"Open Sans\",sans-serif; margin-bottom: 0.6em; line-height: 1.2em; font-size: 1.1em;\n}\n.bz3-solid-box .accent { color: white;\n}\n.bz3-solid-box .bz3-solid-box-item { line-height: 1.2em; padding: 0.4em 0.6em; font-weight: 700; font-size: .95em; overflow: hidden; text-overflow: ellipsis;\n}\n.bz3-solid-box .bz3-solid-box-container a { color: #002d45;\n}\n.bz3-solid-box a { color: #fff;\n}\n@media screen and (min-width: 40em) { .bz3-solid-box .bz3-solid-box-item { font-size: .8em; }\n}\n\u003c/style\u003e"},{"blockName":"acf/stock-movers-compact","attrs":{"name":"acf/stock-movers-compact","data":{"title":"Cannabis Movers","title_link":"","tickers":["HMLSF","MJ","MJNE","YOLO","MJUS","ACRZF","APHA","ACB","CTST","CGC","CRON","CURLF","TGODF","GTBIF","GWPH","HEXO","HRVSF","ITHUF","MRMD","MMNFF","OGI","SMG","TLRY","YCBD","GNLN","IIPR","PYX","GMVP","IVITF","TBPMF","BBRRF","CNPOF","XXII","EVVLF","GSRX","CWBHF","CVSI","ACCA","CNBX","FLOOF","CBMJ","GABLF","NABIF","BGRDF","CURR","CPTRF","HERTF","CHOOF","CWWBF","ADVT","IMLFF","KSHB","VREOF","LRSNF","RMHB","HHPHF","IILBF","BHHKF","CLSH","QILFF","MDCL","ALYI","LDSYF","INSY","HZEMF","TRSSF","CADMF","VGWCF","AGEEF","APPB","HSTRF","CANN","VIVO","MMJFF","NOBDF","ACNNF","KALTF","MTEC","NWVCF","ALEAF","EMOR","ISOLF","RGI","CANX","LBUY","SVVTF","AUSAF","NTEC","KBEVF","FUAPF","CAPD","CNGGF","KAYS","RHNMF","RSSFF","GRWG","NCNNF","GEATF","EMHTF","LXRP","SUGR","GGTTF","BLEVF","WDEXF","GLDFF","BLOZF","ACRGF","ALGWF","RIV","PUFXF","JWCAF","VVCIF","EEVVF","HLIX","PKPH","CRLBF","ZYNE","DYMEF","TRPX","ORHOF","MGWFF","LVCNF","ZBISF","CBDY","CNXXF","GENE","BMMJ","NXGWF","CXXIF","CNVCF","CPHRF","HMPPF","ATTBF","KALY","HEMP","PHGRF","KHRNF","FFRMF","MBII","LQSIF","INSHF","SOLCF","BLGVF","SOL","CNTMF","INLB","MGCLF","HRVOF","GBHPF","CBWTF","OILFF","VFF","DRVD","WIZP","RLLRF","SARSF","AHGIF","CBIIF","CANVF","LIBFF","TGIFF","EVIO","ARNA","WRLD","HBOSF","ICNAF","ELLXF","GRNH","HITIF","CVHIF","FNNZF","BUGVF","MPXOF","LVRLF","CBIS","FSDDF","LNLHF","LGGCF","ZLDAF","LXLLF","LHSIF","PMD","NDVAF","LFCOF","LMLLF","VRNDF","PHOT","MXC","FLWPF","BOSQF","FFNTF","UGRO","CANN","CNBS","SNDL","ZDPY","TCNNF","PSDN","AYRWF","LIFD","AAWH","LFLY","MAPS","TLLTF","XTXXF","ayrwf","FFLWF","FFNTF","INCR","FLGC","SSIC","GRAMF","GLASF","GHBWF","AVTBF","LOVFF","CLVR",""],"see_all_link":"/cannabis/stocks/","see_all_text":"See all cannabis stocks","style":"light"},"align":"","mode":"edit"},"innerBlocks":[],"innerHTML":"","symbols":["HMLSF","MJ","MJNE","YOLO","MJUS","ACRZF","APHA","ACB","CTST","CGC","CRON","CURLF","TGODF","GTBIF","GWPH","HEXO","HRVSF","ITHUF","MRMD","MMNFF","OGI","SMG","TLRY","YCBD","GNLN","IIPR","PYX","GMVP","IVITF","TBPMF","BBRRF","CNPOF","XXII","EVVLF","GSRX","CWBHF","CVSI","ACCA","CNBX","FLOOF","CBMJ","GABLF","NABIF","BGRDF","CURR","CPTRF","HERTF","CHOOF","CWWBF","ADVT","IMLFF","KSHB","VREOF","LRSNF","RMHB","HHPHF","IILBF","BHHKF","CLSH","QILFF","MDCL","ALYI","LDSYF","INSY","HZEMF","TRSSF","CADMF","VGWCF","AGEEF","APPB","HSTRF","CANN","VIVO","MMJFF","NOBDF","ACNNF","KALTF","MTEC","NWVCF","ALEAF","EMOR","ISOLF","RGI","CANX","LBUY","SVVTF","AUSAF","NTEC","KBEVF","FUAPF","CAPD","CNGGF","KAYS","RHNMF","RSSFF","GRWG","NCNNF","GEATF","EMHTF","LXRP","SUGR","GGTTF","BLEVF","WDEXF","GLDFF","BLOZF","ACRGF","ALGWF","RIV","PUFXF","JWCAF","VVCIF","EEVVF","HLIX","PKPH","CRLBF","ZYNE","DYMEF","TRPX","ORHOF","MGWFF","LVCNF","ZBISF","CBDY","CNXXF","GENE","BMMJ","NXGWF","CXXIF","CNVCF","CPHRF","HMPPF","ATTBF","KALY","HEMP","PHGRF","KHRNF","FFRMF","MBII","LQSIF","INSHF","SOLCF","BLGVF","SOL","CNTMF","INLB","MGCLF","HRVOF","GBHPF","CBWTF","OILFF","VFF","DRVD","WIZP","RLLRF","SARSF","AHGIF","CBIIF","CANVF","LIBFF","TGIFF","EVIO","ARNA","WRLD","HBOSF","ICNAF","ELLXF","GRNH","HITIF","CVHIF","FNNZF","BUGVF","MPXOF","LVRLF","CBIS","FSDDF","LNLHF","LGGCF","ZLDAF","LXLLF","LHSIF","PMD","NDVAF","LFCOF","LMLLF","VRNDF","PHOT","MXC","FLWPF","BOSQF","FFNTF","UGRO","CANN","CNBS","SNDL","ZDPY","TCNNF","PSDN","AYRWF","LIFD","AAWH","LFLY","MAPS","TLLTF","XTXXF","ayrwf","FFLWF","FFNTF","INCR","FLGC","SSIC","GRAMF","GLASF","GHBWF","AVTBF","LOVFF","CLVR",""]},{"blockName":"acf/widget-container","attrs":{"name":"acf/widget-container","data":{"widget":{"ID":168314,"post_author":"27","post_date":"2022-02-03 13:08:08","post_date_gmt":"2022-02-03 18:08:08","post_content":"\u003c!-- wp:heading {\"textAlign\":\"center\"} --\u003e\n\u003ch2 class=\"has-text-align-center\"\u003e\u003cstrong\u003eViridian Chart Of The Week\u003c/strong\u003e\u003c/h2\u003e\n\u003c!-- /wp:heading --\u003e\n\n\u003c!-- wp:paragraph --\u003e\n\u003cp\u003e\u003cstrong\u003eThis week's Viridian Chart of the Week explores the relationship between financial strength and YTD stock performance.\u003c/strong\u003e\u003c/p\u003e\n\u003c!-- /wp:paragraph --\u003e\n\n\u003c!-- wp:image {\"id\":320076,\"sizeSlug\":\"full\",\"linkDestination\":\"none\"} --\u003e\n\u003cfigure class=\"wp-block-image size-full\"\u003e\u003cimg src=\"https://www.benzinga.com/wp-content/uploads/2024/06/unnamed20.png\" alt=\"\" class=\"wp-image-320076\"/\u003e\u003c/figure\u003e\n\u003c!-- /wp:image --\u003e","post_title":"Viridian Capital Chart of the Week","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"viridian-capital-chart-of-the-week","to_ping":"","pinged":"","post_modified":"2024-06-24 11:30:16","post_modified_gmt":"2024-06-24 15:30:16","post_content_filtered":"","post_parent":0,"guid":"https://www.benzinga.com/?post_type=widget\u0026#038;p=168314","menu_order":0,"post_type":"widget","post_mime_type":"","comment_count":"0","filter":"raw"}},"align":"","mode":"edit"},"innerBlocks":[],"innerHTML":"","dynamic":true,"blocks":[{"blockName":"core/heading","attrs":{"textAlign":"center","data":[]},"innerBlocks":[],"innerHTML":"\n\u003ch2 class=\"has-text-align-center\"\u003e\u003cstrong\u003eViridian Chart Of The Week\u003c/strong\u003e\u003c/h2\u003e\n","tag":"h2","id":"viridian-chart-of-the-week","html":"\u003cstrong\u003eViridian Chart Of The Week\u003c/strong\u003e"},{"blockName":"core/paragraph","attrs":{"data":[]},"innerBlocks":[],"innerHTML":"\n\u003cp\u003e\u003cstrong\u003eThis week's Viridian Chart of the Week explores the relationship between financial strength and YTD stock performance.\u003c/strong\u003e\u003c/p\u003e\n","html":"\u003cstrong\u003eThis week's Viridian Chart of the Week explores the relationship between financial strength and YTD stock performance.\u003c/strong\u003e","tag":"p"},{"blockName":"core/image","attrs":{"id":320076,"sizeSlug":"full","linkDestination":"none","data":[]},"innerBlocks":[],"innerHTML":"\n\u003cfigure class=\"wp-block-image size-full\"\u003e\u003cimg src=\"https://cdnwp-s3.benzinga.com/wp-content/uploads/2024/06/24112936/unnamed20.png\" alt=\"\" class=\"wp-image-320076\"/\u003e\u003c/figure\u003e\n","image":{"image_id":320076,"attachment_id":320076,"title":"unnamed20","caption":null,"sizes":{"original":{"height":714,"width":658,"url":"https://cdnwp-s3.benzinga.com/wp-content/uploads/2024/06/24112936/unnamed20.png"},"medium":{"height":300,"width":276,"url":"https://cdnwp-s3.benzinga.com/wp-content/uploads/2024/06/24112936/unnamed20-276x300.png"},"thumbnail":{"height":150,"width":150,"url":"https://cdnwp-s3.benzinga.com/wp-content/uploads/2024/06/24112936/unnamed20-150x150.png"},"Multi Rating Pro Thumbnail":{"height":100,"width":100,"url":"https://cdnwp-s3.benzinga.com/wp-content/uploads/2024/06/24112936/unnamed20-100x100.png"},"slideshow-img":{"height":600,"width":658,"url":"https://cdnwp-s3.benzinga.com/wp-content/uploads/2024/06/24112936/unnamed20-658x600.png"},"web-stories-poster-portrait":{"height":714,"width":640,"url":"https://cdnwp-s3.benzinga.com/wp-content/uploads/2024/06/24112936/unnamed20-640x714.png"},"web-stories-publisher-logo":{"height":96,"width":96,"url":"https://cdnwp-s3.benzinga.com/wp-content/uploads/2024/06/24112936/unnamed20-96x96.png"},"web-stories-thumbnail":{"height":163,"width":150,"url":"https://cdnwp-s3.benzinga.com/wp-content/uploads/2024/06/24112936/unnamed20-150x163.png"}}}}]}]},"unmonetized_interstitial":null,"sidebar_placement":null,"left_sidebar":null,"global_footer":{"id":160497,"title":"Advertise With Us","type":"footer","blocks":[{"blockName":"core/paragraph","attrs":{"data":[]},"innerBlocks":[],"innerHTML":"\n\u003cp\u003e\u003cstrong\u003eWant to advertise with us? \u003ca href=\"https://www.benzinga.com/money/advertise-with-us/\" target=\"_blank\" rel=\"noreferrer noopener\"\u003eSend us a message\u003c/a\u003e. \u003c/strong\u003e\u003c/p\u003e\n","html":"\u003cstrong\u003eWant to advertise with us? \u003ca href=\"https://www.benzinga.com/money/advertise-with-us/\" target=\"_blank\" rel=\"noreferrer noopener\"\u003eSend us a message\u003c/a\u003e. \u003c/strong\u003e","tag":"p"}]},"content_footer":null,"footer":null,"layout":{"settings":{"cache_max_age":0,"display_y_position":0,"show_author_credentials":false,"floating_cta_hide":false,"footer_hide":false,"hide_article_footer":false,"hide_article_header":false,"hide_navigation_bar":false,"hide_menu_bar_items":false,"simple_article_title":false,"hide_quotes_searchbar":false,"hide_sidebar_placement":false,"hide_sidebar":false,"hide_site_footer":false,"ignore_compare_products_popup":false,"is_root_path":false,"no_direct_partnership":false,"popup_delay":0,"popup_hide":false,"post_alternative_title":"","post_exclusive_partner":"","post_update_frequency":"","post_verified_by_user":null,"banner_text":"","banner_link":"","menu_location":"page"}},"surrogate_keys":"page-type:full-width post-id:232396","author":{"wordpress_id":5860,"slug":"benzinga","avatar":"//secure.gravatar.com/avatar/d34e67a3708a958bb67f0ec0d657580c?d=mm","display_name":"Benzinga"}},"pageTargeting":{"BZ_CHANNEL":"cannabis"},"parselyPopularStories":[{"id":42202403,"author":"Maureen Meehan","created":"Tue, 26 Nov 2024 17:42:49 -0400","updated":"Tue, 26 Nov 2024 17:42:49 -0400","title":"Elizabeth Warren, Bernie Sanders \u0026 12 Congress Members To Biden: Issue Clemency And Pardons For Cannabis Prisoners","teaser":"While Biden pardoned individuals with federal marijuana possession convictions, these measures have resulted in no prison releases.","body":"\u003cp\u003eA group of 14 Democratic lawmakers is urging President \u003cstrong\u003eJoe Biden\u003c/strong\u003e to expand his marijuana pardons and deprioritize federal cannabis prosecutions before the end of his term. \u003c/p\u003e\n\n\n\n\u003cp\u003eIn a letter addressed to \u003cstrong\u003eBiden\u003c/strong\u003e and VP \u003cstrong\u003eKamala Harris\u003c/strong\u003e, Senators \u003cstrong\u003eElizabeth Warren\u003c/strong\u003e (D-MA), \u003cstrong\u003eBarbara Lee\u003c/strong\u003e (D-CA), \u003cstrong\u003eBernie Sanders \u003c/strong\u003e(I-VT) as well as Reps. \u003cstrong\u003eEarl Blumenauer\u003c/strong\u003e (D-OR) and \u003cstrong\u003eIlhan Omar\u003c/strong\u003e (D-MN), along with nine more colleagues applauded Biden for getting the ball rolling on cannabis rescheduling but that more needs to be done before he leaves office.\u003c/p\u003e\n\n\n\n\u003ch2 class=\"wp-block-heading\"\u003e\u003cstrong\u003eRescheduling Cannabis Is Not Enough\u003c/strong\u003e\u003c/h2\u003e\n\n\n\n\u003cp\u003e\"Moving marijuana to Schedule III represents progress, and we urge the Drug Enforcement Administration to complete that process as soon as possible. But it will not end federal criminalization, resolve its harms, or meaningfully address the gap between federal and state cannabis policy,\" the lawmakers said in the letter, which was first \u003ca href=\"https://www.rollingstone.com/politics/politics-features/dems-biden-decriminalize-weed-trump-1235181464/\"\u003ereported\u003c/a\u003e by Rolling Stone. \"Possession and use of recreational marijuana—and much state-legal medical marijuana—will continue to be a violation of federal law.\"\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eRead Also\u003c/strong\u003e: \u003ca href=\"https://www.benzinga.com/news/legal/24/11/42177984/joe-biden-how-about-pardoning-non-violent-cannabis-prisoners-along-with-those-thanksgiving-turkeys\"\u003e\u003cstrong\u003eJoe Biden, How About Pardoning Non-Violent Cannabis Prisoners Along With Those Thanksgiving Turkeys?\u003c/strong\u003e\u003c/a\u003e\u003c/p\u003e\n\n\n\n\u003cp\u003eWhile lawmakers credited Biden for pardoning individuals with federal marijuana possession convictions, they rightly pointed out that these measures have resulted in no prison releases.\u003c/p\u003e\n\n\n\n\u003cp\u003e\"President Biden should issue broader clemency — including another round of pardons and commutations to reduce sentences or end terms of incarceration — for individuals convicted of other cannabis-related offenses,\" the lawmakers wrote. \"Additionally, the President should again urge state governors to expand marijuana clemency and decriminalize low-level marijuana conduct under state law.\"\u003c/p\u003e\n\n\n\n\u003cp\u003eThe congress members urged the Biden administration to grant broader clemency, including additional pardons and sentence commutations; they encouraged governors to extend similar pardons at the state level.\u003c/p\u003e\n\n\n\n\u003ch2 class=\"wp-block-heading\"\u003e\u003cstrong\u003eFederal Convictions Still Persist\u003c/strong\u003e\u003c/h2\u003e\n\n\n\n\u003cp\u003eThe second part of their request focused on issuing a memorandum to deprioritize federal enforcement against state-legal cannabis activity. Despite declining federal cannabis prosecutions due to state-level legalizations, the lawmakers noted that the threat of federal convictions persists. \u003c/p\u003e\n\n\n\n\u003cp\u003eThen there are the racial disparities in enforcement, the letter pointed out and further cited recent incidents where Customs and Border Protection (CBP) seized state-legal cannabis, including cases in New Mexico.\u003c/p\u003e\n\n\n\n\u003cp\u003eSignatories also include \u003cstrong\u003eCory Booker\u003c/strong\u003e (D-NJ), \u003cstrong\u003eRon Wyden\u003c/strong\u003e (D-OR), \u003cstrong\u003eJohn Hickenlooper\u003c/strong\u003e (D-CO), \u003cstrong\u003eKirsten Gillibrand\u003c/strong\u003e (D-NY) and \u003cstrong\u003eBen Ray Lujan \u003c/strong\u003e(D-NM) as well as Reps. \u003cstrong\u003eJan Schakowsky\u003c/strong\u003e (D-IL), \u003cstrong\u003eDina Titus\u003c/strong\u003e (D-NV), \u003cstrong\u003eJim McGovern\u003c/strong\u003e (D-MA) and \u003cstrong\u003eEleanor Holmes Norton\u003c/strong\u003e (D-DC).\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eNow Read:\u003c/strong\u003e\u003c/p\u003e\n\n\n\n\u003cul\u003e\n\u003cli\u003e\u003ca href=\"https://www.benzinga.com/markets/cannabis/24/11/42087262/president-biden-people-are-still-in-jail-for-marijuana-despite-your-promise-cannabis-clemency-advocates-call-for-change\"\u003e\u003cstrong\u003ePresident Biden, People Are Still In Jail For Marijuana Despite Your Promise, Cannabis Clemency Advocates Call For Change\u003c/strong\u003e\u003c/a\u003e\u003c/li\u003e\n\u003c/ul\u003e\n\n\n\n\u003cp\u003e\u003cem\u003ePhoto: Benzinga edit Adam Schultz on Wikimedia Commons and David Smart on Shutterstock\u003c/em\u003e\u003ca href=\"https://www.benzinga.com/apis?utm_source=benzinga.com\u0026amp;utm_campaign=article-bottom\" target=\"_blank\" rel=\"noreferrer noopener\"\u003e\u003c/a\u003e\u003c/p\u003e","url":"https://www.benzinga.com/news/legal/24/11/42202403/elizabeth-warren-bernie-sanders-12-congress-members-to-biden-issue-clemency-and-pardons-for-cannabis-prisoners","image":[{"size":"thumb","url":"https://cdn.benzinga.com/files/imagecache/250x187xUP/images/story/2024/11/26/joe-biden-cannabis-liberty-adam-schultz-.jpeg"},{"size":"small","url":"https://cdn.benzinga.com/files/imagecache/1024x768xUP/images/story/2024/11/26/joe-biden-cannabis-liberty-adam-schultz-.jpeg"},{"size":"large","url":"https://cdn.benzinga.com/files/imagecache/2048x1536xUP/images/story/2024/11/26/joe-biden-cannabis-liberty-adam-schultz-.jpeg"}],"channels":[{"name":"Cannabis"},{"name":"Government"},{"name":"News"},{"name":"Politics"},{"name":"Legal"}],"stocks":[],"tags":[{"name":"cannabis legalization"},{"name":"Cannabis pardons"},{"name":"Congress Members"},{"name":"Joe Biden"},{"name":"Stories That Matter"}]},{"id":42077935,"author":"Maureen Meehan","created":"Tue, 19 Nov 2024 19:28:00 -0400","updated":"Tue, 19 Nov 2024 19:28:01 -0400","title":"Trump Picks Dr. Oz, Who Says Seniors Should Give Medical Marijuana A Try, To Lead Centers For Medicare And Medicaid Services","teaser":"Trump to nominate TV personality Dr. Oz as administrator Centers for Medicare and Medicaid Services. Oz, known for his TV show, will work with RFK Jr. to take on the illness industrial complex.","body":"\u003cp\u003ePresident-elect Donald J. Trump \u003ca href=\"https://www.benzinga.com/general/health-care/24/11/42077057/trump-picks-dr-oz-as-centers-for-medicare-and-medicaid-services-administrator\"\u003eannounced on Tuesday afternoon\u003c/a\u003e that he will nominate TV personality Dr. \u003cstrong\u003eMehmet Oz\u003c/strong\u003e to serve as the administrator of the Centers for \u003ca href=\"https://www.benzinga.com/etfs/24/11/42044642/trump-appears-frustrated-as-elon-musk-chimes-in-on-treasury-secretary-adds-more-names-to-a-list-of-potential-picks\" target=\"_blank\" rel=\"noreferrer noopener\"\u003eMedicare and Medicaid Services (CMS)\u003c/a\u003e. The appointment is among a string of TV hosts — mostly from Fox News — to be chosen to join Trump's cabinet.\u003c/p\u003e\n\n\n\n\u003cp\u003eIn a statement, Trump said the celebrity TV host will \"work closely with Robert F. Kennedy Jr. to take on the illness industrial complex.\"\u003c/p\u003e\n\n\n\n\u003cp\u003eThough a household name due to his long-running \u0026#8220;\u003cstrong\u003eThe Dr. Oz Show\u003c/strong\u003e\" (2009-2022), Oz got into politics when he \u003ca href=\"https://www.benzinga.com/markets/cannabis/22/06/27558526/dr-oz-to-face-john-fetterman-in-unprecedented-unpredictable-pa-senate-race-and-cannabis-is-on-th\"\u003eunsuccessfully ran for Senate\u003c/a\u003e against now Sen. \u003cstrong\u003eJohn Fetterman\u003c/strong\u003e (D-Penn.) in 2022, during which time the good doctor seemed to forge an alliance with Trump.\u003c/p\u003e\n\n\n\n\u003cp\u003eAt the time,\u003cstrong\u003e Scientific American\u003c/strong\u003e\u0026nbsp;\u003ca href=\"https://www.scientificamerican.com/article/dr-oz-shouldnt-be-a-senator-or-a-doctor/\" target=\"_blank\" rel=\"noreferrer noopener\"\u003ewrote \u003c/a\u003eDr. Oz should not\u0026nbsp;be a senator or a doctor, noting that his misinformation had already tarnished medicine and would do much worse in the halls of Congress.\u0026nbsp;\"Dr. Oz\u0026nbsp;has long pushed misleading, science-free and unproven alternative therapies such as homeopathy, as well as fad diets, detoxes and cleanses.\"\u003c/p\u003e\n\n\n\n\u003ch1 class=\"wp-block-heading\"\u003e\u003cstrong\u003eDonald Trump Begs To Differ\u003c/strong\u003e\u003c/h1\u003e\n\n\n\n\u003cp\u003eNews outlets are quick to\u003ca href=\"https://www.axios.com/2024/11/19/trump-dr-oz-cms-cabinet\"\u003e point out\u003c/a\u003e that Dr. Oz has no experience running a large government body like the CMS but that seems to not matter because, according to the President-elect.\u003c/p\u003e\n\n\n\n\u003cp\u003e\u0026#8220;There may be no Physician more qualified and capable than Dr. Oz to Make America Healthy Again,\u0026#8221; Trump said in a statement, referring to the words of \u003ca href=\"https://www.benzinga.com/topic/robert-f-kennedy-jr\"\u003eRobert Kennedy Jr\u003c/a\u003e. who will, if confirmed run the \u003cstrong\u003eDept. of Health and Human Services\u003c/strong\u003e.\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eRead Also: \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/11/42036132/trump-wants-matt-gaetz-confirmed-100-so-does-the-cannabis-industry\"\u003eTrump Wants Matt Gaetz Confirmed \u0026#8216;100%,\u0026#8217; So Does The Cannabis Industry\u003c/a\u003e\u003c/strong\u003e\u003c/p\u003e\n\n\n\n\u003ch1 class=\"wp-block-heading\"\u003e\u003cstrong\u003eDr. Oz On Cannabis\u003c/strong\u003e\u003c/h1\u003e\n\n\n\n\u003cp\u003eThe multimillionaire TV host initially called cannabis a \u0026#8220;mixed bag for easing pain.\u0026#8221; But a recent discussion with\u0026nbsp;\u003cstrong\u003eMichael Roizen,\u0026nbsp;\u003c/strong\u003eM.D., of the Wellness Institute at the Cleveland Clinic, Dr. \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/08/40492959/trump-endorsed-dr-oz-on-medical-marijuana-and-pain-give-it-a-try\"\u003eOz said\u003c/a\u003e, \u0026#8220;Our advice: If your physician recommends it to manage pain, especially if you\u0026#8217;re 65 and older, give it a try.\u0026#8221;\u003c/p\u003e\n\n\n\n\u003cp\u003eWhile Dr. Oz cautions against cannabis consumption for recreational purposes, he said he believes marijuana for pain represents a \"safer solution than, for example, narcotics in many cases.\"\u003c/p\u003e\n\n\n\n\u003cp\u003eDuring his Senate race, Dr. Oz often criticized Fetterman\u0026#8217;s support for cannabis legalization though several years earlier he himself \u003ca href=\"https://www.marijuanamoment.net/dr-oz-claims-dea-and-fda-blame-each-other-for-keeping-marijuana-illegal/\"\u003ereferred to cannabis\u003c/a\u003e\u0026nbsp;as \"one of the most underused tools in America\" and that the U.S. should\u0026nbsp;\"completely change our policy on marijuana.\"\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eNow Read:\u003c/strong\u003e\u003c/p\u003e\n\n\n\n\u003cul\u003e\n\u003cli\u003e\u003ca href=\"https://www.benzinga.com/markets/cannabis/24/11/42069004/how-trumps-election-could-revolutionize-cannabis-and-cryptocurrency-ceo-says\"\u003eHow Trump\u0026#8217;s Election Could Revolutionize Cannabis And Cryptocurrency, CEO Says\u003c/a\u003e\u003c/li\u003e\n\u003c/ul\u003e","url":"https://www.benzinga.com/general/health-care/24/11/42077935/trump-picks-dr-oz-who-says-seniors-should-give-medical-marijuana-a-try-to-lead-centers-for-medicare-and-medicaid-services","image":[{"size":"thumb","url":"https://cdn.benzinga.com/files/imagecache/250x187xUP/images/story/2024/11/19/Dr--Oz-weed.jpeg"},{"size":"small","url":"https://cdn.benzinga.com/files/imagecache/1024x768xUP/images/story/2024/11/19/Dr--Oz-weed.jpeg"},{"size":"large","url":"https://cdn.benzinga.com/files/imagecache/2048x1536xUP/images/story/2024/11/19/Dr--Oz-weed.jpeg"}],"channels":[{"name":"Cannabis"},{"name":"Government"},{"name":"News"},{"name":"Health Care"},{"name":"Politics"},{"name":"Top Stories"}],"stocks":[],"tags":[{"name":"Centers For Medicare And Medicaid Services"},{"name":"Donald Trump"},{"name":"Dr. Dr. Mehmet Oz"},{"name":"Robert F. Kennedy Jr."}]},{"id":42190193,"author":"Nina Zdinjak","created":"Tue, 26 Nov 2024 10:11:32 -0400","updated":"Tue, 26 Nov 2024 10:11:33 -0400","title":"Tilray Introduces New Indica Strain With 'Potent THC And A Unique Terpene Profile'","teaser":" ","body":"\u003cp\u003e\u003cstrong\u003eCannabis giant Tilray Brands, Inc.\u003c/strong\u003e (NASDAQ:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/TLRY#NASDAQ\"\u003eTLRY\u003c/a\u003e) announced the latest small batch indica strain by its craft cannabis brand, \u003cstrong\u003eBroken Coast: Platinum Pavé\u003c/strong\u003e. This new cultivar is one of the first from Broken Coast\u0026#8217;s state-of-the-art Vancouver Island, BC facility. Platinum Pavé is grown under optimized conditions in single-strain, laboratory-grade rooms. Each batch is precisely pruned, slowly cold cured and rigorously inspected for purity.\u003c/p\u003e\n\n\n\n\u003cp\u003e\"We're excited for consumers to get their hands on this exceptional indica,\" stated \u003cstrong\u003eKevin Anderson,\u003c/strong\u003e master grower at Broken Coast. \"After phenohunting over 500 seeds, we're extremely proud to cultivate a strain with potent THC and a unique terpene profile. With our slow cold curing process, we take pride in preserving trichome density, delivering the purest expression of the Spritzer x Pavé cross to deliver something special.\"\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eRead Also: \u003c/strong\u003e\u003ca href=\"https://www.benzinga.com/analyst-ratings/analyst-color/24/11/41811378/aurora-vs-canopy-tilray-which-nasdaq-listed-cannabis-stock-offers-the-best-growth-p\"\u003eAurora vs. Canopy \u0026amp; Tilray: Which NASDAQ-Listed Cannabis Stock Offers The Best Growth Potential?\u003c/a\u003e\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cem\u003e\u003cstrong\u003eGet Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter \u003ca href=\"https://newsletteremail.benzinga.com/subscribe\" target=\"_blank\" rel=\"noreferrer noopener\"\u003ehere\u003c/a\u003e. If you're serious about the business, you can't afford to miss out.\u003c/strong\u003e\u003c/em\u003e\u003c/p\u003e\n\n\n\n\u003ch2 class=\"wp-block-heading\"\u003ePlatinum Pavé Higlights\u003c/h2\u003e\n\n\n\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003eLineage:\u003c/strong\u003e Spritzer x Pavé.\u003c/li\u003e\n\n\n\n\u003cli\u003e\u003cstrong\u003eAromas:\u003c/strong\u003e Sweet, earthy with a potent hint of diesel.\u003c/li\u003e\n\n\n\n\u003cli\u003e\u003cstrong\u003eRich terpene profile featuring:\u003c/strong\u003e Limonene, Caryophyllene, Linalool.\u003c/li\u003e\n\n\n\n\u003cli\u003e\u003cstrong\u003eTHC range:\u003c/strong\u003e\u0026nbsp;Potent and suitable for winding down after a long day or enjoying socially.\u003c/li\u003e\n\u003c/ul\u003e\n\n\n\n\u003cp\u003eDespite the laborious process, the team is dedicated to thoughtfully choosing strains and refining their growing and curing techniques to develop the best product possible. Platinum Pavé joins Broken Coast's renowned craft cannabis portfolio, including Cherry Cheesecake, EmergenZ, Sour OG, Holy Grail Kush, Amnesia Haze, and most recent fan favorite, Milk \u0026amp; Cookies.\u003c/p\u003e\n\n\n\n\u003cp\u003eCraft flower enthusiasts can experience the handcrafted genetics of Broken Coast\u0026#8217;s Platinum Pavé, available in 7g exclusively in British Columbia, with 3.5g whole flower, and in pre-rolls – 3\u0026#215;0.5g and 5\u0026#215;0.5g multipacks coming to Ontario and Alberta in the new year.\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003ePrice Action\u003c/strong\u003e\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eTilray shares traded flat at $1.42 during Tuesday's pre-market session.\u003c/strong\u003e\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eRead Next:\u003c/strong\u003e\u003c/p\u003e\n\n\n\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003e\u003ca href=\"https://www.benzinga.com/markets/cannabis/24/11/41997646/tilray-joins-german-cannabis-fiesta-with-first-locally-grown-strains\"\u003eTilray Joins German Cannabis Fiesta With First Locally Grown Strains\u003c/a\u003e\u003c/strong\u003e\u003c/li\u003e\n\u003c/ul\u003e\n\n\n\n\u003cp\u003e\u003cem\u003eCourtesy photo \u003c/em\u003e\u003c/p\u003e","url":"https://www.benzinga.com/markets/cannabis/24/11/42190193/tilray-introduces-new-indica-strain-with-potent-thc-and-a-unique-terpene-profile","image":[{"size":"thumb","url":"https://cdn.benzinga.com/files/imagecache/250x187xUP/images/story/2024/11/26/New-Project-173.jpeg"},{"size":"small","url":"https://cdn.benzinga.com/files/imagecache/1024x768xUP/images/story/2024/11/26/New-Project-173.jpeg"},{"size":"large","url":"https://cdn.benzinga.com/files/imagecache/2048x1536xUP/images/story/2024/11/26/New-Project-173.jpeg"}],"channels":[{"name":"Cannabis"},{"name":"News"}],"stocks":[{"name":"TLRY"}],"tags":[{"name":"Kevin Anderson"},{"name":"premium"}]},{"id":42152643,"author":"Maureen Meehan","created":"Sat, 23 Nov 2024 13:30:25 -0400","updated":"Sat, 23 Nov 2024 13:30:25 -0400","title":"DEA Banned From Random Airport Searches After Scathing Justice Department Report Uncovers Corruption","teaser":"The DEA has been barred from conducting random searches of travelers\u0026#39; belongings at airports and transit hubs following a Justice Department investigation that exposed corrupt practices.","body":"\u003cp\u003eThe \u003ca href=\"https://www.benzinga.com/topic/dea\"\u003eDrug Enforcement Administration \u003c/a\u003e(DEA) has been barred from conducting random searches of travelers\u0026#8217; belongings at airports and transit hubs following a \u003cstrong\u003eJustice Department\u003c/strong\u003e investigation that exposed corrupt practices. The investigation, led by Inspector General \u003cstrong\u003eMichael Horowitz\u003c/strong\u003e, uncovered failures to properly document searches, potential racial profiling and questionable partnerships with airline employees. \u003c/p\u003e\n\n\n\n\u003cp\u003eOne airline worker reportedly received tens of thousands of dollars over several years as a kickback for flagging passengers based on travel patterns, such as purchasing last-minute tickets. \u003c/p\u003e\n\n\n\n\u003cp\u003e\"The DOJ Office of the Inspector General (OIG) found that the DEA has repeatedly failed to comply with its own policies, creating significant operational and legal risks,\" according to the \u003ca href=\"https://oig.justice.gov/news/doj-oig-releases-management-alert-identifying-concerns-deas-transportation-interdiction\"\u003ereport\u003c/a\u003e.\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eRead Also: \u003ca href=\"https://www.benzinga.com/markets/cannabis/23/07/33156524/dea-turns-50-unveiling-the-ineffectiveness-of-the-ongoing-war-on-drugs-now-what\"\u003e$1 Trillion And 50 Years Later, Is The DEA\u0026#8217;s War On Drugs A Failure?\u003c/a\u003e\u003c/strong\u003e\u003c/p\u003e\n\n\n\n\u003cp\u003eThe decision to suspend the searches was issued on November 12 by the deputy attorney general after reviewing the draft report. The Justice Department's memo restricts DEA agents from engaging in consensual encounters at transit locations unless tied to active investigations or approved under special circumstances.\u003c/p\u003e\n\n\n\n\u003ch2 class=\"wp-block-heading\"\u003e\u003cstrong\u003eSystemic Corruption\u003c/strong\u003e\u003c/h2\u003e\n\n\n\n\u003cp\u003eThe report follows a widely circulated video released by the \u003ca href=\"https://ij.org/press-release/department-of-justice-suspends-controversial-airport-interdictions-after-viral-footage-showing-dea-agents-threatening-abusing-innocent-traveler/\"\u003eInstitute for Justice\u003c/a\u003e (IJ), a nonprofit civil rights organization. One case cited in the memo involved a traveler approached by a DEA Task Force Officer at an airport. The video shows a traveler, identified as David C., refusing to consent to a search at an airport. Despite his objections, agents took his backpack, claimed a drug-detection dog alerted them and conducted the search, which yielded no illegal items. The delay, which caused David to miss his flight, resulted in widespread public criticism.\u003c/p\u003e\n\n\n\n\u003cp\u003eFurther investigation revealed systemic issues. The DEA rarely documents its searches unless they result in seizures or arrests, making it impossible to determine how many travelers have been impacted. In one case, musician Brian Moore had $8,500 seized at an airport, money intended for a music video project. He was never charged with a crime but spent a year and $15,000 in legal fees to recover his funds. Moore said the experience ruined his music career.\u003c/p\u003e\n\n\n\n\u003cp\u003eA 2016 \u003ca href=\"https://www.usatoday.com/story/news/2016/08/10/dea-travel-record-airport-seizures/88474282/\"\u003eUSA Today investigation\u003c/a\u003e found that DEA agents seized over $209 million from more than 5,200 travelers at 15 major airports over a decade, with most funds shared with local police. Critics argue these practices incentivize unconstitutional searches for profit.\u003c/p\u003e\n\n\n\n\u003cp\u003eThe Institute for Justice has since sued the DEA and TSA, advocating for legislation to eliminate these financial incentives. The DEA has yet to respond to the findings.\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eNow Read:\u003c/strong\u003e\u003c/p\u003e\n\n\n\n\u003cul\u003e\n\u003cli\u003e\u003ca href=\"https://www.benzinga.com/markets/cannabis/24/08/40586896/dea-can-still-make-cannabis-arrests-in-legal-weed-states-like-ohio-but-its-not-our-goal\"\u003e\u003cstrong\u003eDEA Can Still Make Cannabis Arrests In Legal Weed States Like Ohio, But It\u0026#8217;s Not \u0026#8216;Our Goal\u0026#8217;\u003c/strong\u003e\u003c/a\u003e\u003c/li\u003e\n\u003c/ul\u003e\n\n\n\n\u003cp\u003e\u003cem\u003ePhoto: Courtesy of DEA\u003c/em\u003e\u003c/p\u003e","url":"https://www.benzinga.com/markets/cannabis/24/11/42152643/dea-banned-from-random-airport-searches-after-scathing-justice-department-report-uncovers-corruption","image":[{"size":"thumb","url":"https://cdn.benzinga.com/files/imagecache/250x187xUP/images/story/2024/11/23/DEA-MM.jpeg"},{"size":"small","url":"https://cdn.benzinga.com/files/imagecache/1024x768xUP/images/story/2024/11/23/DEA-MM.jpeg"},{"size":"large","url":"https://cdn.benzinga.com/files/imagecache/2048x1536xUP/images/story/2024/11/23/DEA-MM.jpeg"}],"channels":[{"name":"Cannabis"},{"name":"Government"},{"name":"News"},{"name":"Top Stories"}],"stocks":[],"tags":[{"name":"DEA"},{"name":"Dept. Of Justice"},{"name":"Inspector General Michael Horowitz"},{"name":"Institute for Justice"}]}],"taxonomies":{"page-type":[{"term_taxonomy_id":190,"term_id":190,"taxonomy":"page-type","description":"","parent":0,"count":83,"term":{"term_id":190,"name":"Full Width","slug":"full-width"}}]},"tickers":["HMLSF","MJ","MJNE","YOLO","MJUS","ACRZF","APHA","ACB","CTST","CGC","CRON","CURLF","TGODF","GTBIF","GWPH","HEXO","HRVSF","ITHUF","MRMD","MMNFF","OGI","SMG","TLRY","YCBD","GNLN","IIPR","PYX","GMVP","IVITF","TBPMF","BBRRF","CNPOF","XXII","EVVLF","GSRX","CWBHF","CVSI","ACCA","CNBX","FLOOF","CBMJ","GABLF","NABIF","BGRDF","CURR","CPTRF","HERTF","CHOOF","CWWBF","ADVT","IMLFF","KSHB","VREOF","LRSNF","RMHB","HHPHF","IILBF","BHHKF","CLSH","QILFF","MDCL","ALYI","LDSYF","INSY","HZEMF","TRSSF","CADMF","VGWCF","AGEEF","APPB","HSTRF","CANN","VIVO","MMJFF","NOBDF","ACNNF","KALTF","MTEC","NWVCF","ALEAF","EMOR","ISOLF","RGI","CANX","LBUY","SVVTF","AUSAF","NTEC","KBEVF","FUAPF","CAPD","CNGGF","KAYS","RHNMF","RSSFF","GRWG","NCNNF","GEATF","EMHTF","LXRP","SUGR","GGTTF","BLEVF","WDEXF","GLDFF","BLOZF","ACRGF","ALGWF","RIV","PUFXF","JWCAF","VVCIF","EEVVF","HLIX","PKPH","CRLBF","ZYNE","DYMEF","TRPX","ORHOF","MGWFF","LVCNF","ZBISF","CBDY","CNXXF","GENE","BMMJ","NXGWF","CXXIF","CNVCF","CPHRF","HMPPF","ATTBF","KALY","HEMP","PHGRF","KHRNF","FFRMF","MBII","LQSIF","INSHF","SOLCF","BLGVF","SOL","CNTMF","INLB","MGCLF","HRVOF","GBHPF","CBWTF","OILFF","VFF","DRVD","WIZP","RLLRF","SARSF","AHGIF","CBIIF","CANVF","LIBFF","TGIFF","EVIO","ARNA","WRLD","HBOSF","ICNAF","ELLXF","GRNH","HITIF","CVHIF","FNNZF","BUGVF","MPXOF","LVRLF","CBIS","FSDDF","LNLHF","LGGCF","ZLDAF","LXLLF","LHSIF","PMD","NDVAF","LFCOF","LMLLF","VRNDF","PHOT","MXC","FLWPF","BOSQF","FFNTF","UGRO","CANN","CNBS","SNDL","ZDPY","TCNNF","PSDN","AYRWF","LIFD","AAWH","LFLY","MAPS","TLLTF","XTXXF","ayrwf","FFLWF","FFNTF","INCR","FLGC","SSIC","GRAMF","GLASF","GHBWF","AVTBF","LOVFF","CLVR",""],"tradeIdeas":[{"action":null,"allocation":null,"avatarProps":{"id":1564,"name":"Long2630565246","photo":"https://secure.gravatar.com/avatar/16d0f95817d3cae043b2fd750968cbfb"},"comments":[],"companyName":"Cronos Group","contributor":null,"contributorId":561917,"createdAt":"2021-12-01 13:43 UTC","downvotes":0,"duration":null,"durationText":null,"financialAssetPositionProps":{"direction":"LONG"},"id":213144,"modelId":24374425,"modelType":"App\\Node","multiplier":0,"node":null,"numComments":null,"numZing":null,"position":"LONG","price":0,"reason":"Use this refer https://a.webull.com/8XVdRBYwhQvK8aSXwM to open up a new account. Then refer 3 friends to do the same. And you will receive a free share of Apple. Estimated worth $160. With the chance to earn up to 10 free shares. Estimated worth of $1600.","reviewedAt":null,"reviewerId":null,"risk":null,"status":"approved","tags":[],"tickerProps":{"symbol":"CRON"},"tickers":"CRON","tips":[],"trader":{"benzingaUID":561917,"createdAt":"2021-10-13 14:12 UTC","id":1564,"name":"Long2630565246","numTrades":333,"profilePicture":"https://secure.gravatar.com/avatar/16d0f95817d3cae043b2fd750968cbfb","status":null,"tradeIdeas":null,"updatedAt":"2022-04-30 03:05 UTC","verified":1},"traderId":1564,"updatedAt":"2021-12-01 13:43 UTC","upvotes":0},{"action":null,"allocation":null,"avatarProps":{"id":1604,"name":"mikidobry569050","photo":"https://secure.gravatar.com/avatar/5138d1fca383193d51ec1dae525faa01"},"comments":[],"companyName":null,"contributor":null,"contributorId":565643,"createdAt":"2021-10-15 22:44 UTC","downvotes":0,"duration":null,"durationText":null,"financialAssetPositionProps":{"direction":"LONG"},"id":12031,"modelId":23383808,"modelType":"App\\Node","multiplier":0,"node":{"author":"Natan Ponieman","authorId":156617,"channels":["Cannabis","News","Penny Stocks","Small Cap","Events","Top Stories","Markets"],"created":"2021-10-14T21:04:53.000000Z","id":23383808,"tags":["Tom Zuber","zuber lawler"],"teaser":"\u003cp\u003eIn a mature cannabis landscape, mergers and acquisitions are a key instrument for building out an expansion strategy.\u003c/p\u003e","thumbnail":"https://cdn.benzinga.com/files/images/story/2012/screenshot_2021-10-14_161328.jpg","title":"How Cannabis M\u0026A Is Driving Growth For Jushi, Lowell Farms, The Parent Company","updated":"2021-10-14T21:04:53.000000Z"},"numComments":null,"numZing":null,"position":"LONG","price":0,"reason":"I dont have but watch in... Its new legal industrie and start grow up cannabis show us huge potential in medicine","reviewedAt":null,"reviewerId":null,"risk":null,"status":"approved","tags":[],"tickerProps":{"symbol":"GRAMF"},"tickers":"GRAMF","tips":[],"trader":{"benzingaUID":565643,"createdAt":"2021-10-15 21:02 UTC","id":1604,"name":"mikidobry569050","numTrades":116,"profilePicture":"https://secure.gravatar.com/avatar/5138d1fca383193d51ec1dae525faa01","status":null,"tradeIdeas":null,"updatedAt":"2022-04-30 03:05 UTC","verified":1},"traderId":1604,"updatedAt":"2021-10-15 22:44 UTC","upvotes":0},{"action":null,"allocation":null,"avatarProps":{"id":1135,"name":"garrettgradin520160","photo":"https://secure.gravatar.com/avatar/eefec05ff4a342ae4cdf79264ca90c95"},"comments":[],"companyName":"Innovative Ind Props","contributor":null,"contributorId":517464,"createdAt":"2021-09-26 00:04 UTC","downvotes":0,"duration":null,"durationText":null,"financialAssetPositionProps":{"direction":"LONG"},"id":9798,"modelId":23102189,"modelType":"App\\Node","multiplier":0,"node":{"author":"Henry Khederian","authorId":161885,"channels":["Education","General"],"created":"2021-09-25T21:00:25.000000Z","id":23102189,"tags":null,"teaser":"\u003cp\u003eInvestors who\u0026nbsp;added \u003cstrong\u003eInnovative\u003c/strong\u003e \u003cstrong\u003eIndustrial Properties Inc\u003c/strong\u003e (NYSE: \u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/iipr#NYSE\"\u003eIIPR\u003c/a\u003e) to their portfolio one year ago are living the high life.\u003c/p\u003e","thumbnail":"https://cdn.benzinga.com/files/images/story/2012/seedling-1062908_1.jpg","title":"This Cannabis Stock Has A Better 1-Year Return Than Tesla, Nio, GM, Apple, Disney And Microsoft","updated":"2021-09-25T21:00:26.000000Z"},"numComments":null,"numZing":25,"position":"LONG","price":0,"reason":"Seems like a solid inestment. Right now corporate cannabis is taking over. Small cannabis business going extinct","reviewedAt":null,"reviewerId":null,"risk":null,"status":"approved","tags":[],"tickerProps":{"symbol":"IIPR"},"tickers":"IIPR","tips":[],"trader":{"benzingaUID":517464,"createdAt":"2021-09-12 18:11 UTC","id":1135,"name":"garrettgradin520160","numTrades":17,"profilePicture":"https://secure.gravatar.com/avatar/eefec05ff4a342ae4cdf79264ca90c95","status":null,"tradeIdeas":null,"updatedAt":"2022-04-30 02:57 UTC","verified":1},"traderId":1135,"updatedAt":"2022-01-30 16:14 UTC","upvotes":0}],"url":"","headerProps":{"marketTickers":["SMG","TLRY","IIPR","CGC","ACB","SNDL","GTBIF","TCNNF","MJ","GNLN"],"quotes":{"SMG":{"symbol":"SMG","dxSymbol":"SMG","exchange":"XNYS","isoExchange":"XNYS","bzExchange":"NYSE","otcMarket":"","otcTier":"","type":"STOCK","name":"Scotts Miracle Gro","companyStandardName":"The Scotts Miracle Gro Co","description":"Scotts Miracle-Gro Company (The) Common Stock","sector":"Materials","industry":"Chemicals","open":79.28,"high":80,"low":77.42,"close":77.8,"bidPrice":77.22,"askPrice":78.49,"askSize":1,"bidSize":1,"size":0,"bidTime":1732665977000,"askTime":1732664960000,"lastTradePrice":77.8,"lastTradeTime":1732657156508,"volume":1075635,"change":-3.93,"changePercent":-4.81,"previousClosePrice":81.73,"previousCloseDate":"2024-11-25T16:00:00.000-05:00","fiftyDayAveragePrice":82.37,"hundredDayAveragePrice":75.74,"twoHundredDayAveragePrice":71.39,"averageVolume":753886,"fiftyTwoWeekHigh":93.9,"fiftyTwoWeekLow":53.43,"marketCap":4420681580,"sharesOutstanding":56821100,"sharesFloat":42523579,"forwardPE":27.1739,"dividendYield":3.23,"dividend":2.64,"ethPrice":77.8,"ethVolume":16440,"ethTime":1732657156508,"currency":"USD","issuerName":"Scotts Miracle-Gro Company","primary":true,"shortDescription":"Ordinary Shares - Class A","issuerShortName":"Scotts Miracle Gro"},"TLRY":{"symbol":"TLRY","dxSymbol":"TLRY","exchange":"XNAS","isoExchange":"XNAS","bzExchange":"NASDAQ","otcMarket":"","otcTier":"","type":"STOCK","name":"Tilray Brands","companyStandardName":"Tilray Brands Inc","description":"Tilray Brands, Inc. - Common Stock","sector":"Health Care","industry":"Pharmaceuticals","open":1.41,"high":1.42,"low":1.35,"close":1.36,"bidPrice":1.35,"askPrice":1.36,"askSize":5723,"bidSize":862,"size":116819,"bidTime":1732665999000,"askTime":1732665388000,"lastTradePrice":1.36,"lastTradeTime":1732665868205,"volume":21433039,"change":-0.06,"changePercent":-4.23,"previousClosePrice":1.42,"previousCloseDate":"2024-11-25T16:00:00.000-05:00","fiftyDayAveragePrice":1.6,"hundredDayAveragePrice":1.71,"twoHundredDayAveragePrice":1.8,"averageVolume":25570107,"fiftyTwoWeekHigh":2.97,"fiftyTwoWeekLow":1.28,"marketCap":1228469309,"sharesOutstanding":903286257,"sharesFloat":897251749,"ethPrice":1.36,"ethVolume":326680,"ethTime":1732665868205,"currency":"USD","issuerName":"Tilray Brands Inc","primary":true,"shortDescription":"Ordinary Shares","issuerShortName":"Tilray Brands"},"IIPR":{"symbol":"IIPR","dxSymbol":"IIPR","exchange":"XNYS","isoExchange":"XNYS","bzExchange":"NYSE","otcMarket":"","otcTier":"","type":"STOCK","name":"Innovative Ind Props","companyStandardName":"Innovative Industrial Properties Inc","description":"Innovative Industrial Properties, Inc. Common Stock","sector":"Real Estate","industry":"Industrial REITs","open":111.49,"high":112.165,"low":108.92,"close":109.15,"bidPrice":109.1,"askPrice":109.88,"askSize":99,"bidSize":4,"size":0,"bidTime":1732666017000,"askTime":1732664962000,"lastTradePrice":109.15,"lastTradeTime":1732665600002,"volume":292043,"change":-2.65,"changePercent":-2.37,"previousClosePrice":111.8,"previousCloseDate":"2024-11-25T16:00:00.000-05:00","fiftyDayAveragePrice":125.52,"hundredDayAveragePrice":122.78,"twoHundredDayAveragePrice":112.55,"averageVolume":200067,"fiftyTwoWeekHigh":138.35,"fiftyTwoWeekLow":78.1,"marketCap":3092419571,"sharesOutstanding":28331833,"sharesFloat":18442316,"pe":19.928699,"forwardPE":19.3798,"dividendYield":6.8,"dividend":7.6,"payoutRatio":132.62,"ethPrice":109.1,"ethVolume":6267,"ethTime":1732663816888,"currency":"USD","issuerName":"Innovative Industrial Properties Inc","primary":true,"shortDescription":"Ordinary Shares","issuerShortName":"Innovative Ind Props"},"CGC":{"symbol":"CGC","dxSymbol":"CGC","exchange":"XNAS","isoExchange":"XNAS","bzExchange":"NASDAQ","otcMarket":"","otcTier":"","type":"STOCK","name":"Canopy Gwth","companyStandardName":"Canopy Growth Corp","description":"Canopy Growth Corporation - Common Shares","open":4.05,"high":4.1,"low":3.92,"close":3.94,"bidPrice":3.93,"askPrice":3.94,"askSize":7,"bidSize":60,"size":193518,"bidTime":1732665381000,"askTime":1732663183000,"lastTradePrice":3.93,"lastTradeTime":1732663895093,"volume":5066479,"change":-0.22,"changePercent":-5.3,"previousClosePrice":4.15,"previousCloseDate":"2024-11-25T16:00:00.000-05:00","fiftyDayAveragePrice":4.45,"hundredDayAveragePrice":5.38,"twoHundredDayAveragePrice":6.2,"averageVolume":5088495,"fiftyTwoWeekHigh":14.92,"fiftyTwoWeekLow":2.755,"marketCap":414065680,"sharesOutstanding":105360224,"sharesFloat":77988938,"ethPrice":3.93,"ethVolume":74386,"ethTime":1732663895093,"currency":"USD","primary":false,"issuerShortName":"Canopy Gwth"},"ACB":{"symbol":"ACB","dxSymbol":"ACB","exchange":"XNAS","isoExchange":"XNAS","bzExchange":"NASDAQ","otcMarket":"","otcTier":"","type":"STOCK","name":"Aurora Cannabis","companyStandardName":"Aurora Cannabis Inc","description":"Aurora Cannabis Inc. - Common Shares","open":4.58,"high":4.59,"low":4.39,"close":4.41,"bidPrice":4.4,"askPrice":4.47,"askSize":5,"bidSize":23,"size":10638,"bidTime":1732665315000,"askTime":1732665315000,"lastTradePrice":4.47,"lastTradeTime":1732664334580,"volume":1532269,"change":-0.1,"changePercent":-2.19,"previousClosePrice":4.57,"previousCloseDate":"2024-11-25T16:00:00.000-05:00","fiftyDayAveragePrice":5.35,"hundredDayAveragePrice":5.7,"twoHundredDayAveragePrice":5.52,"averageVolume":971802,"fiftyTwoWeekHigh":9.35,"fiftyTwoWeekLow":2.84,"marketCap":245300905,"sharesOutstanding":54877160,"ethPrice":4.47,"ethVolume":35100,"ethTime":1732664334580,"currency":"USD","primary":false,"issuerShortName":"Aurora Cannabis"},"SNDL":{"symbol":"SNDL","dxSymbol":"SNDL","exchange":"XNAS","isoExchange":"XNAS","bzExchange":"NASDAQ","otcMarket":"","otcTier":"","type":"STOCK","name":"SNDL","companyStandardName":"SNDL Inc","description":"SNDL Inc. - Common Shares","sector":"Health Care","industry":"Pharmaceuticals","open":2.01,"high":2.025,"low":1.95,"close":1.96,"bidPrice":1.96,"askPrice":1.97,"askSize":2,"bidSize":60,"size":16578,"bidTime":1732666019000,"askTime":1732665372000,"lastTradePrice":1.97,"lastTradeTime":1732665486237,"volume":2002337,"change":-0.05,"changePercent":-2.48,"previousClosePrice":2.02,"previousCloseDate":"2024-11-25T16:00:00.000-05:00","fiftyDayAveragePrice":2.04,"hundredDayAveragePrice":2.07,"twoHundredDayAveragePrice":1.99,"averageVolume":2009340,"fiftyTwoWeekHigh":2.93,"fiftyTwoWeekLow":1.3,"marketCap":523153962,"sharesOutstanding":265560387,"sharesFloat":265560387,"forwardPE":31.25,"ethPrice":1.97,"ethVolume":25888,"ethTime":1732665486237,"currency":"USD","issuerName":"SNDL Inc","primary":true,"shortDescription":"Ordinary Shares","issuerShortName":"SNDL"},"GTBIF":{"symbol":"GTBIF","dxSymbol":"GTBIF","exchange":"OOTC","isoExchange":"OOTC","bzExchange":"OTC","otcMarket":"OP","otcTier":"QX","type":"STOCK","name":"Green Thumb Industries","companyStandardName":"Green Thumb Industries Inc","description":"GREEN THUMB INDUS SUB VTG by Green Thumb Industries Inc.","open":8.57,"high":9.47,"low":8.57,"close":9.34,"bidPrice":9.27,"askPrice":9.38,"askSize":0,"bidSize":0,"size":100,"bidTime":1732658402000,"askTime":1732658402000,"lastTradePrice":9.34,"lastTradeTime":1732654740769,"volume":462756,"change":0.33,"changePercent":3.66,"previousClosePrice":9.01,"previousCloseDate":"2024-11-25T16:00:00.000-05:00","fiftyDayAveragePrice":10.08,"hundredDayAveragePrice":10.47,"twoHundredDayAveragePrice":11.58,"averageVolume":403187,"fiftyTwoWeekHigh":16.33,"fiftyTwoWeekLow":7.5,"marketCap":2208673641,"sharesOutstanding":236474694,"sharesFloat":207267256,"pe":33.37037,"forwardPE":17.1233,"currency":"USD","primary":false,"issuerShortName":"Green Thumb Industries"},"TCNNF":{"symbol":"TCNNF","dxSymbol":"TCNNF","exchange":"OOTC","isoExchange":"OOTC","bzExchange":"OTC","otcMarket":"OP","otcTier":"QX","type":"STOCK","name":"Trulieve Cannabis","companyStandardName":"Trulieve Cannabis Corp","description":"TRULIEVE CANNABIS CORP by Trulieve Cannabis Corporation","open":6,"high":6.18,"low":5.75,"close":5.92,"bidPrice":5.71,"askPrice":6.04,"askSize":0,"bidSize":0,"size":200,"bidTime":1732658402000,"askTime":1732658402000,"lastTradePrice":5.92,"lastTradeTime":1732654792629,"volume":597196,"change":-0.15,"changePercent":-2.47,"previousClosePrice":6.07,"previousCloseDate":"2024-11-25T16:00:00.000-05:00","fiftyDayAveragePrice":10.51,"hundredDayAveragePrice":10.22,"twoHundredDayAveragePrice":10.36,"averageVolume":551414,"fiftyTwoWeekHigh":14.5,"fiftyTwoWeekLow":4.75,"marketCap":1120008292,"sharesOutstanding":189190590,"sharesFloat":159756764,"currency":"USD","primary":false,"issuerShortName":"Trulieve Cannabis"},"MJ":{"symbol":"MJ","dxSymbol":"MJ","exchange":"ARCX","isoExchange":"ARCX","bzExchange":"ARCA","otcMarket":"","otcTier":"","type":"ETF","name":"Amplify ETF Trust Amplify Alternative Harvest ETF","companyStandardName":"Amplify ETF Trust Amplify Alternative Harvest ETF","description":"Amplify ETF Trust Amplify Alternative Harvest ETF","open":2.62,"high":2.64,"low":2.55,"close":2.6,"bidPrice":2.5,"askPrice":2.82,"askSize":100,"bidSize":2,"size":0,"bidTime":1732665307000,"askTime":1732661594000,"lastTradePrice":2.6,"lastTradeTime":1732657381848,"volume":1157868,"change":-0.01,"changePercent":-0.38,"previousClosePrice":2.61,"previousCloseDate":"2024-11-25T16:00:00.000-05:00","fiftyDayAveragePrice":3.09,"hundredDayAveragePrice":3.25,"twoHundredDayAveragePrice":3.5,"averageVolume":935950,"fiftyTwoWeekHigh":4.83,"fiftyTwoWeekLow":2.46,"ethPrice":2.6,"ethVolume":5999,"ethTime":1732657381848,"currency":"USD","issuerName":"Amplify ETF Trust","primary":false,"shortDescription":"Amplify Alternative Harvest ETF"},"GNLN":{"symbol":"GNLN","dxSymbol":"GNLN","exchange":"XNAS","isoExchange":"XNAS","bzExchange":"NASDAQ","otcMarket":"","otcTier":"","type":"STOCK","name":"Greenlane Hldgs","companyStandardName":"Greenlane Holdings Inc","description":"Greenlane Holdings, Inc. - Class A Common Stock","sector":"Consumer Discretionary","industry":"Distributors","open":1.89,"high":1.924,"low":1.7607,"close":1.83,"bidPrice":1.82,"askPrice":1.85,"askSize":2,"bidSize":4,"size":1639,"bidTime":1732663449000,"askTime":1732661940000,"lastTradePrice":1.76,"lastTradeTime":1732658127202,"volume":47460,"change":-0.13,"changePercent":-6.88,"previousClosePrice":1.89,"previousCloseDate":"2024-11-25T16:00:00.000-05:00","fiftyDayAveragePrice":3.62,"hundredDayAveragePrice":4.35,"twoHundredDayAveragePrice":4.97,"averageVolume":1278635,"fiftyTwoWeekHigh":21.8,"fiftyTwoWeekLow":1.7,"marketCap":2354028,"sharesOutstanding":1337516,"sharesFloat":1337516,"ethPrice":1.76,"ethVolume":4730,"ethTime":1732658127202,"currency":"USD","issuerName":"Greenlane Holdings Inc","primary":true,"shortDescription":"Ordinary Shares - Class A","issuerShortName":"Greenlane Hldgs"}}},"metaProps":{"author":"Benzinga","dateCreated":"2023-03-10T09:19:44.000000Z","description":"The latest cannabis news on Benzinga Cannabis. 30+ daily articles on cannabis stocks + hemp, CBD \u0026 psychedelics finance, business, politics and culture.","dimensions":{"authorName":"Benzinga","contentType":"channel"},"image":null,"pageType":"channel","title":"Cannabis News - Benzinga Cannabis"}},"__N_SSP":true},"page":"/cannabis","query":{},"buildId":"WM8kbeRE-wCNojMmjQ6we","isFallback":false,"isExperimentalCompile":false,"gssp":true,"scriptLoader":[]}</script></body></html>